Citrus Sinensis ID: 003786
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 795 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.963 | 0.978 | 0.465 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.923 | 0.863 | 0.462 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.969 | 0.910 | 0.443 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.927 | 0.884 | 0.450 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.925 | 0.866 | 0.446 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.952 | 0.897 | 0.438 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.927 | 0.872 | 0.428 | 1e-178 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.945 | 0.877 | 0.427 | 1e-175 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.955 | 0.902 | 0.418 | 1e-172 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.916 | 0.894 | 0.441 | 1e-171 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 691 bits (1783), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/812 (46%), Positives = 519/812 (63%), Gaps = 46/812 (5%)
Query: 1 MENLHLLYNFISCVFILSIKLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYR 60
ME ++L+ I +F +I L+ A D + ++ ++DG+ +VS FE+GFFSPG S+ R
Sbjct: 1 MEATNVLHLLIISLFS-TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNR 59
Query: 61 YLGIWYKQIP-DTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSR---- 115
YLGIWYK+I T+VWVANR+SP++D + L +S G L L N N IWSS+ S
Sbjct: 60 YLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQK 119
Query: 116 -EVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQ 174
++NP+ Q+LDTGNLVVR+ S +DY+WQS D+P D L GMK G + TGL R+
Sbjct: 120 ASLRNPIVQILDTGNLVVRN---SGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 175 TSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSY--SYLYKP 232
TSW++ DDPS GNYT+++D + +P+ SV + +GPWNG F +P+ + +Y+
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 233 TVVDNEDEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGH 292
V E+E+YY Y N V+ ++LNP+G +Q W + ++W + S C Y
Sbjct: 237 EYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTL 296
Query: 293 CGANSICSFDKKPHCECLKGFELKSHHNKTR---PGTCVRSQSSDCKSG-DRFIMLDDVK 348
CG+ C+ ++ P C CLKGF K+ CVR DC G D F+ + +K
Sbjct: 297 CGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLK 356
Query: 349 LPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRN 408
LPD + +++M++ EC+ CL+NCTC AY+ + G GC++WFGDLIDIR+ ++
Sbjct: 357 LPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNE-- 414
Query: 409 NGQSIYIRVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSLA 468
NGQ +Y+R+ +SE+ET + + + +++R E D P L
Sbjct: 415 NGQDLYVRLASSEIETLQRE-------SSRVSSRKQE-----------EEDLELPFLDLD 456
Query: 469 SVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL 528
+VS AT+ FS NKLG+GGFGPVYKG L GQEVAVKRLS S QG EEFKNEIKLIAKL
Sbjct: 457 TVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKL 516
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
QHRNLV++LG C++ EE++LIYEY PNKSLD F+FD + L W RV II+GIA+G+L
Sbjct: 517 QHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGML 576
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
YLH+ SRLR+IHRDLKASN+LLD DMN KISDFG+AR GGDE ++ T R+VGTYGYMSP
Sbjct: 577 YLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSP 636
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TNSLTLLGHAWDLWKDDRAWELID 707
EY G FS+KSDVFSFGVL+LE +S +RN F N + L LLGHAW + +D+A+E+ID
Sbjct: 637 EYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIID 696
Query: 708 PTLQNEASYLI--LNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSI 765
+ NE+ I + R I++GLLCVQ+D DRP M VV ++ + + L PRQP F +
Sbjct: 697 EAV-NESCTDISEVLRVIHIGLLCVQQDPKDRPNM-SVVVLMLSSEMLLLDPRQPGFFNE 754
Query: 766 RGL--KNTILPANGKARVCSGNCLTLSEMDAR 795
R L +T+ + + S N T+S +D R
Sbjct: 755 RNLLFSDTV---SINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 664 bits (1714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/797 (46%), Positives = 493/797 (61%), Gaps = 63/797 (7%)
Query: 22 SIAADNITPSR--FIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPD-TIVWVAN 78
SI+A+ ++ S I +VS FELGFF PG YLGIWYK I T VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSR-EVKNP-VAQLLDTGNLVVRDNF 136
R++P+ S L IS+ LV+L+Q++ +WS+NL+ +V++P VA+LLD GN V+RD
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-- 142
Query: 137 SSNSSED-YLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIH 195
S NS+ D LWQSFD P+DTLL MKLGWD KTG R+ SWKS DDPS G+++ +L+
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 196 VLPKLCTYNGSVKLLCSGPWNGAIFAAIPS---YSYLYKPTVVDNEDEIYYRYDSYNSPV 252
P++ +N ++ SGPWNG F+ +P + Y+ +++E+ Y + S V
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVF-NFTTSKEEVTYSFRITKSDV 261
Query: 253 IMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKKPHCECLKG 312
L ++ SG +Q W E + W F+ P C Y CG C + P C C+KG
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321
Query: 313 FELKSHHN-KTRPGT--CVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAE 369
F+ ++ R G+ CVR C GD F+ L +KLPD AS++ + VKECE +
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381
Query: 370 CLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELETKKSQD 429
CL++C C A+AN+ + G GSGC+ W G+L DIR GQ +Y+R+ A++LE K+++
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNY--AKGGQDLYVRLAATDLEDKRNRS 439
Query: 430 --------------MLQFDI----------NMSIAT-------RANELCKGNKAANSR-- 456
+L F I ++ I T R+ +L +SR
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRH 499
Query: 457 ------TRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ 510
T D P+ V+ AT NFS NKLG+GGFG VYKG+LL+GQE+AVKRLS
Sbjct: 500 ISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKT 559
Query: 511 SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL 570
S QG +EFKNE+KLIA+LQH NLVRLL CC++ EK+LIYEY+ N SLD LFD ++ +
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619
Query: 571 LGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630
L W R II GIA+GLLYLHQ SR R+IHRDLKASNILLDK M PKISDFGMARIFG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTL 689
E ++ T+++VGTYGYMSPEYA G+FS+KSDVFSFGVLLLE +SSKRN F N++ L L
Sbjct: 680 ETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNL 739
Query: 690 LGHAWDLWKDDRAWELIDPTLQNEAS----YLILNRYINVGLLCVQEDAADRPTMFEVVS 745
LG W WK+ + E+IDP + + +S + IL R I +GLLCVQE A DRPTM V+
Sbjct: 740 LGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMSLVIL 798
Query: 746 MLTNKTINLPHPRQPAF 762
ML +++ +P P+ P +
Sbjct: 799 MLGSESTTIPQPKAPGY 815
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 662 bits (1709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/829 (44%), Positives = 501/829 (60%), Gaps = 58/829 (6%)
Query: 21 LSIAADNI--TPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIP-DTIVWVA 77
S+ A N T S I + ++S SQ FELGFF+P S YLGIWYK IP T VWVA
Sbjct: 23 FSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVA 82
Query: 78 NRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSR-EVKNPVA-QLLDTGNLVVRDN 135
NR++P+ SN L IS+ LV+ +Q++ +WS+N++ +V++PVA +LLD GN V+RD+
Sbjct: 83 NRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDS 141
Query: 136 FSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTG-LERYQTSWKSDDDPSPGNYTHRLDI 194
+N +LWQSFD P+DTLL+ MK+GWD K+G R SWK+ DDPS G+++ +L
Sbjct: 142 -KNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRT 200
Query: 195 HVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSYSYL--YKPTVVDNEDEIYYRYDSYNSPV 252
P+ YN SGPW G F+++P + + +N ++ Y Y + +
Sbjct: 201 SGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNI 260
Query: 253 IMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKKPHCECLKG 312
L L+ +G +Q L W E ++W+ + P C Y CG C + P C C+KG
Sbjct: 261 YSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKG 320
Query: 313 FELKSHHNKTRPGT--CVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAEC 370
FE + R + CVR C D F+ L ++LPD E S+++ + +KECE C
Sbjct: 321 FEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERC 380
Query: 371 LKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELETK--KSQ 428
LK C C A+AN+ + GSGC++W G L DIR GQ +Y+RV A +LE K KS+
Sbjct: 381 LKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNY--AKGGQDLYVRVAAGDLEDKRIKSK 438
Query: 429 DMLQFDINMSIA---------------------------------TRANELCKGNKAANS 455
++ I +SI + NEL K +++ S
Sbjct: 439 KIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTS 498
Query: 456 RTRDSWF---PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 512
+ + + P+ +++ AT NFST+NKLG+GGFG VYKG LL+G+E+AVKRLS S
Sbjct: 499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558
Query: 513 QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLG 572
QG +EF NE++LIAKLQH NLVRLLGCC++ EK+LIYEY+ N SLD LFD T+ + L
Sbjct: 559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618
Query: 573 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632
W R II GIA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMARIFG +E
Sbjct: 619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLG 691
++ T+R+VGTYGYMSPEYA G+FS+KSDVFSFGVLLLE +S KRN F N+N L LLG
Sbjct: 679 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 738
Query: 692 HAWDLWKDDRAWELIDP----TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
W WK+ + E++DP L +E + R I +GLLCVQE A DRP M V+ ML
Sbjct: 739 FVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVML 798
Query: 748 TNKTINLPHPRQPAFSSIR-GLKNTILPANGKARVCSGNCLTLSEMDAR 795
++T +P P++P F R L+ + + C+ N +TLS +DAR
Sbjct: 799 GSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/795 (45%), Positives = 487/795 (61%), Gaps = 58/795 (7%)
Query: 23 IAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPD-TIVWVANRNS 81
I+ D I + +RDGE ++S+ +RF GFFS G S+ RY+GIWY QI TIVWVANR+
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PIFDSNAVLTISNGGKLVLLNQTNGT--IWSSNLSREVKNP--VAQLLDTGNLVVRDNFS 137
PI D++ ++ SN G L + N T IWS+N+S + P VA L D GNLV+ D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 SNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVL 197
S W+SFDHP+DT L M+LG+ K GL+R TSWKS DP G+ R++
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 198 PKLCTYNGSVKLLCSGPWNGAIFAAIPSY--SYLYKPTVVDNEDEIYYRYDSYNSPVIMT 255
P+L Y G G W G ++ +P Y++ + V+NEDE+ + Y ++ VI
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 256 LKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSF--DKKPHCECLKGF 313
+N +G + W R++ W F+S+P C Y HCG N C K C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 314 ELKSHHN---KTRPGTCVRSQ-SSDCKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAE 369
E K + + G C + + +S C D F+ L +K+PD +AS++ ++ +KEC+
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 370 CLKNCTCRAYANS-KVTGEGS-GCLMWFGDLIDIRKADDRNNGQSIYIRVPASELET--- 424
CLKNC+C AYA++ + G+ GCL W G ++D R N+GQ YIRV EL
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTY--LNSGQDFYIRVDKEELARWNR 430
Query: 425 ---KKSQDMLQFDINMSIATR---------ANELCKGNKAANS----------------- 455
+ +L I++ A E K N+ +S
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRF 490
Query: 456 ---RTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 512
+ R+ P+F L ++ AAT NFS++NKLG GGFGPVYKG L N E+AVKRLS SG
Sbjct: 491 EQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSG 550
Query: 513 QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLG 572
QG EEFKNE+KLI+KLQHRNLVR+LGCC+ELEEK+L+YEY+PNKSLD+F+F + L
Sbjct: 551 QGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELD 610
Query: 573 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632
W R+ I+ GIA+G+LYLHQ SRLR+IHRDLKASNILLD +M PKISDFGMARIFGG+++
Sbjct: 611 WPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQM 670
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692
+ T R+VGT+GYM+PEYA +G FSIKSDV+SFGVL+LE ++ K+N+ F +S L+GH
Sbjct: 671 EGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHEESS-NLVGH 729
Query: 693 AWDLWKDDRAWELIDPTLQNEA-SYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751
WDLW++ A E+ID + E + + I +GLLCVQE+A+DR M VV ML +
Sbjct: 730 IWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNA 789
Query: 752 INLPHPRQPAFSSIR 766
NLP+P+ PAF+S R
Sbjct: 790 TNLPNPKHPAFTSAR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/815 (44%), Positives = 492/815 (60%), Gaps = 79/815 (9%)
Query: 22 SIAADNITPSRFIRDG---EKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPD-TIVWVA 77
S+AA+ I +RDG + LVS + FELGFFSPG S +R+LGIWY I D +VWVA
Sbjct: 23 SMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVA 82
Query: 78 NRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREV---KNPVAQLLDTGNLVVRD 134
NR +PI D + VL ISN G LVLL+ N T+WSSN+ N V + DTGN V+
Sbjct: 83 NRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVL-- 140
Query: 135 NFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDI 194
S ++ +W+SF+HP+DT L M++ + +TG SW+S+ DPSPGNY+ +D
Sbjct: 141 --SETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDP 198
Query: 195 HVLPKLCTYNGS-VKLLCSGPWNGAIFAAIPSYS----YLYKPTVVDNEDE---IYYRYD 246
P++ + G+ + SG WN AIF IP+ S YLY + DE +Y+ Y
Sbjct: 199 SGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYV 258
Query: 247 SYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFD-KKP 305
+ V++ K+ +G + L WNE + W F S PD C Y CG IC
Sbjct: 259 PSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNG 318
Query: 306 HCECLKGFELKSHHNKTRPGTCVRSQSSDCKSG-----DRFIMLDDVKLPDFVEASLNES 360
C C+ G+E S N +R C R C+ D F+ L VKLPDF E +
Sbjct: 319 ICSCIHGYEQVSVGNWSR--GCRRRTPLKCERNISVGEDEFLTLKSVKLPDF-EIPEHNL 375
Query: 361 MNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPAS 420
++ ++C CL+NC+C AY+ + G G GC++W DL+D+++ + G S++IR+ S
Sbjct: 376 VDPEDCRERCLRNCSCNAYS---LVG-GIGCMIWNQDLVDLQQFE--AGGSSLHIRLADS 429
Query: 421 EL-ETKKSQDMLQFDI------------------------------NMSIATRANELCKG 449
E+ E +K++ + + N + +L K
Sbjct: 430 EVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKS 489
Query: 450 NKAANS------------RTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLL 497
+ ++ S P+FSL +++ AT +F EN+LG GGFGPVYKG L
Sbjct: 490 KETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549
Query: 498 NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557
+G+E+AVKRLS +SGQG +EFKNEI LIAKLQHRNLVRLLGCC E EEK+L+YEYMPNKS
Sbjct: 550 DGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKS 609
Query: 558 LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617
LDFFLFD TK+ L+ W R IIEGIA+GLLYLH+ SRLR+IHRDLK SN+LLD +MNPK
Sbjct: 610 LDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPK 669
Query: 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677
ISDFGMARIFGG++ ++ T R+VGTYGYMSPEYA +GLFS+KSDV+SFGVLLLE +S KR
Sbjct: 670 ISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKR 729
Query: 678 NTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADR 737
NT ++ +L+G+AW L+ R+ EL+DP ++ S R I+V +LCVQ+ AA+R
Sbjct: 730 NTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAER 789
Query: 738 PTMFEVVSMLTNKTINLPHPRQPAFSSIRGLKNTI 772
P M V+ ML + T L PRQP F+S R +N+I
Sbjct: 790 PNMASVLLMLESDTATLAAPRQPTFTSTR--RNSI 822
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 637 bits (1642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/821 (43%), Positives = 495/821 (60%), Gaps = 64/821 (7%)
Query: 29 TPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIP-DTIVWVANRNSPIFDSN 87
T S I + ++S SQ FELGFF+P S YLGIWYK IP T VWVANR++P+ SN
Sbjct: 33 TESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSN 92
Query: 88 AVLTISNGGKLVLLNQTNGTIWSSNLSR-EVKNPVA-QLLDTGNLVVRDNFSSNSSEDYL 145
L IS G LV+ +Q++ +WS+N++ +V++PVA +LLD GN ++RD S+ L
Sbjct: 93 GTLKIS-GNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD-----SNNRLL 146
Query: 146 WQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNG 205
WQSFD P+DTLLA MKLGWD KTG R SWK+ DDPS G ++ +L+ P+ +
Sbjct: 147 WQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSK 206
Query: 206 SVKLLCSGPWNGAIFAAIP---SYSYL-YKPTVVDNEDEIYYRYDSYNSPVIMTLKLNPS 261
L SGPWNG F+++P Y+ Y T +++E+ Y Y + + L LN +
Sbjct: 207 ESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTA--SKEEVTYSYRINKTNLYSRLYLNSA 264
Query: 262 GKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKKPHCECLKGFE-LKSHHN 320
G +Q L W E ++W+ + P C Y CG C + P+C C+KGF+ +
Sbjct: 265 GLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAW 324
Query: 321 KTRPGT--CVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAECLKNCTCRA 378
R G+ C+R C D F L +KLPD ++ + +K C+ CL++C C A
Sbjct: 325 DLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTA 384
Query: 379 YANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELETK--KSQDMLQFDIN 436
+AN+ + GSGC++W +++D+R GQ +Y+R+ A+ELE K K++ ++ I
Sbjct: 385 FANADIRNGGSGCVIWTREILDMRNY--AKGGQDLYVRLAAAELEDKRIKNEKIIGSSIG 442
Query: 437 MSIA---------------------------------TRANELCKGNKAANSRTRDSWFP 463
+SI + N++ + S+ + S +
Sbjct: 443 VSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYL 502
Query: 464 MFSLASV---SAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKN 520
L + + AT NFS +NKLG+GGFG VYKGRLL+G+E+AVKRLS S QG +EF N
Sbjct: 503 ELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMN 562
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
E++LIAKLQH NLVRLLGCC++ EK+LIYEY+ N SLD LFD T+ + L W R II
Sbjct: 563 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 622
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIV 640
GIA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMARIFG +E ++ T+R+V
Sbjct: 623 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 682
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKD 699
GTYGYMSPEYA G+FS+KSDVFSFGVLLLE +S KRN F N+N L LLG W WK+
Sbjct: 683 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 742
Query: 700 DRAWELIDP----TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLP 755
E++DP +L ++ + R I +GLLCVQE A DRP M V+ ML ++T +P
Sbjct: 743 GNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 802
Query: 756 HPRQPAFSSIRG-LKNTILPANGKARVCSGNCLTLSEMDAR 795
P++P F R L+ + + C+ N +TLS +DAR
Sbjct: 803 QPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 344/803 (42%), Positives = 493/803 (61%), Gaps = 66/803 (8%)
Query: 22 SIAADN-ITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPD-TIVWVANR 79
S +DN I S+ ++DG+ + S +RF GFFS G SK RY+GIWY Q+ + TIVWVANR
Sbjct: 18 SCYSDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANR 77
Query: 80 NSPIFDSNAVLTISNGGKLVLLNQTNGT--IWSSNLSREVKNP--VAQLLDTGNLVVRDN 135
+ PI D++ ++ S G L + NGT IWS+++ ++ P VA+L D GNLV+ D
Sbjct: 78 DHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDP 137
Query: 136 FSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIH 195
+ S W+SF+HP++TLL MK G+ ++G++R TSW+S DP GN T+R++
Sbjct: 138 VTGKS----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERR 193
Query: 196 VLPKLCTYNGSVKLLCSGPWNGAIFAAIPSYS--YLYKPTVVDNEDEIYYRYDSYNSPVI 253
P++ Y G +G W G ++ +P + +++ + V+N DE+ Y ++ V
Sbjct: 194 GFPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVT 253
Query: 254 MTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSIC--SFDKKPHCECLK 311
+ LN +G +Q WN R++ W F+S P+ C Y HCG N C + +K C CL
Sbjct: 254 TRMVLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLP 313
Query: 312 GFELKSHHN---KTRPGTCVRSQS-SDCKSGDRFIMLDDVKLPDFVEASLNESMNVKECE 367
G+E K+ + + C R ++ S C + F L VK+P+ +++ ++ +KECE
Sbjct: 314 GYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECE 373
Query: 368 AECLKNCTCRAYANSKVTGE--GSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASEL--- 422
CLKNC+C AYA++ + GCL W G+++D R ++GQ Y+RV SEL
Sbjct: 374 QRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTY--LSSGQDFYLRVDKSELARW 431
Query: 423 -----ETKKSQDMLQFDINMSIA----------------TRANELCKGNKA--------- 452
KK ++ + + T++N L K +
Sbjct: 432 NGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLE 491
Query: 453 -------ANSRTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVK 505
++R P+F L++++ AT NF+ +NKLG GGFGPVYKG L NG E+AVK
Sbjct: 492 DSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVK 551
Query: 506 RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS 565
RLS SGQG EEFKNE+KLI+KLQHRNLVR+LGCC+E EEK+L+YEY+PNKSLD+F+F
Sbjct: 552 RLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHE 611
Query: 566 TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
+ L W R+ II GI +G+LYLHQ SRLR+IHRDLKASN+LLD +M PKI+DFG+AR
Sbjct: 612 EQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLAR 671
Query: 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN 685
IFGG++++ T R+VGTYGYMSPEYA G FSIKSDV+SFGVL+LE ++ KRN+ F
Sbjct: 672 IFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYE-E 730
Query: 686 SLTLLGHAWDLWKDDRAWELIDPTLQNEASY--LILNRYINVGLLCVQEDAADRPTMFEV 743
SL L+ H WD W++ A E+ID L E +Y + + +++GLLCVQE+++DRP M V
Sbjct: 731 SLNLVKHIWDRWENGEAIEIID-KLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSV 789
Query: 744 VSMLTNKTINLPHPRQPAFSSIR 766
V ML + I+LP P+ PAF++ R
Sbjct: 790 VFMLGHNAIDLPSPKHPAFTAGR 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 615 bits (1587), Expect = e-175, Method: Compositional matrix adjust.
Identities = 350/819 (42%), Positives = 487/819 (59%), Gaps = 67/819 (8%)
Query: 5 HLLYNFISCVFILSI----KLSIAADNI--TPSRFIRDGEKLVSSSQRFELGFFSPGKSK 58
H Y VF++ I LSI + + T S I + LVS FE+GFF S+
Sbjct: 9 HHSYMSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTN-SR 67
Query: 59 YRYLGIWYKQIPD-TIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSR-- 115
+ YLG+WYK++ D T VWVANR++P+ ++ L IS G LVLL+ +N +W +NL+R
Sbjct: 68 W-YLGMWYKKVSDRTYVWVANRDNPLSNAIGTLKIS-GNNLVLLDHSNKPVWWTNLTRGN 125
Query: 116 EVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQT 175
E VA+LL GN V+RD+ S+N + +YLWQSFD+P+DTLL MKLG++LKTGL R+ T
Sbjct: 126 ERSPVVAELLANGNFVMRDS-SNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLT 184
Query: 176 SWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPS---YSYLYKP 232
SW+S DDPS GN++++L+ LP+ + + SGPWNG F+ IP SY+
Sbjct: 185 SWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVY- 243
Query: 233 TVVDNEDEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLP-DRFCQFYG 291
++N +E+ Y + N+ L L G Q L W R W F+S P D C Y
Sbjct: 244 NFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYI 303
Query: 292 HCGANSICSFDKKPHCECLKGFE---LKSHHNKTRPGTCVRSQSSDCKSGDRFIMLDDVK 348
CG + C + P C C++GF ++ + G C+R C SGD F + +K
Sbjct: 304 MCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMK 362
Query: 349 LPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRK-ADDR 407
LP+ A+++ S+ VKEC+ C+ +C C A+AN+ + GSGC++W L DIR A D
Sbjct: 363 LPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDA 422
Query: 408 NNGQSIYIRVPASELETKK--SQDMLQFDINMSIA------------------------- 440
+GQ +Y+R+ A+++ K+ S ++ + +S+
Sbjct: 423 IDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIAN 482
Query: 441 TRANELCKGNKAANSRTRDS---------WFPMFSLASVSAATANFSTENKLGEGGFGPV 491
T+ N+ N+ S R+ P+ + +V AT NFS+ NKLG+GGFG V
Sbjct: 483 TQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIV 542
Query: 492 YKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551
YKGRLL+G+E+AVKRLS S QG +EF NE+ LIA+LQH NLV++LGCCIE +EK+LIYE
Sbjct: 543 YKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYE 602
Query: 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611
Y+ N SLD +LF T+ + L W R I G+A+GLLYLHQ SR R+IHRDLK SNILLD
Sbjct: 603 YLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLD 662
Query: 612 KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
K+M PKISDFGMARIF DE ++ T ++VGTYGYMSPEYA G+FS KSDVFSFGV++LE
Sbjct: 663 KNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLE 722
Query: 672 TLSSKRNTDFSNTNSLT-LLGHAWDLWKDDRAWELIDPTLQNEASYLI-------LNRYI 723
+S K+N F N + LL + W WK+ RA E++DP + + S + + I
Sbjct: 723 IVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCI 782
Query: 724 NVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAF 762
+GLLCVQE A RP M VV M ++ +P P+ P +
Sbjct: 783 QIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGY 821
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 605 bits (1561), Expect = e-172, Method: Compositional matrix adjust.
Identities = 346/827 (41%), Positives = 470/827 (56%), Gaps = 67/827 (8%)
Query: 24 AADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQI-PDTIVWVANRNSP 82
+++ T + IR+G+ L+S + FELGFF+P S RY+GIWYK I P T+VWVANR P
Sbjct: 28 TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKP 87
Query: 83 IFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSE 142
+ D L I++ G LV++N N TIWS+N+ E N VA L TG+LV+ S +
Sbjct: 88 LLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVL---CSDSDRR 144
Query: 143 DYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCT 202
+ W+SF++P+DT L GM++ + G R WKS+ DPSPG Y+ +D ++
Sbjct: 145 KWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVI 204
Query: 203 YNGSVKLLCSGPWNGAIFAAIP------SYSYLYK-PTVVDNEDEIYYRYDSYNSPVIMT 255
+ G + SGPWN AIF IP +Y Y +K + D + +Y+ Y + +S +
Sbjct: 205 WEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLR 264
Query: 256 LKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKK---PHCECLKG 312
+ P G + WN+ R W P C+ Y CG S+C K+ C C+ G
Sbjct: 265 FWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDG 324
Query: 313 FELKSH---HNKTRPGTCVRSQSSDCKSG------DRFIMLDDVKLPDFVEASLNESMNV 363
FE +N+ G C R +C D F +L +K+PDF L+ N
Sbjct: 325 FEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--NS 382
Query: 364 KECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELE 423
+ C+ C ++C+C+AYA G GC++W DLID+ + G SI IR+ S+L
Sbjct: 383 ETCKDVCARDCSCKAYA----LVVGIGCMIWTRDLIDMEHFE--RGGNSINIRLAGSKLG 436
Query: 424 TKKSQDMLQFDINMSIATRANELC--------KGNKAANSRTRDSW-------------- 461
K L + I LC K KA + +D
Sbjct: 437 GGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSP 496
Query: 462 -------------FPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLS 508
P+FS SV++AT +F+ ENKLG+GGFG VYKG G+E+AVKRLS
Sbjct: 497 IKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLS 556
Query: 509 SQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKE 568
+S QG EEFKNEI LIAKLQHRNLVRLLGCCIE EK+L+YEYMPNKSLD FLFD +K+
Sbjct: 557 GKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQ 616
Query: 569 NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
L W R +I GIA+GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDFGMARIF
Sbjct: 617 GSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFN 676
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT 688
+ + T R+VGTYGYM+PEYA +G+FS KSDV+SFGVL+LE +S ++N F T+ +
Sbjct: 677 YRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGS 736
Query: 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
L+G+AW LW + E+IDP +++ R I+VG+LC Q+ RP M V+ ML
Sbjct: 737 LIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLE 796
Query: 749 NKTINLPHPRQPAFSSIRGLKNTILPANGKARVCSGNCLTLSEMDAR 795
++T LP PRQP F S + L +G V S N +T + + R
Sbjct: 797 SQTSQLPPPRQPTFHSFLNSGDIELNFDGHD-VASVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 603 bits (1556), Expect = e-171, Method: Compositional matrix adjust.
Identities = 345/781 (44%), Positives = 483/781 (61%), Gaps = 52/781 (6%)
Query: 28 ITPSRFIRDGEKLVSSSQRFELGFFS---PGKSKYRYLGIWYKQIPDTIVWVANRNSPIF 84
ITP F++DG+ L S Q F+LGFFS + ++R+LG+WY + P +VWVANRN+P++
Sbjct: 28 ITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PFAVVWVANRNNPLY 86
Query: 85 DSNAVLTISNGGKLVLLNQTNGTIWSSNLSREV-----KNPVAQLLDTGNLVVRDNFSSN 139
++ L +S+ G L L + + +WSS+ S NP+ ++ +GNL+ SS+
Sbjct: 87 GTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI-----SSD 141
Query: 140 SSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPK 199
E LWQSFD+P +T+LAGMKLG + KT +E +SWK+ DPSPG++T LD LP+
Sbjct: 142 GEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQ 201
Query: 200 LCTY-NG----SVKLLCSGPWNGAIFAAIPSY---SYLYKPTVVDNEDEIYYRYDSYNSP 251
L NG S +L G WNG F P+ + L+ + E+ Y + +
Sbjct: 202 LILRKNGDSSYSYRL---GSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHR- 257
Query: 252 VIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKK--PHCEC 309
++ L LN +GK+ I +++N+ W + P+ C +Y CGA ++C + K P C C
Sbjct: 258 IVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSC 316
Query: 310 LKGFELKSHH--NKTRPG-TCVRSQSSDCKSGDRFIMLDDVKLPD--FVEASLNESMNVK 364
L+GF+ KS N +R CV ++C+ D F+ +KLPD + M ++
Sbjct: 317 LQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLE 376
Query: 365 ECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELET 424
+C+ +C NC+C AYAN+ + G GCL+WFGDL+D+R+ + GQ +YIR+ +++E
Sbjct: 377 DCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYS--SFGQDVYIRMGFAKIEF 434
Query: 425 KKSQDMLQFDINMSIATRA---------NELCKGNKAANSRT----RDSWFPMFSLASVS 471
K + + ++ ++ K + N R D P+F ++S
Sbjct: 435 KGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTIS 494
Query: 472 AATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR 531
AT +FS N LG GGFGPVYKG+L +GQE+AVKRLS+ SGQG EEFKNE+KLIAKLQHR
Sbjct: 495 IATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHR 554
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
NLVRLLGCCI+ EE +LIYEYMPNKSLDFF+FD + L W R+ II G+A+G+LYLH
Sbjct: 555 NLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLH 614
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
Q SRLR+IHRDLKA N+LLD DMNPKISDFG+A+ FGGD+ +S T R+VGTYGYM PEYA
Sbjct: 615 QDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYA 674
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRAWELIDPTL 710
G FS+KSDVFSFGVL+LE ++ K N F + + L LLGH W +W +DR E+ +
Sbjct: 675 IDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEW 734
Query: 711 QNEASYLI-LNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSIRGLK 769
E S + + R I+V LLCVQ+ DRPTM VV M + + +LPHP QP F + R +
Sbjct: 735 LEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLPHPTQPGFFTNRNVP 793
Query: 770 N 770
+
Sbjct: 794 D 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 795 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.963 | 0.955 | 0.546 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.964 | 0.709 | 0.518 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.974 | 0.932 | 0.500 | 0.0 | |
| 359493721 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.954 | 0.944 | 0.5 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.924 | 0.937 | 0.503 | 0.0 | |
| 357446263 | 839 | Serine/threonine protein kinase [Medicag | 0.958 | 0.908 | 0.489 | 0.0 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.922 | 0.414 | 0.505 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.978 | 0.951 | 0.488 | 0.0 | |
| 359493730 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.990 | 0.491 | 0.0 | |
| 302143157 | 818 | unnamed protein product [Vitis vinifera] | 0.959 | 0.932 | 0.485 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 818 bits (2112), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/777 (54%), Positives = 534/777 (68%), Gaps = 11/777 (1%)
Query: 1 MENLHLLYNFISCVFILSIK-LSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKY 59
ME+L + F S +FI S+ LS +AD ITP ++DG+ L+S SQ FELGFFSPG SKY
Sbjct: 1 MESLPF-FIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKN 119
RY+GIWYK+ P+T+VWVANRN+P+ D VLTI N G LVLL+Q IWSSN S +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKS 179
PVAQLLD+GNLVVRDN SS ++E Y WQSFD PSDTLL GMKLGW+LKTG ERY +W+S
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 DDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPS-YSYLYKPTVVDNE 238
DPSPG++T+RLDIH LP+L GSVK + SGPWNG F P ++ +++P +V NE
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 239 DEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSI 298
DEIYY Y N+ V L LN SG ++ L+ +N W +S+P C+ YG CGAN I
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 299 CSFDKKPHCECLKGF-----ELKSHHNKTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFV 353
C P CECLKGF E N C + DC+SG+ F+ L VKLPD +
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLL 359
Query: 354 EASLNESMNVKECEAECLKNCTCRAYANSKVTG--EGSGCLMWFGDLIDIRKADDRNNGQ 411
E LNESMN+KECEAEC KNC+C A+A + ++G +GSGCLMWFG+LIDIR+ GQ
Sbjct: 360 EFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQ 419
Query: 412 SIYIRVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSLASVS 471
I+IRVPASELE +S + +A+ + L + R P+F L +++
Sbjct: 420 DIHIRVPASELEMARSSKRKKMLKTALVASMSALLGIFVSGMDRRKEGMEAPLFDLDTIA 479
Query: 472 AATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR 531
AT NF+ ++ +G GGFG VYKG+LL GQE+AVK+LS SGQG EEF+NE+ LIAKLQHR
Sbjct: 480 TATNNFAPDSIIGAGGFGSVYKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHR 539
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
NLV LLG CI EE++LIYEYMPNKSLD+F+FD + LLGW R II GIA+GLLYLH
Sbjct: 540 NLVGLLGSCIHREERMLIYEYMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLH 599
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
Q S+L+++HRDLK SN+LLD ++ PKISDFG+ARI G D ++KT+R++GTYGYM+PEYA
Sbjct: 600 QDSKLQIVHRDLKPSNVLLDSNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYA 659
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRAWELIDPTL 710
G FS+KSDVFS GVLLLE +S K+N F + + LLGHAW +W + RA ELID L
Sbjct: 660 IDGKFSVKSDVFSLGVLLLEIISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDTGL 719
Query: 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSIRG 767
++ + L R I VGLLCVQ+ DRP M VV ML N+ LP P+QP F RG
Sbjct: 720 EDTSGKSQLLRCIQVGLLCVQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFFIERG 776
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/790 (51%), Positives = 518/790 (65%), Gaps = 23/790 (2%)
Query: 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIF 84
AD+I + I D E LVSS Q FELGFFSPG SK RYLGIWYK P T VWVANRN+PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDY 144
DS VLTI N G LVLLNQ+ IWS NLSR +NPVAQLL+TGNLV+RD S+ +S+ Y
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDG-SNETSKSY 414
Query: 145 LWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYN 204
+WQSFD PSDT+L GMK+GW+LKTGL+R TSWKS DDPS G++++ DI+VLP L
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 205 GSVKLLCSGPWNGAIFAAIPSY-SYLYKPTVVDNEDEIYYRYDSYNSPVIMTLKLNPSGK 263
GS K++ SGPWNG F + + +YK V N DE+Y Y+S N+ +I L LN SG
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 264 IQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKKPHCECLKGFELKSHHN--- 320
+Q L+ + + W+ +S+P C+ YGHCGAN IC K CECL GF KS
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 321 -KTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAECLKNCTCRAY 379
T G C R DC+ + F+ + VKLPD ++ + ++++EC+ CL NC+C AY
Sbjct: 595 FNTSSG-CTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAY 653
Query: 380 ANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELETKKSQDMLQFDINMSI 439
A + G G GCLMW GDLIDIR+ + + IYIR+ SEL +Q + I + I
Sbjct: 654 AYTNPNGSG-GCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVI 712
Query: 440 ATRANELCKG-------------NKAANSRTRDSWFPMFSLASVSAATANFSTENKLGEG 486
+T + L G S+ + P+F L +++ AT NFS NK+G G
Sbjct: 713 STFSGILTLGLSFWFRFWKKRTMGTDQESKKENLELPLFDLPTIATATNNFSNTNKIGAG 772
Query: 487 GFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546
GFG VYKG L G VAVKRLS S QG +EFKNE LIAKLQH+NLVRLLGCCI+ EE+
Sbjct: 773 GFGSVYKGNLPEGVAVAVKRLSKNSAQGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEER 832
Query: 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 606
IL+YEYMPNKSLD+F+FD + LL W R I+ GIA+GLLYLHQ SR ++IHRDLK S
Sbjct: 833 ILLYEYMPNKSLDYFIFDQNRRALLAWDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTS 892
Query: 607 NILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFG 666
NILLD ++NPKISDFG+ARIFG +E++++TKRIVGTYGYMSPEY G FSIK DVFSFG
Sbjct: 893 NILLDDNLNPKISDFGLARIFGENEMETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFG 952
Query: 667 VLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINV 725
VLLLE +S ++N FS+ + LLGHAW LW+ +RA EL+D L++ + R I V
Sbjct: 953 VLLLEIVSGEKNRGFSHPDHHHNLLGHAWLLWEQNRALELMDACLEDSCVASQVLRCIQV 1012
Query: 726 GLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSIRGLKNTILPANGKARVCSGN 785
GLLCVQ ADRP M V+ ML N+ LP P+ P F + R +T +GK + S N
Sbjct: 1013 GLLCVQNLPADRPAMSSVIFMLGNEGATLPQPKHPGFFTERSSVDTD-TMSGKIELHSEN 1071
Query: 786 CLTLSEMDAR 795
+T+S + R
Sbjct: 1072 AVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/827 (50%), Positives = 534/827 (64%), Gaps = 52/827 (6%)
Query: 10 FISCVFILSIKLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQI 69
+S VF LSI S A ++I ++ + DG+ LVSS FELGFFSPG S+ RY+GIWYK+I
Sbjct: 16 LLSIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKI 74
Query: 70 PD-TIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTG 128
T+VWVANRN+P+ DS+ +L + G L +N TNGTIWSSN+SR NPVAQLLDTG
Sbjct: 75 SSFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTG 134
Query: 129 NLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNY 188
NLVVR + N E++LWQSFD+P D+ L GMK G TGL RY TSWKS DPS G Y
Sbjct: 135 NLVVRAE-NDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKY 193
Query: 189 THRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAI------PSYSYLYKPTVVDNEDEIY 242
T++LD + LP+ GSV SGPWNG F+ + P Y++ + V N++EIY
Sbjct: 194 TNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEF----VFNQEEIY 249
Query: 243 YRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFD 302
Y+Y NS V+ + L+P G +Q W +R + W + + C + CGA+ +C+ +
Sbjct: 250 YKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNIN 309
Query: 303 KKPHCECLKGFELKSHHNKTRPG---TCVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNE 359
P C+CLK FE KS T CVR DC +G+ FI +K+PD ++ N+
Sbjct: 310 NSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNK 369
Query: 360 SMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPA 419
++N++ECE CLKNC+C AYAN V GSGC++WFGDLIDIR+ ++ NGQ IYIR+ A
Sbjct: 370 TINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNE--NGQDIYIRIAA 427
Query: 420 SELET------KKSQDMLQFDINMSIATRANELC----------------KGNKAAN--- 454
S ++ KK ++ +++ +A LC +GN N
Sbjct: 428 SVIDKPVKSRGKKRVRIIVIPVSL-VAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPEQ 486
Query: 455 -----SRTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSS 509
SR D P+F LA+++ AT FS NKLG+GGFGPVYKG L +GQE+AVKRLS
Sbjct: 487 DRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQEIAVKRLSK 546
Query: 510 QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN 569
+S QG EF+NE+ IAKLQHRNLV+LLGCCIELEE++LIYEYMPNKSLD F+FD +
Sbjct: 547 RSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSFIFDKRRNM 606
Query: 570 LLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629
LL W R II GIA+GLLYLHQ SRLR+IHRDLKASNILLD +MNPKISDFGMAR FGG
Sbjct: 607 LLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDFGMARSFGG 666
Query: 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-NSLT 688
DE + T RIVGTYGYMSPEYA GLFS+KSDVFSFGVL+LE +S ++N F + + L
Sbjct: 667 DETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRKNRGFRHAEHKLN 726
Query: 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
LLGHAW L K+ R +LID ++ + + R I V LLCVQ+ DRP M VV ML+
Sbjct: 727 LLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPEDRPKMSIVVLMLS 786
Query: 749 NKTINLPHPRQPAFSSIRGLKNTILPANGKARVCSGNCLTLSEMDAR 795
+ + LP P++P F + R L N + K + S N LT + ++AR
Sbjct: 787 SDIV-LPQPKEPGFFTERDLSNDS-SSTIKHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/804 (50%), Positives = 526/804 (65%), Gaps = 45/804 (5%)
Query: 7 LYNFISCVFILS-----IKLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRY 61
L N VF+ S +++S A D+IT ++ I+DGE ++S+ FELGF G SK +Y
Sbjct: 31 LGNLGKLVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQY 90
Query: 62 LGIWYKQI-PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNP 120
LGIWYK++ P T+VWVANR P+ DS+ VL +++ G LV+LN +NG IWSSN SR +NP
Sbjct: 91 LGIWYKKVTPRTVVWVANRELPVTDSSGVLKVTDQGSLVILNGSNGLIWSSNSSRSARNP 150
Query: 121 VAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSD 180
AQLLD+GNLV++ S+ +++LWQSFD+P DTLL GMK G + TGL+RY +SWKS+
Sbjct: 151 TAQLLDSGNLVIKSGNDSDP-DNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSN 209
Query: 181 DDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSY--SYLYKPTVVDNE 238
DDPS G++T+ LD P+L +GS + SGPWNG F P + ++ + V NE
Sbjct: 210 DDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNE 269
Query: 239 DEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSI 298
E+Y+ Y NS V+ L LNP+G +Q LIW R ++W + + C Y CGA S
Sbjct: 270 KEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYST 329
Query: 299 CSFDKKPHCECLKGFELKSHHN---KTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFVEA 355
C+ + P C C+KGF K + CVR S DC+ GD F+ VKLPD +
Sbjct: 330 CNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFVKCSGVKLPDTRNS 389
Query: 356 SLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYI 415
NESMN+KEC + CL+NC+C AY NS + G GSGCL+WFGDLID+++ + NGQ YI
Sbjct: 390 WFNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLWFGDLIDVKEFTE--NGQDFYI 447
Query: 416 RVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSLASVSAATA 475
R+ ASELE L N R D P+F L ++ AT
Sbjct: 448 RMAASELE----------------------LNNEGAETNERQEDLELPLFDLDTILNATH 485
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
NFS NKLGEGGFGPVYKG L +G+E+AVKRLS +S QG +EFKNE+ I+KLQHRNLV+
Sbjct: 486 NFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVK 545
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
LLGCCI EEK+LIYEYMPNKSL+FF+FD + +L W R II GIA+GLLYLHQ SR
Sbjct: 546 LLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSR 605
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
LR+IHRDLKA N+LLD +MNP+ISDFGMAR FGG+E Q++TKR+VGTYGYMSPEYA G+
Sbjct: 606 LRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGTYGYMSPEYAIDGV 665
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRAWELIDPTLQNEA 714
+S+KSDVFSFGVLLLE +S KRN F++ + L LLGHAW L+ + ELID ++ +
Sbjct: 666 YSVKSDVFSFGVLLLEIISGKRNRGFNHPDHDLNLLGHAWTLYMERTPLELIDASVGDTY 725
Query: 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSIRGLKNTILP 774
+ + R +NVGLLCVQ DRP M VV ML+++ L P++P F + R +L
Sbjct: 726 NQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGA-LRQPKEPGFFTER----NMLE 780
Query: 775 ANG---KARVCSGNCLTLSEMDAR 795
A+ K V SGN T++ ++ R
Sbjct: 781 ADSLQCKHAVFSGNEHTITILEGR 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/773 (50%), Positives = 513/773 (66%), Gaps = 38/773 (4%)
Query: 10 FISCVFILSIKLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQI 69
F+ + +I++S A D I+P +FI DG+ +VS+ Q FELGFFSPG S RYLGIWYK+
Sbjct: 16 FVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKKF 75
Query: 70 P-DTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTG 128
T+VWVANR +PIFD + VL +N G L+LLN T +WSSN + NPVAQLL++G
Sbjct: 76 STGTVVWVANRENPIFDHSGVLYFTNQGTLLLLNGTKDVVWSSNRTTPKNNPVAQLLESG 135
Query: 129 NLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNY 188
NLVV+D SN E +LWQSFD+P DT L MKLG +L TGL+ +SWKS DDP+ G Y
Sbjct: 136 NLVVKDGNDSNP-ESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARGEY 194
Query: 189 THRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAI------PSYSYLYKPTVVDNEDEIY 242
+ +D +L G +G WNG F P Y Y + V N+ E+Y
Sbjct: 195 SLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEF----VLNDKEVY 250
Query: 243 YRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFD 302
+ ++ NS V +N SG ++ L W + W +F++ + C Y CG+N+ C+ D
Sbjct: 251 FNFELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCNID 310
Query: 303 KKPHCECLKGFELKSHHN---KTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNE 359
K P C CL GFE KS + + G CVR + C G+ F+ +KLPD + N
Sbjct: 311 KSPVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWYNT 370
Query: 360 SMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPA 419
S+++KEC+ CLK C+C AYAN+ V G GSGCL+WFGDLID+R+ N GQ +YIR+ A
Sbjct: 371 SISLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREF--VNTGQDLYIRMAA 428
Query: 420 SELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSLASVSAATANFST 479
S L K +++L+ D + ++SR + P+ L++++ AT NFS+
Sbjct: 429 SYL--GKMKNILEMDYD----------------SHSRKEELELPIIDLSTIAKATGNFSS 470
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
KLGEGGFG VYKG L GQ++AVKRLS SGQG EEFKNE+ LIAKLQHRNLV+LLGC
Sbjct: 471 NKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 529
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
CIE +E++LIYEYMPNKSLD+F+FD ++ LL W TR+ II+GIA+GLLYLHQ SRLR+I
Sbjct: 530 CIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLDWPTRISIIDGIARGLLYLHQDSRLRII 589
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRDLKASN+LLD DMNPKISDFGMARIFGG++ ++ TKR+VGTYGYM+PEYA +GLFS+K
Sbjct: 590 HRDLKASNVLLDTDMNPKISDFGMARIFGGNQTEANTKRVVGTYGYMAPEYAVEGLFSVK 649
Query: 660 SDVFSFGVLLLETLSSKRNTD-FSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718
SD+FSFGVL+LE +S ++N FS+ + L L+GHAW LW ++R+ EL D TL +
Sbjct: 650 SDIFSFGVLVLEIVSGRKNRGFFSHNHHLNLVGHAWKLWMEERSLELTDNTLGASHALSE 709
Query: 719 LNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSIRGLKNT 771
+ RYI+VGLLCVQ+ DRP M V ML ++ +LP P+QP F R + T
Sbjct: 710 IIRYIHVGLLCVQQQPDDRPNMSTAVLMLGGES-SLPQPKQPGFFLERNVPRT 761
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357446263|ref|XP_003593409.1| Serine/threonine protein kinase [Medicago truncatula] gi|355482457|gb|AES63660.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/797 (48%), Positives = 515/797 (64%), Gaps = 35/797 (4%)
Query: 1 MENLHLLYNFISCVFILSIKLSI---AADNITPSRFIRDGEKLVSSSQRFELGFFSPGKS 57
ME ++ ++ F L+ I A D ITP +FI + L+S SQ FELGFF+P S
Sbjct: 1 MEKTEFIFLLLATCFHLTTLFPIPSKAEDTITPPQFITGNQTLISPSQNFELGFFTPKNS 60
Query: 58 KYRYLGIWYKQIP-DTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSRE 116
Y YLGIWYKQI IVWVANR+ P+ D N LT +N GKL++LN +W+SN S
Sbjct: 61 TYTYLGIWYKQIHIKNIVWVANRDKPLLDHNGTLTFNNDGKLIILNYGGSVLWASNSSGP 120
Query: 117 VKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTS 176
K PVAQLLDTGN V++ NF +SE+ LWQSFD+PS+TLL GMKLG + KTGL + TS
Sbjct: 121 AKTPVAQLLDTGNFVLK-NFEDENSEEILWQSFDYPSNTLLPGMKLGRNFKTGLNIHLTS 179
Query: 177 WKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSY--SYLYKPTV 234
WK+ D+PS G Y++ +D LP+L G K+ SGPW + P + ++KP
Sbjct: 180 WKNIDNPSSGEYSYSVDPRGLPQLFLQKGKKKIFRSGPWYVEQYKGDPVLRENPIFKPVF 239
Query: 235 VDNEDEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCG 294
V + DE+YY +++ + ++ L+ SG IQH WN+ W + F++ C YG CG
Sbjct: 240 VFDSDEVYYSFETKDD-IVSRFVLSESGLIQHFTWNDHRSNWFSEFNVQGDRCDDYGICG 298
Query: 295 ANSICSFDKKPHCECLKGFELKSHHNKTR---PGTCVRSQSSDCKSGDRFIMLDDVKLPD 351
A C+ P C+CL GFE ++ H+ CVR S C++GD F +KLPD
Sbjct: 299 AYGTCNIKNSPICKCLNGFEPRNMHDWKMLDWSSGCVRENSKVCRNGDVFKKFIGMKLPD 358
Query: 352 FVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQ 411
VE +N S+N+ +CE EC KNC+C AYA + G+GC+ WFGDL DIR +D N Q
Sbjct: 359 SVEFHVNYSINIDQCEVECSKNCSCVAYAKLDINASGNGCIAWFGDLFDIR--EDSVNEQ 416
Query: 412 SIYIRVPASEL----ETKKSQDMLQFDINMSIAT--------------RANELCKGNKAA 453
++RV ASEL E K + ++ +++S+A+ R N +
Sbjct: 417 DFFVRVSASELDSNVERNKRKKLILLFVSISVASTIITSALWLIIKKWRRNRAKETGIRL 476
Query: 454 NSRTRDSWF--PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 511
+ T S F P F +A + AAT NFS NK+GEGGFGPVYKG+L +GQE+AVKRLS S
Sbjct: 477 SVDTSKSEFELPFFEIAIIEAATRNFSFYNKIGEGGFGPVYKGQLPSGQEIAVKRLSENS 536
Query: 512 GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLL 571
GQG +EFKNE+ I++LQHRNLV+LLGCCI+ E+K+L+YEYMPN+SLD LFD TK + L
Sbjct: 537 GQGLQEFKNEVIFISQLQHRNLVKLLGCCIQGEDKMLVYEYMPNRSLDSLLFDETKRSAL 596
Query: 572 GWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631
W R+ II+GIA+GL+YLH+ SRLR+IHRDLKASN+LLD +MNPKISDFGMAR+FGGD+
Sbjct: 597 SWQKRLDIIDGIARGLVYLHRDSRLRIIHRDLKASNVLLDGEMNPKISDFGMARMFGGDQ 656
Query: 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLL 690
+ KTKR+VGTYGYM PEYA G FS KSDV+SFGVLLLE LS K+N F + + L LL
Sbjct: 657 TEEKTKRVVGTYGYMPPEYAMDGHFSFKSDVYSFGVLLLELLSGKKNRGFFHPDHKLNLL 716
Query: 691 GHAWDLWKDDRAWELIDPTLQNEASYL-ILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
GHAW LW + + EL+DP L+++ S + + I +GLLCVQ+ +RPTM VV ML
Sbjct: 717 GHAWKLWNEGKVIELMDPLLEDQVSTPESILKCIQIGLLCVQQHPEERPTMSSVVLMLDG 776
Query: 750 KTINLPHPRQPAFSSIR 766
+++ LP PR+P S R
Sbjct: 777 ESVLLPKPRRPGLYSER 793
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/777 (50%), Positives = 502/777 (64%), Gaps = 44/777 (5%)
Query: 15 FILSI-KLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDT- 72
++LS+ ++S+A D I ++ I DGE + S+ FELGFFSPG SK RYLGIWYK+
Sbjct: 13 YVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKASKKP 72
Query: 73 IVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVV 132
+VWVANR SPI DS+ VL ++ G LVL+N TNG +W+S SR ++P AQLL++GNLV+
Sbjct: 73 VVWVANRESPITDSSGVLKVTQPGILVLVNGTNGILWNSTSSRSAQDPNAQLLESGNLVM 132
Query: 133 RDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRL 192
R N + E++LWQSFD+P DTLL GMKLG + GL+RY +SWKS DDPS GN+T+ +
Sbjct: 133 R-NGNDRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGNFTYWI 191
Query: 193 DIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPS------YSYLYKPTVVDNEDEIYYRYD 246
D P+L NG GPWNG F+ IP YSY Y V NE EIYY Y
Sbjct: 192 DPSGFPQLLLRNGLAVAFRPGPWNGIRFSGIPQLTINPVYSYEY----VSNEKEIYYIYS 247
Query: 247 SYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKKPH 306
NS VIM L L P G Q IW ++ W + + C Y CG N IC D+ P+
Sbjct: 248 LVNSSVIMRLVLTPDGAAQRSIWTDKKNEWTLYSTAQRDQCDNYAICGVNGICKIDQSPN 307
Query: 307 CECLKGFELKSHHN---KTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNESMNV 363
CEC+KGF K N + CVRS DC+ GD F+ VKLPD + NESMN+
Sbjct: 308 CECMKGFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFNESMNL 367
Query: 364 KECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELE 423
KEC + CL NC+C AYANS + G GSGCL+WFGDLIDIR D NGQ Y+R+ A++LE
Sbjct: 368 KECASLCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIR--DFTENGQEFYVRMAAADLE 425
Query: 424 TKKSQ-----------------DMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFS 466
T K + +L F M ++ E +G + P+F
Sbjct: 426 TTKEKRLGNRLNSIFVNSLILHSILHFAAYMEHNSKGGENNEGQEHLE-------LPLFD 478
Query: 467 LASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIA 526
L ++ AT NFS++NKLGEGGFGPVYKG L GQE+AVK +S S QG +EFKNE++ IA
Sbjct: 479 LDTLLNATNNFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESIA 538
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
KLQHRNLV+LLGCCI E++LIYE+MPNKSLD F+FD + +L W R II GIAQG
Sbjct: 539 KLQHRNLVKLLGCCIHGRERLLIYEHMPNKSLDLFIFDQMRRRVLDWPKRFLIINGIAQG 598
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
LLYLH+ SRLR+IHRDLKA NILLD +M PKISDFG+ FGG+E+++ T R+ T GYM
Sbjct: 599 LLYLHRDSRLRIIHRDLKAENILLDNEMIPKISDFGITGSFGGNEIETNTTRVARTLGYM 658
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-NSLTLLGHAWDLWKDDRAWEL 705
SPEYA++GL+S KSDVFSFGVL+LE +S KRN F++ + L+LLGHAW + +DR+ E
Sbjct: 659 SPEYAREGLYSTKSDVFSFGVLVLEIVSGKRNKGFNHPYHDLSLLGHAWTFFMEDRSSEF 718
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAF 762
ID ++ N + + IN+GLLCVQ DRP+M VV ML ++ LP P++P F
Sbjct: 719 IDASMGNTCNLSEVLCSINLGLLCVQRFPEDRPSMHSVVLMLGSEGA-LPQPKEPYF 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/823 (48%), Positives = 530/823 (64%), Gaps = 45/823 (5%)
Query: 10 FISCVFILS-----IKLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGI 64
F VF+ S +++S A D+IT ++ I+DGE ++S+ FELGF G SK +YLGI
Sbjct: 4 FTELVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGI 63
Query: 65 WYKQI-PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQ 123
WYK++ P T+VWVANR P+ DS+ L +++ G LV+LN +NG IWSSN SR +NP AQ
Sbjct: 64 WYKKVTPRTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQ 123
Query: 124 LLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDP 183
LLD+GNLV++ S+ +++LWQSFD+P DTLL GMK G + TGL+RY +SWKS+DDP
Sbjct: 124 LLDSGNLVIKSGNDSDP-DNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDP 182
Query: 184 SPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSY--SYLYKPTVVDNEDEI 241
S G++T+ LD P+L +GS + SGPWNG F P + ++ + V NE E+
Sbjct: 183 SKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEM 242
Query: 242 YYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSF 301
Y+ Y NS V+ L LNP+G +Q LIW R ++W + + C Y CGA S C+
Sbjct: 243 YFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYSTCNI 302
Query: 302 DKKPHCECLKGFELKSHHN---KTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFVEASLN 358
+ P C C+KGF K + CVR S DC+ GD F VKLPD + N
Sbjct: 303 HRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSWFN 362
Query: 359 ESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVP 418
ESMN+KEC + C +NC+C AY NS + G GSGCL+WFGDLIDI++ + NGQ YIR+
Sbjct: 363 ESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTE--NGQDFYIRMA 420
Query: 419 ASELE-----TKK-----------SQDMLQFDINMSIATR------ANELCKGNKAANSR 456
ASEL+ TK+ +L + + + + EL N R
Sbjct: 421 ASELDAISKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGAETNER 480
Query: 457 TRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQE 516
D P+F L ++ AT NFS NKLGEGGFGPVYKG L +G+E+AVKRLS +S QG +
Sbjct: 481 QEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLD 540
Query: 517 EFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR 576
EFKNE+ I+KLQHRNLV+LLGCCI EEK+LIYEYMPNKSL+FF+FD + +L W R
Sbjct: 541 EFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKR 600
Query: 577 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT 636
II GIA+GLLYLHQ SRLR+IHRDLKA N+LLD +MNP+ISDFGMAR FGG+E ++T
Sbjct: 601 FVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETIART 660
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWD 695
KR+VGTYGYMSPEYA G++S+KSDVFSFGVL LE +S KRN F++ + L LLGHAW
Sbjct: 661 KRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLXLEIISGKRNRGFNHPDHDLNLLGHAWT 720
Query: 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLP 755
L+ + ELID ++ + + R +NVGLLCVQ DRP M VV ML+++ LP
Sbjct: 721 LYMEGTPLELIDASVGYTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGA-LP 779
Query: 756 HPRQPAFSSIRGLKNTILPANG---KARVCSGNCLTLSEMDAR 795
P++P F + R + L A+ K V SGN T++ ++ R
Sbjct: 780 QPKEPGFFTERNM----LEADSLQCKHAVFSGNEHTITILEGR 818
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493730|ref|XP_003634656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1908), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/802 (49%), Positives = 512/802 (63%), Gaps = 39/802 (4%)
Query: 1 MENLHLLYNFISCVFILSIKLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYR 60
M+ L + S VF L +++S A D I ++ IRDGE + S+ F+LGFFSPG SK R
Sbjct: 1 MDALATVVFIFSYVFSL-LRISTAVDTINVNQHIRDGETITSAGGTFQLGFFSPGDSKNR 59
Query: 61 YLGIWYKQI-PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKN 119
YLGIWYK++ P T+VWVANR SP+ DS+ VL ++ G LV+++ TNG +W+SN SR ++
Sbjct: 60 YLGIWYKKVAPQTVVWVANRESPLTDSSGVLKVTQQGTLVVVSGTNGILWNSNSSRSAQD 119
Query: 120 PVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKS 179
P AQLL++GNLV+R N + + E++LWQSFD+P DTLL GMK GW+ TGL+RY +SWKS
Sbjct: 120 PNAQLLESGNLVMR-NGNDSDPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKS 178
Query: 180 DDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSYS--YLYKPTVVDN 237
DDPS GN+T+ +D+ P+ NG +GPWNG F IP + L+ V N
Sbjct: 179 ADDPSKGNFTYGIDLSGFPQPFLRNGLTVKFRAGPWNGVRFGGIPQLTNNSLFTFDYVSN 238
Query: 238 EDEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANS 297
E EIY+ Y NS V + L P G + W ++ W + + C Y CG
Sbjct: 239 EKEIYFIYYLVNSSVFVRRVLTPDGYSRRFTWTDKKNEWTLYSTAQRDDCDNYAICGVYG 298
Query: 298 ICSFDKKPHCECLKGFELKSHHN---KTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFVE 354
IC D+ P CEC+KGF K N CVRS DC+ GD F+ VKLPD
Sbjct: 299 ICKIDESPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTRN 358
Query: 355 ASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIY 414
+ +ESMN+KEC + CL+NC+C AYANS + G GSGCL+WF DLIDIR D NGQ Y
Sbjct: 359 SWFDESMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLIDIR--DFTQNGQEFY 416
Query: 415 IRVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSLASVSAAT 474
R+ ASE M ++ E +G + + P+F+LA++ AT
Sbjct: 417 ARMAASESGY------------MDHKSKEGENNEGQEHLD-------LPLFNLATLLNAT 457
Query: 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
NFS ENKLGEGGFGPVYKG L GQE+AVK +S S QG +EFKNE++ I KLQHRNLV
Sbjct: 458 NNFSEENKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESITKLQHRNLV 517
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+LLGCCI E++LIYEYMPNKSLD ++FD + +L W R II GIA+GLLYLHQ S
Sbjct: 518 KLLGCCIHGRERLLIYEYMPNKSLDLYIFDHMRSRVLDWPKRFLIINGIARGLLYLHQDS 577
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
RLR+IHRDLKA NILLD +M PKISDFG+AR FGG+E ++ T R+VGT GYMSPEYA +G
Sbjct: 578 RLRIIHRDLKAENILLDNEMTPKISDFGIARSFGGNETEANTTRVVGTLGYMSPEYASEG 637
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRAWELIDPTLQNE 713
L+S KSDVFSFGVLLLE +S KRN FS+ + L LLGHAW L+ + + E ID ++ N
Sbjct: 638 LYSTKSDVFSFGVLLLEIVSGKRNRRFSHPDHDLNLLGHAWTLYIEGGSLEFIDTSIVNT 697
Query: 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSIRGLKNTIL 773
+ + + R INVGLLCVQ DRP+M V+ ML ++ P P++P F + R +
Sbjct: 698 CNLIEVLRSINVGLLCVQRFPDDRPSMHSVILMLGSEGAP-PRPKEPCFFTDRNMM---- 752
Query: 774 PANGKARVCSGNCLTLSEMDAR 795
+A SG T++ ++AR
Sbjct: 753 ----EANSSSGIQPTITLLEAR 770
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143157|emb|CBI20452.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/804 (48%), Positives = 509/804 (63%), Gaps = 41/804 (5%)
Query: 15 FILSI-KLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIP-DT 72
++LS+ ++S+A D I ++ I DGE + S+ FELGFFSPG SK RYLGIWYK++ T
Sbjct: 13 YVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKVATGT 72
Query: 73 IVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVV 132
+VWVANR SP+ DS+ VL ++ G LVL+N TNG +W+S+ SR ++P AQLL++GNLV+
Sbjct: 73 VVWVANRESPLTDSSGVLKVTEQGILVLVNDTNGILWNSSSSRSAQDPNAQLLESGNLVM 132
Query: 133 RDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRL 192
R N + + E++LWQSFD+P DTLL GMK GW+ TGL+RY +SWKS DDPS GN+T+ +
Sbjct: 133 R-NGNDSDPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKSTDDPSKGNFTYGI 191
Query: 193 DIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSYS--YLYKPTVVDNEDEIYYRYDSYNS 250
D+ P+ NG +GPWNG F IP + L+ V NE EIY Y NS
Sbjct: 192 DLSGFPQPFLRNGLAVKFRAGPWNGVRFGGIPQLTNNSLFTSDYVSNEKEIYSIYYLVNS 251
Query: 251 PVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKKPHCECL 310
V + L P G + W ++ W + + C Y CG IC D+ P CEC+
Sbjct: 252 SVFVRRVLTPDGYSRRFTWTDKKNEWTLYATAQSDDCDNYAICGVYGICKIDESPKCECM 311
Query: 311 KGFELKSHHN---KTRPGTCVRSQSSDCKSGDRFIMLDDVKLPDFVEASLNESMNVKECE 367
KGF K N C+RS DC+ GD F+ VKLPD + NESMN+KEC
Sbjct: 312 KGFRPKFQSNWDMADWSNGCIRSTPLDCQKGDGFVKYSGVKLPDTRNSWFNESMNLKECA 371
Query: 368 AECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQSIYIRVPASELETKKS 427
+ CL+NC+C AYANS + G GSGCL+WFGDLIDIR D +NGQ Y+R+ ASELE S
Sbjct: 372 SLCLRNCSCTAYANSDIRGGGSGCLLWFGDLIDIR--DFTHNGQEFYVRMAASELEASSS 429
Query: 428 QD---------------------MLQFDINMSIATRANELCKGNKAANSRTRDS------ 460
+L + + + + + K + +RD
Sbjct: 430 IKSSSKKKKKHVIIISISTTGIVLLSLVLTLYVLKKRKKQLKRKGYMDHNSRDENNEGQA 489
Query: 461 --WFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEF 518
P+F L ++ AT NFS+ NKLGEGGFGPVYKG L GQE+AVK +S+ S QG +EF
Sbjct: 490 HLELPLFDLDTLLNATNNFSSYNKLGEGGFGPVYKGILQEGQEIAVKMMSNTSRQGLKEF 549
Query: 519 KNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVR 578
KNE++ IAKLQHRNLV+LLGCCI E++LIYEYMPNKSLDFF+FD + L W R
Sbjct: 550 KNEVESIAKLQHRNLVKLLGCCIHGRERMLIYEYMPNKSLDFFIFDQMQSVALDWSKRFL 609
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638
II GIA+GLLYLHQ SRLR+IHRDLKA NILLD +M+PKISDFG+AR FGG+E ++ T R
Sbjct: 610 IINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEMSPKISDFGIARCFGGNETEANTTR 669
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLW 697
+ GT GYMSPEYA +GL+S KSDVFSFGVL+LE +S KRN F++ + L LLGHAW L+
Sbjct: 670 VAGTLGYMSPEYASEGLYSTKSDVFSFGVLVLEIVSGKRNRGFNHPDHDLNLLGHAWTLF 729
Query: 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHP 757
+DR+ E ID ++ N + R IN+GLLCVQ DRP+M V ML ++ LP P
Sbjct: 730 MEDRSSEFIDASMGNSCILSEVLRSINLGLLCVQRFPDDRPSMHSVALMLGSEGA-LPQP 788
Query: 758 RQPAFSSIRGLKNTILPANGKARV 781
++P F R + P+ ++ +
Sbjct: 789 KEPCFFIDRNMMEANSPSGIQSTI 812
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 795 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.475 | 0.444 | 0.501 | 6.6e-175 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.471 | 0.442 | 0.498 | 2.8e-174 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.475 | 0.448 | 0.497 | 6.1e-170 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.397 | 0.372 | 0.580 | 3.6e-166 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.964 | 0.979 | 0.421 | 2.7e-148 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.417 | 0.4 | 0.508 | 7.5e-148 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.417 | 0.394 | 0.528 | 2e-145 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.373 | 0.357 | 0.534 | 6.2e-142 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.962 | 0.950 | 0.409 | 1.3e-141 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.455 | 0.426 | 0.506 | 5.6e-141 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 6.6e-175, Sum P(2) = 6.6e-175
Identities = 199/397 (50%), Positives = 258/397 (64%)
Query: 407 RNNGQSIYIRVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFS 466
R +SI I P + + + S+D+L ++ I++R + + + N T D P+
Sbjct: 465 RKQKRSILIETPIVDHQLR-SRDLLMNEV--VISSRRH-ISRENN-----TDDLELPLME 515
Query: 467 LASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIA 526
V+ AT NFS NKLG+GGFG VYKG+LL+GQE+AVKRLS S QG +EFKNE+KLIA
Sbjct: 516 FEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIA 575
Query: 527 KLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
+LQH NLVR + N SLD LFD ++ + L W R II GIA+G
Sbjct: 576 RLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARG 635
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
LLYLHQ SR R+IHRDLKASNILLDK M PKISDFGMARIFG DE ++ T+++VGTYGYM
Sbjct: 636 LLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYM 695
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRAWEL 705
SPEYA G+FS+KSDVFSFGVLLLE +SSKRN F N++ L LLG W WK+ + E+
Sbjct: 696 SPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEI 755
Query: 706 IDPTLQNEAS----YLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPA 761
IDP + + +S + IL R I +GLLCVQE A DRPTM V+ ML +++ +P P+ P
Sbjct: 756 IDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPG 814
Query: 762 FSSIRGLKNTILPANGKARVCSG---NCLTLSEMDAR 795
+ R L +T ++ K R N +T+S +DAR
Sbjct: 815 YCLERSLLDTD-SSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 884 (316.2 bits), Expect = 2.8e-174, Sum P(2) = 2.8e-174
Identities = 199/399 (49%), Positives = 257/399 (64%)
Query: 407 RNNGQSIYIRVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWF---P 463
R +SI I+ P +L +SQD L NEL K +++ S+ + + P
Sbjct: 463 RKQKRSITIQTPIVDLV--RSQDSLM-----------NELVKASRSYTSKENKTDYLELP 509
Query: 464 MFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIK 523
+ +++ AT NFST+NKLG+GGFG VYKG LL+G+E+AVKRLS S QG +EF NE++
Sbjct: 510 LMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVR 569
Query: 524 LIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEGI 583
LIAKLQH NLVR + N SLD LFD T+ + L W R II GI
Sbjct: 570 LIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGI 629
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
A+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMARIFG +E ++ T+R+VGTY
Sbjct: 630 ARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTY 689
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRA 702
GYMSPEYA G+FS+KSDVFSFGVLLLE +S KRN F N+N L LLG W WK+ +
Sbjct: 690 GYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKE 749
Query: 703 WELIDP----TLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHP 757
E++DP L +E ++ IL R I +GLLCVQE A DRP M V+ ML ++T +P P
Sbjct: 750 LEIVDPINIDALSSEFPTHEIL-RCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQP 808
Query: 758 RQPAFSSIRG-LKNTILPANGKARVCSGNCLTLSEMDAR 795
++P F R L+ + + C+ N +TLS +DAR
Sbjct: 809 KRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 889 (318.0 bits), Expect = 6.1e-170, Sum P(2) = 6.1e-170
Identities = 197/396 (49%), Positives = 257/396 (64%)
Query: 407 RNNGQSIYIRVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFS 466
R +SI I+ P ++ +SQD L IN + +R +G + ++ P+
Sbjct: 459 RKQKRSITIQTP--NVDQVRSQDSL---INDVVVSR-----RGYTSKEKKSEYLELPLLE 508
Query: 467 LASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIA 526
L +++ AT NFS +NKLG+GGFG VYKGRLL+G+E+AVKRLS S QG +EF NE++LIA
Sbjct: 509 LEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIA 568
Query: 527 KLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
KLQH NLVR + N SLD LFD T+ + L W R II GIA+G
Sbjct: 569 KLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARG 628
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
LLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMARIFG +E ++ T+R+VGTYGYM
Sbjct: 629 LLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYM 688
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDRAWEL 705
SPEYA G+FS+KSDVFSFGVLLLE +S KRN F N+N L LLG W WK+ E+
Sbjct: 689 SPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEI 748
Query: 706 IDP----TLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQP 760
+DP +L ++ ++ IL R I +GLLCVQE A DRP M V+ ML ++T +P P++P
Sbjct: 749 VDPINIDSLSSKFPTHEIL-RCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRP 807
Query: 761 AFSSIRG-LKNTILPANGKARVCSGNCLTLSEMDAR 795
F R L+ + + C+ N +TLS +DAR
Sbjct: 808 GFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 3.6e-166, Sum P(3) = 3.6e-166
Identities = 187/322 (58%), Positives = 234/322 (72%)
Query: 451 KAANSRTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ 510
KA N+ S P+FSL +++ AT +F EN+LG GGFGPVYKG L +G+E+AVKRLS +
Sbjct: 507 KAVNT----SELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGK 562
Query: 511 SGQGQEEFKNEIKLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENL 570
SGQG +EFKNEI LIAKLQHRNLVR MPNKSLDFFLFD TK+ L
Sbjct: 563 SGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQAL 622
Query: 571 LGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630
+ W R IIEGIA+GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGMARIFGG+
Sbjct: 623 IDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGN 682
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL 690
+ ++ T R+VGTYGYMSPEYA +GLFS+KSDV+SFGVLLLE +S KRNT ++ +L+
Sbjct: 683 QNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLI 742
Query: 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750
G+AW L+ R+ EL+DP ++ S R I+V +LCVQ+ AA+RP M V+ ML +
Sbjct: 743 GYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESD 802
Query: 751 TINLPHPRQPAFSSIRGLKNTI 772
T L PRQP F+S R +N+I
Sbjct: 803 TATLAAPRQPTFTSTR--RNSI 822
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
Identities = 342/811 (42%), Positives = 465/811 (57%)
Query: 1 MENLHLLYNFISCVFILSIKLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYR 60
ME ++L+ I +F +I L+ A D + ++ ++DG+ +VS FE+GFFSPG S+ R
Sbjct: 1 MEATNVLHLLIISLFS-TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNR 59
Query: 61 YLGIWYKQIP-DTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKN 119
YLGIWYK+I T+VWVANR+SP++D + L +S G L L N N IWSS+ S
Sbjct: 60 YLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSS----- 114
Query: 120 PVAQLLDTGNLVVR--D--NF---SSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLER 172
P +Q N +V+ D N +S +DY+WQS D+P D L GMK G + TGL R
Sbjct: 115 PSSQKASLRNPIVQILDTGNLVVRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNR 174
Query: 173 YQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSY--SYLY 230
+ TSW++ DDPS GNYT+++D + +P+ SV + +GPWNG F +P+ + +Y
Sbjct: 175 FLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIY 234
Query: 231 KPTVVDNEDEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFY 290
+ V E+E+YY Y N V+ ++LNP+G +Q W + ++W + S C Y
Sbjct: 235 RYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQY 294
Query: 291 GHCGANSICSFDKKPHCECLKGFELKSHHNKTRPGTCVRSQSSD-CKSGDRFIMLDDVKL 349
CG+ C+ ++ P C CLKGF K+ P V S+ C R + LD K
Sbjct: 295 TLCGSYGSCNINESPACRCLKGFVAKT------PQAWVAGDWSEGCV---RRVKLDCGKG 345
Query: 350 PD-FVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRN 408
D F++ S + + + + KN KV C + DIR D
Sbjct: 346 EDGFLKISKLKLPDTRTSWYD--KNMDLNEC--KKVCLRNCTCSAY--SPFDIR---DGG 396
Query: 409 NGQSIYIRVPASELE-TKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSL 467
G ++ E + QD+ + I T E + + + D P L
Sbjct: 397 KGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSRVS-SRKQEEEDLELPFLDL 455
Query: 468 ASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAK 527
+VS AT+ FS NKLG+GGFGPVYKG L GQEVAVKRLS S QG EEFKNEIKLIAK
Sbjct: 456 DTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAK 515
Query: 528 LQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGL 587
LQHRNLV+ PNKSLD F+FD + L W RV II+GIA+G+
Sbjct: 516 LQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGM 575
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
LYLH+ SRLR+IHRDLKASN+LLD DMN KISDFG+AR GGDE ++ T R+VGTYGYMS
Sbjct: 576 LYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMS 635
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-NSLTLLGHAWDLWKDDRAWELI 706
PEY G FS+KSDVFSFGVL+LE +S +RN F N + L LLGHAW + +D+A+E+I
Sbjct: 636 PEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEII 695
Query: 707 DPTLQNEASYLI-LNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSI 765
D + + + + R I++GLLCVQ+D DRP M VV ML+++ + L PRQP F +
Sbjct: 696 DEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLD-PRQPGFFNE 754
Query: 766 RGLK-NTILPANGKARVCSGNCLTLSEMDAR 795
R L + + N + S N T+S +D R
Sbjct: 755 RNLLFSDTVSIN--LEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 7.5e-148, Sum P(2) = 7.5e-148
Identities = 170/334 (50%), Positives = 219/334 (65%)
Query: 463 PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEI 522
P+F ++ AT NFS NKLG+GGFG VYKGRL G ++AVKRLS SGQG EEF NE+
Sbjct: 498 PLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEV 557
Query: 523 KLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEG 582
+I+KLQHRNLVR MP LD +LFD K+ LL W TR II+G
Sbjct: 558 VVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDG 617
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
I +GL+YLH+ SRL++IHRDLKASNILLD+++NPKISDFG+ARIF G+E + T R+VGT
Sbjct: 618 ICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGT 677
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGHAWDLWKDDR 701
YGYM+PEYA GLFS KSDVFS GV+LLE +S +RN+ F N + L +AW LW
Sbjct: 678 YGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGE 737
Query: 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPA 761
L+DP + E + R ++VGLLCVQ+ A DRP++ V+ ML+++ NLP P+QPA
Sbjct: 738 DIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPA 797
Query: 762 FSSIRGLKNTILPANGKARVCSGNCLTLSEMDAR 795
F RG R N ++L+++ R
Sbjct: 798 FIPRRGTSEVESSGQSDPRASINN-VSLTKITGR 830
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.0e-145, Sum P(2) = 2.0e-145
Identities = 176/333 (52%), Positives = 224/333 (67%)
Query: 463 PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEI 522
P+FS SV++AT +F+ ENKLG+GGFG VYKG G+E+AVKRLS +S QG EEFKNEI
Sbjct: 511 PIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEI 570
Query: 523 KLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEG 582
LIAKLQHRNLVR MPNKSLD FLFD +K+ L W R +I G
Sbjct: 571 LLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGG 630
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
IA+GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDFGMARIF + + T R+VGT
Sbjct: 631 IARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702
YGYM+PEYA +G+FS KSDV+SFGVL+LE +S ++N F T+ +L+G+AW LW +
Sbjct: 691 YGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKT 750
Query: 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAF 762
E+IDP +++ R I+VG+LC Q+ RP M V+ ML ++T LP PRQP F
Sbjct: 751 KEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTF 810
Query: 763 SSIRGLKNTILPANGKARVCSGNCLTLSEMDAR 795
S + L +G V S N +T + + R
Sbjct: 811 HSFLNSGDIELNFDGHD-VASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 6.2e-142, Sum P(2) = 6.2e-142
Identities = 161/301 (53%), Positives = 213/301 (70%)
Query: 464 MFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIK 523
+F + ++ AT NFS+ NKLG+GGFGPVYKG+L++G+E+AVKRLSS SGQG +EF NEI+
Sbjct: 507 LFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSSSSGQGTDEFMNEIR 566
Query: 524 LIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEGI 583
LI+KLQH+NLVR + NKSLD FLFDST + + W R II+G+
Sbjct: 567 LISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKFEIDWQKRFNIIQGV 626
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
A+GLLYLH+ SRLRVIHRDLK SNILLD+ M PKISDFG+AR+ G + Q T+R+VGT
Sbjct: 627 ARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQYQDNTRRVVGTL 686
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703
GYM+PEYA G+FS KSD++SFGVLLLE + ++ + FS TLL +AW+ W + +
Sbjct: 687 GYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSEEGK-TLLAYAWESWCETKGV 745
Query: 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTIN-LPHPRQPAF 762
+L+D L + + + R + +GLLCVQ ADRP E++SMLT TI+ LP P+QP F
Sbjct: 746 DLLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMSMLT--TISELPSPKQPTF 803
Query: 763 S 763
+
Sbjct: 804 T 804
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1385 (492.6 bits), Expect = 1.3e-141, P = 1.3e-141
Identities = 335/818 (40%), Positives = 461/818 (56%)
Query: 12 SCVFILSI--KLSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQI 69
+C+ +L I AA N + IR + L S +ELGFFSP ++ +Y+GIW+K+I
Sbjct: 7 ACLLLLIIFPTCGYAAINTSSPLSIR--QTLSSPGGFYELGFFSPNNTQNQYVGIWFKKI 64
Query: 70 -PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTG 128
P +VWVANR++P+ S A LTIS+ G L+LL+ IWS+ + A+LLDTG
Sbjct: 65 VPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHAELLDTG 124
Query: 129 NLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNY 188
N VV D+ S N LWQSF+H +T+L L +D G +R T+WKS+ DPSPG +
Sbjct: 125 NFVVIDDVSGNK----LWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEF 180
Query: 189 THRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSY--SYLYKPTVVDNE--DEIYYR 244
+ + + + GSV GPW F+ I SY+ +VV + +
Sbjct: 181 SLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAGTGSFS 240
Query: 245 YDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKK 304
Y + + + + L P GK++ ++W++ N W+ SLP+ C YG CG +C
Sbjct: 241 YSTLRNYNLSYVTLTPEGKMK-ILWDDGNN-WKLHLSLPENPCDLYGRCGPYGLCVRSDP 298
Query: 305 PHCECLKGFELKSHHNKTR---PGTCVRSQSSDC----------KSGDRFIMLDDVKLPD 351
P CECLKGF KS + CVR C K D F + DVK PD
Sbjct: 299 PKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTPD 358
Query: 352 FVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRNNGQ 411
+ + +N ++C CL NC+C A+A G GCL+W G+L D ++G+
Sbjct: 359 LHQFA--SFLNAEQCYQGCLGNCSCTAFAYIS----GIGCLVWNGELADT--VQFLSSGE 410
Query: 412 SIYIRVPASELE-TKKSQDMLQFDINMSI----ATRANEL----CKGNKA-ANSRTRD-- 459
++IR+ +SEL + + + ++ +++SI A L K N A N R
Sbjct: 411 FLFIRLASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDV 470
Query: 460 SWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFK 519
S F + ++ AT NFS NKLG+GGFGPVYKG+L++G+E+ VKRL+S SGQG EEF
Sbjct: 471 SGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFM 530
Query: 520 NEIKLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRI 579
NEI LI+KLQHRNLVR M NKSLD F+FD + L W R I
Sbjct: 531 NEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNI 590
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
I+GIA+GLLYLH+ SRLRVIHRDLK SNILLD MNPKISDFG+AR+F G + Q T+R+
Sbjct: 591 IQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRV 650
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS-NTNSLTLLGHAWDLWK 698
VGT GYMSPEYA GLFS KSD++SFGVL+LE +S KR + F S LL + WD W
Sbjct: 651 VGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWC 710
Query: 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPR 758
+ L+D L + + R + +GLLCVQ +A DRP +V+SMLT+ T +LP P+
Sbjct: 711 ETGGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSAT-DLPVPK 769
Query: 759 QPAFSSIRGLKNT-ILPANGKARVCSGNCLTLSEMDAR 795
QP F+ + L + +L AN + + S N +T S + R
Sbjct: 770 QPIFA-VHTLNDMPMLQANSQDFL-SVNEMTESMIQGR 805
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 5.6e-141, Sum P(2) = 5.6e-141
Identities = 189/373 (50%), Positives = 246/373 (65%)
Query: 424 TKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSLASVSAATANFSTENKL 483
T+ Q+ DI+ SI R ++ + K+ + ++SL + AT+NFS NKL
Sbjct: 486 TQSQQNSAMLDISQSI--RFDDDVEDGKSHELK-------VYSLDRIRTATSNFSDSNKL 536
Query: 484 GEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRXXXXXXXX 543
GEGGFGPVY G L G+EVAVKRL SGQG EEFKNE+ LIAKLQHRNLVR
Sbjct: 537 GEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPR 596
Query: 544 XXXXXXXXXMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 603
MPNKSLD FLF+ K+ LL W R IIEGIA+GLLYLH+ SRLRV+HRDL
Sbjct: 597 EEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDL 656
Query: 604 KASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVF 663
KASNILLD DM PKISDFGMAR+FGGD+ Q T R+VGT+GYMSPEYA +G+FS+KSDV+
Sbjct: 657 KASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVY 716
Query: 664 SFGVLLLETLSSKRNTDFS-NTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRY 722
FGVL+LE ++ KR F + +SL + G+AW W +D A ELIDP ++ S + R
Sbjct: 717 GFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRC 776
Query: 723 INVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSSIRGLKNTILPANGKARVC 782
I++ LLCVQ+ A +RP + V+ ML+N + +LP+PR P +RG + ++ K R
Sbjct: 777 IHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLM-LRGREIESSKSSEKDRSH 835
Query: 783 SGNCLTLSEMDAR 795
S +T++++ R
Sbjct: 836 SIGTVTMTQLHGR 848
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4655 | 0.9635 | 0.9782 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pg.C_LG_XI001046 | hypothetical protein (802 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 795 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-57 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-42 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-40 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-37 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-36 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-34 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 5e-34 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-27 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 8e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-26 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-26 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.004 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 3e-57
Identities = 96/283 (33%), Positives = 134/283 (47%), Gaps = 43/283 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNL 533
KLGEG FG VYKG L EVAVK L S Q EEF E +++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
V+LLG C E E +++ EYMP L +L + L + IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMSPEYAQ 652
IHRDL A N L+ +++ KISDFG++R ++ D + K ++ +M+PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA-WDLWKDDRAWELID---- 707
+G F+ KSDV+SFGVLL E + LG + + E +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT---------------LGEEPYPGMSNAEVLEYLKKGYR 222
Query: 708 ---PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
P Y ++ L C ED DRPT E+V +L
Sbjct: 223 LPKPPNCPPELYKLM-------LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 7e-56
Identities = 98/299 (32%), Positives = 136/299 (45%), Gaps = 68/299 (22%)
Query: 481 NKLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVR 535
KLGEG FG VYKG+L EVAVK L S + +++F E +++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFL------FDSTKENLLGWGTRVRIIEGIAQGLLY 589
LLG C E E L+ EYM L +L F S +++ L + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMSP 648
L + +HRDL A N L+ +D+ KISDFG++R ++ D + KT + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID- 707
E + G+F+ KSDV+SFGVLL WE+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLL---------------------------------WEIFTL 203
Query: 708 -----PTLQN-EASYLILNRYI------------NVGLLCVQEDAADRPTMFEVVSMLT 748
P L N E + Y + L C Q D DRPT E+V L
Sbjct: 204 GATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-55
Identities = 94/283 (33%), Positives = 133/283 (46%), Gaps = 44/283 (15%)
Query: 480 ENKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNL 533
KLGEG FG VYKG+L EVAVK L S Q EEF E +++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
V+LLG C E E ++ EYM L +L L + IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMSPEYAQ 652
IHRDL A N L+ +++ KISDFG++R ++ D + + ++ +M+PE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLK 176
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA-WDLWKDDRAWELID---- 707
+G F+ KSDV+SFGVLL E + LG + ++ E +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLEYLKNGYR 221
Query: 708 ---PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
P Y ++ L C ED DRPT E+V +L
Sbjct: 222 LPQPPNCPPELYDLM-------LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-51
Identities = 79/193 (40%), Positives = 108/193 (55%), Gaps = 11/193 (5%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
LGEGGFG VY R G++VA+K + S EE EI+++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
+ L+ EY SL L + E L +RI+ I +GL YLH +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 601 RDLKASNILLDKD-MNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-YAQQGLFSI 658
RDLK NILLD D K++DFG++++ D+ KT IVGT YM+PE +G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 659 KSDVFSFGVLLLE 671
KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 77/200 (38%), Positives = 109/200 (54%), Gaps = 13/200 (6%)
Query: 482 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVR 535
KLGEG FG VYKG L +VAVK L + + +EEF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
LLG C + E ++ EYMP L FL L +++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+HRDL A N L+ +++ KISDFG++R I+ D + + + +M+PE + G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179
Query: 655 LFSIKSDVFSFGVLLLETLS 674
F+ KSDV+SFGVLL E +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 88/273 (32%), Positives = 126/273 (46%), Gaps = 23/273 (8%)
Query: 477 FSTENKLGEGGFGPVYKGRLLN-GQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ KLG G FG VYK + G+ VAVK L S+ + + + EI+++ +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
VRL+ + + L+ EY L +L ++ L +I I +GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-YAQ 652
+IHRDLK NILLD++ KI+DFG+A+ S VGT YM+PE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLG 172
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLG-HAWDLWKDDRAWELIDPTLQ 711
+ K DV+S GV+L E L+ FS N L L L E +
Sbjct: 173 GNGYGPKVDVWSLGVILYELLT--GKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVV 744
EA LI C+ +D + RPT E++
Sbjct: 231 EEAKDLIKK--------CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 85/269 (31%), Positives = 118/269 (43%), Gaps = 23/269 (8%)
Query: 477 FSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEE-FKNEIKLIAKLQHRNLV 534
+ KLGEG FG VY R G+ VA+K + + + E EIK++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
RL + ++ L+ EY L L K L + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
++HRDLK NILLD+D + K++DFG+AR E K VGT YM+PE
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714
+ D++S GV+L E L+ K F + L L + K + + + EA
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLELFKK--IGKPKPPFPPPEWDISPEA 227
Query: 715 SYLILNRYINVGLLCVQEDAADRPTMFEV 743
LI LL D R T E
Sbjct: 228 KDLIRK------LLVK--DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 9e-42
Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 30/267 (11%)
Query: 481 NKLGEGGFGPVYKGRLL-NGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
LG G FG VY G+ +AVK LS S + E + EI++++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 538 GCCIELEEK-ILIY-EYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
G + E+ + I+ EY+ SL L F E ++ TR I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-----QILEGLAYLH-- 118
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
++HRD+K +NIL+D D K++DFG A+ G E T + GT +M+PE +
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID-PTLQN 712
+ +D++S G ++E + K +S + L+K + E + P +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP--PWSELGN-----PMAALYKIGSSGEPPEIPEHLS 230
Query: 713 EASYLILNRYINVGLLCVQEDAADRPT 739
E + L + C++ D RPT
Sbjct: 231 EEAKDFLRK-------CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 56/115 (48%), Positives = 70/115 (60%), Gaps = 6/115 (5%)
Query: 70 PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGN 129
T+VWVANR +P+ DS+ L + + G LVL + +WSSN S + VA L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPS 184
LV+ DN S LWQSFDHP+DTLL G K G ++ G R TSWKS+ DPS
Sbjct: 61 LVLYDN-----SGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 75/203 (36%), Positives = 110/203 (54%), Gaps = 16/203 (7%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
F+ E KLG G FG V++G N VA+K L S Q++F+ E++ + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDS-----TKENLLGWGTRVRIIEGIAQGLLYLH 591
C E +I E M SL FL +L+ +V A+G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV------AEGMAYLE 121
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+ IHRDL A NIL+ +D+ K++DFG+AR+ D S K+I Y + +PE A
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAA 176
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
G FS KSDV+SFG+LL E +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 73/225 (32%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 481 NKLGEGGFGPVYKGRLLN-----GQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLV 534
+LGEG FG V R G++VAVK L+ S Q + +F+ EI+++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 535 RLLGCCIELEEKI--LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ G C + + LI EY+P+ SL +L ++ + + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINL-KRLLLFSSQICKGMDYLGS 127
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIVGTYGYMSPEY 650
R IHRDL A NIL++ + KISDFG+A++ D K + Y +PE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD 695
+ FS SDV+SFGV L E + + L ++G A
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-37
Identities = 53/122 (43%), Positives = 70/122 (57%), Gaps = 6/122 (4%)
Query: 31 SRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVL 90
S + G+ LVSS FELGFF Y I YK T+VWVANR++P S+ L
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTL 59
Query: 91 TISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFD 150
T+ + G LV+ + + +WSSN +R N V LLD GNLV+ D S ++LWQSFD
Sbjct: 60 TLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD-----SDGNFLWQSFD 114
Query: 151 HP 152
+P
Sbjct: 115 YP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 17/200 (8%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
F K+G+GGFG VYK R G+EVA+K + +S + +E+ NEI+++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDST----KENLLGWGTRVRIIEGIAQGLLYLH 591
G ++ +E ++ E+ SL L ST E+ + + + + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-----VCKELLKGLEYLH 115
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRD+KA+NILL D K+ DFG++ +VGT +M+PE
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVI 169
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 170 NGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRN 532
N+ + +G G FG VYKG L G VA+K++S + + + EI L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 533 LVRLLGCCIELEEKILIY-EYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLY 589
+V+ +G IE + + I EY N SL + F E+L+ + + QGL Y
Sbjct: 61 IVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVLQGLAY 114
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
LH+ VIHRD+KA+NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPE 169
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ S SD++S G ++E L+
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 75/198 (37%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
E KLG G FG V+ G +VAVK L + E F E +++ KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
C E E ++ EYM SL FL + L V + IA+G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQQ 653
IHRDL A NIL+ +++ KI+DFG+AR+ DE ++ G + +PE A
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANY 178
Query: 654 GLFSIKSDVFSFGVLLLE 671
G F+IKSDV+SFG+LL E
Sbjct: 179 GRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 80/231 (34%), Positives = 121/231 (52%), Gaps = 32/231 (13%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRL--LNGQE----VAVKRL-SSQSGQGQEE 517
L++V F E LGEG FG VYKG L N + VA+K L + + Q+E
Sbjct: 2 IPLSAV-----RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE 54
Query: 518 FKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLF-------------D 564
F+ E +L++ LQH N+V LLG C + + +++EY+ + L FL D
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 565 STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
T ++ L + I IA G+ YL S +HRDL A N L+ + + KISDFG++
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 625 R-IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R I+ D + ++K ++ +M PE G F+ +SD++SFGV+L E S
Sbjct: 172 RDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 51/121 (42%), Positives = 70/121 (57%), Gaps = 7/121 (5%)
Query: 31 SRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVL 90
S + G+ LVS + FELGFF+ + Y I YK T+VWVANR++P+ D + L
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNPVSD-SCTL 58
Query: 91 TISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFD 150
T+ + G LVL + +WSSN + N V LLD GNLV+ D S ++LWQSFD
Sbjct: 59 TLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD-----SDGNFLWQSFD 113
Query: 151 H 151
+
Sbjct: 114 Y 114
|
Length = 114 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 87/283 (30%), Positives = 123/283 (43%), Gaps = 43/283 (15%)
Query: 481 NKLGEGGFGPVYKG--RLLNGQE--VAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+LG G FG V KG + +G+E VAVK L G++EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDS---TKENLLGWGTRVRIIEGIAQGLLYLHQ 592
L+G C E +L+ E P L +L +L +V A G+ YL
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARI--FGGDELQSKT--KRIVGTYGYMSP 648
+HRDL A N+LL KISDFGM+R G D ++ T + + Y +P
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---AP 167
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706
E G FS KSDV+S+GV L E S +K + + +L L +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR-------- 219
Query: 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
P + Y I+ C + DRPT E+ S
Sbjct: 220 -PEECPQEIYSIMLS-------CWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 89/279 (31%), Positives = 138/279 (49%), Gaps = 36/279 (12%)
Query: 480 ENKLGEGGFGPVYKGRL-LNGQE---VAVKRLSSQSGQGQE-EFKNEIKLIAKLQHRNLV 534
E +G G FG V +GRL L G++ VA+K L + S Q +F E ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
RL G + ++I EYM N SLD FL + G V ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK--RIVGTYGYMSPEYAQ 652
+ +HRDL A NIL++ ++ K+SDFG++R E TK +I + +PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIA 181
Query: 653 QGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710
F+ SDV+SFG+++ E +S + D SN + + + + L P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-----------PPP 230
Query: 711 QN--EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ A Y ++ L C Q+D +RPT ++VS L
Sbjct: 231 MDCPSALYQLM-------LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 79/262 (30%), Positives = 128/262 (48%), Gaps = 29/262 (11%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
++G G FG V+ G L ++VA+K + + +E+F E +++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 542 ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 601
E L++E+M + L +L + T + + + +G+ YL + VIHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 602 DLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQQGLFSI 658
DL A N L+ ++ K+SDFGM R D+ S T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA-WELIDPTLQNEASYL 717
KSDV+SFGVL+ E S + + +NS ++ + A + L P L +++ Y
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYKPRLASQSVYE 232
Query: 718 ILNRYINVGLLCVQEDAADRPT 739
++ C +E DRP+
Sbjct: 233 LMQH-------CWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 82/277 (29%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLVRLLGCC 540
K+G+G FG VYKG L EVAVK S +F E +++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
++ + ++ E +P SL FL K+N L +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 601 RDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
RDL A N L+ ++ KISDFGM+R G + K+I + +PE G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID-------PTLQ 711
+SDV+S+G+LL ET S +T + + + E I+ P L
Sbjct: 175 ESDVWSYGILLWETF-SLGDTPYPG-------------MSNQQTRERIESGYRMPAPQLC 220
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
E Y ++ C D +RP+ E+ + L
Sbjct: 221 PEEIYRLML-------QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 17/195 (8%)
Query: 482 KLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+GEG G VYK G+EVA+K++ + Q +E NEI ++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 541 IELEEKILIYEYMPNKSL----DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
+ +E ++ EYM SL + + + + QGL YLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI------AYVCREVLQGLEYLHS---Q 135
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
VIHRD+K+ NILL KD + K++DFG A + +SK +VGT +M+PE ++ +
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 657 SIKSDVFSFGVLLLE 671
K D++S G++ +E
Sbjct: 194 GPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 35/229 (15%)
Query: 483 LGEGGFGPVYKGRLLNGQE------VAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLVR 535
LGEG FG V+ G + + VAVK L + S +++F+ E +L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFL-----------------FDSTKENLLGWGTRVR 578
G C E + I+++EYM + L+ FL + T LL +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL------Q 126
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTK 637
I IA G++YL + +HRDL N L+ D+ KI DFGM+R ++ D +
Sbjct: 127 IAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH 183
Query: 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686
++ +M PE F+ +SDV+SFGV+L E + + + +N
Sbjct: 184 TMLPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 483 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542
LG G FG V+ G+ +VA+K + + +++F E K++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 602
++ EYM N L +L ++ LG + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 603 LKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQQGLFSIK 659
L A N L+ +D K+SDFG+AR D+ S GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 660 SDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717
SDV+SFGVL+ E S + FSN+ + + + L++ P L Y
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---------PKLAPTEVYT 232
Query: 718 ILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
I+ C E DRP +++S LT
Sbjct: 233 IMY-------SCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRN 532
++ LG+G G VYK R G+ A+K++ + +++ E+K + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYL 590
+V+ G + E ++ EYM SL L K E +L + R I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-----QILKGLDYL 115
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H + +IHRD+K SN+L++ KI+DFG++++ Q T VGT YMSPE
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPER 171
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID--- 707
Q +S +D++S G+ LLE K F + +EL+
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK--FPFLPPGQPSF-------------FELMQAIC 216
Query: 708 ----PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTIN 753
P+L E +I+ C+Q+D RP+ E +L + I
Sbjct: 217 DGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE---LLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 88/265 (33%), Positives = 129/265 (48%), Gaps = 29/265 (10%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
KLG G FG V++G N VAVK L + ++F E +++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 542 ELEEKILIY-EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
LEE I I E M SL +L L + + +A G+ YL + IH
Sbjct: 72 -LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQQGLFS 657
RDL A N+L+ ++ K++DFG+AR+ D +++ G + +PE A FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 658 IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717
IKSDV+SFG+LL E ++ R TN A L + D+ + + P + Y
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQGYRMPCPPGCPKELYD 235
Query: 718 ILNRYINVGLLCVQEDAADRPTMFE 742
I+ L C +ED DRPT FE
Sbjct: 236 IM-------LDCWKEDPDDRPT-FE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 95/286 (33%), Positives = 139/286 (48%), Gaps = 48/286 (16%)
Query: 483 LGEGGFGPVYKG-RLLNGQEVAVKR--LSSQSGQGQE---EFKNEIKLIAKLQHRNLVRL 536
LG G FG VY+G L +G AVK L+ GQE + + EI L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 537 LGCCIELEEKILIY-EYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
LG E E+ + I+ E +P SL L + S E ++ TR I GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY-AQ 652
R +HRD+K +NIL+D + K++DFGMA+ S K G+ +M+PE AQ
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRN-TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
QG + + +D++S G +LE + K + ++ +G + +L I L
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-------PPIPDHLS 228
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHP 757
+EA I L C+Q D + RPT + L L HP
Sbjct: 229 DEAKDFI--------LKCLQRDPSLRPT----AAEL------LEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 483 LGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VYKG + VA+K L ++ + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKE----NLLGWGTRVRIIEGIAQGLLYLHQ 592
LG C+ + LI + MP L ++ + LL W + IA+G+ YL +
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
R++HRDL A N+L+ + KI+DFG+A++ DE + + +M+ E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+++ KSDV+S+GV + E ++
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 3e-30
Identities = 78/311 (25%), Positives = 126/311 (40%), Gaps = 20/311 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQH-R 531
++ KLGEG FG VY R + + VA+K L+ + + E F EI+++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
N+V+L + L+ EY+ SL+ L ++ L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 592 QYSRLRVIHRDLKASNILLDKDMN-PKISDFGMARIFGGD----ELQSKTKRIVGTYGYM 646
+IHRD+K NILLD+D K+ DFG+A++ + + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 647 SPEYAQQGLF---SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703
+PE S SD++S G+ L E L+ F + + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPT- 232
Query: 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFS 763
+ L LI ++ + +D +R + +S + L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 764 SIRGLKNTILP 774
L
Sbjct: 293 KPDDSAPLRLS 303
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
++G+G FG VY R +G+ +K LS+ S + +E+ NE+K++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKEN-------LLGWGTRVRIIEGIAQGLLYL 590
E + ++ EY L + KE +L W + + L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H SR +++HRD+K NI L + K+ DFG++++ +KT +VGT Y+SPE
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKR 677
Q ++ KSD++S G +L E + K
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 483 LGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLV 534
LG G FG VY+G + VAVK L + Q ++EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN----LLGWGTRVRIIEGIAQGLLYL 590
+LLG C+ E + +I E M L +L D+ E LL + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 591 HQYSRLRVIHRDLKASNILL-----DKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYG 644
Q + IHRDL A N L+ D D KI DFG+AR I+ D + + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE G F+ +SDV+SFGVL+ E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 88/266 (33%), Positives = 126/266 (47%), Gaps = 28/266 (10%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
KLG G FG V+ G +VA+K L S E F E L+ +LQH LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 540 CIELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+ E +I EYM N SL DF + L + + IA+G+ ++ R
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNY 123
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY--GYMSPEYAQQGLF 656
IHRDL+A+NIL+ + + KI+DFG+AR+ +E T R + + +PE G F
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTF 180
Query: 657 SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716
+IKSDV+SFG+LL E ++ R TN + +R + + P E Y
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-------ERGYRMPRPDNCPEELY 233
Query: 717 LILNRYINVGLLCVQEDAADRPTMFE 742
+ LC +E +RPT FE
Sbjct: 234 -------ELMRLCWKEKPEERPT-FE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 15/220 (6%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLLNGQEVAVKR--LSSQSGQGQEEFKNEIKLIAKLQHRN 532
+F NK+G+G FG V+K R + + A+K+ LS + + +EE +E +++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL---LGWGTRVRIIEGIAQGLLY 589
++R ++ + ++ EY N L L L W R I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
LH +++HRD+K+ N+ LD N KI D G+A++ + + T IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689
+ ++ KSDV++ GV+L E + K D +N +L L
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 67/198 (33%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 483 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542
+G+G FG V G GQ+VAVK L S Q F E ++ L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 602
++ EYM SL +L S ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 603 LKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY--GYMSPEYAQQGLFSIKS 660
L A N+L+ +D+ K+SDFG+A+ + Q + G + +PE ++ FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTKS 180
Query: 661 DVFSFGVLLLETLSSKRN 678
DV+SFG+LL E S R
Sbjct: 181 DVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEF----KNEIKLIAKLQHRNLVR 535
++GEG +G VYK R G+ VA+K++ + +E F EIKL+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 536 LLGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
L + +++EYM + D + E ++ + +GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE---- 649
++HRD+K SNIL++ D K++DFG+AR + T R++ T Y PE
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 650 ---YAQQGLFSIKSDVFSFGVLLLETLSSK 676
Y + D++S G +L E K
Sbjct: 176 ATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 73/231 (31%), Positives = 107/231 (46%), Gaps = 24/231 (10%)
Query: 471 SAATANFSTENKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SSQSGQGQEEFKNEIK 523
+ + LG G FG VY+G R +G +VAVK L S S Q + +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRI 579
+++K H+N+VRL+G E + ++ E M L FL ++ + + L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMARIFGGDELQSKT 636
+A+G YL + IHRD+ A N LL KI+DFGMAR K
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-------SKRNTD 680
R + +M PE G+F+ K+DV+SFGVLL E S + N +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-27
Identities = 33/67 (49%), Positives = 47/67 (70%), Gaps = 1/67 (1%)
Query: 335 CKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMW 394
C GD F+ L ++KLPD A ++ S+ +KECE CL NC+C AYA + + G GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRG-GSGCLIW 59
Query: 395 FGDLIDI 401
G+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 64/197 (32%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 483 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+G FG V R + G+ A+K L + + E E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ EEK+ L+ EY P L L +KE I L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLH---SLG 113
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+I+RDLK NILLD D + K++DFG+A+ + S+T GT Y++PE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 658 IKSDVFSFGVLLLETLS 674
D +S GVLL E L+
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 87/290 (30%), Positives = 124/290 (42%), Gaps = 34/290 (11%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQG-QEEFKNEIKLIAK 527
+N LG G FG V+ + +E V VK L + Q EF+ E+ + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFL------FDSTKENLLGWGTRVRIIE 581
L H+N+VRLLG C E E +I EY L FL + K L +V +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVG 641
IA G+ +L S R +HRDL A N L+ K+S +++ E K + +
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALI 180
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR--NTDFSNTNSLTLLGHAWDLWKD 699
+++PE Q+ FS KSDV+SFGVL+ E + S+ L L A L
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-AGKL--- 236
Query: 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
EL P Y ++ R C + DRP+ E+VS L
Sbjct: 237 ----ELPVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 87/271 (32%), Positives = 133/271 (49%), Gaps = 30/271 (11%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
KLG G FG V+ G N +VAVK L + + F E L+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 542 ELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
+ E +I EYM SL DF D + LL + IA+G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
RDL+A+N+L+ + + KI+DFG+AR+ +E ++ + +PE G F+IKS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185
Query: 661 DVFSFGVLLLETLSSKR--NTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN--EASY 716
DV+SFG+LL E ++ + SN++ ++ L + + P ++N + Y
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-----------PRMENCPDELY 234
Query: 717 LILNRYINVGLLCVQEDAADRPTMFEVVSML 747
I+ C +E A +RPT + S+L
Sbjct: 235 DIMK-------TCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRL 536
+LG G G V K G+ +AVK + + + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFL---FDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
G + + EYM SLD L E +LG +I + +GL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH-- 117
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ ++IHRD+K SNIL++ K+ DFG++ G + S K VGT YM+PE Q
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQG 173
Query: 654 GLFSIKSDVFSFGVLLLE 671
+S+KSD++S G+ L+E
Sbjct: 174 NDYSVKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNL 533
++LGEG G V K RL N + A+K +++ Q++ E+++ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 534 VRLLGCCI-ELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRV------RIIEGIAQ 585
V+ G + E I I EY SLD S + + G R+ +I E + +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645
GL YLH ++IHRD+K SNILL + K+ DFG++ G+ + S GT Y
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFY 169
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLE 671
M+PE Q +SI SDV+S G+ LLE
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 87/295 (29%), Positives = 145/295 (49%), Gaps = 39/295 (13%)
Query: 482 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSSQSGQ-GQEEFKNEIK 523
KLGEG FG V+ ++ VAVK L + + + +F EIK
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLF------DSTKENL--LGWGT 575
++++L+ N++RLL CI + +I EYM N L+ FL + K ++ + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 576 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQS 634
+ + IA G+ YL S L +HRDL N L+ K+ KI+DFGM+R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW 694
+ R V +MS E G F+ SDV++FGV L E L+ + +S + ++ +
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247
Query: 695 DLWKDD-RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
+ ++D R L P L ++ Y ++ L C + +A +RP+ E+ + L
Sbjct: 248 EFFRDQGRQVYLPKPALCPDSLYKLM-------LSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 81/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 483 LGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGQE-EFKNEIKLIAKLQHRNLVR 535
LG+G FG VY+G VA+K ++ + + EF NE ++ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLF----DSTKENLLGWGTRVRIIE---GIAQGLL 588
LLG + +++ E M L +L ++ LG T + I+ IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMS 647
YL + +HRDL A N ++ +D+ KI DFGM R I+ D + K ++ +M+
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WMA 189
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705
PE + G+F+ KSDV+SFGV+L E TL+ + SN L + L +
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE----- 244
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
++ L+ +C Q + RPT E+VS L
Sbjct: 245 ---NCPDKLLELM--------RMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-26
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 2/108 (1%)
Query: 212 SGPWNGAIFAAIP--SYSYLYKPTVVDNEDEIYYRYDSYNSPVIMTLKLNPSGKIQHLIW 269
SGPWNG F+ IP Y +N +E+YY Y N+ + L L+ G ++ W
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERFTW 62
Query: 270 NERNRTWEAFFSLPDRFCQFYGHCGANSICSFDKKPHCECLKGFELKS 317
++ W F+S P C YG CG C + P C C+KGF K+
Sbjct: 63 IPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 75/201 (37%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 483 LGEGGFGPV--YKGRLLN---GQEVAVKRLSSQSGQGQEE-FKNEIKLIAKLQHRNLVRL 536
LGEG FG V Y N G+ VAVK L + GQ +K EI ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 537 LGCCIELEEKI--LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
GCC E K LI EY+P SL +L ++ L + + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
IHRDL A N+LLD D KI DFG+A+ + G E + + + E ++
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 654 GLFSIKSDVFSFGVLLLETLS 674
FS SDV+SFGV L E L+
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 88/298 (29%), Positives = 131/298 (43%), Gaps = 43/298 (14%)
Query: 482 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SSQSGQGQEEFKNEIK 523
KLGEG FG V+ Q+ VAVK L S +E+F E+K
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFL--------FDSTKENLLGWGT 575
++++L N+ RLLG C +I EYM N L+ FL + L + T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 576 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGD--EL 632
+ + IA G+ YL L +HRDL N L+ K+ KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692
Q R +M+ E G F+ KSDV++FGV L E L+ R + + ++ +
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245
Query: 693 AWDLWKDDRAWELID-PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
A ++DD + P + Y + L C + D DRPT E+ L
Sbjct: 246 AGHFFRDDGRQIYLPRPPNCPKDIY-------ELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 71/226 (31%), Positives = 112/226 (49%), Gaps = 23/226 (10%)
Query: 482 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+LGEG FG V+ LL Q+ VAVK L S +++F+ E +L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFL---------FDSTKE---NLLGWGTRVRIIEGI 583
G C E ++++EYM + L+ FL ++ L G + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
A G++YL + L +HRDL N L+ + + KI DFGM+R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT--DFSNTNSL 687
+M PE F+ +SD++SFGV+L E + + SNT ++
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 84/285 (29%), Positives = 142/285 (49%), Gaps = 47/285 (16%)
Query: 480 ENKLGEGGFGPVYKGRL-LNGQE---VAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
+ +G G FG V++G L + G++ VA+K L + Q ++F +E ++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKE----NLLGWGTRVRIIEGIAQGLLYL 590
RL G + + ++I EYM N +LD +L D E L+G ++ GIA G+ YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL 123
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG------ 644
S + +HRDL A NIL++ ++ K+SDFG++R+ D + T T G
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIR 175
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTNSLTLLGHAWDLWKDDRA 702
+ +PE F+ SDV+SFG+++ E +S + D SN + + +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---------NDG 226
Query: 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ L P A Y ++ L C Q+D A RP ++V++L
Sbjct: 227 FRLPAPMDCPSAVYQLM-------LQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 71/211 (33%), Positives = 116/211 (54%), Gaps = 26/211 (12%)
Query: 483 LGEGGFGPVYKG-RLLNGQEVAVKR--LSSQSGQGQ-------EEFKNEIKLIAKLQHRN 532
+G G FG VY G +G+ +AVK+ L S S + + EI L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVR-IIEGIAQGLLY 589
+V+ LG ++ + + EY+P S+ L + + +E L VR + I +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL------VRNFVRQILKGLNY 121
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR----IVGTYGY 645
LH +R +IHRD+K +NIL+D KISDFG+++ + L +KT + G+ +
Sbjct: 122 LH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
M+PE +Q ++ K+D++S G L++E L+ K
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
KLG G FG V+ G +VAVK L + E F E +++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
E E ++ EYM SL FL D L V + +A G+ Y+ R+ I
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY--GYMSPEYAQQGLFS 657
HRDL+++NIL+ + KI+DFG+AR+ +E T R + + +PE A G F+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFT 181
Query: 658 IKSDVFSFGVLLLETLSSKR 677
IKSDV+SFG+LL E ++ R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 31/226 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR---LLNGQE---VAVKRLSSQ-SGQGQEEFKNEIKLIAKL 528
N +G+G FG V++ R LL + VAVK L + S Q +F+ E L+A+
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFD---STKENLLGWGTRVR------- 578
H N+V+LLG C + L++EYM L+ FL + +L + R
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 579 ---------IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFG 628
I + +A G+ YL S + +HRDL N L+ ++M KI+DFG++R I+
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
D ++ + +M PE ++ +SDV+++GV+L E S
Sbjct: 183 ADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 84/277 (30%), Positives = 119/277 (42%), Gaps = 34/277 (12%)
Query: 482 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRL 536
KLG+G FG V +G VAVK L S ++F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE---GIAQGLLYLHQ 592
G + L + ++ E P SL D +++ LG + + IA G+ YL
Sbjct: 62 YG--VVLTHPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIVGTYGYMSPEY 650
R IHRDL A NILL D KI DFG+ R D + V + + +PE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710
+ FS SDV+ FGV L E + ++ + + L K D+ E ++
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP-WAGLSGSQI------LKKIDKEGERLE--- 221
Query: 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ EA NV L C + ADRPT + L
Sbjct: 222 RPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
F KLGEG +G VYK GQ VA+K + + +E EI ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 536 LLGCCIELEEKILIYEY-----------MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
G + + ++ EY + NK+L E + I+
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT--------EEEIA-----AILYQTL 109
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
+GL YLH + IHRD+KA NILL+++ K++DFG++ +K ++GT
Sbjct: 110 KGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPF 164
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+M+PE Q+ ++ K+D++S G+ +E
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 65/219 (29%), Positives = 113/219 (51%), Gaps = 29/219 (13%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGQ--EEFKNEIKLIAKLQHRNLVR 535
LG G F Y+ R + G +AVK+++ + S Q + E + EI+L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
+LG E L E+M S+ L + + KE ++ + E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 594 SRLRVIHRDLKASNILLDKD-MNPKISDFGMA-----RIFGGDELQSKTKRIVGTYGYMS 647
++IHRD+K +N+L+D +I+DFG A + G E Q + ++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFMA 176
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSK---RNTDFSN 683
PE + + DV+S G +++E ++K SN
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 77/226 (34%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 470 VSAATANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGQEEFKNEI 522
++ +T F E LGE FG VYKG L Q VA+K L ++ G +EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 523 KLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLF-------------DSTKEN 569
+ ++LQH N+V LLG + + +I+ Y + L FL D T ++
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 570 LLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFG 628
L V I+ IA G+ +L S V+H+DL N+L+ +N KISD G+ R ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
D + ++ +MSPE G FSI SD++S+GV+L E S
Sbjct: 177 ADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 86/272 (31%), Positives = 128/272 (47%), Gaps = 37/272 (13%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+LG G FG V G+ +VA+K + S ++EF E K++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 542 ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE---GIAQGLLYL--HQYSRL 596
+ ++ EYM N L +L +E+ + +++E + +G+ YL Q+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL----REHGKRF-QPSQLLEMCKDVCEGMAYLESKQF--- 121
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQQ 653
IHRDL A N L+D K+SDFG++R DE S VG+ + PE
Sbjct: 122 --IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLY 175
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713
FS KSDV++FGVL+ E S + NS T+ K + L P L +E
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE-------KVSQGLRLYRPHLASE 228
Query: 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
Y I+ C E A +RPT +++S
Sbjct: 229 KVYAIMYS-------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 70/198 (35%), Positives = 106/198 (53%), Gaps = 7/198 (3%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG+G FG V+ G VA+K L + E F E +++ KL+H LV+L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
E E ++ EYM SL FL + L V + IA G+ Y+ R+ +
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRDL+A+NIL+ +++ K++DFG+AR+ +E ++ + +PE A G F+IK
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 660 SDVFSFGVLLLETLSSKR 677
SDV+SFG+LL E + R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 71/217 (32%), Positives = 110/217 (50%), Gaps = 38/217 (17%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK----NEIKLIAKLQHR 531
+ KLGEG +G VYK R G+ VA+K++ + +E EI L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 532 NLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA----QG 586
N+V+LL E K+ L++EY + L +L D L +I+ I +G
Sbjct: 59 NIVKLLDVIHT-ERKLYLVFEYC-DMDLKKYL-DKRPGPL-----SPNLIKSIMYQLLRG 110
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
L Y H + R++HRDLK NIL+++D K++DFG+AR F G L++ T +V T Y
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYR 165
Query: 647 SPE-------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+PE Y S D++S G + E ++ K
Sbjct: 166 APEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 37/275 (13%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+LG G FG V+ G+ +VA+K ++ + +E+F E K++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 542 ELEEKILIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ + ++ E+M N L +L +K+ LL + + + +G+ YL + S
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS------MCQDVCEGMEYLERNS--- 120
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT--KRIVGTYGYMSPEYAQQGL 655
IHRDL A N L+ K+SDFGM R DE S + K V + PE
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV---KWSPPEVFNFSK 177
Query: 656 FSIKSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713
+S KSDV+SFGVL+ E + + SN + ++ + L++ P L +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---------PKLASM 228
Query: 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
Y V C E RPT E++ +T
Sbjct: 229 TVY-------EVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 34/273 (12%)
Query: 483 LGEGGFGP--VYK----GRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG +Y+ L+ +EV + RLS + + + NEI +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 537 LGCCIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
++ + +LI EY +L + K L + + I + Y+H+
Sbjct: 65 YNHFMD-DNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
++HRD+K NI L K K+ DFG+++I G + ++T +VGT YMSPE Q
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVK 177
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK-DDRAWELIDPTLQNEA 714
++ KSD+++ G +L E L+ KR F TN L L + K + + +E
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRT--FDATNPLNL------VVKIVQGNYTPVVSVYSSEL 229
Query: 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
L+ + +Q+D RPT EV+
Sbjct: 230 ISLVHS--------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 84/289 (29%), Positives = 139/289 (48%), Gaps = 45/289 (15%)
Query: 475 ANFSTENKLGEGGFGPVYKGRL-LNGQE---VAVKRLSSQSGQGQE-EFKNEIKLIAKLQ 529
+ E +G G FG V GRL L G+ VA+K L + + Q +F +E ++ +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRIIEGIAQ 585
H N++ L G + + +++ EYM N SLD FL T L+G ++ GIA
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG------MLRGIAS 117
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG- 644
G+ YL S + +HRDL A NIL++ ++ K+SDFG++R+ D + T R G
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GG 169
Query: 645 -----YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD 699
+ +PE F+ SDV+S+G+++ E +S + +N D+ K
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKA 221
Query: 700 -DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ + L P A + ++ L C Q+D +RP ++VS+L
Sbjct: 222 IEEGYRLPAPMDCPAALHQLM-------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 483 LGEGGFGPVYKGRL----LNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LGEG FG V +G+L + +VAVK +L + EEF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 537 LGCCIELEEK------ILIYEYMPNKSLDFFLFDSTKENL---LGWGTRVRIIEGIAQGL 587
+G C E ++I +M + L FL S L L T ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDEL-QSKTKRIVGTYGY 645
YL S IHRDL A N +L +DM ++DFG+++ I+ GD Q + ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
++ E +++ KSDV++FGV + E +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 80/273 (29%), Positives = 131/273 (47%), Gaps = 39/273 (14%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRN 532
F+ ++G G FG VY R + + VA+K++S Q E++++ E++ + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRI---IEGIAQGLLY 589
+ GC + L+ EY + D + + K+ L V I G QGL Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAY 130
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
LH + R IHRD+KA NILL + K++DFG A L S VGT +M+PE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPE 181
Query: 650 Y---AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706
+G + K DV+S G+ +E ++R N N+++ L H + ++D
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQND------ 230
Query: 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPT 739
PTL + +++ C+Q+ DRP+
Sbjct: 231 SPTLSSNDWSDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 27/278 (9%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+ E KLG G FG V+ +VAVK + S E F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+L + E +I E+M SL FL S + + + IA+G+ ++ Q +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
IHRDL+A+NIL+ + KI+DFG+AR+ +E ++ + +PE G
Sbjct: 123 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 178
Query: 655 LFSIKSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRA-WELIDPTLQ 711
F+IKSDV+SFG+LL+E ++ R SN + L + + + + EL +
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN---- 234
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
+ + C + +RPT + S+L +
Sbjct: 235 -------------IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 483 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG VY ++ G+E+AVK+ S ++ + + EI+L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 537 LGCCIELEEKILIY-EYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
GC + +E + I+ EYMP S+ L + + E + TR I +G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH-- 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
++HRD+K +NIL D N K+ DFG + R+ + K + GT +MSPE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 653 QGLFSIKSDVFSFGVLLLETLSSK 676
+ K+DV+S G ++E L+ K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGQEEFKNEIKLIAKL 528
NF E K+G+G F VYK LL+G+ VA+K++ + Q+ K EI L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN-LLGWGTRVRIIEGIAQGL 587
H N+++ L IE E ++ E L + K+ L+ T + + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
++H R++HRD+K +N+ + K+ D G+ R F + + VGT YMS
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMS 174
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLE 671
PE + ++ KSD++S G LL E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G +G VY R L+ Q +A+K + + + + EI L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 542 ELEEKILIY-EYMPNKSLDFFLFD-----STKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
E I+ E +P SL L E + + T+ I +GL YLH
Sbjct: 76 E-NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLHD--- 126
Query: 596 LRVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+++HRD+K N+L++ KISDFG ++ G + T+ GT YM+PE +G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKG 184
Query: 655 L--FSIKSDVFSFGVLLLETLSSK 676
+ +D++S G ++E + K
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 11/211 (5%)
Query: 483 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEE---FKNEIKLIAKLQHRNLVRLLGC 539
+G G FG V+ R Q++ + + ++E +NE +++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
+E + +++ EY P +L ++ LL T I+ Q LL LH ++
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDT---ILHFFVQILLALHHVHTKLIL 123
Query: 600 HRDLKASNILLDK-DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
HRDLK NILLDK M KI DFG+++I +SK +VGT Y+SPE + ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689
KSD+++ G +L E S KR + +N +L L
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 70/214 (32%), Positives = 100/214 (46%), Gaps = 35/214 (16%)
Query: 483 LGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
LG+G FG V R G+ VAVK+L + + +F+ EI+++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 538 GCCIEL--EEKILIYEYMPNKSLDFFL------FDSTKENLLGWGTRVRIIEGIAQGLLY 589
G C L+ EY+P SL +L D K L I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS--------QICKGMEY 123
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG----- 644
L R +HRDL NIL++ + KI DFG+ ++ Q K V G
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP----QDKEYYKVREPGESPIF 176
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE--TLSSK 676
+ +PE + FS+ SDV+SFGV+L E T S K
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 8e-24
Identities = 73/214 (34%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 482 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSS-QSGQGQEEFKNEIKLIAKLQHRNLVR 535
+LGE FG +YKG L + Q VA+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLF--------------DSTKENLLGWGTRVRIIE 581
LLG + + +++EY+ L FL D T ++ L G + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIV 640
IA G+ YL + +H+DL A NIL+ + ++ KISD G++R I+ D + + K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M PE G FS SD++SFGV+L E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 71/198 (35%), Positives = 104/198 (52%), Gaps = 17/198 (8%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+GEG FG V +G GQ+VAVK + + F E ++ KL H+NLVRLLG +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 542 ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 601
I++ E M +L FL + L+ ++ +A+G+ YL +++HR
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 602 DLKASNILLDKDMNPKISDFGMARI--FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
DL A NIL+ +D K+SDFG+AR+ G D + K + +PE + FS K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSSK 177
Query: 660 SDVFSFGVLLLETLSSKR 677
SDV+S+GVLL E S R
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 76/270 (28%), Positives = 129/270 (47%), Gaps = 30/270 (11%)
Query: 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
+G G VY L N ++VA+KR+ + +E + E++ +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+ +E L+ Y+ SL + S L +++ + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 599 IHRDLKASNILLDKDMNPKISDFGM-ARIF-GGDELQSKTKRIVGTYGYMSPEYAQQGL- 655
IHRD+KA NILL +D + KI+DFG+ A + GGD + K VGT +M+PE +Q
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTNS-----LTLLGHAWDLWKDDRAWELIDPTL 710
+ K+D++SFG+ +E + +S LTL P+L
Sbjct: 184 YDFKADIWSFGITAIELATGA--APYSKYPPMKVLMLTLQNDP--------------PSL 227
Query: 711 QNEASYLILNR-YINVGLLCVQEDAADRPT 739
+ A Y ++ + + LC+Q+D + RPT
Sbjct: 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 478 STENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
+ ++KLG G +G VY+G VAVK L + EEF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
LG C +I E+M +L +L + ++ + + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL--QSKTKRIVGTYGYMSPEYAQQG 654
IHRDL A N L+ ++ K++DFG++R+ GD + K + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180
Query: 655 LFSIKSDVFSFGVLLLE 671
FSIKSDV++FGVLL E
Sbjct: 181 KFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 83/270 (30%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+ KLG+G FG V+ G +VA+K L + E F E +++ KL+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
E E ++ E+M SL FL + + L V + IA G+ Y+ R+ I
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRDL+A+NIL+ ++ KI+DFG+AR+ +E ++ + +PE A G F+IK
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 660 SDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLIL 719
SDV+SFG+LL E ++ R N L + +R + + P E+ + ++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREV-------LEQVERGYRMPCPQGCPESLHELM 236
Query: 720 NRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
LC ++D +RPT + S L +
Sbjct: 237 K-------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 84/303 (27%), Positives = 142/303 (46%), Gaps = 47/303 (15%)
Query: 482 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSSQSGQ-GQEEFKNEIK 523
KLGEG FG V+ ++N Q+ VAVK L + + + +F E+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFF-----LFDSTKENLLGWG---- 574
++++L+ N++RLLG C++ + +I EYM N L+ F L D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 575 -------TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-I 626
+ + + IA G+ YL S L +HRDL N L+ +++ KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686
+ GD + + R V +M+ E G F+ SDV++FGV L E L + +
Sbjct: 189 YAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247
Query: 687 LTLLGHAWDLWKDD-RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
++ +A + ++D R L P + Y ++ L C D +RP+ ++ +
Sbjct: 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM-------LQCWSRDCRERPSFSDIHA 300
Query: 746 MLT 748
LT
Sbjct: 301 FLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 68/233 (29%), Positives = 111/233 (47%), Gaps = 30/233 (12%)
Query: 480 ENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ +LGEG FG V+ N VAVK L + +++F+ E +L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL-------------LGWGTRVRII 580
V+ G C + + I+++EYM + L+ FL + + LG + I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIV 640
IA G++YL + +HRDL N L+ ++ KI DFGM+R D + R+
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182
Query: 641 G----TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689
G +M PE F+ +SDV+SFGV+L E + + F +N+ +
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 476 NFSTENKLGEGGFGPVYK-GRLLNGQEVAVKR--LSSQSGQGQEEFKNEIKLIAKLQHRN 532
+F KLG+G +G VYK RL + Q A+K L S S + +E+ NEI+++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 533 LVR-----LLGC--CIELEEKILIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIA 584
++ L G CI + EY P L + K L+ RI +
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
+GL LH+ +++HRDLK++NILL + KI D G++++ ++ K +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPH 166
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
YM+PE + +S KSD++S G LL E
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-23
Identities = 68/194 (35%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 483 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQE-EFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G FG V+KG L + VAVK Q + +F +E +++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 542 ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 601
+ + ++ E +P DF F K++ L V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 602 DLKASNILLDKDMNPKISDFGMARIF-GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
DL A N L+ ++ KISDFGM+R G S K+I + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 661 DVFSFGVLLLETLS 674
DV+S+G+LL ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKL-QH 530
+F +GEG F V + +E A+K L + + + K E +++ +L H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 531 RNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGL 587
+++L + EE + + EY PN L ++ + S E + I L
Sbjct: 62 PGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEILLAL 115
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL--------------- 632
YLH +IHRDLK NILLDKDM+ KI+DFG A++ +
Sbjct: 116 EYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 633 ---QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ + VGT Y+SPE + SD+++ G ++ + L+ K
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 82/274 (29%), Positives = 128/274 (46%), Gaps = 41/274 (14%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRN 532
FS ++G G FG VY R + N + VA+K++S Q E++++ E++ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
++ GC + L+ EY + D L + K+ L + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHS 133
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY-- 650
++ +IHRD+KA NILL + K+ DFG A I + VGT +M+PE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 651 -AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709
+G + K DV+S G+ +E ++R N N+++ L H
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH----------------I 226
Query: 710 LQNEASYLILNR----YINVGLLCVQEDAADRPT 739
QNE+ L + N C+Q+ DRPT
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
F+ +G+G FG VYK Q VA+K + + + + E+ + EI+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+ G ++ + +I EY S D K L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD--ELQSKTKRIVGTYGYMSPEYAQ 652
IHRD+KA+NILL ++ + K++DFG++ G SK VGT +M+PE +
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 653 QGLFSIKSDVFSFGVLLLE 671
Q + K+D++S G+ +E
Sbjct: 172 QSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-22
Identities = 82/275 (29%), Positives = 135/275 (49%), Gaps = 33/275 (12%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKN---EIKLIAKLQHRN 532
F+ ++G G FG VY R + EV A+K++S Q E++++ E+K + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ GC + L+ EY + D L + K+ L I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY-- 650
++ +IHRD+KA NILL + K++DFG A I S VGT +M+PE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 651 -AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709
+G + K DV+S G+ +E ++R N N+++ L H + +++ PT
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQNE------SPT 243
Query: 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVV 744
LQ+ +++ C+Q+ DRPT E++
Sbjct: 244 LQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 55/177 (31%), Positives = 92/177 (51%), Gaps = 12/177 (6%)
Query: 482 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG--QEEFKNEIKLIAKLQHRNLVRLLG 538
++GEG G V+K + G+ VA+K+++ + +G + EIK + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+L+ EYMP+ L L D E L + + +G+ Y+H +
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE--YAQQ 653
+HRDLK +N+L+ D KI+DFG+AR+F +E + + + V T Y +PE Y +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGAR 176
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 69/231 (29%), Positives = 113/231 (48%), Gaps = 27/231 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN---GQE---VAVKRLSSQSGQGQEEFKNEIKLIAKLQ 529
N + +LGEG FG V+ N Q+ VAVK L S +++F E +L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFL----------FDSTKENLLGWGTRVRI 579
H ++V+ G C+E + I+++EYM + L+ FL + + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
+ IA G++YL + +HRDL N L+ +++ KI DFGM+R D + R+
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178
Query: 640 VG----TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686
G +M PE F+ +SDV+S GV+L E + + + +N+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 38/285 (13%)
Query: 482 KLGEGGFGPVYKGRLLNGQE---------------VAVKRLSSQ-SGQGQEEFKNEIKLI 525
KLGEG FG V+ E VAVK L + + + +F EIK++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 526 AKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE---- 581
++L++ N++RLLG C+ + +I EYM N L+ FL E+ + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 582 -----GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSK 635
IA G+ YL + L +HRDL N L+ KI+DFGM+R ++ GD + +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD 695
R V +M+ E G F+ SDV++FGV L E + + +S + ++ + +
Sbjct: 189 -GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247
Query: 696 LWKDD-RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT 739
+++ R L L + ++ R C D DRPT
Sbjct: 248 FFRNQGRQIYLSQTPLCPSPVFKLMMR-------CWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 69/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VYKG + E VA+K L+ +G + EF +E ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN-----LLGWGTRVRIIEGIAQGLLYLH 591
LG C+ + L+ + MP+ L ++ + K+N LL W + IA+G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+ R++HRDL A N+L+ + KI+DFG+AR+ GDE + +M+ E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
F+ +SDV+S+GV + E ++
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 82/282 (29%), Positives = 136/282 (48%), Gaps = 39/282 (13%)
Query: 480 ENKLGEGGFGPVYKGRL-LNGQE---VAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
E +G G FG V +GRL L G+ VA+K L S + Q +F +E ++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRIIEGIAQGLLYL 590
L G + ++I E+M N +LD FL + T L+G ++ GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL 122
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVG---TYGYMS 647
S + +HRDL A NIL++ ++ K+SDFG++R D +G + +
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705
PE F+ SDV+S+G+++ E +S + D SN + + + ++ + L
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---------EQDYRL 230
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
P A + ++ L C Q+D RP ++VS L
Sbjct: 231 PPPMDCPTALHQLM-------LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 12/208 (5%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGQEEFKNEIKL 524
++ SV ++ K+G+G G VY + GQEVA+K+++ Q +E NEI +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
+ + +H N+V L + +E ++ EY+ SL D E + G +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM-ARIFGGDELQSKTKRIVGTY 643
Q L +LH +VIHRD+K+ NILL D + K++DFG A+I QSK +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 179
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+M+PE + + K D++S G++ +E
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 481 NKLGEGGFGPVYK-GRLLNGQEVAVKRLS--SQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+G+G FG V K R +G+ + K + + + + +++ +E+ ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 538 GCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGI-----AQGLLY 589
I +Y EY L + KE I E Q LL
Sbjct: 66 DR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-------YIEEEFIWRILTQLLLA 117
Query: 590 LH-----QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
L+ V+HRDLK +NI LD + N K+ DFG+A+I G D S K VGT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPY 175
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
YMSPE + KSD++S G L+ E
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-21
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 10/91 (10%)
Query: 331 QSSDCKSG---DRFIMLDDVKLPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTGE 387
+C D F+ L DVKLPD AS +++++EC CL NC+C AYA +
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNNG--- 55
Query: 388 GSGCLMWFGDLIDIRKADDRNNGQSIYIRVP 418
GCL+W G L ++R + G ++Y+R+
Sbjct: 56 SGGCLLWNGLLNNLRSLS--SGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 33/215 (15%)
Query: 483 LGEGGFGPVYKG-RLLNGQEVAVK------RLSSQSGQGQ----EEFKNEIKLIAKLQHR 531
+G+G +G VY + G+ +AVK ++ + Q + ++EI+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 532 NLVRLLGCCIELEEKILIY-EYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLL 588
N+V+ LG EE + I+ EY+P S+ L + E L+ + T + +GL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLA 122
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR----IFGGDELQSKTKRIVGTYG 644
YLH ++HRDLKA N+L+D D KISDFG+++ I+ D+ S + G+
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS----MQGSVF 175
Query: 645 YMSPE--YAQQGLFSIKSDVFSFGVLLLETLSSKR 677
+M+PE ++ +S K D++S G ++LE + +R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 25/201 (12%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
K+GEG +G VYK R L G+ VA+K RL ++ EI L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 539 CCIELEEKILIYEYMPNKSLDFFL---FDSTKENLLGWGTRVRIIEG----IAQGLLYLH 591
+ L++E+ LD L DS+ L +I+ + QG+ Y H
Sbjct: 66 VVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLD----PPLIKSYLYQLLQGIAYCH 116
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+ RV+HRDLK N+L+D++ K++DFG+AR F G +++ T +V T Y +PE
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171
Query: 652 QQG-LFSIKSDVFSFGVLLLE 671
+S D++S G + E
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 33/271 (12%)
Query: 481 NKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRL 536
+++G G FG VY + E VAVK++S Q E++++ E+K + +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
GC ++ L+ EY + D + L I G QGL YLH ++
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHNM- 142
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY---AQQ 653
IHRD+KA NILL + K++DFG A S VGT +M+PE +
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDE 194
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713
G + K DV+S G+ +E ++R N N+++ L H + ++D PTLQ+
Sbjct: 195 GQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQND------SPTLQSN 243
Query: 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVV 744
+++ C+Q+ +RP E++
Sbjct: 244 EWTDSFRGFVD---YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 67/206 (32%), Positives = 114/206 (55%), Gaps = 13/206 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
NF K+GEG +G VYK R L G+ VA+K RL +++ EI L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
+V+LL I E K+ L++E++ ++ L F+ D++ + + + + QGL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-Y 650
+ RV+HRDLK N+L++ + K++DFG+AR F G +++ T +V T Y +PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSK 676
+S D++S G + E ++ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
+++ K+GEG +G VYKGR GQ VA+K RL S+ EI L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLF-DSTKENLLGWGTRVR-IIEGIAQGLLYL 590
+V L ++ LI+E++ S+D + DS + V+ + I QG+L+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H RV+HRDLK N+L+D K++DFG+AR F G ++ T +V T Y +PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEV 172
Query: 651 AQQG-LFSIKSDVFSFGVLLLETLSSK 676
+S D++S G + E + K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 84/275 (30%), Positives = 133/275 (48%), Gaps = 35/275 (12%)
Query: 483 LGEGGFGPVYKGRLL--NGQEV--AVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLVRLL 537
+G+G FG VY G L+ +GQ++ AVK L+ + + E+F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 538 GCCIELE-EKILIYEYMPNKSLDFFLFDSTK----ENLLGWGTRVRIIEGIAQGLLYLHQ 592
G C+ E +++ YM + L F+ T ++L+G+G +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY--GYMSPEY 650
+ +HRDL A N +LD+ K++DFG+AR E S +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710
Q F+ KSDV+SFGVLL E L ++ + + +S + + L + R L+ P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWE-LMTRGAPPYPDVDSFDITVY---LLQGRR---LLQPEY 226
Query: 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
+ Y V L C RPT E+VS
Sbjct: 227 CPDPLY-------EVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 43/219 (19%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN-----EIKLIAKLQ 529
+ KLGEG + VYK R G+ VA+K++ + ++ N EIKL+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 530 HRNLVRLLGCCIELEEKILIYEYMP--------NKSLDFFLFDSTKENLLGWGTRVRIIE 581
H N++ LL L++E+M +KS+ D K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKS----------YML 109
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG--GDELQSKTKRI 639
+GL YLH ++HRDLK +N+L+ D K++DFG+AR FG ++ +
Sbjct: 110 MTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ---- 162
Query: 640 VGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETL 673
V T Y +PE LF + D++S G + E L
Sbjct: 163 VVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 547 ILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 604
+ E+M SLD +LG +I + +GL YL Y+ R++HRD+K
Sbjct: 79 CMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRIMHRDIK 131
Query: 605 ASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFS 664
SNIL++ K+ DFG++ G+ + S VGT YMSPE Q G +++KSDV+S
Sbjct: 132 PSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 665 FGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL------- 717
G+ ++E K FSN + L +L+ +Q L
Sbjct: 188 LGISIIELALGKFPFAFSNIDDDGQDDPMGIL-------DLLQQIVQEPPPRLPSSDFPE 240
Query: 718 ILNRYINVGLLCVQEDAADRPTMFEVVSM 746
L +++ C+ +D +RPT ++ +M
Sbjct: 241 DLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 483 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGFG V ++ G+ A K+L + +G++ NE K++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQYSRL 596
E ++ + L+ M L + +++ + R I GL +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE--ARAIFYAAQIICGLEHLHQ---R 114
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
R+++RDLK N+LLD N +ISD G+A G K K GT GYM+PE Q ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 657 SIKSDVFSFGVLLLETLSSK 676
D F+ G L E ++ +
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
++G G +G VYK R + G+ VA+K + + G E + EI ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 540 CIELEEKILIYEYMPNKSLDFF---LFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
+ ++ ++ EY SL E + + R + +GL YLH+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGM-ARIFGGDELQSKTKRIVGTYGYMSPEYAQ--- 652
IHRD+K +NILL +D + K++DFG+ A++ +K K +GT +M+PE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 653 QGLFSIKSDVFSFGVLLLE 671
+G + K D+++ G+ +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 37/283 (13%)
Query: 482 KLGEGGFGPVYKG---RLLNGQ---EVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLV 534
+LG+G FG VY+G ++ G+ VAVK ++ S S + + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLG-----WGTRVRIIEGIAQGL 587
RLLG + + +++ E M + L +L EN G +++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYM 646
YL+ + +HRDL A N ++ D KI DFGM R I+ D + K ++ M
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW-M 188
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
+PE + G+F+ SD++SFGV+L E +L+ + SN L + L + D E
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 248
Query: 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ ++ +C Q + RPT E+V++L
Sbjct: 249 RVTDLMR----------------MCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 9e-21
Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGQEEFKNEIKL 524
S+ SV ++ K+G+G G VY + GQEVA+K+++ Q +E NEI +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
+ + ++ N+V L + +E ++ EY+ SL D E + G +
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ NILL D + K++DFG + QSK +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL 690
+M+PE + + K D++S G++ +E + + + N N L L
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--PPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 9e-21
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKL 524
S+ SV ++ K+G+G G VY + GQEVA+++++ Q +E NEI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
+ + ++ N+V L + +E ++ EY+ SL D E + G +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 126
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ NILL D + K++DFG + QSK +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL 690
+M+PE + + K D++S G++ +E + + + N N L L
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRL--LNGQ----EVAVKRLSSQSGQGQ-EEFKNEIKLIAKL 528
N LGEG FG V K L G+ VAVK L + + + +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK--------------------- 567
H ++++L G C + +LI EY SL FL +S K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 568 ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627
E L G + I++G+ YL + ++++HRDL A N+L+ + KISDFG++R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
++ K + +M+ E +++ +SDV+SFGVLL E ++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 35/197 (17%)
Query: 471 SAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK----NEIKLI 525
+ ++ KLGEG FG VYK R + G+ VA+K++ + + + F EIK++
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKIL 61
Query: 526 AKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLD-------FFLFDSTKENLLGWGTRVR 578
KL+H N+V L+ + E D LL V+
Sbjct: 62 KKLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVK 111
Query: 579 --------IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630
+ + +G+ YLH+ ++HRD+KA+NIL+D KI+DFG+AR + G
Sbjct: 112 LTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 631 ELQSKTKRIVGTYGYMS 647
K GT Y +
Sbjct: 169 PPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN--EIKLIAKLQHRNLVRLLG 538
K+GEG +G VYK R L G+ VA+K++ + EIKL+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWG-TRVR-IIEGIAQGLLYLHQYSRL 596
+ L++E+M D L+ K+ G + ++ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-YAQQGL 655
++HRDLK N+L++ + K++DFG+AR FG V T Y +PE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKG 175
Query: 656 FSIKSDVFSFGVLLLETLS 674
+S D++S G + E LS
Sbjct: 176 YSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 485 EGGFGPVYKGRLLNG-----QEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLVRLLG 538
EG FG ++ G L++ +EV VK + + + Q E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 539 CCIELEEK-ILIYEYMPNKSLDFFLFD---STKENLLGWGTR--VRIIEGIAQGLLYLHQ 592
CIE E ++Y YM +L FL N T+ V + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDE--LQSKTKRIVGTYGYMSPE 649
+ VIH+D+ A N ++D+++ KI+D ++R +F D L R V +M+ E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWMALE 189
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
+S SDV+SFGVLL E
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQ---HRNL 533
++GEG +G VYK R L G+ VA+K++ S+ G + EI L+ +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 534 VRLLGCC--IELEEKI---LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
VRLL C + ++ L++E++ ++ L +L + L T ++ + +G+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
+LH + R++HRDLK NIL+ D KI+DFG+ARI+ + +V T Y +P
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAP 175
Query: 649 EYAQQGLFSIKSDVFSFGVLLLE 671
E Q ++ D++S G + E
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 481 NKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQ--EEFKNEIKLIAKLQHRNLVRLL 537
NK+G G FG VY L+ E+ AVK + Q + +E +E+K++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 538 GCCIELE-EKILIY-EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
G +E+ EK+ I+ EY +L+ L + RV ++ + +GL YLH +
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQ-LLEGLAYLHSH-- 118
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFG------GDELQSKTKRIVGTYGYMSPE 649
++HRD+K +NI LD + K+ DFG A G+E+QS + GT YM+PE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPE 173
Query: 650 YAQQGLFSIK---SDVFSFGVLLLETLSSKR 677
G +D++S G ++LE + KR
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 483 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542
+G+G FG V G G +VAVK + + + + F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 543 LEEKILIY-EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 601
+ + I EYM SL +L S ++LG ++ + + + YL + +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 602 DLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSD 661
DL A N+L+ +D K+SDFG+ + Q K V + +PE ++ FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVK---WTAPEALREKKFSTKSD 181
Query: 662 VFSFGVLLLETLSSKR 677
V+SFG+LL E S R
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 475 ANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQH 530
ANF E K+G G F VY+ LL+ + VA+K++ + +++ EI L+ +L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLL-----GWGTRVRIIEGIAQ 585
N+++ L IE E ++ E L + K+ L W V++ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE- 120
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645
H +SR RV+HRD+K +N+ + K+ D G+ R F + + +VGT Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLE 671
MSPE + ++ KSD++S G LL E
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 71/204 (34%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 483 LGEGGFGPV----YKGRLLN-GQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLVRL 536
LGEG FG V Y N G++VAVK L +SG + K EI+++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 537 LGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL--HQ 592
G C E LI E++P+ SL +L +N + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE--LQSKTKRIVGTYGYMSPEY 650
Y +HRDL A N+L++ + KI DFG+ + D+ K + Y +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 651 AQQGLFSIKSDVFSFGVLLLETLS 674
Q F I SDV+SFGV L E L+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 7e-20
Identities = 78/285 (27%), Positives = 134/285 (47%), Gaps = 33/285 (11%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKL 524
++ S+ ++ K+G+G G V+ + GQEVA+K+++ Q +E NEI +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
+ +L++ N+V L + +E ++ EY+ SL D E + +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ N+LL D + K++DFG + QSK +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
+M+PE + + K D++S G++ +E + + + N N L RA
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--PPYLNENPL-------------RALY 225
Query: 705 LI----DPTLQN-EASYLILNRYINVGLLCVQEDAADRPTMFEVV 744
LI P LQN E I ++N C++ D R + E++
Sbjct: 226 LIATNGTPELQNPEKLSPIFRDFLN---RCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 482 KLGEGGFGPVYKGRL-LNGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
++G G FG V+ GRL + VAVK + + +F E +++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
C + + ++ E + + DF F T+ L ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT---KRIVGTYGYMSPEYAQQGLF 656
HRDL A N L+ + KISDFGM+R D + + T K+I + +PE G +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQI--PVKWTAPEALNYGRY 173
Query: 657 SIKSDVFSFGVLLLETLS 674
S +SDV+SFG+LL E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 69/205 (33%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 483 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+L +++ KRL + +G E E +++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTR-VRIIEGIAQGLLYLHQYS 594
+ + + L+ M L + +++ +EN R I GL +LHQ
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL---QSKTKRIVGTYGYMSPEYA 651
R+I+RDLK N+LLD D N +ISD G+A EL QSKTK GT G+M+PE
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAV-----ELKDGQSKTKGYAGTPGFMAPELL 169
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSK 676
Q + D F+ GV L E ++++
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 78/282 (27%), Positives = 134/282 (47%), Gaps = 39/282 (13%)
Query: 482 KLGEGGFGPVYKGRLLNG-------QEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNL 533
+LG+G FG VY+G + G VA+K ++ + S + + EF NE ++ + ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLF-------DSTKENLLGWGTRVRIIEGIAQG 586
VRLLG + + ++I E M L +L ++ + +++ IA G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGY 645
+ YL+ + +HRDL A N ++ +D KI DFGM R I+ D + K ++ +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 187
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703
MSPE + G+F+ SDV+SFGV+L E TL+ + SN L + L K D
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCP 247
Query: 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
+++ ++ +C Q + RP+ E++S
Sbjct: 248 DMLFELMR----------------MCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 10/191 (5%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+GEG G V R +G++VAVK + + Q +E NE+ ++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
+ EE ++ E++ +L D + L + E + Q L YLH VIH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
RD+K+ +ILL D K+SDFG D K K +VGT +M+PE + + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 661 DVFSFGVLLLE 671
D++S G++++E
Sbjct: 199 DIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 63/199 (31%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 482 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRLL 537
+LG G FG V KG ++ Q +VA+K L +++ + ++E E +++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
G C E E +L+ E L+ FL S K++ + V ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY--GYMSPEYAQQGL 655
+HRDL A N+LL KISDFG+++ G D+ K R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA-RSAGKWPLKWYAPECINFRK 174
Query: 656 FSIKSDVFSFGVLLLETLS 674
FS +SDV+S+G+ + E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGQEEFKNEIKLIAKLQH 530
F LG G FG VYKG + E VA+K L + S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN--------LLGWGTRVRIIEG 582
++ RLLG C+ + LI + MP L D +E+ LL W +
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQ------ 117
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
IA+G+ YL + R++HRDL A N+L+ + KI+DFG+A++ G DE + +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ +SDV+S+GV + E ++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCC 540
+GEG +G VYK R GQ VA+K + +EE K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 541 IELEEKI------LIYEYMPNKSLDFFLFDSTKENLLGWGTRVR------IIEGIAQGLL 588
I+ L+ E S+ D K L G R++ I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVT----DLVK-GLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR---IVGTYGY 645
YLH+ +VIHRD+K NILL K+ K+ DFG++ +L S R +GT +
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-----QLDSTLGRRNTFIGTPYW 179
Query: 646 MSPE-----YAQQGLFSIKSDVFSFGVLLLE 671
M+PE + +SDV+S G+ +E
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 483 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G FG VYK + G A K + +S + E+F EI ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 542 ELEEKILIY-EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
E K+ I E+ +LD + + L R + + + L +LH + +VIH
Sbjct: 73 -YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS--- 657
RDLKA NILL D + K++DFG++ LQ K +GT +M+PE F
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 658 --IKSDVFSFGVLLLE 671
K+D++S G+ L+E
Sbjct: 185 YDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 483 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG VY GR L ++V S ++ + + EI+L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 537 LGCCIELEEKIL--IYEYMPNKSLDFFLFDSTKENLLGWG------TRVRIIEGIAQGLL 588
GC + EK L EYMP S+ K+ L +G TR + I +G+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTR-KYTRQILEGMS 120
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ------SKTKRIVGT 642
YLH ++HRD+K +NIL D N K+ DFG ++ LQ + + + GT
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICMSGTGIRSVTGT 172
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+MSPE + K+DV+S G ++E L+ K
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 483 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VY GR L ++V S ++ + + EI+L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 537 LGCCIELEEKIL--IYEYMPNKSLDFFLFDSTKENLLGWG------TRVRIIEGIAQGLL 588
GC + EEK L EYMP S+ K+ L +G TR R I QG+
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTR-RYTRQILQGVS 120
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVGTYGYMS 647
YLH ++HRD+K +NIL D N K+ DFG + RI + K + GT +MS
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
PE + K+DV+S ++E L+ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
F+ ++G+G FG VYKG +EV A+K + + + + E+ + EI ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 535 RLLGCCIELEEKILIYEYMPNKS-LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
R G ++ + +I EY+ S LD +E + I+ I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
R IHRD+KA+N+LL + + K++DFG+A + Q K VGT +M+PE +Q
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 654 GLFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 176 SAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 475 ANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSS---QSGQGQEEFKNEIKLIAKLQH 530
ANF E K+G G F VY+ LL+G VA+K++ + + + EI L+ +L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLL-----GWGTRVRIIEGIAQ 585
N+++ IE E ++ E L + K+ L W V++ +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE- 120
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645
H +SR RV+HRD+K +N+ + K+ D G+ R F + + +VGT Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703
MSPE + ++ KSD++S G LL E L S D N SL +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC------------KKI 220
Query: 704 ELID-PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746
E D P L ++ L + +N +C+ D RP + V +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 69/227 (30%), Positives = 117/227 (51%), Gaps = 22/227 (9%)
Query: 482 KLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGQEEFKN--EIKLIAKLQ---HRNLV 534
++GEG +G V+K R L G+ VA+KR+ Q+G+ E+ ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 535 RLLGCCI----ELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
RL C + E K+ L++E++ ++ L +L D E + T ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
LH + RV+HRDLK NIL+ K++DFG+ARI+ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696
Q ++ D++S G + E +R F ++ + LG D+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 483 LGEGGFGPVYKGRLL------NGQEVAVKRL-SSQSGQGQEEFKNEI---KLIAKLQHRN 532
LGEG FG V K + VAVK L + + + +E+ K+I K H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---------- 582
++ LLG C + ++ EY + +L FL R E
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 583 ---IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
+A+G+ +L + IHRDL A N+L+ +D KI+DFG+AR + KT
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 58/157 (36%), Positives = 86/157 (54%), Gaps = 10/157 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
NF KLGEG + VYKGR G+ VA+K L ++ G + EI L+ +L+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
+VRL I E K+ L++EYM +K L ++ L T + +G+ + H
Sbjct: 60 IVRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
+ RV+HRDLK N+L++K K++DFG+AR FG
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 30/283 (10%)
Query: 481 NKLGEGGFGPVYKG---RLLNGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
+++G G FG V G R ++ V VK L +S + Q F E++ +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWG---TRVRIIEGIAQGLLYLHQY 593
LG CIE +L+ E+ P L +L S + + R+ +A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARI-FGGDELQSKTKRIVGTYGYMSPEYA- 651
IH DL N L D++ KI D+G+A + D +K V +++PE
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVE 175
Query: 652 --QQGLFSIK----SDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705
Q L S+++S GV + E L + + + + + +L ++ +L
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLSDEQVLKQV----VREQDIKL 230
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
P L + S +R+ V C D RPT EV +LT
Sbjct: 231 PKPQLDLKYS----DRWYEVMQFCWL-DPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 27/206 (13%)
Query: 482 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSSQSGQG--QEEFKNEIKLIAKLQHRNLVRL 536
+LG G FG V KG ++ ++ VAVK L + + ++E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDS---TKENLLGWGTRVRIIEGIAQGLLYLHQY 593
+G C E E +L+ E L+ FL + T++N+ ++ ++ G+ YL +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI------TELVHQVSMGMKYLEET 114
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG-----YMSP 648
+ +HRDL A N+LL KISDFG+++ G DE K K T+G + +P
Sbjct: 115 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAP 167
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E FS KSDV+SFGVL+ E S
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
LGEG FG V +G+L +VAVK +++ + E+F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 538 GCCIELEEK------ILIYEYMPNKSLDFFLFDS---TKENLLGWGTRVRIIEGIAQGLL 588
G C++ E ++I +M + L FL S L V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDEL-QSKTKRIVGTYGYM 646
YL S IHRDL A N +L+++MN ++DFG++ +I+ GD Q + ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLE 671
+ E +++ KSDV+SFGV + E
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 481 NKLGEGGFGPVYKGRLLNGQEVAVKRL---SSQSGQGQEEFKN---EIKLIAKLQHRNLV 534
LG+G +G VY G GQ +AVK++ +S ++E++ E+ L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ LG C++ + E++P S+ L F E + T+ +I++G+A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR---IFGGDELQSKT-KRIVGTYGYMSP 648
V+HRD+K +N++L + K+ DFG AR G S K + GT +M+P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSK 676
E + + KSD++S G + E + K
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 483 LGEGGFGPVYKGRLLN-GQEVAVKRL-----SSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG VY + G+E+AVK++ S ++ + + EI+L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 537 LGCCIELEEKIL--IYEYMPNKSLDFFLFDSTKENLLGWG------TRVRIIEGIAQGLL 588
GC + E+ L E+MP S+ K+ L +G TR + I +G+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTR-KYTRQILEGVS 120
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ-SKTKRIVGTYGYMS 647
YLH ++HRD+K +NIL D N K+ DFG ++ L + K + GT +MS
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
PE + K+D++S G ++E L+ K
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 476 NFSTENKLGEGGFGPVY--KGRLLNGQEVAVK-RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
+ K+GEG FG +Y K + + V + L+ + +E K E+ L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSL-------DFFLFDSTKENLLGWGTRVRIIEGIAQ 585
+V E ++ EY L LF +++ +L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
GL ++H +++HRD+K+ NI L K+ M K+ DFG+AR + T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689
Y+SPE Q ++ K+D++S G +L E + K + +N + L L
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 480 ENKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQSGQG-QEEFKNEIKLIAKL-QHRNLV 534
++ +GEG FG V K R+ + A+KR+ + + +F E++++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 535 RLLGCCIELEEKILIYEYMPNKSL-DF------------FLFDSTKENLLGWGTRVRIIE 581
LLG C L EY P+ +L DF F ++ + L +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVG 641
+A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R G E+ K
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ SDV+S+GVLL E +S
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 28/207 (13%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ K+GEG G V + G++VAVK++ + Q +E NE+ ++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE-GIA-------Q 585
V + + +E ++ E++ +L + T R+ E IA +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIV------------THTRMNEEQIATVCLAVLK 126
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM-ARIFGGDELQSKTKRIVGTYG 644
L +LH VIHRD+K+ +ILL D K+SDFG A++ E+ + K +VGT
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEV-PRRKSLVGTPY 180
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+M+PE + + + D++S G++++E
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 51/284 (17%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQH-RNLVRLLGC 539
LG G +G V K R + G +AVKR+ + + Q Q+ ++ + + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 540 CIELEEKILIYEYMPNKSLDFF---LFD---STKENLLGWGTRVRIIEGIAQGLLYLHQY 593
+ + E M + SLD F ++D + E++LG +I I + L YLH
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLH-- 120
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI-VGTYGYMSPE--- 649
S+L VIHRD+K SN+L++++ K+ DFG++ G + S K I G YM+PE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 650 --YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD-----DRA 702
Q+G + +KSDV+S G+ ++E L +D WK +
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIE---------------LATGRFPYDSWKTPFQQLKQV 220
Query: 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746
E P L E ++N C++++ +RP E++
Sbjct: 221 VEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLS----SQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
LG GGFG V ++ + A+K + ++GQ QE +E +++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFLFDSTKEN-LLGWGTRVRIIEGIAQGLLYLHQYSR 595
+ ++ I ++ EY L + ++ L T I + YLH
Sbjct: 60 -RTFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH---N 111
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+I+RDLK N+LLD + K+ DFG A+ + KT GT Y++PE
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKG 168
Query: 656 FSIKSDVFSFGVLLLETL 673
+ D +S G+LL E L
Sbjct: 169 YDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 6e-18
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 483 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCI 541
+G G +G VYKGR + ++A ++ +G +EE K EI ++ K HRN+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 542 E-----LEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
+ +++++ L+ E+ S+ L +TK N L I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ--- 652
+VIHRD+K N+LL ++ K+ DFG++ D + +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 653 --QGLFSIKSDVFSFGVLLLE 671
+ KSD++S G+ +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 475 ANFSTENKLGEGGFGPVYKG--RLLNGQE--VAVKRL-SSQSGQGQEEFKNEIKLIAKLQ 529
+ E LG G FG + +G +L + +E VA+ L + S + + F E + +
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
H N+VRL G +++ EYM N +LD FL E L G + ++ G+A G+ Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG----- 644
L S + +H+ L A +L++ D+ KIS F + + K++ I T
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTTMSGKSPV 172
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +PE Q FS SDV+SFG+++ E +S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 483 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRL 536
LG G FG V+KG + + VA+K + +SG Q +E + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN--------LLGWGTRVRIIEGIAQGLL 588
LG C + L+ + P SL D +++ LL W + IA+G+
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQ------IAKGMY 123
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
YL ++ R++HR+L A NILL D +I+DFG+A + D+ + +M+
Sbjct: 124 YLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E G ++ +SDV+S+GV + E +S
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 29/187 (15%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK----NEIKLIAKLQHRNLVR 535
K+G+G FG V+K R Q VA+K++ +E F EIK++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV----------RIIEGIAQ 585
L+ C Y K + +F+ + +L G + ++++ +
Sbjct: 76 LIEICRTKATP-----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK---TKRIVGT 642
GL Y+H R +++HRD+KA+NIL+ KD K++DFG+AR F + T R+V T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 643 YGYMSPE 649
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKN---EIKLIAKLQHR 531
+F +G+G FG V + + +++ A+K ++ Q + +N E +++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRI-IEGIAQGLLYL 590
LV L + E L+ + + L + L K + +V+ I I L YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS----EEQVKFWICEIVLALEYL 116
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H +IHRD+K NILLD+ + I+DF +A D L T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEV 170
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKR 677
+ +S+ D +S GV E L KR
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 24/200 (12%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK-NEIKLIAKLQ-HRNLVRLLG 538
+LG+G FG VY R G+ VA+K++ + +E E+K + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVR-IIEGIAQGLLYLHQ--YSR 595
E +E ++EYM +L + L K +R II I QGL ++H+ +
Sbjct: 66 VFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESV-IRSIIYQILQGLAHIHKHGF-- 120
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK---TKRIVGTYGYMSPE-YA 651
HRDLK N+L+ KI+DFG+AR E++S+ T V T Y +PE
Sbjct: 121 ---FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEILL 171
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
+ +S D+++ G ++ E
Sbjct: 172 RSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 480 ENKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQG-QEEFKNEIKLIAKL-QHRNLV 534
E+ +GEG FG V + + A+K L + + +F E++++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDS---------TKE----NLLGWGTRVRIIE 581
LLG C + EY P +L FL S KE + L ++
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVG 641
+A G+ YL S + IHRDL A N+L+ +++ KI+DFG++R G+E+ K
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ KSDV+SFGVLL E +S
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 480 ENKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQ 529
+ +LG+G FG VY + RL +E+ V L+ +++ Q +E +L++KL
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLD 60
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGL 587
H +V+ +E + +I EY + LD L T + L + ++ E Q L
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFIQLL 116
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
L +H + R++HRDLKA NI L ++ KI DFG++R+ G + T GT YMS
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMS 173
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLE 671
PE + + KSD++S G +L E
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 68/215 (31%), Positives = 116/215 (53%), Gaps = 32/215 (14%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFK-NEIKLIAKLQHRNL 533
+ K+GEG +G VYK R + + +A+K++ Q +G EI L+ ++QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDFFL---FDSTKENLLGWGTRVRIIEG----IAQ 585
VRL + E+++ L++EY LD L DS+ + + R+I+ I +
Sbjct: 64 VRLQDV-VHSEKRLYLVFEY-----LDLDLKKHMDSSPD----FAKNPRLIKTYLYQILR 113
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDELQSKTKRIVGTYG 644
G+ Y H + RV+HRDLK N+L+D+ N K++DFG+AR F G +++ T +V T
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLW 168
Query: 645 YMSPEY---AQQGLFSIKSDVFSFGVLLLETLSSK 676
Y +PE ++ +S D++S G + E ++ K
Sbjct: 169 YRAPEILLGSRH--YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 46/282 (16%)
Query: 483 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VYKG + E VA+K L + S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN--------LLGWGTRVRIIEGIAQGLL 588
LG C+ + L+ + MP L D +EN LL W + IA+G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQ------IAKGMS 123
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
YL + +R++HRDL A N+L+ + KI+DFG+AR+ DE + +M+
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 649 EYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706
E F+ +SDV+S+GV + E T +K LL ++ L
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL---------EKGERLP 231
Query: 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
P + Y+I+ + C D+ RP E+V +
Sbjct: 232 QPPICTIDVYMIMVK-------CWMIDSECRPRFRELVDEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 483 LGEGGFGPVYKGR---LLNGQ---EVAVKRLSSQSGQGQEE-FKNEIKLIAKL-QHRNLV 534
LG G FG V + L +VAVK L + + E +E+K+++ L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDS-----TKENLLGWGTRVRIIEGIAQGLLY 589
LLG C ++I EY L FL T E+LL + +V A+G+ +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV------AKGMAF 156
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE---LQSKTKRIVGTYGYM 646
L + IHRDL A N+LL KI DFG+AR D ++ + V +M
Sbjct: 157 LASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV---KWM 210
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+PE +++ +SDV+S+G+LL E S
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 58/198 (29%), Positives = 107/198 (54%), Gaps = 17/198 (8%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
+LG+G FG VYK + G A K + ++S + E++ EI+++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
+ ++ E+ P ++D + + + L +V I + + L YLH +++IH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR--IVGTYGYMSPEYA-----QQ 653
RDLKA N+LL D + K++DFG++ +++ +R +GT +M+PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 654 GLFSIKSDVFSFGVLLLE 671
+ K+D++S G+ L+E
Sbjct: 190 TPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 31/219 (14%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK----NEIKLIAKLQHR 531
F ++GEG +G VYK R G+ VA+K++ + + E F EIK++ +L HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66
Query: 532 NLVRLLGCCIE----LEEK------ILIYEYMPNK---SLDFFLFDSTKENLLGWGTRVR 578
N+V L + L+ K L++EYM + L+ L +++++
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KS 120
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638
++ + +GL Y H+ + L HRD+K SNILL+ K++DFG+AR++ +E + T +
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 639 IVGTYGYMSPE-YAQQGLFSIKSDVFSFGVLLLETLSSK 676
++ T Y PE + + DV+S G +L E + K
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 58/198 (29%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
F+ ++G+G FG V+KG Q+V A+K + + + + E+ + EI ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 535 RLLGCCIELEEKILIYEYMPNKS-LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
+ G ++ + +I EY+ S LD E + +++ I +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHSE 120
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ IHRD+KA+N+LL + + K++DFG+A + Q K VGT +M+PE QQ
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 654 GLFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 176 SAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 61/192 (31%), Positives = 100/192 (52%), Gaps = 18/192 (9%)
Query: 483 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
LG G G VYK LL + +AVK + + + Q++ +E++++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 541 IELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
+E +I I E+M SLD ++ E++LG RI + +GL YL L+++
Sbjct: 69 F-VENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRD+K SN+L++ K+ DFG++ + S K VGT YM+PE + I
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 660 SDVFSFGVLLLE 671
SDV+S G+ +E
Sbjct: 174 SDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-17
Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 24/273 (8%)
Query: 480 ENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
EN + G G YKG+ + NG + VK ++ + +EI + KLQH N+V+L+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIG 750
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
C + LI+EY+ K+L L L W R +I GIA+ L +LH V
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
+ +L I++D P + L + + Y++PE + +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718
KSD++ FG++L+E L+ K D +++ A + D IDP+++ + S +
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS--V 915
Query: 719 LNRYI----NVGLLCVQEDAADRPTMFEVVSML 747
I N+ L C D RP +V+ L
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 9e-17
Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKL-QHRN 532
LGEG FG V K R VAVK L + + + +E++L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFL-----------FDSTK--ENLLGWGTRVRI 579
++ LLG C + +I EY +L FL FD TK E L + V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
+A+G+ YL SR R IHRDL A N+L+ +D KI+DFG+AR + KT
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFG+L+ E +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 21/198 (10%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQH---RNLVRLL 537
+G G +G VY+G+ + G+ VA+K ++ + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
G ++ +I EY S+ + E + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI--VGTYGYMSPEYAQQG 654
VIHRD+KA+NIL+ N K+ DFG+A + Q+ +KR VGT +M+PE +G
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 655 -LFSIKSDVFSFGVLLLE 671
+ K+D++S G+ + E
Sbjct: 177 KYYDTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 21/226 (9%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN--EIKLIAKLQ---HRNLVR 535
++G G +G VYK R +G VA+K + Q+ + E+ L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 536 LLGCCIEL----EEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
L+ C E K+ L++E++ ++ L +L D L T ++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H ++HRDLK NIL+ K++DFG+ARI+ Q +V T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696
Q ++ D++S G + E +R F + LG +DL
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEADQLGKIFDL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
F+ K+G+G FG V+KG Q+V A+K + + + + E+ + EI ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 535 RLLGCCIELEEKILIYEYMPNKS-LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
+ G ++ + +I EY+ S LD E + I+ I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 120
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ IHRD+KA+N+LL + K++DFG+A + Q K VGT +M+PE +Q
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 654 GLFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 176 SAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 24/216 (11%)
Query: 477 FSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQH 530
F+ LG+G FG V + +L + Q+VAVK L + S EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 531 RNLVRLLGCCIELEEK------ILIYEYMPNKSLDFFLFDS-TKEN--LLGWGTRVRIIE 581
N+++L+G + K ++I +M + L FL S E L T VR +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQ--SKTKR 638
IA G+ YL S IHRDL A N +L+++M ++DFG+++ I+ GD + +K
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
V +++ E +++ SDV++FGV + E ++
Sbjct: 178 PV---KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 476 NFSTENKLGEGGFGPVYK-------GRLLNGQEVAVKRLSSQSGQGQ-----EEFKNEIK 523
++ LG G FG VYK LL +E+ V + + + + +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 524 LIAK-LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG 582
+I + L+H N+VR +E + ++ + + L F+S KE T RI
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKK-QRFTEERIWNI 118
Query: 583 IAQ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
Q L YLH+ R ++HRDL +NI+L +D I+DFG+A+ + +SK +
Sbjct: 119 FVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSV 173
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD 699
VGT Y PE + + K+DV++FG +L + F +TN L+L
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSL---------- 221
Query: 700 DRAWELIDPTLQNEASYLILNRYINVGLL------CVQEDAADRPTMFEVVSMLTN 749
A +++ EA Y L + + C+ DA RP + +V +M+++
Sbjct: 222 --ATKIV------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 483 LGEGGFGPVYKGRLLNG---QEVAVKRLSSQSGQG-QEEFKNEIKLIAKL-QHRNLVRLL 537
+GEG FG V K R+ + A+KR+ + + +F E++++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 538 GCCIELEEKILIYEYMPNKSL-DF------------FLFDSTKENLLGWGTRVRIIEGIA 584
G C L EY P+ +L DF F ++ + L + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R G E+ K
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ SDV+S+GVLL E +S
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 44/123 (35%), Positives = 71/123 (57%), Gaps = 13/123 (10%)
Query: 551 EYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNI 608
E+M SLD L + + EN+LG +I + +GL YL + + +++HRD+K SNI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 609 LLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVL 668
L++ K+ DFG++ G + S VGT YMSPE Q ++++SD++S G+
Sbjct: 132 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 669 LLE 671
L+E
Sbjct: 188 LVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 27/246 (10%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGQEEFK---NEIKLIAKLQHRN 532
F ++G+GG+G V+ + + E VA+KR+ E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
LV+LL + E L EY+P DF + L R + E + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH- 118
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
L IHRDLK N L+D + K++DFG+++ + + +VG+ YM+PE +
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLR 171
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-SLTLLGH-----AWDLWKD------D 700
+ D +S G +L E L S N + L + ++ D D
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231
Query: 701 RAWELI 706
AW+LI
Sbjct: 232 EAWDLI 237
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 15/214 (7%)
Query: 482 KLGEGGFGPVYKGRLL----NGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
K+GEG FG K L+ +G++ +K + S S + +EE + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
E ++ +Y L + ++ + L +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLF---PEDQILDWFVQICLALKHVHD 119
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+++HRD+K+ NI L KD K+ DFG+AR+ ++T +GT Y+SPE +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRP 177
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689
++ KSD+++ G +L E + K + N +L L
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 31/194 (15%)
Query: 477 FSTENKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQSGQGQ---EEFKNEIKLIAKLQH 530
+ E +G G +G VYK + N G+E A+K+ Q + EI L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 531 RNLVRLLGCCIELEEKI--LIYEYMPNKSLDFFLFDSTKENLLGWGTRVR-IIEGIAQGL 587
N+V L+ +E +K L+++Y + F + + + V+ ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMARIF--------GGDELQSK 635
YLH V+HRDLK +NIL+ + KI D G+AR+F D
Sbjct: 122 HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 636 TKRIVGTYGYMSPE 649
+V T Y +PE
Sbjct: 174 --PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 482 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRL 536
+GEG FG VY+G ++ VAVK + + +E+F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
+G E ++ E P L +L + L + + ++ L YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL--QSKTKRIVGTYGYMSPEYAQQG 654
R +HRD+ A N+L+ K+ DFG++R + SK K + +M+PE
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI---KWMAPESINFR 183
Query: 655 LFSIKSDVFSFGVLLLETLS 674
F+ SDV+ FGV + E L
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 40/210 (19%)
Query: 483 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQH-RNLVRLLG- 538
+G G FG V K G +AVKR+ S + Q+ ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 539 ------C--CIELEEKILIYEYMPNKSLDFFLFDSTK----ENLLGWGTRVRIIEGIAQG 586
C C+EL + L Y ++++ K E +LG +I +
Sbjct: 72 LFREGDCWICMELMDISLDKFYK-------YVYEVLKSVIPEEILG-----KIAVATVKA 119
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK-RIVGTYGY 645
L YL + L++IHRD+K SNILLD++ N K+ DFG++ G + S K R G Y
Sbjct: 120 LNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPY 173
Query: 646 MSPE----YAQQGLFSIKSDVFSFGVLLLE 671
M+PE A+ G + ++SDV+S G+ L E
Sbjct: 174 MAPERIDPSARDG-YDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 467 LASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIA 526
L+++ F +G G +G VYKGR + ++A ++ + +EE K EI ++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 527 KL-QHRNLVRLLGCCIEL------EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRI 579
K HRN+ G I+ ++ L+ E+ S+ L +TK N L I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT-DLVKNTKGNALKEDWIAYI 126
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
I +GL +LH + +VIHRD+K N+LL ++ K+ DFG++ D +
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181
Query: 640 VGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLE 671
+GT +M+PE + +SD++S G+ +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 40/221 (18%)
Query: 475 ANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN--EIKLIAKLQHR 531
F N++GEG +G VY+ R +G+ VA+K++ + + + EI L+ L+H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 532 NLVRLLGCCI--ELEEKILIYEY--------MPNKSLDFFLFDSTKENLLGWGTRVR-II 580
N+V L + L+ L+ EY + N F S + V+ ++
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPF----SESQ--------VKCLM 114
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIV 640
+ +GL YLH+ +IHRDLK SN+LL KI+DFG+AR + G + T ++V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV 170
Query: 641 GTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
T Y +PE L + D+++ G +L E L+ K
Sbjct: 171 -TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 43/210 (20%)
Query: 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN----EIKLIAKLQHRNLVR 535
N++G G G VYK G+ A+K + G ++ + EI+++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 536 LLGCCIELEEKILIYEYMPNKSLD-------FFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
E ++ E+M SL+ FL D ++ I+ GIA
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA---- 182
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG--DELQSKTKRIVGTYGYM 646
YLH R ++HRD+K SN+L++ N KI+DFG++RI D S VGT YM
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAYM 235
Query: 647 SPEYA----QQGLFS-IKSDVFSFGVLLLE 671
SPE G + D++S GV +LE
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKL-QHRN 532
LGEG FG V K + VAVK L + + + +E++++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFL-----------FDSTK--ENLLGWGTRVRI 579
++ LLG C + ++ EY +L +L FD+ K E L + V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
+A+G+ YL + + IHRDL A N+L+ +D KI+DFG+AR + KT
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVYKGRLLNGQE--------VAVKRLSSQSGQGQ-EEFKNEIKLIAKL-QHRN 532
LGEG FG V + + VAVK L S + + + +E++++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLF-------------DSTKENLLGWGTRVRI 579
++ LLG C + +I EY +L +L E L + V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
+A+G+ YL + + IHRDL A N+L+ +D KI+DFG+AR + KT
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFK---NEIKLIAKL-QHRNLVRLL 537
LG+G FG V L E+ AVK L ++ + E +++A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQYSR 595
C + ++++ + EY+ L F + S + + R R I GL +LH+
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFYAAEIVLGLQFLHERG- 116
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+I+RDLK N+LLD + + KI+DFGM + I GG T GT Y++PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSY 170
Query: 654 GLFSIKSDVFSFGVLLLETL 673
+ D ++ GVLL E L
Sbjct: 171 QPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 54/202 (26%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+F ++G G +G VYK R +N G+ A+K + + G+ + EI ++ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSLD--FFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
G + ++ + E+ SL + + E+ + + +R + QGL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA- 651
+ +HRD+K +NILL + + K++DFG++ +K K +GT +M+PE A
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAA 179
Query: 652 --QQGLFSIKSDVFSFGVLLLE 671
++G ++ D+++ G+ +E
Sbjct: 180 VERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
++ ++G G +G VYK R L G+ AVK + + G + EI ++ + +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSLD--FFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
G + E+ + EY SL + + E + + R + QGL YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHS 124
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA- 651
++ HRD+K +NILL + + K++DFG+A +K K +GT +M+PE A
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAA 179
Query: 652 --QQGLFSIKSDVFSFGVLLLE 671
+ G ++ D+++ G+ +E
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 49/150 (32%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 482 KLGEGGFGPVYKGRLLNGQE-VAVKRLSSQS-GQGQEEFK-NEIKLIAKLQHRNLVRLLG 538
K+GEG +G V+K + E VA+KR+ +G EI L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
++ L++EY ++ L + FDS ++ + + + + +GL + H + V
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQ-LLKGLAFCHSH---NV 120
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFG 628
+HRDLK N+L++K+ K++DFG+AR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 70/223 (31%), Positives = 112/223 (50%), Gaps = 46/223 (20%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK----NEIKLIAKLQH 530
+ N++ EG +G VY+ R G+ VA+K+L + + E F EI ++ KLQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQH 63
Query: 531 RNLVRL----LGCCIELEEKI-LIYEYMPN--KSL-----DFFLFDSTKENLLGWGTRVR 578
N+V + +G ++ KI ++ EY+ + KSL FL K L+ ++
Sbjct: 64 PNIVTVKEVVVGSNLD---KIYMVMEYVEHDLKSLMETMKQPFLQSEVK-CLM-----LQ 114
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638
++ G+A +LH ++HRDLK SN+LL+ KI DFG+AR + G L+ T+
Sbjct: 115 LLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQL 166
Query: 639 IVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
+V T Y +PE L K D++S G + E L+ K
Sbjct: 167 VV-TLWYRAPEL----LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 486 GGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---QEEFKNEIKLIAKLQHRNLVRLLGCCI 541
G +G V+ + G A+K + ++ E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 542 ELEEKI-LIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+ ++ + L+ EY+P L L S E++ R+ I E I L YLH +
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDV----ARIYIAE-IVLALEYLHSNG---I 114
Query: 599 IHRDLKASNILLDKDMNPKISDFG------MARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
IHRDLK NIL+D + + K++DFG + R ++ + + KRIVGT Y++PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
S D +S G +L E L
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 24/194 (12%)
Query: 499 GQEVAVKRLSSQSGQGQEE---FKNEIKLIAKLQHRNLVRLL--GCCIELEEKIL--IYE 551
G EVA+K L + + + + + F+ E L A+L H N+V LL G +L ++E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFE 59
Query: 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL- 610
Y+P ++L L + L G R++ + L H ++HRDLK NI++
Sbjct: 60 YVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113
Query: 611 --DKDMNPKISDFGMARIFGG----DELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVF 663
+ K+ DFG+ + G D ++T ++GT Y +PE + + SD++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 664 SFGVLLLETLSSKR 677
++G++ LE L+ +R
Sbjct: 174 AWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 14/179 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKN----EIKLIAKLQH 530
+ +GEG +G V K R G+ VA+K+ + + E+ K E+K++ +L+H
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRH 59
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
N+V L L++EY+ L+ L +++ L R I + Q + Y
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-SYIWQLLQAIAYC 116
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
H +IHRD+K NIL+ + K+ DFG AR T V T Y +PE
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 31/203 (15%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS--GQGQEE-FKNEIKLIAKLQHRNLVRLLG 538
LG G FG V R + A+K LS Q E NE +++ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ--------GLLYL 590
+ L+ EY+P L F + R E +A+ L YL
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL-FSHLRKSG----------RFPEPVARFYAAQVVLALEYL 117
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H L +++RDLK N+LLD D KI+DFG A+ ++ +T + GT Y++PE
Sbjct: 118 HS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEI 169
Query: 651 AQQGLFSIKSDVFSFGVLLLETL 673
+ D ++ G+L+ E L
Sbjct: 170 ILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKL-QHRN 532
LGEG FG V K + VAVK L + + + +E++++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFL-----------FDSTK--ENLLGWGTRVRI 579
++ LLG C + +I EY +L +L +D + + + + V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR + KT
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVL+ E +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/175 (31%), Positives = 86/175 (49%), Gaps = 19/175 (10%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
K+GEG +G V+K R GQ VA+K+ S ++ EI+++ +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGW--GTRVRIIEGIAQGLLYLHQYSRL 596
+ L++EY D + + ++N G +II Q + + H+++
Sbjct: 68 VFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN-- 120
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIVGTYGYMSPE 649
IHRD+K NIL+ K K+ DFG ARI GD+ V T Y +PE
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD----YVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 482 KLGEGGFGPV-YKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+GEG G V G++VAVK++ + Q +E NE+ ++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 541 IELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
+ +E ++ E++ +L D E + + + + L YLH VI
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VI 140
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRD+K+ +ILL D K+SDFG + K K +VGT +M+PE + + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 660 SDVFSFGVLLLETLSSK 676
D++S G++++E + +
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 57/178 (32%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIKLIAKLQHRN 532
+G G +G V G++VA+K++ F + EIKL+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 533 LVRLLGCCI-----ELEEKILIYEYMP---------NKSLD-----FFLFDSTKENLLGW 573
++ LL + + ++ E M + L +FL+ +L
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY-----QIL-- 113
Query: 574 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631
+GL YLH VIHRDLK SNIL++ + + KI DFG+AR DE
Sbjct: 114 -----------RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 55/193 (28%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 482 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+GEG G V + +G+ VAVK++ + Q +E NE+ ++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 541 IELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
+ +E ++ E++ +L D E + + + + L LH VI
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG---VI 138
Query: 600 HRDLKASNILLDKDMNPKISDFGM-ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
HRD+K+ +ILL D K+SDFG A++ E+ + K +VGT +M+PE + +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRR-KSLVGTPYWMAPELISRLPYGP 195
Query: 659 KSDVFSFGVLLLE 671
+ D++S G++++E
Sbjct: 196 EVDIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 52/149 (34%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 482 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
++G G FG V G + +V VK L S S Q Q +F E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV--RIIEGIAQGLLYLHQYSR 595
G C E+ +L+ E+ P L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMA 624
IH DL N LL D+ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 17/198 (8%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
+LG+G FG VYK + G A K + ++S + E++ EI ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
++ E+ ++D + + + L RV + + + L YLH+ ++IH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR--IVGTYGYMSPEY-----AQQ 653
RDLKA NIL D + K++DFG++ ++ +R +GT +M+PE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 654 GLFSIKSDVFSFGVLLLE 671
+ K+DV+S G+ L+E
Sbjct: 183 RPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 50/231 (21%)
Query: 467 LASVSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGQEEFKNEI 522
+V T + +G G FG V R L GQ VA+K++ S + ++ E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-EL 60
Query: 523 KLIAKLQHRNLVRLLGCCIE-LEEKILIYEYM-------------PNKSLDFFLFDSTKE 568
KL+ L+H N++ L I LE+ + E + + + +FL+
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ---- 116
Query: 569 NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
I +GL Y+H V+HRDLK SNIL++++ + KI DFG+ARI
Sbjct: 117 --------------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-- 157
Query: 629 GDELQSKTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSK 676
+ V T Y +PE Q+ + ++ D++S G + E L K
Sbjct: 158 ---QDPQMTGYVSTRYYRAPEIMLTWQK--YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 475 ANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQH 530
+ +G G FG V+ R ++ A+K ++ + ++ NE +++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 531 RNLVRLLGCCIELEEKIL--IYEYMPNKSLDFFL-----FDSTKENLLGWGTRVRIIEGI 583
++RL E +++ L + EY+P L +L F ++ I
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYA--------SEI 110
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
L YLH +++RDLK NILLDK+ + K++DFG A+ +L+ +T + GT
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTP 162
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
Y++PE Q + D ++ G+L+ E L
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 47/225 (20%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRN 532
+ + +GEG +G V G +VA+K++S Q Q + EIK++ + +H N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64
Query: 533 LVRLLGCCI-----ELEEKILIYEYMP-------------NKSLDFFLFDSTKENLLGWG 574
++ +L + ++ E M N + +FL+
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ---------- 114
Query: 575 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634
I +GL Y+H + V+HRDLK SN+LL+ + + KI DFG+ARI + +
Sbjct: 115 --------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 635 KT-KRIVGTYGYMSPE--YAQQGLFSIKSDVFSFGVLLLETLSSK 676
V T Y +PE +G ++ D++S G +L E LS++
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN-LVRLL 537
K+GEG +G VYK R G+ VA+K RL EI L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 538 GCCIELEEKI------LIYEYMPNKSLDFFLFDSTKE---NLLGWGTRVRIIEGIAQGLL 588
+EEK L++EY+ + L F+ DS L T + + +G+
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
+ H++ V+HRDLK N+L+DK KI+D G+ R F ++S T IV T Y +
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYRA 179
Query: 648 PEYAQQGL-FSIKSDVFSFGVLLLETL 673
PE +S D++S G + E
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 63/251 (25%), Positives = 111/251 (44%), Gaps = 51/251 (20%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGQEEFKN------------EIKLI 525
LGEG +G V K L G+ VA+K+ + S ++ + E+K++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 526 AKLQHRNLVRLLGCCIELEEKILIYEYMPN---KSLD--FFLFDSTKENLLGWGTRVRII 580
+++H N++ L+ +E + L+ + M + K +D L +S + I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC---------IL 125
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI- 639
I GL LH++ +HRDL +NI ++ KI+DFG+AR +G +
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 640 -----------VGTYGYMSPEY---AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN 685
V T Y +PE A++ F++ D++S G + E L+ K F N
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK--PLFPGEN 238
Query: 686 SLTLLGHAWDL 696
+ LG ++L
Sbjct: 239 EIDQLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 482 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
+GEG +G V K + GQ VA+K+ S ++ EI+++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ L++E++ + LD D K N L + + I +G+ + H ++
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMSPE 649
+IHRD+K NIL+ + K+ DFG AR + E+ + V T Y +PE
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQE----VAVKRLSS----QSGQGQEEFKNEIKLIAK 527
NF LG G +G V+ R + G + A+K L Q + E + E +++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
++ + L + + K+ LI +Y+ L L+ + VR+ IA+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE----SEVRVY--IAEI 114
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+L L +L +I+RD+K NILLD + + ++DFG+++ F +E + + GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 647 SPEYAQQGL--FSIKSDVFSFGVLLLETLS 674
+PE + G D +S GVL E L+
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 483 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGFG V ++ G+ A KRL + +G+ NE +++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDS-----TKENLLGWGTRVRIIEGIAQGLLYLHQY 593
+ L+ M L F +++ +E L + I GL LH+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLHRE 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+ ++RDLK NILLD + +ISD G+A +I G+ ++ + VGT GYM+PE
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLN 174
Query: 653 QGLFSIKSDVFSFGVLLLETLSSK 676
+++ D + G L+ E + +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 483 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G++ +++ KR+ + G+ NE +++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
+ L+ M L F ++ E G V I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
R+++RDLK NILLD + +ISD G+A + G ++ + VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 656 FSIKSDVFSFGVLLLETLSSK 676
++ D ++ G LL E ++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 26/204 (12%)
Query: 483 LGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGQEEF--KNEIKLIAKLQHRNLVRL 536
LG+G FG V+ R + GQ A+K L + + ++ K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDFF----LFDSTKENLLGWGTRVRI-IEGIAQGLLYL 590
+ E K+ LI LDF LF + ++ V+ + +A L +L
Sbjct: 64 -HYAFQTEGKLYLI--------LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H L +I+RDLK NILLD++ + K++DFG+++ E K GT YM+PE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEV 169
Query: 651 AQQGLFSIKSDVFSFGVLLLETLS 674
+ + +D +SFGVL+ E L+
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 53/215 (24%)
Query: 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHR--NLVRL 536
+G G G VYK R G +AVK++ + EE K ++ ++ K H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 537 LGC---------CIELEE------KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE 581
G C+EL I +P E++LG ++
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIP-------------EDILG-----KMTV 121
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK-RIV 640
I + L YL + + VIHRD+K SNILLD N K+ DFG++ G + SK K R
Sbjct: 122 AIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSA 175
Query: 641 GTYGYMSPEY----AQQGLFSIKSDVFSFGVLLLE 671
G YM+PE + I++DV+S G+ L+E
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG--QEEFKNEIKLIAKLQHRNL 533
+F ++LG G G V K + + ++L + + + E++++ + +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLH 591
V G E + E+M SLD L ++ + E +LG +V I + +GL YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGLAYLR 120
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+ + +++HRD+K SNIL++ K+ DFG++ G + S VGT YMSPE
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERL 174
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
Q +S++SD++S G+ L+E
Sbjct: 175 QGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 38/94 (40%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIV 640
IA GL +LH +I+RDLK N++LD + + KI+DFGM + IFGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
GT Y++PE + D ++FGVLL E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 67/247 (27%), Positives = 116/247 (46%), Gaps = 43/247 (17%)
Query: 483 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G++ +++ KRL +SG+ + EI L+ N +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55
Query: 537 LGCCIELEEKI---LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ---GLLYL 590
+ E K L+ M L + +++ + L R+I AQ G+L+L
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL----EMERVIHYSAQITCGILHL 111
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVGTYGYMSPE 649
H + +++RD+K N+LLD N ++SD G+A + G ++ T+R GT GYM+PE
Sbjct: 112 HS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AGTNGYMAPE 164
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709
++ +S D F+ G + E ++ + T F + H + K+ EL T
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR--TPFKD--------HKEKVAKE----ELKRRT 210
Query: 710 LQNEASY 716
L++E +
Sbjct: 211 LEDEVKF 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 45/123 (36%), Positives = 71/123 (57%), Gaps = 13/123 (10%)
Query: 551 EYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNI 608
E+M SLD L + + E +LG +V I + +GL YL + + +++HRD+K SNI
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNI 135
Query: 609 LLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVL 668
L++ K+ DFG++ G + S VGT YMSPE Q +S++SD++S G+
Sbjct: 136 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 669 LLE 671
L+E
Sbjct: 192 LVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSS----QSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
LG+G FG V RL +G+ AVK L Q + + L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQYSRL 596
C + + E++ L F + S + + R R I L++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARARFYAAEITSALMFLHDKG-- 116
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+I+RDLK N+LLD + + K++DFGM + IF G T GT Y++PE Q+
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEM 171
Query: 655 LFSIKSDVFSFGVLLLETLS 674
L+ D ++ GVLL E L
Sbjct: 172 LYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 483 LGEGGFGPVYKGRL-LNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+G G +G V G++VA+K+LS QS + E++L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 540 CIELEEKILIYEYMPNKSLDFF--------LFDSTKENLLGW----GTRVR-IIEGIAQG 586
+ P SL+ F L + N++ ++ ++ I +G
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
L Y+H +IHRDLK SNI +++D KI DFG+AR + V T Y
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 182
Query: 647 SPE-------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+PE Y Q D++S G ++ E L+ K
Sbjct: 183 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 483 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGFG V ++ G+ A K+L + +G+ NE +++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWG-TRVRIIEGIAQGLLYLHQYSRLR 597
+ L+ M L F ++ N+ G R + A+ L R R
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-----NMGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+++RDLK NILLD + +ISD G+A I G+ ++ + VGT GYM+PE + +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEVVKNERY 178
Query: 657 SIKSDVFSFGVLLLETLSSK 676
+ D + G L+ E + K
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 38/93 (40%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIV 640
I GL +LH+ +I+RDLK N+LLDKD + KI+DFGM + + G + K
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
GT Y++PE + ++ D +SFGVLL E L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 51/148 (34%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 481 NKLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+KLGEG + VYKGR L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ L++EY+ +K L +L D N + + + +GL Y H R +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRK 124
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAR 625
V+HRDLK N+L+++ K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 483 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G++ +++ KR+ + G+ NE +++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
E ++ + L+ M L F +++ R I A+ L R
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF----DEQRAIFYAAELCCGLEDLQR 120
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R+++RDLK NILLD + +ISD G+A +I G+ ++ + VGT GYM+PE
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNE 176
Query: 655 LFSIKSDVFSFGVLLLETL 673
++ D + G L+ E +
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 37/99 (37%), Positives = 57/99 (57%)
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
Q LL +H +IHRD+K++NILL + K+ DFG ++++ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683
Y++PE ++ +S K+D+FS GVLL E L+ KR D N
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 481 NKLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
KLGEG + V+KGR L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ L++EY+ +K L ++ D N++ + I +GL Y H R +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT-KRIVGTYGYMSPE-YAQQGL 655
V+HRDLK N+L+++ K++DFG+AR + +KT V T Y P+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 656 FSIKSDVFSFGVLLLETLSSK 676
+S + D++ G + E S +
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEV----AVKRLSS----QSGQGQEEFKNEIKLIAK 527
NF LG G +G V+ R + G + A+K L Q + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLF--DSTKENLLGWGTRVRIIEG-I 583
++ + L + E K+ LI +Y+ + L+ D+ E+ VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRFYSGEI 114
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
L +LH +L +++RD+K NILLD + + ++DFG+++ F +E + +T GT
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTI 170
Query: 644 GYMSPEYAQ-QGLFSIKSDVFSFGVLLLE--------TLSSKRNT 679
YM+PE + +G D +S G+L+ E TL +RNT
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLLG 538
LG+G FG V L G+ AVK L ++ + E +++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 539 CCIELEEKIL-IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQYSRL 596
C + +E + + E++ L F + D + +L R I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY----RATFYAAEIVCGLQFLHSKG-- 116
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+I+RDLK N++LD+D + KI+DFGM + +FG ++ GT Y++PE Q
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGL 171
Query: 655 LFSIKSDVFSFGVLLLETL 673
++ D +SFGVLL E L
Sbjct: 172 KYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEE--FKNEIKLIAKLQHRNLVRLLGC 539
+G+G +G V R +G++ +K+L+ ++ +E + E +L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 540 CIELEEKIL--IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
E E+ +L + + L + K LL V IA L YLH+
Sbjct: 68 W-EGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
++HRDLK N+ L + K+ D G+AR+ + T ++GT YMSPE ++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYN 180
Query: 658 IKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687
KSDV++ G + E + K + + NSL
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 35/84 (41%), Positives = 53/84 (63%), Gaps = 6/84 (7%)
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H ++R V++RDLK +NILLD+ + +ISD G+A F + K VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEV 166
Query: 651 AQQGL-FSIKSDVFSFGVLLLETL 673
Q+G+ + +D FS G +L + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 31/282 (10%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
++G G FG V + VA VK L ++ S + Q EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV---RIIEGIAQGLLYLHQYS 594
G C+E +L++EY L +L S ++ + R+ IA G+ ++H+++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL--SQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARI-FGGDELQSKTKRIVGTYGYMSPEYA-- 651
L H DL N L D+ K+ D+G+ + D ++++ + V +++PE
Sbjct: 120 FL---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVGE 175
Query: 652 -QQGLFSIK----SDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706
GL + + S+V++ GV L E + +S+ + +L H D+ +L
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQP-YSHLSDREVLNHVI----KDQQVKLF 230
Query: 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
P L+ S R+ V C R T EV +LT
Sbjct: 231 KPQLELPYS----ERWYEVLQFCWLS-PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFK---NEIKLIAKLQHRNLVRLLG 538
LG+G FG V L EV A+K L ++ E +++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 539 CCIELEEKIL-IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQYSRL 596
CC + ++++ + EY+ L F + S K + R R + L++LH++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD----EPRSRFYAAEVTLALMFLHRHG-- 116
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
VI+RDLK NILLD + + K++DFGM + I G T GT Y++PE Q+
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIAPEILQEL 171
Query: 655 LFSIKSDVFSFGVLLLETLSSK 676
+ D ++ GVL+ E ++ +
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 54/158 (34%), Positives = 86/158 (54%), Gaps = 13/158 (8%)
Query: 472 AATANFSTENKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGQEEFK--NEIKLIAKL 528
AAT+ + E KLGEG + VYKG +NGQ VA+K +S ++ +G F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 529 QHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGL 587
+H N+V LL I +E + ++EYM + + L + R+ + + + +GL
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGL 116
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
Y+H ++HRDLK N+L+ K++DFG+AR
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEV----AVKRLSS----QSGQGQEEFKNEIKLIAK 527
NF LG G +G V+ R ++G + A+K L Q + E + E +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
++ + L + + K+ LI +Y+ L F S +E ++ E I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
L +LH +L +I+RD+K NILLD + + ++DFG+++ F DE++ + GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 647 SPEYAQQGL--FSIKSDVFSFGVLLLETLS 674
+P+ + G D +S GVL+ E L+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
++LG+G +G VYK G +A+K RL + + E+ ++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDFY 65
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
G + EYM SLD + RI + +GL +L +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY------A 651
+IHRD+K +N+L++ + K+ DFG++ G+ + S K +G YM+PE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
Q ++++SDV+S G+ +LE
Sbjct: 180 QNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 48/166 (28%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK-----NEIKLIAKLQHRNLVR 535
KLGEG + VYKGR L GQ VA+K + + EE E L+ L+H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLE----HEEGAPFTAIREASLLKDLKHANIV- 66
Query: 536 LLGCCIELEEKI-LIYEYM-----------PN----KSLDFFLFDSTKENLLGWGTRVRI 579
L I ++ + L++EY+ ++ FLF LL
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF-----QLL-------- 113
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
+GL Y HQ RV+HRDLK N+L+ + K++DFG+AR
Sbjct: 114 -----RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 25/202 (12%)
Query: 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAK------LQHRNLVR 535
LG+G FG V+ L Q A+K L ++ E ++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 536 LLGCCIELEEKIL-IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQY 593
L C + +E + + EY+ L F + K +L R I GL +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDL----PRATFYAAEIICGLQFLHSK 115
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYA 651
+++RDLK NILLD D + KI+DFGM + + G +KT GT Y++PE
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEIL 168
Query: 652 QQGLFSIKSDVFSFGVLLLETL 673
++ D +SFGVLL E L
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+G+GG G VY + + VA+K++ S++ ++ F E K+ A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 538 GCCIELEEKILIYEYMPN------KSL--DFFLFDSTKENL---LGWGTRVRIIEGIAQG 586
C + +Y MP KSL + +S + L G + I I
Sbjct: 69 SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE--------------L 632
+ Y+H S+ V+HRDLK NILL I D+G A +E
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 633 QSKTK--RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
S T +IVGT YM+PE S +D+++ GV+L + L+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 39/156 (25%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
E L+ + H +++R+ + ++ +P+ S D + + + + L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKR 638
+ I +GL YLH R+IHRD+K NI ++ I D G A+ + L
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG----- 215
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ GT +PE + ++ K+D++S G++L E L+
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 464 MFSLASVSAATANFSTENKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGQEEFKNEI 522
M L S+ T + +G+G +G VYK +G AVK L S EE + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEY 69
Query: 523 KLIAKL-QHRNLVRLLGCCIELEEKI-----LIYEYMPNKSLDFFLFDSTKENLLGWGTR 576
++ L H N+V+ G + ++ + L+ E S+ + + LL G R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 577 VR------IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630
+ I+ G GL +LH R+IHRD+K +NILL + K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 631 ELQSKTKRIVGTYGYMSPEY---AQQGLFS--IKSDVFSFGVLLLE 671
L+ T VGT +M+PE QQ +S + DV+S G+ +E
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 35/84 (41%), Positives = 52/84 (61%), Gaps = 6/84 (7%)
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H ++R V++RDLK +NILLD+ + +ISD G+A F + K VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEV 166
Query: 651 AQQGL-FSIKSDVFSFGVLLLETL 673
Q+G + +D FS G +L + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 483 LGEGGFG-PVYKGRLLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
+GEG FG + + + Q+ A+K + +S E+ + E L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 541 IELEEKILIYEYMPNKSLDFFLFDS-----TKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
++ EY L + ++ +L W + + G+ ++H+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
RV+HRD+K+ NI L ++ K+ DFG AR+ + T VGT Y+ PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176
Query: 656 FSIKSDVFSFGVLLLE 671
++ KSD++S G +L E
Sbjct: 177 YNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN--EIKLIAKLQ-HRNLVRL 536
K+GEG F V K + G+ A+K + + + E+ N EI+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 537 LGCCIELEEK--ILIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ + + L++E M D L++ K + L + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-YA 651
R + HRD+K NIL+ D K++DFG R G T+ I T Y +PE
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLL 171
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
G + K D+++ G + E LS
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 482 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
E L++EY+ + D L ++ + + + +GL Y+HQ +
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY---I 124
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAR 625
+HRDLK N+L+ K++DFG+AR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 57/229 (24%)
Query: 475 ANFSTENKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGQEEFKN--EIKLIAKLQHR 531
+ + +G G +G V +G++VA+K++ + E+K++ +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLD---FFLFDSTKENLLGWGTRVRIIEG------ 582
N++ + IL P + + + D + +L II
Sbjct: 65 NIIAIR--------DIL----RPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTE 106
Query: 583 ---------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633
+ +GL Y+H + VIHRDLK SN+L+++D +I DFGMAR G
Sbjct: 107 EHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSP 161
Query: 634 SKTKRI----VGTYGYMSPEYAQQGLFSI-----KSDVFSFGVLLLETL 673
++ K V T Y +PE L S+ D++S G + E L
Sbjct: 162 TEHKYFMTEYVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 39/94 (41%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGG-DELQSKTKRIV 640
+A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR I+ D ++ R+
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVLL E S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 481 NKLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+KLGEG + V+KGR L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
L++EY+ + D + NL+ + + +GL Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAR 625
++HRDLK N+L+++ K++DFG+AR
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-10
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 336 KSGDRFIMLDDVKLPDFVEASLNESMNVKECEAECLK-NCTCRAYANSKVTGEGSGCLMW 394
KS D F+ L + KLP F ++ +++EC ++CL NC+CR++ + T GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGT---KGCLLW 56
Query: 395 -FGDLIDIRKADDRNNGQSIYIRV 417
L D R + G +Y ++
Sbjct: 57 SESSLGDARLF--PSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 483 LGEGGFGPVYKGRLLNGQE----VAVKRLSS----QSGQGQEEFKNEIKLIAKLQHRNLV 534
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
L+ + LI EY+ L L +E + T + I+ L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+I+RDLK NILLD + K++DFG+ + I G + T GT YM+PE
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILM 173
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+ D +S G L+ + L+
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 52/179 (29%)
Query: 499 GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL--------------LGCCIELE 544
+ VAVK++ Q + EIK+I +L H N+V++ +G EL
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGT----RVRIIE-GIAQGLLYLHQYSRLRVI 599
++ EYM ++ N+L G R+ + +GL Y+H + V+
Sbjct: 90 SVYIVQEYM----------ETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VL 136
Query: 600 HRDLKASNILLD-KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
HRDLK +N+ ++ +D+ KI DFG+ARI + P Y+ +G S
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARI-------------------VDPHYSHKGYLS 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 5e-10
Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 25/182 (13%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKL-QHRNLVR 535
KLG+G +G V+K + VA+K++ + Q F+ EI + +L H N+V+
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 536 LLGCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
LL I+ E IY EYM + L + N+L + I+ + + L Y+H
Sbjct: 72 LLNV-IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKALKYIH- 124
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI-----VGTYGYMS 647
S VIHRDLK SNILL+ D K++DFG+AR EL+ + V T Y +
Sbjct: 125 -SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATRWYRA 180
Query: 648 PE 649
PE
Sbjct: 181 PE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 30/190 (15%)
Query: 495 RLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE--- 551
RL+ + A R + Q +NEI + +L H N++++ E+IL E
Sbjct: 194 RLIAKRVKAGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANT 238
Query: 552 YMPNKSLDF----FLFDST---KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 604
YM + DF F++D K+ L TR I++ + + Y+H ++IHRD+K
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIK 294
Query: 605 ASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFS 664
NI L+ D + DFG A F E ++ VGT SPE + +D++S
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353
Query: 665 FGVLLLETLS 674
G++LL+ LS
Sbjct: 354 CGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
IA GL +LH +I+RDLK N++LD + + KI+DFGM + D + +KT GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGT 164
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
Y++PE + D ++FGVLL E L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 483 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSSQSGQGQEEFKNEIKLIAKLQHRN 532
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
LV+L G C+ E I++ EY+ LD FL L W ++ + + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 593 YSRLRVIHRDLKASNILLDKDMNP-------KISDFGMARIFGG-DELQSKTKRIVGTYG 644
+++H ++ NIL+ + K+SD G+ +E +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169
Query: 645 YMSPEYAQQGLFSIKS--DVFSFGVLLLE 671
+++PE + G S+ D +SFG LLE
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 8/176 (4%)
Query: 510 QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKEN 569
++ G + EI ++ + HR ++ L+ K + MP D F +
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 570 LLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629
L + I + + L YLH +IHRD+K NI LD+ N + DFG A
Sbjct: 182 L-PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN 685
+ GT SPE + K+D++S G++L E +S K T F
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 40/191 (20%)
Query: 499 GQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555
GQ VA+K+LS + Q K E+ L+ + H+N++ LL + P
Sbjct: 41 GQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQ 87
Query: 556 KSLDFF--------LFDSTKENL-------LGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600
KSL+ F L D+ NL L ++ + G+ +LH +IH
Sbjct: 88 KSLEEFQDVYLVMELMDA---NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIH 141
Query: 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
RDLK SNI++ D KI DFG+AR G + T +V Y Y +PE +
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 198
Query: 661 DVFSFGVLLLE 671
D++S G ++ E
Sbjct: 199 DIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 498 NGQEVAVKRLSSQSGQGQEEFK---NEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554
VAVK+++ S +E+ K EI +LQH N++ + I E ++ M
Sbjct: 24 TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 555 NKS----LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610
S L + E + + I++ + L Y+H IHR +KAS+ILL
Sbjct: 83 YGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIHS---KGFIHRSVKASHILL 134
Query: 611 DKDMNPKISDFGMAR-IFGGDELQSK----TKRIVGTYGYMSPEYAQQGL--FSIKSDVF 663
D +S + + + Q K V ++SPE QQ L ++ KSD++
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194
Query: 664 SFGV 667
S G+
Sbjct: 195 SVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 36/105 (34%), Positives = 59/105 (56%), Gaps = 5/105 (4%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
I+ GL +LH R +I+RDLK N++LD + + KI+DFGM + D + ++T GT
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGT 164
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687
Y++PE + D +++GVLL E L+ + D + + L
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
+A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR D +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++I+SDV+SFGVLL E S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 483 LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+G G +G V G VAVK+LS QS + E++L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 540 CIELEEKILIYEYMPNKSLDFF--------LFDSTKENLLGWGTRVR-----IIEGIAQG 586
+ P +SL+ F L + N++ +I I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
L Y+H +IHRDLK SN+ +++D KI DFG+AR DE+ V T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184
Query: 647 SPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL 690
+PE + ++ D++S G ++ E L+ + T F T+ + L
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 483 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+G G +G V Y RL Q+VAVK+LS QS E++L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLG--WGTRVR-----------IIEGIA 584
+ P S++ F NL+G V+ +I +
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
+GL Y+H +IHRDLK SN+ +++D +I DFG+AR DE+ V T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRW 180
Query: 645 YMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSK 676
Y +PE + ++ D++S G ++ E L K
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 45/123 (36%), Positives = 71/123 (57%), Gaps = 13/123 (10%)
Query: 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 613
P ++ D + T E+L+ + +V A+G+ +L SR + IHRDL A NILL ++
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQV------ARGMEFLA--SR-KCIHRDLAARNILLSEN 210
Query: 614 MNPKISDFGMAR-IFGG-DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
KI DFG+AR I+ D ++ + R+ +M+PE +++ +SDV+SFGVLL E
Sbjct: 211 NVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWE 268
Query: 672 TLS 674
S
Sbjct: 269 IFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
I +GL YLH ++HRD+K N+L++ + KI DFG+AR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 643 YGYMSPEY---AQQGLFSIKSDVFSFGVLLLETLSSK 676
Y Y +PE ++ ++ D++S G + E L +
Sbjct: 169 Y-YRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 72/230 (31%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIKLIAKLQHRN 532
+G G +G V + ++VA+K++++ F N EIKL+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 533 LVRLLGCCI-----ELEEKILIYEYM---------PNKSL-----DFFLFDSTKENLLGW 573
++ + + ++YE M +++L +FL+
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 574 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633
+ +GL Y+H + V+HRDLK SN+LL+ + + KI DFG+AR ++
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGD 163
Query: 634 SKTKRIVGTYGYMSPE-------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
T+ +V T Y +PE Y +I DV+S G + E L K
Sbjct: 164 FMTEYVV-TRWYRAPELLLNCSEYTT----AI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 483 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGQEEFKN----EIKLIAKLQHRNLVRLL 537
+GEG +G V K R +E VA+K+ + + EE K E+K++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ L++EY+ L+ E + ++ I Q + +H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELL------EEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
++HRD+K N+L+ + K+ DFG AR + T+ V T Y SPE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE-YVATRWYRSPELLLGAPYG 179
Query: 658 IKSDVFSFGVLLLE 671
D++S G +L E
Sbjct: 180 KAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 53/222 (23%)
Query: 475 ANFSTENKLGEGGFGPV----YKGRLLNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAK 527
++F LG G FG V +KG G+ A+K L + + + E ++ +
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYM---------------PNKSLDFFLFDSTKENLL 571
L H +V ++ C + E ++ + E++ PN F+ E +L
Sbjct: 75 LSHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY----HAELVL 129
Query: 572 GWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631
+ YLH +I+RDLK N+LLD + K++DFG A+ +
Sbjct: 130 AFE--------------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----K 167
Query: 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
+ +T + GT Y++PE Q D ++ GVLL E +
Sbjct: 168 VPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQ--EVAVKRLSSQSGQGQEEFK---NEIKLIAKLQH 530
+F+ LG G FG V N VA+KR Q++ +E K++ + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLY 589
V L G + L+ E++ FL + + N +G +I+ L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV-------LI 143
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
L +++RDLK N+LLDKD K++DFG A++ + ++T + GT Y++PE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198
Query: 650 YAQQGLFSIKSDVFSFGVLLLETL 673
+D ++ G+ + E L
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 53/230 (23%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSS----QSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+G G FG V+ R + +V A+K L + Q + E ++A +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKLY 67
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG------IAQGLLYL 590
+ EE + L+ EYMP +L+ R + IA+ +L L
Sbjct: 68 -YSFQDEEHLYLVMEYMPGG------------DLMNLLIRKDVFPEETARFYIAELVLAL 114
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-------------------------R 625
+L IHRD+K NIL+D D + K++DFG+
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 626 IFGGDELQSKTKR--IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
+ D Q + + VGT Y++PE + + ++ D +S GV+L E L
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 46/213 (21%)
Query: 483 LGEGGFGPV----YKGRLLNGQEVAVKRLSSQSGQGQEEF------KNEIKLIAKLQHRN 532
LG G FG V YK G+ A+K L ++E K + +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSL------DFFLFDSTKENLLGWGTRVRIIEGIAQ 585
LV L C + E+ + + EY L D F + R + A
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-------------SEPRAVFYAAC 109
Query: 586 ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIV 640
GL YLH+ ++++RDLK N+LLD + KI+DFG+ + + GD +T
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFC 162
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
GT +++PE + ++ D + GVL+ E L
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 483 LGEGGFGPV-YKGRLLNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+G G +G V G +VA+K+L QS + E++L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 540 C---IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
+ L+ Y MP D L K L ++ + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG-- 138
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL- 655
+IHRDLK N+ +++D KI DFG+AR + S+ V T Y +PE +
Sbjct: 139 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 656 FSIKSDVFSFGVLLLETLSSK 676
++ D++S G ++ E L+ K
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+G G +G VYK + +G++ L G G EI L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 541 IELEEK--ILIYEYMPNKSLDFFLFD-STKENLLGWGTRVRIIEGIAQGLLY-----LHQ 592
+ ++ L+++Y + F ++K N V++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 593 YSRLRVIHRDLKASNILL----DKDMNPKISDFGMARIFGGD-ELQSKTKRIVGTYGYMS 647
V+HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 648 PEYAQQGLFSIKS-DVFSFGVLLLETLSSK-----RNTDFSNTN 685
PE K+ D+++ G + E L+S+ R D +N
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 55/212 (25%)
Query: 486 GGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE 544
G FG VY + G A+K L +IAK Q N+ + E
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSD------------MIAKNQVTNV--------KAE 46
Query: 545 EKILIYE-YMPNKSLDFFLFDSTKENLL---------GWGTRVRIIEGIAQ--------- 585
I++ + P + ++ F S K+ L + ++ + G+ +
Sbjct: 47 RAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAE 105
Query: 586 ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
G+ LHQ +IHRD+K N+L+D+ + K++DFG++R G E K+ VGT
Sbjct: 106 VVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156
Query: 643 YGYMSPEYAQQGLFSIK-SDVFSFGVLLLETL 673
Y++PE G+ K SD +S G ++ E L
Sbjct: 157 PDYLAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 483 LGEGGFGPVYKG--------RLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
LG+G F ++KG L+ EV +K L E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
G C+ +E I++ EY+ SLD +L +NL+ ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 595 RLRVIHRDLKASNILL-----DKDMNP---KISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+ H ++ A N+LL K NP K+SD G++ E+ +RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 647 SPEYAQQGL-FSIKSDVFSFGVLLLETLS 674
PE + S+ +D +SFG L E S
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 41/265 (15%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+G G +G VYK + +G++ L G G EI L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 541 IELEEK--ILIYEYMPNKSLDFFLFD-STKEN----LLGWGTRVRIIEGIAQGLLYLHQY 593
+ ++ L+++Y + F ++K N L ++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 594 SRLRVIHRDLKASNILL----DKDMNPKISDFGMARIFGGD-ELQSKTKRIVGTYGYMSP 648
V+HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 649 EYAQQGLFSIKS-DVFSFGVLLLETLSSK-----RNTDFSNTNS---------LTLLGHA 693
E K+ D+++ G + E L+S+ R D +N +++G
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG-- 242
Query: 694 WDLWKDDRAWELID-----PTLQNE 713
+ D+ WE I PTLQ +
Sbjct: 243 ---FPADKDWEDIRKMPEYPTLQKD 264
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLLG 538
LG+G FG V R +G+ A+K L + ++E + E +++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQYSRLR 597
+ + EY+ L F L ++E + R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL---SRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+++RDLK N++LDKD + KI+DFG+ + D KT GT Y++PE + +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYG 173
Query: 658 IKSDVFSFGVLLLETLSSK 676
D + GV++ E + +
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 483 LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQHRNLVRLLG- 538
+G G +G V G++VA+K+LS QS + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 539 --CCIELEEKILIYEYMPNKSLDF-----FLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
+ +E Y MP D K L + + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL--------VYQMLCGLKYIH 134
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRDLK N+ +++D KI DFG+AR ++ V T Y +PE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVI 186
Query: 652 QQGLFSIKS-DVFSFGVLLLETLSSK 676
+ ++ D++S G ++ E L+ K
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 38/101 (37%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIV 640
I GL Y+H + V+HRDLK N+L++ D KI DFG+AR F E V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 641 GTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
T Y +PE + S +S DV+S G +L E L K
Sbjct: 171 ATRWYRAPEI----MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 483 LGEGGFGPVY-KGRLLNGQEVAVKRLSSQSGQGQEEFKNEIK----LIAKLQHRNLVRLL 537
+G+G FG V R +G AVK L ++ ++E + + L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
E+ + +Y+ L F L + L R E +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---LN 116
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+I+RDLK NILLD + ++DFG+ + G E + T GT Y++PE ++ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 658 IKSDVFSFGVLLLETL 673
D + G +L E L
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 21/105 (20%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR---------IFGGDELQ 633
+AQG+ +L + IHRD+ A N+LL KI DFG+AR + G L
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN 678
K +M+PE +++++SDV+S+G+LL E S ++
Sbjct: 278 VK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 491 VYKGRLLNGQEVAVKRL---SSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG----CCIEL 543
+YKG N +EV ++ + +NEIK + ++ N++++ G +L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 603
LI EY L L KE L + T++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 604 KASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS---IKS 660
+ + L+ ++ KI G+ +I L S + V Y S + +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 661 DVFSFGVLLLETLSSK 676
D++S GV+L E + K
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
+A+G+ +L + IHRDL A NILL KI DFG+AR D
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+S+G+LL E S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEF---KNEIKLIAKLQHRNLVRLLG 538
+G G + V RL N Q A+K + + E+ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
C + ++ L+ EY+ L F + + L R E I L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+I+RDLK N+LLD D + K++D+GM + + GD T GT Y++PE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRGEE 172
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTN 685
+ D ++ GVL+ E ++ + D N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
I L YLH S V++RDLK N++LDKD + KI+DFG+ + G + + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
Y++PE + + D + GV++ E + +
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEE---FKNEIKLIAKLQHRNLVRLLG 538
+G G FG V R + ++V A+K LS + + F E ++A +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL-- 108
Query: 539 CCIELEEKIL--IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
++K L + EYMP D S + W R E + L +H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGG--DLVNLMSNYDIPEKW-ARFYTAE-VVLALDAIHSMG-- 162
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL-QSKTKRIVGTYGYMSPEY----A 651
IHRD+K N+LLDK + K++DFG + + + T VGT Y+SPE
Sbjct: 163 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQG 219
Query: 652 QQGLFSIKSDVFSFGVLLLETL 673
G + + D +S GV L E L
Sbjct: 220 GDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIV 640
I L YLH V++RDLK N++LDKD + KI+DFG+ + I G K
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 156
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
GT Y++PE + + D + GV++ E +
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
I L YLH V++RD+K N++LDKD + KI+DFG+ + D KT GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 158
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
Y++PE + + D + GV++ E + +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 483 LGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCC 540
+G+G +G V+K NG + AVK L EE + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 541 IELEEKI-----LIYEYMPNKSLDFFLFDSTKENLLGWGTRVR------IIEGIAQGLLY 589
+ + K L+ E S+ D K L G R+ I+ GL +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVT----DLVK-GFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
LH + IHRD+K +NILL + K+ DFG++ L+ T VGT +M+PE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPE 194
Query: 650 Y--AQQGL---FSIKSDVFSFGVLLLE 671
+Q L + + DV+S G+ +E
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVG 641
+A+ +L + +L +HRD+K N+LLDK+ + +++DFG R+ +QS VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 642 TYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETL 673
T Y+SPE Q +G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 499 GQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLLGCCI------ELEEKILI 549
G VAVK+LS + Q Q K E+ L+ + H+N++ LL E ++ L+
Sbjct: 46 GINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609
E M + E + ++ + G+ +LH +IHRDLK SNI+
Sbjct: 105 MELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 155
Query: 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ D KI DFG+AR + + T +V Y Y +PE + D++S G ++
Sbjct: 156 VKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 212
Query: 670 LE 671
E
Sbjct: 213 GE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 2/159 (1%)
Query: 519 KNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVR 578
++E+ +A H +V+ ++ +LI EY L+ + KE+L V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638
++ Q +L L + +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677
GT Y++PE ++ +S K+D++S GV+L E L+ R
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 483 LGEGGFGPVY-KGRLLNGQEVAVKRLSSQSGQGQEEFKNEIK----LIAKLQHRNLVRLL 537
+G+G FG V R L+G+ AVK L + ++E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
E+ + +++ L F L +E IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+++RDLK NILLD + ++DFG+ + G T GT Y++PE ++ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 658 IKSDVFSFGVLLLETL 673
D + G +L E L
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD-ELQSKTKRIVG 641
IA+ +L +H +L +HRD+K N+LLD + + +++DFG D +QS VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 642 TYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETL 673
T Y+SPE Q G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
I+ L YLH+ +I+RDLK N+LLD + + K++D+GM + G T GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTD 680
Y++PE + + D ++ GVL+ E ++ + D
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
A+ L L + VI+RDLK NILLD + + DFG+ ++ D+ KT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGT 156
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
Y++PE ++ D ++ GVLL E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 9/100 (9%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIV 640
I+ L +LH+ +I+RDLK N+LLD + + K++D+GM + I GD T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFC 157
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTD 680
GT Y++PE + + D ++ GVL+ E ++ + D
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
+A+G+ +L + +HRDL A N+LL + KI DFG+AR D
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE L++ SDV+S+G+LL E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 4e-07
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 44/243 (18%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLLG 538
K+G G FG V+ + QE + S G + E E+ ++ +L+H+N+VR +
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 539 CCIELEEKIL--IYEYMPNKSLD------FFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
+ + L + E+ L + +F +E+ + V I + L Y
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDITRQLLHALAYC 134
Query: 591 HQY----SRLRVIHRDLKASNILLD-------------KDMN----PKISDFGMARIFGG 629
H + RV+HRDLK NI L ++N KI DFG+++ G
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG- 193
Query: 630 DELQSKTKRIVGTYGYMSPEYA--QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687
++S VGT Y SPE + + KSD+++ G ++ E S K T F N+
Sbjct: 194 --IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANNF 249
Query: 688 TLL 690
+ L
Sbjct: 250 SQL 252
|
Length = 1021 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIK----LIAKLQHRNLVRLL 537
+G+G FG V + +G+ AVK L ++ ++E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-IAQGLLYLHQYSRL 596
++ + +Y+ L FF + R R IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL-FFHLQRERSFP---EPRARFYAAEIASALGYLHS---L 115
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+I+RDLK NILLD + ++DFG+ + G E T GT Y++PE ++ +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 657 SIKSDVFSFGVLLLETLS 674
D + G +L E L
Sbjct: 174 DRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 22/186 (11%)
Query: 500 QEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLLGCCI------ELEEKILIY 550
+ VA+K+LS + Q Q K E+ L+ + H+N++ LL E ++ L+
Sbjct: 43 RNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101
Query: 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610
E M + E + ++ + G+ +LH +IHRDLK SNI++
Sbjct: 102 ELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 152
Query: 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLL 670
D KI DFG+AR G + T +V Y Y +PE + D++S G ++
Sbjct: 153 KSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 671 ETLSSK 676
E + K
Sbjct: 210 EMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 33/147 (22%), Positives = 60/147 (40%), Gaps = 15/147 (10%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV--RLLGC 539
L G VY ++ +K S+ + + + E+ ++ L + L ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
L+ E++ ++LD + ++E + I E +A+ L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLD----EVSEEE------KEDIAEQLAELLAKLHQLPLLVLC 111
Query: 600 HRDLKASNILLDKDMNPKISDFGMARI 626
H DL NIL+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 67/253 (26%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGQEEF---KNEIKLIAKL 528
+F T +G+G FG V RL+ G+ A+K L +++ K E ++A+
Sbjct: 2 DFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQG 586
+V L + + LI E++P L L +D+ E++ TR + E +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECV--- 111
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-------------RIFGGDELQ 633
L + +L IHRD+K NIL+D+ + K+SDFG++ ++ G +
Sbjct: 112 -LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 634 S---------------------------KTKRI-----VGTYGYMSPE-YAQQGLFSIKS 660
+ K +R+ VGT Y++PE + QQG + +
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQEC 229
Query: 661 DVFSFGVLLLETL 673
D +S G ++ E L
Sbjct: 230 DWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+G G FG V R + Q+V +L S+ + F E + I + V L C
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 540 CIELEEKI-LIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
+ ++ + ++ EYMP L + +D ++ W A+ +L L +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHSM 161
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-- 653
+IHRD+K N+LLDK + K++DFG DE + VGT Y+SPE +
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 654 --GLFSIKSDVFSFGVLLLETL 673
G + + D +S GV L E L
Sbjct: 220 GDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 458 RDSWFPMFSLA-SVSAATANFSTENKLGEGGFGPV---YKGRLLNGQEVAVKRLSSQSGQ 513
RD+ F + S + +G G G V Y L + VA+K+LS + Q
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLS-RPFQ 62
Query: 514 GQEEFKN---EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFF-----LFDS 565
Q K E+ L+ + H+N++ LL + P KSL+ F + +
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMEL 110
Query: 566 TKENL-------LGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618
NL L ++ + G+ +LH +IHRDLK SNI++ D KI
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
DFG+AR G + T +V Y Y +PE + D++S G ++ E +
Sbjct: 168 LDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 64/228 (28%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIKLIAKLQHRN 532
+G+G +G V G++VA+K++ + F++ EIKL+ L+H +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 533 LVRLLGCCI-----ELEEKILIYEYM---------PNKSL-----DFFLFDSTKENLLGW 573
+V + + E ++ +++E M N L FFL+ LL
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY-----QLL-- 113
Query: 574 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI-FGGDEL 632
+ L Y+H + V HRDLK NIL + D KI DFG+AR+ F
Sbjct: 114 -----------RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKS----DVFSFGVLLLETLSSK 676
V T Y +PE G F K D++S G + E L+ K
Sbjct: 160 AIFWTDYVATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEE---FKNEIKLIAKLQHR 531
+F ++ +G G FG V R G A+K + QE F+ E +++
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFL---FDSTKENLLGWGTRVRIIEGIAQGLL 588
+ +L + + L+ EY P L L D E++ + +A+ +L
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM------AQFY--LAELVL 113
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
+H ++ +HRD+K N+L+D+ + K++DFG A ++ +K VGT Y++P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAP 172
Query: 649 EYAQ------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686
E +G + ++ D +S GV+ E + + + F S
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR--SPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKNEIK----LIAKLQHRNLVRLL 537
+G+G FG V R ++ AVK L ++ ++E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
++ + +Y+ L + L + L R E IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+++RDLK NILLD + ++DFG+ + E T GT Y++PE + +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 658 IKSDVFSFGVLLLETL 673
D + G +L E L
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 58/244 (23%)
Query: 476 NFSTENKLGEGGFGPVYKGRL----LNGQEVAVKRL--SSQSGQGQ-EEFKNEIKLIAKL 528
+F + +G G FG V RL G A+K+L S + Q + E ++A+
Sbjct: 2 DFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA 58
Query: 529 QHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQ 585
+ +V+L + E + LI EY+P + L D+ E TR I E I
Sbjct: 59 DNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----ETRFYIAETI-- 111
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM------------ARIFGGDEL- 632
L + +L IHRD+K N+LLD + K+SDFG+ RI
Sbjct: 112 --LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 633 ---------QSKTKRI--------------VGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
S ++ VGT Y++PE Q ++ + D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 670 LETL 673
E L
Sbjct: 230 YEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
E ++ + H ++++L G + LI +P D + + + K N+ + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI-AICDILAIE 188
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIV 640
+ + + YLH+ R+IHRD+KA NI ++ + + DFG A F D +K
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
GT +PE + + D++S G++L E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVG 641
+A G+ +L + +HRDL A N+L+ + KI DFG+AR I SK +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL- 303
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE L++ SDV+SFG+LL E +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
A+ +L L + IHRD+K N+LLDK + K++DFG + + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 207
Query: 644 GYMSPEYAQQ----GLFSIKSDVFSFGVLLLETL 673
Y+SPE + G + + D +S GV L E L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RIFGGDELQSKTKRIVG 641
+A+ ++ + +L +HRD+K NIL+D + + +++DFG ++ +QS VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 165
Query: 642 TYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETL 673
T Y+SPE Q +G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
IA+ +L L + +++RDLK NILLD + + DFG+++ D T GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGT 159
Query: 643 YGYMSPE-YAQQGLFSIKSDVFSFGVLLLE 671
Y++PE + ++ D +S GVL+ E
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 44/222 (19%)
Query: 483 LGEGGFGPVYKGRLL-----------------------NGQE--VAVKRLSSQSGQGQEE 517
LG+G +Y GRL NG+E V +K L
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 518 FKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV 577
F L++++ H +L + G C+ E I++ E++ + LD L + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 578 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNP--KISDFGMARIFGGD 630
+ + +A L YL + ++H ++ A NILL + +P K+SD G++ F
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLE 671
+ + +RI +++PE G S +D +SFG LLE
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI---------FGG----DELQ 633
L YLH Y ++HRDLK N+L+ + K++DFG+++I + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
K++ GT Y++PE + + D ++ G++L E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 19/52 (36%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 575 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626
V+ I +A L YLH++ +IHRDLK N+L+ + + K++DFG++++
Sbjct: 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 49/238 (20%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGQEE---FKNEIKLIAKL 528
+F + +G G FG V RL+ G A+K L +E+ + E ++ +
Sbjct: 2 DFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
+V++ + LI E++P + L K+ L T+ I A+ +L
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVL 112
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA--------------------RIFG 628
+ +L IHRD+K N+LLD + K+SDFG+ F
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 629 GDELQSKTK-------------RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
+ SK K VGT Y++PE Q ++ D +S GV++ E L
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 29/156 (18%)
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLL 588
+ N ++L L+ +LI +Y+ D LFD K E L +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
LH++ +IH D+K N+L D+ + + D+G+ +I G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 648 PEYAQQGLFSIKSDV--FSF-----GVLLLETLSSK 676
PE IK SF GVL E L+ K
Sbjct: 175 PE-------KIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 49/238 (20%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGQEE---FKNEIKLIAKL 528
+F + +G G FG V RL+ G A+K L +E+ + E ++ +
Sbjct: 2 DFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
+V++ + LI E++P + L K+ L T+ I E + L
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETV----L 112
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA--------------------RIFG 628
+ +L IHRD+K N+LLD + K+SDFG+ F
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 629 GDELQSKTK-------------RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
+ SK K VGT Y++PE Q ++ D +S GV++ E L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 36/195 (18%)
Query: 462 FPMFSLASV------SAATANFSTENKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQ 510
MF LA + S +F KLGEG FG VYK L+N + +K+ +++
Sbjct: 113 VDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATE 171
Query: 511 SGQGQEEFKNE------IKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL------ 558
G E + NE A + L + + +E L++ Y +L
Sbjct: 172 YGAV-EIWMNERVRRACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQS 228
Query: 559 -DF------FLFDSTKENLLGWGTRVRIIEGIAQGLLY-LHQYSRLRVIHRDLKASNILL 610
+F +L ++ G +II+ I + +L+ L ++HRD+K NI+
Sbjct: 229 KEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288
Query: 611 DKDMNP-KISDFGMA 624
+ KI D G A
Sbjct: 289 SEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 41/132 (31%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--------------- 627
IA+ + ++ IHRD+K NIL+D+D + K++DFG+ F
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 628 --------------GGDELQSKTKR------------IVGTYGYMSPEYAQQGLFSIKSD 661
L+ +R +VGT Y++PE + ++ D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 662 VFSFGVLLLETL 673
+S GV+L E L
Sbjct: 227 WWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 45/136 (33%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG-------------- 628
IA+ L + ++ IHRD+K NIL+D D + K++DFG+ F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 629 -------------------GDELQSKTKR------------IVGTYGYMSPEYAQQGLFS 657
GD L++ +R +VGT Y++PE + ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 658 IKSDVFSFGVLLLETL 673
D +S GV+L E L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 481 NKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGQEEFKN-EIKLIAKLQHRNLVRLLG 538
N +G G FG VY+ ++ E VA+K++ ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 539 C----CIELEEKIL----IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
C + EK + + E++P + + + L + + L Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAR-IFGGDELQSKTKRIVGTYGYMSP 648
H S+ + HRDLK N+L+D + + K+ DFG A+ + G Q I + Y +P
Sbjct: 187 H--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYICSRF-YRAP 239
Query: 649 EYAQQGL-FSIKSDVFSFGVLLLETL 673
E ++ D++S G ++ E +
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 483 LGEGGFGPVYKGRLL-----------NGQEVAV--KRLSSQSGQGQEEFKNEIKLIAKLQ 529
LG G +Y G L +E+ V K L F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
H+++V L G C+ E I++ E++ LD F+ K ++L + ++ + +A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKSDVLTTPWKFKVAKQLASALSY 120
Query: 590 LHQYSRLRVIHRDLKASNILL-----DKDMNP--KISDFG-----MARIFGGDELQSKTK 637
L ++H ++ NILL D + P K+SD G ++R Q +
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVE 170
Query: 638 RIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLE 671
RI +++PE + SI +D +SFG L E
Sbjct: 171 RI----PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 8/78 (10%)
Query: 483 LGEGGFGPVYK------GRLLNGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKL-QHRNLV 534
LG G FG V + G+ N VAVK L +S +E +E+K+++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 535 RLLGCCIELEEKILIYEY 552
LLG C ++I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 26/108 (24%)
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK- 637
I+ G +GL YLHQ IHR++KAS+IL IS G+ + G L S +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 638 ----RIVGTY--------GYMSPEYAQQGL--FSIKSDVFSFGVLLLE 671
++V + ++SPE +Q L +++KSD++S G+ E
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 34/136 (25%), Positives = 55/136 (40%), Gaps = 45/136 (33%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG-------------- 628
IA+ + ++ IHRD+K NIL+D+D + K++DFG+ F
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 629 -------------------GDELQSKTKR------------IVGTYGYMSPEYAQQGLFS 657
GD L+ +R +VGT Y++PE + ++
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 658 IKSDVFSFGVLLLETL 673
D +S GV+L E L
Sbjct: 227 QLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 60/249 (24%), Positives = 92/249 (36%), Gaps = 60/249 (24%)
Query: 482 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLL 537
LG+G G V+ RL G+ A+K L + + + K E +++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ--------GLL 588
+ E + L+ +Y P L F L + E +A+ L
Sbjct: 68 -ASFQTETYLCLVMDYCPGGEL-FRLLQRQPGK--------CLSEEVARFYAAEVLLALE 117
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDF---------GMARIFGGDELQSKTKRI 639
YLH L +++RDLK NILL + + +SDF + ++
Sbjct: 118 YLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 640 ------------------VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL-------S 674
VGT Y++PE D ++ G+LL E L
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 675 SKRNTDFSN 683
S R+ FSN
Sbjct: 235 SNRDETFSN 243
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 14/102 (13%)
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD----MNPKISDFGMARIFGGDELQ- 633
I++G+ + L Y+H + +HR +KAS+IL+ D ++ S+ M I G L+
Sbjct: 106 ILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM--INHGQRLRV 160
Query: 634 --SKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLE 671
K V ++SPE QQ L + KSD++S G+ E
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 795 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.33 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.31 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.0 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.88 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.87 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.63 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.31 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.18 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.12 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.1 | |
| PLN02236 | 344 | choline kinase | 97.03 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.95 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.76 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.63 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.47 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.37 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=435.77 Aligned_cols=286 Identities=45% Similarity=0.759 Sum_probs=252.5
Q ss_pred CCCcccHHhHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeee
Q 003786 461 WFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540 (795)
Q Consensus 461 ~~~~~~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 540 (795)
....|++.++..+|++|...+.||+|+||.||+|...+++.||||++.....+...+|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765433155699999999999999999999999
Q ss_pred eecc-eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 541 IELE-EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 541 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
.+.+ +.+||||||++|+|+++|+..... .++|..+++|+.++|+||+|||+....+||||||||+|||||+++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 78999999999999999999999988889999999999999999999999
Q ss_pred ccccccccCCCccccccccc-ccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-CcchhHhHhHhhhc
Q 003786 620 DFGMARIFGGDELQSKTKRI-VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TNSLTLLGHAWDLW 697 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~-~~~~~~~~~~~~~~ 697 (795)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+... .....+..+++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765431 1111222 79999999999999999999999999999999999999988654 44445788888888
Q ss_pred cCcccccccCcccc-chhhH-HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 698 KDDRAWELIDPTLQ-NEASY-LILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 698 ~~~~~~~~id~~l~-~~~~~-~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...+..+++|+.+. ..... .+..++..++.+|++.+|++||+|.||+++|+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 99999999999987 44443 678889999999999999999999999999955
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=383.11 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=209.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecce-eeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE-KILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~E 551 (795)
.+.+..+.||+|..|+||+++++ +++.+|+|++.... ....+++.+|++++++.+||+||++|+.|..... ..++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45677889999999999999976 58889999995443 3445789999999999999999999999999994 999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
||++|||+.++... +.+++....+++.+|++||.|||+. ++||||||||+||||+..|.|||||||.+..+-+.
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999998433 5589999999999999999999963 24999999999999999999999999999876533
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
...+++||..|||||.+.+..|+.++||||||++++|+++|+.|+...................++.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp---------- 299 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP---------- 299 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC----------
Confidence 4466899999999999999999999999999999999999999997653222222211111111111
Q ss_pred chhhH-HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASY-LILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~-~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+. .+..++.+++..||+.||.+||++.|+++|
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222 366788999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=399.44 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=214.3
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.+|...+.||+|||+.||.++. ..|+.||+|++.+. .....+.+.+|++|.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 67999999999764 3445678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|+|+.++|..++ .+++.+++.++..++.||+.||.|||+++ |||||||..|++|+++.+|||+|||||..+..+
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988 36678999999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ....+.+|||.|.|||++....++..+||||+|||||.||.|++||+.....+... ..+. .+.
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~------~Ik~---~~Y----- 235 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN------KIKL---NEY----- 235 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH------HHHh---cCc-----
Confidence 3 34566899999999999999999999999999999999999999998654222211 0000 011
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+.....+..+||.++|+.||.+|||+++|+.+
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222445677899999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=381.94 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=207.5
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCcc-------chHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQ-------GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.+.|.+.+.||+|+||.|-+|.. .+|+.||||+++++... .....++|+++|++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35688999999999999999975 46999999999775221 12335799999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC---CCeeeeccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFG 622 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~vkL~DFG 622 (795)
.|+||||+.||.|.+.+. ..+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999998884 4556888888999999999999999999 9999999999999765 779999999
Q ss_pred cccccCCCcccccccccccccccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD 699 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
+|+..+.. ...++++|||.|.|||++.++. +..|+|+||+||+||-+++|.+||........ + ..+...
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l----~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-L----KEQILK 396 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-H----HHHHhc
Confidence 99987633 3567799999999999997653 44588999999999999999999975443221 0 111122
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
++.. +.........++..++|.+||..||++|||+.|++++
T Consensus 397 G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2211 1223445567788999999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=376.94 Aligned_cols=205 Identities=32% Similarity=0.529 Sum_probs=183.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..+|.+.++||+|+||+||+|+++ ++.+||||.+.+. .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 478999999999999999999975 4899999999766 4556677889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC------CCeeeeccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD------MNPKISDFGMA 624 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~------~~vkL~DFGla 624 (795)
|||.||+|.++++. .+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999944 446999999999999999999999998 9999999999999764 56899999999
Q ss_pred cccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 687 (795)
+.+.... ...+.+|++-|||||+++...|+.|+|+||+|+|||+|++|+.||+.....+.
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 9887544 34568999999999999999999999999999999999999999986554433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.19 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=209.6
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||+||+++.+ +++.+|+|++++.. ....+..++|..+|.+++||+||+++..|++.+++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4578999999999999999999865 48899999997753 2345678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|+||+.||.|..+| .+++.+++..+..++.+|+.||.|||+++ ||||||||+|||||.+|+++|+||||++..-
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999 45566999999999999999999999999 9999999999999999999999999999543
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ...+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+..... .....++
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------~~I~~~k------- 241 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------DKILKGK------- 241 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH------HHHhcCc-------
Confidence 22 23456689999999999999999999999999999999999999999876533221 1111111
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCC----CHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRP----TMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RP----t~~evl~~ 746 (795)
....+.....+..+++.++|+.+|++|. .+.+|-+|
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 0112222445778899999999999995 56666554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=382.90 Aligned_cols=258 Identities=32% Similarity=0.497 Sum_probs=210.7
Q ss_pred CCccccccCcCCcccEEEeEecCcceEEEEEecccCccc--hHHHHHHHHHHHhcCCcccceeeeeeeecc-eeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG--QEEFKNEIKLIAKLQHRNLVRLLGCCIELE-EKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 552 (795)
+..+.+.||+|+||+||+|.+.....||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 345556799999999999998554449999997643222 568999999999999999999999999988 79999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-CeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~~~~~~ 631 (795)
|++|+|..+++.. ....+++..+..++.+||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 45679999999999999999999999863 99999999999999998 99999999998754322
Q ss_pred ccccccccccccccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQ--QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....... .. ...... .
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~~---~~v~~~---------~ 262 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--VA---SAVVVG---------G 262 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--HH---HHHHhc---------C
Confidence 1223368999999999999 6699999999999999999999999997654411 11 111111 1
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.+...+......+..++.+||+.||+.||++.+++..|+....
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1222233356788899999999999999999999999976433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=373.44 Aligned_cols=255 Identities=27% Similarity=0.332 Sum_probs=213.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
...+|.+++.||+|+|++|++|+.. ++++||||++.+.. ......+..|-.+|.+| .||.|++||..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3478999999999999999999854 59999999997753 23345677899999999 8999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+|+||+++|+|.++| .+.+.+++..+..++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||-|+.+
T Consensus 151 FvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999 44577999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc---------cc--ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 628 GGDELQ---------SK--TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 628 ~~~~~~---------~~--~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
...... .. ...++||..|.+||++..+..+..+|+|+||||||+|+.|.+||-..++... .+....
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--FqkI~~- 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--FQKIQA- 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--HHHHHH-
Confidence 543221 11 2458999999999999999999999999999999999999999976543322 111100
Q ss_pred ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+.-..+...++...+||.+.|..||.+|+|..+|.+|.=.
T Consensus 302 -------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 302 -------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF 341 (604)
T ss_pred -------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence 1112333344677889999999999999999999998544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=350.13 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=208.9
Q ss_pred ccCCccccccCcCCcccEEEeE-ecCcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeee-eeeecce-eeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLG-CCIELEE-KIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 548 (795)
..+|++.++||+|.||.||+++ ..+|..+|.|.+.-. +....+....|+.+|++|+|||||++++ .|.++.. +++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4679999999999999999997 457999999988633 2334566789999999999999999998 5666655 889
Q ss_pred EeecCCCCChhhhhhcc-CCcccCChhhHHHHHHHHHHHHHHHHhcC-CCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 549 IYEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLLYLHQYS-RLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
|||+|.+|+|..++..- ...+.+++..+++++.|++.||..+|++- +..|+||||||.||+|+.+|.|||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999998543 34567999999999999999999999943 22499999999999999999999999999999
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
+.... ......+|||.||+||.+....|+.|+||||+||++|||..-++||.+.+ -..+... ...+.
T Consensus 178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~K----I~qgd----- 244 (375)
T KOG0591|consen 178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCKK----IEQGD----- 244 (375)
T ss_pred hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHHH----HHcCC-----
Confidence 87554 34456899999999999999999999999999999999999999997652 1111111 11111
Q ss_pred Cccccchhh-HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 707 DPTLQNEAS-YLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 707 d~~l~~~~~-~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
....+ ...+..+..||..|+..||+.||+...+++.+
T Consensus 245 ----~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 245 ----YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ----CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 11233 45677888999999999999999865555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=346.25 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=209.5
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccCc-c-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-Q-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|+...++|+|+||+||++++++ |+.||||++..... . -.+-..+|+++|++|+|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888999999999999999764 99999999865432 2 23456799999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
||+..-|+++-. ...-++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+....
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999887776542 2334788999999999999999999998 9999999999999999999999999999886322
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH---------hhhc-cCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA---------WDLW-KDD 700 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~---------~~~~-~~~ 700 (795)
...+..+.|.+|.|||.+.+ ..|...+||||+||++.||++|.+-|++.++-++.+.... ...+ ..+
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 22344688999999998877 7999999999999999999999999998776555333221 1111 111
Q ss_pred ccccccCcccc-----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 RAWELIDPTLQ-----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~~id~~l~-----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+.-|... +...+.....+++++..||+.||.+|++-+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111111 11223344577899999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=370.21 Aligned_cols=254 Identities=33% Similarity=0.501 Sum_probs=214.9
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
+.+.+++.||+|.||.||.|++.....||+|.+... ....+.|.+|+++|++|+|++||+++++|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345677899999999999999977779999999654 3456788999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
.|+|.++|.. .....+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||||+....+....
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999965 34456888999999999999999999998 9999999999999999999999999999655444432
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
. ....-...|.|||.+....|+.|+|||||||+|+||+| |+.|++..... ++.+.++...+-+
T Consensus 361 ~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~le~GyRlp 424 (468)
T KOG0197|consen 361 S-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLELLERGYRLP 424 (468)
T ss_pred c-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHHHhccCcCC
Confidence 2 22233668999999999999999999999999999998 55565543321 2233445555566
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+..++..+.+|+..||+.+|++|||++.+...|+.
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 777788899999999999999999999999988876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.76 Aligned_cols=274 Identities=25% Similarity=0.326 Sum_probs=212.8
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.+|...++||+|.||.||+|++ ++|+.||||++.... +.-.....+|++.|+.++|+||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999985 569999999996542 2224567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
||+. +|+..+.+ +...+....+..++.++++||+|||.+. |+||||||+|+|++++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 78777744 3456888999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCcccccc----
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDDRAWEL---- 705 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~---- 705 (795)
... ...+-|..|.|||.+.+ ..|+..+|+||.|||+.||+.|.+-|++.++-++ ..+-.+-....+....++
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 322 22377999999998877 5899999999999999999999988776553332 221111111111111111
Q ss_pred -------cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCC
Q 003786 706 -------IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPH 756 (795)
Q Consensus 706 -------id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~ 756 (795)
..+...+..-.......++++..|+..||.+|++++|+++|-.....+.|.
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 111111112334455679999999999999999999999987665433333
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.26 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=211.9
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
..|...++||+|+.|.||.++. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 5678889999999999999974 468899999998877677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
+||+|.+.+. ...+++.++..+++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999883 344899999999999999999999998 99999999999999999999999999998765543
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
...+.+|||.|||||++....|++|+||||||+++.||+-|.+|+-....- ...+.....+. + .-.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-----rAlyLIa~ng~------P--~lk 490 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNGT------P--KLK 490 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-----HHHHHHhhcCC------C--CcC
Confidence 445689999999999999999999999999999999999999998542211 11111111111 1 112
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+||+.|+++||++.|+|+|
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 334455678899999999999999999999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=355.99 Aligned_cols=273 Identities=22% Similarity=0.279 Sum_probs=214.3
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|+++++||+|+||.||+|+.+ +|..+|+|++++... ...+..+.|-.+|...++|.||+||..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5689999999999999999999865 599999999987643 344667899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||++||++..+| .+.+.|+++.+..++.+++.||..||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 45677999999999999999999999998 9999999999999999999999999985321
Q ss_pred C----------------------Ccccc-----c------------------ccccccccccccccccccCCCCcccchh
Q 003786 629 G----------------------DELQS-----K------------------TKRIVGTYGYMSPEYAQQGLFSIKSDVF 663 (795)
Q Consensus 629 ~----------------------~~~~~-----~------------------~~~~~gt~~y~APE~~~~~~~~~k~Dvw 663 (795)
. .+... . ....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 00010 0 1235799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCC---CH
Q 003786 664 SFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRP---TM 740 (795)
Q Consensus 664 SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP---t~ 740 (795)
|||||+||||.|.+||........---...|... +..+.......+..++|.+||. ||++|. .+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 9999999999999999765543321111112110 0001111122577889999999 999997 57
Q ss_pred HHHHHHHccccCC------CCCCCCCCccc
Q 003786 741 FEVVSMLTNKTIN------LPHPRQPAFSS 764 (795)
Q Consensus 741 ~evl~~L~~~~~~------l~~p~~p~~~~ 764 (795)
.||.+|--..... .+.|..|....
T Consensus 440 ~EIK~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 440 EEIKKHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred HHHhcCCccccCCcchhhcCCCCCCCCCCC
Confidence 8888764332222 34555555443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=331.14 Aligned_cols=237 Identities=27% Similarity=0.364 Sum_probs=200.6
Q ss_pred ccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|+..+.||.|+||.|.+++.+. |..+|+|++.+..- ...+...+|..+|+.+.||+++++++.|.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4789999999999999999999764 78899999987532 2345677899999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||++||.|..+++. .+.+++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999954 345899999999999999999999998 99999999999999999999999999997642
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.+-+.+|||.|+|||++..+.|..++|+|||||++|||+.|.+||-.... ...... .-+++
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~K----I~~~~-------- 257 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEK----ILEGK-------- 257 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHH----HHhCc--------
Confidence 35678999999999999999999999999999999999999999965443 211111 11111
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCC
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADR 737 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~R 737 (795)
+ ..+......+.+|+...|+.|-.+|
T Consensus 258 v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 V--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 1233344567789999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.03 Aligned_cols=268 Identities=24% Similarity=0.307 Sum_probs=208.4
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec--ceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 547 (795)
..+.|+.+++||+|.||.||+|+. .+|+.||+|+++... ......+.+|+.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346789999999999999999985 569999999997654 44456778999999999999999999998876 6899
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
||+|||++. |.-++. ...-.+++.++..++.|++.||.|+|..+ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999999874 444442 22335889999999999999999999998 999999999999999999999999999988
Q ss_pred CCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhh-----hccCc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWD-----LWKDD 700 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~-----~~~~~ 700 (795)
....... .+..+-|..|.|||++.+ ..|+.++|+||.||||.||+.|++.+.+..+-.+ ..+-.... .|...
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 6554332 344677999999998877 5899999999999999999999999988764332 22211111 11111
Q ss_pred cc--ccccCcccc-----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 701 RA--WELIDPTLQ-----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 701 ~~--~~~id~~l~-----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
++ ...+.+... .+.....+...++|+..+|..||.+|.|+.++|+.=
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 11 111111110 111233456778999999999999999999999853
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.02 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=209.1
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHH-HHHHHHHHHhcC-Ccccceeeeeeeecc-eeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEE-FKNEIKLIAKLQ-HRNLVRLLGCCIELE-EKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 548 (795)
..++|.+.++||.|.||.||+|+. .++..||||+++++...-.+. =.+|++.|++|+ |||||+|++++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 347899999999999999999984 468899999997654332222 248999999998 999999999999988 9999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||||+. +|..++.+. ++.+++..+..|+.||++||+|+|.+| ++|||+||+|||+.....+||+|||+|+...
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999975 677777443 778999999999999999999999998 9999999999999989999999999999875
Q ss_pred CCccccccccccccccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH--hHh----HhhhccCc-
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL--LGH----AWDLWKDD- 700 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~--~~~----~~~~~~~~- 700 (795)
.... .+..+.|.+|.|||++ +...|+.+.|+|++|||++|+.+-++-|++.++-++-+ +.. .+..|.++
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 4432 3446789999999976 66899999999999999999999999998876444321 110 01111110
Q ss_pred ccccccC--------ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 701 RAWELID--------PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 701 ~~~~~id--------~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.....+. ..+.. .-.....++++++..|++.||.+|||+.|.+++--.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred HHHHHhccCCCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 0000011 11111 112256788999999999999999999999998533
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.32 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=212.7
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..++|++...||.|..++||+|+. +.+..||||++.-+.- ...+.+++|++.|+.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999984 5689999999975432 33588999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
.||.+||+.+++...-..+ +++..+..|.+++++||.|||++| .||||||+.||||+.+|.|||+|||....+-..
T Consensus 104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999996544433 889999999999999999999998 999999999999999999999999997754222
Q ss_pred c--cccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 631 E--LQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 631 ~--~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
. .......++||+.|||||+++. ..|+.|+||||||++..||.+|..||.....-...+.... +....+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq------n~pp~~~ 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ------NDPPTLL 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc------CCCCCcc
Confidence 1 1122256799999999999654 4799999999999999999999999975443333222111 1111111
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
-..+..+........+.+++..||+.||.+|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1122223334445578899999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=349.74 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=204.0
Q ss_pred ccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecc--eeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 550 (795)
..+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|.....+ ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3567888999999999999998654 8999999986653333677999999999999999999999855544 588999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~~~~ 629 (795)
||+++|+|.+++..... .+++..+..+..||++||.|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999954432 5999999999999999999999998 999999999999999 79999999999987653
Q ss_pred -CcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 630 -DELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 630 -~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
...........||+.|||||++..+ ....++|||||||++.||+||.+||........... ......
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~----~ig~~~------- 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL----LIGRED------- 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH----HHhccC-------
Confidence 1112233457899999999999864 334599999999999999999999864210000000 001111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
....++...+....+++.+|++.+|++||||+++|++.
T Consensus 240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11134444566778999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.51 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=208.0
Q ss_pred HHccCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc----Cc-cchHHHHHHHHHHHhcC-Ccccceeeeeeeecc
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ----SG-QGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELE 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 544 (795)
...++|.+++.||+|+||+|+.|++ .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999975 46899999977654 22 34567789999999999 999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeecccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGM 623 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DFGl 623 (795)
+.++||||+.+|.|.+++.. .+.+.+..+..++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 456888999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL-FS-IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......... ...+.
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k------i~~~~ 239 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK------IRKGE 239 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH------HhcCC
Confidence 99873 1123456689999999999999877 75 889999999999999999999986332222111 11110
Q ss_pred cccccCccccchhhHHH-HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWELIDPTLQNEASYLI-LNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~-~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ..+... ...+..++.+||+.+|.+|+++.+|+++
T Consensus 240 ---~-------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 240 ---F-------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ---c-------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 0 111112 5678899999999999999999999965
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=361.13 Aligned_cols=272 Identities=21% Similarity=0.287 Sum_probs=220.3
Q ss_pred HHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcC-Ccccceeeeeeeecce
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEE 545 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 545 (795)
....++|.+.++||+|.||+|+++..+ +++.+|||++++.. ..+.+..+.|.+|+.... ||+++.++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445689999999999999999999875 47889999998753 345677889999988775 9999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
+++||||+.||++..+ .+...+++..+..++..|+.||+|||+++ |||||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999994332 34467999999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
..-. ....+++++|||.|||||++.+..|+.++|+|||||+|||||.|..||++.++++..-... ..
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-----~d------ 583 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-----ND------ 583 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-----cC------
Confidence 6432 2246778999999999999999999999999999999999999999998766544321110 00
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHHHcc--------ccCCCCCCCCCCcccccc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTM-----FEVVSMLTN--------KTINLPHPRQPAFSSIRG 767 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~L~~--------~~~~l~~p~~p~~~~~~~ 767 (795)
++ ..+.....+.+.++.++|..+|++|.-+ .+|.++-=. +...+++|..|...+.+.
T Consensus 584 -~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D 653 (694)
T KOG0694|consen 584 -EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPED 653 (694)
T ss_pred -CC----CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhh
Confidence 11 1233455678889999999999999855 555554111 233467777777665444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.81 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=211.3
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..|...+.||+|.||.||+|.. .+++.||+|++.-.. ....+.+++|+.+|..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577778999999999999985 468999999997654 34468899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
|.||++.+.+ .....+++..+.-++++++.|+.|||.++ .+|||||+.|||+..+|.+||+|||.+........
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999988 33445588889999999999999999998 99999999999999999999999999987765543
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. ..+++|||.|||||+++...|+.|+||||||++.+||++|.+|+..... .++..+|.+....
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------------MRVLFLIPKSAPP 229 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------------ceEEEeccCCCCC
Confidence 3 3678999999999999988999999999999999999999999865433 2222233322222
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+.+++..||..||+.||++.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2333556678899999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=357.16 Aligned_cols=260 Identities=28% Similarity=0.385 Sum_probs=202.7
Q ss_pred ccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeecc-
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE- 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 544 (795)
.++|++.++||+|+||.||+|++ .+++.||||++..... .....+.+|+.+|+++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999964 2356799999865432 2345788999999999 8999999999887654
Q ss_pred eeeEEeecCCCCChhhhhhccCC---------------------------------------------------------
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTK--------------------------------------------------------- 567 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 567 (795)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998864221
Q ss_pred --cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccccccccccc
Q 003786 568 --ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645 (795)
Q Consensus 568 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 645 (795)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 124677788999999999999999988 999999999999999999999999999865332222222334567889
Q ss_pred ccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHH
Q 003786 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYIN 724 (795)
Q Consensus 646 ~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 724 (795)
+|||++.+..++.++|||||||++|||++ |..||+....... ... ....+... ..+...+..+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~----~~~~~~~~---------~~~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQ----RLKDGTRM---------RAPENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHH----HHhcCCCC---------CCCCCCCHHHHH
Confidence 99999999999999999999999999997 9999876432221 111 11111110 011223456789
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 725 VGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 725 li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
++.+||+.+|++|||+.||+++|+..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=355.49 Aligned_cols=247 Identities=27% Similarity=0.358 Sum_probs=210.1
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
+-|++++.||.|+.|.|-+|++ .+|+..|||++.+.. ......+.+|+.+|+.+.||||+++|+++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5689999999999999999986 579999999997652 223467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|.|.+++ .+.+.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||||.+-.++
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999988 45567999999999999999999999998 999999999999999999999999999875443
Q ss_pred cccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. .-.+.||+|.|.|||++++.+| +.++||||.|||||.||+|+.||+..+...+ +..+ ..+.
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L--LlKV----~~G~-------- 228 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL--LLKV----QRGV-------- 228 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH--HHHH----HcCc--------
Confidence 3 3345799999999999999887 5899999999999999999999984433222 2111 1111
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
-+.+..++.++.+|+.+||..||++|.|++||++|
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12334456678899999999999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=348.21 Aligned_cols=247 Identities=27% Similarity=0.383 Sum_probs=207.9
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+.. ....+.+.+|++|+++++|||||.+++.|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999854 58899999997653 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+.| +|..+|. ..+.++++.+..++.++..||.|||+.. |+|||+||.|||++..|.+|++|||+|+......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 9999994 4556999999999999999999999987 9999999999999999999999999999775433
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
...+...|||.|||||+..+++|+..+|.||||||+|||++|++||-.... .........++-.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----~~Lv~~I~~d~v~--------- 218 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----TQLVKSILKDPVK--------- 218 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----HHHHHHHhcCCCC---------
Confidence 234557899999999999999999999999999999999999999853221 1111111111111
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++...|+.||..|.+..+++.|
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122455678899999999999999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.60 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=210.9
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
-.+|++.+.||+|.||+|-+++. ..|+.||||.+++. +.++...+++|++||..|+||||+.+|.+|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999974 77999999999765 344556788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||..+|.|.+++ ...+.+++.++.++++||..|+.|+|.++ ++|||||.+|||||.++++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 44566999999999999999999999987 99999999999999999999999999998765
Q ss_pred CcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ...+++|+|.|.+||++.+.+| .+.+|-|||||+||.|+.|..||++.+...+ + .+...+...+ |
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l--v----rQIs~GaYrE---P 273 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL--V----RQISRGAYRE---P 273 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH--H----HHhhcccccC---C
Confidence 54 3456899999999999999988 5889999999999999999999987553221 1 1122222211 1
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..+....-||.|||..||++|.|+.+|..+.
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1123456799999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=344.87 Aligned_cols=267 Identities=28% Similarity=0.448 Sum_probs=203.6
Q ss_pred ccCCccccccCcCCcccEEEeEecC-----------------cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVR 535 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 535 (795)
.++|++.++||+|+||.||+++..+ +..||+|++.... ......+.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 3469999987543 233467899999999999999999
Q ss_pred eeeeeeecceeeEEeecCCCCChhhhhhccC----------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEE
Q 003786 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDST----------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599 (795)
Q Consensus 536 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 599 (795)
+++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 1134677888999999999999999988 99
Q ss_pred eccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003786 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 600 HrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~ 679 (795)
||||||+|||++.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||+++..+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998654333222233345678999999998889999999999999999999754443
Q ss_pred CCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 680 DFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
++........................ ...+...+..+.+++.+||+.+|++|||+.+|.++|+.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 33332222222222111111110000 00112234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.31 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=208.8
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..+.+.+.++||+|.||+||+|++ ...||||++..... +..+.|++|+.++++-+|.||+-+.|+|..... .+|+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 345678889999999999999986 35799999976543 345789999999999999999999999998888 9999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
.+|.|-+|..+++... ..++....+.|+.|||+|+.|||.++ |||||||..||+|.+++.|||+||||+..-..-
T Consensus 467 qwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred hhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 9999999999996543 55888899999999999999999998 999999999999999999999999999753221
Q ss_pred ccccccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.-........|...|||||+++. .+|++.+||||||+++|||++|..|+.....+++. |..++-.-..|
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--------fmVGrG~l~pd 613 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--------FMVGRGYLMPD 613 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------EEecccccCcc
Confidence 11122233467889999999864 47999999999999999999999998743332221 11122111111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.. ....+.+.++.+|+..||..++++||.+.+|+.+|+....
T Consensus 614 ~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 614 LS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 1233456688899999999999999999999998887443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=367.26 Aligned_cols=259 Identities=30% Similarity=0.451 Sum_probs=214.4
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
..+.+..+.||+|.||+||+|+.. +.+-||||.++..... ...+|++|+++|..++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345667789999999999999742 3456999999876555 778999999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCC-----------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 547 ILIYEYMPNKSLDFFLFDSTK-----------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
++|+|||..|+|.+||..... ...++..+.+.|+.|||.|+.||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999964332 223778899999999999999999887 999999999999999999
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHh
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 694 (795)
|||+||||++.....++........-..+|||||.+..+.|+.++|||||||+|||+++ |+-|+.....++.-
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI------ 715 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI------ 715 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH------
Confidence 99999999998766655444333445789999999999999999999999999999997 66666543322211
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+++ -+.+..++.++..|+..||+.+|++||+++||-..|..-
T Consensus 716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 11122222 346667788999999999999999999999999998763
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=334.98 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=202.9
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--------------ccchHHHHHHHHHHHhcCCccccee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--------------GQGQEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l 536 (795)
...++|++.+.||+|.||+|-+|+.. +++.||||++.+.. ....+..++|+.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34588999999999999999999864 58999999997531 1123578899999999999999999
Q ss_pred eeeeeec--ceeeEEeecCCCCChhhhhhccCCccc-CChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC
Q 003786 537 LGCCIEL--EEKILIYEYMPNKSLDFFLFDSTKENL-LGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 613 (795)
Q Consensus 537 ~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~ 613 (795)
+.+..+. +++|||+|||..|.+...- ..+. +++.++++++.++..||.|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998754 6789999999999885432 2333 899999999999999999999998 9999999999999999
Q ss_pred CCeeeeccccccccCCC---cccccccccccccccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 003786 614 MNPKISDFGMARIFGGD---ELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686 (795)
Q Consensus 614 ~~vkL~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 686 (795)
|+|||+|||.+..+... ..........|||.|||||....+ ..+.+.||||+||+||.|+.|+.||-....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 99999999999876221 222334457899999999987652 236788999999999999999999854221
Q ss_pred hhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 687 LTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+.+. . ++++..+.-...+++.+++.+||.++|+.||+.|.+..+|..|.
T Consensus 325 ~~l~----~--------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 LELF----D--------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHH----H--------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1111 1 11222222223335566788999999999999999999999886
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=310.66 Aligned_cols=250 Identities=28% Similarity=0.352 Sum_probs=210.5
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++++.||+|.||.||.|+.+ ++-.||+|++.+.. .+...++.+|++|-..|+||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3478999999999999999999865 57789999997642 3445789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
++||.+.|++...|... +.+.+++..+..++.|+|.||.|+|.++ ||||||||+|+|++..+.+||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999988532 3456889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.....+.+||..|.+||...+..++.++|+|++|++.||++.|.+||+.... ...+-.. ...++.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI--------~k~~~~-- 240 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRI--------RKVDLK-- 240 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHH--------HHcccc--
Confidence 2345668999999999999999999999999999999999999999976542 1111110 111111
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+........++|..|+..+|.+|.+..|++++
T Consensus 241 -----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 -----FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 123345577889999999999999999999886
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.72 Aligned_cols=259 Identities=28% Similarity=0.367 Sum_probs=202.5
Q ss_pred ccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
.++|++.++||+|+||.||+|+. .++..||||++.... ....+.+.+|+.+|+.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999963 235689999986432 23346788999999999 89999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCC----------------------------------------------------------
Q 003786 546 KILIYEYMPNKSLDFFLFDSTK---------------------------------------------------------- 567 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 567 (795)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854221
Q ss_pred --------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 568 --------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 568 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124678889999999999999999988 999999999999999999999999999865433221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......++..|+|||.+.+..++.++|||||||++|||++ |..|+........ ... ....... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~----~~~~~~~---------~ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYK----MIKEGYR---------M 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHH----HHHhCcc---------C
Confidence 12222345678999999999999999999999999999998 7877754332211 111 1111100 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+.++.+++.+||+.+|++||++.||+++|+.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0111123568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=342.12 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=205.3
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.+.||+|+||.||+++.. ++..+|+|++.... ....+.+.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999865 58889999986542 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999843 335788999999999999999999853 4999999999999999999999999998765322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc-Cccc--------
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK-DDRA-------- 702 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~-------- 702 (795)
......|++.|+|||++.+..++.++|||||||++|||++|+.||............. ..... ....
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG-RPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc-ccccccccCCccccCccc
Confidence 2234578999999999999999999999999999999999999996543221110000 00000 0000
Q ss_pred --------------------ccccC----ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 703 --------------------WELID----PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 703 --------------------~~~id----~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.++.+ ..............+.+++.+||+.||++|||++||+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000 0000000112446788999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=335.55 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=197.1
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCccc---hHHHHHHHHHHHhcCCcccceeeeeeee----cceeeEEeecC
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG---QEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKILIYEYM 553 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~ 553 (795)
..||+|+++.||+|.. +|+.||||++....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999987 78999999997653333 4677899999999999999999999877 34678999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
++|+|.+++.. ...+++..+..++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999853 34588899999999999999999985 5 8899999999999999999999999998654322
Q ss_pred ccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||........ .... ...... +
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~--~~~i---~~~~~~-----~-- 241 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI--YDLI---INKNNS-----L-- 241 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH--HHHH---HhcCCC-----C--
Confidence 23468899999999976 6899999999999999999999999975432221 1111 001100 0
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.||++|||++||++.|+.
T Consensus 242 --~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 242 --KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred --CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111234568899999999999999999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.40 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=201.7
Q ss_pred CCccccccCcCCcccEEEeEe-cCcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.|+..+.||+|+||.||++.. .+++.||+|++.+.. ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 468999999986532 2233567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988775322 235788999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........ .
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~~~~~----------~ 221 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--VDRRVKED----------Q 221 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--HHHHhhcc----------c
Confidence 12335789999999999999999999999999999999999999976443211100 00000000 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 746 (795)
...+......+.+|+.+||+.||++||+ +++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1112223456788999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.69 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=204.9
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.++||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999875 48899999997542 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 345888999999999999999999998 99999999999999999999999999986532
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
......||+.|+|||++.+..++.++|||||||++|||++|..||.............. +... . -.+..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~-~---~~~~~ 222 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY---WKET-L---QRPVY 222 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh---cccc-c---cCCCC
Confidence 23346799999999999999999999999999999999999999975442221110000 0000 0 00100
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..........+.+++.+||+.+|++||++.+++++.
T Consensus 223 -~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 223 -DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred -CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 000122345778899999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.83 Aligned_cols=246 Identities=23% Similarity=0.260 Sum_probs=201.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998843 345888999999999999999999988 999999999999999999999999999865322
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||........ .... .....
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~~~i----~~~~~-------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI--YEKI----LAGKL-------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----HhCCc--------
Confidence 2235789999999999998999999999999999999999999865432111 1110 00000
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~L 747 (795)
..+......+.+++.+||+.||.+||+ +++++++-
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 011122346778999999999999995 89988763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.52 Aligned_cols=259 Identities=29% Similarity=0.403 Sum_probs=202.3
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.+ +|||||++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357999999999999999998732 24579999997543 22345688999999999 89999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCC----------------------------------------------------------
Q 003786 546 KILIYEYMPNKSLDFFLFDSTK---------------------------------------------------------- 567 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 567 (795)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999988853211
Q ss_pred ---------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccc
Q 003786 568 ---------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638 (795)
Q Consensus 568 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 638 (795)
...+++..+.+++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 123677888999999999999999988 99999999999999999999999999986543221112222
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHH
Q 003786 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717 (795)
Q Consensus 639 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
..+++.|||||++.+..++.++|||||||++|||++ |+.||........ .... ..... ....+..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~----~~~~~---------~~~~~~~ 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKM----VKRGY---------QMSRPDF 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHH----HHccc---------CccCCCC
Confidence 345678999999998999999999999999999997 9999865432211 1110 01100 0001111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 718 ILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 718 ~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 23567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.16 Aligned_cols=257 Identities=21% Similarity=0.237 Sum_probs=209.7
Q ss_pred HccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...+|++.+.||.|.-|+||++++.. +..+|+|++.+.... ...+.+.|.+||+.++||.++.||..|+.+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34678999999999999999999764 688999999876433 34566789999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||||+||+|..+++. +..+.+++..+..++.+|+.||+|||..| ||+|||||+||||.++|+|-|+||.|+....
T Consensus 155 ~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999887744 45577999999999999999999999998 9999999999999999999999999975321
Q ss_pred C---------------------------------C-c--------------------ccccccccccccccccccccccC
Q 003786 629 G---------------------------------D-E--------------------LQSKTKRIVGTYGYMSPEYAQQG 654 (795)
Q Consensus 629 ~---------------------------------~-~--------------------~~~~~~~~~gt~~y~APE~~~~~ 654 (795)
. . . .......++||-+|+|||++++.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 00123356899999999999999
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCC
Q 003786 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDA 734 (795)
Q Consensus 655 ~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP 734 (795)
..+.++|+|+|||++|||+.|..||-+.+......- ++-..+.-...+.....+.+||.+.|..||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N--------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN--------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH--------------HhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 999999999999999999999999987664332111 000111111112455678899999999999
Q ss_pred CCCCC----HHHHHHHH
Q 003786 735 ADRPT----MFEVVSML 747 (795)
Q Consensus 735 ~~RPt----~~evl~~L 747 (795)
++|.- +.||.+|-
T Consensus 377 ~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHP 393 (459)
T ss_pred hhhhccccchHHhhcCc
Confidence 99998 99998874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=313.51 Aligned_cols=273 Identities=23% Similarity=0.295 Sum_probs=206.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeee--ecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCI--ELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 548 (795)
.++|+..++|++|.||.||+|+.+ +++.||+|+++..... -.-.-.+|+.+|.+++|||||.+..+.. +-+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467999999999999999999865 5889999999764321 1234679999999999999999988765 4467999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||||++ +|..++.... ..+...++..+..|+++|++|||... |+||||||+|+|+...|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 6777774333 45788999999999999999999987 9999999999999999999999999999887
Q ss_pred CCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh---------Hhhhcc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH---------AWDLWK 698 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~---------~~~~~~ 698 (795)
... ...+..+-|..|.|||++.+ ..|+.++|+||+|||+.||+++++-|++.++-++..... .|..+.
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 552 23455778999999998876 579999999999999999999999988776433311111 111111
Q ss_pred CcccccccC--c----cccchhhHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCC
Q 003786 699 DDRAWELID--P----TLQNEASYL-ILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754 (795)
Q Consensus 699 ~~~~~~~id--~----~l~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l 754 (795)
.......+. + .+...+... ..+.-.+++..+|..||.+|.|++|.|++=-....++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 111111000 0 001111111 3355678999999999999999999999754433333
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=326.29 Aligned_cols=269 Identities=25% Similarity=0.316 Sum_probs=207.8
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecc--cCccchHHHHHHHHHHHhcCCcccceeeeeeee-----c
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE-----L 543 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 543 (795)
.....|...+.||+|+||.|..+... +|+.||||++.. +.....++..+|+++|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456777899999999999999864 689999999973 344556788899999999999999999998865 4
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
...|+|+|+| ..+|...+. .+..++...+..++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 5789999999 567888873 3444889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCC-cchhHhHhHhhhccCc-
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-NSLTLLGHAWDLWKDD- 700 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~- 700 (795)
|+...........+..+.|..|.|||++. ...|+.+.||||.||||.||++|++-|++.+. .+..++...-....+.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 99875432233345678899999999764 57899999999999999999999999988763 3333322211111111
Q ss_pred -------ccccccCc--ccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 701 -------RAWELIDP--TLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 701 -------~~~~~id~--~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.....+.. ... ...-+......++++.+||..||.+|+|++|.|+|-
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11111110 000 111123345678999999999999999999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=332.95 Aligned_cols=265 Identities=20% Similarity=0.279 Sum_probs=203.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999875 57889999986542 2335678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988876542 2345888999999999999999999988 9999999999999999999999999998754322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHhH--------hhh-ccCcc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGHA--------WDL-WKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~--------~~~-~~~~~ 701 (795)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||+......... .... ... .....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12233568999999999998889999999999999999999999997644222111 0000 000 00000
Q ss_pred cccccCcccc------chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWELIDPTLQ------NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......+... .......+..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000001000 01111234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.88 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=215.2
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecce-eeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE-KILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 549 (795)
.++|..++++|+|+||.++.++++ +++.+++|++... .....+...+|+.++++++|||||.+++.|.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367899999999999999999875 4778999988654 33334568899999999999999999999999988 9999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|+||+||+|.+.|.... ...++++.+..++.||+.|+.|||++. |+|||||+.||+++.++.|||+|||+|+..+.
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999996544 567899999999999999999999776 99999999999999999999999999999876
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. ....+..||+.||.||++.+.+|..|+|||||||++|||++-+++|...+......- +.+.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k---------------i~~~ 221 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK---------------INRG 221 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH---------------Hhhc
Confidence 54 234568999999999999999999999999999999999999999876543322111 1112
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+.....++..++..||+.+|+.||++.++|.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2344566677888999999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=342.49 Aligned_cols=247 Identities=22% Similarity=0.260 Sum_probs=202.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
..+|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999875 58899999986532 23346788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999988853 345788899999999999999999988 99999999999999999999999999986543
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .......
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~----~i~~~~~------- 232 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--IYE----KILAGRL------- 232 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--HHH----HHhcCCc-------
Confidence 2 223579999999999999999999999999999999999999986433211 111 1111110
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~L 747 (795)
..+.....++.+++.+||+.||++||+ ++++++|-
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 011112346778999999999999997 78888763
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=340.82 Aligned_cols=242 Identities=23% Similarity=0.275 Sum_probs=196.3
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 58899999997542 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT 636 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 636 (795)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888843 345889999999999999999999998 9999999999999999999999999987532211 123
Q ss_pred cccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhH
Q 003786 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716 (795)
Q Consensus 637 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~ 716 (795)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... .. .. . ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~~---~~-~~------~----~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELI---LM-EE------I----RFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HHHH---Hc-CC------C----CCCC
Confidence 346799999999999999999999999999999999999999864332111 1100 00 00 0 1112
Q ss_pred HHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 717 LILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 717 ~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.....+.+++.+||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2345678899999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.50 Aligned_cols=257 Identities=30% Similarity=0.464 Sum_probs=206.6
Q ss_pred cCCccccccCcCCcccEEEeEecC------cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.+.||+|+||.||+|+... .+.||+|.+.... ......+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578899999999999999998543 2579999986443 233467899999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC
Q 003786 548 LIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 614 (795)
++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854321 145788889999999999999999988 99999999999999999
Q ss_pred CeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhH
Q 003786 615 NPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 615 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~--~~-- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--IE-- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH--
Confidence 999999999986543332223334567889999999988899999999999999999998 9888864332211 11
Q ss_pred hhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...... ....+...+.++.+++.+||+.+|.+||+++||+++|+.
T Consensus 238 --~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 111233455788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.72 Aligned_cols=266 Identities=24% Similarity=0.273 Sum_probs=198.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 588999999875432 234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCCc-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9974 56555533 2345788899999999999999999998 9999999999999999999999999987543221
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh--hccCccc------
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD--LWKDDRA------ 702 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~--~~~~~~~------ 702 (795)
.......+++.|+|||++.+ ..++.++|||||||++|||++|..||.........+...... .......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 12233568999999998865 568999999999999999999999997543222111111000 0000000
Q ss_pred -------ccccCc-cccchh-hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 703 -------WELIDP-TLQNEA-SYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 703 -------~~~id~-~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.....+ .+.... .......+.+++.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 000000 000000 001124577899999999999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.66 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=200.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 367999999999999999999865 58899999986543 2334578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++ +|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9985 787777432 234788899999999999999999988 9999999999999999999999999997643222
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHhHh-----hhccC----c
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGHAW-----DLWKD----D 700 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~-----~~~~~----~ 700 (795)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ..... ..+.. .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 12233568999999998865 568999999999999999999999987654222111 10000 00000 0
Q ss_pred ccccccCccccch----hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 RAWELIDPTLQNE----ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~~id~~l~~~----~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+..... ........+.+++.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0001111111000 011223567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.03 Aligned_cols=246 Identities=29% Similarity=0.424 Sum_probs=203.1
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCC
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 557 (795)
...+-||.|+.|.||+|++ .++.||||+++.. -..+++=|++|+||||+.+.|+|...--+++|||||+.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3456799999999999998 5789999988532 2347788999999999999999999999999999999999
Q ss_pred hhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccc
Q 003786 558 LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK 637 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~ 637 (795)
|..+|. ....+.......+..+||.|+.|||.+. |||||||.-||||..+..|||+|||.++..... ...-
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999994 4456788899999999999999999987 999999999999999999999999999976543 2334
Q ss_pred ccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHH
Q 003786 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717 (795)
Q Consensus 638 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
.+.||..|||||+++..+.+.|+|||||||+|||||||..|+..-+... .+|..-...+.-..+..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------------IIwGVGsNsL~LpvPst 335 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------------IIWGVGSNSLHLPVPST 335 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------------eEEeccCCcccccCccc
Confidence 5899999999999999999999999999999999999998874322111 11222222233334455
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCC
Q 003786 718 ILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754 (795)
Q Consensus 718 ~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l 754 (795)
++.-+.-|+.+||+..|..||++++|+.||.-....+
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 6667777899999999999999999999997644443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.94 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=206.2
Q ss_pred ccCCccccccCcCCcccEEEeEecC------cceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|.+.+.||+|+||.||+|+..+ ++.||||++...... ..+.+.+|+++|++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999997532 478999998765433 457899999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccC-----------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 547 ILIYEYMPNKSLDFFLFDST-----------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 2345788899999999999999999988 999999999999999999
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHh
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 694 (795)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..|+........ ....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~--~~~~- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV--IECI- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHH-
Confidence 99999999976533322222233456788999999999999999999999999999998 9988764432221 1111
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
..+... ..+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 238 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111110 111223456789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.63 Aligned_cols=247 Identities=22% Similarity=0.259 Sum_probs=201.5
Q ss_pred HccCCccccccCcCCcccEEEeEecC--cceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|+... +..||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999998543 3689999986532 233457889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999998843 345889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... .....||+.|||||++.+..++.++|||||||++|||++|..||....... .... .. ....
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~---i~-~~~~----- 245 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQK---IL-EGII----- 245 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHHH---Hh-cCCC-----
Confidence 322 234679999999999998889999999999999999999999996533211 1111 10 1100
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
..+......+.+++.+||+.+|++|+ ++++++++
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01112234567899999999999995 89999987
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=307.50 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=205.8
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecc--cCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.+.|++.+.||+|.|+.||++.+ ++|+.+|+|++.. .+..+.+++.+|+.|-+.|+|||||+|.+...+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46789999999999999999864 5799999998853 23447789999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeecccccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFGla~~~ 627 (795)
|+|.|+.|-.-|- .+..+++..+...+.||+.||.|+|..+ |||||+||+|+++.. .--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999965552 3356888899999999999999999988 999999999999953 345999999999988
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
+... ..-...|||+|||||+++..+|+..+|||+.|||||-|+.|.+||-..+.... .+.. ..+..
T Consensus 164 ~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl--ye~I----~~g~y----- 229 (355)
T KOG0033|consen 164 NDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YEQI----KAGAY----- 229 (355)
T ss_pred CCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH--HHHH----hcccc-----
Confidence 7332 34457899999999999999999999999999999999999999865443322 1111 11100
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...........++..+|+.+||..||.+|.|+.|.|.+
T Consensus 230 -d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 -DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11112233445577789999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=305.07 Aligned_cols=266 Identities=24% Similarity=0.243 Sum_probs=211.3
Q ss_pred HHHHccCCccccccCcCCcccEEEeE-ecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecce---
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE--- 545 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 545 (795)
+....++|.+.+.||+|||+-||+++ ..+++.||+|++.-...++.+..++|++.-++++||||++++++...+..
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34566889999999999999999998 45688999999876667788899999999999999999999998775544
Q ss_pred --eeEEeecCCCCChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 546 --KILIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 546 --~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
.|++++|...|+|.+.+..... ...+++.++..++.+|++||++||+.. .++.||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 8999999999999888865443 458999999999999999999999986 479999999999999999999999999
Q ss_pred cccccCCCccc-------cccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh
Q 003786 623 MARIFGGDELQ-------SKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692 (795)
Q Consensus 623 la~~~~~~~~~-------~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 692 (795)
.+....-.... .....-..|..|.|||.+.- ...+.++|||||||+||+|+.|..||+..-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------- 246 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------- 246 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence 98754211100 01112246889999998853 4678999999999999999999999974221
Q ss_pred HhhhccCccccc-ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 693 AWDLWKDDRAWE-LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 693 ~~~~~~~~~~~~-~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+.+.- ...+.+.-+...-.++.+.++|.+|||.||.+||++.+++..+..
T Consensus 247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1111111 111122111122267789999999999999999999999998865
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.17 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=197.2
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.|++++.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 58899999996542 2234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998843 345888899999999999999999988 9999999999999999999999999976431100
Q ss_pred c---------------------------------------------cccccccccccccccccccccCCCCcccchhhHH
Q 003786 632 L---------------------------------------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFG 666 (795)
Q Consensus 632 ~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlG 666 (795)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0011235799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHh--hccCCCCCCCCHHHHH
Q 003786 667 VLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLL--CVQEDAADRPTMFEVV 744 (795)
Q Consensus 667 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~--cL~~dP~~RPt~~evl 744 (795)
|++|||++|..||.............. +. .. .. ..........+.+++.+ |+..+|..||++.|++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~---~~-~~-~~-------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVIN---WE-NT-LH-------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHc---cc-cc-cC-------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999975442221111000 00 00 00 00011123456677777 4556666799999999
Q ss_pred HHH
Q 003786 745 SML 747 (795)
Q Consensus 745 ~~L 747 (795)
++-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 973
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.69 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=202.4
Q ss_pred cCCccccccCcCCcccEEEeEec----CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.+|++.+.||+|+||.||+|++. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56889999999999999999753 356899999876432 3345788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|++++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998543 245889999999999999999999988 99999999999999999999999998765422
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~----~~~~------- 225 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAV----EDGF------- 225 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH----HCCC-------
Confidence 211 11112345678999999999999999999999999999775 998886443221 11111 1110
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+...+..+.+++..||+.+|++||++++|++.|+.
T Consensus 226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 011122345577889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.93 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=204.4
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEecccCc-cchHHHHHHHHHHHhcC-Ccccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 545 (795)
.++|+++++||+|+||.||+|+.. .+..||||++..... ...+.+.+|+++|+++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 468999999999999999999752 134699999965432 23467899999999996 9999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCC----------------------------------------------------------
Q 003786 546 KILIYEYMPNKSLDFFLFDSTK---------------------------------------------------------- 567 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 567 (795)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988854211
Q ss_pred -----------------------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC
Q 003786 568 -----------------------------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 568 -----------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~ 612 (795)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 123677788899999999999999988 999999999999999
Q ss_pred CCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhH
Q 003786 613 DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLG 691 (795)
Q Consensus 613 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 691 (795)
++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|++........ ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-YN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-HH
Confidence 99999999999986543322222233456788999999998899999999999999999997 88888653322111 10
Q ss_pred hHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 692 HAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 692 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...... ....+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 352 ----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 352 ----KIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ----HHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 001110 0011123345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.64 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=197.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecce-----eeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE-----KIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~l 548 (795)
-.|+..+.+|.|+||.||+|+.. ++++||||+.-.. .+.-.+|+++|+++.|||||+|..+|..... ..+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34677899999999999999864 4789999988543 2344579999999999999999998875432 348
Q ss_pred EeecCCCCChhhhhhc-cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeeccccccc
Q 003786 549 IYEYMPNKSLDFFLFD-STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARI 626 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DFGla~~ 626 (795)
||||||. +|.+.+.. ...+..++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 56566643 223455788889999999999999999988 9999999999999976 9999999999998
Q ss_pred cCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhHhhhccCcccc-
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHAWDLWKDDRAW- 703 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~- 703 (795)
+...+.. ....-|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|++.+..++. .+...-.....+.+.
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 7655432 33456889999998876 58999999999999999999999999886643332 111111111111110
Q ss_pred ------cccCcccc-----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 704 ------ELIDPTLQ-----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 704 ------~~id~~l~-----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+.-.+.+. .-.......+.++++.++|+.+|.+|.++.|++.+-
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 11111111 112334556788999999999999999999999873
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.20 Aligned_cols=252 Identities=30% Similarity=0.431 Sum_probs=202.7
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
.+|++.+.||+|+||.||+++..++..+|+|.+... ....+.+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468889999999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999885432 35788999999999999999999988 999999999999999999999999999865332221
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+....++.++||||||+++|||++ |+.|+....... ....... ..+ ...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~i~~---~~~---~~~~----- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMISR---GFR---LYRP----- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHC---CCC---CCCC-----
Confidence 1122345678999999988889999999999999999999 888886443211 1111111 101 0011
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=322.79 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=205.5
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.+.||+|++|.||+|...+++.||+|.+.... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45689999999999999999988778889999986543 34677999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985433 345789999999999999999999988 999999999999999999999999999876532211
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+....... ..... ..... .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~----~~~~~---------~ 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQV----DQGYR---------M 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----HcCCC---------C
Confidence 1111223468999999998899999999999999999999 888875432111 11111 00000 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.50 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=210.2
Q ss_pred HHccCCccccccCcCCcccEEEeEecCc-ceEEEEEecccCccchHHHHHHHHHHHhcC-Ccccceeeeeee-e------
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCI-E------ 542 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-~------ 542 (795)
....++++.+.|.+|||+.||+|+...+ .+||+|++...+....+.+++|+++|++|+ |+|||.+++... .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3446788899999999999999998765 999999987777788899999999999997 999999999322 1
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
.-+.+|.||||.+|.|-+++......+ |.+.++++|+.++++|+++||... .+|||||||-|||||..++..||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 235679999999999999986554444 999999999999999999999985 789999999999999999999999999
Q ss_pred cccccCCCcccc-------ccccccccccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh
Q 003786 623 MARIFGGDELQS-------KTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692 (795)
Q Consensus 623 la~~~~~~~~~~-------~~~~~~gt~~y~APE~~---~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 692 (795)
-+...-...... ..-...-|+.|.|||.+ .+.++++|+|||+|||+||-|+....||+....-.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------ 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence 987432211000 01122468999999976 67899999999999999999999999998543221
Q ss_pred HhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 693 AWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+++..+.-...+....++.+||..||+.||++||++-+|+..+-.
T Consensus 266 ------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 266 ------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 223333333335677899999999999999999999999987644
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.76 Aligned_cols=255 Identities=31% Similarity=0.471 Sum_probs=210.1
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
..+|++.++||+|+||.||+|+..+++.+|+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45789999999999999999998888999999997766556778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999996533 345788999999999999999999988 999999999999999999999999999866432211
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+........ ..... .. ...
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~--~~~~~----~~---------~~~ 223 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--YDQIT----AG---------YRM 223 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHHHH----hC---------CcC
Confidence 123346778999999988899999999999999999998 7888865432111 11110 00 011
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1122334577899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.44 Aligned_cols=242 Identities=23% Similarity=0.271 Sum_probs=196.1
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+++|+.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 58999999997542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT 636 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 636 (795)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 345889999999999999999999988 9999999999999999999999999987532211 122
Q ss_pred cccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhH
Q 003786 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716 (795)
Q Consensus 637 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~ 716 (795)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... ... .. . ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~~---~~~-~~------~----~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FEL---ILM-ED------I----KFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HHH---hcc-CC------c----cCCC
Confidence 345799999999999999999999999999999999999999865332111 110 000 00 0 0111
Q ss_pred HHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 717 LILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 717 ~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.....+.+++.+||+.||++|| ++.|++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2345678899999999999997 89999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=333.38 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=202.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999875 57889999886542 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999843 345788899999999999999999752 3999999999999999999999999998755322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh-Hhh-hccCcc--------
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH-AWD-LWKDDR-------- 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~~~-~~~~~~-------- 701 (795)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+............. ... ......
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1233568999999999998899999999999999999999999987544222111000 000 000000
Q ss_pred ----------------cccccCccccc---h-hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 ----------------AWELIDPTLQN---E-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ----------------~~~~id~~l~~---~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+.+..... . .......++.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000 0 000123567899999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.63 Aligned_cols=268 Identities=24% Similarity=0.332 Sum_probs=204.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcc-cceeeeeeeecc-----
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRN-LVRLLGCCIELE----- 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 544 (795)
...|+..++||+|+||+||+|+.+ +|+.||+|+++-... .......+|+.+|++|+|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 355777889999999999999854 689999999976543 24466789999999999999 999999999887
Q ss_pred -eeeEEeecCCCCChhhhhhccCCc-ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 545 -EKILIYEYMPNKSLDFFLFDSTKE-NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 -~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
..++|+||++. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999865 677777543322 34666889999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc-
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD- 700 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 700 (795)
+|+.+.-.. .....-++|..|.|||++.+. .|+...||||+|||++||++++.-|++..+.++.. ........+
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~--~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF--RIFRLLGTPN 241 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH--HHHHHcCCCC
Confidence 999765332 123446789999999988775 89999999999999999999998888766533321 111111111
Q ss_pred -cccc---------ccCcccc--chhhHHHH---HHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 701 -RAWE---------LIDPTLQ--NEASYLIL---NRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 701 -~~~~---------~id~~l~--~~~~~~~~---~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..|. ..-+... ......++ ....+++.+||+.+|.+|.|++.+++|-..
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF 305 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence 1111 1001110 01111111 367899999999999999999999997443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.06 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=208.8
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888899999999999999742 355689999876555556789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 549 IYEYMPNKSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 1234788999999999999999999988 999999999999999999
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHh
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 694 (795)
+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~--- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIE--- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---
Confidence 99999999986543332222333456889999999998999999999999999999998 888875433221 111
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
........+ .....+..+.+++.+||+.+|++||++++|+++|+....
T Consensus 237 -~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 111234567899999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.79 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=202.3
Q ss_pred HccCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
..++|++.+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999998742 25679999986432 2234568899999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCC-------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 546 KILIYEYMPNKSLDFFLFDSTK-------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854321 123567788899999999999999987 999999999999999999999
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhc
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+....... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~---- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFV---- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----
Confidence 99999886543332222222345788999999998899999999999999999998 677775433211 11110
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....... .+...+..+.+++.+||+.+|++||++.|++++|+.
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0111100 111234567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=351.53 Aligned_cols=254 Identities=18% Similarity=0.211 Sum_probs=204.3
Q ss_pred cCCccccccCcCCcccEEEeEec-C-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-N-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..|.+.+.||+|+||.||+|... + ++.||+|.+..........+++|+.+|+.++|||||++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34899999999999999999754 3 677889877555444456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999998875432 2345788899999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. +..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~~~~---~~-~~~--------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQV---LY-GKY--------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---Hh-CCC---------
Confidence 2223345679999999999999999999999999999999999999986533211 11110 00 000
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||+.+|++||++.+++.+
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01112234567899999999999999999998753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=336.28 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=195.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..+|+..++||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356778899999999999999865 589999999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.... ...+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999985432 2456778899999999999999988 9999999999999999999999999998654321
Q ss_pred cccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||................. ..
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--~~------ 292 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM--SQ------ 292 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc--cC------
Confidence 11234579999999998743 2345799999999999999999999974332222111111000 00
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...........+.+++.+||+.+|++||++.||+++
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122334578899999999999999999999986
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.17 Aligned_cols=242 Identities=23% Similarity=0.270 Sum_probs=195.3
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 58999999997542 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT 636 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 636 (795)
+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 345889999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred cccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhH
Q 003786 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716 (795)
Q Consensus 637 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~ 716 (795)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... .. .. .. .+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~~---~~-~~------~~----~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELI---LM-EE------IR----FPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHH---hc-CC------CC----CCC
Confidence 345799999999999999999999999999999999999999864432211 1100 00 00 00 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 717 LILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 717 ~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.....+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2345677899999999999998 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.09 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=205.9
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36789999999999999999998788899999986432 34578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988543 2345778889999999999999999987 999999999999999999999999999876433211
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+....++.++|||||||++|+|++ |..|+....... ..... ......
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~----~~~~~~--------- 223 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSAL----QRGYRM--------- 223 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHH----HcCCCC---------
Confidence 1222345778999999988889999999999999999998 888886433211 11111 111000
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
......+..+.+++.+|++.+|++||++++++++|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=333.17 Aligned_cols=252 Identities=26% Similarity=0.319 Sum_probs=213.8
Q ss_pred HccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCcc---chHHHHHHHHHHHhcC-Ccccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 547 (795)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+++|+++. |||||.+++.|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34679999999999999999998765 999999999776443 3468999999999998 999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC----CCeeeecccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD----MNPKISDFGM 623 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~----~~vkL~DFGl 623 (795)
+|||++.||.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999888655 2899999999999999999999988 9999999999999533 5799999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.............. .
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~------~--- 253 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR------G--- 253 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc------C---
Confidence 998765 2345668999999999999999999999999999999999999999977654333221110 1
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+..+..+........+.++|..||..||.+|+|+.++++|
T Consensus 254 ---~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 ---DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1122333445556778899999999999999999999996
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=341.74 Aligned_cols=261 Identities=31% Similarity=0.406 Sum_probs=206.8
Q ss_pred ccCCccccccCcCCcccEEEeEecC--c--ce-EEEEEecc---cCccchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN--G--QE-VAVKRLSS---QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++..+.++||+|+||.||+|++.. + .. ||||.... .......+|.+|+++|++++|||||++||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3556677999999999999998643 2 23 89998874 234566789999999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
+++|||+|+||+|+++|..... .++..+...++.+.|.||+|||+++ +|||||..+|+|++.++.+||+||||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999954332 5889999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
...... .......-...|+|||.+....|+.++|||||||++||+++ |..|+......+.. ...
T Consensus 311 ~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------~kI------- 375 (474)
T KOG0194|consen 311 AGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------AKI------- 375 (474)
T ss_pred CCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------HHH-------
Confidence 643111 11111234678999999999999999999999999999998 77777654422111 000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCC
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLP 755 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~ 755 (795)
+........+...+..+..++.+|++.+|++||+|.++.+.|+.......
T Consensus 376 -~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 -VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 01111222233445667788889999999999999999999877544433
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=326.98 Aligned_cols=257 Identities=30% Similarity=0.427 Sum_probs=202.9
Q ss_pred cCCccccccCcCCcccEEEeEe-----cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|++.+.||+|+||.||+|+. ..++.+|+|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999974 245789999986432 2334678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccC--------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC
Q 003786 549 IYEYMPNKSLDFFLFDST--------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 614 (795)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884321 1234778889999999999999999988 99999999999999999
Q ss_pred CeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhH
Q 003786 615 NPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 615 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+...... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999986543332222333456778999999988889999999999999999998 88887543221 111111
Q ss_pred hhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...... ..+...+.++.+++.+||+.+|++||++.+|+++|..
T Consensus 240 ----~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011100 1111234567889999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.32 Aligned_cols=240 Identities=23% Similarity=0.263 Sum_probs=193.5
Q ss_pred cCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
||+|+||.||+|+.. +++.||+|++.+. .......+.+|+.+|++++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4788999998653 223346678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccc
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988843 345889999999999999999999988 9999999999999999999999999998543221 12334
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHH
Q 003786 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..... . ...+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~--~~---~~~~~-~----------~~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM--YR---KILQE-P----------LRFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH--HH---HHHcC-C----------CCCCCcC
Confidence 6799999999999999999999999999999999999999865332111 11 11110 0 0111223
Q ss_pred HHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 003786 719 LNRYINVGLLCVQEDAADRPT---MFEVVSM 746 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt---~~evl~~ 746 (795)
...+.+++.+||+.||++||+ +.|++++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 456778999999999999985 5666664
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.62 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=206.2
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999742 245689999876655556789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccC----------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 549 IYEYMPNKSLDFFLFDST----------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
||||+++++|.+++.... +...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885432 2234889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhc
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..|+....... .... .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~----i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC----I 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----H
Confidence 99999986543332222233446788999999998899999999999999999998 888875433211 1111 1
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
....... .+...+..+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 236 ~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 236 TQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111110 0112334688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=333.96 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=198.6
Q ss_pred CCccccccCcCCcccEEEeEe----cCcceEEEEEecccC----ccchHHHHHHHHHHHhc-CCcccceeeeeeeeccee
Q 003786 476 NFSTENKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
+|++.++||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588899999999999999975 257889999986532 22345678899999999 599999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988843 345889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhHhhhccCccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 704 (795)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......... .... ....
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~------ 225 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RILK------ 225 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHhc------
Confidence 533221 122345799999999998765 5889999999999999999999999654322111 1110 0000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.++. .+......+.+++.+||+.||++|| ++++++++
T Consensus 226 -~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 1112344677899999999999999 77888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.61 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=210.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.-|.+.+.||+|.|.+|-++++. +|.+||||++.+.. ......+.+|++.|+.++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45888899999999999999864 79999999997653 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE-CCCCCeeeeccccccccCCC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll-~~~~~vkL~DFGla~~~~~~ 630 (795)
.=++|+|.++|..+. .-+.+..+.+++.||..|+.|+|+.+ +|||||||+|+.+ .+-|-|||+|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996543 45889999999999999999999998 9999999999877 56789999999999887655
Q ss_pred cccccccccccccccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ...+.+|+..|.|||++.+..|+ +++||||||||||.|++|++||+..++.... ..++|-.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL--------------TmImDCK 235 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL--------------TMIMDCK 235 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh--------------hhhhccc
Confidence 4 34557999999999999998886 6789999999999999999999765432221 1222322
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
-..+.....++.+||..||+.||++|.+.+||+..
T Consensus 236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 23456677899999999999999999999999874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=340.92 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=199.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999865 58899999996532 233456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998843 345889999999999999999999998 999999999999999999999999998754321
Q ss_pred cccc------------------------------------cccccccccccccccccccCCCCcccchhhHHHHHHHHHh
Q 003786 631 ELQS------------------------------------KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674 (795)
Q Consensus 631 ~~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt 674 (795)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 003786 675 SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT---MFEVVSM 746 (795)
Q Consensus 675 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl~~ 746 (795)
|..||........ ... .......... + ........+.+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~~~--~~~---i~~~~~~~~~--~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET--YRK---IINWKETLQF--P-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH--HHH---HHcCCCccCC--C-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999975432111 110 0000000000 0 000123456788888997 9999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.33 Aligned_cols=259 Identities=28% Similarity=0.395 Sum_probs=201.3
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeec-c
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL-E 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 544 (795)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999632 247899999864322 2335678899999999 899999999988654 5
Q ss_pred eeeEEeecCCCCChhhhhhccCC---------------------------------------------------------
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTK--------------------------------------------------------- 567 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 567 (795)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988853221
Q ss_pred -cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccc
Q 003786 568 -ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646 (795)
Q Consensus 568 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 646 (795)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125788889999999999999999987 9999999999999999999999999998754332222233345678899
Q ss_pred cccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHH
Q 003786 647 SPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINV 725 (795)
Q Consensus 647 APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l 725 (795)
|||++.+..++.++|||||||++|||++ |..|+........ +.. ....... ...+......+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~---------~~~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCR----RLKEGTR---------MRAPEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHH----HHhccCC---------CCCCccCCHHHHHH
Confidence 9999999999999999999999999998 9888864322111 110 0011100 01112234567899
Q ss_pred HHhhccCCCCCCCCHHHHHHHHcc
Q 003786 726 GLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 726 i~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+.+||+.+|++||++.||+++|+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=352.02 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=206.5
Q ss_pred HHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc--
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE-- 544 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 544 (795)
+....++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++|+||++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445679999999999999999999854 68999999986542 334467889999999999999999988775433
Q ss_pred ------eeeEEeecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCee
Q 003786 545 ------EKILIYEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 545 ------~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vk 617 (795)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3679999999999999886433 2356889999999999999999999988 99999999999999999999
Q ss_pred eeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 618 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~~~~---- 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VMHKT---- 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH----
Confidence 999999987654332233345679999999999999999999999999999999999999986543211 11100
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 258 ~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00100 11122334578899999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.51 Aligned_cols=264 Identities=26% Similarity=0.347 Sum_probs=195.5
Q ss_pred cCCccccccCcCCcccEEEeEec--CcceEEEEEecccCc--cchHHHHHHHHHHHhc---CCcccceeeeeee-----e
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKL---QHRNLVRLLGCCI-----E 542 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 542 (795)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46899999999999999999863 367899998865322 2234566788877766 6999999999885 3
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
....++||||++ ++|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456889999997 57877774332 344788999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhHhhhccCcc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~ 701 (795)
+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||......... .............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99865433 2233457899999999998889999999999999999999999998765432211 0000000000000
Q ss_pred cc-------cccCccc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AW-------ELIDPTL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~-------~~id~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. ....+.. ...........+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0000000 011112234567799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=341.98 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=195.5
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
+|+++++||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999864 58889999986542 2234578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998843 345788899999999999999999998 9999999999999999999999999975331000
Q ss_pred ---------------------------------------------ccccccccccccccccccccccCCCCcccchhhHH
Q 003786 632 ---------------------------------------------LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFG 666 (795)
Q Consensus 632 ---------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlG 666 (795)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC---HHHH
Q 003786 667 VLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT---MFEV 743 (795)
Q Consensus 667 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~ev 743 (795)
|++|||++|+.||............ ..+. . .+.............+++.+|+ .+|++|++ +.|+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i---~~~~--~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKV---INWQ--T-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHH---HccC--C-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999999754322111100 0000 0 0000011122345567777765 49999997 8888
Q ss_pred HHH
Q 003786 744 VSM 746 (795)
Q Consensus 744 l~~ 746 (795)
++|
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.64 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=204.1
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999865 58999999997542 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56889999999999999999999988 999999999999999999999999999865432
Q ss_pred c---------------------------ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 631 E---------------------------LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 631 ~---------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234579999999999999999999999999999999999999987544
Q ss_pred CcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHHH
Q 003786 684 TNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT-MFEVVSML 747 (795)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~L 747 (795)
.... .... ..+... +........+..+.+++..||+ +|.+||+ +.+++++.
T Consensus 235 ~~~~--~~~i-~~~~~~---------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQET--YNKI-INWKES---------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHH--HHHH-hccCCc---------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 2111 1000 000000 0000001134567889999998 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.00 Aligned_cols=266 Identities=30% Similarity=0.400 Sum_probs=202.1
Q ss_pred CccccccCcCCcccEEEeEe-----cCcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeE
Q 003786 477 FSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKIL 548 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 548 (795)
|++.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|+++|++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988652 3577899999865432 3456788999999999999999999987754 35789
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 24889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCcccc-cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQS-KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 322111 1122345667999999988889999999999999999999999875433221111111111111111111222
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.......+...+..+.+++.+||+.+|++||++++|+++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 221112233345678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.77 Aligned_cols=261 Identities=19% Similarity=0.193 Sum_probs=196.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+|++.++||+|+||.||++... +++.||+|... ...+.+|+++|++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999864 58899999753 23578999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+. ++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 86 577766633 235788999999999999999999988 9999999999999999999999999997543211
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCc-----chhHhHhHhhhccCc--c----
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-----SLTLLGHAWDLWKDD--R---- 701 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~-----~~~~~~~~~~~~~~~--~---- 701 (795)
........||+.|+|||++.+..++.++|||||||++|||++|..|+-..... ....+.......... .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 11223467999999999999999999999999999999999999876432210 000000000000000 0
Q ss_pred ----ccc---------ccCccccc--hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 702 ----AWE---------LIDPTLQN--EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 702 ----~~~---------~id~~l~~--~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
..+ ...+.... ......+..+.+++.+||+.||++|||++|++++--
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000 00000000 011124557889999999999999999999998643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.83 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=195.6
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec-----ceee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEKI 547 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 547 (795)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999864 5899999998643 223345688999999999999999999987643 2479
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+. ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 578777743 345889999999999999999999998 999999999999999999999999999854
Q ss_pred CCCcc-ccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhH--------hh
Q 003786 628 GGDEL-QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHA--------WD 695 (795)
Q Consensus 628 ~~~~~-~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~--------~~ 695 (795)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 111234578999999999876 67899999999999999999999998754421110 00000 00
Q ss_pred hccCcccc---cccCccccch---hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 696 LWKDDRAW---ELIDPTLQNE---ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 696 ~~~~~~~~---~~id~~l~~~---~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+...... ..+.+..... ........+.+++.+||+.+|++||+++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 0000000000 001123457799999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.16 Aligned_cols=265 Identities=30% Similarity=0.437 Sum_probs=205.7
Q ss_pred ccCCccccccCcCCcccEEEeEecC-----------------cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVR 535 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 535 (795)
..+|++.++||+|+||.||+++... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999987542 2458999987543 234567889999999999999999
Q ss_pred eeeeeeecceeeEEeecCCCCChhhhhhccC--------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCc
Q 003786 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDST--------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 607 (795)
Q Consensus 536 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 607 (795)
+++++..+...++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1235889999999999999999999988 9999999999
Q ss_pred EEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCc
Q 003786 608 ILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTN 685 (795)
Q Consensus 608 Ill~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~~~~~ 685 (795)
|+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543332233334556789999999988889999999999999999998 455554322
Q ss_pred chhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 686 SLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...........+......... ..+...+.++.+++.+||+.+|++||++.||+++|..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 222222222111111111111 1112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=321.95 Aligned_cols=255 Identities=31% Similarity=0.472 Sum_probs=203.5
Q ss_pred cCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
++|++.+.||+|+||.||+|+... ...||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999998642 4579999986543 23346788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999985432 36889999999999999999999987 99999999999999999999999999997652
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
...........+++.|+|||.+.+..++.++||||||+++|+|++ |..|+....... ..... .....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~----~~~~~------ 226 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAV----EDGYR------ 226 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHH----HcCCC------
Confidence 221112222345678999999998899999999999999999997 888875332111 11111 11100
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++.+||+.+|++||++.||+++|+.
T Consensus 227 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 ---LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01112234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=337.27 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=195.6
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+++|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 58899999996532 223456888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999843 345889999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------------ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 003786 631 ELQ---------------------------------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 631 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~ 677 (795)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhcc--CCCCCCCCHHHHHHH
Q 003786 678 NTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQ--EDAADRPTMFEVVSM 746 (795)
Q Consensus 678 p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~--~dP~~RPt~~evl~~ 746 (795)
||........ ...... +... . .+.+. ......+.+++.+++. .++..||+++||+++
T Consensus 235 Pf~~~~~~~~--~~~i~~-~~~~-~--~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQET--YKKVMN-WKET-L--IFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHH--HHHHHc-CcCc-c--cCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9965432211 111100 0000 0 00110 0122345566666443 344457999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=321.39 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=204.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.+|++.++||+|+||.||+|... .++.||+|++... ....+++.+|++++++++||||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999865 4888999998643 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999885432 345788899999999999999999987 999999999999999999999999999876433221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|||||||++|||++ |..|++....... . ...... ...
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--~----~~~~~~---------~~~ 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y----ELLEKG---------YRM 224 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--H----HHHHCC---------CCC
Confidence 1112234678999999998999999999999999999998 8888865332111 1 111110 011
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1122234578889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=340.59 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=197.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.++||+|+||.||+++.. +++.||||++.+.. ....+.+++|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999854 68899999986532 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998843 345788899999999999999999998 999999999999999999999999998643210
Q ss_pred cc-------------c--------------------------------ccccccccccccccccccccCCCCcccchhhH
Q 003786 631 EL-------------Q--------------------------------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSF 665 (795)
Q Consensus 631 ~~-------------~--------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSl 665 (795)
.. . .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCC---CCHHH
Q 003786 666 GVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADR---PTMFE 742 (795)
Q Consensus 666 Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~R---Pt~~e 742 (795)
||++|||++|..||........ .... ........+ + ........+.+++.+||+ +|.+| |++.|
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~--~~~i---~~~~~~~~~--p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET--YRKI---INWRETLYF--P-----DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH--HHHH---HccCCccCC--C-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999965442211 1100 000000000 0 001123457789999998 66665 69999
Q ss_pred HHHHH
Q 003786 743 VVSML 747 (795)
Q Consensus 743 vl~~L 747 (795)
++++.
T Consensus 302 ~l~hp 306 (377)
T cd05629 302 IKSHP 306 (377)
T ss_pred HhcCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=332.56 Aligned_cols=242 Identities=25% Similarity=0.325 Sum_probs=194.7
Q ss_pred cccCcCCcccEEEeEe----cCcceEEEEEecccC----ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 481 NKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++||+|+||.||+++. ..++.||||++.+.. ......+.+|+.+|+.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357889999986532 22335678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|..++.. .+.+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999888843 345778889999999999999999988 9999999999999999999999999987532221
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... .. ....
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~--~~~---~~-~~~~---------- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT--IDK---IL-KGKL---------- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH--HHH---HH-cCCC----------
Confidence 122345799999999999988899999999999999999999999875432111 111 00 0100
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
..+......+.+++.+||+.+|++|| ++.+++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 01112335678999999999999999 89998885
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=320.25 Aligned_cols=252 Identities=29% Similarity=0.424 Sum_probs=202.5
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
++|++.+.||+|+||.||+|+..++..+|||.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 568889999999999999998877778999988643 3345779999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999885432 25789999999999999999999988 999999999999999999999999998865433221
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|||||||++|+|++ |..|+........ .... ....+. .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~---~~~~~~----------~ 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VEKV---SQGLRL----------Y 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHH---hcCCCC----------C
Confidence 1112345678999999988889999999999999999998 8888764332111 1111 000000 0
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112457789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.72 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=200.3
Q ss_pred cCCccccccCcCCcccEEEeEec-Ccc----eEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|++.+.||+|+||.||+|+.. +++ .||||++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56999999999999999999853 333 38999986543 33456788999999999999999999998764 5779
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988543 234788899999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............++..|+|||.+.+..++.++|||||||++|||++ |..|++....... .. .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~----- 229 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SS----ILEKGER----- 229 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HHhCCCC-----
Confidence 4332222222334678999999999999999999999999999997 9988865332211 11 0111100
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...+......+.+++.+||+.+|++||++.+++..|...
T Consensus 230 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 230 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111234677899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.96 Aligned_cols=250 Identities=34% Similarity=0.515 Sum_probs=193.6
Q ss_pred cccccCcCCcccEEEeEec-----CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 479 TENKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+.+.||.|.||.||+|.+. .+..|+||.+.... ....+.+.+|++.+++++||||+++++++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999865 26779999996533 23468899999999999999999999999988889999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++|+|.+++... ....+++..+..++.||++||+|||+.+ ++|++|+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2345889999999999999999999987 99999999999999999999999999987633332
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
............|+|||.+....++.++||||||+++|||++ |+.|+..... ....... .....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~----~~~~~--------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKL----KQGQR--------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHH----HTTEE---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc----ccccc---------
Confidence 223333457789999999999889999999999999999999 6777654321 1111111 11111
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
...+...+..+.+++..||+.+|++||++.+|++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222345678999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.62 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=197.6
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.+|++.++||+|+||.||+++.. +++.||||++.+.. ......+.+|+++|++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 58899999986532 223466889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999843 345788899999999999999999988 999999999999999999999999997533100
Q ss_pred c-----------------------------------------ccccccccccccccccccccccCCCCcccchhhHHHHH
Q 003786 631 E-----------------------------------------LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669 (795)
Q Consensus 631 ~-----------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil 669 (795)
. .........||+.|||||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCC---CHHHHHHH
Q 003786 670 LETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRP---TMFEVVSM 746 (795)
Q Consensus 670 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP---t~~evl~~ 746 (795)
|||++|+.||............. .+... .. .+ ........+.+++.+|+ .+|++|+ ++.|++++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~---~~~~~--~~--~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVI---NWETT--LH--IP-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHh---ccCcc--cc--CC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999997654322111100 00000 00 00 01112345566777766 4999999 89999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.93 Aligned_cols=247 Identities=25% Similarity=0.309 Sum_probs=196.6
Q ss_pred cCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
||+|+||+||+++.. +++.||+|++.+... ...+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 588999999865322 2335678899999999999999999999999999999999999999
Q ss_pred hhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccc
Q 003786 559 DFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK 637 (795)
Q Consensus 559 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~ 637 (795)
...+.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88775422 3456889999999999999999999988 99999999999999999999999999976543321 223
Q ss_pred ccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHH
Q 003786 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717 (795)
Q Consensus 638 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ...... ... ...+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~---------~~~--~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQRIL---------NDS--VTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-HHHhhc---------ccC--CCCccc
Confidence 45789999999999999999999999999999999999999875432211100 000000 000 011223
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 718 ILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 718 ~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.+..+.+++.+||+.+|++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 445678899999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.53 Aligned_cols=265 Identities=28% Similarity=0.411 Sum_probs=200.0
Q ss_pred cCCccccccCcCCcccEEEeEecC---------------cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
.+|++.++||+|+||.||+++... ...||+|.+.... ....+.+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987532 2348999986542 233457899999999999999999999
Q ss_pred eeeecceeeEEeecCCCCChhhhhhccCC---------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEE
Q 003786 539 CCIELEEKILIYEYMPNKSLDFFLFDSTK---------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 539 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 609 (795)
++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854221 123678888999999999999999988 999999999999
Q ss_pred ECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH
Q 003786 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~ 689 (795)
++.++.+||+|||++................++..|+|||.+..+.++.++|||||||++|+|+++..+.++........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999986543322222223345778999999988889999999999999999998543333322222222
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.......+....... ....+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 242 ~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQI------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccc------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 211111111110000 00111123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.95 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=195.4
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
++||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 68899999886543 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccc
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988432 235788999999999999999999988 99999999999999999999999999875432211111111
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHH
Q 003786 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717 (795)
Q Consensus 639 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
...+..|+|||.+.++.++.++|||||||++|||++ |..|+........ .... .. ......+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~~----~~---------~~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REAI----EQ---------GVRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHHH----Hc---------CCCCCCccc
Confidence 223467999999998899999999999999999997 7777754322111 1000 00 000111222
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 718 ILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 718 ~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3457788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=357.63 Aligned_cols=258 Identities=31% Similarity=0.480 Sum_probs=211.0
Q ss_pred cCCccccccCcCCcccEEEeEecC--cc----eEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...++.+.||+|.||.||.|...+ +. .||||.+.+. +.+...+|.+|..+|++++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456778899999999999998643 33 3899999765 4456688999999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC----cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTK----ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
+++|||.+|+|..+|++.+. ...+...+.+.++.+||+|+.|||+++ +|||||..+|+||+....|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999976532 345788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
|+.+...++........-...|||||.++.+.|+.|+|||||||+|||+++ |..|++..+..+... .+ ...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~~---~~gg-- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--DV---LEGG-- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--HH---HhCC--
Confidence 996655554443333233568999999999999999999999999999997 666766544322211 11 1111
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
+-+.+..++..+.+|+..||+.+|++||++..|++.+...
T Consensus 922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 2234556777888999999999999999999999977653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=325.95 Aligned_cols=242 Identities=27% Similarity=0.355 Sum_probs=191.0
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHh-cCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAK-LQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 47889999987532 2234455667777765 4899999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888843 345888999999999999999999988 9999999999999999999999999997543222 22
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... .. .. + ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~~i---~~-~~------~----~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FDSI---LN-DR------P----HFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HHHH---Hc-CC------C----CCC
Confidence 3346799999999999998999999999999999999999999875432211 1110 00 00 0 011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHH-HHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMF-EVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~ 746 (795)
......+.+++.+||+.+|++||++. +++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 12334667899999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=331.32 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=195.6
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHH---HhcCCcccceeeeeeeecceeeEE
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLI---AKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 58999999997542 22345677776665 466799999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|...+. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 245899999999999999999999988 99999999999999999999999999875322
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .... .. .. .
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~~i---~~-~~------~- 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FDSI---VN-DE------V- 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HHHH---Hh-CC------C-
Confidence 11 223346799999999999999999999999999999999999999875432211 1100 00 00 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L 747 (795)
..+......+.+++.+||+.||++|| ++.+++++.
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 01112345677899999999999999 677887753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.91 Aligned_cols=252 Identities=29% Similarity=0.438 Sum_probs=201.7
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
.+|++.+.||+|+||.||+++...+..+|+|++.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4588899999999999999988777889999986432 345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999885432 35789999999999999999999988 999999999999999999999999999865422211
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++||||||+++|+|++ |..|+....... ..... ... ....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~----~~~---------~~~~ 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESV----SAG---------YRLY 221 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHH----HcC---------CcCC
Confidence 1111234567999999998899999999999999999998 788876433211 11111 000 0001
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.+...+..+.+++.+||+.+|++||++.|++++|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11123557889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.45 Aligned_cols=257 Identities=30% Similarity=0.411 Sum_probs=202.3
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.+|++.++||+|+||.||+|+.. .++.||||++...... ..+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45788899999999999999753 2578999999754322 2466889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC
Q 003786 548 LIYEYMPNKSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 614 (795)
+++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999998884221 1234778889999999999999999988 99999999999999999
Q ss_pred CeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhH
Q 003786 615 NPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 615 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+...... .....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~- 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEM- 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-
Confidence 999999999886543332222233456789999999988889999999999999999998 77776543221 11111
Q ss_pred hhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...... ...+...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 239 ---i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 ---IRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 11122345567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.77 Aligned_cols=253 Identities=19% Similarity=0.295 Sum_probs=201.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999865 58899999997542 234456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 245889999999999999999999988 999999999999999999999999999876433
Q ss_pred cccccccccccccccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQ------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .. ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~---~i~~~~~~~~ 229 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--YN---NIMNFQRFLK 229 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--HH---HHHcCCCccC
Confidence 221 223357899999999986 45688999999999999999999999865432111 11 1111111000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .........+.+++..||+ +|++||++.+++++
T Consensus 230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0111234567789999998 99999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.01 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=200.1
Q ss_pred CccccccCcCCcccEEEeEecC----cceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecce-----
Q 003786 477 FSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 545 (795)
|++.+.||+|+||.||+|+... +..||||++.... ....+.+.+|++.++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 3679999986532 2234678999999999999999999998876554
Q ss_pred -eeEEeecCCCCChhhhhhccC---CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecc
Q 003786 546 -KILIYEYMPNKSLDFFLFDST---KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 546 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DF 621 (795)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999998885432 2346888999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCc
Q 003786 622 GMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDD 700 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
|+++...............++..|+|||.+....++.++|||||||++|||++ |..|+....... ..... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~----~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYL----RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcC
Confidence 99986543332222222345678999999988899999999999999999999 888875432211 11111 011
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.. ...+......+.+++.+||+.+|++||++.|+++.|+.
T Consensus 232 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 NR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 10 01122344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.97 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=197.0
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCc-ccceeeeeeeecceeeEEe
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHR-NLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 550 (795)
+|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|.+++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999865 47889999997532 23456778899999999765 5888999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345788999999999999999999988 999999999999999999999999998743211
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~----~~~------~-- 218 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQSIM----EHN------V-- 218 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHH----cCC------C--
Confidence 1 123345799999999999999999999999999999999999999975432211 11110 000 0
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTM-----FEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~ 746 (795)
..+......+.+++.+||+.+|++||+. .+++++
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111234467789999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=332.21 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=194.7
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68899999997542 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888743 3458899999999999999999997 56 9999999999999999999999999987532221 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ...... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~~i--~~~~~~------------~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELI--LMEEIR------------FP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HHHH--hcCCCC------------CC
Confidence 2345799999999999999999999999999999999999999865432211 1100 000000 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
......+.+++.+||+.||++|+ ++.+++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12234677899999999999996 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.79 Aligned_cols=262 Identities=18% Similarity=0.257 Sum_probs=193.8
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec--------
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-------- 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 543 (795)
...+|++.+.||+|+||.||+|... +++.||||++... .....+|+.+|++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 5889999988543 23456799999999999999999886432
Q ss_pred ceeeEEeecCCCCChhhhhhc-cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-Ceeeecc
Q 003786 544 EEKILIYEYMPNKSLDFFLFD-STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDF 621 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DF 621 (795)
...++||||+++ +|..++.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999986 55554432 233456889999999999999999999998 99999999999999665 6999999
Q ss_pred ccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc
Q 003786 622 GMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD 700 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
|+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||........ +.. ........
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~-i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVR-IIQVLGTP 290 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHH-HHHHhCCC
Confidence 9998654322 1223578999999998865 4799999999999999999999999876442221 111 10100000
Q ss_pred c----------ccc-----ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 701 R----------AWE-----LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 701 ~----------~~~-----~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. ..+ .....+....+...+..+.+++.+||+.+|++|||+.|++++-
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0 000 0000111111222345788999999999999999999999863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=337.74 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=201.7
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.++||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999865 58899999986432 2234557889999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++|+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24788889999999999999999988 9999999999999999999999999998654
Q ss_pred CCcccccccccccccccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .. ..........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~---~i~~~~~~~~ 267 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YS---KIMDHKNSLT 267 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH--HH---HHHcCCCcCC
Confidence 3221 122345799999999988653 488999999999999999999999875432111 11 1111100000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHH
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAAD--RPTMFEVVSML 747 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L 747 (795)
. ......+..+.+++.+||+.+|++ ||++.|++++.
T Consensus 268 ~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 268 F-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred C-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0 011123456778999999999988 99999999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.57 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=203.4
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|...++||+|+||.||+++.. ++..+|+|.+........+.+.+|+++++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999632 356799999876665666789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 549 IYEYMPNKSLDFFLFDSTK------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
+|||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 134788899999999999999999988 9999999999999999999
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..|+........ ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~-- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IECI-- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HHHH--
Confidence 9999999976543322222223345788999999998899999999999999999998 8888753322111 1100
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
...... ..+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 238 --~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 --TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000 011123356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.27 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=202.5
Q ss_pred HccCCccccccCcCCcccEEEeEecC------cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
..++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34679999999999999999998653 5678999886433 2334578999999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCC----cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---Ceee
Q 003786 546 KILIYEYMPNKSLDFFLFDSTK----ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKI 618 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL 618 (795)
.++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 135888999999999999999999988 99999999999998765 5999
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhc
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||+....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~~~---- 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--MEFV---- 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHH----
Confidence 99999987643322222222334568999999998899999999999999999997 8888865432221 1111
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
..... ...+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 0111223457789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.01 Aligned_cols=257 Identities=29% Similarity=0.422 Sum_probs=201.8
Q ss_pred CCccccccCcCCcccEEEeEec------CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
+|++.+.||+|+||.||+|+.. ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999753 235688988865432 234678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccC---------------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCc
Q 003786 549 IYEYMPNKSLDFFLFDST---------------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 607 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 607 (795)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1234778889999999999999999987 9999999999
Q ss_pred EEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 003786 608 ILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNS 686 (795)
Q Consensus 608 Ill~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 686 (795)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|++......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986533222122223446778999999988889999999999999999998 888886433221
Q ss_pred hhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 687 LTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
+.. ...... ....+......+.+++.+||+.+|++||++.|+++.|+..
T Consensus 238 --~~~----~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 --LFN----LLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHH----HHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111 111110 0111122345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.76 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=194.7
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
++||+|+||.||+|+.. +++.||||++.+.. ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 47899999987542 23345677899998866 799999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|...+.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888843 345788999999999999999999998 9999999999999999999999999987543222 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... .... .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~~i---~~~~----~~-------~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--FESI---LHDD----VL-------YP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--HHHH---HcCC----CC-------CC
Confidence 3345799999999999999999999999999999999999999975442221 1111 0100 00 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-------CHHHHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRP-------TMFEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RP-------t~~evl~~ 746 (795)
......+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11235677899999999999999 88899876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.00 Aligned_cols=259 Identities=28% Similarity=0.401 Sum_probs=205.2
Q ss_pred HccCCccccccCcCCcccEEEeEecC------cceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
..++|++.+.||+|+||.||++.... ...+|+|.+.... .....++.+|+++++++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34678999999999999999997532 3679999987532 23345688999999999 7999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhcc-------------CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 545 EKILIYEYMPNKSLDFFLFDS-------------TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
..+++|||+++++|..++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998542 22345888899999999999999999987 99999999999999
Q ss_pred CCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHh
Q 003786 612 KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLL 690 (795)
Q Consensus 612 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--F 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--H
Confidence 999999999999987654332222223345678999999988899999999999999999997 8888764332211 1
Q ss_pred HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
. ....... ...+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 245 ~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 245 K----LLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred H----HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 1 1111110 01112234567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.68 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=197.0
Q ss_pred CccccccCcCCcccEEEeEecC-cc--eEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec------ce
Q 003786 477 FSTENKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------EE 545 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 545 (795)
|.+.++||+|+||.||+|+... ++ .+|+|.+... .....+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998654 32 5899988653 233456788999999999999999999987532 24
Q ss_pred eeEEeecCCCCChhhhhhccC---CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 546 KILIYEYMPNKSLDFFLFDST---KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
.+++|||+++++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988874321 2345889999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+....... ... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYD----YLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HHHcCC
Confidence 9987643332222223346778999999999999999999999999999999 788876432211 111 111111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
... ........+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 100 111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.52 Aligned_cols=242 Identities=24% Similarity=0.350 Sum_probs=193.9
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 58899999986532 23445677888888876 699999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999888843 345889999999999999999999988 9999999999999999999999999987532221 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ...... . .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~~----i~~~~~---~-------~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL--FEA----ILNDEV---V-------YP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HHH----HhcCCC---C-------CC
Confidence 3345799999999999999999999999999999999999999975442221 111 011100 0 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCH------HHHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTM------FEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~ 746 (795)
......+.+++.+||+.||++||++ ++++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1234567889999999999999998 677765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.63 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=194.0
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999997642 22345677899988877 799999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 345889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc---hhHhHhHhhhccCcccccccCccccc
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS---LTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence 234679999999999999999999999999999999999999996422111 111111111111110 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCC------HHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPT------MFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt------~~evl~~ 746 (795)
..+......+.+++.+||+.||++||+ +.+++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 112223456778999999999999998 5687765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.53 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=196.8
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEe
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 550 (795)
+|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999865 47889999987542 22334567788888777 5899999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|...+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888843 345888999999999999999999988 999999999999999999999999999754322
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i~----~~~~-------- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIM----EHNV-------- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HHHHH----hCCC--------
Confidence 1 122346799999999999999999999999999999999999999975432211 11110 0000
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTM-----FEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~ 746 (795)
..+......+.+++.+||+.+|++|++. .+++++
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0111234567889999999999999984 677654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.08 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=207.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 68999999875432 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||+++++|..++.... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988875432 2345788899999999999999999987 99999999999999999999999999887643
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.|+.............. .... .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~-----~~- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCD-----YP- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcCC-----CC-
Confidence 321 12235688999999999888899999999999999999999999854332222221111 0000 00
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..........+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111223446788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.29 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=204.8
Q ss_pred ccCCccccccCcCCcccEEEeEecC------cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3678899999999999999997542 4679999986543 23345788999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCC-------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 547 ILIYEYMPNKSLDFFLFDSTK-------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
++||||+++++|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854322 234678889999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhcc
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ .... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~----~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--LKFV----I 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--HHHH----h
Confidence 9999986544332222333456789999999988889999999999999999998 8888764332211 1111 1
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
...... .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 11112567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.46 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=195.1
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+++.. +++.||||++.+.. ......+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 58899999997542 23345678899999988 799999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999888743 345899999999999999999999998 9999999999999999999999999987422111 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc---hhHhHhHhhhccCcccccccCccccc
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS---LTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||+...... ................
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 334679999999999999999999999999999999999999997432111 1001111111111100
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCC------HHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPT------MFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt------~~evl~~ 746 (795)
..+......+.+++.+||+.||++||+ +.+++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 011123456788999999999999997 6788875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=300.18 Aligned_cols=253 Identities=27% Similarity=0.359 Sum_probs=204.3
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC----ccch----HHHHHHHHHHHhc-CCcccceeeeeeee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS----GQGQ----EEFKNEIKLIAKL-QHRNLVRLLGCCIE 542 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~ 542 (795)
...+|...+.||.|..++|-++-+ ++++++|+|++.... .+.. +.-.+|+.||+++ -||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 346788889999999999998865 468999999885421 1122 3455799999998 59999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
+.-.++|+|.|+.|.|.++| ...-.+++.+..+|+.|+..|+.|||..+ ||||||||+|||++++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 99999999999999999999 34456899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQ------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
++..+.... .....+|||+|+|||.++. ..|+..+|+|++|||+|.|+.|.+||--. .++..+..
T Consensus 169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~---- 239 (411)
T KOG0599|consen 169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRM---- 239 (411)
T ss_pred eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHH----
Confidence 999876554 3445899999999998853 46889999999999999999999997421 11111111
Q ss_pred ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..++.. .+..+...+......++|.+||+.||.+|.|++|+|+|
T Consensus 240 ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111111 12233445566778899999999999999999999986
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.89 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=202.7
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.++||+|+||.||+|+..+...||+|++.... ...+.+.+|++++++++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35799999999999999999988777789999997533 34567899999999999999999999874 45679999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998543 2345788999999999999999999988 999999999999999999999999999866433221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|||||||++|||++ |..|++....... .... .... ..
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~~~~----~~~~---------~~ 222 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQV----ERGY---------RM 222 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--HHHH----hcCC---------CC
Confidence 1122346778999999988899999999999999999999 7777754332111 1100 0000 00
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
......+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1122345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.76 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=200.2
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...++|++.+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 4788999998642 1223456889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998843 24788899999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ . ..........
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--~---~~i~~~~~~~ 266 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--Y---SKIMDHKNSL 266 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--H---HHHHhCCccc
Confidence 43221 122346799999999998653 378999999999999999999999975432111 1 0111110000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAAD--RPTMFEVVSML 747 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L 747 (795)
.. .........+.+++..||+.+|.+ ||++.|++++-
T Consensus 267 ~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 267 NF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 00 011123456678889999866654 89999999973
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.36 Aligned_cols=254 Identities=31% Similarity=0.452 Sum_probs=202.8
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.++||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 35789999999999999999998888899999986543 34567999999999999999999999875 45689999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999885432 334788999999999999999999988 999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++||||||+++|+|++ |..|+....... ..... ... ...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~----~~~---------~~~ 222 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQV----ERG---------YRM 222 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----HcC---------CCC
Confidence 1112345678999999988889999999999999999999 888875432211 11111 000 001
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122334568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.11 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=217.2
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccc-hHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.....++++||+|-||.|.++....+..||||+++...... ..+|.+|+++|.+|+|||||+++++|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 35567889999999999999998778999999998765444 47899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
|++|+|..++..+.... +.-....+|+.||+.|++||.+.+ +|||||.++|+|++.++++||+|||+++-+...+.
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999997654433 455667789999999999999987 99999999999999999999999999997665555
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....+.+-...|||||.+.-+.++.++|||+||+++||+++ ...|++. ....+.+.........+....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~--lt~e~vven~~~~~~~~~~~~------ 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ--LTDEQVVENAGEFFRDQGRQV------ 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh--hhHHHHHHhhhhhcCCCCcce------
Confidence 555555667889999999999999999999999999999875 4555543 333333444444433333222
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+..++..+.+++..|+..+-++||+++++..+|..
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 122344566788899999999999999999999998865
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.44 Aligned_cols=255 Identities=28% Similarity=0.374 Sum_probs=198.4
Q ss_pred cCCccccccCcCCcccEEEeEec-Ccc----eEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|++.+.||+|+||.||+|+.. +++ .+++|.+..... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888999999999999999864 344 477787754322 23356788888999999999999999875 455789
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 245889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ . ......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~--~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV--P----DLLEKGERL--AQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--H----HHHHCCCcC--CC
Confidence 3332222334557789999999988899999999999999999998 9888865432211 1 111111110 01
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
+. .....+.+++.+|++.+|++||++.|+++.|...
T Consensus 233 ~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 233 PQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 1234567889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.10 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=208.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999876 68999999886422 233567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||+++++|..++.... ....+++..+..++.++++||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998885432 2345788999999999999999999988 99999999999999999999999999886543
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.|+............. ......
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~------- 225 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEKCDY------- 225 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh----hhcCCC-------
Confidence 221 1223468899999999988889999999999999999999999985443221111111 000000
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...........+.+++.+||+.+|++||++.+|+++|...
T Consensus 226 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 -PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0011113455778999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.82 Aligned_cols=263 Identities=29% Similarity=0.437 Sum_probs=200.7
Q ss_pred cCCccccccCcCCcccEEEeEec-----------------CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCccccee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 536 (795)
++|++.++||+|+||.||+++.. ++..+|+|++.... ....+.+.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 23468999987542 3345678999999999999999999
Q ss_pred eeeeeecceeeEEeecCCCCChhhhhhccCC--------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcE
Q 003786 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTK--------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNI 608 (795)
Q Consensus 537 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 608 (795)
++++...+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999998864321 134677789999999999999999998 99999999999
Q ss_pred EECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCcc
Q 003786 609 LLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTNS 686 (795)
Q Consensus 609 ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~~~~~~ 686 (795)
+++.++.+||+|||+++.+.............+++.|+|||....+.++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 999999999999999986543322222223345678999998888889999999999999999998 5556543222
Q ss_pred hhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 687 LTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
................... ...+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111111100000 0111223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.23 Aligned_cols=252 Identities=26% Similarity=0.328 Sum_probs=201.7
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
+|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 58899999986532 2223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2345889999999999999999999998 9999999999999999999999999998653222
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......|++.|+|||++.+..++.++||||+||++|||++|+.||......... .......... .
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~~~~~~~~~----------~ 221 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EEVERRVKED----------Q 221 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HHHHHHhhhc----------c
Confidence 122357899999999999889999999999999999999999999754322110 0000000000 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
...+......+.+++.+||+.||++|| ++.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112223455678999999999999999 88899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.91 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=202.5
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+|++.+.||+|+||.||+|+. .+++.||+|++..........+++|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 36799999999999999999986 46889999999765555566788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998843 345788999999999999999999987 9999999999999999999999999998653221
Q ss_pred cccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.......|++.|+|||.+. ...++.++|||||||++|||++|+.|+......... . ...... ...+.
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~-----~~~~~~---~~~~~ 230 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-F-----LMSKSN---FQPPK 230 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-e-----eeecCC---CCCCC
Confidence 1123356889999999874 345788999999999999999999988533211110 0 000000 00011
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.. .....+..+.+++.+||+.+|++||++++|+++|
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 10 0112345778999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.21 Aligned_cols=242 Identities=26% Similarity=0.355 Sum_probs=192.0
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 58899999997542 23345677788888754 899999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999888843 345788999999999999999999988 9999999999999999999999999987432111 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..... ... .+.+ +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~----~~~------~~~~----~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESI----RVD------TPHY----P 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhC------CCCC----C
Confidence 334679999999999999999999999999999999999999996543221 11111 000 0111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHH-HHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMF-EVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~ 746 (795)
......+.+++.+||+.||++||++. ++++|
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11334677899999999999999984 67644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=314.53 Aligned_cols=254 Identities=31% Similarity=0.438 Sum_probs=204.4
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 36789999999999999999998888999999986543 3457889999999999999999999986 456789999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999998885432 345788899999999999999999987 999999999999999999999999999866432221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+....++.++||||||+++|||++ |+.|+........ .... .... ..
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~~~---------~~ 222 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--IQNL----ERGY---------RM 222 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH----HcCC---------CC
Confidence 1122345678999999998899999999999999999998 9998865432211 1111 1110 00
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+.++.+++.+||+.+|++||++++++++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=324.80 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=195.8
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEe
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 550 (795)
+|+..+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 58899999987532 233456778999998885 577888999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 345889999999999999999999988 999999999999999999999999998754322
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~----~~~~-------- 218 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIM----EHNV-------- 218 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHH----hCCC--------
Confidence 1 12234569999999999999999999999999999999999999987543211 111110 0000
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTM-----FEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~ 746 (795)
..+......+.+++.+||+.+|.+|++. .+++++
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 0111233467789999999999999974 566554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.84 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=205.7
Q ss_pred HccCCccccccCcCCcccEEEeEecC-----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeee-cce
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEE 545 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 545 (795)
..++|++.+.||+|+||.||+|.... ++.|++|++.... ....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999998765 6889999886432 2335668899999999999999999998776 467
Q ss_pred eeEEeecCCCCChhhhhhccCCc-----ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKE-----NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
.++++||+++++|..++...... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998543322 45889999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccC
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKD 699 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..+.... ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYL----KD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHH----Hc
Confidence 999986543332222223456778999999988889999999999999999998 9988864322 1111111 11
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.... ......+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 235 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1000 01112345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.09 Aligned_cols=259 Identities=27% Similarity=0.395 Sum_probs=204.6
Q ss_pred HccCCccccccCcCCcccEEEeEec--------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIE 542 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 542 (795)
...+|++.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3577899999999999999999741 24579999886542 33456789999999999 89999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEE
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 609 (795)
....++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999865321 234777889999999999999999988 999999999999
Q ss_pred ECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 003786 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLT 688 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 688 (795)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..|+........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~- 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence 99999999999999987654332222333446778999999988899999999999999999998 7777754322111
Q ss_pred HhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.. ........ ..+...+..+.+++.+||+.+|++||++.||++.|..
T Consensus 249 -~~----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 249 -FK----LLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred -HH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 11 11111100 1112234577889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.50 Aligned_cols=246 Identities=28% Similarity=0.405 Sum_probs=194.2
Q ss_pred ccCcCCcccEEEeEe---cCcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 482 KLGEGGFGPVYKGRL---LNGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+||+|+||.||+|.. .+++.+|+|++..... ...+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999964 3578899999864432 23467899999999999999999999875 55678999999999
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc-c
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS-K 635 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~-~ 635 (795)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||.||+++.++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 345889999999999999999999988 9999999999999999999999999998764332211 1
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....++..|+|||.+....++.++|||||||++|||++ |..||....... ..... ..... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~i----~~~~~---------~~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQMI----ESGER---------MEC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HCCCC---------CCC
Confidence 122234678999999988889999999999999999998 898886533221 11111 11111 111
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+...+..+.++|.+||+.+|++||++.+|++.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=314.65 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=201.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-----cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-----QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|++.+.||+|++|.||++... +++++|+|.+..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56899999999999999999864 589999998864321 123568899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|+||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988843 345788899999999999999999988 9999999999999999999999999997654
Q ss_pred CCccccc-ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSK-TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~---~~~~~~~------ 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IF---KIATQPT------ 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--HH---HHhccCC------
Confidence 3221111 1235678899999999998899999999999999999999999854321111 10 0000000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111222344567889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.80 Aligned_cols=259 Identities=28% Similarity=0.385 Sum_probs=203.3
Q ss_pred ccCCccccccCcCCcccEEEeEec--------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.++|.+.+.||+|+||.||+++.. +.+.+|+|.+.... .....++.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999742 23569999987542 23446788899999999 799999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999865321 234788899999999999999999987 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhH
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTL 689 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..|+....... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--H
Confidence 9999999999999876543222122222234578999999998899999999999999999998 778875432211 1
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
... ...... ...+......+.+++.+||+.+|++||++.+|++.|...
T Consensus 252 ~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 FKL----LKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHH----HHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111 011110 111222345777899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.22 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=192.0
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHh-cCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAK-LQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 47889999997542 2334556678888876 4899999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
|+|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999988843 345788899999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ... .+. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i----~~~------~~~----~~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSI----RMD------NPC----YP 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhC------CCC----CC
Confidence 234578999999999999899999999999999999999999986543211 11111 000 011 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHH-HHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMF-EVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~ 746 (795)
......+.+++.+||+.+|++||++. +++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 12334677899999999999999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.08 Aligned_cols=270 Identities=26% Similarity=0.388 Sum_probs=200.5
Q ss_pred cCCccccccCcCCcccEEEeEec-----CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec--ceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 547 (795)
.+|++.+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 4788999998766555567899999999999999999999987543 4678
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 235889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccc-cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh-hccCcccccc
Q 003786 628 GGDELQS-KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD-LWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 705 (795)
....... ......++..|+|||.+.+..++.++|||||||+++||++|..++................ ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322111 1111223456999999988899999999999999999999876653221110000000000 0000000000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+............+..+.+++.+||+.+|++|||+.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 11110111112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=334.60 Aligned_cols=258 Identities=26% Similarity=0.358 Sum_probs=201.6
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCc-cchHHHHHHHHHHHhcC-Ccccceeeeeeeeccee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 546 (795)
++|.+.++||+|+||.||+|++. .++.||||++..... ...+.+.+|+++|.++. ||||+++++++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 56888899999999999999742 346799999975432 22457889999999997 99999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCC-----------------------------------------------------------
Q 003786 547 ILIYEYMPNKSLDFFLFDSTK----------------------------------------------------------- 567 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 567 (795)
++||||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999864321
Q ss_pred ------------------------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 568 ------------------------------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 568 ------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 123566678889999999999999987 99999999999999
Q ss_pred CCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHh
Q 003786 612 KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLL 690 (795)
Q Consensus 612 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 690 (795)
+++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+......... .
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-Y 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-H
Confidence 999999999999986532221112223456789999999998889999999999999999998 88887643322211 1
Q ss_pred HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.. ...+. ....+......+.+++.+||+.+|++||++++|++.|+.
T Consensus 353 ~~----~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 353 NA----IKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HH----HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 00 00010 001111234578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.30 Aligned_cols=258 Identities=28% Similarity=0.387 Sum_probs=203.6
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+++.. .+..+|||++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999741 34579999987543 23346789999999999 79999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+++++|..++.... ...+++..+..++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999885422 234789999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ .... .....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~----~~~~~--- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKL----IKEGY--- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHH----HHcCC---
Confidence 6543321111222346788999999999999999999999999999998 8888754332211 1110 11110
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+......+.+++.+||+.+|++||++.|+++.|..
T Consensus 262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111224568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.27 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=202.2
Q ss_pred HccCCccccccCcCCcccEEEeEec------CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
..++|++.++||+|+||.||+|+.. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 245799998864432 233467889999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCC-------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 546 KILIYEYMPNKSLDFFLFDSTK-------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
.++||||+++|+|.+++..... ...+.+..+..++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999854221 233456678899999999999999988 999999999999999999999
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhc
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ..... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~---~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFV---M 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH---H
Confidence 99999986543332222223345778999999998899999999999999999998 677775432211 11110 0
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...... .+...+..+.+++.+||+.+|++||++.++++.|...
T Consensus 236 -~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 -DGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -cCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 010000 1112235788999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.98 Aligned_cols=250 Identities=36% Similarity=0.518 Sum_probs=203.6
Q ss_pred cccCcCCcccEEEeEecC----cceEEEEEecccCccc-hHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|.... +..+++|++....... .+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998653 7889999997654333 67899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCC------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 556 KSLDFFLFDSTK------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 556 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
++|.+++..... ...+++..+..++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 366899999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
...........+++.|+|||.+....++.++|||||||++|||++ |..|+....... ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~----~~~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYL----RKGY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----HcCC-------
Confidence 432223344567889999999988899999999999999999999 588886542211 11111 1110
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
....+...+..+.+++.+||+.+|++||++.|++++|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=322.19 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=199.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.++||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999865 578899999865432 2345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 986 676666432 345788899999999999999999988 9999999999999999999999999997643222
Q ss_pred ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHh--------HhhhccCccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGH--------AWDLWKDDRA 702 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~--------~~~~~~~~~~ 702 (795)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .... .|........
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 11223467899999998865 56899999999999999999999999765432211 1100 0000000000
Q ss_pred ccccC-ccccc----hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 703 WELID-PTLQN----EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 703 ~~~id-~~l~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
....+ +.... .........+.+++.+||+.||.+|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 00000 00000 01112345678999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.12 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=199.1
Q ss_pred cCCccccccCcCCcccEEEeEecC-cc--eEEEEEeccc-CccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 549 (795)
++|++.+.||+|+||.||+|+..+ +. .+++|.+... .....+.+.+|+++++++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998654 33 4788887642 233456788999999999 799999999999999999999
Q ss_pred eecCCCCChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 550 YEYMPNKSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
+||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985432 1134788899999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||++...... ........+..|+|||.+....++.++|||||||++|||++ |..||........ ...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~--~~~--- 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL--YEK--- 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH---
Confidence 99999998643211 11111223567999999988899999999999999999997 9988865432211 111
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.... .....+......+.+++.+||+.+|.+||++.++++.|...
T Consensus 231 -~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 231 -LPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred -HhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 01111122345678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.82 Aligned_cols=238 Identities=25% Similarity=0.300 Sum_probs=191.6
Q ss_pred cccCcCCcccEEEeEe----cCcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 481 NKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
+.||+|+||.||+++. .+++.||+|++.+... .....+.+|+++|++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999975 3578999999975432 234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999888843 345889999999999999999999998 9999999999999999999999999988653321 1
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ... ... ... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~---i~~-~~~----------~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET--MTM---ILK-AKL----------GM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH--HHH---HHc-CCC----------CC
Confidence 23346799999999999988899999999999999999999999865432111 110 000 000 01
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCHHH
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTMFE 742 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~~e 742 (795)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1223456778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.71 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=194.9
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 47899999997542 23345677899999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888743 335889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||........ .... ..... ..+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~~i----~~~~~----------~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQSI----LEDEV----------RYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HHHH----HcCCC----------CCC
Confidence 2345789999999999999999999999999999999999999865432111 1110 00000 011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTM-----FEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~ 746 (795)
......+.+++.+||+.||++||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1234567899999999999999999 888875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.95 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=207.1
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++. .+++.+|||.+.... .....++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999985 478999999886532 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||+++++|.+++.... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885422 2356889999999999999999999988 99999999999999999999999999886543
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.............. . ....+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~-----~~~~~- 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----E-----QCDYP- 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh----h-----cCCCC-
Confidence 221 12235688999999999988999999999999999999999999864332221111110 0 00001
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..........+.+++.+||+.+|++|||+.+|+++++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11112345578899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.02 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=190.1
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHH-HHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||||++.+.. .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 58999999986532 122334455554 56789999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999888843 345888999999999999999999998 9999999999999999999999999987532211 22
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+.... ... ... ... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~---i~~-~~~----------~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM--YDN---ILN-KPL----------RLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH--HHH---HHc-CCC----------CCC
Confidence 3346799999999999999999999999999999999999999865432111 110 000 000 011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHH----HHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMF----EVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~----evl~~ 746 (795)
......+.+++.+||+.+|++||++. |++++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 12245678899999999999999984 66553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=317.17 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=198.0
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.++||+|+||.||+|+. .+++.||+|++... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 46889999998654 233446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 3677888999999999999999988 999999999999999999999999999765322
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhH-hHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLG-HAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~id~~l~ 711 (795)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||............ .......... .+.+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~- 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL- 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC-
Confidence 223357899999999999889999999999999999999999998643211111000 0000000000 0000
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......++.+++.+||+.+|++||+++|++++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011133467899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=332.02 Aligned_cols=258 Identities=21% Similarity=0.254 Sum_probs=201.1
Q ss_pred HHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
+....++|++.+.||+|+||.||+++.. +++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445689999999999999999999875 58889999986432 2234567889999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999998843 23788889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
....... .......||+.|||||++.+. .++.++|||||||++|||++|..||...+.... .. .......
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~---~i~~~~~ 264 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YS---KIMNHKN 264 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH--HH---HHHcCCC
Confidence 7643321 122346799999999998653 388999999999999999999999975432111 11 1111111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHH
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAAD--RPTMFEVVSML 747 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L 747 (795)
.... .........+.++|.+||+..+.+ ||++.|++++.
T Consensus 265 ~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 SLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111 011123456778999999854443 78999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=319.13 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=202.8
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|+.. ++..+|+|++.... .....++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999986543 23356788999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCC-------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTK-------------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 607 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 607 (795)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999853221 124677888999999999999999987 9999999999
Q ss_pred EEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 003786 608 ILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNS 686 (795)
Q Consensus 608 Ill~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 686 (795)
|+++.++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322122222345678999999988899999999999999999997 777775332211
Q ss_pred hhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 687 LTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.... ....... ..+...+.++.+++.+||+.+|++||++.|+++.|+.
T Consensus 241 --~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 --VIYY----VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHH----HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 1111111 0112234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.29 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=204.7
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+|++.+.||+|+||.||+|+. .+++.+|+|.+........+.+.+|+.+++.+.||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 36899999999999999999985 46889999999766555667889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 999999998842 34788899999999999999999988 9999999999999999999999999988653322
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... .. ..... ... +
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-~~----~~~~~-~~~-----~-- 236 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YL----IATNG-TPE-----L-- 236 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-HH----HhcCC-CCC-----C--
Confidence 1122356889999999998888999999999999999999999998654321111 10 00000 000 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122344567889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.35 Aligned_cols=270 Identities=27% Similarity=0.389 Sum_probs=200.6
Q ss_pred cCCccccccCcCCcccEEEeEe-----cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec--cee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
..|++.+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999973 347889999986543 33346789999999999999999999998875 567
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999988432 235789999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
....... .......++..|+|||.+.+..++.++|||||||++|||++++.|...........................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432211 122234567789999999888899999999999999999998765432111000000000000000000000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+............+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 00000011112245678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=327.06 Aligned_cols=260 Identities=28% Similarity=0.385 Sum_probs=199.3
Q ss_pred ccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeec-c
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL-E 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 544 (795)
.++|++.++||+|+||.||+|+. .+++.||||++..... .....+.+|+.+|.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36799999999999999999963 3467899999965432 2345688999999999 689999999988654 4
Q ss_pred eeeEEeecCCCCChhhhhhccCC---------------------------------------------------------
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTK--------------------------------------------------------- 567 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 567 (795)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999988854211
Q ss_pred -------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccc
Q 003786 568 -------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIV 640 (795)
Q Consensus 568 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 640 (795)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123677788899999999999999988 9999999999999999999999999998653322212222234
Q ss_pred cccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHH
Q 003786 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLIL 719 (795)
Q Consensus 641 gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~ 719 (795)
+++.|+|||.+.+..++.++||||||+++|+|++ |..|++....... .... ....... ..+....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~----~~~~~~~---------~~~~~~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRR----LKEGTRM---------RAPDYTT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHH----HhccCCC---------CCCCCCC
Confidence 5678999999988899999999999999999997 8888765332211 1110 1111100 0011123
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 720 NRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 720 ~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..+.+++..||+.+|++||++.||+++|+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=325.26 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=194.2
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57889999997542 23345678899999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999888743 345899999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-hhHhHhHhhhccCcccccccCccccchh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS-LTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CC
Confidence 334679999999999999999999999999999999999999996433211 1111111111111100 01
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCH------HHHHHH
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTM------FEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~ 746 (795)
+......+.+++.+||+.||++||++ .+++++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11233456789999999999999984 577765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=332.10 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=199.0
Q ss_pred ccCCccccccCcCCcccEEEeEec---CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..+|++.++||+|+||.||++... .++.||+|.+... ....+|+++|++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999643 3578999988542 34568999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|++. ++|..++ .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5676666 23356899999999999999999999998 999999999999999999999999999866543
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-hhHhHhHhhhccCccc--cc---
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS-LTLLGHAWDLWKDDRA--WE--- 704 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~--~~--- 704 (795)
..........||+.|+|||++....++.++|||||||++|||++|+.||....... ...+............ ..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33233334679999999999999999999999999999999999999986544221 1111110000000000 00
Q ss_pred --------ccCccccch--h-----hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 705 --------LIDPTLQNE--A-----SYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 705 --------~id~~l~~~--~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
......... . .......+.++|.+||+.+|++||++.|++.+-
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000 0 011234677899999999999999999999874
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.69 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=197.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999865 58899999996532 233467888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998843 345889999999999999999999998 999999999999999999999999998754221
Q ss_pred cc---------------------------------cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 003786 631 EL---------------------------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 631 ~~---------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~ 677 (795)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 000123579999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 003786 678 NTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT---MFEVVSM 746 (795)
Q Consensus 678 p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl~~ 746 (795)
||........ ..... .+.. .. .+.+. ......+.+++.+++. +|++|++ +.|+++|
T Consensus 235 Pf~~~~~~~~--~~~i~-~~~~-~~--~~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQET--YRKVM-NWKE-TL--VFPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHH--HHHHH-cCCC-ce--ecCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9975432221 11100 0000 00 00110 0123456677877764 9999985 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.15 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=192.4
Q ss_pred cCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
||+|+||.||+++.. +|+.||+|++..... .....+..|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 589999999864321 2234556799999999999999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccc
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 88875432 234788889999999999999999988 9999999999999999999999999998654322 1223
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHH
Q 003786 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+......... ......... .. +.. .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~-~~----~~~-----~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLE-DE----VKF-----EHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhc-cc----ccc-----ccccC
Confidence 56899999999999888999999999999999999999998643321111 000001000 00 000 01123
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 719 LNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+.+++.+||+.||++||++.|+++.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 4567899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.10 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=204.2
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|++|.||+|+.. +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999865 5889999998643 234456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2346888899999999999999999987 99999999999999999999999999886643321
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......|++.|+|||++.+..++.++|+|||||++++|++|+.|+....... ..... .... ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~~~---------~~ 219 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILKI----IRGV---------FP 219 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HcCC---------CC
Confidence 2233568899999999999899999999999999999999999986544211 11110 0000 01
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.04 Aligned_cols=267 Identities=24% Similarity=0.267 Sum_probs=212.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHH---HHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEE---FKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
-++|...+.||+|.||+|.+++.+ +++-+|||++++.......+ -..|-++|+..+||++..|...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 478999999999999999999865 58999999998865444433 45799999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||..||.|..+| .+...+++..+..+-.+|..||.|||+.+ ||+||||.+|+|+|++|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 9999999999888 45667899999999999999999999987 999999999999999999999999999852
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
-..-..+++++|||+|+|||++....|+.++|+|.+||++|||++|+.||-..+.....-+..... -
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed----~--------- 385 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED----L--------- 385 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh----c---------
Confidence 122245677999999999999999999999999999999999999999996554333221211111 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHHcc--------ccCCCCCCCCCCccc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSMLTN--------KTINLPHPRQPAFSS 764 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L~~--------~~~~l~~p~~p~~~~ 764 (795)
..+.....+...|+...|..||.+|. .+.||.++-=. ....+++|..|..-+
T Consensus 386 ---kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtS 450 (516)
T KOG0690|consen 386 ---KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTS 450 (516)
T ss_pred ---cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccc
Confidence 12222334566788889999999996 45566554211 123466676665433
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=322.14 Aligned_cols=260 Identities=27% Similarity=0.385 Sum_probs=203.1
Q ss_pred ccCCccccccCcCCcccEEEeEec--------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.++|.+.++||+|+||.||+++.. ....+|+|.+.... .....++.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367889999999999999999742 24569999886532 23356788999999999 699999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 544 EEKILIYEYMPNKSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
...++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999986432 1245788889999999999999999988 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhH
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTL 689 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--L 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999986543222111222234568999999998899999999999999999999 788875433211 1
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
.... ...... ..+...+..+.+++.+||+.+|++||++.|+++.|....
T Consensus 246 ~~~~----~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 FKLL----REGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHH----HcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 111110 111223446778999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=324.41 Aligned_cols=237 Identities=22% Similarity=0.281 Sum_probs=187.2
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHH-HHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+++.. +|+.+|||++.+.. ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 58999999996542 223344555655 46779999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988874 3345889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+.... ... ... ... .+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~~---~~~-~~~--~~--------~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM--YDN---ILH-KPL--VL--------R 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--HHH---HHc-CCc--cC--------C
Confidence 3346799999999999999999999999999999999999999865432211 111 000 000 01 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMF 741 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~ 741 (795)
+.....+.+++.+||+.+|++||++.
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 11334677899999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.92 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=197.1
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChh
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLD 559 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 559 (795)
++||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999875432 23456889999999999999999999999999999999999999999
Q ss_pred hhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccccc
Q 003786 560 FFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639 (795)
Q Consensus 560 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 639 (795)
+++... ...+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988533 234788999999999999999999988 999999999999999999999999998754322211 11122
Q ss_pred ccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHH
Q 003786 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718 (795)
Q Consensus 640 ~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
.+++.|+|||++....++.++|||||||++|+|++ |..||........ .... ..... ...+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~~~----~~~~~---------~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--REQV----EKGYR---------MSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHH----HcCCC---------CCCCCCC
Confidence 34678999999988889999999999999999998 8888864332111 1111 11100 0111223
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 719 LNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=332.65 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=196.9
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc-----eee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE-----EKI 547 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 547 (795)
+|++.++||+|+||.||+++.. +++.||||++.... ....+++.+|+++|+.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999864 68999999986532 233467889999999999999999999998776 789
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+|+||+.+ +|...+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999974 6666663 2345889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc---
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW--- 703 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 703 (795)
..... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ..............
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence 43221 11223467899999998876 4589999999999999999999999976542211 11000000000000
Q ss_pred -------c-ccCcccc-c------hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 -------E-LIDPTLQ-N------EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 -------~-~id~~l~-~------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. +...... . .........+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000 0 0111224567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.91 Aligned_cols=237 Identities=23% Similarity=0.279 Sum_probs=186.8
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHH-HHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986532 122334555554 67889999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999887743 345788899999999999999999988 9999999999999999999999999987532221 22
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||.+.+..++.++|||||||++|||++|..||...+.... .. .... .. ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~---~i~~-~~----------~~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM--YD---NILH-KP----------LQLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH--HH---HHhc-CC----------CCCC
Confidence 3446799999999999988999999999999999999999999865432111 11 1111 00 0111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMF 741 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~ 741 (795)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22345678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=328.15 Aligned_cols=262 Identities=22% Similarity=0.230 Sum_probs=196.8
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecc----
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE---- 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 544 (795)
...++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34588999999999999999999864 5889999998653 2234567889999999999999999999986543
Q ss_pred --eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 545 --EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 468999999865 444442 23678889999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc-----
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW----- 697 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----- 697 (795)
+++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ........
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~ 243 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPSA 243 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCcH
Confidence 997543221 22335789999999999999999999999999999999999999975432111 00000000
Q ss_pred --------------cCc------ccccccCcccc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 698 --------------KDD------RAWELIDPTLQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 698 --------------~~~------~~~~~id~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
... ...+....... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000 00000000000 001112235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=317.61 Aligned_cols=270 Identities=28% Similarity=0.412 Sum_probs=204.1
Q ss_pred cCCccccccCcCCcccEEEeEec-----CcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeee--ccee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 546 (795)
.+|++.+.||+|+||.||+++.. .++.+|||++...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 3678999999765433 46789999999999999999999999887 5578
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999985432 25888999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........++..|+|||.+....++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 652221 1111123445679999999888899999999999999999999988754322211100000000000000011
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+........+...+..+.+++.+||+.+|++||++.||+++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 11111111122334678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.63 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=194.7
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhc---CCcccceeeeeeee-----cc
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKL---QHRNLVRLLGCCIE-----LE 544 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 544 (795)
+|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999865 588999999865422 2234566787777765 69999999998764 34
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..++||||+++ +|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 7777764322 244889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc---cCcc
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW---KDDR 701 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~---~~~~ 701 (795)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|++||........ ........ ....
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhh
Confidence 8664322 12335689999999999888999999999999999999999999865432211 11110000 0000
Q ss_pred ccc-------ccCccc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWE-------LIDPTL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~-------~id~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... ...+.. ...........+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000 011222345667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.63 Aligned_cols=248 Identities=30% Similarity=0.430 Sum_probs=197.6
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChh
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLD 559 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 559 (795)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999767999999998765433 4568899999999999999999999999999999999999999999
Q ss_pred hhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccccc
Q 003786 560 FFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI 639 (795)
Q Consensus 560 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 639 (795)
+++... ...+++..+..++.+++++|.|||+.+ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988543 234778889999999999999999988 999999999999999999999999999865422211111222
Q ss_pred ccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHH
Q 003786 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718 (795)
Q Consensus 640 ~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
.++..|+|||.+.+..++.++|+|||||++|||++ |..|+........ ... ..... ....+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~~----~~~~~---------~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RER----IESGY---------RMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HHH----HhcCC---------CCCCCccC
Confidence 34667999999988899999999999999999999 7777754332111 111 00000 00112223
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 719 LNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
+..+.+++.+|++.+|++||++.||++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.05 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=192.0
Q ss_pred cccCcCCcccEEEeEecC---cceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 481 NKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999997543 45799998865432 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCC--cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 557 SLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 557 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+|.+++..... ....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864332 234566777889999999999999988 9999999999999999999999999997543332222
Q ss_pred cccccccccccccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 635 KTKRIVGTYGYMSPEYAQQG-------LFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~-------~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
......++..|+|||++.+. .++.++|||||||++|||++ |+.||......... .... . .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~~---~-~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTV---R-EQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHHh---h-cccCCCC
Confidence 22335678899999988542 35889999999999999996 99898654332211 1110 0 1111111
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
++.+.. .....+.+++..|+ .+|++|||++||++.|+
T Consensus 232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222111 12345677888998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=313.99 Aligned_cols=252 Identities=31% Similarity=0.447 Sum_probs=199.8
Q ss_pred CccccccCcCCcccEEEeEecC-cceEEEEEecccCccchH--HHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 477 FSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQE--EFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
|++++.||+|+||.||+++... ++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999998765 678999999766433322 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++. ....+++..+..++.||++||.+||+.+ |+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999985 4456889999999999999999999998 99999999999999999999999999976411 12
Q ss_pred ccccccccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCcccccccCcccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......++..|+|||++. +..++.++||||||+++++|++|..|+........ ........ .. .. .. .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~~-~~---~~-~- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---RP-LP---SS-S- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---TH-HH---HH-T-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---cc-cc---cc-c-
Confidence 2344567899999999998 78899999999999999999999999875421111 11100000 00 00 00 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+.+++.+||+.+|++||++.+++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000012678899999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.54 Aligned_cols=253 Identities=30% Similarity=0.440 Sum_probs=201.4
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
++|++.++||+|++|.||+|+...+..+|+|++.... ...+.+.+|++++++++|||++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688999999999999999988777789999886433 34567899999999999999999998875 456889999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999988543 2344788899999999999999999988 999999999999999999999999999865433211
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ..... .... ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~----~~~~---------~~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQV----ERGY---------RMP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcCC---------CCC
Confidence 1122346778999999988889999999999999999999 888876432211 11111 0000 001
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122344678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.09 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=199.3
Q ss_pred ccCCccccccCcCCcccEEEeEec-Ccc----eEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|++.++||+|+||.||+|+.. +++ .||+|++.... ....+++.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 367889999999999999999743 444 48999986543 2345678899999999999999999999875 4578
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988542 345889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............+++.|+|||.+.+..++.++|||||||++|||++ |..|+....... .... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~--- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDL----LEKGERL--- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----HHCCCcC---
Confidence 43322111222335678999999988899999999999999999998 888875432211 1111 1111100
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0111234467789999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=331.33 Aligned_cols=262 Identities=21% Similarity=0.231 Sum_probs=195.7
Q ss_pred HccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
....|.+.+.||+|+||.||++++.. ++.||||... ...+.+|+++|++++|+|||++++++......++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35679999999999999999998754 7889999642 2346789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
++. ++|..++... ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 5776666432 235899999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-Cc-----chhHhHhHhh-hccCccccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TN-----SLTLLGHAWD-LWKDDRAWE 704 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~-~~-----~~~~~~~~~~-~~~~~~~~~ 704 (795)
.........||+.|+|||++.+..++.++|||||||+||||++|..++-... .. ...+...... .........
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2222234579999999999999999999999999999999999886653221 10 0111110000 000000000
Q ss_pred cc----------------Cccccchhh---HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 705 LI----------------DPTLQNEAS---YLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 705 ~i----------------d~~l~~~~~---~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .+....... ......+.+||.+||+.||++|||+.|+|++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000000 0122367789999999999999999999986
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.71 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=199.4
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999865 58899999986432 22346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
++ ++|..++........+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 98 578777755444466899999999999999999999988 9999999999999999999999999997653221
Q ss_pred ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh-Hh-----hhccCcc---c
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH-AW-----DLWKDDR---A 702 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~~-----~~~~~~~---~ 702 (795)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.|+............. .. ..|.... .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223457889999998865 457899999999999999999999986543211110000 00 0000000 0
Q ss_pred cc-ccCc---cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WE-LIDP---TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~-~id~---~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .... ............++.+++.+||+.||++|||+.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 0000 00000111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.75 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=200.3
Q ss_pred cCCccccccCcCCcccEEEeEecC-c---ceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.+|++.+.||+|+||.||+|+... + ..||||.+... .....+++..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999998653 3 35999998654 233456899999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|++++... .+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 345788999999999999999999988 99999999999999999999999999876543
Q ss_pred Cccccccc-ccc--cccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 630 DELQSKTK-RIV--GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~~~~~~~-~~~--gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
........ ... .+..|+|||.+....++.++|||||||++|||++ |..|+....... ...... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~---~~~~---- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIE---QDYR---- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHH---cCCc----
Confidence 22111111 111 2457999999998899999999999999999886 998886433211 111110 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++..||+.+|.+||++.+|+++|+.
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01112234567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.05 Aligned_cols=198 Identities=27% Similarity=0.410 Sum_probs=160.4
Q ss_pred ccccCcCCcccEEEeEec---CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeee--cceeeEEeecCC
Q 003786 480 ENKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILIYEYMP 554 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 554 (795)
+++||+|+||.||+|+.. +++.+|+|.+... .....+.+|+++|++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 4678999998643 234567899999999999999999998864 456789999987
Q ss_pred CCChhhhhhccC------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE----CCCCCeeeeccccc
Q 003786 555 NKSLDFFLFDST------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMA 624 (795)
Q Consensus 555 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~vkL~DFGla 624 (795)
+ +|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6666553211 1235888899999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCcc-ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 625 RIFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 625 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
+....... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643221 122334678999999998876 468999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.71 Aligned_cols=245 Identities=28% Similarity=0.426 Sum_probs=205.4
Q ss_pred ccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChhh
Q 003786 482 KLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDF 560 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 560 (795)
+||+|.||+||.|++.+ ...+|||.+........+-+..|+..-+.|+|.|||+++|.+.++...-+.||.+|||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999765 56799999988777777889999999999999999999999999999999999999999999
Q ss_pred hhhccCCcccC--ChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccccccccCCCccccccc
Q 003786 561 FLFDSTKENLL--GWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGGDELQSKTK 637 (795)
Q Consensus 561 ~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~~~~~~~~~~~~ 637 (795)
++...- +++ .+..+..+..||++||.|||+.. |||||||-+|+||+. .|.+||+|||.++.+.+- ...+.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 995433 334 67788899999999999999987 999999999999964 688999999999876433 34567
Q ss_pred ccccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 638 RIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 638 ~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
++.||..|||||++..+ .|..++|||||||++.||.||++||--...++-... +-+- -+...+++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-------kVGm------yKvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-------KVGM------YKVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-------hhcc------eecCCCCc
Confidence 78999999999999765 589999999999999999999999954433322111 1110 01234567
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+...+...+|.+|...+|.+||+++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7778889999999999999999999999973
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.40 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=201.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.++||+|+||.||+++.. +++.+|+|.+.... ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999865 57889999886542 22345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ..+++..+..++.||++||.|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999998533 45788999999999999999999742 3999999999999999999999999998754322
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh-HhhhccCcc----------
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH-AWDLWKDDR---------- 701 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~~---------- 701 (795)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.|+............. .........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1234578999999999988889999999999999999999999986543221110000 000000000
Q ss_pred -------cccccCcccc---chh-hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 702 -------AWELIDPTLQ---NEA-SYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 702 -------~~~~id~~l~---~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..+..+.... ... .......+.+++.+||+.+|++||++.+|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 000 011345688999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.50 Aligned_cols=255 Identities=33% Similarity=0.470 Sum_probs=205.3
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.++||+|+||.||+|...+++.+|||.+.... ...+++.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46799999999999999999998778889999987533 44578999999999999999999999999989999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999985432 245788999999999999999999988 999999999999999999999999999866432211
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|+|||||++|+|++ |+.|+...... ........ ... .
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~---~~~----------~ 223 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVER---GYR----------M 223 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc---CCC----------C
Confidence 1112234568999999998899999999999999999998 88887543221 11111100 000 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111124567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=345.70 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=200.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.++||+|+||.||+|+.. +++.||||++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999865 589999999975422 23457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCC--------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 551 EYMPNKSLDFFLFDSTK--------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998853211 123455677899999999999999988 9999999999999999999999999
Q ss_pred cccccCCCcc----------------cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 003786 623 MARIFGGDEL----------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686 (795)
Q Consensus 623 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 686 (795)
+++....... ........||+.|||||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 011123569999999999999999999999999999999999999986533221
Q ss_pred hhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHcc
Q 003786 687 LTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRP-TMFEVVSMLTN 749 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~ 749 (795)
.... .. ..++.- .......+..+.+++.+||+.||++|| +++++++.|+.
T Consensus 239 i~~~----~~--------i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYR----DV--------ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhh----hh--------ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1100 00 000000 000112345677899999999999996 56667666654
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.11 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=199.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-Ccc--eEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.+.||+|+||.||+|++. ++. .+|+|.+.... ......+.+|++++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357899999999999999999864 344 45777765432 23446788999999999 89999999999999999999
Q ss_pred EeecCCCCChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 549 IYEYMPNKSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
||||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986432 1235788899999999999999999988 999999999999999999
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHh
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 694 (795)
+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ....
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~- 236 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKL- 236 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HHHH-
Confidence 999999998643211 11111234668999999988889999999999999999998 9988864332211 1110
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...... ..+......+.+++.+||+.+|++||++.+++++|..
T Consensus 237 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 ---PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred ---hcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111000 0111233467899999999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.80 Aligned_cols=238 Identities=24% Similarity=0.278 Sum_probs=186.8
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHH-HHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEI-KLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 47889999986532 12223444444 456788999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+.+..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988843 345778888899999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|..||........ .... .. ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i---~~-~~~----------~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNI---LN-KPL----------QLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HHHH---Hh-CCc----------CCC
Confidence 3346799999999999999999999999999999999999999865432211 1110 00 000 011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMFE 742 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~e 742 (795)
......+.+++.+||+.+|.+||++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 123456778999999999999998874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=327.65 Aligned_cols=262 Identities=23% Similarity=0.232 Sum_probs=196.7
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL----- 543 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 543 (795)
...++|++.+.||+|+||.||+++.. .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999999999999864 58899999986532 22345678899999999999999999988643
Q ss_pred -ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 544 -EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 544 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
...++||||++++ |...+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 3468999999764 544442 23778889999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh-------
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD------- 695 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~------- 695 (795)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 240 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPE 240 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence 998653322 22335789999999999998999999999999999999999999875431111 0000000
Q ss_pred -----------hccC-cccccccCc-----cc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 696 -----------LWKD-DRAWELIDP-----TL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 696 -----------~~~~-~~~~~~id~-----~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... .....+..+ .+ ...........+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 000000000 00 001112234567899999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.83 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=201.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357899999999999999999864 5889999998765545556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998843 345889999999999999999999998 9999999999999999999999999987654221
Q ss_pred cccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.......|++.|+|||++. ...++.++|||||||++|+|++|..|+......... .... ..... .+.
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~----~~~~~----~~~ 230 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMT----KSNFQ----PPK 230 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hhhh----ccCCC----CCc
Confidence 2223457899999999874 456889999999999999999999987543221111 0000 00000 000
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... .......+.+++.+||+.+|++||++++|+++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 01123467789999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.77 Aligned_cols=250 Identities=29% Similarity=0.416 Sum_probs=203.6
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46789999999999999999986 478999999976543 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999885432 235889999999999999999999988 9999999999999999999999999998653221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....+..|+|||.+....++.++||||||++++||++ |..|+....... +..... .... .
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~----~~~~---------~ 218 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVE----KGYR---------M 218 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHh----cCCC---------C
Confidence 12334668999999988889999999999999999997 888875432111 111111 1100 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.+|++||++.|++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1112234677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.20 Aligned_cols=249 Identities=31% Similarity=0.409 Sum_probs=198.7
Q ss_pred cccCcCCcccEEEeEecC--c--ceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLLN--G--QEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999998643 2 3699999977655 456789999999999999999999999988 889999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc-c
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ-S 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~-~ 634 (795)
++|..++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998865432 46889999999999999999999988 999999999999999999999999999876432211 1
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+........ ...... ..... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~~~~---~~~~~---------~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--LKKIDK---EGERL---------E 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHh---cCCcC---------C
Confidence 1123457789999999998899999999999999999998 9999864332211 111100 00000 0
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.22 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=201.4
Q ss_pred cCCccccccCcCCcccEEEeEecC-c---ceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.+|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468888999999999999998653 3 369999886542 23356788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999988542 245788999999999999999999988 99999999999999999999999999986543
Q ss_pred Cccccc-ccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 630 DELQSK-TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
...... ......++.|+|||++....++.++|||||||++|||++ |+.|+....... .... .....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~----i~~~~------ 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKA----INDGF------ 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHH----HhcCC------
Confidence 221111 111223467999999988889999999999999999997 999986433211 1111 11110
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
........+..+.+++.+|++.+|++||++.+|+++|++
T Consensus 228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 001111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.62 Aligned_cols=252 Identities=27% Similarity=0.343 Sum_probs=199.6
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.|+..+.||+|+||.||++... +++.||||.+.+... .....+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999864 588999999865422 223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998885432 234888999999999999999999987 9999999999999999999999999987643222
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||......... . ......... .
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~-~~~~~~~~~----------~ 221 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-E-EVERLVKEV----------Q 221 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-H-HHHhhhhhh----------h
Confidence 112346899999999999889999999999999999999999999753321110 0 000000000 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 746 (795)
...+......+.+++.+||+.+|++||| +.|++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0111223456788999999999999999 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.89 Aligned_cols=245 Identities=33% Similarity=0.433 Sum_probs=200.5
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.|+-.+.||.|+||.||-++.. +.+.||||++.-...+ ....+..|+..|++++|||+|.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667789999999999999864 5788999999755444 34578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
||-| |-.+++.- ..+.+-+.++..|+.+.++||+|||+++ .||||||..||||++.|.|||+|||.|.+..
T Consensus 107 YClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 107 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 9964 55566632 3456888999999999999999999998 9999999999999999999999999998754
Q ss_pred ccccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
....++|||.|||||++. .+.|+-|+||||||++..||.-.++|.-..+.-.-.+ +.. . .-.|
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY--HIA---Q------NesP 243 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA---Q------NESP 243 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH--HHH---h------cCCC
Confidence 345689999999999874 4689999999999999999999998875443222111 110 0 0112
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+. ..+....+++++..||+.-|.+|||..+++++
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 222 34566788899999999999999999999886
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.22 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=201.6
Q ss_pred cCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.+|++.+.||+|+||.||+|+... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578899999999999999998642 3369999886532 23346789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 235788899999999999999999988 99999999999999999999999999987643
Q ss_pred Ccccc-cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 630 DELQS-KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... ......++..|+|||.+.+..++.++|+|||||++||+++ |..|+........ .... .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~~~----~~~~~----- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IKAI----EEGYR----- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HHHH----hCCCc-----
Confidence 22111 1112233568999999998899999999999999999886 9988864432211 1111 11100
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++.+|++.+|++||++.++++.|..
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 01112234567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=303.61 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=209.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+-|.++.+||+|+||.||++.++ .|+.+|||.+... .+.+++..|+.||++++.|++|++||.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34788899999999999999764 5999999998654 46688999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
..|+..++++ .+++.+.+.++..++...++||+|||... -||||||..||||+.+|..||+|||.|-.+... .
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence 9999999985 35677999999999999999999999986 899999999999999999999999999866433 2
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc--Ccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI--DPTLQ 711 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i--d~~l~ 711 (795)
....+..|||-|||||++..-.|+.++||||||++..||..|++|+..-..- +...++ .|.-.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RAIFMIPT~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RAIFMIPTKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------------ceeEeccCCCCCC
Confidence 3455688999999999999999999999999999999999999998532211 111111 11111
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
-..+......+-+++.+||-.+|++|-|+.++++|
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12345566788899999999999999999999986
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.36 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=200.1
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCccc---------hHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG---------QEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
+|.+.+.||+|++|.||+|... +++.+|+|.+....... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 57899999886543221 2567899999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++|+||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345788899999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 626 IFGGDELQ----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 626 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
........ .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ .. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~---~~~~--- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IF---KIGE--- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HH---HHhc---
Confidence 76422111 111234688999999999988899999999999999999999999865322111 00 0000
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... ...+......+.+++.+||+.+|.+||++.||+++
T Consensus 227 ---~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ---NAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---cCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 001 11222344677889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.06 Aligned_cols=261 Identities=22% Similarity=0.256 Sum_probs=196.7
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL----- 543 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 543 (795)
...++|++.+.||+|+||.||+++.. .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34578999999999999999999864 58899999986532 23346778999999999999999999987543
Q ss_pred -ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 544 -EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 544 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 5555552 23678889999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc----
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK---- 698 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 698 (795)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... .........
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 246 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP 246 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence 998654322 22335789999999999999999999999999999999999999975442111 000000000
Q ss_pred ---------------C-cc----cccccCccc----cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 699 ---------------D-DR----AWELIDPTL----QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 699 ---------------~-~~----~~~~id~~l----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .. ..+.+.+.. ...........+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00 000000000 001111223467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.01 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=204.8
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
++|++.+.||+|+||.||+|+... ++.+++|.+..... .+.+.+|++++++++||||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999998765 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999988432 345889999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||++.+..++.++|||||||++++|++|+.|+............ .... .+. ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------~~~~-----~~~--~~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------PNKP-----PPT--LS 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------ccCC-----CCC--CC
Confidence 223355889999999999889999999999999999999999998754322211100 0000 000 11
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+||+.+|++||++.||+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122344578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.24 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=200.9
Q ss_pred CCccccccCcCCcccEEEeEecCcceEEEEEecccCc------cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG------QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
+|++.+.||+|+||.||+|...+++.+|||.+..... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999887889999998864321 1235688999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998432 34788899999999999999999987 99999999999999999999999999886532
Q ss_pred Cc----ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 630 DE----LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~----~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. .........|+..|+|||.+.+..++.++|||||||++|+|++|..||............ . . ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~-~--~~~~---- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-G-A--HRGL---- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-h-h--ccCC----
Confidence 11 111223356899999999999888999999999999999999999998643321111000 0 0 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ...+......+.+++.+||+.+|++||++.|++++
T Consensus 227 -~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 -M----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -C----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 11122244567889999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=322.28 Aligned_cols=193 Identities=22% Similarity=0.304 Sum_probs=163.8
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
....+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999865 4778999975432 2456999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|++.+ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYSS-DLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccCC-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99964 66666643 2345889999999999999999999988 999999999999999999999999999753221
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~ 679 (795)
.......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356899999999999999999999999999999999866554
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.38 Aligned_cols=259 Identities=27% Similarity=0.384 Sum_probs=202.5
Q ss_pred cCCccccccCcCCcccEEEeEecC--------cceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
.+|++.+.||+|+||.||+++... ...||+|.+.... ....+++.+|+++++++ +||||+++++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 568999999999999999997421 2368999886432 23456789999999999 7999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 545 EKILIYEYMPNKSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
..++++||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999985432 2234777888999999999999999988 99999999999999
Q ss_pred CCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHh
Q 003786 612 KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLL 690 (795)
Q Consensus 612 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~ 246 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--F 246 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--H
Confidence 999999999999986543322222222334578999999999999999999999999999998 7787754332111 1
Q ss_pred HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
.. ....... ..+......+.+++.+|++.+|++||++.|+++.|....
T Consensus 247 ~~----~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 247 KL----LKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HH----HHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11 1111100 111123456789999999999999999999999997743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.22 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=201.9
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999865 5889999998543 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887432 2345788899999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.... .. .. ...... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~---~~-~~~~~~---------~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--IL---KV-CQGSYK---------P 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HH---HH-hcCCCC---------C
Confidence 12335688999999999988899999999999999999999999864332111 11 11 011110 1
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+||+.+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234467789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=308.58 Aligned_cols=240 Identities=21% Similarity=0.350 Sum_probs=187.8
Q ss_pred cccCcCCcccEEEeEecC-------------cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 481 NKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
+.||+|+||.||+|+... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997422 2358899886655455567889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC-------eeeec
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-------PKISD 620 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-------vkL~D 620 (795)
+||||+++++|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887432 345888999999999999999999988 999999999999987664 89999
Q ss_pred cccccccCCCcccccccccccccccccccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCCCcchhHhHhHhhhcc
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETL-SSKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..|+......... ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~ 223 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------RFYE 223 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH------HHHh
Confidence 9998754321 2245788999999886 467899999999999999998 577766532211110 0000
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.. ..... .....+.+++.+||+.+|++||++.+|++.++
T Consensus 224 ~~--~~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQ--CMLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cC--ccCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 00000 11346778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=306.50 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=205.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999864 5788999999766555678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999988542 245889999999999999999999987 9999999999999999999999999988654321
Q ss_pred cccccccccccccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQG---LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.......++..|+|||.+... .++.++|||||||++|||++|..|+............ . . .. ...+.
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-~----~-~~---~~~~~ 225 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-S----K-SN---FPPPK 225 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H----h-cc---CCCcc
Confidence 122335688899999998776 8899999999999999999999998654322111110 0 0 00 00001
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+ ......+..+.+++.+||+.+|.+||++.+|+.+
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 1122345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.60 Aligned_cols=266 Identities=20% Similarity=0.240 Sum_probs=193.9
Q ss_pred HhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCc------ccceeeeee
Q 003786 468 ASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR------NLVRLLGCC 540 (795)
Q Consensus 468 ~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~ 540 (795)
..+....++|++.++||+|+||.||+|+.. .++.||||++.... .....+..|++++++++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455688999999999999999999864 57889999996432 2344567788888887654 588898888
Q ss_pred eec-ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCC----
Q 003786 541 IEL-EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDM---- 614 (795)
Q Consensus 541 ~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~---- 614 (795)
... .+.++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 765 4678899987 6677777743 34588999999999999999999974 6 99999999999998765
Q ss_pred ------------CeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 003786 615 ------------NPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS 682 (795)
Q Consensus 615 ------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~ 682 (795)
.+||+|||++.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||+..
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999876432 1223467999999999999999999999999999999999999999765
Q ss_pred CCcch-hHhHhHhhh----cc----Cccccccc------Cccccc-----------hhhHHHHHHHHHHHHhhccCCCCC
Q 003786 683 NTNSL-TLLGHAWDL----WK----DDRAWELI------DPTLQN-----------EASYLILNRYINVGLLCVQEDAAD 736 (795)
Q Consensus 683 ~~~~~-~~~~~~~~~----~~----~~~~~~~i------d~~l~~-----------~~~~~~~~~l~~li~~cL~~dP~~ 736 (795)
..... ..+...... +. .....++. .+.... .........+++||.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 43211 111110000 00 00000000 000000 000112345779999999999999
Q ss_pred CCCHHHHHHH
Q 003786 737 RPTMFEVVSM 746 (795)
Q Consensus 737 RPt~~evl~~ 746 (795)
|||++|+++|
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.52 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=196.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 58899999986521 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999988432 345888999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. .......||+.|||||++.. ..++.++|||||||++|||++|+.||........ .. ..........+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~~---~i~~~~~~~~~ 229 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHKEHFQF 229 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--HH---HHHcCCCcccC
Confidence 21 11223468999999999863 4578899999999999999999999864332111 11 11111111110
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCC--CCCCCHHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDA--ADRPTMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP--~~RPt~~evl~~L 747 (795)
.+ .....+..+.+++.+||...+ ..||++.+++++-
T Consensus 230 -~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 230 -PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred -CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 00 011134456778888775533 3488999999973
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.97 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=199.4
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeec------
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 543 (795)
.+.+.|++.+.||+|+||.||+|+.. +++.+|+|++... ......+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677999999999999999999865 5888999998644 34456789999999998 699999999998753
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999988542 2345888999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
+....... .......|++.|+|||++. +..++.++|||||||++|||++|..|+.......... ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc
Confidence 98653221 2233467899999999885 3468899999999999999999999985432111110 0000
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ..... .....+..+.+++.+||+.+|.+|||+.|++++
T Consensus 231 ~-~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 N-PAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred C-CCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 00000 111233467899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.16 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=203.4
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.++||+|+||.||+++...+..+|+|.+... ....+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4679999999999999999998777788999988643 2345678899999999999999999999887 7789999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2345778889999999999999999987 999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||++....++.++|+|||||++|+|++ |+.|+...+.... ... .......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~~----~~~~~~~--------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IRA----LERGYRM--------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--HHH----HhCCCCC---------
Confidence 1222345678999999998889999999999999999998 8888865432211 111 0111100
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.98 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=196.2
Q ss_pred HHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec---
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--- 543 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 543 (795)
+....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3445678999999999999999999864 58899999986532 22345677899999999999999999987643
Q ss_pred ---ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 544 ---EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 544 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
...++++|++ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3468899987 778877763 234889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD 699 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.........
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 234 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGT 234 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCC
Confidence 9999865422 233578999999999876 5789999999999999999999999865432111 0000000000
Q ss_pred c--ccc---------cccC--ccccch----hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 D--RAW---------ELID--PTLQNE----ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 ~--~~~---------~~id--~~l~~~----~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ... ..+. +..... ........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 0000 000000 000112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.24 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=204.6
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999975 468999999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998842 34789999999999999999999998 99999999999999999999999999886543321
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....... . .. .....+ .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~--~---~~-~~~~~~-------~ 236 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--I---AT-NGTPEL-------Q 236 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--H---Hh-cCCccc-------C
Confidence 12335688999999999988899999999999999999999999865442211110 0 00 000000 0
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+......+.++|.+||+.+|++||++.+|+++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 112234467789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.14 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=193.1
Q ss_pred ccCcCCcccEEEeEec---CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCC
Q 003786 482 KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 557 (795)
.||+|+||.||+|... .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 355799999865532 23467899999999999999999999875 457899999999999
Q ss_pred hhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc-cc
Q 003786 558 LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS-KT 636 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~-~~ 636 (795)
|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988532 345889999999999999999999988 9999999999999999999999999998654332111 11
Q ss_pred cccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 637 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
....+++.|+|||.+....++.++|||||||++|||++ |..|+........ .. ...... ....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~---------~~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--MS----FIEQGK---------RLDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH----HHHCCC---------CCCCC
Confidence 11233578999999988889999999999999999996 9988864432211 11 011111 01112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
......+.+++..||+.+|++||++.+|.+.|..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 2234677789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.06 Aligned_cols=252 Identities=26% Similarity=0.329 Sum_probs=207.7
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.-+.|+.-++||+||||.||-++.. +|+.+|.|.+.+. ..+++....+|-+||.+++.++||.+-..|...+.++|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3466888899999999999999854 5999999988654 23455667899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|+..|.||+|..+|..... ..+++..+..++.+|+.||.+||+.. ||+|||||+|||||+.|++.|+|+|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999976543 56899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.... ....+||.+|||||++++..|+..+|+|||||+||||+.|+.||-...+..- .+-+|.
T Consensus 339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---------------~eEvdr 400 (591)
T KOG0986|consen 339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---------------REEVDR 400 (591)
T ss_pred CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---------------HHHHHH
Confidence 5543 2334899999999999999999999999999999999999999853321111 011111
Q ss_pred cc---cchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 709 TL---QNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 709 ~l---~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
++ ..+.+....++..++....|+.||++|. .+.+|.+|
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 11 1234455667777888889999999996 45577665
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.16 Aligned_cols=248 Identities=28% Similarity=0.415 Sum_probs=198.1
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeee-ecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI-ELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~ 553 (795)
.+|++.+.||+|+||.||++.. .+..+|+|.+... ...+.+.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788999999999999999976 4788999988543 33567899999999999999999999764 456789999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999885432 335788999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+........ .... ..... .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~--~~~~----~~~~~---------~ 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRV----EKGYK---------M 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----hcCCC---------C
Confidence 22344678999999998899999999999999999997 8888764322111 1110 01100 1
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
......+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112234567889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.33 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=201.9
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
.+|++.+.||+|+||.||++...+++.+|+|++... ......+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468888999999999999998877889999988643 2345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999888532 234788899999999999999999988 999999999999999999999999998865432211
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.++.++.++||||||+++|||++ |..|+....... .... . ... .....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~---~-~~~--~~~~~~~~--- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVET---I-NAG--FRLYKPRL--- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHH---H-hCC--CCCCCCCC---
Confidence 1122335678999999988889999999999999999998 888876433211 1111 0 000 01111111
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.+..+.+++.+||+.+|++||++.|++++|.
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2357889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.39 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=199.9
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
|++.++||+|+||.||+|+.. ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 678899999999999999865 4778999998765555567788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999888743 2345889999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred ccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 636 TKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....+++.|+|||++. +..++.++|||||||++|||++|+.|+........ .... .. .......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~---~~-~~~~~~~---- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKI---AK-SEPPTLA---- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHH---hh-cCCCCCC----
Confidence 23456899999999873 35678899999999999999999999864332111 1100 00 0000000
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.+......+.+++.+||+.+|++||++.+++++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 230 ---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1112345678999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=314.74 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=204.6
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+|++.+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46899999999999999999986 46899999999765555567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998842 34788899999999999999999988 99999999999999999999999999876543321
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....... ..... . +. .
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~-~-----~~--~ 235 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG-T-----PE--L 235 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC-C-----CC--C
Confidence 12235688999999999988899999999999999999999999864332111100 00000 0 00 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234567789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=308.51 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=188.6
Q ss_pred cccCcCCcccEEEeEecC---cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 481 NKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.||+|+||.||+|+... ...+|+|.+.... ......+.+|+++++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3568888775432 233456889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCC--cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 557 SLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 557 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+|.+++..... ....++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567778899999999999999988 9999999999999999999999999987543322211
Q ss_pred ccccccccccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 635 KTKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
......+++.|+|||++.. ..++.++|||||||++|||++ |..|+....... ..... ... ....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~---~~~-~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQV---VRE-QDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHH---hhc-cCccCC
Confidence 2233446778999998743 457889999999999999999 677775432211 11110 111 111111
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.+.+ .......+.+++..|+ .+|++||++++|++.|.
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2221 1223345566778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=310.42 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=201.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999875 6899999988653 223346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+++++|..++........+++..+..++.||++||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999998886543344689999999999999999999974 5 999999999999999999999999998765322
Q ss_pred ccccccccccccccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||........ ....... ....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~-~~~~---- 226 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQLSAI-VDGD---- 226 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHHHHHH-hhcC----
Confidence 12334688899999988543 358899999999999999999999864332111 1100000 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+..+...+.+++.+||+.+|++||++.+++++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 011222355677889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=312.40 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=201.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 67999999999999999999875 48899999997766566678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|..++... ...+++..+..++.|++++|.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998877432 235889999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 634 SKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.......+++.|+|||++. ...++.++|||||||++|||++|+.|+........ .. .. ........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~----~~-~~~~~~~~--- 235 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LL----KI-AKSEPPTL--- 235 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HH----HH-hcCCCccC---
Confidence 1223456889999999884 34578899999999999999999999854331111 11 00 00000000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0112234467889999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=310.33 Aligned_cols=252 Identities=24% Similarity=0.299 Sum_probs=198.8
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.|+..+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+++|++++|+||+++++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677789999999999999864 58899999986542 2223457889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988875432 235899999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......|+..|+|||.+.+..++.++|+|||||++|||++|..||......... .... ....... .
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~~-~~~~~~~------~--- 222 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEVD-RRVLETE------E--- 222 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH-Hhhhccc------c---
Confidence 122356899999999998889999999999999999999999998754321111 0000 0000000 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 746 (795)
.........+.+++..||+.+|++||+ +.+++++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 011123345678999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.43 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=199.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
+++.+.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4455666678999999999999864 577899999876655566789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccccccccCCC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~~~~~ 630 (795)
|+++++|.+++......-..++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999864322212267788899999999999999987 999999999999976 679999999998765432
Q ss_pred cccccccccccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ......|++.|+|||++... .++.++||||||+++|+|++|+.|+............. ...
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~--~~~----------- 227 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV--GMF----------- 227 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh--hhh-----------
Confidence 21 12234588999999998654 47899999999999999999999985432211111000 000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......+......+.+++.+||+.+|++||++.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222344567889999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=306.98 Aligned_cols=248 Identities=31% Similarity=0.427 Sum_probs=194.9
Q ss_pred cccCcCCcccEEEeEecC----cceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875543 24567899999999999999999999875 5568999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc-
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS- 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~- 634 (795)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 35789999999999999999999987 9999999999999999999999999998664322111
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|||||||++|+|++ |..|+....... ...... .... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~~----~~~~---------~~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLE----SGER---------LP 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHH----cCCc---------CC
Confidence 1111223567999999988899999999999999999998 898886543221 111111 1100 01
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1122345678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=317.95 Aligned_cols=264 Identities=19% Similarity=0.219 Sum_probs=194.6
Q ss_pred cccccCcC--CcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 479 TENKLGEG--GFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 479 ~~~~LG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+.++||+| +|++||+++. .+++.||||++.... ....+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6789999976 468999999986542 233456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc-
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL- 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~- 632 (795)
++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 234788999999999999999999988 99999999999999999999999987553321110
Q ss_pred ----ccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc---cC----
Q 003786 633 ----QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW---KD---- 699 (795)
Q Consensus 633 ----~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~---~~---- 699 (795)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||.................. ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 011122356788999999876 46899999999999999999999998653322111000000000 00
Q ss_pred --------------ccccc--c---cCc----cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 --------------DRAWE--L---IDP----TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 --------------~~~~~--~---id~----~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+ . ..+ .............+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 0 000 00001112234578899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.54 Aligned_cols=250 Identities=32% Similarity=0.478 Sum_probs=197.4
Q ss_pred cccCcCCcccEEEeEecC-------cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 481 NKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 2579999886543 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccC----CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-----Ceeeecccc
Q 003786 553 MPNKSLDFFLFDST----KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-----NPKISDFGM 623 (795)
Q Consensus 553 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-----~vkL~DFGl 623 (795)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2234788899999999999999999987 99999999999999887 899999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+................++..|+|||++.+..++.++|||||||++|||++ |..|+...... ...... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~----~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHV----TAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHH----hcCC-
Confidence 986543332222223345788999999999999999999999999999998 99888643321 111111 0000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
....+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00112234567789999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=310.28 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=203.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.+.||.|++|.||+|+.. +++.+|+|++.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999865 58899999986543 33446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988432 6889999999999999999999988 9999999999999999999999999998765332
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......+++.|+|||.+.+..++.++|||||||++|+|++|..|+...+.... ... ..... .+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~~----~~~~~-----~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LFL----IPKNN-----PPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HHH----hhhcC-----CCCCcc
Confidence 122345788999999999888899999999999999999999999864432111 100 00000 011111
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ..+..+.+++.+||+.+|++||++++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 134567889999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.31 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=186.8
Q ss_pred ccCcCCcccEEEeEecC-------------------------cceEEEEEecccCccchHHHHHHHHHHHhcCCccccee
Q 003786 482 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 536 (795)
.||+|+||.||+|+... ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13488998866544445678899999999999999999
Q ss_pred eeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC--
Q 003786 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-- 614 (795)
Q Consensus 537 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-- 614 (795)
++++.+....++||||+++++|+.++... .+.+++..+..++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888532 345788999999999999999999987 99999999999997654
Q ss_pred -----CeeeeccccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCCCCCcch
Q 003786 615 -----NPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETL-SSKRNTDFSNTNSL 687 (795)
Q Consensus 615 -----~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~ell-tG~~p~~~~~~~~~ 687 (795)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998643211 12357788999998865 56899999999999999995 68888765432221
Q ss_pred hHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 688 TLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
... . . .... +.. .....+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~~--~-~--~~~~--------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERF--Y-E--KKHR--------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH--H-H--hccC--------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 100 0 0 0000 000 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.65 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=204.2
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357889999999999999999864 58899999886543 3345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|..++.. .+.+++..+..++.+++.+|.|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999988743 345889999999999999999999742 3999999999999999999999999998754221
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch------hHhHhHhhhccCcccccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL------TLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 705 (795)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........ .............
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 12345789999999999888999999999999999999999999875432210 0011110111000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+.+ .....+..+.+++.+||+.+|++||++.|+++++-.
T Consensus 230 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 230 -PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0001 111244568899999999999999999999997544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.97 Aligned_cols=248 Identities=29% Similarity=0.420 Sum_probs=193.0
Q ss_pred cccCcCCcccEEEeEecC-cc--eEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+..+ +. .+++|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998754 43 46888886432 33456788999999999 799999999999999999999999999
Q ss_pred CChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 556 KSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 556 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 1234788899999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... .... .....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK----LPQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHH----HhCCC
Confidence 98632211 11111234567999999988899999999999999999997 998885433211 1111 01110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
. ...+......+.+++.+|++.+|.+||++.++++.|..
T Consensus 229 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred C---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0 01111233467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=304.30 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=200.6
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec-ceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-EEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E 551 (795)
+|++.+.||+|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999865 47889999986432 23445788999999999999999999887644 45789999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++... ....+++..+..++.+++.||.+||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888543 2345889999999999999999999988 9999999999999999999999999998664322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+++.|+|||++.+..++.++||||||+++++|++|+.|++..+.... .. .. ..+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~---~~-~~~~~--------- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--VY---RI-IEGKL--------- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HH---HH-HhcCC---------
Confidence 223345689999999999999999999999999999999999999864332111 10 00 01111
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.83 Aligned_cols=257 Identities=24% Similarity=0.296 Sum_probs=202.5
Q ss_pred HHHccCCccccccCcCCcccEEEeEecCcceEEEEEecc--cCccchHHHHHHHHHHHhcC-Ccccceeeeeeeecceee
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 547 (795)
......|++.++||+||.+.||++...+.+.||+|++.. .+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345677999999999999999999988888999987643 34556678999999999996 999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||= ..+|..+|..... .++.-.+..+..||++|+.++|+++ |||.||||.|+|+ ..|.+||+|||+|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 999973 4578888844332 2232378889999999999999998 9999999999999 5689999999999988
Q ss_pred CCCcccccccccccccccccccccccCC-----------CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGL-----------FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~-----------~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
..+...-.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||..- . ..+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~-n~~a- 580 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------I-NQIA- 580 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------H-HHHH-
Confidence 7766555556789999999999885432 468899999999999999999998521 1 0111
Q ss_pred ccCcccccccCccccchhhHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 697 WKDDRAWELIDPTLQNEASYL-ILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
++..+++|...-+.+.. ...++++++..||+.||++||+..|+|++-
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 12233444222111111 112388999999999999999999999864
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=309.67 Aligned_cols=264 Identities=25% Similarity=0.311 Sum_probs=201.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999875 58899999886432 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|+.++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999887632 335889999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh-Hh--------hhccCcc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH-AW--------DLWKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~~--------~~~~~~~ 701 (795)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+...... .. ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999998866 568899999999999999999999987544322111100 00 0000000
Q ss_pred c-ccccCcccc--c---hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 A-WELIDPTLQ--N---EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~-~~~id~~l~--~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .....+... . .........+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000000000 0 0111234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=309.48 Aligned_cols=256 Identities=29% Similarity=0.399 Sum_probs=202.0
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999853 2467999988654433 3567999999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCc------ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKE------NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DF 621 (795)
+||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654422 25889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCc
Q 003786 622 GMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDD 700 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..|+...... ...... ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~----~~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRL----QAG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHH----HcC
Confidence 99875432221 12223456788999999988888999999999999999998 67776432221 111111 111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.... ......+..+.+++.+||+.+|++||++.|++++|.
T Consensus 235 ~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1100 011123457888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=313.79 Aligned_cols=265 Identities=23% Similarity=0.294 Sum_probs=199.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 367999999999999999999865 57899999986443 2334567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|++ ++|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 998 4787777432 335788899999999999999999988 9999999999999999999999999997643221
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHh--------Hhhhcc-Cc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGH--------AWDLWK-DD 700 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~--------~~~~~~-~~ 700 (795)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... .... .|.... ..
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11223457899999998765 45889999999999999999999998755432111 0000 000000 00
Q ss_pred ccccccCccccc----hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 RAWELIDPTLQN----EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~~id~~l~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....-.+.... .........+.++|.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000011100 1112234467899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.15 Aligned_cols=240 Identities=24% Similarity=0.380 Sum_probs=188.2
Q ss_pred cccCcCCcccEEEeEecC--------cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 481 NKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+.||+|+||.||+|.... ..++|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 234888887655445557788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC--------eeeeccccc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--------PKISDFGMA 624 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--------vkL~DFGla 624 (795)
+++|+|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999985432 35788899999999999999999988 999999999999987765 699999998
Q ss_pred cccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhHhHhHhhhccCccc
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+........ .... .. .
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~~~----~~-~- 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQFY----ED-R- 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HHHH----Hc-c-
Confidence 75432 123467889999999876 46899999999999999999995 44432221111 1000 00 0
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
. ..+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 222 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.79 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=203.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.++||+|+||.||+++.. +++.+|+|++........+.+.+|++++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999864 5889999998766555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999988542 245889999999999999999999998 9999999999999999999999999987543222
Q ss_pred cccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 633 QSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.......+++.|+|||.+. ...++.++|+|||||++|+|++|+.|+........ .. . ......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~---~-~~~~~~----- 225 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL---K-ILKSEP----- 225 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH---H-HhcCCC-----
Confidence 1223356899999999874 34578899999999999999999999865432111 10 0 001100
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.+ ..+......+.+++..||+.+|.+||++.+++++
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0112234567789999999999999999999885
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.02 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=199.9
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4677789999999999999864 57889999986442 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ..+++..+..++.||++|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 99999988732 35788899999999999999999987 9999999999999999999999999998654322
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.......++..|+|||.+.+..++.++|||||||++|||++|+.|+.......... ..... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~---------~~~~ 220 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------LIPKN---------SPPT 220 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------hhhcC---------CCCC
Confidence 12223468899999999998899999999999999999999999875332211100 00000 0111
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122344567899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.71 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=206.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 57889999986532 23557889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++........+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865444456889999999999999999999988 99999999999999999999999999986643322
Q ss_pred c--ccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 633 Q--SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 633 ~--~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. .......|+..|+|||.+... .++.++|+|||||++++|++|+.|+........ .. ...... .+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~----~~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LM----LTLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HH----HHhcCC------CCC
Confidence 1 122345689999999998776 789999999999999999999999864432211 11 000110 001
Q ss_pred ccchh-hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEA-SYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.... .......+.+++.+||+.+|++||++.+|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11101 12345677899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.62 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=200.6
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+.|.....||+|+||.||++... +++.||||.+........+.+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 33455577999999999999864 58899999986655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 99999988732 34788999999999999999999988 9999999999999999999999999987653322
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.......|+..|+|||.+.+..++.++|||||||++|||++|..|+....... ....... .+.+.+..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~---------~~~~~~~~- 240 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRIRD---------NLPPRVKD- 240 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---------cCCCcccc-
Confidence 12233568999999999988889999999999999999999999986433211 1111000 01111110
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.......+.+++.+|++.+|++|||+.|++++-
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 112334677899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.87 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=200.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.++||+|+||.||+|... +++.||+|++.+.... ..+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999875 4889999988653322 34568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|+.+... ...+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 234889999999999999999999987 9999999999999999999999999998654332
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh-----------ccC
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL-----------WKD 699 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~ 699 (795)
.......++..|+|||++.+ ..++.++|||||||++|||++|++|++....... ....... ...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ--LYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH--HHHHHHHhCCCchhhHHHhcc
Confidence 12233567899999998865 4578899999999999999999988864432111 0000000 000
Q ss_pred cccc-cccCccccc-----hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 DRAW-ELIDPTLQN-----EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 ~~~~-~~id~~l~~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... ....+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 000000000 0112345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=319.61 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=201.0
Q ss_pred CCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcC-C-----cccceeeeeeeecceeeE
Q 003786 476 NFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-H-----RNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 548 (795)
+|++.+.||+|.||.|.+|.. ++++.||||+++.. ..-..+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 799999999999999999975 56999999999643 233456678999999997 4 489999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC--Ceeeeccccccc
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM--NPKISDFGMARI 626 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~--~vkL~DFGla~~ 626 (795)
|+|.+. .+|.++|..+. ...++...+..++.||+.||..||+.+ |||+|||||||||.+.. .|||+|||.+..
T Consensus 266 VfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999885 47888885443 345889999999999999999999988 99999999999997543 699999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhH------------
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHA------------ 693 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~------------ 693 (795)
..... .....+..|.|||++.+.+|+.+.|+||||||++||++|.+-|++.++.++. .+...
T Consensus 341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 54332 2456788999999999999999999999999999999998888877644431 11110
Q ss_pred ---hhhccC-ccc------ccc----------------cCcccc--------chhhHHHHHHHHHHHHhhccCCCCCCCC
Q 003786 694 ---WDLWKD-DRA------WEL----------------IDPTLQ--------NEASYLILNRYINVGLLCVQEDAADRPT 739 (795)
Q Consensus 694 ---~~~~~~-~~~------~~~----------------id~~l~--------~~~~~~~~~~l~~li~~cL~~dP~~RPt 739 (795)
...+.. ... .+. .+.... ..........+++++.+||+.||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000011 000 000 000000 0011133456789999999999999999
Q ss_pred HHHHHHHH
Q 003786 740 MFEVVSML 747 (795)
Q Consensus 740 ~~evl~~L 747 (795)
+.|+++|-
T Consensus 496 p~qal~Hp 503 (586)
T KOG0667|consen 496 PAQALNHP 503 (586)
T ss_pred HHHHhcCc
Confidence 99999973
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.37 Aligned_cols=238 Identities=27% Similarity=0.426 Sum_probs=187.6
Q ss_pred cccCcCCcccEEEeEecCcc-----------eEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 481 NKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
+.||+|+||.||+|...... .+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999875432 4788877544333 6788999999999999999999999988 778999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-------Ceeeeccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-------NPKISDFG 622 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-------~vkL~DFG 622 (795)
|||+++++|++++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985433 25788899999999999999999987 99999999999999888 79999999
Q ss_pred cccccCCCcccccccccccccccccccccccC--CCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhHhHhHhhhccC
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSS-KRNTDFSNTNSLTLLGHAWDLWKD 699 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
++..... .....++..|+|||++... .++.++|||||||+++||++| ..|+........ .. . +..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~-~---~~~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ER-F---YQD 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HH-H---Hhc
Confidence 9986532 1224567789999998776 789999999999999999995 555543321111 00 0 000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
... .-.+ ....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~~--~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR--LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC--CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0000 0157789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.66 Aligned_cols=255 Identities=19% Similarity=0.242 Sum_probs=197.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.++||+|+||.||+++.. +++.||+|++.+.. ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 57889999986531 223455788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 245788899999999999999999988 999999999999999999999999999865433
Q ss_pred ccccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .. ..........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~---~i~~~~~~~~- 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHEERFQ- 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--HH---HHHcCCCccc-
Confidence 21 12233579999999998865 5688999999999999999999999864332111 11 1111110000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAAD--RPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 746 (795)
+.+ ........+.+++.+||+..+.+ |+++++++++
T Consensus 229 ~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 001 11123456778899999866554 5689999886
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.49 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=210.9
Q ss_pred ccCCccccccCcCCcccEEEeEecC---cc--eEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.+.....+.||+|-||.||+|.+.+ |+ .||||..+.. .....+.|..|..+|++++|||||+++|.|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3455667889999999999997532 33 4899988763 45567899999999999999999999999864 5779
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+|||.++-|.|..+|.. +...++......++.||+.||+|||++. .|||||..+|||+...--|||+|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999953 3456888889999999999999999987 999999999999999999999999999988
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHH-hCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL-SSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
......... ...-..-|||||.+.-..++.++|||.|||.+|||+ .|..||.+-. ...+...+
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk---------------NsDVI~~i 605 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK---------------NSDVIGHI 605 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc---------------ccceEEEe
Confidence 766654433 334467899999999999999999999999999988 5888886532 22233334
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+..-+-+.++.++..+..++.+||.++|.+||++.||...|+.
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 4444556778888899999999999999999999999887654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.04 Aligned_cols=255 Identities=20% Similarity=0.258 Sum_probs=196.3
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.++||+|+||.||+++... ++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998654 7789999986421 223345788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 235788899999999999999999988 999999999999999999999999998754322
Q ss_pred cccccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... .. ..........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~--~~---~i~~~~~~~~- 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHKERFQ- 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH--HH---HHhCCCcccc-
Confidence 21 1223357999999999885 34689999999999999999999999865432111 11 1111110000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAAD--RPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 746 (795)
+ + .........+.+++.+||..++.+ ||++.|++++
T Consensus 229 ~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 011123456778888888655444 7899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=310.77 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=202.9
Q ss_pred HHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeee---
Q 003786 467 LASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCI--- 541 (795)
Q Consensus 467 ~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 541 (795)
+..+....++|++.+.||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4455567789999999999999999999864 57899999886432 2346788999999999 6999999999874
Q ss_pred --ecceeeEEeecCCCCChhhhhhcc-CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 542 --ELEEKILIYEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 542 --~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 22345788899999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 693 (795)
+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+........ ..
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~--- 239 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LF--- 239 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hh---
Confidence 99999886543221 2233468999999998753 4578999999999999999999999864332111 00
Q ss_pred hhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. ..........++ ......+.+++.+||+.+|++||++.||++++
T Consensus 240 -~-~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 -K-IPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -h-ccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 000111111111 11234678899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.78 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=203.4
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|+..+.||.|+||.||.++.. +++.+++|.+.... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 58899999886432 34456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 345788999999999999999999987 99999999999999999999999999986643331
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||.+.+..++.++||||||++++||++|..|++....... .. .. ......
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~---~~-~~~~~~--------- 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL--VV---KI-VQGNYT--------- 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH--HH---HH-HcCCCC---------
Confidence 22345689999999999888899999999999999999999999865332211 10 00 011110
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.........+.+++.+||+.+|++||++.++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01122345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=344.48 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=198.9
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec--cee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
....+|++.++||+|+||.||+++.. .++.+|+|++.... ......+..|+.+|++|+|||||+++++|.+. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999999999999865 47789999886432 23346788999999999999999999988654 568
Q ss_pred eEEeecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCC----CcEEeccCCCCcEEECCC--------
Q 003786 547 ILIYEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSR----LRVIHRDLKASNILLDKD-------- 613 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiHrDikp~NIll~~~-------- 613 (795)
++||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999885432 23568999999999999999999998541 349999999999999642
Q ss_pred ---------CCeeeeccccccccCCCccccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 003786 614 ---------MNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFS 682 (795)
Q Consensus 614 ---------~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~ 682 (795)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998654322 2234579999999998854 46899999999999999999999998643
Q ss_pred CCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 683 NTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... +... ..... .+. .......+.+||..||+.+|.+||++.|++++
T Consensus 247 ~~~~q-li~~----lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFSQ-LISE----LKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHHH-HHHH----HhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 32111 1111 11110 000 01123567889999999999999999999964
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.45 Aligned_cols=251 Identities=36% Similarity=0.515 Sum_probs=199.7
Q ss_pred CccccccCcCCcccEEEeEecC-----cceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 477 FSTENKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
+++.+.||+|+||.||+++... ++.+|+|++...... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998654 378999999655433 5678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++..... ..+++..+..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 22789999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
...... ...+++.|+|||.+....++.++||||||+++++|++ |..|+....... ..... ......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~----~~~~~~------ 223 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLEYL----KKGYRL------ 223 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----hcCCCC------
Confidence 222111 2336789999999988889999999999999999998 777765422211 11111 111110
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..+...+.++.+++.+||+.+|++|||+.|++++|
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112455788899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.06 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=159.3
Q ss_pred ccccCcCCcccEEEeEec---CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeee--cceeeEEeecCC
Q 003786 480 ENKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILIYEYMP 554 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 554 (795)
..+||+|+||.||+|+.. +++.||+|.+... .....+.+|+++|++++||||+++++++.. ....++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999864 3578999998643 233568899999999999999999998854 456789999988
Q ss_pred CCChhhhhhcc------CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE----CCCCCeeeeccccc
Q 003786 555 NKSLDFFLFDS------TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMA 624 (795)
Q Consensus 555 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~vkL~DFGla 624 (795)
+ +|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 555554211 12235788889999999999999999988 9999999999999 56689999999999
Q ss_pred cccCCCccc-cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 625 RIFGGDELQ-SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 625 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876433211 12234578999999998876 468999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.09 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=214.9
Q ss_pred CCccccccCcCCcccEEEeEecC----cceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
...+.++||.|.||.|++|+++. ...||||.++.... ....+|..|+.||.+++||||++|.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45678899999999999998753 34599999976543 44578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||++|+||.||+.+. +.+.+.+...++++||.|++||-+++ +|||||..+||||+.+...|++||||++.+..+
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999996544 55889999999999999999999998 999999999999999999999999999987544
Q ss_pred ccccccccccc--ccccccccccccCCCCcccchhhHHHHHHHHH-hCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQSKTKRIVG--TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL-SSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~g--t~~y~APE~~~~~~~~~k~DvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
. ....++..| ..+|.|||.+....++.++|||||||+|||.+ .|.+|+-... +.++...++
T Consensus 785 ~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---------------NQdVIkaIe 848 (996)
T KOG0196|consen 785 P-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---------------NQDVIKAIE 848 (996)
T ss_pred C-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---------------hHHHHHHHH
Confidence 3 222232333 56899999999999999999999999999977 5888864322 222333445
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..++-+.+.+++..+.+|+..|||.|..+||.+.||+.+|.+.
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 5566677888999999999999999999999999999998773
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=308.61 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=200.6
Q ss_pred cCCccccccCcCCcccEEEeEecC-cc----eEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|++.+.||+|+||.||+|.... ++ .+|+|.+..... ...+++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578889999999999999998543 33 589998865432 345678899999999999999999999887 78899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|+||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 234889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............++..|+|||.+....++.++|+||||+++|||++ |+.|++....... .... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~~~~----- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PDLL----EKGER----- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHH----hCCCC-----
Confidence 3322111112224568999999988899999999999999999998 9999865432221 1111 11100
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...+......+.+++.+||..+|++||++.++++.|...
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001111224577899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.65 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=203.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..|+..++||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++.||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778899999999999999865 58899999986542 33456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988843 34788889999999999999999987 99999999999999999999999999976543321
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|+|||||++|||++|..|+.......... .+......
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---------------~~~~~~~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---------------LIPKNNPP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---------------hhhcCCCC
Confidence 2233467889999999988889999999999999999999999986433211110 00011112
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2334456678899999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.41 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=200.2
Q ss_pred cCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.+|.+.+.||+|+||.||+|...+ ...+|||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568889999999999999998643 2468999886554 3445689999999999999999999998865 567899
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 234789999999999999999999987 99999999999999999999999999986644
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
..... .....++..|+|||.+....++.++|||||||++|||++ |..||........ .... ......
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~----~~~~~~----- 227 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRI----ENGERL----- 227 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHH----HcCCcC-----
Confidence 32211 122334568999999988889999999999999999986 9999865432211 1111 111100
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+|+..+|++|||+.++++.|..
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0112234578889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.53 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=187.2
Q ss_pred cCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhc---CCcccceeeeeeeecceeeEEeecCCC
Q 003786 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKL---QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
||+|+||.||+|+.. +++.||||++.+... .....+..|..++..+ +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 589999999865322 1223445677777665 699999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888843 345889999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred ccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 636 TKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ... ...... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--~~~----i~~~~~------~~~--- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--YRN----IAFGKV------RFP--- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--HHH----HHcCCC------CCC---
Confidence 3346799999999988754 589999999999999999999999865432211 110 000000 000
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCC----CHHHHHHH
Q 003786 715 SYLILNRYINVGLLCVQEDAADRP----TMFEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RP----t~~evl~~ 746 (795)
.......+.+++.+||+.+|++|| ++.+++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 011234667899999999999998 57777775
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.19 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=198.8
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---c-------chHHHHHHHHHHHhcCCcccceeeeeeeecc
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---Q-------GQEEFKNEIKLIAKLQHRNLVRLLGCCIELE 544 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 544 (795)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... . ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999754 588999998753211 0 1246788999999999999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 45888899999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
................|+..|+|||.+.... ++.++|+||||+++++|++|..|+....... . ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~----~~~~~~~~~~ 230 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-A----MFKLGNKRSA 230 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-H----HHHhhccccC
Confidence 8654322112223356889999999887654 8999999999999999999999985322111 0 1111111100
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.+...........+.+++.+||+.+|++||++.+|+++
T Consensus 231 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 -----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111222345678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.83 Aligned_cols=254 Identities=27% Similarity=0.368 Sum_probs=203.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|+..+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36888899999999999999875 58899999987653 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 567888999999999999999999 76 9999999999999999999999999987653221
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+................... ... +.+
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~-----~~~- 224 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPP-----PRL- 224 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCC-----CCC-
Confidence 112668899999999998899999999999999999999999986543211111111111100 000 011
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+.++|.+||+.+|++||++.+++++
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 --PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011145568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=313.22 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=198.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-Ccc----eEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++|+..+.||+|+||.||+|+.. +++ .+|+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356888899999999999999854 344 478888865432 2234688999999999999999999998754 467
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999988532 235788899999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+........ .. ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~--- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--PD----LLEKGERL--- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHCCCCC---
Confidence 43322222223345778999999988899999999999999999997 8888864321111 11 11111100
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..+......+.+++..|+..+|++||++.+++++|...
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00111234677899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.29 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=194.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-----cchHHHHHHHHHHHhcCCcccceeeeeeeec--cee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-----QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.+|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999864 588999998864321 2235688899999999999999999988753 567
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998843 234788889999999999999999987 99999999999999999999999999876
Q ss_pred cCCCcc-cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||........ ... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--~~~---~~~~~----- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--IFK---IATQP----- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--HHH---HhcCC-----
Confidence 532111 1112234688999999999988899999999999999999999999864321111 000 00000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+ ..+......+..++ +|+..+|++||+++||+++
T Consensus 226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 011 11222334455566 6888999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=318.18 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=204.7
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+.|+++..||.|+||.||++..++ +--.|-|++.....+..+.+.-|++||..++||+||+|++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457888899999999999998654 4446778887777778889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
.||-.+.++..- ...+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+..... ..
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 999999888543 345889999999999999999999998 99999999999999999999999999864321 12
Q ss_pred cccccccccccccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 634 SKTKRIVGTYGYMSPEYA-----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~-----~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.....+.|||.|||||+. +..+|+.++||||||++|.||..+.+|....+.-.. + ..........++.|
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--l----lKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAKSEPPTLLQP 258 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--H----HHHhhcCCCcccCc
Confidence 234568999999999986 457899999999999999999999988643221111 0 11111222222222
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......+.+++..||..||..||++.++++|
T Consensus 259 -------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 -------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2345567789999999999999999999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.94 Aligned_cols=248 Identities=29% Similarity=0.394 Sum_probs=200.2
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC-----ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999875 68999999886533 12346788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
+||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998432 34788899999999999999999988 99999999999999999999999999886543
Q ss_pred CcccccccccccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.|+....... ... ........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~---~~~~~~~~------ 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVF---KIGRSKEL------ 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHH---HHHhcccC------
Confidence 32 223456889999999887766 8999999999999999999999986433111 110 00000000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||+.+|.+||++.+++++
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11122234567789999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.06 Aligned_cols=263 Identities=23% Similarity=0.294 Sum_probs=195.9
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999865 58899999986532 22335678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++ +|..++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 985 666655332 345889999999999999999999988 9999999999999999999999999998654321
Q ss_pred cccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH----------hhhccCcc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA----------WDLWKDDR 701 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~----------~~~~~~~~ 701 (795)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|+.|+.........+.... +.......
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 112234578899999988664 579999999999999999999988643322211111000 00000000
Q ss_pred ccc---ccCcccc-chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWE---LIDPTLQ-NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~---~id~~l~-~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... ....... .+........+.+++.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 0000000 01112234677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.10 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=199.9
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
|+...+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444568999999999999864 5889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence 999887732 34788999999999999999999988 9999999999999999999999999987654322 12
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+........ .... ....... . ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~----~~~~~~~-----~--~~~ 240 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRL----RDSPPPK-----L--KNA 240 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----hccCCCC-----c--ccc
Confidence 2335689999999999988899999999999999999999999864332111 1110 0000000 0 001
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
......+.+++.+||+.+|++||++.+++++-
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 12234577899999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.36 Aligned_cols=247 Identities=29% Similarity=0.415 Sum_probs=197.7
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
++|++.+.||+|+||.||++.. .++.+|+|++... ...+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5689999999999999999975 6788999998643 2346789999999999999999999998654 5799999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|..++.... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999985432 335788899999999999999999987 999999999999999999999999998754321
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+..|+|||.+.+..++.++|+|||||++|||++ |+.|+........ ... ..... ...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~---------~~~ 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KEC----VEKGY---------RME 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HHH----HhCCC---------CCC
Confidence 112234578999999988899999999999999999997 8888764332111 111 11110 011
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.....+..+.+++.+||+.+|++||++.+|++.|..
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112234567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.09 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=196.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-----ccchHHHHHHHHHHHhcCCcccceeeeeeeec--cee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.+|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999864 58899999875321 12235788899999999999999999988764 457
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999988432 34788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.|+....... ... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~----~~~~~~----- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIF----KIATQP----- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHH----HHhcCC-----
Confidence 5432111 12233568899999999988889999999999999999999999986432111 110 000000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+......+.+++.+|+. +|++||+++||+++
T Consensus 226 ----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111233445567788888985 99999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=300.92 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=188.4
Q ss_pred cccCcCCcccEEEeEecCc---ceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 481 NKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.||+|+||.||+++..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 345677665432 234578999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 557 SLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 557 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
+|.+++..... ....++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999864322 234566677899999999999999987 99999999999999999999999999864322221222
Q ss_pred cccccccccccccccccc-------CCCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 636 TKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLSS-KRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.....++..|+|||++.. ..++.++|||||||++|||+++ ..|+..... ....... . ......+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~---~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHV---I-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---H-hhcccccCC
Confidence 234568899999998753 2457899999999999999975 556543221 1111111 1 111122233
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
+.+... ....+.+++..|+ .+|++||++++|++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333222 3346677888899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.12 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=201.6
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999864 58999999987543 23356789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998885433 45889999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc-----------Cc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK-----------DD 700 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~ 700 (795)
.......++..|+|||.+.+ ..++.++||||+||+++||++|.+++........ ......... ..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ--LAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH--HHHHHHHcCCCChHHHhhccCc
Confidence 12233568999999998865 4578999999999999999999777754332111 111000000 00
Q ss_pred cccccc-Ccccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 RAWELI-DPTLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~~i-d~~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+..+ .+... ..........+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00000 01112334788899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.60 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=197.0
Q ss_pred CccccccCcCCcccEEEeEec----CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecc------
Q 003786 477 FSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
|.+.+.||+|+||.||+|... +++.+|||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3688999998653 2234567889999999999999999999886543
Q ss_pred eeeEEeecCCCCChhhhhhccC---CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecc
Q 003786 545 EKILIYEYMPNKSLDFFLFDST---KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DF 621 (795)
..++++||+++++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988774322 1234788889999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCc
Q 003786 622 GMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDD 700 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
|+++...............+++.|++||.+....++.++|||||||++|||++ |+.|+...... ....... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH---cCC
Confidence 99986543322222223345678999999998899999999999999999999 77777543221 1111110 000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
... ........+.+++.+||+.+|++||++.++++.|+.
T Consensus 233 ~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 233 RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000 011234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.24 Aligned_cols=249 Identities=29% Similarity=0.397 Sum_probs=189.5
Q ss_pred cccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeee-ecceeeEEeecCC
Q 003786 481 NKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCI-ELEEKILIYEYMP 554 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~ 554 (795)
+.||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998532 4579999885432 234567889999999999999999999776 4556789999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc-
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ- 633 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~- 633 (795)
+++|..++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999985432 23566778899999999999999987 999999999999999999999999999755332111
Q ss_pred -ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 634 -SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 634 -~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......++..|+|||.+.+..++.++|||||||++|||++|. +|+.... ........ ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~---~~~~~~--------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYL---LQGRRL--------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH---hcCCCC---------
Confidence 1112234577899999998888999999999999999999964 4444322 11111111 111000
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0011123467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.47 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=201.6
Q ss_pred CCccccccCcCCcccEEEeEe-cCcceEEEEEecccCc------cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 476 NFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSG------QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
+|+..+.||+|++|.||+++. .+++.+|+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 4688999999864321 124678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-Ceeeecccccccc
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARIF 627 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~~ 627 (795)
|+||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 345788999999999999999999998 99999999999998876 5999999999866
Q ss_pred CCCccc--ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 628 GGDELQ--SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......++..|+|||.+.+..++.++||||||+++++|++|..|+........... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~~--------- 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL--IFKI--------- 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH--HHHH---------
Confidence 433111 112234688999999999888899999999999999999999999864332211111 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+......+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00001122333455678889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.28 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=197.1
Q ss_pred CCccccccCcCCcccEEEeEec---CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeec--ceee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKI 547 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 547 (795)
+|++.++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999864 47899999997632 33446788999999999999999999999988 8899
Q ss_pred EEeecCCCCChhhhhhccC-C-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC----CCCeeeecc
Q 003786 548 LIYEYMPNKSLDFFLFDST-K-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK----DMNPKISDF 621 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~----~~~vkL~DF 621 (795)
+||||+++ +|..++.... . ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 4555543222 2 236888999999999999999999988 999999999999999 999999999
Q ss_pred ccccccCCCcc-ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-------hHhHh
Q 003786 622 GMARIFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-------TLLGH 692 (795)
Q Consensus 622 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-------~~~~~ 692 (795)
|++........ ........+++.|+|||.+.+ ..++.++|||||||++++|++|+.|+........ .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543221 112234567899999998765 4689999999999999999999999875543220 00000
Q ss_pred HhhhccC------------ccccc---ccC------ccccchhhH--HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 693 AWDLWKD------------DRAWE---LID------PTLQNEASY--LILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 693 ~~~~~~~------------~~~~~---~id------~~l~~~~~~--~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....... ..... ... ..+...... ....++.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 00000 000 000000111 233468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.77 Aligned_cols=261 Identities=25% Similarity=0.317 Sum_probs=199.4
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc-----chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-----GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
+|++.+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999864 5899999999754322 235577899999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+ +++|..++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885432 36889999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--------
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD-------- 700 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 700 (795)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+++....... ............
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhc
Confidence 321 1223356788999998854 567899999999999999999977775433211 111111000000
Q ss_pred -ccccccCcccc-----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 -RAWELIDPTLQ-----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 -~~~~~id~~l~-----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........... ..........+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 01112335678899999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.77 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=213.3
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.+....++||.|.||.||.|.++. .-.||||.++.. .-..++|..|..+|+.++|||+|+|+|+|..+...|+|+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 456677899999999999998765 567999999543 455789999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
..|+|.++|+...+ ..++.-..++++.||+.|+.||..++ +|||||..+|.|+.++-.|||+||||++++..+.+.
T Consensus 346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 99999999976543 34666778899999999999999998 999999999999999999999999999998766543
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
... ...-.+-|.|||-+.-+.++.|+|||+|||+||||.| |..|+++-+- ..++++++..++.
T Consensus 422 AHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------------SqVY~LLEkgyRM 485 (1157)
T KOG4278|consen 422 AHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYGLLEKGYRM 485 (1157)
T ss_pred ccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------------HHHHHHHhccccc
Confidence 221 1223567999999999999999999999999999997 6666654221 1233455556666
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+.+..++....+|+..||+.+|.+||++.|+-+.++.
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 6777788889999999999999999999999887765
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.26 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=202.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 58899999886532 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|++++.+..++. +...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999988776653 2344789999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh-HhHh--------hhccCcc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL-GHAW--------DLWKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~-~~~~--------~~~~~~~ 701 (795)
. .......++..|+|||++... .++.++||||||+++|+|++|+.|+........... .... ..+....
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122335678999999999887 889999999999999999999998865432211000 0000 0000000
Q ss_pred cc---cccCccc----cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AW---ELIDPTL----QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~---~~id~~l----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. +..+... ....+...+..+.++|.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0000000 001112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.61 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=199.3
Q ss_pred CCccccccCcCCcccEEEeEecC--cceEEEEEecccC----------ccchHHHHHHHHHHHh-cCCcccceeeeeeee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQS----------GQGQEEFKNEIKLIAK-LQHRNLVRLLGCCIE 542 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 542 (795)
+|++.+.||+|+||.||+|+... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998754 6789999875321 1223456778888865 799999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhcc-CCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
.+..++||||+++++|.+++... .....+++..+..++.|++.+|.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887432 233458889999999999999999996 44 99999999999999999999999
Q ss_pred cccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD 700 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+........ .... ...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--~~~~----~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--ATKI----VEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--HHHH----hhc
Confidence 99998754332 23345689999999999988899999999999999999999999854321111 1100 001
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
... +. ........+.+++.+||+.||++||++.|+.++++
T Consensus 229 ~~~----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 00 01122356788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.44 Aligned_cols=254 Identities=23% Similarity=0.267 Sum_probs=202.5
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|++|.||+++... ++.+|+|.+...... ..+.+.+|+++++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368899999999999999998754 899999999764322 3456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+.+++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 2356889999999999999999999987 999999999999999999999999998754321
Q ss_pred ccc---------------------------ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 631 ELQ---------------------------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 631 ~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123468899999999998889999999999999999999999986543
Q ss_pred CcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC----HHHHHHH
Q 003786 684 TNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT----MFEVVSM 746 (795)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt----~~evl~~ 746 (795)
.... +. ...... ..-.........+.+++.+||+.+|++||+ +.|++++
T Consensus 237 ~~~~-~~----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDET-FS----NILKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHH-HH----HHhcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 2211 11 000000 000011114567889999999999999999 7888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.80 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=201.6
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 5889999998643 223446789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999988885422 234688899999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......|++.|+|||++.+..++.++|+|||||++++|++|+.|+........ .. .... +.. .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~---~~~~-~~~---------~ 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--VL---KIIR-GSY---------P 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--HH---HHhc-CCC---------C
Confidence 12234688999999999888899999999999999999999999864332111 10 0000 000 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.+|++||++.+|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122334568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.56 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=202.4
Q ss_pred HHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 467 LASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 467 ~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
+.++....++|++.+.||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++...+
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3445556789999999999999999999864 58899999986432 2346788999999999 7999999999987543
Q ss_pred -----eeeEEeecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 545 -----EKILIYEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 545 -----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 5799999999999998875322 2345889999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCcccccccccccccccccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 693 (795)
+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.|+........ ..
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~--- 243 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LF--- 243 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HH---
Confidence 99999886543221 12234688999999987543 368999999999999999999999864322111 11
Q ss_pred hhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .......+.+ +......+.++|.+||+.+|++||++.|++++
T Consensus 244 -~~-~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 -KI-PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HH-hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 1111111111 11233468899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.23 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=200.6
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|+..+.||+|+||.||++... +++.+|||.+.... ....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 58899999986542 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-CeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~~~~~~ 631 (795)
+++++|.+++.... ...+++..+..++.+++++|.|||+++ |+|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999985432 345788999999999999999999987 99999999999998654 57999999998764322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......++..|+|||.+.+..++.++||||||+++++|++|+.|++....... .... .....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~----~~~~~--------- 218 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKI----MSGTF--------- 218 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHH----HhcCC---------
Confidence 12235688999999999988899999999999999999999999865432221 1110 00000
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||+.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01111234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=353.80 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=208.0
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
...+...+.||+|+||.||+|+. .+++.||||++..... ...+|++++++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677888999999999999986 4689999999864322 223568899999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++|+|.+++. .++|..+.+++.||++||+|||..+..+|+||||||+||+++.++.+++. |+.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999983 27899999999999999999996655569999999999999999888875 665543221
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....+|+.|||||++.+..++.|+|||||||++|||++|+.|++...........+.............+++.+..
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 12236889999999999999999999999999999999999998644333333444433333333344445555432
Q ss_pred --hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 713 --EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 713 --~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+..++.+++.+|++.+|++||+|+||+++|+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 23445666788999999999999999999999999874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.12 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=200.5
Q ss_pred HHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeee--
Q 003786 467 LASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIE-- 542 (795)
Q Consensus 467 ~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 542 (795)
+..+..+.+.|++.+.||+|+||.||+|+.. +++.+|+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344456688999999999999999999864 58899999885542 3446788999999998 69999999999863
Q ss_pred ----cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 543 ----LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 543 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
....+++|||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457799999999999999885432 344778888999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCcccccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 693 (795)
+|||++....... .......|++.|+|||.+. ...++.++|||||||++|||++|..||......... ..
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~-- 237 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FL-- 237 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hh--
Confidence 9999987543221 1223456899999999875 356888999999999999999999998543211110 00
Q ss_pred hhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .... .+.+ .....+..+.+++.+||+.+|.+||++.||+++
T Consensus 238 --~-~~~~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 --I-PRNP-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --H-hhCC-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 0000 0000 111234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.27 Aligned_cols=256 Identities=28% Similarity=0.400 Sum_probs=201.4
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecc-----
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE----- 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 544 (795)
...++|++.+.||+|++|.||+|+.. +++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999875 57889999986543 3456799999999999 6999999999997654
Q ss_pred -eeeEEeecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 545 -EKILIYEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 -~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999998885432 2456889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|..|+........ ... .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~ 230 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFK-----I 230 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHH-----h
Confidence 987653222 12233568999999998753 3578899999999999999999999864321111 110 0
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... +.+ ..+......+.+++.+||..||++|||+.+++++
T Consensus 231 ~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 01100 011 1122245678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.59 Aligned_cols=252 Identities=28% Similarity=0.372 Sum_probs=208.4
Q ss_pred cCCccccccCcCCcccEEEeEec--Ccc--eEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL--NGQ--EVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
++..+.++||+|.||+|++|.+. .|+ .||||.+...... ....|.+|+.+|.+|+|||+|+|||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 45667789999999999999764 344 5899999765444 56789999999999999999999999887 788999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
+|.++.|+|.+.|++ .....+.......++.|||.|+.||..++ +|||||..+|+||-..-.|||+||||.+.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999977 45567888899999999999999999987 99999999999999999999999999998765
Q ss_pred Cccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 630 DELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.+.. .......-...|+|||.++...++.++|||+|||+||||++ |..||.+....+ +.+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---------------IL~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---------------ILKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---------------HHHhcc
Confidence 4322 22222334678999999999999999999999999999997 566765433221 223444
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..-+-..+..+++++++++..||..+|++|||+..|.+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 333444566788999999999999999999999999854
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=305.57 Aligned_cols=265 Identities=23% Similarity=0.268 Sum_probs=196.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++.+|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 5889999998654322 3346789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+. +++...+... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5665555322 234677888899999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc---------
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD--------- 700 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 700 (795)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||+........+. ..+......
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE-KIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH-HHHHHcCCCChhhhhhhh
Confidence 11 1223457899999998875 4588999999999999999999999875443222111 111111100
Q ss_pred ---c-cccccCccccchh-----hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 ---R-AWELIDPTLQNEA-----SYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ---~-~~~~id~~l~~~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ............. .......+.+++.+|++.+|++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 0000000000000 00113466789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.32 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=201.3
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee--cceeeEEe
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILIY 550 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 550 (795)
+|++.+.||.|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5788899999999999999854 57899999986432 2334568899999999999999999998764 45678999
Q ss_pred ecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcC--CCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 551 EYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
||+++++|.+++.... ....+++..+..++.||++||.|||..+ ..+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999885432 2456889999999999999999999332 234999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... ......+++.|+|||.+....++.++|+||||+++++|++|..|+...... ...... ....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~~------ 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASKI----KEGK------ 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHHH----hcCC------
Confidence 54331 123356899999999998888999999999999999999999998754411 111111 1111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+......+.+++.+||+.+|++||++.+|+++
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111222345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=302.55 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=201.1
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 550 (795)
++|+..++||.|++|.||++... +++.+|+|++..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888899999999999999875 588899999875432 3456789999999999999999999998654 4679999
Q ss_pred ecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||+++++|.+++.... ....+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988774322 2345788899999999999999999988 99999999999999999999999999875432
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..|++................ .......+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~- 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI-VNMPNPELKDE- 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH-hcCCchhhccC-
Confidence 21 1234578899999999989999999999999999999999999876532111111111000 01011111100
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. ........+.+++.+||+.+|++|||+.||+++
T Consensus 232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 001234578899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=305.35 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=204.3
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999754 5789999998765555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 34778899999999999999999988 99999999999999999999999999876543321
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||........... ...... +. .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----~~~~~~------~~--~ 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGT------PE--L 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----hhcCCC------CC--C
Confidence 22334688999999999888899999999999999999999999865432111000 000000 00 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234567789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.76 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=197.2
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|+..+.||.|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999865 58899999886432 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+. ++|..++.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 57877774432 345888999999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc-cCcc---------
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW-KDDR--------- 701 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~--------- 701 (795)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ ......... ....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhHHH
Confidence 112233568899999988664 468899999999999999999999865432211 111000000 0000
Q ss_pred -----cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 -----AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 -----~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+ ..........+.+++.+||+.||++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000 01111233567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.12 Aligned_cols=245 Identities=26% Similarity=0.314 Sum_probs=200.8
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 58999999986532 223467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999888433 46889999999999999999999988 999999999999999999999999999875433
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..|+....... .... .....
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~~--------- 214 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--IYEK----ILEGK--------- 214 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HhcCC---------
Confidence 233568999999999988889999999999999999999999986543111 1100 00110
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
...+......+.+++.+||+.+|.+|| +++|++++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 011122345778899999999999999 88888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.35 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=206.2
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.+.||+|++|.||+++... ++.|+||++..... .....+.+|+.++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998764 89999999876543 3457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568899999999999999999999 87 9999999999999999999999999998764333
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC-cchhHhHhHhhhccCcccccccCccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-NSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.. .....++..|+|||.+....++.++|+||||+++|+|++|..|+..... ......... . ....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~-~~~~-------- 220 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---C-DGPP-------- 220 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---h-cCCC--------
Confidence 21 1235688999999999988999999999999999999999999865542 111111111 1 1100
Q ss_pred cchhhHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYL-ILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+.. .+..+.+++.+||+.+|++||++.+++++
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122 45678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.08 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=197.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367999999999999999999865 588999999865432 223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 8888775332 35788999999999999999999988 9999999999999999999999999987543211
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--ccc-----
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD--RAW----- 703 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~----- 703 (795)
. ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||......... ....+...... ..+
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHhcCCCChhhhhhhhh
Confidence 1 1122346889999998865 56899999999999999999999998654421111 11111111000 000
Q ss_pred --c-------ccCccccchhhHHH--HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 --E-------LIDPTLQNEASYLI--LNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 --~-------~id~~l~~~~~~~~--~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+ ...+.......... ...+.+++.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00000000000011 1566789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.31 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=201.1
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|+||.||+|... +++.|++|.+...... ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 6889999998765443 567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998853 334788899999999999999999988 99999999999999999999999999987643322
Q ss_pred ccc--ccccccccccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 633 QSK--TKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 633 ~~~--~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... .....+++.|+|||++.... ++.++||||||+++++|++|+.||........... .. . . .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-~~--~-~-~~-----~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HV--G-A-GH-----K 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-HH--h-c-CC-----C
Confidence 111 12356788999999987765 89999999999999999999999864432111111 00 0 0 00 0
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.+. ........+.+++.+||+.+|++||++.+++.+
T Consensus 225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0010 011124556789999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.81 Aligned_cols=248 Identities=25% Similarity=0.270 Sum_probs=202.5
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
+|++.+.||+|+||.||+|+.. +++.||+|++.+... ...+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999875 589999999975432 345688999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+.+++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988433 46889999999999999999999988 9999999999999999999999999998654332
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......|+..|+|||.+....++.++|+||||+++|+|++|..|+.............. ... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~----------~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK---QET----------AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH---hcc----------cc
Confidence 22335688899999999888899999999999999999999999876543211111110 000 00
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCH--HHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTM--FEVVS 745 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~--~evl~ 745 (795)
...+...+..+.+++.+||+.+|.+||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11222234678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=290.95 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=201.4
Q ss_pred cccCcCCcccEEEeE-ecCcceEEEEEecccCccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
+.||+|+|+.|-.+. +.++++||||++.+.......++.+|++++...+ |+||++|+++|++++..|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999986 6789999999999988888899999999999996 99999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---CeeeeccccccccCCC-----
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMARIFGGD----- 630 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL~DFGla~~~~~~----- 630 (795)
..+| .+++.+++.++.+++.+|+.||.+||.+| |.||||||+|||..+.. -|||+||.|..-....
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9998 44566899999999999999999999999 99999999999996554 4899999987643211
Q ss_pred ccccccccccccccccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc----
Q 003786 631 ELQSKTKRIVGTYGYMSPEYA-----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR---- 701 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~-----~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 701 (795)
.......+.+|+.+|||||+. ....|+.++|.||||||||-|++|.+||-+.-..+. -|..++
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~ 309 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRV 309 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHH
Confidence 111223346899999999975 234689999999999999999999999965432221 011111
Q ss_pred ----cccccCcc---ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 ----AWELIDPT---LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ----~~~~id~~---l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+++-|... +.+.-...+..+..++|...|..++.+|.++.+++++
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 11111111 1122334456677899999999999999999999874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=306.93 Aligned_cols=256 Identities=20% Similarity=0.254 Sum_probs=199.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||.||+++.. .++.||+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999865 478999999865432 23456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 245888999999999999999999987 999999999999999999999999998742110
Q ss_pred cc-------------cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 631 EL-------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 631 ~~-------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|..||....... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~~~---- 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQV---- 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----
Confidence 00 001112457889999999988889999999999999999999999986432211 11110
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.... ...+. .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~---~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDD---IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhcc---cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 00010 001234567899999999999999997666666555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=301.39 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=200.8
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+|++.++||+|++|.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 588999999875432 23467788999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 86 77777755444456899999999999999999999988 9999999999999999999999999997653221
Q ss_pred cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh-HhH--------hhhccCcccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL-GHA--------WDLWKDDRAW 703 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~-~~~--------~~~~~~~~~~ 703 (795)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|..|+........... ... +..+......
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 11223457889999998765 4578999999999999999999999875543221100 000 0000000000
Q ss_pred cccCccc----cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTL----QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+.. ...........+.+++.+|++.+|.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 011112334577899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=304.28 Aligned_cols=264 Identities=24% Similarity=0.303 Sum_probs=196.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcC-Ccccceeeeeeeecce-----
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 545 (795)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 58899999886542 223467888999999995 6999999999887766
Q ss_pred eeEEeecCCCCChhhhhhccCC--cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFG 622 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFG 622 (795)
.++||||+++ +|..++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78777754322 346889999999999999999999988 999999999999998 8999999999
Q ss_pred cccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc--C
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK--D 699 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~ 699 (795)
++..+.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........... ...... .
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH--IFKLLGTPT 232 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHHHhCCCC
Confidence 988653221 11122356889999998865 4679999999999999999999999875432221110 000000 0
Q ss_pred ccccc-c---c----Ccccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 DRAWE-L---I----DPTLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 ~~~~~-~---i----d~~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+. . . -+... ....+.....+.++|.+||+.+|.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0 0 00000 01112345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.51 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=206.3
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeEEe
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILIY 550 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 550 (795)
+|+..+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 688999999865542 4467889999999999999999999999988 8899999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985432 6889999999999999999999987 999999999999999999999999999876544
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
..........++..|+|||.+....++.++||||||+++++|++|..|+........ ..+.... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~---------~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA----ALYKIGS---------SGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHhccc---------cCC
Confidence 321123345688999999999888899999999999999999999999876541111 1111110 011
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+......+.+++.+|++.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 112223335678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.46 Aligned_cols=273 Identities=26% Similarity=0.332 Sum_probs=200.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 548 (795)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999864 589999999864322 2234567899999999999999999998755 46899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+.+ +|..++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 677776432 245889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC--cccc--
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD--DRAW-- 703 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~-- 703 (795)
... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... +......... ...+
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--LDLIIQLLGTPNESIWPG 235 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChhhchh
Confidence 332 11222345788999998865 5689999999999999999999999875442221 1111010000 0000
Q ss_pred -------ccc--Cccccchh---hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCC
Q 003786 704 -------ELI--DPTLQNEA---SYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPH 756 (795)
Q Consensus 704 -------~~i--d~~l~~~~---~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~ 756 (795)
... ........ .......+.++|.+||+.||++|||+.|++++--....++|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 000 00000000 011245667899999999999999999999975444444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=302.44 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=193.9
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHH-HHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKL-IAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.+ ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999865 58999999986543 2234456666665 566789999999999999999999999
Q ss_pred cCCCCChhhhhhcc-CCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 552 YMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 552 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|++ ++|..++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5777766432 2335689999999999999999999986 5 99999999999999999999999999986532
Q ss_pred Cccccccccccccccccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQ----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.|+.........+. .... ...
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~--- 225 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK----QVVE-EPS--- 225 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH----HHHh-cCC---
Confidence 21 1223468899999998854 4578999999999999999999999864322111111 0000 000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.+ .....+..+.+++.+||+.+|++||++.+++++
T Consensus 226 --~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 --PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 011234568899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.69 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=204.5
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999875 688999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|.+++.... ..+++..+..++.|++.||.+||..+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46889999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....++..|+|||.+....++.++|+||||+++++|++|+.|+...+....... . ..........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~----~~~~~~~~~~------- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK--I----ATNGPPGLRN------- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--H----HhcCCCCcCc-------
Confidence 2345788999999999888899999999999999999999999865432111110 0 0000001110
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124568899999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.24 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=207.8
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccc--hHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG--QEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
....|.+.+.||+|.|++|.++++. ++.+||||++.+..... .+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567999999999999999999864 59999999998764333 35688999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+.+|.+.+++..+. .+.+..+..++.|+..|++|||+++ |||||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999995443 4566889999999999999999998 99999999999999999999999999998764
Q ss_pred CcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ...+.+|++.|.|||++.+..| .+.+|+||+|++||.|+.|..||++..-....-- .+..
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--------------vl~g 270 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--------------VLRG 270 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch--------------heee
Confidence 33 3456899999999999998766 6899999999999999999999986542222100 0000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. -.++.....++-++++++|-.+|.+|++++++.++
T Consensus 271 k--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 K--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred e--ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0 11222334567789999999999999999999875
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=301.57 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=199.6
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
-|++.+.||+|+||.||+|... +++.+|||++.... ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3677889999999999999754 68899999886432 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|..++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988842 34789999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|+|||||++|+|++|..|+........ .. .. .... ...
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~---~~-~~~~---------~~~ 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--LF---LI-PKNN---------PPT 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--HH---HH-hcCC---------CCC
Confidence 12235688899999999888899999999999999999999999864322111 10 00 0000 011
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112234567789999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.55 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=198.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 549 (795)
++|++.+.||+|+||.||+|+.. +++.+|+|.+..... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999875 588999999864322 2234567899999999999999999998877 889999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++ +|..++.... ..+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 8877774322 35889999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHh--------HhhhccC
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGH--------AWDLWKD 699 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~--------~~~~~~~ 699 (795)
.. .......+++.|+|||.+.+. .++.++|+||||+++++|++|..|+......... .... .|..+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999988654 5789999999999999999999998754422110 0000 0000000
Q ss_pred cc------cccccCccccchhhHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 DR------AWELIDPTLQNEASYL-ILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 ~~------~~~~id~~l~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
-. ........+....+.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0000000111111111 35567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.41 Aligned_cols=278 Identities=23% Similarity=0.248 Sum_probs=218.9
Q ss_pred HHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecc---cCccchHHHHHHHHHHHhcCCcccceeeeeeee
Q 003786 467 LASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSS---QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 467 ~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
...+....++|++++.||+|+||.|.+++++ +++.||+|++.+ ........|..|-.+|..-+.+=|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4445556789999999999999999999875 588999999987 233455678999999999999999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
..++|+|||||+||+|-.++. +...+++..+..++..|..||..||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999883 3346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
.+-.+..+.. ......+|||-|.+||++.. +.|+..+|+||+||++|||+.|..||-.. .++.....+.
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHh
Confidence 9987765443 33455789999999999853 57999999999999999999999998432 2222222222
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC---HHHHHHHHccccC------CCCCCCCCCccc
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT---MFEVVSMLTNKTI------NLPHPRQPAFSS 764 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl~~L~~~~~------~l~~p~~p~~~~ 764 (795)
.......+- ...+++....+||...|. +|+.|.. +.++..|.=+... ..++|.+|.+.+
T Consensus 295 ~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 295 NHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred chhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence 111111111 112245566778887665 7888887 9999987533222 256677777655
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.31 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=199.9
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
.|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455678999999999999864 588999999865544555678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998844 34788899999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......|++.|+|||.+.+..++.++|||||||++|||++|..|+...... ...... ..... +.+. .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~----~~~~~-----~~~~--~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRI----RDNLP-----PKLK--N 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHH----HhcCC-----CCCc--c
Confidence 122356899999999998888999999999999999999999998543211 111110 00100 0110 0
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11134578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.81 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=199.1
Q ss_pred CCccccccCcCCcccEEEeEe-cCcceEEEEEecccC-ccchHHHHHHHHHHHhcC---CcccceeeeeeeecceeeEEe
Q 003786 476 NFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 550 (795)
.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999986 468899999986542 334567889999999997 999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 25889999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..|+.......... ...... .+.
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~~~~~~-----~~~ 221 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------LIPKSK-----PPR 221 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------ccccCC-----CCC
Confidence 3 12233568899999998865 457899999999999999999999986533211100 000000 011
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+... .....+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1110 134567889999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.04 Aligned_cols=254 Identities=27% Similarity=0.366 Sum_probs=205.3
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..+.|+..+.||+|++|.||+|.+. +++.+++|++..... ..+.+.+|++++++++|+||+++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567889999999999999999876 588999999975543 56778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985432 36889999999999999999999987 9999999999999999999999999987654322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|..|+........ .... ....... .
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~~----~~~~~~~-----~- 236 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFLI----TTKGIPP-----L- 236 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----HhcCCCC-----C-
Confidence 1 22334578899999999888899999999999999999999999864322111 1000 0000000 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.........+.+++.+||+.+|.+||++.+|+++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 01112345678999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.39 Aligned_cols=262 Identities=22% Similarity=0.252 Sum_probs=197.2
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec------
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 543 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. ......++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 6899999998643 223345677899999999999999999987643
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
...++||||+.+ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999975 67666632 1788889999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHh------------
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLL------------ 690 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~------------ 690 (795)
++...... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ..+
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654322 12334678999999999999999999999999999999999999865432110 000
Q ss_pred Hh---HhhhccCc-------ccccccCccc----cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 691 GH---AWDLWKDD-------RAWELIDPTL----QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 691 ~~---~~~~~~~~-------~~~~~id~~l----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. ....+... ...+++...+ ...........+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000000 0001111100 011122345567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=329.05 Aligned_cols=256 Identities=28% Similarity=0.369 Sum_probs=191.6
Q ss_pred HHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL----- 543 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 543 (795)
+....+|+..+.||+||||.||+++.+ +|+.||||+|.... ......+.+|+..|.+|+|||||++|..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678999999999999999999865 79999999996553 33446788999999999999999998632110
Q ss_pred --------------------------------------------------------------------------------
Q 003786 544 -------------------------------------------------------------------------------- 543 (795)
Q Consensus 544 -------------------------------------------------------------------------------- 543 (795)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHH
Q 003786 544 ----------------------------------EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589 (795)
Q Consensus 544 ----------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 589 (795)
..+|+=||||+..+|.+++.++.... ....+++++++|+.||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 01367789999988888885443221 356889999999999999
Q ss_pred HHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC----C------------Cccccccccccccccccccccccc
Q 003786 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG----G------------DELQSKTKRIVGTYGYMSPEYAQQ 653 (795)
Q Consensus 590 LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APE~~~~ 653 (795)
+|+++ ||||||||.||+|+++..|||+|||+|.... . .......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99998 9999999999999999999999999998721 0 011112345789999999999876
Q ss_pred C---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhc
Q 003786 654 G---LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCV 730 (795)
Q Consensus 654 ~---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL 730 (795)
. .|+.|+|+|||||||+||+. ||....+....+- ..+.+.+... +. ........-.++|.+|+
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~-----~LR~g~iP~~--~~----f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT-----NLRKGSIPEP--AD----FFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH-----hcccCCCCCC--cc----cccccchHHHHHHHHHh
Confidence 4 59999999999999999984 4544332222111 1122222221 11 11122233457999999
Q ss_pred cCCCCCCCCHHHHHH
Q 003786 731 QEDAADRPTMFEVVS 745 (795)
Q Consensus 731 ~~dP~~RPt~~evl~ 745 (795)
+.||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999987
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.60 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=193.3
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcC-Ccccceeeeeeeec--ceeeEEee
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIEL--EEKILIYE 551 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 551 (795)
|++.++||+|+||.||+|+.. +++.||+|++.... ........+|+.++.++. ||||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999864 58899999986542 222334557899999885 99999999999987 88999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++ +|.+.+... ...+++..+..++.||++||.|||+.+ ++||||||+||+++. +.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 666666332 246889999999999999999999988 999999999999999 999999999998654322
Q ss_pred ccccccccccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc-----------cC
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW-----------KD 699 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~ 699 (795)
. .....++..|+|||.+. +..++.++|||||||++|||++|..||...+.... ........ ..
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ--IAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH--HHHHHHHcCCCCHHHHHhhcc
Confidence 1 12345789999999764 45678999999999999999999999976442211 11100000 00
Q ss_pred cccccccCcccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 DRAWELIDPTLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 ~~~~~~id~~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+... .......+..+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 11122346788999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.69 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=196.7
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
|++.+.||.|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999864 68999999986543 223457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
+ ++|..++.... ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 5 68888874332 235889999999999999999999987 9999999999999999999999999997653221
Q ss_pred ccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc-cCcc-------ccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW-KDDR-------AWE 704 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~-------~~~ 704 (795)
.......+++.|+|||++.+. .++.++||||||+++|+|++|..||......... ........ .... ..+
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL-FRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhhhhhchh
Confidence 111223568899999987654 5789999999999999999999998654321110 00000000 0000 000
Q ss_pred c---c---CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 705 L---I---DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 705 ~---i---d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. . ...............+.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0 0000011122234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.33 Aligned_cols=243 Identities=26% Similarity=0.300 Sum_probs=188.3
Q ss_pred ccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHh---cCCcccceeeeeeeecceeeEEeecCC
Q 003786 482 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAK---LQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..+++. .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 588999998865422 112334455444433 479999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|..++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 345899999999999999999999998 9999999999999999999999999987553221
Q ss_pred cccccccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....|++.|+|||.+. +..++.++||||+||++|+|++|..||............... . .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~----------~~~~~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L----------TVNVE 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h----------cCCcC
Confidence 12346899999999886 456899999999999999999999998654322221111100 0 00111
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L 747 (795)
.+.....++.+++.+||+.||++|| +++|+++|.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 2233456788999999999999999 699999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.41 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=200.2
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999865 48899999986532 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC-eeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-PKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-vkL~DFGla~~~~~~~ 631 (795)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999885432 234788999999999999999999987 999999999999998864 6999999998664322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......|++.|+|||++.+..++.++|+|||||+++||++|..|+........ . .... .....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~-~~~~~-------- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--V---LKIC-QGYFA-------- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--H---HHHh-cccCC--------
Confidence 1 12234689999999999888899999999999999999999999864332111 1 1111 11110
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+.+++.+|++.+|++|||+.|++++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=337.23 Aligned_cols=258 Identities=26% Similarity=0.339 Sum_probs=207.1
Q ss_pred HHHHccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
++..+-+++-..+||.|.||.||.+.. .+|.-.|+|-+.... ......+.+|..+|..++|||+|++||+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 344567889999999999999999975 458889999775443 33446788999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++.||||.+|+|.+.+.. ....++.....+..|++.|++|||++| ||||||||+||+|+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999843 233566667778899999999999999 99999999999999999999999999998
Q ss_pred cCCCc--ccccccccccccccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 627 FGGDE--LQSKTKRIVGTYGYMSPEYAQQG---LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 627 ~~~~~--~~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+.+.. .........||+.|||||++.+. ...-++|||||||++.||+||++||...+. ...+..++.. +
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIMy~V~~----g- 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIMYHVAA----G- 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHHhHHhc----c-
Confidence 76542 22334567899999999999653 467789999999999999999999964331 1111111100 0
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
-..+++.....+-.+++..||+.||++|-++.|++++-
T Consensus 1458 --------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1458 --------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred --------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 12234444666777899999999999999999999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.71 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=195.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----cee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
+++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 68999999986432 23345678899999999999999999886644 357
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++|+||+.+ +|..++. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 6666652 235889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc-cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc---c
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD---R 701 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~ 701 (795)
....... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ........... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHHH
Confidence 5432211 11223568999999998654 5789999999999999999999999865432111 00000000000 0
Q ss_pred cccccCc-----------ccc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWELIDP-----------TLQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~-----------~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+.+. ... ..........+.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000 00111234568899999999999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=302.51 Aligned_cols=247 Identities=30% Similarity=0.419 Sum_probs=195.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888999999999999999865 588999999864332 22356889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++ ++.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99985 555555322 235889999999999999999999988 999999999999999999999999998764322
Q ss_pred cccccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
....+++.|+|||.+. ...++.++||||||+++|||++|..|+.......... ..... ..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-----~~~~~-~~----- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQN-DS----- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-----HHhcC-CC-----
Confidence 2346788999999874 4568899999999999999999999986433211110 00000 00
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+.+ ........+.+++.+||+.+|++||++.+|+++.
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 011 1112445688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=325.29 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=187.0
Q ss_pred HccCCccccccCcCCcccEEEeEecC--cceEEEEE--------------ecc---cCccchHHHHHHHHHHHhcCCccc
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN--GQEVAVKR--------------LSS---QSGQGQEEFKNEIKLIAKLQHRNL 533 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~h~ni 533 (795)
..++|+++++||+|+||.||++.... +...++|. +.+ ........+.+|+++|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999986532 22222221 111 111234568899999999999999
Q ss_pred ceeeeeeeecceeeEEeecCCCCChhhhhhccCC--cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 534 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
|++++++.+.+..++|+|++.+ +|..++..... ........+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999865 45444432211 122334567789999999999999988 99999999999999
Q ss_pred CCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCC-CCCCCcc-hhH
Q 003786 612 KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT-DFSNTNS-LTL 689 (795)
Q Consensus 612 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~-~~~~~~~-~~~ 689 (795)
.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..++ ....... ..+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987643321 1223357999999999999999999999999999999999987543 3222111 111
Q ss_pred hHhHhhhcc--Cc-------ccccccCcc----ccchhh-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 690 LGHAWDLWK--DD-------RAWELIDPT----LQNEAS-----YLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 690 ~~~~~~~~~--~~-------~~~~~id~~----l~~~~~-----~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.... .... .. ..++.++.. ...... ......+.+++.+||+.||++|||+.|++++-
T Consensus 381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 1111 0000 00 000111000 000000 01223567789999999999999999999863
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=295.66 Aligned_cols=244 Identities=27% Similarity=0.352 Sum_probs=193.1
Q ss_pred cCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
||+|+||.||++... +++.+|+|.+.+.. ....+.+.+|+++|++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999754 58899999986532 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccc
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++..... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 988854332 35889999999999999999999988 9999999999999999999999999987654321 2223
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCcccccccCccccchhhHH
Q 003786 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDDRAWELIDPTLQNEASYL 717 (795)
Q Consensus 639 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ..+.. .... .....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~----------~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTLE----------MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---cccc----------ccccCCcc
Confidence 4678899999999888899999999999999999999999865443111 11100 0000 00111222
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 718 ILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 718 ~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
....+.+++.+||+.+|++|| ++.+++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 355678999999999999999 77777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.94 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=195.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|+..+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999864 58899999986543 234567889999999996 9999999999999999999999
Q ss_pred cCCCCChhhhhhc--cCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 552 YMPNKSLDFFLFD--STKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|+.. ++..+... ......+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9875 44433211 11235688999999999999999999975 5 9999999999999999999999999997654
Q ss_pred CCcccccccccccccccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQG---LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... .......... ..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~-~~---- 227 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK-GD---- 227 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcC-CC----
Confidence 322 11234688999999998765 689999999999999999999999864331 1111101000 00
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+.+........+..+.+++.+||+.+|++|||+.+|+++
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112223345678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=296.70 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=200.5
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
|++.+.||+|++|.||++... +++.+++|++...... ....+.+|++++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 6889999998654322 4567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++ +|..++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 86 777766432 246889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC--cccc-cccC--
Q 003786 634 SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD--DRAW-ELID-- 707 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~-~~id-- 707 (795)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.... .......... ...+ ...+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCchHhcccchhhh
Confidence 112234578899999988776 789999999999999999999998865442211 1110000000 0000 0000
Q ss_pred -----------ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 -----------PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 -----------~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..............+.++|.+||+.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000012233456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=292.49 Aligned_cols=249 Identities=21% Similarity=0.248 Sum_probs=192.7
Q ss_pred hHHHHccCCcccccc--CcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 469 SVSAATANFSTENKL--GEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 469 ~i~~~~~~~~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
++....++|++.+.+ |+|+||.||+++.. +++.+|+|++....... .|+.....+ +||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344455677777777 99999999999864 57889999986532111 122222222 7999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-Ceeeecccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGM 623 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGl 623 (795)
..++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999998433 36899999999999999999999988 99999999999999998 999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+...... ....++..|+|||++.+..++.++|||||||++|||++|+.|+................. . ..
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-~~- 226 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--Q-KK- 226 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--c-cc-
Confidence 8765322 224688999999999988999999999999999999999999974433322211111111 0 00
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT-MFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~ 746 (795)
..........+.+++.+||+.+|.+||+ ++|++++
T Consensus 227 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 227 --------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0111134457889999999999999996 6999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.90 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=192.6
Q ss_pred ccccccCcCCcccEEEeEec-CcceEEEEEec--c--cCccchHHHHHHHHHHHhcCCcccceeeeeeeecce--eeEEe
Q 003786 478 STENKLGEGGFGPVYKGRLL-NGQEVAVKRLS--S--QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE--KILIY 550 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 550 (795)
+...+||+|+|-+||+|-+. +|.+||--.++ . +.....++|..|+.+|+.|+|||||++|+++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 55678999999999999753 47777643332 1 233445889999999999999999999999987766 67899
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~~~~ 629 (795)
|.|..|+|..++.. .+.++...+..+++||++||.|||++. ++|||||||.+||+|+. -|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999844 344777899999999999999999986 78999999999999975 58999999999998754
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .....|||.|||||... ..|+..+||||||+.++||+|+..|+.--.... ++...+..-.+......+-|
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-QIYKKV~SGiKP~sl~kV~d-- 270 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-QIYKKVTSGIKPAALSKVKD-- 270 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-HHHHHHHcCCCHHHhhccCC--
Confidence 32 33478999999999887 889999999999999999999999874322111 11111111111111111112
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+.++|.+||.. .++|||+.|+|++
T Consensus 271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 ----------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3567899999999 9999999999985
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.96 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=195.9
Q ss_pred cCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
||.|++|.||+++.. +++.+|+|++.+... ...+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999875 488999999865432 3346789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccc
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 234788999999999999999999987 9999999999999999999999999998764332 1223
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHH
Q 003786 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..+++.|+|||.+....++.++|+||||+++|+|++|..|+.............. .... .....+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---------~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI---LKGN---------GKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH---hccC---------CCCCCCccc
Confidence 4688999999999888899999999999999999999999875543222111111 0000 001112222
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 003786 719 LNRYINVGLLCVQEDAADRPT-----MFEVVSM 746 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 746 (795)
...+.+++.+||+.+|++||+ +.|++++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 567889999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=302.74 Aligned_cols=262 Identities=21% Similarity=0.257 Sum_probs=193.9
Q ss_pred cccCcC--CcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEG--GFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
..||+| +||+||++++. +++.||||++.... ....+.+++|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 89999999864 68999999986432 22346788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc--
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ-- 633 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~-- 633 (795)
++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998885432 234788889999999999999999987 999999999999999999999999865433211100
Q ss_pred ---ccccccccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC---------
Q 003786 634 ---SKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD--------- 699 (795)
Q Consensus 634 ---~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------- 699 (795)
.......++..|+|||++.+. .++.++|||||||++|||++|..|+....................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 001112356679999998764 578999999999999999999999865432211100000000000
Q ss_pred -----------------c-----ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 -----------------D-----RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 -----------------~-----~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .........+.......+...+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0001111112222334566788999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.65 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=197.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec-----ce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 545 (795)
..+|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999864 5899999998653 223345677899999999999999999987654 34
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 577777732 345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhh--------
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWD-------- 695 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~-------- 695 (795)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.... ........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 654322 11233467889999998765 5689999999999999999999999865432111 00000000
Q ss_pred hccCccccccc-------CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 696 LWKDDRAWELI-------DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 696 ~~~~~~~~~~i-------d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..........+ ++.. ..........+.+++.+||+.+|++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 0000 01112345678899999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=279.18 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=196.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 551 (795)
++.+.+..||.|.-|.|++.++. +|..+|||.+.+.. .+..+++...+.++.+.+ +|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45566778999999999999865 48999999997653 334466777888777665 8999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
.|.. .++.++.. -.+.+++..+-++...+.+||.||.+++ .|||||+||+|||+|+.|++||+|||++-.+-...
T Consensus 172 lMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8843 44555532 2345888888899999999999999876 69999999999999999999999999987654332
Q ss_pred cccccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
..++..|-+.|||||.+.- ..|+.++||||||++|+||.||..|+...+.+-..+.... .++. |
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl----n~eP------P 313 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL----NEEP------P 313 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH----hcCC------C
Confidence 2344679999999998853 4799999999999999999999999987554332222111 1111 1
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+.... .+...+++++..||+.|+.+||...+++++
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 121111 145678889999999999999999999874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=281.84 Aligned_cols=279 Identities=23% Similarity=0.325 Sum_probs=202.8
Q ss_pred ccCCccccccCcCCcccEEEeEecC-----cceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeee-cce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 545 (795)
...|+.+.+||+|.||.||+|.-.+ .+.+|||+++.+... --...-+|+..++.++||||+.|..+|.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3578999999999999999995322 337999998654222 23567799999999999999999999987 778
Q ss_pred eeEEeecCCCCChhhhhhc--cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC----CCeeee
Q 003786 546 KILIYEYMPNKSLDFFLFD--STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD----MNPKIS 619 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~----~~vkL~ 619 (795)
.++++||.+...+ .+|+- ..+.+.++...+..|+.||+.|+.|||+.. |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987544 44432 223357889999999999999999999987 9999999999999877 899999
Q ss_pred ccccccccCCCcc-ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCc-----ch--hHh
Q 003786 620 DFGMARIFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN-----SL--TLL 690 (795)
Q Consensus 620 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~-----~~--~~~ 690 (795)
|||+++++...-. .......+-|..|.|||.+.+ ..|+.+.|||+.|||+.||++-.+-|...... .. +.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998865432 223455678999999998876 58999999999999999999988777543310 00 111
Q ss_pred HhHhhhccC--cccccccCc-------------cccchhh---HH-----HHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 691 GHAWDLWKD--DRAWELIDP-------------TLQNEAS---YL-----ILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 691 ~~~~~~~~~--~~~~~~id~-------------~l~~~~~---~~-----~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
......... ...|.-+.. ....... .. -.....+|+.++|+.||.+|.|+++.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 111111110 011110000 0000000 00 011257899999999999999999999998
Q ss_pred ccccCCCCC
Q 003786 748 TNKTINLPH 756 (795)
Q Consensus 748 ~~~~~~l~~ 756 (795)
.....++|.
T Consensus 339 yF~~d~lpp 347 (438)
T KOG0666|consen 339 YFTEDPLPP 347 (438)
T ss_pred ccccCCCCC
Confidence 776666653
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.03 Aligned_cols=261 Identities=27% Similarity=0.351 Sum_probs=197.8
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeEEee
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILIYE 551 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 551 (795)
|++.+.||+|++|.||+|+.. +++.+|+|++.... ......+.+|++++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999875 48899999997653 33345688999999999999999999999988 88999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 787777432 246889999999999999999999987 9999999999999999999999999998764432
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc---Cccc-----
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK---DDRA----- 702 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~----- 702 (795)
. .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ ......... ....
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchhhcccccc
Confidence 1 11223456888999997765 4689999999999999999999999865442211 111100000 0000
Q ss_pred ---cccc------CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 ---WELI------DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ---~~~i------d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... ...+.......+...+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 0000011111125678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=292.85 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=203.5
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.++||+|+||.||+++.. +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 68899999986532 23345778899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999885422 2355788999999999999999999988 9999999999999999999999999998765431
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.....+++.|+|||.+.+..++.++|+||||+++++|++|+.|+...+.... ... ..... .
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~----~~~~~---------~ 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYK----VQRGK---------Y 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HhcCC---------C
Confidence 2234578899999999999999999999999999999999999865432211 110 01111 1
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223455678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.55 Aligned_cols=267 Identities=21% Similarity=0.295 Sum_probs=199.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee----ccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 546 (795)
..+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999864 58999999987542 2344677889999999999999999998763 3467
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 578887733 344899999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccc--cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhH--------h
Q 003786 627 FGGDELQ--SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHA--------W 694 (795)
Q Consensus 627 ~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~--------~ 694 (795)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5332211 11123578899999998765 56899999999999999999999999654422110 00000 0
Q ss_pred hhccCcccccccCc---cc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 695 DLWKDDRAWELIDP---TL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 695 ~~~~~~~~~~~id~---~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
...........++. .. ...........+.+++.+||+.+|++||++.+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000000000 00 0011122456788999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.00 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=197.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc-----CccchHHHHHHHHHHHhcCCcccceeeeeeeec--cee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.+|++.+.||+|+||.||+|+.. +++.||+|++... .......+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 5889999987532 122345788999999999999999999998764 457
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++|+||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988843 234788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~---~~~------ 224 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI---ATQ------ 224 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH---HcC------
Confidence 532111 111223568999999999988889999999999999999999999986432111 11110 000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......+......+.+++.+|++ +|..||++.+++++
T Consensus 225 ---~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 225 ---PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 01112233445678889999999 57999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.81 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=195.1
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 588999999865422 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccccccccCCC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~~~~~ 630 (795)
|+++ +|..++... ....+++..+..++.||+.||+|||+++ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9975 666665332 2233577788899999999999999987 999999999999985 557999999999765322
Q ss_pred ccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--ccc----
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD--RAW---- 703 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~---- 703 (795)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.|+........ ........... ..+
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChhhccccc
Confidence 1 11223467889999998866 4678999999999999999999999875432211 11100000000 000
Q ss_pred ---c--ccCcccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ---E--LIDPTLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ---~--~id~~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ...+... ..........+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000000 00112234567899999999999999999999974
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=300.86 Aligned_cols=248 Identities=31% Similarity=0.422 Sum_probs=195.1
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.|+..+.||+|+||.||+++.. +++.+|+|++..... .....+.+|++++++++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3778899999999999999864 588999999864322 233568889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 666655322 344889999999999999999999988 99999999999999999999999999875432
Q ss_pred ccccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.....|++.|+|||++. .+.++.++|||||||++|||++|..|+........ .... ..... +
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~---~~~~~------~ 242 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI---AQNES------P 242 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH---HhccC------C
Confidence 22346889999999873 45789999999999999999999999754321111 1000 00000 0
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..........+.+++.+||+.+|.+||++.+|++++-.
T Consensus 243 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 ---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00111234467889999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=296.03 Aligned_cols=260 Identities=16% Similarity=0.178 Sum_probs=182.8
Q ss_pred ccCCccccccCcCCcccEEEeEecC----cceEEEEEecccCccchH-----------HHHHHHHHHHhcCCcccceeee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGQE-----------EFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~~ 538 (795)
..+|++.++||+|+||.||+|+..+ +..+|+|+.......... ....+...+..++|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998654 345666654332211111 1122334456678999999998
Q ss_pred eeeecc----eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC
Q 003786 539 CCIELE----EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 539 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 614 (795)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 766543 34677887644 44444422 123467788899999999999999988 99999999999999999
Q ss_pred CeeeeccccccccCCCcc-----cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH
Q 003786 615 NPKISDFGMARIFGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689 (795)
Q Consensus 615 ~vkL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~ 689 (795)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999986532211 111223469999999999999999999999999999999999999997653222111
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.......... +..+.+. ....+..+.+++..|++.+|++||++.++++.++
T Consensus 244 ~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKR-----LHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHH-----hhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111111000 0001000 1112456788999999999999999999998763
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.69 Aligned_cols=256 Identities=27% Similarity=0.353 Sum_probs=198.5
Q ss_pred CCccccccCcCCcccEEEeEe-cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecc------eee
Q 003786 476 NFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE------EKI 547 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 547 (795)
.|...+.||+|+||.||+|++ .+|+.||||.+++.. ....+...+|+++|++++|||||++++.-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 356678999999999999995 569999999997643 345677889999999999999999999865544 457
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC--CCCC--eeeecccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMN--PKISDFGM 623 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~~--vkL~DFGl 623 (795)
+|||||.+|+|...+.+.....-+++.+.+.+...+..||.|||+++ |+||||||.||++- .+|. .||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988777788999999999999999999999887 99999999999993 4444 69999999
Q ss_pred ccccCCCcccccccccccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD-- 700 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 700 (795)
|+.+..+. ......||+.|++||... .+.|+..+|.|||||++|+.+||..||.....+............+..
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99876554 456689999999999998 589999999999999999999999999654433211111110111110
Q ss_pred -----------c-cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCC
Q 003786 701 -----------R-AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRP 738 (795)
Q Consensus 701 -----------~-~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP 738 (795)
+ .+...-|. ..........++-..+..+|..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 00000011 1223344555677778888888998887
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.61 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=197.0
Q ss_pred cccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCC
Q 003786 479 TENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 557 (795)
...+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3468999999999999864 688999999865544556678999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccc
Q 003786 558 LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK 637 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~ 637 (795)
|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 104 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 104 LTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 9887732 24788899999999999999999988 9999999999999999999999999987654322 1123
Q ss_pred ccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHH
Q 003786 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717 (795)
Q Consensus 638 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
...|++.|+|||.+.+..++.++|+||+||++|+|++|..|+........ ....... ..+.+. ....
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~~~~~~~---------~~~~~~--~~~~ 241 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRDN---------LPPKLK--NLHK 241 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhh---------CCcccC--Cccc
Confidence 35688999999999888899999999999999999999999864332111 1111000 000000 0011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 718 ILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 718 ~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+.+++.+||+.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23456789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=290.59 Aligned_cols=245 Identities=21% Similarity=0.244 Sum_probs=189.6
Q ss_pred cccCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHHHH-HhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIKLI-AKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||||++.+.... ....+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 5889999998654321 223345555544 455899999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998843 345889999999999999999999987 99999999999999999999999999875432
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..|+........ ... ...... .......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~~~~------~~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FDN----ILSRRI------NWPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHH----HHhccc------CCCCccc
Confidence 2235688999999999888899999999999999999999999865432211 100 000000 0011111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..++..+.+++.+||+.+|++||++.++.+.|..
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 2345678899999999999999987666555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=298.77 Aligned_cols=264 Identities=20% Similarity=0.203 Sum_probs=194.3
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
.+++.+|.|+++.||+++. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 4445555666655555544 6899999998654 334557899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc---
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL--- 632 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~--- 632 (795)
++|.+++.... ...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986432 234788899999999999999999988 99999999999999999999999999875432111
Q ss_pred --ccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh----ccCc----
Q 003786 633 --QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL----WKDD---- 700 (795)
Q Consensus 633 --~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~---- 700 (795)
........++..|+|||++.. ..++.++|+|||||+++||++|..||......... ....... ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML-LEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCccccccCchhh
Confidence 111233457788999999866 35889999999999999999999998654322111 1110000 0000
Q ss_pred ---cccc----ccCcc----ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 701 ---RAWE----LIDPT----LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 701 ---~~~~----~id~~----l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.... ..++. ............+.+++.+||+.+|++|||+++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0000 00000 01112233456788999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=304.39 Aligned_cols=266 Identities=26% Similarity=0.301 Sum_probs=197.6
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhc-CCcccceeeeeeeec--cee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 546 (795)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578999999999999999999865 5889999988543 223345677899999999 999999999998654 367
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++ +|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYMET-DLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEeccccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999999984 88777733 25788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc---cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHhHhh------
Q 003786 627 FGGDELQ---SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGHAWD------ 695 (795)
Q Consensus 627 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~~------ 695 (795)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5433211 12234568999999998754 568899999999999999999999986544222100 000000
Q ss_pred --hccCcccccccCc---cc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 696 --LWKDDRAWELIDP---TL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 696 --~~~~~~~~~~id~---~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+.......+++. .- ...........+.+++.+||+.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000100 00 000111134678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.29 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=196.5
Q ss_pred CCccccccCcCCcccEEEeEe----cCcceEEEEEecccCc----cchHHHHHHHHHHHhc-CCcccceeeeeeeeccee
Q 003786 476 NFSTENKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQSG----QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
+|++.+.||+|+||.||+++. .+|+.||+|++..... ...+.+.+|+++++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 3688999999865321 2346788999999999 599999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
....... ......|+..|+|||.+.. ..++.++||||||+++|+|++|..|+........ ............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE---- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-HHHHHHHhhccC----
Confidence 5433211 1223568899999998865 3578899999999999999999999864332111 111111110000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
...+......+.+++.+||+.+|++|| ++.+++++
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011222345677899999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=289.28 Aligned_cols=248 Identities=30% Similarity=0.409 Sum_probs=202.1
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578999999976543 3456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988433 56899999999999999999999988 99999999999999999999999999987654332
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. .....++..|+|||.+.+..++.++||||+|+++++|++|..|+........ .+.... ... .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~---------~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRIVQ-DDH---------P 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhc-cCC---------C
Confidence 1 2335688999999999888899999999999999999999999864331111 011100 000 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.+|++||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1112234577789999999999999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=299.75 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=193.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecce-----
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 545 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999865 58899999886432 2223456789999999999999999999876543
Q ss_pred ---eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 546 ---KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 546 ---~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
.++||||+.+ +|...+.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 67666632 2235889999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccc--ccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhcc
Q 003786 623 MARIFGGDELQ--SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWK 698 (795)
Q Consensus 623 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~ 698 (795)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ ..+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865432211 112234578899999987654 578999999999999999999998865432211 11111100000
Q ss_pred Cc-----ccccccC----c-cccchhh-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 699 DD-----RAWELID----P-TLQNEAS-----YLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 699 ~~-----~~~~~id----~-~l~~~~~-----~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. ......+ + ....... ......+.++|.+||+.+|++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 0000000 0 0000000 0112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=290.27 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=205.2
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|++.+.||+|+||.||++... +++.+|+|++..... .....+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999865 588999999865433 4556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+++++|.+++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885432 2356899999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|..|+........ ... . .....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~---~-~~~~~--------- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL--ALK---I-LKGQY--------- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH--HHH---H-hcCCC---------
Confidence 122335788999999999888899999999999999999999999865432111 111 0 01110
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||..+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11112334577889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.34 Aligned_cols=266 Identities=26% Similarity=0.339 Sum_probs=197.2
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc----
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE---- 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 544 (795)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999875 48899999986542 223456788999999999999999999987655
Q ss_pred ------eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 545 ------EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 545 ------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
..++|+||+++ ++...+... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 555555322 345889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++|+........ +.......
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELISRLC 234 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHh
Confidence 99999986643321 11122346788999998765 4578999999999999999999999865432111 11111100
Q ss_pred cCc-----------ccccccCccc--cc---hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 KDD-----------RAWELIDPTL--QN---EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~-----------~~~~~id~~l--~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... ......++.. .. ......+..+.+++..||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0000000000 00 0111234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.74 Aligned_cols=242 Identities=26% Similarity=0.310 Sum_probs=187.8
Q ss_pred ccCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHH---HHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 482 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIK---LIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
.||+|+||.||+++.. +++.||+|.+.+.... ....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5889999998654221 1223444444 3444579999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|..++.. .+.+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988843 346899999999999999999999988 9999999999999999999999999987653221
Q ss_pred cccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||.............. ... ... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~------~~~----~ 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT------MAV----E 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---hhc------cCC----C
Confidence 2234689999999998754 689999999999999999999999875432221111100 000 001 1
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.+......+.+++.+||+.+|++|| ++.+++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1122345788899999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.91 Aligned_cols=250 Identities=27% Similarity=0.342 Sum_probs=203.1
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 549 (795)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999865 68999999986532 233467889999999998 99999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998843 336899999999999999999999988 99999999999999999999999999987644
Q ss_pred Cccc------------------ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhH
Q 003786 630 DELQ------------------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLG 691 (795)
Q Consensus 630 ~~~~------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~ 691 (795)
.... .......++..|+|||.+....++.++|+||||++++++++|+.|+....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TFQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HHH
Confidence 3221 22234567899999999988889999999999999999999999987544211 111
Q ss_pred hHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCH----HHHHHH
Q 003786 692 HAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTM----FEVVSM 746 (795)
Q Consensus 692 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~----~evl~~ 746 (795)
... . .....+...+..+.+++.+||+.+|++||++ ++++++
T Consensus 233 ~~~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 KIL---K-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHH---h-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 110 0 0011122235578899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.33 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=195.7
Q ss_pred cCcCCcccEEEeEecC-cceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 483 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
||+|+||.||+++... ++.+++|++..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998764 89999999865433 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc------
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL------ 632 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~------ 632 (795)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988542 35889999999999999999999988 99999999999999999999999999876432211
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
........++..|+|||.+....++.++||||||+++|+|++|..|+........ ... . ..... . .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~---~-~~~~~----~----~ 220 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQN---I-LNGKI----E----W 220 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---H-hcCCc----C----C
Confidence 1122335678899999999888899999999999999999999999865432211 110 0 00000 0 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.........+.+++.+||+.+|++|||+.++.+.|..
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0000124677899999999999999999666665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=289.84 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=197.4
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
...+|.++.+||+|+||+|.++..+ +.+-+|||++++.. ..+.+--..|-++|... +-|.+++++.+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3467899999999999999999754 46779999997753 23344556788888766 4689999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+.||+|-.++. +-+.+.+..+..++.+||-||-+||+++ ||+||||.+|||||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999988884 3445778899999999999999999998 999999999999999999999999999852
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
--. ...+.+++|||.|+|||++...+|+.++|+||+||+||||+.|.+||++.++....... ++
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--------------~e 564 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--------------ME 564 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------------HH
Confidence 211 23466799999999999999999999999999999999999999999987654432111 11
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCC
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRP 738 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP 738 (795)
.. -..+...+.+...++...|..+|.+|.
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 113334455677788888999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=290.30 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=195.4
Q ss_pred CccccccCcCCcccEEEeEecC-cceEEEEEecccCcc--chHHHHHHHHHHHhc---CCcccceeeeeeeecce-----
Q 003786 477 FSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKL---QHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 545 (795)
|++.+.||+|+||.||+|+... ++.+|+|++...... ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999764 899999999643222 234566788877766 59999999999998776
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.+++|||+++ +|.+++.... ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999985 7877774322 235889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC------
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD------ 699 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 699 (795)
...... ......++..|+|||.+.+..++.++|+|||||++|||++|..|+........ ..........
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhc
Confidence 764332 12234578899999999988999999999999999999999988865432211 1111110000
Q ss_pred --ccc--ccccCccc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 --DRA--WELIDPTL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 --~~~--~~~id~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... ........ ...........+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 00000000 011222345677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=298.57 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=199.8
Q ss_pred ccccCcCCcccEEEeEe-cCcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 480 ENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
.+.||+|.||+||-|++ ++|+.||||++.+. ....+..+++|+.||++++||.||.+.-.|+..+..+.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999986 46999999999764 3345578999999999999999999999999999999999999877
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC---CCeeeeccccccccCCCccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~vkL~DFGla~~~~~~~~~ 633 (795)
-|+-+|. ...+.+++.....++.||+.||.|||.++ |+|+||||+|||+.+. ..+||+|||+|++++...+
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 7766663 33456888888999999999999999998 9999999999999654 4799999999999876553
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.+..+|||.|+|||+++++.|...-|+||.|||+|--++|..||.-. +++. .++.+. ++ ...
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAa----------FM---yPp 785 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAA----------FM---YPP 785 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccc----------cc---cCC
Confidence 34578999999999999999999999999999999999999887532 2221 111111 11 112
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+.....+++|...||..-++|-+..+-+.+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2233455677899999999999999999887764
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=298.49 Aligned_cols=267 Identities=22% Similarity=0.281 Sum_probs=197.5
Q ss_pred ccCCc-cccccCcCCcccEEEeEec-CcceEEEEEecccCccc--------------hHHHHHHHHHHHhcCCcccceee
Q 003786 474 TANFS-TENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG--------------QEEFKNEIKLIAKLQHRNLVRLL 537 (795)
Q Consensus 474 ~~~~~-~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 537 (795)
.++|. +.+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35565 4577999999999999865 58999999986532221 12477899999999999999999
Q ss_pred eeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCee
Q 003786 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 538 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vk 617 (795)
+++...+..++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 578777743 345888999999999999999999988 99999999999999999999
Q ss_pred eeccccccccCCCcc------------cccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 003786 618 ISDFGMARIFGGDEL------------QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNT 684 (795)
Q Consensus 618 L~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~ 684 (795)
|+|||++........ ........+++.|+|||.+.+. .++.++|||||||++|||++|..|+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999986541110 1111223568889999988764 579999999999999999999999875543
Q ss_pred cchhHhHhHhhhccCcc-----------cccccCccc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 685 NSLTLLGHAWDLWKDDR-----------AWELIDPTL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 685 ~~~~~~~~~~~~~~~~~-----------~~~~id~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
... ............ ......... ...........+.+++.+||+.+|++||++.|++.+.-.
T Consensus 240 ~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 240 IDQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 221 111111110000 000000000 001112234567899999999999999999999986433
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.77 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=193.4
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc----
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE---- 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 544 (795)
....+|.+.+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 33578999999999999999999864 68999999986532 223456889999999999999999999987543
Q ss_pred --eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 545 --EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 45899999864 565544 124788999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc--cC
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW--KD 699 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--~~ 699 (795)
+++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ........ ..
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 235 (342)
T cd07879 163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPG 235 (342)
T ss_pred CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCC
Confidence 98754321 223467889999998876 4689999999999999999999999975432111 10000000 00
Q ss_pred cccccccC-----------ccc-cchh---hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 700 DRAWELID-----------PTL-QNEA---SYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 700 ~~~~~~id-----------~~l-~~~~---~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+.+. +.. .... .+.....+.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000 0000 11233567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.15 Aligned_cols=255 Identities=24% Similarity=0.289 Sum_probs=198.1
Q ss_pred CCccccccCcCCcccEEEeEe----cCcceEEEEEecccC----ccchHHHHHHHHHHHhc-CCcccceeeeeeeeccee
Q 003786 476 NFSTENKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
+|++.+.||+|++|.||+++. .+++.||||++.+.. ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999974 246789999986432 22345688999999999 599999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|..++.. ...+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988843 345788899999999999999999987 99999999999999999999999999886
Q ss_pred cCCCcccccccccccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
+..... .......|+..|+|||.+.+.. ++.++||||||+++|||++|..|+......... ..........
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ-SEISRRILKS----- 227 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH-HHHHHHHHcc-----
Confidence 543321 1122346889999999987654 789999999999999999999998643221110 0000000000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+ ..+......+.+++.+||+.+|++|||+.++.+.|..
T Consensus 228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 1112233467789999999999999999888777655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=298.70 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=194.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeeecc------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|++.++||+|+||.||+|+.. +++.+|||++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 5889999988654322 2346788999999999999999999876543
Q ss_pred --eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 545 --EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
..++|+||+.+ ++...+.. ....+++..+..++.||++||.|||+++ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999976 45555532 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc---------cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh
Q 003786 623 MARIFGGDELQ---------SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692 (795)
Q Consensus 623 la~~~~~~~~~---------~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 692 (795)
++......... .......+++.|+|||.+.+ ..++.++|||||||++|||++|++|+........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~--~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ--LHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 99865432211 11123457888999998765 4689999999999999999999999865443221 111
Q ss_pred HhhhccCc---------cccc----ccCccccc---hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 693 AWDLWKDD---------RAWE----LIDPTLQN---EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 693 ~~~~~~~~---------~~~~----~id~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........ .... ........ .........+.+++.+||+.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11100000 0000 00000000 0111223567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.99 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=193.5
Q ss_pred ccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCc-cchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++|++.+.||+|+||.||+|+... ++.||||++..... ....++..|+.++.++. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678999999999999999999764 88999999865432 23455677887777775 999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||+.+ ++..++... ...+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99864 666665332 23688899999999999999999974 5 99999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
... .....++..|+|||.+... .++.++||||||+++|+|++|+.|+........ .... ..... ...
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~---~~~~~-~~~- 238 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTK---ILQEE-PPS- 238 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHH---HhcCC-CCC-
Confidence 221 1223578899999988654 388999999999999999999999864322111 1111 11111 000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+. .......++.+++.+||+.+|++||++.+++++.
T Consensus 239 ----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 ----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00 0012345688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.00 Aligned_cols=262 Identities=24% Similarity=0.284 Sum_probs=196.2
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEeecC
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
|++.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+++++ ||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999975 478899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 778887774432 245889999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccccccccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH------hhhcc-----Ccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA------WDLWK-----DDR 701 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~------~~~~~-----~~~ 701 (795)
......++..|+|||.+. ...++.++|+||||++++||++|+.|+.............. ...+. ...
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122346788999999875 45689999999999999999999998865543221100000 00000 000
Q ss_pred cccccCcccc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWELIDPTLQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+..... ..........+.+++.+||+.+|++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00111124678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.17 Aligned_cols=262 Identities=25% Similarity=0.289 Sum_probs=200.9
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc-----eee
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE-----EKI 547 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 547 (795)
+|++.+.||+|++|.||+|+.. +++.+|||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999875 48899999987643 344567899999999999999999999988775 789
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++ +|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 78777743 236889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcc-cccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc-------
Q 003786 628 GGDEL-QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK------- 698 (795)
Q Consensus 628 ~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~------- 698 (795)
..... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHh
Confidence 44321 0112334678899999999887 899999999999999999999999875542211 000000000
Q ss_pred ----CcccccccC---ccc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 699 ----DDRAWELID---PTL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 699 ----~~~~~~~id---~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+. ... ...........+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000 000111234577899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.15 Aligned_cols=269 Identities=22% Similarity=0.239 Sum_probs=199.1
Q ss_pred cHHhHHHHccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee
Q 003786 466 SLASVSAATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 466 ~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
...++....++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456677789999999999999999999985 468899999986532 2234668889999999999999999998764
Q ss_pred c------ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 543 L------EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 543 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
. ...++++|++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 3357777776 7788877632 34788999999999999999999988 9999999999999999999
Q ss_pred eeeccccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|+................
T Consensus 160 kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999875432 1233567899999998866 578999999999999999999999986543211100000000
Q ss_pred hccCcccccccCcc-----------c-cc---hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 696 LWKDDRAWELIDPT-----------L-QN---EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 696 ~~~~~~~~~~id~~-----------l-~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..........+... . .. .........+.+++..||+.+|.+||++.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00000000000000 0 00 00001234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=302.29 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=194.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec---------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--------- 543 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 543 (795)
..+|++.+.||.|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999864 5889999998766556667889999999999999999999876543
Q ss_pred -----ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCee
Q 003786 544 -----EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPK 617 (795)
Q Consensus 544 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vk 617 (795)
...++||||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 47877663 234788999999999999999999988 999999999999974 56789
Q ss_pred eeccccccccCCCccc-cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh-
Q 003786 618 ISDFGMARIFGGDELQ-SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW- 694 (795)
Q Consensus 618 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~- 694 (795)
|+|||++......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...............
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765322111 11122357889999997654 56889999999999999999999999654321111000000
Q ss_pred hhccC---cccc----cccC-cc--cc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 695 DLWKD---DRAW----ELID-PT--LQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 695 ~~~~~---~~~~----~~id-~~--l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... .... ..+. .. .. .........++.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 0000 0000 00 00 00111234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.26 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=197.5
Q ss_pred hHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc-
Q 003786 469 SVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE- 544 (795)
Q Consensus 469 ~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 544 (795)
++....++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+++|++++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34455678999999999999999999754 68899999985432 223456889999999999999999999987654
Q ss_pred -----eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 545 -----EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 545 -----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 358999998 6788877732 35889999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH-----
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA----- 693 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~----- 693 (795)
|||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||..............
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999865322 223467889999998876 4688999999999999999999999865432111000000
Q ss_pred ----hhhccCcccccccC--cccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 694 ----WDLWKDDRAWELID--PTLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 694 ----~~~~~~~~~~~~id--~~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
............+. +... ..........+.+++.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 0000 01112234467899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.47 Aligned_cols=270 Identities=22% Similarity=0.265 Sum_probs=217.2
Q ss_pred HHccCCccccccCcCCcccEEEeEecCcc-eEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLLNGQ-EVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
....+++.+..||-||||.|=+++..... .+|+|++++.. ...++.+..|-.||...+.|.||++|..|.+....|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34567888899999999999999865433 48999887653 344567889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
++||-|-||.|...+. .++.++...+..++..+.+|+.|||.++ ||+|||||+|++|+.+|.+||.|||+|+.+
T Consensus 497 mLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999994 4566899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... .+-+++|||+|.|||++.++.++.++|.||||+++|||++|.+||...+.-...-+ .++.....
T Consensus 571 ~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-----ILkGid~i---- 638 (732)
T KOG0614|consen 571 GSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-----ILKGIDKI---- 638 (732)
T ss_pred ccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-----HHhhhhhh----
Confidence 6543 56679999999999999999999999999999999999999999976553222111 11111111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHH--cc------ccCCCCCCCCCCccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSML--TN------KTINLPHPRQPAFSS 764 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~L--~~------~~~~l~~p~~p~~~~ 764 (795)
..+........++|.+....+|.+|.- +.+|.+|- ++ ....+|+|.+|....
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence 123334456678888899999999976 67777763 22 123467777765543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=294.65 Aligned_cols=244 Identities=30% Similarity=0.410 Sum_probs=191.2
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
|...++||+|+||.||+|+.. +++.|++|++...... ..+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 5889999998654322 235678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+.+ ++.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 975 56555532 2345888999999999999999999988 9999999999999999999999999986432
Q ss_pred cccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
......|+..|+|||++. ...++.++|||||||++|+|++|..|+........ ... .... .....
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~~~---~~~~-~~~~~---- 240 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH---IAQN-DSPTL---- 240 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH---HHhc-CCCCC----
Confidence 122356889999999874 45688999999999999999999999754332111 110 0000 00000
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+.+++.+||+.+|.+||++.+++++
T Consensus 241 ----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223457789999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=296.51 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=196.9
Q ss_pred HHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee-ccee
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEK 546 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 546 (795)
...+++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345688999999999999999999855 68999999886432 2334678899999999999999999999875 5678
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++++||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 457877763 234678888899999999999999988 99999999999999999999999999875
Q ss_pred cCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHh--------Hhhh
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGH--------AWDL 696 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~--------~~~~ 696 (795)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... ... ....
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 123467889999998765 578999999999999999999999986543211100 000 0000
Q ss_pred ccCcccccccCc-cccch-----hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 697 WKDDRAWELIDP-TLQNE-----ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 697 ~~~~~~~~~id~-~l~~~-----~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+++.. ..... ........+.++|.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 00000 111234678899999999999999999999886
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=288.21 Aligned_cols=262 Identities=26% Similarity=0.347 Sum_probs=198.7
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
|+..+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999875 48999999997653 333467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 48988885432 35889999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh--HhH-------hHhhhccCcccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT--LLG-------HAWDLWKDDRAW 703 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~--~~~-------~~~~~~~~~~~~ 703 (795)
......++..|+|||.+.+. .++.++|||||||+++||++|+.|+......... ... ..|..+......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234467889999988766 8899999999999999999999888654321110 000 000000000000
Q ss_pred cccCccc----cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTL----QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...-+.. .....+.....+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 001111225578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=285.47 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=195.0
Q ss_pred CCccccccCcCCcccEEEeEecC-cceEEEEEeccc-----CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-----SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
+|.+.++||+|+||.||+++... +..+++|++... .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998643 455666655431 122334577899999999999999999999999999999
Q ss_pred eecCCCCChhhhhhcc-CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
+||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23356899999999999999999999988 999999999999975 569999999988654
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .......|++.|+|||.+.+..++.++|+||||+++++|++|..|+..... ..... .. .... .
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~---~~-~~~~-----~- 222 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVL---RI-VEGP-----T- 222 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHH---HH-HcCC-----C-
Confidence 322 122335688899999999888899999999999999999999999854321 11110 00 0010 0
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||+.+|++||++.|++++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 ---PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11123345578889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=294.19 Aligned_cols=249 Identities=31% Similarity=0.410 Sum_probs=194.3
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..|+..+.||+|+||.||+|+.. +++.+|+|.+.... .....++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777889999999999999865 57889999886432 223456788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+. +++.+.+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5676665322 234788899999999999999999987 999999999999999999999999998765322
Q ss_pred cccccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
....+++.|+|||.+. ...++.++|||||||++|+|++|..|+........ .... .....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~----~~~~~----- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI----AQNES----- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHH----hhcCC-----
Confidence 2346889999999874 35688999999999999999999998754321111 1000 00000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+. .........+.++|.+||+.+|++||++.+++++.-.
T Consensus 232 ~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00 0112344567889999999999999999999987433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-33 Score=273.09 Aligned_cols=254 Identities=19% Similarity=0.213 Sum_probs=198.0
Q ss_pred HccCCcc-ccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeec----ce
Q 003786 473 ATANFST-ENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL----EE 545 (795)
Q Consensus 473 ~~~~~~~-~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 545 (795)
.+++|++ .++||-|-.|+|..+.++ +++++|+|++. +....++|++.--.. .|||||.+++++... .-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566765 367999999999999764 68999999984 345678899886544 699999999987643 34
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeeccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFG 622 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFG 622 (795)
+.+|||.|+||.|...+.+. ....+.+.++..|+.||+.|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 57899999999999888543 3456899999999999999999999998 999999999999964 4569999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+|+..... ....+.+-||.|.|||++....|+..+|+||+||++|-|++|.+||-......+..-. ......+.
T Consensus 210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM--k~rI~~gq- 283 (400)
T KOG0604|consen 210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KRRIRTGQ- 283 (400)
T ss_pred cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH--HhHhhccC-
Confidence 99975422 2334567899999999999999999999999999999999999998543322221100 00001110
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+ .+.++.....++...++|..+|..+|.+|.|+.+++.+
T Consensus 284 y-----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 11233445566778899999999999999999999985
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=299.88 Aligned_cols=260 Identities=25% Similarity=0.305 Sum_probs=197.4
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecce---
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE--- 545 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 545 (795)
...++|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999875 57899999986432 2234567789999999999999999998876654
Q ss_pred ---eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 546 ---KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 546 ---~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5688887743 35889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc---
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK--- 698 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 698 (795)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ +........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPD 236 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCC
Confidence 99865322 233467889999998865 4688999999999999999999999865432111 110000000
Q ss_pred --------CcccccccC---ccccc---hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 699 --------DDRAWELID---PTLQN---EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 699 --------~~~~~~~id---~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+. ..... .........+.+++.+||+.+|++|||+.||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000 00000 0111235678899999999999999999999885
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=295.19 Aligned_cols=264 Identities=24% Similarity=0.258 Sum_probs=191.5
Q ss_pred CCccccccCcCCcccEEEeEec-C--cceEEEEEecccC--ccchHHHHHHHHHHHhc-CCcccceeeeeeeec----ce
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-N--GQEVAVKRLSSQS--GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL----EE 545 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 545 (795)
+|++.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 3 6789999986432 22345678899999999 599999999875433 45
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++++||+. ++|...+. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 57877773 3345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHh--------H
Q 003786 626 IFGGDELQ--SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGH--------A 693 (795)
Q Consensus 626 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~--------~ 693 (795)
........ .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+...... ... .
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 11233578999999998765 568999999999999999999999987544211100 000 0
Q ss_pred hhhccCcccccc------cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 694 WDLWKDDRAWEL------IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 694 ~~~~~~~~~~~~------id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
............ ................+.+++.+||+.+|++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 00000000111124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=285.13 Aligned_cols=271 Identities=27% Similarity=0.375 Sum_probs=203.3
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHh--cCCcccceeeeeeeecc----eee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAK--LQHRNLVRLLGCCIELE----EKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 547 (795)
....++.+.||+|.||.||+|++ +++.||||++.. +..+.+++|..|... ++|+||++++++-.... ..+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 45567788999999999999998 569999999964 456778888888764 58999999999876655 789
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC------CCcEEeccCCCCcEEECCCCCeeeecc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS------RLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiHrDikp~NIll~~~~~vkL~DF 621 (795)
||+||.+.|+|-++|. ...++|....+++..|++||+|||+.- ...|+|||||.+||||..|+...|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999994 456899999999999999999999763 347999999999999999999999999
Q ss_pred ccccccCCCcccccccccccccccccccccccC-CCC-----cccchhhHHHHHHHHHhCCCCCCCCC--CcchhHhHhH
Q 003786 622 GMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFS-----IKSDVFSFGVLLLETLSSKRNTDFSN--TNSLTLLGHA 693 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~-----~k~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~~~ 693 (795)
|+|..+............+||.+|||||++.+. .+. .+.||||+|.+||||++...-..... ..+..+....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988766655556668999999999999764 232 46899999999999999765543211 1111111010
Q ss_pred hhhccCcc-----cccccCccccch-hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 694 WDLWKDDR-----AWELIDPTLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 694 ~~~~~~~~-----~~~~id~~l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
..-..-++ +.+...|.+.+. ....-..-+++.+..||..||+.|.|+.=+-+.+.....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00000001 111112222111 111234567789999999999999999988887766433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=273.91 Aligned_cols=278 Identities=21% Similarity=0.310 Sum_probs=212.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
..++|.+.++||+|+|++|.+++++ +.+.+|+|+++++. .++..=.+.|-.+..+. +||++|-++.+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4578999999999999999999865 58899999997753 33444566777777655 7999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+|.||++||+|-.++ .++..++++.+..+..+|+.||.|||+.| ||+||||.+|+|+|.+|++||+|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999996666 44556999999999999999999999998 999999999999999999999999999853
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC--CcchhHhHhHhhhccCcccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN--TNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
-.. -..+++++|||.|.|||++++..|...+|+|+|||+++||+.|+.||+.-. .++.+........ +
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------i 471 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------I 471 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------H
Confidence 222 234677999999999999999999999999999999999999999997533 2222111111111 1
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCC------HHHHHHHH--------ccccCCCCCCCCCCccccccc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPT------MFEVVSML--------TNKTINLPHPRQPAFSSIRGL 768 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt------~~evl~~L--------~~~~~~l~~p~~p~~~~~~~~ 768 (795)
++..++ ++....-+...++..-|..||.+|.- ++++..+- .-++..+.+|..|.....+++
T Consensus 472 lekqir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l 546 (593)
T KOG0695|consen 472 LEKQIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGL 546 (593)
T ss_pred hhhccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCc
Confidence 111111 22223335567888899999999852 34444321 012445677888887776664
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=303.14 Aligned_cols=252 Identities=29% Similarity=0.413 Sum_probs=209.0
Q ss_pred CccccccCcCCcccEEEeEe-cCc----ceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 477 FSTENKLGEGGFGPVYKGRL-LNG----QEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
....++||+|+||+||+|.+ +.| -+||||++... ..+...++.+|+.+|.+++|||+++|+++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45578999999999999963 444 35899988654 4455688999999999999999999999998777 88999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
+||+.|+|.++++.+ +..+..+..+.+..|||+||.|||++. ++||||..+||||.+-..+||+|||+++....+
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999998653 345788899999999999999999887 999999999999999999999999999998776
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
..+.......-.+.|||-|.+....|+.++|||||||++||++| |..|++.....++. ++++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~---------------dlle~g 916 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP---------------DLLEKG 916 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh---------------HHHhcc
Confidence 65544444445678999999999999999999999999999986 88888765544332 222222
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+-..++.+..++..++.+||..|+..||+++++...++.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 2234555677788899999999999999999999887655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=297.08 Aligned_cols=241 Identities=23% Similarity=0.252 Sum_probs=195.5
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++.|++...+|.|+|+.|-.+.+ .+++..++|++.+. ...-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467888989999999999999875 46899999999765 23345677666555 7999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE-CCCCCeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll-~~~~~vkL~DFGla~~~~~ 629 (795)
|.+.++.+.+.+.... ... .++..|+.+|+.|+.|||.+| +|||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877764322 222 678889999999999999998 9999999999999 6999999999999987654
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ..+.+-|..|.|||++....|+.++||||||++||+|++|+.|+...... ..+.. ....
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~----~i~~---------- 528 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT----RIQM---------- 528 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH----hhcC----------
Confidence 3 22345688999999999999999999999999999999999998754433 11111 1111
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+...+....+|+.+||+.+|.+||+|.++..+
T Consensus 529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11224456678899999999999999999999885
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=301.79 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=212.9
Q ss_pred ccHHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeee
Q 003786 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIE 542 (795)
Q Consensus 465 ~~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 542 (795)
..+..+...++.|++.+.||.|.+|.||+++.. +++..|+|+..... ...+++..|+++|+.+ +|||++.+|+++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555667788999999999999999999854 58899999986543 4567899999999888 69999999999874
Q ss_pred -----cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCee
Q 003786 543 -----LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 543 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vk 617 (795)
++.++||||||.+||..+++.... ...+.|..+..|++.++.|+++||... ++|||||-.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 567899999999999999986544 667999999999999999999999876 99999999999999999999
Q ss_pred eeccccccccCCCccccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh
Q 003786 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692 (795)
Q Consensus 618 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 692 (795)
|+|||++..+... .....+..|||.|||||++.. ..|+..+|+||||++..||.-|.+|+........
T Consensus 164 LvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----- 236 (953)
T KOG0587|consen 164 LVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 236 (953)
T ss_pred Eeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence 9999999876433 234456789999999999854 3578899999999999999999999754332111
Q ss_pred HhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 693 AWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
++...+ +|...-..+..-...+.++|..||..|-++||++.++++|
T Consensus 237 ---LF~IpR-----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 ---LFLIPR-----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---hccCCC-----CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111 1112222345567789999999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=274.94 Aligned_cols=256 Identities=25% Similarity=0.306 Sum_probs=195.9
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+.+-...||.|.||+|++-.++ .|+..|||+++.... ..+.++..|.+...+- +.||||++||.+..+...++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3445578999999999998764 699999999977544 4567788888876555 699999999999999999999999
Q ss_pred CCCCChhhhhh--ccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 553 MPNKSLDFFLF--DSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|+ .||+.+.. ...+...++++..-.|......||.||...- .|||||+||+||||+..|.|||||||++-.+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 95 46654432 1234456888888899999999999998754 7999999999999999999999999999765432
Q ss_pred ccccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
- ..+.-.|-..|||||.+.. ..|+.++||||||++|||+.||..|+...+..-.++. ..... ....+.
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~----~Vv~g-dpp~l~-- 291 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC----QVVIG-DPPILL-- 291 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH----HHHcC-CCCeec--
Confidence 2 1233568889999998854 4599999999999999999999999865443211111 11111 111111
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+....+....+.++|..||..|.++||...+++++
T Consensus 292 --~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 --FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112223456688999999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=277.80 Aligned_cols=239 Identities=27% Similarity=0.325 Sum_probs=193.1
Q ss_pred cCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
||+|+||.||++... +++.+|+|++.+.... ....+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999865 4889999998764322 446789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccc
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988433 35889999999999999999999987 9999999999999999999999999998654332 12334
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHH
Q 003786 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..++..|+|||.+.+...+.++|+||||+++|+|++|..|+...+... ..... .... ...+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~----~~~~----------~~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYEKI----LKDP----------LRFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH----hcCC----------CCCCCCC
Confidence 568899999999988889999999999999999999999986543211 11111 0000 0111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCH---HHHHH
Q 003786 719 LNRYINVGLLCVQEDAADRPTM---FEVVS 745 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt~---~evl~ 745 (795)
+..+.+++.+||+.+|++||++ .++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 4567889999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=314.96 Aligned_cols=146 Identities=27% Similarity=0.390 Sum_probs=130.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|.+.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999875 588999999965432 2236788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
|||+.+++|..++.. ...+++..+..++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998843 345788899999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=248.08 Aligned_cols=265 Identities=23% Similarity=0.257 Sum_probs=197.0
Q ss_pred CCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+|...++||+|.||+||+|+.. +++.||+|+++... +.-.....+|+-+|+.++|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4667789999999999999864 58889999886542 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
|.. .|..+.. .-++.++.+.+..++.|+++||.++|+++ +.||||||.|+||+.+|.+||+|||+++.++-..
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 975 4444432 23456888999999999999999999998 9999999999999999999999999999876443
Q ss_pred cccccccccccccccccccccC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhh--hccCccccc---c
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWD--LWKDDRAWE---L 705 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~---~ 705 (795)
...+.-+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++-|++.+..++ +....+. ...++.... +
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccC
Confidence 223334678999999998874 68999999999999999996 4544555553332 2211111 111211111 1
Q ss_pred cCccccc---------hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQN---------EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~---------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
-|-.... ++-+.....=.+++++.|.-+|..|.++++.+++-..
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 1111110 1111222334578889999999999999999886443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=276.69 Aligned_cols=219 Identities=18% Similarity=0.106 Sum_probs=175.7
Q ss_pred CCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChhhhhhc
Q 003786 486 GGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFD 564 (795)
Q Consensus 486 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 564 (795)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999864 58899999996542 334556666667899999999999999999999999999999888843
Q ss_pred cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccc
Q 003786 565 STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644 (795)
Q Consensus 565 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 644 (795)
. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 2 34889999999999999999999988 999999999999999999999999988655322 122345778
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHH
Q 003786 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYIN 724 (795)
Q Consensus 645 y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 724 (795)
|+|||.+....++.++||||+||++|||++|..|+........ ... ....+......+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------~~~----~~~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------THT----TLNIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------ccc----ccCCcccCCHHHHH
Confidence 9999999888899999999999999999999977643211000 000 00112223456788
Q ss_pred HHHhhccCCCCCCCCH
Q 003786 725 VGLLCVQEDAADRPTM 740 (795)
Q Consensus 725 li~~cL~~dP~~RPt~ 740 (795)
++.+||+.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=278.20 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=199.1
Q ss_pred HHccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--cc-c----hHHHHHHHHHHHhcCCcccceeeeeeeec
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQ-G----QEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~-~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
...++|-+.+.||+|||+.||++.+ ...+.||||+-.... .. . .+...+|..|-+.|+||.||++|++|.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3457899999999999999999974 457788999864321 11 1 12356899999999999999999998754
Q ss_pred -ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC---CCCCeeee
Q 003786 544 -EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKIS 619 (795)
Q Consensus 544 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~---~~~~vkL~ 619 (795)
+..+-|+|||+|.+|+.+| ...+.+++.++..|+.||..||.||.+.. .+|||-||||.||||- .-|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 5677899999999999999 45667999999999999999999999885 6899999999999994 45889999
Q ss_pred ccccccccCCCccc-----cccccccccccccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh
Q 003786 620 DFGMARIFGGDELQ-----SKTKRIVGTYGYMSPEYAQQ----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL 690 (795)
Q Consensus 620 DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~ 690 (795)
||||++++..+... ..++...||.+|++||.+.- ..++.|+||||.|||+|+.+.|+.||....... .++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dIL 694 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DIL 694 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHH
Confidence 99999988654332 23556789999999997632 357899999999999999999999997543222 222
Q ss_pred HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 003786 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 745 (795)
... ..++...+... ..+....+...+|.+||++.-++|....++..
T Consensus 695 qeN-TIlkAtEVqFP--------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 QEN-TILKATEVQFP--------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhh-chhcceeccCC--------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 211 11122222111 12223446678999999999999988777654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.62 Aligned_cols=203 Identities=24% Similarity=0.359 Sum_probs=174.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.-|..++.||-|+||.|.++... +...||+|.+++.+-. .....+.|..||..-+.+-||+||..|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34778899999999999999754 4677999999876433 3456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC--
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG-- 628 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~-- 628 (795)
+|++||++-.+| .+.+.++++.+..++.++..|+.+.|..| +|||||||+|||||.+|+|||+||||+.-+.
T Consensus 709 dYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 999999998888 45567899999999999999999999998 9999999999999999999999999986431
Q ss_pred -------CCcc-------------------------------cccccccccccccccccccccCCCCcccchhhHHHHHH
Q 003786 629 -------GDEL-------------------------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLL 670 (795)
Q Consensus 629 -------~~~~-------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ 670 (795)
..+. .......+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0000 00012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 003786 671 ETLSSKRNTDFSN 683 (795)
Q Consensus 671 elltG~~p~~~~~ 683 (795)
||+.|+.||-...
T Consensus 863 em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 863 EMLVGQPPFLADT 875 (1034)
T ss_pred HHhhCCCCccCCC
Confidence 9999999996544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=262.97 Aligned_cols=275 Identities=22% Similarity=0.359 Sum_probs=200.5
Q ss_pred cCCccccccCcCCcccEEEeEecC-cceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec--------
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-------- 543 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 543 (795)
..|+...+||+|.||.||+|+.++ |++||+|++..+. ..-.....+|+.+|..|+|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 457778899999999999998654 7889999765432 12235667899999999999999999887643
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
...++||.+|+. +|.-++.+. .-.++..++.+++.++..||.|+|... |+|||+||+|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999976 455555322 234788899999999999999999887 99999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHh-------
Q 003786 624 ARIFGGDEL--QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGH------- 692 (795)
Q Consensus 624 a~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~------- 692 (795)
++.+..... ....+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||+++.+-+........ .++..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987643221 222334556999999997765 6899999999999999999999988776553322 22221
Q ss_pred -HhhhccCccccccc--Cccccchhh--HHH------HHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCC
Q 003786 693 -AWDLWKDDRAWELI--DPTLQNEAS--YLI------LNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLP 755 (795)
Q Consensus 693 -~~~~~~~~~~~~~i--d~~l~~~~~--~~~------~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~ 755 (795)
.|....+-..++.+ .|.-..... .+. ....++++.++|..||.+|+.+++++.+--.-..+.|
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 12211222222222 111111111 111 1256789999999999999999999998655444444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=254.56 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=202.1
Q ss_pred HHHccCCccccccCcCCcccEEEeE-ecCcceEEEEEecccCccchHHHHHHHHHHHhcC-Ccccceeeeeeeecce--e
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEE--K 546 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~--~ 546 (795)
....++|++.+++|+|.|+.||.|. ..++++++||+++. ...+.+++|+.||+.|. ||||+++++...+... .
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4467899999999999999999997 45688999999964 34578999999999998 9999999999887654 4
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeecccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAR 625 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DFGla~ 625 (795)
.||+||+.+.+...+. ..+....+..++.++++||.|+|++| |+|||+||.|++||.. -.++|+|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHh
Confidence 6999999988776544 34667788999999999999999999 9999999999999865 569999999999
Q ss_pred ccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc----
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD---- 700 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 700 (795)
++.+... .+-.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-.......+++..+..+-.++
T Consensus 182 FYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 182 FYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 8765432 222456778889998876 67899999999999999999999999766555554444332211110
Q ss_pred --ccccccCcccc----------------chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 701 --RAWELIDPTLQ----------------NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 701 --~~~~~id~~l~----------------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+..-.++|.+. .+.......+.++++.+.|..|..+|||++|...+-
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 00000122111 111112235778999999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=272.19 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=200.2
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHh--cCCcccceeeeeeeec----ceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAK--LQHRNLVRLLGCCIEL----EEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 547 (795)
..+..+.+.||+|.||.||+|++ .|+.||||++... +++...+|.+|.+. |+|+||+.+++.-..+ .+++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 46678899999999999999988 6899999999754 45678888888875 5999999999875544 3678
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-----CCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-----SRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
||++|-++|||.++|. +..++-+..++++..+|.||++||.. |.+.|.|||||..||||.+++...|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999993 35688899999999999999999964 56779999999999999999999999999
Q ss_pred cccccCCC--cccccccccccccccccccccccC----CC-C-cccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh
Q 003786 623 MARIFGGD--ELQSKTKRIVGTYGYMSPEYAQQG----LF-S-IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 623 la~~~~~~--~~~~~~~~~~gt~~y~APE~~~~~----~~-~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 694 (795)
||-..... ...-..+..+||.+|||||++... .+ + ..+||||||.++||++....--+...+....+ .
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py----y 437 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY----Y 437 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc----c
Confidence 99866433 233345567899999999998543 22 2 45899999999999985321110000011110 1
Q ss_pred hhccCcccc---------cccCcccc-chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 695 DLWKDDRAW---------ELIDPTLQ-NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 695 ~~~~~~~~~---------~~id~~l~-~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
+....+... +.+.|.+. ...+......+.+++..||..||..|-|+-.|.+.|.+..
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111111111 11222222 2244566778899999999999999999999998887643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=301.46 Aligned_cols=258 Identities=29% Similarity=0.417 Sum_probs=204.6
Q ss_pred cCCccccccCcCCcccEEEeEec----C----cceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL----N----GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
++..+.+.||+|.||.|++|... . ...||||.+..... ...+.+..|+++|+.+ +|+||+.++++|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 44566679999999999999732 1 35699999876433 3457889999999998 6999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccC-----------Cc--ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 545 EKILIYEYMPNKSLDFFLFDST-----------KE--NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
..++|+||+..|+|..+++... .. ..+.......++.|||.|++||++.. +|||||..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999997655 00 23778889999999999999999987 99999999999999
Q ss_pred CCCCeeeeccccccccCCCcccccccccc--cccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 003786 612 KDMNPKISDFGMARIFGGDELQSKTKRIV--GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLT 688 (795)
Q Consensus 612 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 688 (795)
++..+||+|||+++............ .. -...|||||.+....|+.|+|||||||+||||++ |..|++.-.. ...
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~~ 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TEE 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HHH
Confidence 99999999999999765444332111 12 2345999999999999999999999999999997 5666654110 111
Q ss_pred HhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
+ .+.+.+..+.+.+..+..++.+++..||+.+|++||++.++++.++..
T Consensus 531 l-------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 531 L-------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 112223333445555677888999999999999999999999998873
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=262.40 Aligned_cols=238 Identities=29% Similarity=0.359 Sum_probs=192.5
Q ss_pred CcccEEEeEec-CcceEEEEEecccCccc-hHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChhhhhhc
Q 003786 487 GFGPVYKGRLL-NGQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFD 564 (795)
Q Consensus 487 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 564 (795)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 48999999997665444 68899999999999999999999999999999999999999999998854
Q ss_pred cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccc
Q 003786 565 STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644 (795)
Q Consensus 565 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 644 (795)
.. .+++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2788999999999999999999987 9999999999999999999999999998765432 2334568889
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHH
Q 003786 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYIN 724 (795)
Q Consensus 645 y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 724 (795)
|+|||.+....++.++||||||+++++|++|..|+........ .... ....... . ..........+.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~----~~~~~~~-~------~~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKK----IGKPKPP-F------PPPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH----HhccCCC-C------ccccccCCHHHHH
Confidence 9999999888899999999999999999999999865321111 1111 0111000 0 0000003457889
Q ss_pred HHHhhccCCCCCCCCHHHHHH
Q 003786 725 VGLLCVQEDAADRPTMFEVVS 745 (795)
Q Consensus 725 li~~cL~~dP~~RPt~~evl~ 745 (795)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=296.83 Aligned_cols=263 Identities=19% Similarity=0.185 Sum_probs=168.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-C----cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeee------ee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-N----GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC------CI 541 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 541 (795)
..++|++.++||+|+||.||+|++. + ++.||||++.... ..+...+| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999865 3 6889999875432 11111111 1222223333332222 24
Q ss_pred ecceeeEEeecCCCCChhhhhhccCCc-----------------ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCC
Q 003786 542 ELEEKILIYEYMPNKSLDFFLFDSTKE-----------------NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 604 (795)
Q Consensus 542 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik 604 (795)
.....++|+||+++++|.+++...... .......+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999888543210 01112345679999999999999987 9999999
Q ss_pred CCcEEECC-CCCeeeeccccccccCCCcccccccccccccccccccccccC----------------------CCCcccc
Q 003786 605 ASNILLDK-DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG----------------------LFSIKSD 661 (795)
Q Consensus 605 p~NIll~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~~~k~D 661 (795)
|+|||++. ++.+||+|||+++.+.... ........+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5899999999998653322 1223446789999999965321 2455779
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh-ccCcccccccCccccchh------hHHHHHHHHHHHHhhccCCC
Q 003786 662 VFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL-WKDDRAWELIDPTLQNEA------SYLILNRYINVGLLCVQEDA 734 (795)
Q Consensus 662 vwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~id~~l~~~~------~~~~~~~l~~li~~cL~~dP 734 (795)
||||||+||||+++..+.+.. ...+....... .........+.+...... .........+|+.+||+.||
T Consensus 362 VwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999876553311 11110000000 000000001111100000 00112244589999999999
Q ss_pred CCCCCHHHHHHH
Q 003786 735 ADRPTMFEVVSM 746 (795)
Q Consensus 735 ~~RPt~~evl~~ 746 (795)
++|||+.|+++|
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999996
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=283.95 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=179.9
Q ss_pred HccCCccccccCcCCcccEEEeEe-----------------cCcceEEEEEecccCccchH--------------HHHHH
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSSQSGQGQE--------------EFKNE 521 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E 521 (795)
..++|++.++||+|+||.||+|.. ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 23567999998654322222 23346
Q ss_pred HHHHHhcCCccc-----ceeeeeeee--------cceeeEEeecCCCCChhhhhhccCC---------------------
Q 003786 522 IKLIAKLQHRNL-----VRLLGCCIE--------LEEKILIYEYMPNKSLDFFLFDSTK--------------------- 567 (795)
Q Consensus 522 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------- 567 (795)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 677777653 3567999999999999998864211
Q ss_pred cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccccccccccccc
Q 003786 568 ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647 (795)
Q Consensus 568 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~A 647 (795)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 122456778899999999999999987 99999999999999999999999999976533211 11112335789999
Q ss_pred ccccccCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCCCCCcchh-----HhHhHhhhccC
Q 003786 648 PEYAQQGL--------------------F--SIKSDVFSFGVLLLETLSSKR-NTDFSNTNSLT-----LLGHAWDLWKD 699 (795)
Q Consensus 648 PE~~~~~~--------------------~--~~k~DvwSlGvil~elltG~~-p~~~~~~~~~~-----~~~~~~~~~~~ 699 (795)
||.+.... | ..+.||||+||++|+|++|.. |+......... .....|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875322 1 235799999999999999875 54321100000 00111111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHhhccCCC---CCCCCHHHHHHH
Q 003786 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDA---ADRPTMFEVVSM 746 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP---~~RPt~~evl~~ 746 (795)
... + -...........+++.++|..+| .+|+|++|+++|
T Consensus 459 ~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 0 01112234567789999998766 689999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=264.52 Aligned_cols=264 Identities=22% Similarity=0.234 Sum_probs=198.2
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCC--c----ccceeeeeeeecc
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH--R----NLVRLLGCCIELE 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~ 544 (795)
..+++|.+...||+|.||.|-.+... .+..||||+++.. ..-.+..+-|+++|+++.+ | -+|.+.++|...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34789999999999999999999743 4788999999643 2334556779999999942 3 3788889999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-------------
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD------------- 611 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~------------- 611 (795)
+.++|+|.+ |-|+.+++..+ ....++...+..++.|+++++++||+.. ++|-||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999987 55888888442 3455788899999999999999999987 99999999999993
Q ss_pred -------CCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 003786 612 -------KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT 684 (795)
Q Consensus 612 -------~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~ 684 (795)
++..|||+|||-|+.-... .+..+.|..|.|||++.+-..+..+||||+||||+|+.+|..-|...+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 1345899999999864332 2457889999999999999999999999999999999999988876552
Q ss_pred cch-hHhHhHhh--------------hccCcc--------------cccccCcc-ccchhhHHHHHHHHHHHHhhccCCC
Q 003786 685 NSL-TLLGHAWD--------------LWKDDR--------------AWELIDPT-LQNEASYLILNRYINVGLLCVQEDA 734 (795)
Q Consensus 685 ~~~-~~~~~~~~--------------~~~~~~--------------~~~~id~~-l~~~~~~~~~~~l~~li~~cL~~dP 734 (795)
.+. ...+..-. .+..++ +.+.-.|. ........+..++.+|+..||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 221 11111100 000000 00000000 0111223455679999999999999
Q ss_pred CCCCCHHHHHHH
Q 003786 735 ADRPTMFEVVSM 746 (795)
Q Consensus 735 ~~RPt~~evl~~ 746 (795)
.+|+|+.|++++
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999985
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=234.42 Aligned_cols=110 Identities=52% Similarity=0.768 Sum_probs=83.4
Q ss_pred CCeEEEecCCCCCCccC--cceEEEeeCCceEEeCCCCceEEee-cCCCCc-cccEEEEccCCCeEEeecCCCCCcccce
Q 003786 70 PDTIVWVANRNSPIFDS--NAVLTISNGGKLVLLNQTNGTIWSS-NLSREV-KNPVAQLLDTGNLVVRDNFSSNSSEDYL 145 (795)
Q Consensus 70 ~~t~vW~an~~~p~~~~--~~~l~~~~~g~lvl~~~~~~~~Wst-~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~ 145 (795)
++||||+|||+.|+.+. ..+|.|+.||||||+++.++++|+| ++.+.+ ..+.|.|+|+|||||+| ..+++|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d-----~~~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYD-----SSGNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEE-----TTSEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEe-----ecceEE
Confidence 46999999999999653 4899999999999999999999999 666655 67889999999999998 478999
Q ss_pred ecccCCCchhhhccCeeccccccCcceeEEEecCCCCCC
Q 003786 146 WQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPS 184 (795)
Q Consensus 146 WqSFd~PTDtlLpgqkl~~~~~~~~~~~l~Sw~s~~dps 184 (795)
||||||||||+||||+|+.+..++....++||++..|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=241.24 Aligned_cols=211 Identities=28% Similarity=0.364 Sum_probs=171.5
Q ss_pred HHccCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc-CccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeE
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
...++...+..||+|+||.|=+-++ .+|+..|+|++... ..+...++.+|+.+..+. .+|++|.+||....+...++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3445566678899999999988875 46999999999764 334556778888876554 69999999999999999999
Q ss_pred EeecCCCCChhhhhhc-cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 549 IYEYMPNKSLDFFLFD-STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
.||.|+ .||+.+... -.+...+++..+-+|+..|..||.|||++- .+||||+||+|||++.+|+||+||||++-.+
T Consensus 123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999996 467665532 234567899999999999999999999864 6999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccc----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQ----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT 688 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~ 688 (795)
.+... .+-..|...|||||.+. ...|+.|+||||||+++.||.+++.|++...++-.+
T Consensus 200 ~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q 261 (282)
T KOG0984|consen 200 VDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ 261 (282)
T ss_pred hhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence 53321 12246888999999874 347999999999999999999999999866554443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=284.21 Aligned_cols=247 Identities=27% Similarity=0.365 Sum_probs=189.9
Q ss_pred CccccccCcCCccc-EEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecCC
Q 003786 477 FSTENKLGEGGFGP-VYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 477 ~~~~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
|.-.+.+|.|..|+ ||+|.. +|++||||++-.. .....++|+..|+.- +|||||++|+.-.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789999986 799987 6889999998542 345678999999988 59999999999999999999999995
Q ss_pred CCChhhhhhccCCc-ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---C--CCeeeeccccccccC
Q 003786 555 NKSLDFFLFDSTKE-NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---D--MNPKISDFGMARIFG 628 (795)
Q Consensus 555 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~--~~vkL~DFGla~~~~ 628 (795)
.+|.+++...... ..........+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++...
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4888888653111 11111456788999999999999987 999999999999976 3 468999999999876
Q ss_pred CCcc-cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 629 GDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSS-KRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.... ........||.+|+|||++....-+.++||+||||++|..++| .+||+..-..+.+++... .-...+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~-------~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN-------YTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc-------cceeee
Confidence 5432 2234557899999999999988888899999999999999987 888875444433332111 111111
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+. .+. ...+||.+|+..+|..||++.+|+.|
T Consensus 736 ~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 EPL------PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ccC------chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 110 111 56789999999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=247.95 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=194.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec-----cee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
.+.+-.+.||-|+||+||.++++ +|+.||+|++... .....+.+.+|+++|.-++|.|++..++..+-. +++
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 45667789999999999999875 5999999988543 223456788999999999999999988876543 356
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
|.++|.|.. +|..+| .....++...+.-+.+||++||.|||+.+ |.||||||.|+|++.+..+||+|||+++.
T Consensus 133 YV~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 788888853 566666 33455788888999999999999999998 99999999999999999999999999997
Q ss_pred cCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC-cchhHhHhHhhhccCc----
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNT-NSLTLLGHAWDLWKDD---- 700 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~---- 700 (795)
-..++....+ .-+-|..|.|||++++. .|+.++||||.|||+.||+..+.-|...+. ++..++ .++....
T Consensus 206 ee~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI---tdLLGTPs~Ea 281 (449)
T KOG0664|consen 206 WDQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI---IDLLGTPSQEA 281 (449)
T ss_pred cchhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH---HHHhCCCcHHH
Confidence 6554433332 24568899999999874 799999999999999999987766654331 111111 1111111
Q ss_pred -------ccccccC--------ccccc-hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 701 -------RAWELID--------PTLQN-EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 701 -------~~~~~id--------~~l~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
....++. +.+.. ........+...+..+++..+|..|.+..+.+.++...
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 0000000 01111 01112234556788889999999999999999887553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=237.14 Aligned_cols=211 Identities=38% Similarity=0.585 Sum_probs=183.4
Q ss_pred cCcCCcccEEEeEecC-cceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChhh
Q 003786 483 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDF 560 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 560 (795)
||+|.+|.||+++... ++++++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 899999999765332 35789999999999999999999999999999999999999999999
Q ss_pred hhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccccccccCCCccccccccc
Q 003786 561 FLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGGDELQSKTKRI 639 (795)
Q Consensus 561 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 639 (795)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35788999999999999999999998 999999999999999 89999999999987643321 12335
Q ss_pred ccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHH
Q 003786 640 VGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLI 718 (795)
Q Consensus 640 ~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 678899999998877 889999999999999998
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 719 LNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4677899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=262.79 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=169.0
Q ss_pred HccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCc--------cchHHHHHHHHHHHhcC---Ccccceeeeee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG--------QGQEEFKNEIKLIAKLQ---HRNLVRLLGCC 540 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 540 (795)
...+|...++||+|+||.|+++.++. ..+|+||.+.++.. ...-.+-.|++||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34569999999999999999998764 67899998876421 12234557999999997 99999999999
Q ss_pred eecceeeEEeec-CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 541 IELEEKILIYEY-MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 541 ~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
++++..||+||- =++.+|.++|. ..+.+++.++..|+.||+.|+++||+++ |||||||-+|+.++.+|-+||+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 999999999995 45668888884 3445899999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCC
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~ 679 (795)
|||.+....... ...++||..|.|||++.+..| ...-|||+||++||.++....|+
T Consensus 713 dfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 713 DFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999998765443 455899999999999999877 56679999999999999887775
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=250.42 Aligned_cols=266 Identities=25% Similarity=0.307 Sum_probs=210.5
Q ss_pred cHHhHHHHccCCccccccCcCCcccEEEeEe------cCcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeee
Q 003786 466 SLASVSAATANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 466 ~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
..+++.....+++....+-+|.||.||.|.+ .+.+.|-+|.+... +......+..|...+..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3455666677889999999999999999943 23566888887543 3334567889999999999999999999
Q ss_pred eeeecc-eeeEEeecCCCCChhhhhh-----ccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC
Q 003786 539 CCIELE-EKILIYEYMPNKSLDFFLF-----DSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 539 ~~~~~~-~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~ 612 (795)
++.++. ..+.++.++.-|+|..|+. +......+.-.+...++.|++.|++|||.++ |||.||..+|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 988654 5577789999999999997 3333445777788899999999999999998 999999999999999
Q ss_pred CCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhH
Q 003786 613 DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLG 691 (795)
Q Consensus 613 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 691 (795)
..+|||+|=.+++.+-+.+.......-.....||+||.+.+..|+.++|||||||+||||++ |+.|+..-+..++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--- 508 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--- 508 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---
Confidence 99999999999997766666555444455678999999999999999999999999999996 66665432221111
Q ss_pred hHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 692 HAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 692 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...++ ..+-..+-++++++..++.-||...|++||+++|++.-|.+
T Consensus 509 ---~ylkd---------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 ---HYLKD---------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---HHHhc---------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11111 12223344577889999999999999999999999998865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=266.46 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=205.8
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..++|++..++|.|.||.||+++.+ .++..|+|+++........-++.|+-+++..+|||||.+++.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3478999999999999999999865 588899999988877788889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
||.+|+|.+..+ ....+++.++...+++.+++++|||+++ -+|||||-.|||+++.|.+|++|||.+..+....
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999988763 3456888999999999999999999998 8999999999999999999999999998765332
Q ss_pred cccccccccccccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~---~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.+.+.+.||+.|||||+. +.+.|..++|||++|+...|+---.+|..........++. ....+.. +
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-TkS~~qp--------p 235 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-TKSGFQP--------P 235 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-hccCCCC--------C
Confidence 345568999999999976 4578999999999999999998777664322211111111 1111111 1
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+.+. ..-...+.++++.||-.+|++||+++.+|++
T Consensus 236 ~lkDk--~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 236 TLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cccCC--ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 11111 1223456789999999999999999988774
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=212.09 Aligned_cols=108 Identities=44% Similarity=0.981 Sum_probs=102.9
Q ss_pred EeeCCCCCeeeeccCCC--cccccceeeeCCCeeEEEEecCCCceEEEEEECCCCcEEEEEEecCCCceEEEEecccccC
Q 003786 210 LCSGPWNGAIFAAIPSY--SYLYKPTVVDNEDEIYYRYDSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPDRFC 287 (795)
Q Consensus 210 ~~sg~w~~~~f~~~p~~--~~~~~~~~~~n~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 287 (795)
||+|||+|..|.++|.+ ..++.+.|+.+.+|++|+|...+.+.++|++|+++|++|+|.|++.++.|.+.|++|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999944 4678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCcccCCCCCCCCCccccccccC
Q 003786 288 QFYGHCGANSICSFDKKPHCECLKGFELKS 317 (795)
Q Consensus 288 ~~~g~CG~~g~C~~~~~~~C~C~~gf~~~~ 317 (795)
|+|+.||+||+|+.+..|.|.|++||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988899999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=252.44 Aligned_cols=273 Identities=19% Similarity=0.214 Sum_probs=208.5
Q ss_pred ccHHhHHHHccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcC------Ccccceee
Q 003786 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ------HRNLVRLL 537 (795)
Q Consensus 465 ~~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~ 537 (795)
|++.-......+|.+....|+|-|+.|..|.... |++||||+|... ....+.=+.|++||++|+ --|+++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 5566666778899999999999999999998654 889999999643 223344568999999996 35899999
Q ss_pred eeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCe
Q 003786 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNP 616 (795)
Q Consensus 538 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~v 616 (795)
-.|.+.++++||+|-+. .+|.++|..-.++--|....+..++.|+..||..|...+ |+|.||||+||||++. ..+
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 99999999999999774 578888876666666888899999999999999999988 9999999999999876 458
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh-HhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL-GHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~-~~~~~ 695 (795)
||||||.|...+.++. +...-+.-|.|||++.+-+|+...|+||.||.||||.||+.-|++.....+.-+ .....
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 9999999987665442 223446679999999999999999999999999999999999887764444211 11100
Q ss_pred hc-----cCc---------------------------ccccccCc------ccc-----chhhHHHHHHHHHHHHhhccC
Q 003786 696 LW-----KDD---------------------------RAWELIDP------TLQ-----NEASYLILNRYINVGLLCVQE 732 (795)
Q Consensus 696 ~~-----~~~---------------------------~~~~~id~------~l~-----~~~~~~~~~~l~~li~~cL~~ 732 (795)
.+ ..+ .+...+.| .+. ..-.......+.+|+..||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 00 000 00001111 000 011123455788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003786 733 DAADRPTMFEVVSM 746 (795)
Q Consensus 733 dP~~RPt~~evl~~ 746 (795)
||++|.|..+.|+|
T Consensus 733 dP~KRit~nqAL~H 746 (752)
T KOG0670|consen 733 DPEKRITVNQALKH 746 (752)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=238.66 Aligned_cols=133 Identities=28% Similarity=0.353 Sum_probs=108.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-----C---cccceeeeeeee--
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-----H---RNLVRLLGCCIE-- 542 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 542 (795)
..+|.+.++||.|.|++||++.+. ..+.||+|+.+.. ..-.+....|+++|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 478999999999999999999864 4678999998543 233466788999999984 3 369999999974
Q ss_pred --cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 543 --LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 543 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
+.+++||+|++ |.+|..+|... ..+-++...+.+|+.||+.||.|||.++ +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56899999998 44555555433 2344889999999999999999999987 799999999999994
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=234.36 Aligned_cols=263 Identities=24% Similarity=0.246 Sum_probs=192.3
Q ss_pred ccCCccccccCcCCcccEEEeE-ecCcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec------c
Q 003786 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------E 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 544 (795)
..+|.-.+.+|.|.- .|..+. ...++.||+|++... .....++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357778889999988 555554 346899999988553 233456788999999999999999999998643 4
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..|+|||+|.. +|...+. -.++-+.+..+..|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 57999999964 6666653 23566788999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-------------h---
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-------------T--- 688 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-------------~--- 688 (795)
+.-... -..+..+.|..|.|||++-+..|...+||||+||++.||++|.--|.+.+.-++ .
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 864332 133446789999999999888899999999999999999999988775431111 0
Q ss_pred -HhHhHhhhccCc------cccccc-Ccccc--chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 689 -LLGHAWDLWKDD------RAWELI-DPTLQ--NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 689 -~~~~~~~~~~~~------~~~~~i-d~~l~--~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+...+....... ...+.+ |.... .+.+........+++.+||..+|++|.+++++|+|-.-
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 000011100000 000111 11111 11112223345689999999999999999999998654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=207.64 Aligned_cols=115 Identities=44% Similarity=0.709 Sum_probs=102.6
Q ss_pred CccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCCceEEee
Q 003786 32 RFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSS 111 (795)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst 111 (795)
+.|++|++|+|+++.|++|||.+..+...+.+|||++.+.++||.||++.| ....+.|.|+.||||+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 578999999999999999999997765589999998876789999999998 4667899999999999999999999999
Q ss_pred cCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCC
Q 003786 112 NLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHP 152 (795)
Q Consensus 112 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (795)
++++......|+|+|||||||++. .+.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDS-----DGNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECC-----CCCEEEcCCCCC
Confidence 998634567789999999999983 578999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-26 Score=230.85 Aligned_cols=199 Identities=35% Similarity=0.486 Sum_probs=172.2
Q ss_pred CccccccCcCCcccEEEeEecC-cceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 477 FSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
|++.+.||+|++|.||++.... ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999998765 889999999765544 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+++|..++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999998854322 1788899999999999999999987 99999999999999999999999999987643321 1
Q ss_pred ccccccccccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003786 635 KTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLSSKRNTDF 681 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvil~elltG~~p~~~ 681 (795)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999988 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=235.48 Aligned_cols=267 Identities=22% Similarity=0.350 Sum_probs=198.6
Q ss_pred HHHHccCCccccccCcCCcccEEEeEec----CcceEEEEEecccCccchHHHHHHHHHHHhcC-Ccccceeeeeeeecc
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELE 544 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 544 (795)
+....+.|..+++||+|.|++||++.+. .++.||+|.+... ....++.+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445577899999999999999999753 3678999998654 34567999999999995 999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeecccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGM 623 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGl 623 (795)
+..+|+||+++....+++.. ++...+..+++.+++||+++|.+| ||||||||.|+|.+. -+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888732 567889999999999999999998 999999999999975 46789999999
Q ss_pred ccccCCC---------------c-------------------c--------ccccccccccccccccccccc-CCCCccc
Q 003786 624 ARIFGGD---------------E-------------------L--------QSKTKRIVGTYGYMSPEYAQQ-GLFSIKS 660 (795)
Q Consensus 624 a~~~~~~---------------~-------------------~--------~~~~~~~~gt~~y~APE~~~~-~~~~~k~ 660 (795)
|...... . . ....-...||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 9721000 0 0 000012469999999998865 6789999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh-----------------hccCccccc---------ccC-cc----
Q 003786 661 DVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD-----------------LWKDDRAWE---------LID-PT---- 709 (795)
Q Consensus 661 DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~---------~id-~~---- 709 (795)
||||.|||++-+++++.||-........+...+.. .|....+.. -++ ..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999986544332222211100 111011000 010 00
Q ss_pred ----ccc-hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 710 ----LQN-EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 710 ----l~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+.. ......+..+++++.+|+..||.+|.|+++.|+|-
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 001 11122334678999999999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-26 Score=221.72 Aligned_cols=252 Identities=19% Similarity=0.344 Sum_probs=187.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeee-eeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGC-CIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 550 (795)
.+.|.+.+.||+|.||.+-+++++ +.+.+++|.+.+. .....+|.+|...--.| .|.||+.-|+. |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356999999999999999999875 4788999988654 34567899998876556 58999987764 67777788999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC--CCCCeeeeccccccccC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMARIFG 628 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~~vkL~DFGla~~~~ 628 (795)
||+|.|+|..-+.. .-+.+....+++.|++.||.|+|+++ +||||||.+||||- +..+|||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999877633 34778888999999999999999998 99999999999993 34589999999987643
Q ss_pred CCccccccccccccccccccccccc---C--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQ---G--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~---~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
. .......+..|.|||.... + ...+.+|||.||+++|.+++|..|+......+..+. .|..|......
T Consensus 175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~--~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW--EWEQWLKRKNP 247 (378)
T ss_pred c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH--HHHHHhcccCc
Confidence 2 1223445678999997632 2 246789999999999999999999985444333332 23333333222
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+ |+ .-......+.++..+-|..+|++|=-..++.++
T Consensus 248 ~~--P~----~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 AL--PK----KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cC--ch----hhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11 11 111234566778888999999999555555444
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=196.35 Aligned_cols=113 Identities=44% Similarity=0.721 Sum_probs=99.7
Q ss_pred CccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCCceEEee
Q 003786 32 RFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSS 111 (795)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst 111 (795)
+.|..|++|+|+++.|++|||.+..+ ..+.+|||+..+.++||+|||+.|+.+ .+.|.|+.||||||+|.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56889999999999999999998755 678999998866789999999999854 4899999999999999999999999
Q ss_pred cCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCC
Q 003786 112 NLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDH 151 (795)
Q Consensus 112 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
+++.......|+|+|||||||++ ..+.+|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~-----~~~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYD-----SDGNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEEC-----CCCCEEeCCCCC
Confidence 99744456678999999999998 456899999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=269.50 Aligned_cols=197 Identities=19% Similarity=0.231 Sum_probs=138.5
Q ss_pred hcCC-cccceeeeee-------eecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcE
Q 003786 527 KLQH-RNLVRLLGCC-------IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598 (795)
Q Consensus 527 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 598 (795)
.++| +||++++++| .+....++++|++ +++|.++|... ...+++.++..++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 6888888887 2334567788987 55999998532 345889999999999999999999988 9
Q ss_pred EeccCCCCcEEECC-------------------CCCeeeeccccccccCCCcc--------------ccccccccccccc
Q 003786 599 IHRDLKASNILLDK-------------------DMNPKISDFGMARIFGGDEL--------------QSKTKRIVGTYGY 645 (795)
Q Consensus 599 iHrDikp~NIll~~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 645 (795)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 44566666666653211000 0001124578999
Q ss_pred ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHH
Q 003786 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINV 725 (795)
Q Consensus 646 ~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l 725 (795)
||||++.+..|+.++|||||||+||||++|..|+..... ....... ..+.+.. .........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~---------~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRH---------RVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHH---------hhcChhh-----hhcCHHHHHH
Confidence 999999999999999999999999999998877542110 0000000 0011110 1112334578
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 003786 726 GLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 726 i~~cL~~dP~~RPt~~evl~~ 746 (795)
+.+||+.+|.+||++.||+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=207.35 Aligned_cols=166 Identities=20% Similarity=0.143 Sum_probs=124.7
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
|+|.+++... ...+++..+..++.||++||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6788888432 345899999999999999999999875 999999999999999 99998654321
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+....... ... ++. .....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~------~~~-~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-PAD------DPR-DRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh-ccC------Ccc-ccccH
Confidence 2589999999999999999999999999999999999999865432221111111000 000 000 00111
Q ss_pred HHHHH--HHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 716 YLILN--RYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 716 ~~~~~--~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..... .+.+++.+||+.+|++||++.|+++++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 22222 68899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=222.80 Aligned_cols=177 Identities=20% Similarity=0.270 Sum_probs=135.4
Q ss_pred HHHHccCCccccccCcCCcccEEEeEec--CcceEEEEEeccc-----CccchHHHHHHHHHHHhcCCcccce-eeeeee
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQ-----SGQGQEEFKNEIKLIAKLQHRNLVR-LLGCCI 541 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~ 541 (795)
+.....+|.+.+.||+|+||+||+|++. +++.+|||++... .....+.+.+|+++|++++|+|+++ +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3455678999999999999999999864 4777899987533 1123466899999999999999985 4432
Q ss_pred ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccC-CCCcEEECCCCCeeeec
Q 003786 542 ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL-KASNILLDKDMNPKISD 620 (795)
Q Consensus 542 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi-kp~NIll~~~~~vkL~D 620 (795)
...++||||+++++|.... .. ....++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 --~~~~LVmE~~~G~~L~~~~----~~------~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR----PH------GDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC----cc------chHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 4579999999999996321 10 12467889999999999988 999999 99999999999999999
Q ss_pred cccccccCCCccccc------ccccccccccccccccccC------CCCcccchh
Q 003786 621 FGMARIFGGDELQSK------TKRIVGTYGYMSPEYAQQG------LFSIKSDVF 663 (795)
Q Consensus 621 FGla~~~~~~~~~~~------~~~~~gt~~y~APE~~~~~------~~~~k~Dvw 663 (795)
||+++.+........ .....+++.|+|||.+... ..+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999997654321111 1346788899999988542 233446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=211.45 Aligned_cols=257 Identities=24% Similarity=0.273 Sum_probs=191.3
Q ss_pred CCccccccCcCCcccEEEeEecCc--ceEEEEEecccCccchHHHHHHHHHHHhcCC----cccceeeeee-eecceeeE
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLNG--QEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH----RNLVRLLGCC-IELEEKIL 548 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 548 (795)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986553 5799998876544433478999999999973 6889999988 47778899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-----CCeeeecccc
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-----MNPKISDFGM 623 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-----~~vkL~DFGl 623 (795)
||+.+ |.+|.++..... .+.++...+..++.|++.+|.+||+.| ++||||||+|+++... -.+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 778888764444 567899999999999999999999998 9999999999999865 3589999999
Q ss_pred ccccC--CCc----ccc-c-ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHh
Q 003786 624 ARIFG--GDE----LQS-K-TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAW 694 (795)
Q Consensus 624 a~~~~--~~~----~~~-~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~ 694 (795)
++.+. ... ... . ...+.||..|+++....+...+.+.|+||++.++.|++.|..|+........ .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~-- 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK-- 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH--
Confidence 98322 111 111 1 2345699999999999999999999999999999999999999865432211 11100
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
......... .....+..+.++...+-..+..++|....+...|..
T Consensus 252 -----~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 252 -----DPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred -----Hhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 000001110 111112234444444555899999999999888755
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-20 Score=203.72 Aligned_cols=260 Identities=30% Similarity=0.390 Sum_probs=198.1
Q ss_pred CccccccCcCCcccEEEeEecCcceEEEEEecccCcc---chHHHHHHHHHHHhcCCc-ccceeeeeeeecceeeEEeec
Q 003786 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHR-NLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 552 (795)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 78999998765433 367899999999999988 799999999777778999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-CeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~~~~~~ 631 (795)
+.++++..++........+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966633221135788899999999999999999998 99999999999999998 79999999998654433
Q ss_pred ccc----ccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCc--chhHhHhHhhhccCccc
Q 003786 632 LQS----KTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN--SLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 632 ~~~----~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 702 (795)
... ......|+..|+|||.+.. ..+....|+||+|++++++++|..|+...... .............. ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 2456789999999999987 57899999999999999999999996554431 11111111111111 00
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+. ........+.+++..++..+|..|.++.+....
T Consensus 236 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCcc----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 002223466788889999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=230.39 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=190.1
Q ss_pred ccccccCcCCcccEEEeEecC-cceEEEEEeccc--Cccch----HHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 478 STENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGQ----EEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
...+.+|.|.+|.|+...... .+.++.|.+... ..... ..+..|+.+=..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999888876433 333444433211 11111 12556777778899999999888877777766669
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||++ +|..++.. ...+...++..++.|++.|+.|+|..| |.||||||+|+++..+|.+||+|||.+..+.-.
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 88888733 346788899999999999999999999 999999999999999999999999999876543
Q ss_pred ccc--ccccccccccccccccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQ--SKTKRIVGTYGYMSPEYAQQGLFSI-KSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~--~~~~~~~gt~~y~APE~~~~~~~~~-k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... ......+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||-.....+..+..... ....-.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-------~~~~~~ 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-------SDQRNI 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-------cccccc
Confidence 332 4456678999999999999998875 579999999999999999998765544332211100 000000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 745 (795)
..-........+.+...++.+||+.+|.+|.|+++|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11112344556677889999999999999999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=188.88 Aligned_cols=206 Identities=22% Similarity=0.306 Sum_probs=173.6
Q ss_pred HccCCccccccCcCCcccEEEeE-ecCcceEEEEEecccCccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 550 (795)
..-.|.++++||+|.||+.+.|+ +-+++.||||.....+ ...+++.|++..+.|. .++|...|.+-.++-+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34689999999999999999997 5579999999876543 3456888999988885 799999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-----Ceeeecccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-----NPKISDFGMAR 625 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-----~vkL~DFGla~ 625 (795)
|.+ |-||+++..-.. ..++...+..++.|++.-++|+|+++ +|.|||||+|+||...+ .|.|+|||+|+
T Consensus 104 dLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 987 778888764332 24788999999999999999999998 99999999999997543 48999999999
Q ss_pred ccCCCcc-----cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 003786 626 IFGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686 (795)
Q Consensus 626 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 686 (795)
.+..... ....+...||..||+=-...+...+.+-|+=|||=+++..|-|..||.+.....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 8754332 234456789999999988889999999999999999999999999998765433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-21 Score=193.61 Aligned_cols=171 Identities=16% Similarity=0.153 Sum_probs=134.9
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHH---------HHHHHHHHHhcCCcccceeeeeeeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEE---------FKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
...+|+..+.||.|+||.||++.. +++.+|||++.......... +.+|++.+.+++||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 358899999999999999999765 67789999997654333332 67999999999999999999886643
Q ss_pred --------ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 544 --------EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 544 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
...++||||++|.+|.++.. +++ ....+++.+|..+|+.+ ++||||||+||+++.+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 34568999999999998 99999999999999998
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHH
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ell 673 (795)
++|+|||.......... . ..+.....|..++|+|+||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999875422111 0 11344556778999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-21 Score=184.07 Aligned_cols=203 Identities=22% Similarity=0.294 Sum_probs=167.4
Q ss_pred HccCCccccccCcCCcccEEEeE-ecCcceEEEEEecccCccchHHHHHHHHHHHhcCC-cccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH-RNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 550 (795)
...+|.++++||.|+||.+|.|. ..+|.+||||..+... ...++..|..+...|++ ..|..+..+..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35789999999999999999997 4579999999986543 33467889999999975 67888888899999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC---CCeeeecccccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~vkL~DFGla~~~ 627 (795)
+.+ |-+|+++..-..+ .++-..++-++.|++.-++|+|.++ +|||||||+|+|..-+ ..+.|+|||+++.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 7788877743333 3667788999999999999999998 9999999999999644 46899999999976
Q ss_pred CCCcc-----cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 628 GGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 628 ~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
..... ........||..|.+--.+-+...+.+-|+=|+|.+|..+..|..||.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 43221 223445789999998777777778889999999999999999999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-21 Score=186.99 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=188.0
Q ss_pred CccccccCcCCcccEEEeEecCcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
..+..+|.+...|..|+|++. |..+++|++... .....+.|..|.-.|+.+.||||+.+++.|....+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 445568999999999999984 456667777543 22334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEe-ccCCCCcEEECCCCCeeee--ccccccccCCCc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH-RDLKASNILLDKDMNPKIS--DFGMARIFGGDE 631 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH-rDikp~NIll~~~~~vkL~--DFGla~~~~~~~ 631 (795)
.|+|...++... .-.++..++.+++.+|++|++|||+.. +++- --|....+++|++...+|. |--++..
T Consensus 271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999996543 345777899999999999999999987 3443 4588999999999887764 3222211
Q ss_pred ccccccccccccccccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFS---IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~---~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.....-.|.||+||.++.++-+ .++|+|||++++|||.|...||.....-+...- +.-.
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk--------------iale 404 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK--------------IALE 404 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh--------------hhhc
Confidence 1112346889999999876543 578999999999999999999865432222110 1111
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.++-.+++.....+.+++.-|+..||.+||.+..|+-.|+.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 23334555566778899999999999999999999998876
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=184.34 Aligned_cols=139 Identities=18% Similarity=0.189 Sum_probs=108.5
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCcc--c-------hH-----------------HHHHHHHHHHhcCCccc
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--G-------QE-----------------EFKNEIKLIAKLQHRNL 533 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ni 533 (795)
...||+|+||.||+|...+|+.||||+++..... . .. ...+|+++|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999654211 1 11 22359999999988877
Q ss_pred ceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHH-HhcCCCcEEeccCCCCcEEECC
Q 003786 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL-HQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 534 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHrDikp~NIll~~ 612 (795)
.....+. ....++||||++++++...+. ....++...+..++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 223489999999987765432 224578889999999999999999 6777 99999999999998
Q ss_pred CCCeeeecccccccc
Q 003786 613 DMNPKISDFGMARIF 627 (795)
Q Consensus 613 ~~~vkL~DFGla~~~ 627 (795)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-21 Score=207.23 Aligned_cols=232 Identities=23% Similarity=0.226 Sum_probs=180.5
Q ss_pred ccCcCCcccEEEeEe----cCcceEEEEEecccCccc--hHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEeecCC
Q 003786 482 KLGEGGFGPVYKGRL----LNGQEVAVKRLSSQSGQG--QEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
.+|+|.||.|++++. ..++-+|+|++.+..... ......|..++...+ ||.+|++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999999853 347779999987653221 125567888999997 9999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+|.|...+. ....+.+.....+...++.++.++|+.+ |+|||+|++||+++.+|++|+.|||+.+..-...
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999987773 3344666777788888999999999998 9999999999999999999999999998653222
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
..+||..|||||+++ .+..++|.||||++++||++|..||.. .....+ .......
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~I-----------------l~~~~~~ 206 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRI-----------------LKAELEM 206 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHH-----------------hhhccCC
Confidence 128999999999998 678899999999999999999999864 111000 0011223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCH--HHHHHHH
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTM--FEVVSML 747 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~--~evl~~L 747 (795)
+........+++..++..+|..|--. ..+.+++
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 44455566678888888999998754 3444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=213.42 Aligned_cols=250 Identities=19% Similarity=0.168 Sum_probs=181.7
Q ss_pred CCccccccCcCCcccEEEeEecCcceEEEEEecccC-ccchHHHHHHHHH--HHhcCCcccceeeeeeeecceeeEEeec
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS-GQGQEEFKNEIKL--IAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++...+.||++.|=+|.++++.+|. |+||++-+.. ....+.++++++- ...++|||.+++...-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6888899999999999999987777 9999986654 3445556554444 4455899999998887778888999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC--C-
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG--G- 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~--~- 629 (795)
..+ +|.+.+ ..+..+...+...|+.|++.||..+|..+ |+|+|||.+||||+.-..+.|+||.-.+... .
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 876 455555 45677888889999999999999999998 9999999999999999999999998876431 1
Q ss_pred --Cccccccccccccccccccccccc----------CC-CCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhHhHhHhh
Q 003786 630 --DELQSKTKRIVGTYGYMSPEYAQQ----------GL-FSIKSDVFSFGVLLLETLSS-KRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 630 --~~~~~~~~~~~gt~~y~APE~~~~----------~~-~~~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~ 695 (795)
.++.-...+...-..|.|||.+.. .. .+++.||||+||+++||++- +++|+.. +++.+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc
Confidence 111111122223346999997633 12 67899999999999999975 6666431 11111100
Q ss_pred -hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 696 -LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 696 -~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+...+.| +...+.+++..|++.||++|.++++.|+.-.+
T Consensus 251 ~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 251 NADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred CccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00001111111 12267789999999999999999999997555
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=178.51 Aligned_cols=141 Identities=21% Similarity=0.220 Sum_probs=111.3
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccc--------------------------hHHHHHHHHHHHhcCCccc
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG--------------------------QEEFKNEIKLIAKLQHRNL 533 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 533 (795)
...||+|++|.||+|+..+|+.||||+++...... ...++.|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999997789999999987642110 1224679999999999987
Q ss_pred ceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECC
Q 003786 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 534 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~ 612 (795)
.....+... ..++||||++++++..... ....++...+..++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554443322 3489999999986543321 12346778899999999999999999 87 99999999999999
Q ss_pred CCCeeeeccccccccCC
Q 003786 613 DMNPKISDFGMARIFGG 629 (795)
Q Consensus 613 ~~~vkL~DFGla~~~~~ 629 (795)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=184.79 Aligned_cols=233 Identities=18% Similarity=0.225 Sum_probs=148.2
Q ss_pred CCccccccCcCCcccEEEeEecC-cceEEEEEecccC---ccchHHHHHHHHHHHhcCC----------cccceeeeee-
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQH----------RNLVRLLGCC- 540 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~- 540 (795)
.+..++.||.|+++.||.+++.. ++++|||+..... ....+++++|......+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45667899999999999999764 8999999875432 2334667777766655432 1222222221
Q ss_pred --------eecc--------eeeEEeecCCCCChhhhhh---ccCC-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEe
Q 003786 541 --------IELE--------EKILIYEYMPNKSLDFFLF---DSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIH 600 (795)
Q Consensus 541 --------~~~~--------~~~lv~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 600 (795)
.... ..+++|+-+ .++|..++. .... ...+....+..+..|+++.+++||.+| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1111 235677766 557766653 1111 122334455667789999999999999 999
Q ss_pred ccCCCCcEEECCCCCeeeeccccccccCCCccccccccccccccccccccccc--------CCCCcccchhhHHHHHHHH
Q 003786 601 RDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ--------GLFSIKSDVFSFGVLLLET 672 (795)
Q Consensus 601 rDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~k~DvwSlGvil~el 672 (795)
+||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... ..++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988875442211 1234577999997643 2578999999999999999
Q ss_pred HhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCC
Q 003786 673 LSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADR 737 (795)
Q Consensus 673 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~R 737 (795)
++++.|++.......... .-..+. ..++.+..||..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986432211100 112344 677888999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=171.28 Aligned_cols=184 Identities=18% Similarity=0.147 Sum_probs=137.5
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEecccCcc----chHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEeec
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ----GQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.+...|++|+||+||.+.. .+++++.+.+.....- ....+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998765 6778887777543221 1225889999999995 5889999886 456999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccC-CCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL-KASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi-kp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+.|.+|...+. . ....++.|++++|.++|.+| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999864431 1 12357789999999999998 999999 7999999999999999999998654332
Q ss_pred cc----cc-------ccccccccccccccccccC-CCC-cccchhhHHHHHHHHHhCCCCC
Q 003786 632 LQ----SK-------TKRIVGTYGYMSPEYAQQG-LFS-IKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 632 ~~----~~-------~~~~~gt~~y~APE~~~~~-~~~-~k~DvwSlGvil~elltG~~p~ 679 (795)
.. .. ......++.|++|+...-- ..+ ...++++.|..+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 00 0112357788888754321 233 5679999999999999998765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-18 Score=169.22 Aligned_cols=136 Identities=21% Similarity=0.294 Sum_probs=106.3
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhc-----CCcccceeeeeeeecc---eee-E
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-----QHRNLVRLLGCCIELE---EKI-L 548 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 548 (795)
.-.+.||+|+||.||. ++.....+||++........+.+.+|+.+++.+ .||||+++++++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 544344479998765555667899999999999 5799999999998874 333 7
Q ss_pred Eeec--CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHH-HHHHhcCCCcEEeccCCCCcEEECC----CCCeeeecc
Q 003786 549 IYEY--MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGL-LYLHQYSRLRVIHRDLKASNILLDK----DMNPKISDF 621 (795)
Q Consensus 549 v~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiHrDikp~NIll~~----~~~vkL~DF 621 (795)
|+|| +++++|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 6689999999432 24444 35677888777 8999998 999999999999974 347999995
Q ss_pred ccc
Q 003786 622 GMA 624 (795)
Q Consensus 622 Gla 624 (795)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-18 Score=197.28 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=162.0
Q ss_pred HHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcC---Ccccceeeeeeeecceee
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 547 (795)
....+.|.+.+.||+|+||+||+|...+|+.||+|+-+... .-+|.--.+++.+|+ -+-|+.+...+.-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 44567899999999999999999998889999999876542 222322334444444 355677777777888899
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-------CCCeeeec
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-------DMNPKISD 620 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-------~~~vkL~D 620 (795)
||+||.+.|+|.+++. ..+.+++.....++.|+++.+..||..+ |||+||||+|+||.. .-.++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999984 6677999999999999999999999998 999999999999942 34589999
Q ss_pred cccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~ 676 (795)
||.+..+..-......+..++|-.+-.+|...+.+.++.+|.|.|+.+++-||.|+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 99998654332233455678899999999999999999999999999999999996
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.5e-18 Score=185.09 Aligned_cols=214 Identities=24% Similarity=0.354 Sum_probs=160.5
Q ss_pred HHhcCCcccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCC
Q 003786 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 604 (795)
Q Consensus 525 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik 604 (795)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ..-.+++.-...++++|++||.|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999965 2344788888999999999999999865 22999999
Q ss_pred CCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccC-------CCCcccchhhHHHHHHHHHhCCC
Q 003786 605 ASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-------LFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 605 p~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~~~k~DvwSlGvil~elltG~~ 677 (795)
+.|.++|....+||+|||+.................-..-|.|||.++.. ..+.+.||||||++++||++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431111111122345679999998763 24678999999999999999999
Q ss_pred CCCCCCCcch--hHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 678 NTDFSNTNSL--TLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 678 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
||+....... .++..... .....+.|.+.... +....+..++..||..+|++||++++|-..++.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 9986442221 22221111 11112223222111 333468899999999999999999999887765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=170.68 Aligned_cols=197 Identities=21% Similarity=0.253 Sum_probs=134.9
Q ss_pred CCcccceeeeeeeec---------------------------ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHH
Q 003786 529 QHRNLVRLLGCCIEL---------------------------EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE 581 (795)
Q Consensus 529 ~h~niv~l~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 581 (795)
+|||||+++++|.+. ..+|+||...+. +|..++.... .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 499999999887542 245788876644 6777774322 44566778899
Q ss_pred HHHHHHHHHHhcCCCcEEeccCCCCcEEEC--CCC--CeeeeccccccccCCC----ccccccccccccccccccccccc
Q 003786 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDM--NPKISDFGMARIFGGD----ELQSKTKRIVGTYGYMSPEYAQQ 653 (795)
Q Consensus 582 ~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~--~vkL~DFGla~~~~~~----~~~~~~~~~~gt~~y~APE~~~~ 653 (795)
|+++|+.|||.++ |.|||+|.+||||. +|+ .+.|+|||.+-..... .+.+..-...|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999993 333 5789999998643221 11122223457788999998864
Q ss_pred CC------CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHH
Q 003786 654 GL------FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGL 727 (795)
Q Consensus 654 ~~------~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~ 727 (795)
.+ --.|+|.|+.|.+.||++....||-...+.....-. +.+... ...+..++..+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qL---------Palp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQL---------PALPSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhC---------CCCcccCChHHHHHHH
Confidence 32 135899999999999999999998543322211110 111111 1123334456678899
Q ss_pred hhccCCCCCCCCHHHHHHHH
Q 003786 728 LCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 728 ~cL~~dP~~RPt~~evl~~L 747 (795)
..|+.||++||+..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876544443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-17 Score=167.70 Aligned_cols=147 Identities=16% Similarity=0.160 Sum_probs=112.8
Q ss_pred HHccCCccccccCcCCcccEEEeE--ecCcceEEEEEecccCcc------------------------chHHHHHHHHHH
Q 003786 472 AATANFSTENKLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQ------------------------GQEEFKNEIKLI 525 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l 525 (795)
.....|++.+.||+|++|.||+|. ..+|+.||||++...... ....+..|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 334468899999999999999998 567999999998653210 012356899999
Q ss_pred HhcCCcc--cceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccC
Q 003786 526 AKLQHRN--LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 603 (795)
Q Consensus 526 ~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi 603 (795)
.++.+.. +.+++++ ...++||||+++.+|...... ...+....+..++.||+.++.+||+.+ +|+||||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di 175 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL 175 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence 9997633 3344432 245899999999888655422 223455667899999999999999876 4999999
Q ss_pred CCCcEEECCCCCeeeeccccccccC
Q 003786 604 KASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 604 kp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||+||+++ ++.++|+|||.+....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987543
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=134.13 Aligned_cols=66 Identities=52% Similarity=1.166 Sum_probs=59.3
Q ss_pred CCCCCceeEeccCCCCcccccccccccCHHHHHHHHHhcCCeeeeeeccccCCCceeEEeccccccc
Q 003786 335 CKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDI 401 (795)
Q Consensus 335 C~~~d~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~~c~~w~gdl~~~ 401 (795)
|+++|+|++|++|++|++....++.+.++++|+..|++||||+||+|.++. ++++|++|+|+|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 566799999999999999877776779999999999999999999998665 678999999999985
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-17 Score=189.95 Aligned_cols=210 Identities=20% Similarity=0.291 Sum_probs=143.9
Q ss_pred HccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
...+|..++.|..|+||.||.++++. .+.+|+ ++.++... +++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee-----------------
Confidence 34789999999999999999998764 788998 44333211 111 33333455444
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC--
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG-- 629 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~-- 629 (795)
|+-...+ ...+.++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+.+...-
T Consensus 136 ----gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 2222222 111223322 278899999998 99999999999999999999999999875311
Q ss_pred ------Ccc-----cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-HhHhHhhhc
Q 003786 630 ------DEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT-LLGHAWDLW 697 (795)
Q Consensus 630 ------~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~ 697 (795)
... +-..+..+||+.|.|||++....|...+|+|++|+|+||.+.|..||.+...+.+. .+......|
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 000 11123468999999999999999999999999999999999999999775433321 111111111
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCC
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPT 739 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt 739 (795)
.++ ......+..++|.++|+.+|..|--
T Consensus 278 pE~--------------dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 278 PEE--------------DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ccc--------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 111 1122346677888999999999963
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=159.75 Aligned_cols=145 Identities=19% Similarity=0.201 Sum_probs=113.9
Q ss_pred HhHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCcc----------------------chHHHHHHHHHH
Q 003786 468 ASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ----------------------GQEEFKNEIKLI 525 (795)
Q Consensus 468 ~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 525 (795)
.++......|.+.++||+|+||.||++...+|+.||||++...... .......|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444555568888999999999999998888999999987543210 112356789999
Q ss_pred HhcCCcc--cceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccC
Q 003786 526 AKLQHRN--LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 603 (795)
Q Consensus 526 ~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi 603 (795)
.++.|++ +.+.++ ....++||||+++++|..... ......++.++++++.++|+.+ |+||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 245589999999999876541 1355678899999999999987 999999
Q ss_pred CCCcEEECCCCCeeeeccccccccC
Q 003786 604 KASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 604 kp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=161.23 Aligned_cols=134 Identities=20% Similarity=0.342 Sum_probs=113.5
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCcc--------chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--------GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|++++..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7788999986543211 124577899999999999988877777778888999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++|++|.+++... .. .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887422 12 77899999999999999998 99999999999999 78999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-17 Score=179.42 Aligned_cols=192 Identities=23% Similarity=0.261 Sum_probs=135.4
Q ss_pred CccccccCcCCcccEEEeEecCc---c-eEEEEEecccCccchHHHHHHHHHHHhc-CCcccceee------eeee----
Q 003786 477 FSTENKLGEGGFGPVYKGRLLNG---Q-EVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLL------GCCI---- 541 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~~---~-~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~------~~~~---- 541 (795)
..+.+..+..+++.+...+...+ . .++-+..............+++-.+... +|+..+..- ....
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 44456667777777766653332 2 2333332222212222333344444333 344433321 0111
Q ss_pred -ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 542 -ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 542 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
.....++.|++|.-.+|.++|.........++.....++.|++.|+.| ++ .+|||+||.||+...+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 123467999999999999999766656667888999999999999999 55 99999999999999999999999
Q ss_pred cccccccCCCc----ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh
Q 003786 621 FGMARIFGGDE----LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674 (795)
Q Consensus 621 FGla~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt 674 (795)
||+........ .....+...||..||+||.+.+..|+.|+||||||+||+|++.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99988664433 2234456789999999999999999999999999999999996
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=158.01 Aligned_cols=130 Identities=22% Similarity=0.383 Sum_probs=106.9
Q ss_pred ccCcCCcccEEEeEecCcceEEEEEecccCcc--------chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--------GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.||+|+||.||+|.. +++.+++|+....... ..+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6788999986543211 1256778999999999987666555666777789999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
+|++|.+.+.... ..++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988763211 178999999999999998 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.3e-16 Score=179.45 Aligned_cols=138 Identities=20% Similarity=0.343 Sum_probs=112.6
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEe-cccCc-------cchHHHHHHHHHHHhcCCcccceeeeeeeecc
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRL-SSQSG-------QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE 544 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 544 (795)
....|...+.||+|+||.||+|..... .+++|+. .+... ...+++.+|++++++++|++++..+.++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345567789999999999999987443 4444433 22111 12356889999999999999998888877777
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ .++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999988873 35678999999999999988 9999999999999 6789999999999
Q ss_pred cc
Q 003786 625 RI 626 (795)
Q Consensus 625 ~~ 626 (795)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.8e-16 Score=182.59 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=195.9
Q ss_pred ccCCccccccCcCCcccEEEeEecC--cceEEEEEecccC--ccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 548 (795)
...|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+.+..|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3567888889999999998887543 3456777665443 223345556887777776 9999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHH-hcCCCcEEeccCCCCcEEECCCC-Ceeeeccccccc
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH-QYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARI 626 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~ 626 (795)
++||..++++...+. .......+...+..++.|+..++.|+| ..+ +.||||||+|.+++..+ .+|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999987773 111224667788899999999999999 777 99999999999999999 999999999998
Q ss_pred cCC-Cccccccccccc-ccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 627 FGG-DELQSKTKRIVG-TYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 627 ~~~-~~~~~~~~~~~g-t~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+.. ..........+| ++.|+|||...+. ......|+||.|+++..+++|..|++........+..+. +...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~-----~~~~- 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK-----SNKG- 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec-----cccc-
Confidence 766 454555556778 9999999998884 567889999999999999999999987664443322211 1110
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 745 (795)
...............+++.+++..+|+.|.+.+++..
T Consensus 249 -----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0001112223345667888899999999999998865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.7e-15 Score=146.91 Aligned_cols=137 Identities=20% Similarity=0.260 Sum_probs=98.8
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCcc--chHH----------------------HHHHHHHHHhcCCcc--c
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--GQEE----------------------FKNEIKLIAKLQHRN--L 533 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 533 (795)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5789999999999999878999999998653211 1111 135666666665433 3
Q ss_pred ceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECC
Q 003786 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 534 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~ 612 (795)
.+.+++ ...++||||++++.+......... . ...+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 346899999999544221111100 1 15778899999999999999 76 99999999999999
Q ss_pred CCCeeeeccccccccC
Q 003786 613 DMNPKISDFGMARIFG 628 (795)
Q Consensus 613 ~~~vkL~DFGla~~~~ 628 (795)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=138.33 Aligned_cols=135 Identities=23% Similarity=0.231 Sum_probs=114.7
Q ss_pred cccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCC--cccceeeeeeeecceeeEEeecCCCC
Q 003786 479 TENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH--RNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
+.+.||+|.++.||+++..+ +.+++|....... ...+.+|+.+++.++| +++.+++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998744 7899999865433 5678999999999987 58999999888888899999999988
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
.+..+ +......++.++++++++||.....+++|+||+|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 3456677899999999999987555699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.9e-14 Score=145.97 Aligned_cols=135 Identities=23% Similarity=0.275 Sum_probs=104.3
Q ss_pred cccC-cCCcccEEEeEecCcceEEEEEecccC-------------ccchHHHHHHHHHHHhcCCccc--ceeeeeeeecc
Q 003786 481 NKLG-EGGFGPVYKGRLLNGQEVAVKRLSSQS-------------GQGQEEFKNEIKLIAKLQHRNL--VRLLGCCIELE 544 (795)
Q Consensus 481 ~~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 544 (795)
..|| .||.|+||.++. .+..++||++.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 899999999877 47789999885321 1223567889999999998875 66777654332
Q ss_pred e----eeEEeecCCC-CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 545 E----KILIYEYMPN-KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 545 ~----~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
. .++|||++++ .+|.+++.. ..+++ ..+.+|+++|.+||+.| |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688887732 12333 23678999999999998 9999999999999999999999
Q ss_pred cccccccc
Q 003786 620 DFGMARIF 627 (795)
Q Consensus 620 DFGla~~~ 627 (795)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998753
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.9e-14 Score=116.16 Aligned_cols=71 Identities=24% Similarity=0.458 Sum_probs=60.5
Q ss_pred CCCCCceeEeccCCCCcccccccccccCHHHHHHHHHh---cCCeeeeeeccccCCCceeEEecccc-cccccccCCCCC
Q 003786 335 CKSGDRFIMLDDVKLPDFVEASLNESMNVKECEAECLK---NCTCRAYANSKVTGEGSGCLMWFGDL-IDIRKADDRNNG 410 (795)
Q Consensus 335 C~~~d~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~---nCsC~ay~~~~~~~~~~~c~~w~gdl-~~~~~~~~~~~~ 410 (795)
|..+..|+++.+|++|++.. +++++|++.|++ ||||+||+|.+. +.||++|+++| ++++. ....+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~--~~~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRK--EFSHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHh--ccCCC
Confidence 55667899999999999753 689999999999 999999999753 35899999999 99876 44568
Q ss_pred ccEEEe
Q 003786 411 QSIYIR 416 (795)
Q Consensus 411 ~~lylR 416 (795)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 999998
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=145.73 Aligned_cols=144 Identities=24% Similarity=0.285 Sum_probs=100.8
Q ss_pred CCccccccCcCCcccEEEeEecCcceEEEEEecccCccch----------------------------------------
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQ---------------------------------------- 515 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 515 (795)
.|+ .+.||.|++|.||+|++.+|+.||||+.+.......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 368999999999999999999999999865321100
Q ss_pred HHHHHHHHHHHhcC----Ccccceeeeeee-ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHH-HHHH
Q 003786 516 EEFKNEIKLIAKLQ----HRNLVRLLGCCI-ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ-GLLY 589 (795)
Q Consensus 516 ~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~ 589 (795)
-.+.+|.+.+.++. |.+-+.+...+. ..+..++||||++|++|.++...... .. ....++..++. .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHH
Confidence 02344555555552 322333333332 34567999999999999877632111 11 34456666665 4678
Q ss_pred HHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 590 LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
+|..| ++|+|+||.||+++.++.++|+|||++..+.
T Consensus 273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 89887 9999999999999999999999999998664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.8e-13 Score=137.28 Aligned_cols=211 Identities=19% Similarity=0.197 Sum_probs=144.3
Q ss_pred HHHHHHHHHhcCCcccceeeeeeeec-----ceeeEEeecCCCCChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHH
Q 003786 518 FKNEIKLIAKLQHRNLVRLLGCCIEL-----EEKILIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLH 591 (795)
Q Consensus 518 ~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH 591 (795)
...-..-|-.+.|.|||+++.|+.+. ....+++|||..|++..+|....+ ...+....-.+++.||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 33334556677899999999987654 346899999999999999965443 345777778899999999999999
Q ss_pred hcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC--CCcccccccccccccccccccccccCCCCcccchhhHHHHH
Q 003786 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG--GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669 (795)
Q Consensus 592 ~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~--~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil 669 (795)
+.. .+|+|+++..+-|++..+|-+||.--.-...-. ............+.++|.|||.=....-+.++|||+||+..
T Consensus 194 s~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred ccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 974 789999999999999999999884321111100 00111223334578899999987777778899999999999
Q ss_pred HHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 670 LETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 670 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.||..+..-..........-. ........+.. ..-..++.+|++..|..||+|++++.|.
T Consensus 273 lemailEiq~tnseS~~~~ee-------~ia~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEE-------NIANVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHHheeccCCCcceeehhh-------hhhhheeeccC-----------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 999887643221111000000 00000001111 1122466789999999999999998863
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.5e-12 Score=121.49 Aligned_cols=131 Identities=22% Similarity=0.136 Sum_probs=99.1
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccce-eeeeeeecceeeEEeecCCCCCh
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR-LLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
++.|+.|.++.||+++.. ++.+++|+...... ....+.+|+.+++.+.+.++++ ++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367999999999999864 78899998865432 2345788999999997666554 44432 3346899999999887
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC--CCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
.... .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 112345678999999999886 23369999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.9e-12 Score=108.05 Aligned_cols=80 Identities=39% Similarity=0.868 Sum_probs=63.9
Q ss_pred CCCCCCC---CceeEeccCCCCcccccccccccCHHHHHHHHHhcCCeeeeeeccccCCCceeEEecccccccccccCCC
Q 003786 332 SSDCKSG---DRFIMLDDVKLPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGDLIDIRKADDRN 408 (795)
Q Consensus 332 ~~~C~~~---d~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~~c~~w~gdl~~~~~~~~~~ 408 (795)
+++|.+. +.|+.+.++++|++.... .+.++++|++.|++||+|+||+|.+ ++++|.+|.+.+.+.+.. ..
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~--~~ 74 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSL--SS 74 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEee--cC
Confidence 3457554 689999999999875443 6789999999999999999999963 357899999999887652 23
Q ss_pred CCccEEEecc
Q 003786 409 NGQSIYIRVP 418 (795)
Q Consensus 409 ~~~~lylRl~ 418 (795)
.+.++|||++
T Consensus 75 ~~~~~yiKv~ 84 (84)
T cd01098 75 GGGTLYLRLA 84 (84)
T ss_pred CCcEEEEEeC
Confidence 3678999975
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.3e-12 Score=140.83 Aligned_cols=250 Identities=24% Similarity=0.264 Sum_probs=182.6
Q ss_pred cCCccccccCc--CCcccEEEeEe---cCcceEEEEEeccc--CccchHHHHHHHHHHHhcC-Ccccceeeeeeeeccee
Q 003786 475 ANFSTENKLGE--GGFGPVYKGRL---LNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 546 (795)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .......-.+|+...++++ |++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677788999 99999999986 35788999984332 2233344456777777774 99999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHH----HHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeecc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ----GLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDF 621 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DF 621 (795)
++-+|++. .+|..+. ......++...+.....+..+ ||.++|..+ |+|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~--~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYC--HTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhh--hcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999986 4554444 234456788888899999989 999999987 9999999999999999 88999999
Q ss_pred ccccccCCCccccc---ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc
Q 003786 622 GMARIFGGDELQSK---TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 622 Gla~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|+...++....... ..+..|...|++||.++ +.++.+.|+|++|.++.+-.++....-..-. ..|.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------~~W~ 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN----------SSWS 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----------CCcc
Confidence 99998866543221 23346788999999775 5678899999999999999988765432110 1111
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.+... +..+.......++..++.++++.+|..|++.+.+..+
T Consensus 337 ~~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 337 QLRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111111 1111111122344458889999999999999888764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.4e-12 Score=142.22 Aligned_cols=145 Identities=18% Similarity=0.215 Sum_probs=94.0
Q ss_pred ccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccc----------------------------------hH--
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQG----------------------------------QE-- 516 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-- 516 (795)
..+|+. +.||+|++|.||+|++.+ |++||||++++..... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 799999999999999887 9999999997542100 11
Q ss_pred ----HHHHHHHHHHhcC----Ccccceeeeeeee-cceeeEEeecCCCCChhhhhhccCC---cccCChhhHHHHHHHHH
Q 003786 517 ----EFKNEIKLIAKLQ----HRNLVRLLGCCIE-LEEKILIYEYMPNKSLDFFLFDSTK---ENLLGWGTRVRIIEGIA 584 (795)
Q Consensus 517 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~ 584 (795)
.+.+|+..+.++. +...+.+..++.+ ....+|||||++|+.+.++..-... .+.+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 1233444444442 3333444344332 4567899999999999764211111 011222222223333
Q ss_pred HHHHHHHhcCCCcEEeccCCCCcEEECCCC----CeeeeccccccccCC
Q 003786 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFGMARIFGG 629 (795)
Q Consensus 585 ~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~vkL~DFGla~~~~~ 629 (795)
++..| ++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33455 99999999999999988 999999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=5e-10 Score=110.48 Aligned_cols=138 Identities=13% Similarity=0.124 Sum_probs=98.7
Q ss_pred ccccCcCCcccEEEeEecC-------cceEEEEEecccC------------c----------cchHHHH----HHHHHHH
Q 003786 480 ENKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS------------G----------QGQEEFK----NEIKLIA 526 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~ 526 (795)
...||.|.-+.||.|...+ +..+|||+++... . .....++ +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 4789999875311 0 0012233 7999999
Q ss_pred hcCC--cccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHH-HhcCCCcEEeccC
Q 003786 527 KLQH--RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL-HQYSRLRVIHRDL 603 (795)
Q Consensus 527 ~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHrDi 603 (795)
++.. -++.+++++ ...++||||+.+..+..-. .+...++......+..+++.+|..| |..+ |||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9864 455566654 5678999999875442111 1112244456677889999999999 7777 999999
Q ss_pred CCCcEEECCCCCeeeeccccccccC
Q 003786 604 KASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 604 kp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999996 5789999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.3e-10 Score=125.22 Aligned_cols=166 Identities=19% Similarity=0.232 Sum_probs=126.3
Q ss_pred ecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhh
Q 003786 496 LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGT 575 (795)
Q Consensus 496 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~ 575 (795)
..++.+|.|..+........+..++-++.|+.++||||+++++.+.++...|+|+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44688999998876655445668888999999999999999999999999999999874 34444422 23556
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCC
Q 003786 576 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655 (795)
Q Consensus 576 ~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 655 (795)
...-+.||++||.+||+.+ +++|++|....|+|+..|+.||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6778899999999999766 699999999999999999999999999865433221 111112223455666543222
Q ss_pred CCcccchhhHHHHHHHHHhC
Q 003786 656 FSIKSDVFSFGVLLLETLSS 675 (795)
Q Consensus 656 ~~~k~DvwSlGvil~elltG 675 (795)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 456999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.8e-11 Score=129.67 Aligned_cols=249 Identities=20% Similarity=0.193 Sum_probs=177.2
Q ss_pred HHccCCccccccCcCCcccEEEeEe--cCcceEEEEEecccCccchHHH--HHHHHHHHhc-CCcccceeeeeeeeccee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL--LNGQEVAVKRLSSQSGQGQEEF--KNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
..+.+|..+..||.|.|+.|+.... .++..|++|.+.........++ ..|+.+...+ .|.++++.+..+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3457899999999999999999864 3577899998765433333332 3577666666 489999998888888888
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeecccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAR 625 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DFGla~ 625 (795)
++=-|||.++++...+ .-...+++...+++..|++.++.++|++. ++|+|+||+||++..+ +.-++.|||...
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999987665 22234777888999999999999999987 9999999999999876 788999999986
Q ss_pred ccCCCcccccccccccccccc--cccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYM--SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
.+.-. .....+.-.++ +|+......+-.++|++|||.-+.|.+++..-.+.. ... .
T Consensus 416 ~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~~----------------~ 473 (524)
T KOG0601|consen 416 RLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQS----------------L 473 (524)
T ss_pred cccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccc-ccc----------------e
Confidence 32110 11122333444 555566678899999999999999999886432210 000 0
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
. +........+... +.+..+...++..++..||.+.++..+.+..
T Consensus 474 ~-i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 474 T-IRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred e-eecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 0001011111112 4555667778999999999999988776553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.3e-10 Score=112.68 Aligned_cols=142 Identities=18% Similarity=0.263 Sum_probs=109.4
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCc-cchHHHHHHHHHHHhcCCc--ccceeeeeeeecc---eeeEEeecCC
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHR--NLVRLLGCCIELE---EKILIYEYMP 554 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~E~~~ 554 (795)
+.|+.|..+.||+++..+|+.+++|+...... .....+.+|+++++.+.+. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57999999999999876678999999865432 2456789999999999763 4566777766542 5689999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS---------------------------------------- 594 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 594 (795)
|.++...+.. ..+++.....++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 23566677778888888888888531
Q ss_pred -------------CCcEEeccCCCCcEEECC--CCCeeeeccccccc
Q 003786 595 -------------RLRVIHRDLKASNILLDK--DMNPKISDFGMARI 626 (795)
Q Consensus 595 -------------~~~iiHrDikp~NIll~~--~~~vkL~DFGla~~ 626 (795)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.6e-09 Score=101.65 Aligned_cols=131 Identities=20% Similarity=0.345 Sum_probs=102.6
Q ss_pred cccCcCCcccEEEeEecCcceEEEEE-ecccC--cc-----chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKR-LSSQS--GQ-----GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~-~~~~~--~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+++|+-+.+|.+.. -|..+++|. +.+.- ++ ..++..+|+.+|.+++--.|.-.+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4688999999999966 344566664 33321 11 124567899999999877777666677788889999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++|..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 2567788888899999998 99999999999997665 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.6e-09 Score=99.99 Aligned_cols=143 Identities=22% Similarity=0.327 Sum_probs=108.3
Q ss_pred cccccCcCCcccEEEeEecCcceEEEEE-ecccC-------ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 479 TENKLGEGGFGPVYKGRLLNGQEVAVKR-LSSQS-------GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
....|-||+-+.|+++.. .|+...||. +.+.- .....+.++|++.|.+++--.|.-..=++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456889999999999987 567777773 33321 123456789999999998777766666777888889999
Q ss_pred ecCCC-CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---Ceeeeccccccc
Q 003786 551 EYMPN-KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMARI 626 (795)
Q Consensus 551 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL~DFGla~~ 626 (795)
||+++ .++.+++...-... ........++..|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 46777775433332 223333688899999999999988 99999999999997655 358999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.2e-10 Score=131.19 Aligned_cols=251 Identities=19% Similarity=0.203 Sum_probs=176.3
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...+.+.+.+.+-+|.++.++.++-. .|...++|..... .....+....+-.++-.-+||.+++...-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45577888899999999999988632 3444444443222 2233444555555555556788887777677778899
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
||++|..+++|...++... ..+.+.+...+..+.+++.|||... +.|||++|.|++...+++.+++|||+....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999988875433 4566667777788899999999875 899999999999999999999999854322
Q ss_pred CC-------------------------Cccc----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 003786 628 GG-------------------------DELQ----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN 678 (795)
Q Consensus 628 ~~-------------------------~~~~----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p 678 (795)
.. .... .......||+.|.+||.+.+......+|+|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0000 112345789999999999999999999999999999999999999
Q ss_pred CCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHH
Q 003786 679 TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMF 741 (795)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ 741 (795)
|......... . .+......+ ...+........+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq~~f--~---ni~~~~~~~--------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF--E---NILNRDIPW--------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh--h---ccccCCCCC--------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 8654322221 0 000000000 112223344566778888899999998776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4e-08 Score=106.31 Aligned_cols=169 Identities=21% Similarity=0.304 Sum_probs=130.1
Q ss_pred cccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeee----ecceeeEEeecCCC-CChhhh
Q 003786 488 FGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI----ELEEKILIYEYMPN-KSLDFF 561 (795)
Q Consensus 488 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-gsL~~~ 561 (795)
-.+.|++.. .+|..|++|+++....+.......-+++++++.|+|||++.++|. .+..+++||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788874 579999999996555555555666789999999999999999887 34567899999986 566555
Q ss_pred hhccC------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 562 LFDST------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 562 l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
-+... .....++..++.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 2234677899999999999999999998 88899999999999999999999888776543
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN 678 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p 678 (795)
+.. |.+.+ -.+-|.=.||.+++.|.+|...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11111 1345888999999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.8e-08 Score=96.89 Aligned_cols=126 Identities=25% Similarity=0.321 Sum_probs=84.3
Q ss_pred cEEEeEecCcceEEEEEecccCc---------------------c-----chHHHHHHHHHHHhcCCcc--cceeeeeee
Q 003786 490 PVYKGRLLNGQEVAVKRLSSQSG---------------------Q-----GQEEFKNEIKLIAKLQHRN--LVRLLGCCI 541 (795)
Q Consensus 490 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~-----~~~~~~~E~~~l~~l~h~n--iv~l~~~~~ 541 (795)
.||.|...+|..+|||+.+.... . .....++|++.|.++..-+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999988899999998754210 0 0123568999999998664 5556544
Q ss_pred ecceeeEEeecCC--CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHH-HHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 542 ELEEKILIYEYMP--NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY-LHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 542 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
....+||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 35679999999 65554433111 1245667788888886655 56777 9999999999999888 9999
Q ss_pred eccccccccC
Q 003786 619 SDFGMARIFG 628 (795)
Q Consensus 619 ~DFGla~~~~ 628 (795)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-07 Score=100.60 Aligned_cols=193 Identities=16% Similarity=0.159 Sum_probs=130.8
Q ss_pred CccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccce--------eeeeeeecceee
Q 003786 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVR--------LLGCCIELEEKI 547 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l~~~~~~~~~~~ 547 (795)
...++.||+|+-+.+|-.-. -...+.|+++........+... .|.+. .||-+-. |+|- .......
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecch--hhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence 45578899999999997532 2334568887654433333222 23222 4554332 1121 1222366
Q ss_pred EEeecCCCCCh-hhhhhcc---CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 548 LIYEYMPNKSL-DFFLFDS---TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 548 lv~E~~~~gsL-~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
++|..+++..= ..++... .......|.-+.+.++.++.+.+.||..| .+-+|+.++|+|+.+++.|.|.|=..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence 88888877532 2333222 22345788999999999999999999998 88999999999999999999998554
Q ss_pred ccccCCCcccccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCC
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSS-KRNTDF 681 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG-~~p~~~ 681 (795)
..+..+. ....-.+|..+|.+||... +..-+...|.|.|||++++++.| ++|+.+
T Consensus 164 fqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 164 FQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 4332211 1222357899999999764 34557789999999999999987 888864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.5e-08 Score=100.51 Aligned_cols=134 Identities=18% Similarity=0.140 Sum_probs=96.7
Q ss_pred cccEEEeEecCcceEEEEEecccCc-----------cchHHHHHHHHHHHhcCCccc--ceeeeeeee-----cceeeEE
Q 003786 488 FGPVYKGRLLNGQEVAVKRLSSQSG-----------QGQEEFKNEIKLIAKLQHRNL--VRLLGCCIE-----LEEKILI 549 (795)
Q Consensus 488 ~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~lv 549 (795)
...|+++.. +|+.|.||....... .....+.+|...+.+|...+| .+++++... ....++|
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334666654 677899997643220 112247899999999864443 344555543 2357899
Q ss_pred eecCCCC-ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-------CCCeeeecc
Q 003786 550 YEYMPNK-SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-------DMNPKISDF 621 (795)
Q Consensus 550 ~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-------~~~vkL~DF 621 (795)
+|++++. +|.+++.... ....+......++.++++.+.-||..| |+|+|+++.|||++. ++.+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999986 8888874321 123455677789999999999999998 999999999999975 467999999
Q ss_pred ccccc
Q 003786 622 GMARI 626 (795)
Q Consensus 622 Gla~~ 626 (795)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 99864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-07 Score=94.99 Aligned_cols=136 Identities=20% Similarity=0.218 Sum_probs=99.7
Q ss_pred CccccccCcCCcccEEEeEecCcceEEEEEecccC----------------------ccchHHHHHHHHHHHhcCCc--c
Q 003786 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----------------------GQGQEEFKNEIKLIAKLQHR--N 532 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 532 (795)
..++.+||-|.-+.||.|..+.|.++|||.-+... .......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46678999999999999999999999999543210 01123457899999999755 5
Q ss_pred cceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC
Q 003786 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 533 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~ 612 (795)
+.+.+++ +...+||||++|-.|...- ++.+....++..|+.-+.-+-..| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666544 5567999999997774332 123444455555555555555556 999999999999999
Q ss_pred CCCeeeecccccccc
Q 003786 613 DMNPKISDFGMARIF 627 (795)
Q Consensus 613 ~~~vkL~DFGla~~~ 627 (795)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999776643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-08 Score=113.28 Aligned_cols=155 Identities=21% Similarity=0.288 Sum_probs=104.0
Q ss_pred HHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc------c-ccccccccccccccccccc
Q 003786 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL------Q-SKTKRIVGTYGYMSPEYAQ 652 (795)
Q Consensus 580 ~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~------~-~~~~~~~gt~~y~APE~~~ 652 (795)
+.+++.|+.|+|..- .+||+.|.|++|.++..+..||+.|+.+....+... . .......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445568999999864 799999999999999999999999999875543111 0 0011123456899999999
Q ss_pred cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccC
Q 003786 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQE 732 (795)
Q Consensus 653 ~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~ 732 (795)
....+.++|++|+||++|.+..|+.+.-........+.. . . ...+... ...+...+.++.+=+.+++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~-~--------~~~~~~~-~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-S-R--------NLLNAGA-FGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-h-h--------ccccccc-ccccccCcHHHHHHHHHHhcC
Confidence 988999999999999999999655543221111111000 0 0 0001000 111234455666677789999
Q ss_pred CCCCCCCHHHHHHHH
Q 003786 733 DAADRPTMFEVVSML 747 (795)
Q Consensus 733 dP~~RPt~~evl~~L 747 (795)
++.-||++.++....
T Consensus 252 ~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSIP 266 (700)
T ss_pred CcccCcchhhhhccc
Confidence 999999888887654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=78.36 Aligned_cols=100 Identities=24% Similarity=0.380 Sum_probs=68.7
Q ss_pred CeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEec-CCCCCCccCcceEEEeeCCceEEeCCCCceEEeecCCCC
Q 003786 38 EKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVA-NRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSRE 116 (795)
Q Consensus 38 ~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~a-n~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~ 116 (795)
+.+.+.+|.+.|-|..+|+ |.|... ..+++|.+ +...... ..+.+.|+.||||||+|..+.++|+|.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----EEEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4555655899999999885 344322 25779999 5444422 5789999999999999999999999943 3
Q ss_pred ccccEEEEcc--CCCeEEeecCCCCCcccceecccCCCc
Q 003786 117 VKNPVAQLLD--TGNLVVRDNFSSNSSEDYLWQSFDHPS 153 (795)
Q Consensus 117 ~~~~~a~l~d--~GNlvl~~~~~~~~~~~~~WqSFd~PT 153 (795)
....+...++ +||++ +. ....+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~-----~~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GK-----NDSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EE-----STSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cc-----cceEEeECCCCCCC
Confidence 3456667888 99999 75 34578898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.2e-06 Score=84.95 Aligned_cols=147 Identities=16% Similarity=0.184 Sum_probs=105.4
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecc------cCccchHHHHHHHHHHHhcCCcc--cceeeeeeee----
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSS------QSGQGQEEFKNEIKLIAKLQHRN--LVRLLGCCIE---- 542 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~---- 542 (795)
.++-..---|+||-+-|+...+ +|+.+-+|+-.. ..+.+...|.+|...|.+|...+ +.++...-..
T Consensus 18 ~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~ 96 (216)
T PRK09902 18 GDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEG 96 (216)
T ss_pred CceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCC
Confidence 3333333457799999999876 344688887641 11456788999999999996433 4444422111
Q ss_pred cceeeEEeecCCC-CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC--eeee
Q 003786 543 LEEKILIYEYMPN-KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKIS 619 (795)
Q Consensus 543 ~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--vkL~ 619 (795)
....+||+|-+++ -+|++++.... ....+......++.+++++++-||+.+ +.|+|+.+.||+++.++. ++++
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEE
Confidence 2246799997765 57888774322 223566677899999999999999998 999999999999987777 9999
Q ss_pred ccccccc
Q 003786 620 DFGMARI 626 (795)
Q Consensus 620 DFGla~~ 626 (795)
||.-++.
T Consensus 173 DlEk~r~ 179 (216)
T PRK09902 173 DLEKSRR 179 (216)
T ss_pred Ehhccch
Confidence 9987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.4e-07 Score=89.93 Aligned_cols=123 Identities=24% Similarity=0.252 Sum_probs=91.4
Q ss_pred cceEEEEEecccC-------ccchHHHHHHHHHHHhcCCcc--cceeeeeeeec----ceeeEEeecCCCC-Chhhhhhc
Q 003786 499 GQEVAVKRLSSQS-------GQGQEEFKNEIKLIAKLQHRN--LVRLLGCCIEL----EEKILIYEYMPNK-SLDFFLFD 564 (795)
Q Consensus 499 ~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~E~~~~g-sL~~~l~~ 564 (795)
++.+.+|.+.... .....+..+|...+..|...+ +.+.+++.... ...++|+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 5566666543211 123457889999988886433 44566665542 2458999999984 78888854
Q ss_pred cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---Ceeeecccccccc
Q 003786 565 STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMARIF 627 (795)
Q Consensus 565 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL~DFGla~~~ 627 (795)
... .+......++.++++.++-||..| |+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 112 ~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 WEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 222 556677899999999999999998 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.9e-06 Score=85.78 Aligned_cols=140 Identities=19% Similarity=0.218 Sum_probs=87.2
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeeeeeeecceeeEEeecCCCCC-
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLGCCIELEEKILIYEYMPNKS- 557 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs- 557 (795)
.+||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35578889886532 4456899999999987544 4567777777777889999999963
Q ss_pred hhhhhhc--------------------cCCcccCChhh-HHHHHH----------HHHH-HHHHHHh-cCCCcEEeccCC
Q 003786 558 LDFFLFD--------------------STKENLLGWGT-RVRIIE----------GIAQ-GLLYLHQ-YSRLRVIHRDLK 604 (795)
Q Consensus 558 L~~~l~~--------------------~~~~~~l~~~~-~~~i~~----------~i~~-~l~~LH~-~~~~~iiHrDik 604 (795)
+...+.. ........... ...+.. .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2211100 00000001000 000000 0011 1122221 123457999999
Q ss_pred CCcEEECCCCCeeeeccccccc
Q 003786 605 ASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 605 p~NIll~~~~~vkL~DFGla~~ 626 (795)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.4e-06 Score=98.53 Aligned_cols=146 Identities=17% Similarity=0.224 Sum_probs=93.4
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccc------------------------------hH--------
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG------------------------------QE-------- 516 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~-------- 516 (795)
..|+. +.|+.++-|.||+|++++|++||||+.+..-... .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 6899999999999999999999999886532110 00
Q ss_pred --HHHHHHHHHHhcC----Ccccceeeeeee-ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHH-HH
Q 003786 517 --EFKNEIKLIAKLQ----HRNLVRLLGCCI-ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG-LL 588 (795)
Q Consensus 517 --~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~ 588 (795)
.+.+|...+.++. +.--+++-..+. -.....|+|||++|..+.+...-.. ..++. ..++..++++ +.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHH
Confidence 1234444444442 222233333333 3567789999999999988752222 12332 2233333222 12
Q ss_pred HHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 589 ~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
.+-..| ++|.|..|.||+++.+|++.+.|||+...+..
T Consensus 280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222234 99999999999999999999999999876643
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.4e-06 Score=72.74 Aligned_cols=72 Identities=33% Similarity=0.754 Sum_probs=54.0
Q ss_pred CceeEeccCCCCcccccccccccCHHHHHHHHHh-cCCeeeeeeccccCCCceeEEec-ccccccccccCCCCCccEEEe
Q 003786 339 DRFIMLDDVKLPDFVEASLNESMNVKECEAECLK-NCTCRAYANSKVTGEGSGCLMWF-GDLIDIRKADDRNNGQSIYIR 416 (795)
Q Consensus 339 d~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~-nCsC~ay~~~~~~~~~~~c~~w~-gdl~~~~~~~~~~~~~~lylR 416 (795)
..|+.++++.+++..... ....++++|+..|++ +|+|.||+|.. ++.+|.+|. +.+.+... ....+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~--~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARL--FPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCcccccee--cccCCceeEEe
Confidence 569999999999665432 456799999999999 99999999974 456899999 66665542 33445556654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.9e-06 Score=78.04 Aligned_cols=87 Identities=26% Similarity=0.336 Sum_probs=60.4
Q ss_pred eEEEeeCCceEEeCCC-CceEEeecCCCCc-cccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccc
Q 003786 89 VLTISNGGKLVLLNQT-NGTIWSSNLSREV-KNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDL 166 (795)
Q Consensus 89 ~l~~~~~g~lvl~~~~-~~~~Wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 166 (795)
.+.++.||+||+++.. +.+||++++.... .++.+.|+++|||||++ ..+.++|+|= |
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~-----~~g~~vW~S~-----t----------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYD-----GDGRVVWSSN-----T----------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEe-----CCCCEEEEec-----c-----------
Confidence 3556789999999765 5899999986432 33677899999999998 3467889861 1
Q ss_pred ccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEee
Q 003786 167 KTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCS 212 (795)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~s 212 (795)
....|.|.+.++.+|...++-..+ ...|.|
T Consensus 82 ---------------~~~~~~~~~~L~ddGnlvl~~~~~-~~~W~S 111 (114)
T smart00108 82 ---------------TGANGNYVLVLLDDGNLVIYDSDG-NFLWQS 111 (114)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCCC-CEEeCC
Confidence 012456788888888765433223 456754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.9e-06 Score=83.42 Aligned_cols=138 Identities=17% Similarity=0.178 Sum_probs=93.6
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHH---------HHHHHHHhcCCcc---cceeeee-
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFK---------NEIKLIAKLQHRN---LVRLLGC- 539 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~h~n---iv~l~~~- 539 (795)
...+|...+.+-......|.+... +|+.+++|..+......++.|+ +++..+.+++... +..++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346788888888888888877765 6799999988765443333332 3444444443222 2222222
Q ss_pred ----eeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 540 ----CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 540 ----~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
+......+++|||++|..|.++.. +++ .+...+.+++.-||..| +.|+|+.|.|++++.++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 222345578999999988865431 222 34456778899999998 99999999999998655
Q ss_pred eeeeccccccc
Q 003786 616 PKISDFGMARI 626 (795)
Q Consensus 616 vkL~DFGla~~ 626 (795)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=3e-07 Score=102.05 Aligned_cols=189 Identities=19% Similarity=0.116 Sum_probs=136.6
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc-cceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN-LVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 552 (795)
+..+...+-+++|++++++|.+-...+....+.+.. .....-++++|.+++||| .++.++-+..+....+++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 344555677899999999998754444444555432 255667899999999999 77777777778888999999
Q ss_pred CCCC-ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 553 MPNK-SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
+..+ +-.... ....-.+..-+...+.+.-+++++++|+.- -+|+| ||+..+ +..|..||+....+....
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9887 221111 011112333344455666678899999853 48898 776654 789999999988765443
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTD 680 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~ 680 (795)
..+...+++.++|||+.....+..+.|+|++|+--.+|.-|-+|..
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3455789999999999999999999999999998778877776653
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.1e-06 Score=75.44 Aligned_cols=87 Identities=24% Similarity=0.251 Sum_probs=60.3
Q ss_pred EEEee-CCceEEeCCC-CceEEeecCCCC-ccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccc
Q 003786 90 LTISN-GGKLVLLNQT-NGTIWSSNLSRE-VKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDL 166 (795)
Q Consensus 90 l~~~~-~g~lvl~~~~-~~~~Wst~~~~~-~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 166 (795)
+.++. ||+||+++.. +.+||++++... ...+.+.|+++|||||++ .++.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~-----~~g~~vW~S~~~--------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYD-----GSGTVVWSSNTT--------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEc-----CCCcEEEEeccc---------------
Confidence 44565 9999999765 589999998652 345667899999999998 356788985321
Q ss_pred ccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeC
Q 003786 167 KTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSG 213 (795)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg 213 (795)
.+.+.+.+.+..+|...++-.+ ...+|.|.
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 1245678888888865543333 35577654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-05 Score=82.36 Aligned_cols=144 Identities=23% Similarity=0.207 Sum_probs=85.4
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeeeeeeec---ceeeEEeecCC
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLGCCIEL---EEKILIYEYMP 554 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~---~~~~lv~E~~~ 554 (795)
++.|+.|..+.||++...+ +.+++|..... .....+.+|..+++.+.... +.+++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999866 69999997544 45677889999998886433 45666543322 24578999999
Q ss_pred CCChhh----------------hhh---cc-CCcccCChhh---------HHHH------------HHHHHH-HHHHHHh
Q 003786 555 NKSLDF----------------FLF---DS-TKENLLGWGT---------RVRI------------IEGIAQ-GLLYLHQ 592 (795)
Q Consensus 555 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~ 592 (795)
+..+.. .+. .. .......... .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 110 11 0000000000 0000 111222 2333332
Q ss_pred ----cCCCcEEeccCCCCcEEEC-CCCCeeeeccccccc
Q 003786 593 ----YSRLRVIHRDLKASNILLD-KDMNPKISDFGMARI 626 (795)
Q Consensus 593 ----~~~~~iiHrDikp~NIll~-~~~~vkL~DFGla~~ 626 (795)
.....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345699999999999999 666677999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.1e-05 Score=78.74 Aligned_cols=141 Identities=16% Similarity=0.117 Sum_probs=85.9
Q ss_pred ccCcCCc-ccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEeecCCCCChh
Q 003786 482 KLGEGGF-GPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSLD 559 (795)
Q Consensus 482 ~LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 559 (795)
.|-.|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 788999764 4788888875432 446788999998885 334556777776666789999999998876
Q ss_pred hhhh-------------------ccCCcc-cCChh--hHHHHHH--------------------HHHHHHHHHHh----c
Q 003786 560 FFLF-------------------DSTKEN-LLGWG--TRVRIIE--------------------GIAQGLLYLHQ----Y 593 (795)
Q Consensus 560 ~~l~-------------------~~~~~~-~l~~~--~~~~i~~--------------------~i~~~l~~LH~----~ 593 (795)
.... ...... .+... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 000000 00000 0000000 01111122211 1
Q ss_pred CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 594 ~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
....++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124599999999999999987788999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.4e-05 Score=76.12 Aligned_cols=155 Identities=18% Similarity=0.223 Sum_probs=99.9
Q ss_pred cccHHhHHHHccCCcccc---ccCcCCcccEEEeEecCcceEEEEEecccCccc-------------------hHH----
Q 003786 464 MFSLASVSAATANFSTEN---KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-------------------QEE---- 517 (795)
Q Consensus 464 ~~~~~~i~~~~~~~~~~~---~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~---- 517 (795)
......+.....+..+.. .|+.|.-+.||+|...++..+|||++....... .++
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 344455555554444433 566777888999988789999999986432111 111
Q ss_pred -HHHHHHHHHhcC--CcccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC
Q 003786 518 -FKNEIKLIAKLQ--HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594 (795)
Q Consensus 518 -~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 594 (795)
..+|+..|.++. +-.+.+.+.+ .+..|||||+....+.. ..-+.-.+...++..+..++++.+.-|-...
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pA---P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPA---PRLKDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCC---CCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 135677777664 2333344433 34579999997652210 1111222333357777888888888777633
Q ss_pred CCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 595 ~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
++||+||..=|||+. ++.+.|+||+-+....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 499999999999999 8899999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=2e-05 Score=77.98 Aligned_cols=105 Identities=22% Similarity=0.197 Sum_probs=83.6
Q ss_pred HHHHHHHHhcCC-cccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCc
Q 003786 519 KNEIKLIAKLQH-RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597 (795)
Q Consensus 519 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 597 (795)
.+|..+|+.+++ +++.+++|+| ..++|.||...+++......-..-...+|..+.+|+.++++.+.+|++.-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999986 6999999998 34789999988766421100011123689999999999999999999865556
Q ss_pred EEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 598 VIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 598 iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+...|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=4.2e-05 Score=86.32 Aligned_cols=141 Identities=17% Similarity=0.228 Sum_probs=89.0
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCccc-------------------------------hH------HHHHHHH
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-------------------------------QE------EFKNEIK 523 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~ 523 (795)
+.||.-+.|.||+|++++|+.||||+-++.-... .+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999876532111 00 1234444
Q ss_pred HHHhc----CCcc---cceeeeeeee-cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCC
Q 003786 524 LIAKL----QHRN---LVRLLGCCIE-LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595 (795)
Q Consensus 524 ~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 595 (795)
...+. .|-+ -|++-.++.+ .....|+||||+|..+.+...- ....++...+..-+.+...-+-+ ..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf--~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIF--KTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHH--hcC-
Confidence 33332 3444 2223333332 3578999999999988665421 12224444333333332221111 223
Q ss_pred CcEEeccCCCCcEEECC----CCCeeeeccccccccC
Q 003786 596 LRVIHRDLKASNILLDK----DMNPKISDFGMARIFG 628 (795)
Q Consensus 596 ~~iiHrDikp~NIll~~----~~~vkL~DFGla~~~~ 628 (795)
++|+|=.|.||+++. ++.+.+.|||+...+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6789999999988654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.88 E-value=9.9e-05 Score=76.15 Aligned_cols=73 Identities=15% Similarity=0.255 Sum_probs=47.5
Q ss_pred cccCcCCccc-EEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCc---ccceeeeeeeecc---eeeEEeecC
Q 003786 481 NKLGEGGFGP-VYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR---NLVRLLGCCIELE---EKILIYEYM 553 (795)
Q Consensus 481 ~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~E~~ 553 (795)
+.|+.|+... ||+. +..+++|..+.. .....+.+|.++|..+... -+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 5688777774 9975 346788875432 2355789999999988632 2333444333222 347899999
Q ss_pred CCCChh
Q 003786 554 PNKSLD 559 (795)
Q Consensus 554 ~~gsL~ 559 (795)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=88.66 Aligned_cols=79 Identities=16% Similarity=0.366 Sum_probs=58.5
Q ss_pred ccccCcCCcccEEEeEecCc---ceEEEEEecccC-ccchHHHHHHHHHHHhcC-Cccc--ceeeeeeeec---ceeeEE
Q 003786 480 ENKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQ-HRNL--VRLLGCCIEL---EEKILI 549 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 549 (795)
.++|+.|.+..+|+.+...+ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.++.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999876553 468888764432 223457889999999996 6664 6777777654 357899
Q ss_pred eecCCCCCh
Q 003786 550 YEYMPNKSL 558 (795)
Q Consensus 550 ~E~~~~gsL 558 (795)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=9.2e-05 Score=70.46 Aligned_cols=129 Identities=21% Similarity=0.296 Sum_probs=90.1
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccce-eeeeeeecceeeEEeecCCCC
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR-LLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~E~~~~g 556 (795)
...+.|++|.+|.||++.. .|.++|+|+-+.. .....+..|+++|..++-.++.+ +|.| +..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence 4567899999999999987 4568899976543 45678999999999998776664 4433 2234559999998
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCC-CCcEEECCCCCeeeeccccccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK-ASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik-p~NIll~~~~~vkL~DFGla~~ 626 (795)
.|...-... + .+.+..++..-.-|...| |-|+.|. |..++|-.+..+.|+||.-|..
T Consensus 98 ~L~~~~~~~---------~-rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG---------D-RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc---------c-HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 886543110 1 223344555555566666 9999987 4555555555999999999874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=72.39 Aligned_cols=128 Identities=17% Similarity=0.242 Sum_probs=91.3
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccC----------------ccchHHHHHHHHHHHhcC------Ccccceee
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----------------GQGQEEFKNEIKLIAKLQ------HRNLVRLL 537 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 537 (795)
...||+|+.-.||. +++.....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999996 6677888999987654 223456677777666665 78999999
Q ss_pred eeeeecceeeEEeecCCC--C----ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 538 GCCIELEEKILIYEYMPN--K----SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 538 ~~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
|+....-...+|+|.+.+ | +|.+++. .+.++. ...+. +-+-..||-+.+ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999997643 2 4666662 233444 33333 334455666665 99999999999995
Q ss_pred CC--C--Ceeeec
Q 003786 612 KD--M--NPKISD 620 (795)
Q Consensus 612 ~~--~--~vkL~D 620 (795)
.. + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 33 2 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00016 Score=75.55 Aligned_cols=139 Identities=14% Similarity=0.112 Sum_probs=81.1
Q ss_pred ccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccc-eeeeeeeecceeeEEeecCCCCChhh
Q 003786 482 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYMPNKSLDF 560 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL~~ 560 (795)
.+..|-...+|+.. .+++.+++|+.........-...+|.++++.+....++ +++... ..++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 46678888999987 35778899976543222212357899999998754443 344332 2368999999877642
Q ss_pred h-----------------hhccCC-cccCChh-hHHHHHHH---------HHHHHHHHHhc-----CCCcEEeccCCCCc
Q 003786 561 F-----------------LFDSTK-ENLLGWG-TRVRIIEG---------IAQGLLYLHQY-----SRLRVIHRDLKASN 607 (795)
Q Consensus 561 ~-----------------l~~~~~-~~~l~~~-~~~~i~~~---------i~~~l~~LH~~-----~~~~iiHrDikp~N 607 (795)
. ++.... ...++.. ....+..+ +.+.+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 011110 0111111 11111111 11112222111 12358999999999
Q ss_pred EEECCCCCeeeeccccccc
Q 003786 608 ILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 608 Ill~~~~~vkL~DFGla~~ 626 (795)
|+++.++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999999864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00021 Score=73.61 Aligned_cols=75 Identities=19% Similarity=0.283 Sum_probs=50.7
Q ss_pred ccccCcCCcccEEEeEecC--cceEEEEEecccCccchHHHHHHHHHHHhcCCcccc-eeeeeeeecceeeEEeecCCCC
Q 003786 480 ENKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~g 556 (795)
++.|..|-...+|+....+ ++.|++|+....... .....+|+.+++.+...+++ ++++.+. ..++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3578888899999998664 678999977543221 22345789999988654444 4444322 24899999997
Q ss_pred Chh
Q 003786 557 SLD 559 (795)
Q Consensus 557 sL~ 559 (795)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00055 Score=73.17 Aligned_cols=80 Identities=13% Similarity=0.085 Sum_probs=58.6
Q ss_pred CCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCC---cccceeeeeeee---cceeeEE
Q 003786 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH---RNLVRLLGCCIE---LEEKILI 549 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv 549 (795)
.....+.||+|..+.||.....++ .+++|..+. ......+.+|.+.|+.|.. ..+.++++.+.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 334457899999999999876555 567777432 1234688999999999853 357778877654 3568999
Q ss_pred eecCCCCCh
Q 003786 550 YEYMPNKSL 558 (795)
Q Consensus 550 ~E~~~~gsL 558 (795)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00062 Score=74.99 Aligned_cols=75 Identities=13% Similarity=0.185 Sum_probs=55.2
Q ss_pred cccCcCCcccEEEeEecCc-ceEEEEEeccc-------CccchHHHHHHHHHHHhcC---CcccceeeeeeeecceeeEE
Q 003786 481 NKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQ-------SGQGQEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 549 (795)
+.||.|.+..||++...+| +.++||.-... -....++...|.+.|+.+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999998776 58999975321 1235577888999988863 2345666666 44668899
Q ss_pred eecCCCCC
Q 003786 550 YEYMPNKS 557 (795)
Q Consensus 550 ~E~~~~gs 557 (795)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00047 Score=67.97 Aligned_cols=125 Identities=23% Similarity=0.407 Sum_probs=89.0
Q ss_pred cCCccccccCcCCc-ccEEEeEecCcceEEEEEecc---cCc------------------cchHHHHHHHHHHHhcC---
Q 003786 475 ANFSTENKLGEGGF-GPVYKGRLLNGQEVAVKRLSS---QSG------------------QGQEEFKNEIKLIAKLQ--- 529 (795)
Q Consensus 475 ~~~~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 529 (795)
.+++..+.||.|.- |.||++++ +|+.+|+|++.. ... .-..-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999998 678999999321 100 01124678888887775
Q ss_pred Cccc--ceeeeeeeecc------------------eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHH
Q 003786 530 HRNL--VRLLGCCIELE------------------EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589 (795)
Q Consensus 530 h~ni--v~l~~~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 589 (795)
+.++ |+.+|+..-.. ...+|.||++... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4456 89999874221 1246667665432 1233456677788888
Q ss_pred HHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 590 LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
+|..+ |+-+|+++.|.. .=||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999975 3488999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00063 Score=72.80 Aligned_cols=143 Identities=18% Similarity=0.156 Sum_probs=87.6
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeeee------eeecceeeEEee
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLGC------CIELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E 551 (795)
.+.|..|....+|+.... +..+++|+... ...+.+..|++++..+.+.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 567888888999998753 45789998754 34566788898888885433 4444432 123345689999
Q ss_pred cCCCCChhh----hh----------hccCCc--------ccCChhhH----------HHHHHHHHHHHHHHHhc----CC
Q 003786 552 YMPNKSLDF----FL----------FDSTKE--------NLLGWGTR----------VRIIEGIAQGLLYLHQY----SR 595 (795)
Q Consensus 552 ~~~~gsL~~----~l----------~~~~~~--------~~l~~~~~----------~~i~~~i~~~l~~LH~~----~~ 595 (795)
+++|..+.. .. +..... ....|... ......+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 00 100000 00111110 01112233445555431 12
Q ss_pred CcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 596 LRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 596 ~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987778999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00089 Score=71.89 Aligned_cols=141 Identities=26% Similarity=0.286 Sum_probs=85.5
Q ss_pred cccCcCCcccEEEeEecC-------cceEEEEEecccCccchHHHHHHHHHHHhcCCcccc-eeeeeeeecceeeEEeec
Q 003786 481 NKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~ 552 (795)
+.|..|-...+|+.+..+ ++.+++|+..... .......+|++++..+...++. ++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 567777778999987654 5789999975543 2334567899999888644444 4555443 2468999
Q ss_pred CCCCChhhhh-----------------hccCCcc------cCC--hhhHH--------------------------HHHH
Q 003786 553 MPNKSLDFFL-----------------FDSTKEN------LLG--WGTRV--------------------------RIIE 581 (795)
Q Consensus 553 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~--------------------------~i~~ 581 (795)
++|..+.... +...... ..+ +.... .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 1111100 000 00000 0112
Q ss_pred HHHHHHHHHHh------cCCCcEEeccCCCCcEEECCC----CCeeeeccccccc
Q 003786 582 GIAQGLLYLHQ------YSRLRVIHRDLKASNILLDKD----MNPKISDFGMARI 626 (795)
Q Consensus 582 ~i~~~l~~LH~------~~~~~iiHrDikp~NIll~~~----~~vkL~DFGla~~ 626 (795)
.+.+.+..|.. .....++|+|+.|.|||++.+ +.+.|+||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233334432 134569999999999999985 8899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00053 Score=81.94 Aligned_cols=196 Identities=20% Similarity=0.216 Sum_probs=134.8
Q ss_pred HHHHHHHHHhcCCcccceeeeeeeecceee----EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc
Q 003786 518 FKNEIKLIAKLQHRNLVRLLGCCIELEEKI----LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593 (795)
Q Consensus 518 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 593 (795)
..-|...+.++.|+|++.++.|..+..... +..|++...++...+. .-..++.+....+..++..|+.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777888999999999999877655443 3347888888877773 344577888889999999999999987
Q ss_pred CCCcEEeccCCCC---cEEECCCCCeeee--ccccccccCCCcccccccccccccccccccccccCCCCcc--cchhhHH
Q 003786 594 SRLRVIHRDLKAS---NILLDKDMNPKIS--DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK--SDVFSFG 666 (795)
Q Consensus 594 ~~~~iiHrDikp~---NIll~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k--~DvwSlG 666 (795)
. ..|.=+..+ +--.+.++.+.++ ||+....+...... ....-+..+.|||......++.+ .|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 444444333 4444566777777 88888766443321 11234556788888877665544 7999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 667 VLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 667 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+..+..|..+........ .+++.. ....+.....+|+..++++|+++.+++.+
T Consensus 380 ll~~~~~~~~~i~~~~~~~~-----------------~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVPV-----------------SLLDVL--------STSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHhhhhhcCcccccccchh-----------------hhhccc--------cchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999998876543211100 111110 01134566778999999999999999997
Q ss_pred H
Q 003786 747 L 747 (795)
Q Consensus 747 L 747 (795)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 5
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00062 Score=70.75 Aligned_cols=138 Identities=14% Similarity=0.146 Sum_probs=95.4
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccC-----------------ccc-----hHHHHHHHHHHHhcCC-
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS-----------------GQG-----QEEFKNEIKLIAKLQH- 530 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~-----~~~~~~E~~~l~~l~h- 530 (795)
..=+.++++||-|.-+.||.+-..+|++.++|.-+... ... .-...+|+..|+.|..
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred chhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 33478899999999999999999899999999542110 000 1123578888888853
Q ss_pred cc-cceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEE
Q 003786 531 RN-LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 531 ~n-iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 609 (795)
-. +.+.+++ +..++|||++.+-.|...- . ......+...+..-+--|-.+| +||+|..-=||+
T Consensus 171 gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~---v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 171 GFPVPKPIDH----NRHCVVMELVDGYPLRQVR------H---VEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCCCcccc----cceeeHHHhhcccceeeee------e---cCChHHHHHHHHHHHHHHHHcC---ceecccchheeE
Confidence 32 3344443 4567899999887774332 1 1223334444455556666777 999999999999
Q ss_pred ECCCCCeeeecccccccc
Q 003786 610 LDKDMNPKISDFGMARIF 627 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~ 627 (795)
+++++.++++||--....
T Consensus 235 v~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMVST 252 (465)
T ss_pred EecCCCEEEeechHhhcc
Confidence 999999999999765443
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00049 Score=50.85 Aligned_cols=45 Identities=33% Similarity=0.519 Sum_probs=36.8
Q ss_pred cCCCCCCCCCCcccccccccccCCCCCC-CccccccceeeccccCC
Q 003786 751 TINLPHPRQPAFSSIRGLKNTILPANGK-ARVCSGNCLTLSEMDAR 795 (795)
Q Consensus 751 ~~~l~~p~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 795 (795)
...||.|++|+|...|.....-.....+ ...++.|.||+|+|+||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4579999999999999987665443333 38899999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0062 Score=65.53 Aligned_cols=144 Identities=20% Similarity=0.173 Sum_probs=84.5
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeeeee------eecceeeEEee
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLGCC------IELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~E 551 (795)
.+.++.|....+|+.+.. +..+++|+.... ...+++..|.+++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VGRYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeC-CCcEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 567788888899998754 446888987542 22456677888888775322 33443321 12345689999
Q ss_pred cCCCCChhhh-----------h---hccCCc------c---cCChhhHH------------HHHHHHHHHHHHHHh----
Q 003786 552 YMPNKSLDFF-----------L---FDSTKE------N---LLGWGTRV------------RIIEGIAQGLLYLHQ---- 592 (795)
Q Consensus 552 ~~~~gsL~~~-----------l---~~~~~~------~---~l~~~~~~------------~i~~~i~~~l~~LH~---- 592 (795)
|++|..+... + +..... . .-.|.... .....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654211 0 110000 0 00111000 011123344555532
Q ss_pred cCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 593 ~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
.-...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1234699999999999999888778999999753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.004 Score=68.00 Aligned_cols=142 Identities=18% Similarity=0.202 Sum_probs=83.8
Q ss_pred ccccCcCCcccEEEeEecC-----cceEEEEEecccCccchHHHHHHHHHHHhcCCcccc-eeeeeeeecceeeEEeecC
Q 003786 480 ENKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~ 553 (795)
+++|-.|-.-.+|++...+ ++.|++|+.......... -.+|..+++.+...++. ++++.+..+ .|.||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3567678888999987532 367899988655433333 37799999988755554 455555332 589999
Q ss_pred CCCChhhhh-----------------hccC-C-cc-cCChhhHHHHHHH-----------------HHHHHHHH----Hh
Q 003786 554 PNKSLDFFL-----------------FDST-K-EN-LLGWGTRVRIIEG-----------------IAQGLLYL----HQ 592 (795)
Q Consensus 554 ~~gsL~~~l-----------------~~~~-~-~~-~l~~~~~~~i~~~-----------------i~~~l~~L----H~ 592 (795)
++.++...- +... . .. ...+.++..+..+ +...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 887764210 1100 0 00 1111222222211 11112222 21
Q ss_pred -cCCCcEEeccCCCCcEEECC-CCCeeeeccccccc
Q 003786 593 -YSRLRVIHRDLKASNILLDK-DMNPKISDFGMARI 626 (795)
Q Consensus 593 -~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~ 626 (795)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346999999999999986 47899999998864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0079 Score=65.09 Aligned_cols=143 Identities=20% Similarity=0.210 Sum_probs=79.2
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeee------eeeecceeeEEee
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLG------CCIELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~E 551 (795)
.+.|+.|....+|+.+..+| .+++|++.. ...+.+..|..++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677788889999876544 789998752 23345556667776664222 233332 1123455789999
Q ss_pred cCCCCChhh-----------hh---hccCCc------c--cCCh-hhHHH------------HHHH-HHHHHHHHHhc--
Q 003786 552 YMPNKSLDF-----------FL---FDSTKE------N--LLGW-GTRVR------------IIEG-IAQGLLYLHQY-- 593 (795)
Q Consensus 552 ~~~~gsL~~-----------~l---~~~~~~------~--~l~~-~~~~~------------i~~~-i~~~l~~LH~~-- 593 (795)
|++|..+.. .+ +..... . .+.+ ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999975421 11 110000 0 0111 11110 1111 11122333211
Q ss_pred --CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 594 --SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 594 --~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
-...+||+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 133599999999999998665568999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0078 Score=63.57 Aligned_cols=31 Identities=29% Similarity=0.562 Sum_probs=26.2
Q ss_pred CcEEeccCCCCcEEECCCCC-eeeeccccccc
Q 003786 596 LRVIHRDLKASNILLDKDMN-PKISDFGMARI 626 (795)
Q Consensus 596 ~~iiHrDikp~NIll~~~~~-vkL~DFGla~~ 626 (795)
..++|+|++|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997565 46999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0053 Score=65.10 Aligned_cols=142 Identities=18% Similarity=0.212 Sum_probs=97.3
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEecccCc---------------------cchHH-----HHHHHHHHHhcCCc
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG---------------------QGQEE-----FKNEIKLIAKLQHR 531 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~~~-----~~~E~~~l~~l~h~ 531 (795)
.+...|..|.-+.||.+...+|..+|||+++-... ...+. ...|++.|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44567888999999999998999999998743210 00111 13577777777654
Q ss_pred ccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 532 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
.|.- -.-. .-....|||+|+...... ....+...++...+..+-.++++-+.-|-+.+ ++||.||.-=|+|+
T Consensus 227 GIP~-PePI-lLk~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPC-PEPI-LLKNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY- 298 (520)
T ss_pred CCCC-CCce-eeecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-
Confidence 4221 1110 112347999998643331 22234445777788888999999999998887 69999999999999
Q ss_pred CCCCeeeecccccccc
Q 003786 612 KDMNPKISDFGMARIF 627 (795)
Q Consensus 612 ~~~~vkL~DFGla~~~ 627 (795)
.+|.+.|+|-+-+...
T Consensus 299 hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ECCEEEEEEccccccC
Confidence 5678999998776543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.014 Score=62.18 Aligned_cols=147 Identities=16% Similarity=0.225 Sum_probs=83.9
Q ss_pred cccccCcCCcccEEEeEecCcceEEEEEecc--cCccchHHHHHHHHHHHhcCC--cccceeeeeeeecc--eeeEEeec
Q 003786 479 TENKLGEGGFGPVYKGRLLNGQEVAVKRLSS--QSGQGQEEFKNEIKLIAKLQH--RNLVRLLGCCIELE--EKILIYEY 552 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~ 552 (795)
+.+.+..|-.-.+|..... ++++++. ... .........++|+++|+.+.- .-+.+.++.|.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3444434444445554433 7788888 331 223445678889999988853 23345566776666 56899999
Q ss_pred CCCCChhhhhhccCC-----------------------------------cccCChhhHHHHH--------HHHHHHHHH
Q 003786 553 MPNKSLDFFLFDSTK-----------------------------------ENLLGWGTRVRII--------EGIAQGLLY 589 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~-----------------------------------~~~l~~~~~~~i~--------~~i~~~l~~ 589 (795)
+.|..+...+..... .+...+....+.+ -....-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 988433221110000 0000000001000 011223344
Q ss_pred HHhc-----CCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 590 LHQY-----SRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 590 LH~~-----~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
|+.. +...++|+|+.+.||+++.++.+=|.||+++..-
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4433 2346999999999999999988999999999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.00068 Score=82.64 Aligned_cols=159 Identities=13% Similarity=0.008 Sum_probs=113.8
Q ss_pred HHHHHHHHHhcCCcccceeeeeee--ecceeeEEeecCCCCChhhhhhccCCc-ccCChhhHHHHHHHH-HHHHHHHHhc
Q 003786 518 FKNEIKLIAKLQHRNLVRLLGCCI--ELEEKILIYEYMPNKSLDFFLFDSTKE-NLLGWGTRVRIIEGI-AQGLLYLHQY 593 (795)
Q Consensus 518 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i-~~~l~~LH~~ 593 (795)
...|+.-+++..|+++...+.-.. +....+.+++|+.+|.+...|.....+ ..++..-. ....++ ..+..-.|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v-~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPV-HLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchH-HHHHHHHHhccchhhhc
Confidence 345666667778998887665443 234567889999999998888654433 22333222 233333 4444444443
Q ss_pred C--CCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHH
Q 003786 594 S--RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671 (795)
Q Consensus 594 ~--~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~e 671 (795)
. ..-.+|+++|+-|.+|..+..+|++++|+.++..+. ........+++.|++|++.+.-.++.++|+|..|+-+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 3 234799999999999999999999999999943322 233445678889999999998899999999999999999
Q ss_pred HHhCCCCC
Q 003786 672 TLSSKRNT 679 (795)
Q Consensus 672 lltG~~p~ 679 (795)
.-.|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887665
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.012 Score=62.31 Aligned_cols=76 Identities=16% Similarity=0.258 Sum_probs=50.1
Q ss_pred CccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcC---CcccceeeeeeeecceeeEEeecC
Q 003786 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.+..+.|+.|.-..+|+.+ .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4456789999999999987 578889999875 234567889999998884 345667888887777889999999
Q ss_pred CCC
Q 003786 554 PNK 556 (795)
Q Consensus 554 ~~g 556 (795)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.017 Score=62.35 Aligned_cols=73 Identities=16% Similarity=0.247 Sum_probs=50.4
Q ss_pred ccCcCCcccEEEeEecCc-ceEEEEEecc-------cCccchHHHHHHHHHHHhcC--Ccccc-eeeeeeeecceeeEEe
Q 003786 482 KLGEGGFGPVYKGRLLNG-QEVAVKRLSS-------QSGQGQEEFKNEIKLIAKLQ--HRNLV-RLLGCCIELEEKILIY 550 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~niv-~l~~~~~~~~~~~lv~ 550 (795)
.||.|.-..||++..+++ +.++||.-.. .-+...++..-|.+.|+... .|..| ++|. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999997654 6899995421 22445567778888887764 35444 4443 3556667999
Q ss_pred ecCCCC
Q 003786 551 EYMPNK 556 (795)
Q Consensus 551 E~~~~g 556 (795)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0036 Score=51.48 Aligned_cols=49 Identities=14% Similarity=0.376 Sum_probs=35.1
Q ss_pred ccCCCCcccccccccccCHHHHHHHHHhcCCeeeeeeccccCCCceeEEeccc
Q 003786 345 DDVKLPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTGEGSGCLMWFGD 397 (795)
Q Consensus 345 ~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~~c~~w~gd 397 (795)
.++.++.+..... ...+.++|+..|+.||+|.||.|.. +...|+++.+.
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 4555555433322 3568899999999999999999963 24569988753
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.014 Score=57.85 Aligned_cols=138 Identities=16% Similarity=0.128 Sum_probs=83.8
Q ss_pred eEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHH
Q 003786 501 EVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRI 579 (795)
Q Consensus 501 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 579 (795)
+..+|++....-. ...-+.++.+++++++ .|+++..- ......++.|+|-.... ...-.+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------------~~~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------------NFSNFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------------chhHHH
Confidence 4566776554333 4456788999998886 46666632 44456688998843111 011112
Q ss_pred HHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcc
Q 003786 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659 (795)
Q Consensus 580 ~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k 659 (795)
.. =+++|.-.|+.+ ...+|+|-.|+||+-|++|.+||.|=+..-. .+..|.-- .....+.+
T Consensus 148 ~a-gi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~---~Y~~lT~~ 208 (308)
T PF07387_consen 148 TA-GIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNI---EYESLTQE 208 (308)
T ss_pred HH-hHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEee---eccccChH
Confidence 11 146777888554 3699999999999999999999999554321 01111110 11234566
Q ss_pred cchhhHHHHHHHHHhCC
Q 003786 660 SDVFSFGVLLLETLSSK 676 (795)
Q Consensus 660 ~DvwSlGvil~elltG~ 676 (795)
+.+=+|=.-++++....
T Consensus 209 aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 67766666667766543
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.012 Score=59.55 Aligned_cols=31 Identities=42% Similarity=0.575 Sum_probs=22.1
Q ss_pred CcEEeccCCCCcEEE-CCCCCeeeeccccccc
Q 003786 596 LRVIHRDLKASNILL-DKDMNPKISDFGMARI 626 (795)
Q Consensus 596 ~~iiHrDikp~NIll-~~~~~vkL~DFGla~~ 626 (795)
..++|.||.|.|||+ +.++.++|+||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 795 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 795 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-139 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-138 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-121 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-76 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-62 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-62 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-60 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-60 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-60 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-59 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 9e-58 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-54 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-52 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-51 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-49 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-48 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-48 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-48 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-47 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-47 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-46 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-46 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-46 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-46 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-46 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-45 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-45 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-45 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-45 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-45 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-45 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-45 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-45 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-45 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-44 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-44 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-44 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-44 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-44 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-44 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-44 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 8e-44 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-43 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-43 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-43 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-43 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-43 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-43 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-43 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 9e-43 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-42 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-42 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-42 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-42 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-42 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-41 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-41 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-41 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-41 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-41 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-41 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-41 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-41 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-40 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-40 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-40 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-39 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-39 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-39 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-38 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-38 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-37 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-37 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-37 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-36 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-36 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 9e-36 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 9e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-35 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-35 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 6e-35 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-35 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-34 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-34 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-34 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-33 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-32 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-32 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-32 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 6e-32 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-32 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-31 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-31 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-31 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 7e-31 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-30 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-30 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-30 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-30 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-30 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-29 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-29 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-29 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-29 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-29 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-28 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-28 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-28 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-28 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-28 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-28 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-28 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 9e-28 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-27 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-27 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-27 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-27 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-27 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 7e-27 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 8e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-27 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-26 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-26 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-26 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-26 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-26 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-26 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-26 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-26 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-26 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-26 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 9e-26 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 9e-26 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-25 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-25 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-25 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-25 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 6e-25 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-25 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-24 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-24 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-24 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-24 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-24 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-23 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-23 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-23 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-23 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-22 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-22 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 7e-22 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 9e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-20 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-20 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-20 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-20 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 6e-20 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-19 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-17 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-16 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-16 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 9e-16 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-15 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-15 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-15 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-15 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-15 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-14 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-14 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-14 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-14 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 9e-14 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-13 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-13 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-13 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-12 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-12 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-12 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-12 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-12 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-12 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-12 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-12 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-12 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-12 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-11 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-10 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 6e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 9e-10 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 3e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 8e-09 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 2e-08 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-05 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 7e-08 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 3e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-08 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 9e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-07 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 3e-06 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 3e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-06 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 7e-06 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 6e-05 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 413 bits (1064), Expect = e-139
Identities = 119/289 (41%), Positives = 170/289 (58%), Gaps = 6/289 (2%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQE-EFKNEIK 523
FSL + A+ NFS +N LG GGFG VYKGRL +G VAVKRL + QG E +F+ E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL-LGWGTRVRIIEG 582
+I+ HRNL+RL G C+ E++L+Y YM N S+ L + + L W R RI G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
A+GL YLH + ++IHRD+KA+NILLD++ + DFG+A++ + T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS---NTNSLTLLGHAWDLWKD 699
G+++PEY G S K+DVF +GV+LLE ++ +R D + N + + LL L K+
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
+ L+D LQ + + I V LLC Q +RP M EVV ML
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 410 bits (1057), Expect = e-138
Identities = 111/303 (36%), Positives = 160/303 (52%), Gaps = 18/303 (5%)
Query: 456 RTRDSWFPMFSLASVSAATANFSTE------NKLGEGGFGPVYKGRLLNGQEVAVKRLSS 509
D+ F FS + T NF NK+GEGGFG VYKG + N VAVK+L++
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 510 ----QSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS 565
+ + +++F EIK++AK QH NLV LLG + ++ L+Y YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 566 TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
L W R +I +G A G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTN 685
T RIVGT YM+PE +G + KSD++SFGV+LLE ++ D
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 686 SLTLLGHAWDLWKDDRAWE-LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVV 744
LL ++ +++ E ID + N+A + +V C+ E RP + +V
Sbjct: 241 Q-LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 745 SML 747
+L
Sbjct: 299 QLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-121
Identities = 104/285 (36%), Positives = 164/285 (57%), Gaps = 5/285 (1%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKL 524
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG EEF+ EI+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL-LGWGTRVRIIEGI 583
++ +H +LV L+G C E E ILIY+YM N +L L+ S + + W R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
A+GL YLH + +IHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TNSLTLLGHAWDLWKDDRA 702
GY+ PEY +G + KSDV+SFGV+L E L ++ S + L A + + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+++DP L ++ L ++ + + C+ + DRP+M +V+ L
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-91
Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 33/310 (10%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKL 524
++ + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 525 IAKLQHRNLVRLLGCCIE----LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
+ ++H N+++ +G + LI + SL FL K N++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 581 EGIAQGLLYLHQ-------YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633
E +A+GL YLH+ + + HRD+K+ N+LL ++ I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 634 SKTKRIVGTYGYMSPEYAQQGL-----FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT 688
T VGT YM+PE + + ++ D+++ G++L E S R T
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEY 245
Query: 689 LLGHAWDLWKDDRAWEL--------IDPTLQNE-ASYLILNRYINVGLLCVQEDAADRPT 739
+L ++ + ++ P L++ + + C DA R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 740 MFEVVSMLTN 749
V +T
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 3e-76
Identities = 70/336 (20%), Positives = 124/336 (36%), Gaps = 44/336 (13%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNE--I 522
+ + S N +G G +G VYKG L + + VAVK S + Q F NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 523 KLIAKLQHRNLVRLLGCCIE-----LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV 577
+ ++H N+ R + E +L+ EY PN SL +L + W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 578 RIIEGIAQGLLYLHQ------YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG-- 629
R+ + +GL YLH + + + HRDL + N+L+ D ISDFG++ G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 630 ----DELQSKTKRIVGTYGYMSPEYAQQGL-------FSIKSDVFSFGVLLLETLSSKRN 678
E + VGT YM+PE + + + D+++ G++ E +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 679 TDFSNTNSLTLLGHAWDLWKDDRAWELID--------PTLQNE--ASYLILNRYINVGLL 728
+ + ++ ++ P + L +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 729 CVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAFSS 764
C +DA R T + + + + ++
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-62
Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 26/283 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
E +G G FG V K + ++VA+K++ S+S + + F E++ ++++ H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
C+ L+ EY SL L + + +QG+ YLH +I
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 600 HRDLKASNILLDKDMN-PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
HRDLK N+LL KI DFG A ++Q+ G+ +M+PE + +S
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL-IDPTLQNEASYL 717
K DVFS+G++L E ++ R F W + R + L L
Sbjct: 183 KCDVFSWGIILWEVIT--RRKPFDEIGG-PAFRIMWAVHNGTR---PPLIKNLPKPIESL 236
Query: 718 ILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQP 760
+ C +D + RP+M E+V ++T+ P +P
Sbjct: 237 MTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-62
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 20/272 (7%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+ K+G G FG V++ +G +VAVK L Q + EF E+ ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
G + ++ EY+ SL L S L R+ + +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
++HR+LK+ N+L+DK K+ DFG++R+ L SK+ GT +M+PE + +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSN 217
Query: 658 IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYL 717
KSDV+SFGV+L E + + N N ++ +K R L P N
Sbjct: 218 EKSDVYSFGVILWELAT--LQQPWGNLNPAQVVAAV--GFKCKR---LEIPRNLNPQVAA 270
Query: 718 ILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
I+ C + RP+ ++ +L
Sbjct: 271 IIEG-------CWTNEPWKRPSFATIMDLLRP 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-60
Identities = 82/282 (29%), Positives = 122/282 (43%), Gaps = 35/282 (12%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRL----SSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
E +G GGFG VY+ G EVAVK Q E + E KL A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L G C++ L+ E+ L+ L + V IA+G+ YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 596 LRVIHRDLKASNILLDKDMNP--------KISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
+ +IHRDLK+SNIL+ + + KI+DFG+AR ++ G Y +M+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMA 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707
PE + +FS SDV+S+GVLL E L+ F + L + L
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLT--GEVPFRGIDGLAVAYGV--AMNKLA---LPI 235
Query: 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
P+ E ++ C D RP+ ++ LT
Sbjct: 236 PSTCPEPFAKLMED-------CWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-60
Identities = 73/285 (25%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 480 ENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQ-------EEFKNEIKLIAKLQHR 531
E ++G+GGFG V+KGRL+ + VA+K L +G+ +EF+ E+ +++ L H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
N+V+L G ++ E++P L L D K + + W ++R++ IA G+ Y+
Sbjct: 84 NIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 592 QYSRLRVIHRDLKASNILLDK-----DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
++HRDL++ NI L + K++DFG+++ + ++G + +M
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 647 SPE--YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
+PE A++ ++ K+D +SF ++L L+ F + + + R
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILT--GEGPFDEYSYGKIKFINMIREEGLR--- 248
Query: 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
PT+ + R NV LC D RP +V L+
Sbjct: 249 ---PTIPED----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-59
Identities = 72/299 (24%), Positives = 123/299 (41%), Gaps = 37/299 (12%)
Query: 480 ENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+G FG K G+ + +K L + Q F E+K++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+ + I EY+ +L + ++ W RV + IA G+ YLH + +
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR------------IVGTYGYM 646
IHRDL + N L+ ++ N ++DFG+AR+ ++ Q + R +VG +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT-DFSNTNSLTLLGHAWDLWKDDRAWEL 705
+PE + K DVFSFG++L E + D+ L +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-------RGFLDR 242
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML----TNKTINLPHPRQP 760
P + + I R C D RP+ ++ L + +LP Q
Sbjct: 243 YCPPNCPPSFFPITVR-------CCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-58
Identities = 68/274 (24%), Positives = 132/274 (48%), Gaps = 25/274 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLL 537
++G G FG VYKG+ +G +VAVK L+ + Q + FKNE+ ++ K +H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
G + ++ ++ SL L E + I A+G+ YLH
Sbjct: 87 GYSTA-PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE---YAQQG 654
+IHRDLK++NI L +D KI DFG+A + +++ G+ +M+PE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID-PTLQNE 713
+S +SDV++FG++L E ++ + +SN N+ + + + + +L + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI--IEMVGRGSLSPDLSKVRSNCPK 256
Query: 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
++ C+++ +RP+ +++ +
Sbjct: 257 RMKRLMAE-------CLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 9e-58
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLL 537
KL E G ++KGR G ++ VK L + S + +F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 538 GCCIELEEKIL--IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
G C I +MP SL L + T + V+ +A+G+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEP 132
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE---YAQ 652
L + L + ++++D+DM +IS + F QS + + +++PE
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGR--MYAPAWVAPEALQKKP 184
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
+ +D++SF VLL E ++ R F++ +++ + + R I P +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVT--REVPFADLSNMEIGMKV--ALEGLRP--TIPPGISP 238
Query: 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
S L+ C+ ED A RP +V +L
Sbjct: 239 HVSKLMKI--------CMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 39/295 (13%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLL 537
+G+G FG VY GR +G EVA++ + + + + FK E+ + +H N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
G C+ +I ++L + D + +L +I + I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI---VGTYGYMSPE----- 649
++H+DLK+ N+ D + I+DFG+ I G + + ++ G +++PE
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 650 ----YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705
+ FS SDVF+ G + E + R F + + W + + L
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHA--REWPFKTQPAEAI---IWQMGTGMKP-NL 263
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN---KTINLPHP 757
+ E S ++L C + +RPT +++ ML + L HP
Sbjct: 264 SQIGMGKEISDILLF--------CWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-52
Identities = 69/300 (23%), Positives = 120/300 (40%), Gaps = 43/300 (14%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNE--IKLIAKLQHRNLVRLL 537
+G+G +G V++G G+ VAVK SS+ ++ + E + L+H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68
Query: 538 GCCIELEEKI----LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH-- 591
+ LI Y SL +L + L + +RI+ IA GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 592 ---QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIVGTYGYM 646
+ + HRDLK+ NIL+ K+ I+D G+A + ++L VGT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 647 SPE------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW-DLWKD 699
+PE + D+++FG++L E R + D+ +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMVSNGIVEDYKP---PFYDVVPN 239
Query: 700 DRAWELID---------PTL-QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
D ++E + P + S L + C ++ + R T + LT
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-51
Identities = 67/293 (22%), Positives = 118/293 (40%), Gaps = 29/293 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
++G+G +G V+ G+ G++VAVK + + EI ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAA 99
Query: 540 CIELEEKI----LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH---- 591
I+ LI +Y N SL +L K L + +++ GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 592 -QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIVGTYGYMSP 648
+ + HRDLK+ NIL+ K+ I+D G+A F +E+ VGT YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 649 E------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-----NSLTLLGHAWDLW 697
E I +D++SFG++L E + + L +++
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 698 KDDRAWELIDPTL-QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
++ + + P+ +S L + + C + A R T V L
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-49
Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 25/278 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ ++G G FG V+ GRL + VAVK + + +F E +++ + H N+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
VRL+G C + + ++ E + FL T+ L T ++++ A G+ YL
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES- 231
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
IHRDL A N L+ + KISDFGM+R + + +PE
Sbjct: 232 --KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
G +S +SDV+SFG+LL ET S + + SN + + ++ L P L
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---------EKGGRLPCPELC 340
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
+A + ++ + C + RP+ + L +
Sbjct: 341 PDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 36/290 (12%)
Query: 480 ENKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+LG+G FG V R G+ VAVK+L + + +F+ EI+++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 535 RLLGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ G C + LI EY+P SL +L + + ++ I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG-----YMS 647
R IHRDL NIL++ + KI DFG+ ++ D+ K K G + +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYA 185
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA-WDLWKDDRAWELI 706
PE + FS+ SDV+SFGV+L E + + + ++G+ EL+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 707 D-------PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
P + Y+I+ C + RP+ ++ +
Sbjct: 246 KNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-48
Identities = 72/292 (24%), Positives = 125/292 (42%), Gaps = 40/292 (13%)
Query: 480 ENKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+LG+G FG V R G+ VAVK+L + + +F+ EI+++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 535 RLLGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ G C + LI EY+P SL +L + + ++ I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE----LQSKTK---RIVGTYGY 645
R IHRDL NIL++ + KI DFG+ ++ D+ ++ + +
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------W 214
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA-WDLWKDDRAWE 704
+PE + FS+ SDV+SFGV+L E + + + ++G+ E
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 705 LID-------PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
L+ P + Y+I+ C + RP+ ++ +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 4e-48
Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 35/296 (11%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+ +G+G FG V++G+ G+EVAVK SS+ + + EI L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 104
Query: 540 CIELEEKI----LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ--- 592
+ L+ +Y + SL +L + +++ A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 593 --YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIVGTYGYMSP 648
+ + HRDLK+ NIL+ K+ I+D G+A D + VGT YM+P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 649 E------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702
E + ++D+++ G++ E R + L + + D
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR--RCSIGGIHEDYQLPYYDL-VPSDPSV 277
Query: 703 WELID--------PTLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
E+ P + N S L + C + A R T + L+
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 82/292 (28%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 480 ENKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNL 533
LGEG FG V G+ VAVK L + +G Q + +K EI ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 534 VRLLGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
++ GCC + L+ EY+P SL +L + +G + + I +G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE----LQSKTK---RIVGTYG 644
IHRDL A N+LLD D KI DFG+A+ ++
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------ 202
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
+ +PE ++ F SDV+SFGV L E L+ ++ T L L+G A R E
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 705 LID-------PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
L++ P Y ++ C + +A+ RPT ++ +L
Sbjct: 263 LLERGERLPRPDKCPAEVYHLM-------KNCWETEASFRPTFENLIPILKT 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 7e-47
Identities = 70/202 (34%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ ++G G FG V+ G LN +VA+K + + +E+F E +++ KL H LV+
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L G C+E L+ E+M + L +L T+ L T + + + +G+ YL
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQ 652
VIHRDL A N L+ ++ K+SDFGM R D+ S T GT + SPE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+S KSDV+SFGVL+ E S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 74/290 (25%), Positives = 122/290 (42%), Gaps = 40/290 (13%)
Query: 480 ENKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNL 533
LGEG FG V R G++VAVK L +SG + K EI+++ L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 534 VRLLGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
V+ G C E LI E++P+ SL +L +N + +++ I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE----LQSKTK---RIVGTYG 644
+ +HRDL A N+L++ + KI DFG+ + D+ ++
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------ 194
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
+ +PE Q F I SDV+SFGV L E L+ + L ++G R
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 705 LID-----PTLQN--EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ P N + Y ++ C + ++R + ++
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQLM-------RKCWEFQPSNRTSFQNLIEGF 297
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 77/310 (24%), Positives = 130/310 (41%), Gaps = 47/310 (15%)
Query: 480 ENKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
++LG+G FG V R G VAVK+L Q +F+ EI+++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 535 RLLGCCIELEEK--ILIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRIIEGIAQGLL 588
+ G + L+ EY+P+ L FL LL + + I +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGME 141
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE----LQSKTK---RIVG 641
YL R +HRDL A NIL++ + + KI+DFG+A++ D+ ++ +
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF--- 195
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701
+ +PE +FS +SDV+SFGV+L E + + + L ++G D+ R
Sbjct: 196 ---WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 702 AWELID-------PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754
EL++ P + ++ LC DRP+ + L
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELM-------KLCWAPSPQDRPSFSALGPQLDMLWSGS 305
Query: 755 PHPRQPAFSS 764
AF++
Sbjct: 306 RGCETHAFTA 315
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ + +LG G FG V G+ +VA+K + S ++EF E K++ L H LV+
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQ 83
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L G C + +I EYM N L +L + + + + + + + YL
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQ 652
+ +HRDL A N L++ K+SDFG++R DE S G+ + PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLM 194
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
FS KSD+++FGVL+ E S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-46
Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 25/271 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
++KLG G +G VY+G VAVK L + + EEF E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
C +I E+M +L +L + ++ + + + I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
IHR+L A N L+ ++ K++DFG++R+ GD + + +PE FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398
Query: 659 KSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716
KSDV++FGVLL E + + + LL ++ + + P E Y
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPEGCPEKVY 449
Query: 717 LILNRYINVGLLCVQEDAADRPTMFEVVSML 747
++ C Q + +DRP+ E+
Sbjct: 450 ELM-------RACWQWNPSDRPSFAEIHQAF 473
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+LG G FG V+ G +VAVK L S + F E L+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 540 CIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+E I I EYM N SL FL + L + + IA+G+ ++
Sbjct: 77 V--TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNY 130
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQQGL 655
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E ++ G + +PE G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGT 186
Query: 656 FSIKSDVFSFGVLLLETLS 674
F+IKSDV+SFG+LL E ++
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ +LG G FG V G+ +VAVK + S ++EF E + + KL H LV+
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVK 67
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
G C + ++ EY+ N L +L + L + + + +G+ +L
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ES 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQ 652
+ IHRDL A N L+D+D+ K+SDFGM R D+ S GT + +PE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFH 178
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+S KSDV++FG+L+ E S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 540 CIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+E + + I EYM SL +L S ++LG ++ + + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG------YMSPEYAQ 652
+HRDL A N+L+ +D K+SDFG+ + + + + +PE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALR 187
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+ FS KSDV+SFG+LL E S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 480 ENKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
++KLG G +G VY+G VAVK L + + EEF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
C +I E+M +L +L + ++ + + + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL---EKKNF 132
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK-----RIVGTYGYMSPEYAQQ 653
IHRDL A N L+ ++ K++DFG++R+ GD + + + +PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 654 GLFSIKSDVFSFGVLLLETLS 674
FSIKSDV++FGVLL E +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNG------QEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ +LGEG FG V+ N VAVK L + +++F+ E +L+ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR-------------VRII 580
V+ G C + + I+++EYM + L+ FL + ++ + + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGD--ELQSKTK 637
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + T
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 638 ---RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M PE F+ +SDV+SFGV+L E +
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 480 ENKLGEGGFGPVYKGRLL----NGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLV 534
E +G G G V GRL VA+K L + + + + +F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
RL G +++ EYM N SLD FL T + V ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY--------- 645
L +HRDL A N+L+D ++ K+SDFG++R+ D
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTGGKIP 217
Query: 646 ---MSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+PE FS SDV+SFGV++ E L+
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 22/211 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGQEEFKNEIKLIAKLQ 529
+ + +G G FG VYKG L VA+K L + + + + +F E ++ +
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
H N++RL G + + ++I EYM N +LD FL K+ V ++ GIA G+ Y
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG----- 644
L + + +HRDL A NIL++ ++ K+SDFG++R+ D + T G
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPI 214
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +PE F+ SDV+SFG+++ E ++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNL 533
LG G FG VYKG + E VA+K L + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRIIEGIAQGLL 588
RLLG C L + LI + MP L ++ + + LL W IA+G+
Sbjct: 80 CRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG---- 644
YL R++HRDL A N+L+ + KI+DFG+A++ G +E + + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ +SDV+S+GV + E ++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-45
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ +LGEG FG V+ N VAVK L S +++F+ E +L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR------------VRIIE 581
VR G C E ++++EYM + L+ FL + L G + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGD--ELQSKTK- 637
+A G++YL + L +HRDL N L+ + + KI DFGM+R I+ D + +T
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 638 --RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M PE F+ +SDV+SFGV+L E +
Sbjct: 223 PIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-45
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ +LG G FG V +G ++ VA+K L EE E +++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 536 LLGCCIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
L+G C E +++ E L FL K + ++ ++ G+ YL
Sbjct: 75 LIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG------YMSP 648
+HRDL A N+LL KISDFG+++ G D+ + + +P
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAP 182
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E FS +SDV+S+GV + E LS
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-44
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 540 CIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+E + + ++ EYM SL +L + L G ++ + + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK-RIVGTYGYMSPEYAQQGLFS 657
+HRDL A N+L+ +D K+SDFG+ + + ++ ++ + +PE ++ FS
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL--PVKWTAPEALREKKFS 364
Query: 658 IKSDVFSFGVLLLETLS 674
KSDV+SFG+LL E S
Sbjct: 365 TKSDVWSFGILLWEIYS 381
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 76/221 (34%), Positives = 109/221 (49%), Gaps = 35/221 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRN 532
+LGE FG VYKG L Q VA+K L G +EEF++E L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFL-------------FDSTKENLLGWGTRVRI 579
+V LLG + + +I+ Y + L FL D T ++ L V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 580 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGD--ELQSKT 636
+ IA G+ YL S V+H+DL N+L+ +N KISD G+ R ++ D +L +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 637 K---RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M+PE G FSI SD++S+GV+L E S
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-44
Identities = 81/273 (29%), Positives = 124/273 (45%), Gaps = 31/273 (11%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG G FG V+ +VAVK + S E F E ++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 540 CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVI 599
+ E +I E+M SL FL + IA+G+ ++ + I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSPEYAQQGLF 656
HRDL+A+NIL+ + KI+DFG+AR+ +E ++ G + +PE G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362
Query: 657 SIKSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714
+IKSDV+SFG+LL+E ++ R SN + L +R + + P E
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRPENCPEE 413
Query: 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
Y I+ + C + +RPT + S+L
Sbjct: 414 LYNIM-------MRCWKNRPEERPTFEYIQSVL 439
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-44
Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGQEEFKNEIKLIAKLQH 530
N S + +G G FG V GRL + VA+K L + + + +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
N++RL G + + +++ EYM N SLD FL + V ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMS 647
S + +HRDL A NIL++ ++ K+SDFG+ R+ D + T R G + S
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTS 218
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
PE F+ SDV+S+G++L E +S
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-44
Identities = 82/271 (30%), Positives = 129/271 (47%), Gaps = 27/271 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG+G FG V+ G VA+K L + E F E +++ KL+H LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 540 CIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
EE I I EYM SL FL L V + IA G+ Y+ R+
Sbjct: 248 V--SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
+HRDL+A+NIL+ +++ K++DFG+AR+ +E ++ + +PE A G F+I
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 360
Query: 659 KSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716
KSDV+SFG+LL E + R N L + +R + + P E+ +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECPESLH 411
Query: 717 LILNRYINVGLLCVQEDAADRPTMFEVVSML 747
++ C +++ +RPT + + L
Sbjct: 412 DLM-------CQCWRKEPEERPTFEYLQAFL 435
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNL 533
LG G FG V+KG + E V +K + +SG+ + + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRIIEGIAQGLL 588
VRLLG C + L+ +Y+P SL + + LL WG IA+G+
Sbjct: 78 VRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMY 129
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG---- 644
YL ++HR+L A N+LL +++DFG+A + D+ Q
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPI 181
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E G ++ +SDV+S+GV + E ++
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-44
Identities = 82/271 (30%), Positives = 129/271 (47%), Gaps = 27/271 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG+G FG V+ G VA+K L + E F E +++ KL+H LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 540 CIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
EE I I EYM SL FL L V + IA G+ Y+ R+
Sbjct: 331 V--SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNY 384
Query: 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
+HRDL+A+NIL+ +++ K++DFG+AR+ +E ++ + +PE A G F+I
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 443
Query: 659 KSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716
KSDV+SFG+LL E + R N L + +R + + P E+ +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECPESLH 494
Query: 717 LILNRYINVGLLCVQEDAADRPTMFEVVSML 747
++ C +++ +RPT + + L
Sbjct: 495 DLM-------CQCWRKEPEERPTFEYLQAFL 518
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 480 ENKLGEGGFGPVYKGRLLNG---QEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V KG + VAVK L + ++E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
R++G C E L+ E L+ +L + + + ++ ++ G+ YL
Sbjct: 82 RMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL--- 133
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE----LQSKTKRIVGTYGYMSPE 649
+HRDL A N+LL KISDFG+++ DE Q+ K V + +PE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPE 190
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLS 674
FS KSDV+SFGVL+ E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 76/287 (26%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGQEEFKNEIKLIAKLQH 530
+ LGEG FG VY+G N + VAVK + +E+F +E ++ L H
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 531 RNLVRLLGCCIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
++V+L+G EE I E P L +L +N L T V I + + Y
Sbjct: 73 PHIVKLIGII--EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE--LQSKTK---RIVGTYG 644
L + +HRD+ NIL+ K+ DFG++R ++ S T+ +
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------ 179
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTNSLTLLGHAWDLWKDDRA 702
+MSPE F+ SDV+ F V + E LS + N + + +L ++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---------EKG 230
Query: 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
L P L Y ++ C D +DRP E+V L++
Sbjct: 231 DRLPKPDLCPPVLYTLM-------TRCWDYDPSDRPRFTELVCSLSD 270
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 480 ENKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
+G G FG VY G LL+ AVK L+ + G+ +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 535 RLLGCCIELEEKIL-IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
LLG C+ E L + YM + L F+ + T + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 144
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG------YMS 647
+ + +HRDL A N +LD+ K++DFG+AR D + + G +M+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
E Q F+ KSDV+SFGVLL E ++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGQEEFKNEIKLIAKLQH 530
+GEG FG V++G ++ + VA+K + S +E+F E + + H
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 531 RNLVRLLGCCIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
++V+L+G E + I E L FL ++ L + + ++ L Y
Sbjct: 76 PHIVKLIGVI--TENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE--LQSKTKRIVGTYGYMS 647
L R +HRD+ A N+L+ + K+ DFG++R SK K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
PE F+ SDV+ FGV + E L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE----VAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNL 533
LGEG FG V +G L VAVK + + S + EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 534 VRLLGCCIELE-----EKILIYEYMPNKSLDFFLFDS---TKENLLGWGTRVRIIEGIAQ 585
+RLLG CIE+ + ++I +M L +L S T + T ++ + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTK-----RI 639
G+ YL S +HRDL A N +L DM ++DFG+++ I+ GD + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+++ E +++ KSDV++FGV + E +
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 63/206 (30%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 480 ENKLGEGGFGPVYKGRLL----NGQEVAVKRL---SSQSGQGQEEFKNEIKLIAKLQHRN 532
KLG+G FG V +G VAVK L + ++F E+ + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
L+RL G L + ++ E P SL L + GT R +A+G+ YL
Sbjct: 83 LIRLYGVV--LTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT---YGYMSP 648
R IHRDL A N+LL KI DFG+ R ++ + + + +P
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E + FS SD + FGV L E +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRL--------LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAK 527
+ LG+G F ++KG L+ EV +K L E F +++K
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGL 587
L H++LV G C+ +E IL+ E++ SLD +L +N + ++ + + +A +
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAM 126
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNP--------KISDFGMARIFGGDELQSKTKRI 639
+L +IH ++ A NILL ++ + K+SD G++ + +RI
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQERI 181
Query: 640 VGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLS 674
++ PE + ++ +D +SFG L E S
Sbjct: 182 ----PWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE----VAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
+ +G+G FG VY G ++ + A+K LS + Q E F E L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 535 RLLGCCIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
L+G + E + YM + L F+ + + +A+G+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL--- 140
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY--GYMSPEYA 651
+ + +HRDL A N +LD+ K++DFG+AR E S + + + E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
Q F+ KSDV+SFGVLL E L+
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNL 533
LG G FG VYKG + E VA+K L + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDS----TKENLLGWGTRVRIIEGIAQGLL 588
RLLG C L + LI + MP L ++ + + LL W IA+G+
Sbjct: 80 CRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG---- 644
YL R++HRDL A N+L+ + KI+DFG+A++ G +E + + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ +SDV+S+GV + E ++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 481 NKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNL 533
+LG+G FG VY+G + VA+K + + S + + EF NE ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFL-------FDSTKENLLGWGTRVRIIEGIAQG 586
VRLLG + + ++I E M L +L ++ +++ IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTK-----RIV 640
+ YL + + +HRDL A N ++ +D KI DFGM R I+ D + K R
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+MSPE + G+F+ SDV+SFGV+L E +
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 480 ENKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
+G G FG VY G LL+ AVK L+ + G+ +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 535 RLLGCCIELEEKIL-IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
LLG C+ E L + YM + L F+ + T + +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 208
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYG-----YMS 647
+ + +HRDL A N +LD+ K++DFG+AR ++ + K T +M+
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK----TGAKLPVKWMA 264
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
E Q F+ KSDV+SFGVLL E ++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGQEEFKNEIKLIAKL-QHRNLV 534
++ +GEG FG V K R+ A+KR+ S +F E++++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR-------------VRIIE 581
LLG C L EY P+ +L FL S +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK---- 637
+A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R G + KT
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204
Query: 638 -RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M+ E +++ SDV+S+GVLL E +S
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 480 ENKLGEGGFGPVYKGRLLNG----QEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNL 533
LG+G FG V + +L +VAVK L + EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 534 VRLLGCCIELEEKI------LIYEYMPNKSLDFFLFDS---TKENLLGWGTRVRIIEGIA 584
+L+G + K +I +M + L FL S L T VR + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTK-----R 638
G+ YL S IHRDL A N +L +DM ++DFG++R I+ GD + +
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+++ E L+++ SDV++FGV + E ++
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-42
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 43/229 (18%)
Query: 480 ENKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRN 532
+GEG FG V++ R VAVK L S Q +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR---------------- 576
+V+LLG C + L++EYM L+ FL + +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 577 -----VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGD 630
+ I +A G+ YL S + +HRDL N L+ ++M KI+DFG++R I+ D
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 631 ELQSKTK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
++ R +M PE ++ +SDV+++GV+L E S
Sbjct: 229 YYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 479 TENKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V +G ++ VA+K L EE E +++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
RL+G C E +L+ E L FL K + ++ ++ G+ YL
Sbjct: 400 RLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE----LQSKTKRIVGTYGYMSPEY 650
+HR+L A N+LL KISDFG+++ G D+ +S K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 651 AQQGLFSIKSDVFSFGVLLLETLS 674
FS +SDV+S+GV + E LS
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 480 ENKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKL-Q 529
LGEG FG V + VAVK L + + + +E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG------- 582
H+N++ LLG C + +I EY +L +L + R+ E
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSK 635
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR I D +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 636 TK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
T + +M+PE +++ +SDV+SFGVL+ E +
Sbjct: 217 TNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 480 ENKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRN 532
LGEG FG V K + VAVK L + S + +E ++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---------- 582
+++L G C + +LI EY SL FL +S K G+
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 583 -----------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGD 630
I+QG+ YL + ++++HRDL A NIL+ + KISDFG++R ++ D
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 631 ELQSKTK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+++ + +M+ E +++ +SDV+SFGVLL E ++
Sbjct: 205 SYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 74/303 (24%), Positives = 123/303 (40%), Gaps = 60/303 (19%)
Query: 480 ENKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SSQSGQGQEEFKNEIKLIAKL-Q 529
LGEG FG V + VAVK L + + + +E++++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFL-------------FDSTKENLLGWGTR 576
H+N++ LLG C + +I EY +L +L + E + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 577 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSK 635
V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR I D +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 636 TK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTNSLT 688
T + +M+PE +++ +SDV+SFGVL+ E TL
Sbjct: 263 TNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 689 LL--GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746
LL GH + P Y+++ C + RPT ++V
Sbjct: 317 LLKEGH-----------RMDKPANCTNELYMMM-------RDCWHAVPSQRPTFKQLVED 358
Query: 747 LTN 749
L
Sbjct: 359 LDR 361
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 480 ENKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRN 532
LG G FG VY+G++ +VAVK L S Q + +F E +I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFL----FDSTKENLLGWGTRVRIIEGIAQGLL 588
+VR +G ++ + ++ E M L FL ++ + L + + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 589 YLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAR-IFGGD--ELQSKTK---RI 639
YL IHRD+ A N LL KI DFGMAR I+ +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK- 210
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M PE +G+F+ K+D +SFGVLL E S
Sbjct: 211 -----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 481 NKLGEGGFGPVYKGRLLN------GQEVAVKRL-SSQSGQGQEEFKNEIKLIAKL-QHRN 532
LG G FG V + + VAVK L + +E+K++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG--------- 582
+V LLG C + + +I E+ +L +L E + + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 583 ----IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTK 637
+A+G+ +L + + IHRDL A NILL + KI DFG+AR I+ + K
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 638 -----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +M+PE +++I+SDV+SFGVLL E S
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGQEEFKNEIKLIAKL-QHR 531
LG G FG V + + VAVK L S +E +E+K+++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG--------- 582
N+V LLG C ++I EY L FL + + + +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSK 635
+A+G+ +L + IHRDL A NILL KI DFG+AR I K
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +M+PE +++ +SDV+S+G+ L E S
Sbjct: 205 GNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-41
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 480 ENKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRN 532
LG G FG VY+G++ +VAVK L S Q + +F E +I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFL----FDSTKENLLGWGTRVRIIEGIAQGLL 588
+VR +G ++ + ++ E M L FL ++ + L + + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 589 YLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAR-IFGGD--ELQSKTK---RI 639
YL IHRD+ A N LL KI DFGMAR I+ +
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK- 251
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M PE +G+F+ K+D +SFGVLL E S
Sbjct: 252 -----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 48/285 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+F +G GGFG V+K + ++G+ +KR+ + E+ + E+K +AKL H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 535 RLLGCCIELEEKI----------------LIYEYMPNKSLDFFLFDSTKENLLGWGTRVR 578
GC + + E+ +L+ ++ + + L +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638
+ E I +G+ Y+H ++I+RDLK SNI L KI DFG+ D K R
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRTR 180
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK 698
GT YMSPE + + D+++ G++L E L T+ +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSK---------FFT 229
Query: 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
D R +I + L+ + + DRP E+
Sbjct: 230 DLRD-GIISDIFDKKEKTLLQK--------LLSKKPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 44/292 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNL 533
+F LG GGFG V++ + ++ A+KR+ +E+ E+K +AKL+H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 534 VRLLGCCIE---------LEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIE 581
VR +E K+ +Y + ++L ++ + I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR--- 638
IA+ + +LH ++HRDLK SNI D K+ DFG+ DE +
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 639 -------IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLG 691
VGT YMSPE +S K D+FS G++L E L FS
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVR-- 235
Query: 692 HAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
D R + P L + + + +RP +
Sbjct: 236 ----TLTDVRNLKF--PPLFTQKYP-CEYVMVQ---DMLSPSPMERPEAINI 277
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGQEEFKNEIKLIAKL-QHR 531
LG G FG V + + VAVK L S+ +E +E+K+++ L QH
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFL-----------FDSTKENLLGWGTRVRII 580
N+V LLG C ++I EY L FL + + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRI 639
+AQG+ +L + IHRD+ A N+LL KI DFG+AR I K
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +M+PE +++++SDV+S+G+LL E S
Sbjct: 228 L-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-40
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 480 ENKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SSQSGQGQEEFKNEIKLIAKL-Q 529
LGEG FG V + +VAVK L S + + + +E++++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG------- 582
H+N++ LLG C + +I EY +L +L L E
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSK 635
+A+G+ YL + + IHRDL A N+L+ +D KI+DFG+AR I D +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 636 TK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
T + +M+PE +++ +SDV+SFGVLL E +
Sbjct: 251 TNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-39
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+GEG FG V++G ++ + VA+K + S +E+F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+L+G E +I E L FL ++ L + + ++ L YL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R +HRD+ A N+L+ + K+ DFG++R +K + +M+PE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFR 567
Query: 655 LFSIKSDVFSFGVLLLETLS 674
F+ SDV+ FGV + E L
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 62/267 (23%), Positives = 116/267 (43%), Gaps = 32/267 (11%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
++G G F VYKG EVA + + ++ FK E +++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 539 CCIELEEK----ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+ +L+ E M + +L +L + ++ I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 595 RLRVIHRDLKASNILLD-KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+IHRDLK NI + + KI D G+A + S K ++GT +M+PE ++
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE 204
Query: 654 GLFSIKSDVFSFGVLLLETLSSKR-NTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
+ DV++FG+ +LE +S+ ++ N + + K ++ P ++
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDKVAIPEVKE 261
Query: 713 EASYLILNRYINVGLLCVQEDAADRPT 739
I+ C++++ +R +
Sbjct: 262 -----IIEG-------CIRQNKDERYS 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 61/229 (26%), Positives = 92/229 (40%), Gaps = 43/229 (18%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGQEEFKNEIKLIAKL-QHR 531
LG G FG V + VAVK L +E +E+K++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG--------- 582
N+V LLG C LI+EY L +L ++
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 583 -----------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-IFGGD 630
+A+G+ +L +HRDL A N+L+ KI DFG+AR I
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 631 ELQSKTK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ + +M+PE +G+++IKSDV+S+G+LL E S
Sbjct: 227 NYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 28/276 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGQEEFKNEIKLIAKLQHR 531
NF E K+G G F VY+ LL+G VA+K++ + + + EI L+ +L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 532 NLVRLLGCCIELEEKILIY-EYMPNKSLDFFLFDSTKEN-LLGWGTRVRIIEGIAQGLLY 589
N+++ IE + ++ I E L + K+ L+ T + + L +
Sbjct: 93 NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
+H RV+HRD+K +N+ + K+ D G+ R F + + +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKR--NTDFSNTNSLTLLGHAWDLWKDDRAWELID 707
+ ++ KSD++S G LL E + + D N SL + D
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-----QCD-----YP 256
Query: 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
P + S L + +N +C+ D RP + V
Sbjct: 257 PLPSDHYSE-ELRQLVN---MCINPDPEKRPDVTYV 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
+ K+GEG FG + +G++ +K +S S + +EE + E+ ++A ++H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK----ENLLGWGTRVRIIEGIAQGLL 588
+V+ E ++ +Y L + E+ + + I L
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-----LDWFVQICLALK 139
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
++H +++HRD+K+ NI L KD ++ DFG+AR+ ++ +GT Y+SP
Sbjct: 140 HVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSP 194
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKR 677
E + ++ KSD+++ G +L E + K
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G +G VY GR L N +A+K + + + + EI L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 542 ELEEKILIY-EYMPNKSLDFFLFDS-----TKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
E I I+ E +P SL L E +G + I +GL YLH
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-----FYTKQILEGLKYLHDN-- 141
Query: 596 LRVIHRDLKASNILLD-KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+++HRD+K N+L++ KISDFG ++ G + T+ GT YM+PE +G
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKG 198
Query: 655 L--FSIKSDVFSFGVLLLETLSSKR 677
+ +D++S G ++E + K
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
++ +G G +G K R +G+ + K S + ++ +E+ L+ +L+H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 533 LVRLLGCCIELEEKIL--IYEYMPNKSLDFFLFDSTKEN-LLGWGTRVRIIEGIAQGLLY 589
+VR I+ L + EY L + TKE L +R++ + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 590 LHQ--YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
H+ V+HRDLK +N+ LD N K+ DFG+ARI D +KT VGT YMS
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMS 184
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677
PE + ++ KSD++S G LL E +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+F LG+G FG V K R L+ + A+K++ + +E+ L+A L H+ +V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVV 65
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFF---------LFD--STKENLLGWGTRVRIIEGI 583
R +E + + KS F L+D ++ R+ I
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF------------GGDE 631
+ L Y+H +IHRDLK NI +D+ N KI DFG+A+
Sbjct: 126 LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 632 LQSKTKRIVGTYGYMSPE-YAQQGLFSIKSDVFSFGVLLLE 671
+GT Y++ E G ++ K D++S G++ E
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+S ++G GG V++ Q A+K L Q + ++NEI + KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 534 --VRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
+RL ++ I ++ E N L+ +L K+ + R + + + + +
Sbjct: 89 KIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE- 649
HQ+ ++H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 144 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 650 ----------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ S KSDV+S G +L K
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 25/213 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
++ KLGEGGF V L +G A+KR+ Q +EE + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 535 RLLGCCIELEEK----ILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
RL+ C+ L+ + +L + K N L + ++ GI +GL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIV-------GT 642
+H HRDLK +NILL + P + D G S+ + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 643 YGYMSPE------YAQQGLFSIKSDVFSFGVLL 669
Y +PE + ++DV+S G +L
Sbjct: 207 ISYRAPELFSVQSHCVID---ERTDVWSLGCVL 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 29/219 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+S ++G GG V++ Q A+K L Q + ++NEI + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 534 --VRLLGCCIELEEKILIY-EYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLL 588
+RL ++ I + E N L+ +L S + + + +
Sbjct: 117 KIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK-----SYWKNMLEAVH 169
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
+HQ+ ++H DLK +N L+ D K+ DFG+A D VG YM P
Sbjct: 170 TIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 649 E-----------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
E + S KSDV+S G +L K
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+S ++G GG V++ Q A+K L Q + ++NEI + KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 534 --VRLLGCCIELEEKI-LIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLL 588
+RL ++ I ++ E N L+ +L S + + + +
Sbjct: 70 KIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK-----SYWKNMLEAVH 122
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
+HQ+ ++H DLK +N L+ K+ DFG+A D VGT YM P
Sbjct: 123 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 649 E-----------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
E + S KSDV+S G +L K
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 18/194 (9%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGF ++ + A K + +E+ EI + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKEN--LLGWGTRVRIIEGIAQGLLYLHQYSR 595
E + + ++ E +SL + K L R + I G YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---R 133
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
RVIHRDLK N+ L++D+ KI DFG+A D + K + GT Y++PE +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 656 FSIKSDVFSFGVLL 669
S + DV+S G ++
Sbjct: 192 HSFEVDVWSIGCIM 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
++G G FG V++ + G + AVK++ + + E+ A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 540 CIELEEKILIY-EYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
E + I+ E + SL + E+ + +GL YLH
Sbjct: 119 VRE-GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-----QALEGLEYLHT---R 169
Query: 597 RVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDELQ---SKTKRIVGTYGYMSPEYAQ 652
R++H D+KA N+LL D + + DFG A D L I GT +M+PE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKR 677
K D++S ++L L+
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 18/194 (9%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGF ++ + A K + +E+ EI + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKEN--LLGWGTRVRIIEGIAQGLLYLHQYSR 595
E + + ++ E +SL + K L R + I G YLH+
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR--- 159
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
RVIHRDLK N+ L++D+ KI DFG+A D + K + GT Y++PE +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217
Query: 656 FSIKSDVFSFGVLL 669
S + DV+S G ++
Sbjct: 218 HSFEVDVWSIGCIM 231
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 17/223 (7%)
Query: 454 NSRTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG 512
R R F +F ++LG G G V+K +G +A K + +
Sbjct: 12 QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71
Query: 513 QG-QEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY-EYMPNKSLDFFL--FDSTKE 568
+ + E++++ + +V G + +I I E+M SLD L E
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPE 130
Query: 569 NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
+LG ++ + +GL YL + +++HRD+K SNIL++ K+ DFG++
Sbjct: 131 QILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---- 179
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
G + S VGT YMSPE Q +S++SD++S G+ L+E
Sbjct: 180 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
++ K+G+G G VY + GQEVA+++++ Q +E NEI ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L + +E ++ EY+ SL D E + G + Q L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS--- 134
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+VIHRD+K+ NILL D + K++DFG QSK +VGT +M+PE +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 656 FSIKSDVFSFGVLLLE 671
+ K D++S G++ +E
Sbjct: 193 YGPKVDIWSLGIMAIE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 12/197 (6%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ K+GEG G V R +G++VAVK + + Q +E NE+ ++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
+ + EE ++ E++ +L D + L + E + Q L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGM-ARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
VIHRD+K+ +ILL D K+SDFG A+I + K K +VGT +M+PE +
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRS 216
Query: 655 LFSIKSDVFSFGVLLLE 671
L++ + D++S G++++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 64/294 (21%), Positives = 102/294 (34%), Gaps = 49/294 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKL-QHR 531
+F ++LG G +G V+K R +G+ AVK + + + E+ K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK---ENLLGWGTRVRIIEGIAQGLL 588
VRL E L E SL E + + + L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV----WGYLRD-TLLALA 171
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
+LH ++H D+K +NI L K+ DFG+ G + G YM+P
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAP 225
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708
E Q + +DVFS G+ +LE + G W +
Sbjct: 226 ELLQGS-YGTAADVFSLGLTILEVACNMEL--PHG-------GEGWQQLRQGYLPPEFTA 275
Query: 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHP--RQP 760
L +E ++ ++ ++ D R T + L P RQP
Sbjct: 276 GLSSELRSVL--------VMMLEPDPKLRATAEAL----------LALPVLRQP 311
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 24/216 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNL 533
+ + LG+G V++GR G A+K + + + E +++ KL H+N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 534 VRLLGCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
V+L E E+ P SL L + + L + ++ + G+ +L
Sbjct: 70 VKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 591 HQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+ ++HR++K NI+ D K++DFG AR DE + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
Query: 647 SPE--------YAQQGLFSIKSDVFSFGVLLLETLS 674
P+ Q + D++S GV +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
LG+G F VY+ + G EVA+K + ++G + +NE+K+ +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQLKHPSILELY 77
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFLFDSTKEN---LLGWGTRVRIIEGIAQGLLYLHQY 593
E + L+ E N + K R + I G+LYLH +
Sbjct: 78 NY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH 131
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
++HRDL SN+LL ++MN KI+DFG+A + T + GT Y+SPE A +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATR 186
Query: 654 GLFSIKSDVFSFGVLLLETL 673
++SDV+S G + L
Sbjct: 187 SAHGLESDVWSLGCMFYTLL 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNL 533
+ + LG+G V++GR G A+K + + + E +++ KL H+N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 534 VRLLGCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
V+L E E+ P SL L + + L + ++ + G+ +L
Sbjct: 70 VKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 591 HQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+ ++HR++K NI+ D K++DFG AR DE + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
Query: 647 SPE--------YAQQGLFSIKSDVFSFGVLL 669
P+ Q + D++S GV
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIK-LIAKLQHRNL 533
+LG G +G V K R + +GQ +AVKR+ + Q Q+ ++ + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK------ENLLGWGTRVRIIEGIAQGL 587
V G + + E M + SLD F E++LG +I I + L
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKAL 122
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI-VGTYGYM 646
+LH S+L VIHRD+K SN+L++ K+ DFG++ G + K I G YM
Sbjct: 123 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDDVAKDIDAGCKPYM 176
Query: 647 SPE----YAQQGLFSIKSDVFSFGVLLLE 671
+PE Q +S+KSD++S G+ ++E
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 68/322 (21%), Positives = 116/322 (36%), Gaps = 47/322 (14%)
Query: 480 ENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLL 537
L EGGF VY+ + + +G+E A+KRL S + E+ + KL H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 538 GCCIELEEK-------ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
+E+ L+ + L FL L T ++I + + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI----------V 640
H + +IHRDLK N+LL K+ DFG A S + +
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 641 GTYGYMSPE----YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696
T Y +PE Y+ + K D+++ G +L R F + L ++ + +
Sbjct: 212 TTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCF--RQHPFEDGAKLRIVNGKYSI 268
Query: 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVV----SMLTNKTI 752
T LI +Q + +R ++ EVV + + +
Sbjct: 269 --------PPHDTQYTVFHSLIRA--------MLQVNPEERLSIAEVVHQLQEIAAARNV 312
Query: 753 NLPHPRQPAFSSIRGLKNTILP 774
N P G + L
Sbjct: 313 NPKSPITELLEQNGGYGSATLS 334
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEE-FKNEIKLIAKLQHRNL 533
+ + +LG GGFG V + G++VA+K+ + E + EI+++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 534 VRLLGCCIELEEKI-------LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
V + +K+ L EY L +L L G ++ I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 587 LLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
L YLH+ R+IHRDLK NI+L + + KI D G A+ EL ++ VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTL 187
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLL 669
Y++PE +Q +++ D +SFG L
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 60/297 (20%), Positives = 108/297 (36%), Gaps = 51/297 (17%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLV 534
+F ++ LG G G + + + ++VAVKR+ + E++L+ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
R C + + + E ++ K+ + +++ GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 594 SRLRVIHRDLKASNILL-----DKDMNPKISDFGMARIFGGDEL-QSKTKRIVGTYGYMS 647
L ++HRDLK NIL+ + ISDFG+ + S+ + GT G+++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 648 PEYAQQGLF---SIKSDVFSFGVLLLETLSSKR----NTDFSNTNSLTLLGHAWDLWKDD 700
PE + + D+FS G + +S + N L
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL----DCL 250
Query: 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHP 757
+ D A LI + D RP+ V L HP
Sbjct: 251 HPEKHEDV----IARELIEK--------MIAMDPQKRPSAKHV----------LKHP 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRN 532
+ ++G G +G V K +GQ +AVKR+ S + Q++ ++ ++ +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK-------ENLLGWGTRVRIIEGIAQ 585
+V+ G + + E M + S D F E +LG +I +
Sbjct: 83 IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLATVK 136
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI-VGTYG 644
L +L L++IHRD+K SNILLD+ N K+ DFG++ G + S K G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRP 190
Query: 645 YMSPE----YAQQGLFSIKSDVFSFGVLLLE 671
YM+PE A + + ++SDV+S G+ L E
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQE---EFKNEIKLIAKLQHRNLVRLL 537
KLG GG VY + +VA+K + + +E F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 538 --GCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
EE Y EY+ +L ++ L T + I G+ + H
Sbjct: 78 DVD-----EEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH- 128
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+R++HRD+K NIL+D + KI DFG+A+ L ++T ++GT Y SPE A+
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAK 185
Query: 653 QGLFSIKSDVFSFGVLLLETL 673
+D++S G++L E L
Sbjct: 186 GEATDECTDIYSIGIVLYEML 206
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
F+ K+G+G FG V+KG + VA+K + + + + E+ + EI ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+ G ++ + +I EY+ S D + L I+ I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR--IVGTYGYMSPEYAQ 652
+ IHRD+KA+N+LL + K++DFG+A G ++ KR VGT +M+PE +
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 653 QGLFSIKSDVFSFGVLLLE 671
Q + K+D++S G+ +E
Sbjct: 193 QSAYDSKADIWSLGITAIE 211
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 59/304 (19%), Positives = 109/304 (35%), Gaps = 62/304 (20%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGQEEFKNEI 522
++ S T F K+G G FG V+K L+G A+KR ++ E+
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 523 KLIAKL-QHRNLVRLLGCCIELEEKILIY-EYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
A L QH ++VR E ++ +LI EY SL + ++ + ++ +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 581 EG-IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-------------------KISD 620
+ +GL Y+H + ++H D+K SNI + + P KI D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNT 679
G S + G +++ E Q+ K+D+F+ + ++ ++
Sbjct: 178 LGHVTRI------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE--- 228
Query: 680 DFSNTNSLTLLGHAWDLWKDDRAWELID----PTLQNEASYLILNRYINVGLLCVQEDAA 735
L ++ W I P + S + + + D
Sbjct: 229 ---------------PLPRNGDQWHEIRQGRLPRIPQVLSQE-FTELLK---VMIHPDPE 269
Query: 736 DRPT 739
RP+
Sbjct: 270 RRPS 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 482 KLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------SQSGQGQEEFKNEIKL 524
L +G F + + + A+K+ ++FKNE+++
Sbjct: 38 TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 525 IAKLQHRNLVRLLGCCIELEEKI-LIYEYMPNKSL-----DFFLFDSTKENLLGWGTRVR 578
I +++ + G I +++ +IYEYM N S+ FF+ D +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638
II+ + Y+H + + HRD+K SNIL+DK+ K+SDFG + +++
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG---- 209
Query: 639 IVGTYGYMSPE--YAQQGLFSIKSDVFSFGVLLLETL 673
GTY +M PE + K D++S G+ L
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 38/352 (10%), Positives = 74/352 (21%), Gaps = 64/352 (18%)
Query: 438 SIATRANELCKGNKAANSRTRDSWFPMFSLASV----SAATANFSTENKLGEGGFGPVYK 493
I E K A + +P + +V S L G V+
Sbjct: 21 LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFL 80
Query: 494 GR-LLNGQEVAVKRL---SSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543
R + ++ A+K + S E A+L + L
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 544 --------------------EEKILIYEYMP---NKSLDFFLFDSTKENLLGWGTRVRII 580
+L+ F G +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 581 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIV 640
+ + L ++H N+ + D + D G ++
Sbjct: 201 AQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASS 252
Query: 641 GTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSK-----RNTDFSNTNSLTLLGHA 693
Y E+ F+ + + G+ + + L
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312
Query: 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
+ + ++ LI L D R E +
Sbjct: 313 GTDSLAFGSCTPLPDFVKT----LIG------RFLNF--DRRRRLLPLEAME 352
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 55/206 (26%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ +LG+G FG VYK + G A K + ++S + E++ EI+++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTK---ENLLGWGTRVRIIEGIAQGLLYLHQ 592
LLG + ++ E+ P ++D + + + E + + + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNFLHS 135
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR--IVGTYGYMSPE- 649
R+IHRDLKA N+L+ + + +++DFG++ L++ KR +GT +M+PE
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 650 ----YAQQGLFSIKSDVFSFGVLLLE 671
+ + K+D++S G+ L+E
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN 532
F KLGEG +G VYK GQ VA+K++ + +E EI ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+V+ G + + ++ EY S+ + + L I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGM-ARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+R IHRD+KA NILL+ + + K++DFG+ ++ + +K ++GT +M+PE
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTVIGTPFWMAPEVI 197
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
Q+ ++ +D++S G+ +E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-31
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 30/207 (14%)
Query: 482 KLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNLVRLL- 537
+ GG G +Y +NG+ V +K L Q E + +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 538 -GCCIELEEKILIY---EYMPNKSLDFFLFDSTKENL---LGWGTRVRIIEGIAQGLLYL 590
+ + Y EY+ +SL K + L + + I L YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL--------KRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H + +++ DLK NI+L ++ K+ D G + GT G+ +PE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEI 248
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKR 677
+ G ++ +D+++ G L
Sbjct: 249 VRTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-31
Identities = 70/316 (22%), Positives = 111/316 (35%), Gaps = 70/316 (22%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVR 535
+E LG G G V G+ VAVKR+ + EIKL+ + H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 536 LLGCCIELEEKI-LIYEYMPNKSLDFFL---FDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
C + + + E D L + ++ IA G+ +LH
Sbjct: 74 YY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 592 QYSRLRVIHRDLKASNILLD-------------KDMNPKISDFGMARIFGGDE--LQSKT 636
L++IHRDLK NIL+ +++ ISDFG+ + + ++
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 637 KRIVGTYGYMSPEYAQQGLFSI-------KSDVFSFGVLLLETLSSK------RNTDFSN 683
GT G+ +PE ++ D+FS G + LS + + SN
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 684 --TNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMF 741
+L + L EA+ LI ++ D RPT
Sbjct: 250 IIRGIFSLDEMKCLHDRS----------LIAEATDLISQ------MIDH--DPLKRPTAM 291
Query: 742 EVVSMLTNKTINLPHP 757
+V L HP
Sbjct: 292 KV----------LRHP 297
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 21/203 (10%)
Query: 480 ENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---QEEFKNEIKLIAKLQHRNLVR 535
+G GG G VY+ + + VA+K +S + + E + +LQ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 536 L--LGCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
+ G E +Y + L L ++ L V I+ I L
Sbjct: 99 IHDFG-----EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H HRD+K NIL+ D + DFG+A ++L ++ VGT YM+PE
Sbjct: 151 H---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPER 206
Query: 651 AQQGLFSIKSDVFSFGVLLLETL 673
+ + ++D+++ +L E L
Sbjct: 207 FSESHATYRADIYALTCVLYECL 229
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGQEEFKNEIKLIAKLQH 530
+F LG+G FG VY R + +A+K L ++G + + + E+++ + L+H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRH 68
Query: 531 RNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
N++RL G ++ LI EY P ++ L K + I +A L Y
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSY 124
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
H RVIHRD+K N+LL KI+DFG + S+ + GT Y+ PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPE 177
Query: 650 YAQQGLFSIKSDVFSFGVLLLETL 673
+ + K D++S GVL E L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNL 533
++G G G V+K R G +AVK++ + + ++ ++ K +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
V+ G I + + E M + E +LG ++ I + L YL
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLK 141
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRI-VGTYGYMSPE- 649
+ VIHRD+K SNILLD+ K+ DFG++ G + K K G YM+PE
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAKDRSAGCAAYMAPER 195
Query: 650 ----YAQQGLFSIKSDVFSFGVLLLE 671
+ + I++DV+S G+ L+E
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQE---EFKNEIKLIAKLQHRNLVRLL 537
LG GG V+ R L + ++VAVK L + + F+ E + A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 538 GCCIELEEKILIY----EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
+ EY+ +L + E + + +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ-SKTKRIVGTYGYMSPEYAQ 652
+ +IHRD+K +NI++ K+ DFG+AR ++T ++GT Y+SPE A+
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKR 677
+SDV+S G +L E L+ +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNL 533
++ + +G G V ++VA+KR++ + Q +E EI+ +++ H N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE--GIA------- 584
V + +E L+ + + S+ D K + + +++ IA
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM-ARIFGGDELQSKTKR--IVG 641
+GL YLH + IHRD+KA NILL +D + +I+DFG+ A + G ++ R VG
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 642 TYGYMSPEYAQQGL-FSIKSDVFSFGVLLLE 671
T +M+PE +Q + K+D++SFG+ +E
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFK---NEIKLIAKLQHRN 532
FS ++G G FG VY R + N + VA+K++S Q E+++ E++ + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDST--KENLLGWGTRVRIIEGIAQGLLYL 590
++ GC + L+ EY + D +E + + G QGL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-----VTHGALQGLAYL 170
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE- 649
H +IHRD+KA NILL + K+ DFG A I + VGT +M+PE
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEV 221
Query: 650 --YAQQGLFSIKSDVFSFGVLLLE 671
+G + K DV+S G+ +E
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 41/334 (12%), Positives = 90/334 (26%), Gaps = 80/334 (23%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQH-------- 530
LG+ + G+ V ++ K E+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 531 --------RNLVRLLGCCIELEEK-----------ILIYEYMPNKSLDFF--LFDSTKEN 569
+LV+ + + +Y M + F L + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 570 -LLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
L R+++ + + L LH ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 629 GDELQSKTKRIVGTYGYMSPE-----YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683
G S R + L + D ++ G+ + + ++
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNTD 319
Query: 684 TNSLTLLGHAWDLWKD--DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMF 741
+L + K+ L++ G L + DR
Sbjct: 320 DAALGGSEWIFRSCKNIPQPVRALLE------------------GFL--RYPKEDRLLPL 359
Query: 742 EVVSMLTNKTINLPHPRQPAFSSIRGLKNTILPA 775
+ + P + +R + LP
Sbjct: 360 QAM-------------ETPEYEQLRTELSAALPL 380
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 57/181 (31%), Positives = 94/181 (51%), Gaps = 18/181 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN----EIKLIAKLQH 530
NF K+GEG +G VYK R L G+ VA+K++ + E + EI L+ +L H
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKELNH 61
Query: 531 RNLVRLLGCCIELEEKILIYEYMPN--KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
N+V+LL + L++E++ K D++ + + + QGL
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
+ H + RV+HRDLK N+L++ + K++DFG+AR F G +++ T +V T Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAP 172
Query: 649 E 649
E
Sbjct: 173 E 173
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 24/222 (10%)
Query: 466 SLASVSAATANFSTENKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSSQSGQGQEEFKN 520
++S + +G+G V R G+ V V+R L + S + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS----LDFFLFDSTKENLLGWGTR 576
E+ + H N+V I E ++ +M S + D E + +
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY--- 132
Query: 577 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT 636
I++G+ + L Y+H + +HR +KAS+IL+ D +S + +
Sbjct: 133 --ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 637 -----KRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLE 671
K V ++SPE QQ L + KSD++S G+ E
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 58/263 (22%), Positives = 106/263 (40%), Gaps = 18/263 (6%)
Query: 412 SIYIRVPASELETKKSQDMLQFDINMSIATRANELCKGNKAANSRTRDSWFPMFSLASVS 471
+ + +P E + ++ D+ D I + ++P
Sbjct: 97 TAPVLIPGDERKRRRGYDV---DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 472 AATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH 530
++ +LG G FG V++ G A K + + +E + EI+ ++ L+H
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFD--STKENLLGWGTRVRIIEGIAQGLL 588
LV L + E ++IYE+M LF+ + + N + V + + +GL
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 589 YLHQYSRLRVIHRDLKASNILL-DKDMNP-KISDFGMARIFGGDELQSKTKRIVGTYGYM 646
++H+ +H DLK NI+ K N K+ DFG+ + K GT +
Sbjct: 270 HMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFA 323
Query: 647 SPEYAQQGLFSIKSDVFSFGVLL 669
+PE A+ +D++S GVL
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLS 346
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 64/334 (19%), Positives = 108/334 (32%), Gaps = 83/334 (24%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNL 533
+F +G GGFG V++ + ++ A+KR+ +E+ E+K +AKL+H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK---------------ENLLGWGTRVR 578
VR +E + E D + T +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 579 IIEGIAQGLLY----------LHQYSRLR-----------------------------VI 599
+ + LY L + R ++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 600 HRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK----------RIVGTYGYMSPE 649
HRDLK SNI D K+ DFG+ DE + VGT YMSPE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709
+S K D+FS G++L E L +T +T + + + L+
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFE-LLYSFSTQMERVRIITDV--------RNLKFPLLFTQ 297
Query: 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
+ ++ + +RP ++
Sbjct: 298 KYPQEHMMV--------QDMLSPSPTERPEATDI 323
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN 532
+ +LG G FG V++ G+ K +++ + KNEI ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFD--STKENLLGWGTRVRIIEGIAQGLLYL 590
L+ L + E +LI E++ L FD + ++ + + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 591 HQYSRLRVIHRDLKASNILL-DKDMNP-KISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
H+ ++H D+K NI+ K + KI DFG+A DE K T + +P
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 649 EYAQQGLFSIKSDVFSFGVLL 669
E + +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
S LG G FG V+K G ++A K + ++ + +EE KNEI ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDS--TKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+L + +L+ EY+ L FD + L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 593 YSRLRVIHRDLKASNILL-DKDMNP-KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
+ ++H DLK NIL ++D KI DFG+AR + E K K GT +++PE
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 651 AQQGLFSIKSDVFSFGVLL 669
S +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGQEEFKNEIKLIAKLQH 530
+F LG+G FG VY R N +A+K L + G + + + EI++ + L+H
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRH 73
Query: 531 RNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLL 588
N++R+ ++I L+ E+ P L + K +E +A L
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALH 128
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
Y H +VIHRD+K N+L+ KI+DFG + + + + GT Y+ P
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPP 181
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETL 673
E + K D++ GVL E L
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 21/206 (10%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHR 531
F + KLG G FG V+ +G E +K ++ +S E+ + EI+++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR-----VRIIEGIAQG 586
N++++ + ++ E L + +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 587 LLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
L Y H V+H+DLK NIL KI DFG+A +F DE + GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTA 190
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLL 669
YM+PE ++ + + K D++S GV++
Sbjct: 191 LYMAPEVFKRDV-TFKCDIWSAGVVM 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLV 534
F +G G +G VYKGR + GQ A+K + +G +EE K EI ++ K HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 535 RLLGC-----CIELEEKI-LIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGL 587
G +++++ L+ E+ S+ D L +TK N L I I +GL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREILRGL 142
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
+LHQ +VIHRD+K N+LL ++ K+ DFG++ D + +GT +M+
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMA 197
Query: 648 PEYAQQGLFS-----IKSDVFSFGVLLLE 671
PE KSD++S G+ +E
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 25/186 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN-----EIKLIAKLQ 529
F KLG G + VYKG G VA+K + EE EI L+ +L+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD----SEEGTPSTAIREISLMKELK 61
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPN--KSLDFFLFDSTKENLLGWGTRVRIIEGIA--- 584
H N+VRL + L++E+M N K DS G + +++
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKY----MDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 585 -QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTY 643
QGL + H+ +++HRDLK N+L++K K+ DFG+AR F G + + + +V T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TL 172
Query: 644 GYMSPE 649
Y +P+
Sbjct: 173 WYRAPD 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQSGQGQEEFKNEIKLIAKLQH 530
+ +G+G F V + GQ+ AVK + +S G E+ K E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS--TKENLLGWGT-RV--RIIEGIAQ 585
++V LL +++E+M L + + + V + I +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 586 GLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
L Y H +IHRD+K +LL + K+ FG+A G VGT
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGT 196
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+M+PE ++ + DV+ GV+L
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 56/197 (28%), Positives = 85/197 (43%), Gaps = 16/197 (8%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGQEEFKNEIKLIAKLQHRNLVRLL 537
LGEG +G V + AVK L + G+ K EI+L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 538 GCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+ EEK +Y EY + + DS E + GL YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--- 126
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ-Q 653
++H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 654 GLFS-IKSDVFSFGVLL 669
FS K D++S GV L
Sbjct: 187 DTFSGFKVDIWSAGVTL 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 51/187 (27%), Positives = 93/187 (49%), Gaps = 31/187 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN--------EIKLIA 526
+ K+GEG +G V+K + + VA+KR+ ++ EI L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLK 56
Query: 527 KLQHRNLVRLLGCCIELEEKI-LIYEYMPN--KSLDFFLFDSTKENLLGWGTRVR-IIEG 582
+L+H+N+VRL ++K+ L++E+ K FDS +L V+ +
Sbjct: 57 ELKHKNIVRLHDVLHS-DKKLTLVFEFCDQDLKK----YFDSCNGDLD--PEIVKSFLFQ 109
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
+ +GL + H V+HRDLK N+L++++ K+++FG+AR F G ++ + +V T
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-T 164
Query: 643 YGYMSPE 649
Y P+
Sbjct: 165 LWYRPPD 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 28/185 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKN--------EIKLIAK 527
+ K+GEG +G VYK + G+ VA+KR+ + EI L+ +
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKE 75
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPN--KSLDFFLFDSTKENLLGWGTRVR-IIEGIA 584
L H N+V L+ L++E+M K + D K L ++++ + +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKK----VLDENKTGLQ--DSQIKIYLYQLL 129
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
+G+ + HQ+ R++HRDLK N+L++ D K++DFG+AR F G ++S T +V T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLW 184
Query: 645 YMSPE 649
Y +P+
Sbjct: 185 YRAPD 189
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 44/216 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQH 530
+ + KLG G +G V R + E A+K + +S S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-------- 582
N+++L + L+ E LFD II
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFD-------------EIIHRMKFNEVDA 138
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQ 633
+ G+ YLH+ ++HRDLK N+LL +KD KI DFG++ +F +
Sbjct: 139 AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
K K +GT Y++PE + + K DV+S GV+L
Sbjct: 194 -KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQH 530
++ LG+G FG V K + + QE AVK + +S + E++L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-------- 582
N+++L + ++ E LFD II+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-------------EIIKRKRFSEHDA 123
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQ 633
+ G+ Y+H+ ++HRDLK NILL +KD + KI DFG++ F +
Sbjct: 124 ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
K K +GT Y++PE +G + K DV+S GV+L
Sbjct: 179 -KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN 532
+ LG G FG V++ + + K + G Q K EI ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFD--STKENLLGWGTRVRIIEGIAQGLLYL 590
++ L +EE ++I+E++ + F+ +T L V + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 591 HQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
H + H D++ NI+ + KI +FG AR + + + Y +P
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAP 172
Query: 649 EYAQQGLFSIKSDVFSFGVLL 669
E Q + S +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 44/216 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQH 530
++ LG+G FG V K + + QE AVK + +S + E++L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-------- 582
N+++L + ++ E LFD II+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-------------EIIKRKRFSEHDA 123
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQ 633
+ G+ Y+H+ ++HRDLK NILL +KD + KI DFG++ F +
Sbjct: 124 ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
K K +GT Y++PE + + K DV+S GV+L
Sbjct: 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 26/184 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKN--------EIKLIAK 527
+ K+GEG +G VYK + G+ A+K++ E+ EI ++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKE 56
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPN--KSLDFFLFDSTKENLLGWGTRVRIIEGIAQ 585
L+H N+V+L + +L++E++ K L D + L + + +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAK-SFLLQLLN 111
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645
G+ Y H RV+HRDLK N+L++++ KI+DFG+AR F G ++ T IV T Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWY 166
Query: 646 MSPE 649
+P+
Sbjct: 167 RAPD 170
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 28/187 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN--------EIKLIA 526
+ + LGEG F VYK R Q VA+K++ + E K+ EIKL+
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLLQ 67
Query: 527 KLQHRNLVRLLGCCIELEEKI-LIYEYMPN--KSLDFFLFDSTKENLLGWGTRVR-IIEG 582
+L H N++ LL + I L++++M + + L + ++ +
Sbjct: 68 ELSHPNIIGLLDAFGH-KSNISLVFDFMETDLEV----IIKDNSLVLT--PSHIKAYMLM 120
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
QGL YLHQ+ ++HRDLK +N+LLD++ K++DFG+A+ F G ++ T ++V T
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-T 175
Query: 643 YGYMSPE 649
Y +PE
Sbjct: 176 RWYRAPE 182
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQ 529
+ + + LG+G FG V + + GQE AVK +S + +E E++L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG------- 582
H N+++L + L+ E L FD II
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD-------------EIISRKRFSEVD 127
Query: 583 -------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDEL 632
+ G+ Y+H+ +++HRDLK N+LL KD N +I DFG++ F +
Sbjct: 128 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
K K +GT Y++PE G + K DV+S GV+L
Sbjct: 184 --KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 42/214 (19%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN 532
++ EN +G G +G V A K++ + + FK EI+++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---------- 582
++RL + + L+ E LF+ R++
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFE-------------RVVHKRVFRESDAAR 110
Query: 583 ----IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSK 635
+ + Y H+ L V HRDLK N L D K+ DFG+A F +
Sbjct: 111 IMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---M 164
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ VGT Y+SP+ + + + D +S GV++
Sbjct: 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMM 197
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 32/220 (14%), Positives = 66/220 (30%), Gaps = 22/220 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR------LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ 529
+ LGEG F VY+ N Q+ +K + ++ +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEGIAQGL 587
++ + +L+ E +L + + +T E ++ G + + +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 588 LYLHQYSRLRVIHRDLKASNILL-----------DKDMNPKISDFGMARIFGGDELQSKT 636
+H +IH D+K N +L D + D G + +
Sbjct: 186 EQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
T G+ E ++ + D F + L
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 9e-27
Identities = 31/237 (13%), Positives = 73/237 (30%), Gaps = 54/237 (22%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSS---QSGQGQEEFKNEIKLIAKLQ--------- 529
LG+ + G+ V ++ K E+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 530 ----------------HRNLVRLLGCC--IELEEKILIYEYMPNKSLDFF--LFDSTKEN 569
+ ++R+ + + + +Y M + F L + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 570 -LLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
L R+++ + + L LH Y ++H L+ +I+LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 629 GDELQSKTKRIVGTYGYMSPEY-----------AQQGLFSIKSDVFSFGVLLLETLS 674
+ G+ PE ++ L + D ++ G+++
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIA 526
+ +LG G F V K R G E A K +S+ G +EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQ 585
++ H N++ L + +LI E + LFD ++ L I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 586 GLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARIFGGDELQSKTKRIVG 641
G+ YLH ++ H DLK NI+L + K+ DFG+A + K I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFG 180
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T +++PE +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 48/221 (21%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIA 526
++ +LG G F V K R G+E A K SS+ G +EE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---- 582
+++H N++ L + +LI E + LFD + E
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFD-------------FLAEKESLT 106
Query: 583 ----------IAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARIFG 628
I G+ YLH R+ H DLK NI+L + K+ DFG+A
Sbjct: 107 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ K I GT +++PE +++D++S GV+
Sbjct: 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIA 526
+ +LG G F V K R G E A K +S+ G +EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQ 585
++ H N++ L + +LI E + LFD ++ L I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 586 GLLYLHQYSRLRVIHRDLKASNILL-DKDMNP---KISDFGMARIFGGDELQSKTKRIVG 641
G+ YLH ++ H DLK NI+L DK++ K+ DFG+A + K I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFG 180
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T +++PE +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 25/184 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKN----EIKLIAKL 528
+ +GEG +G V K R G+ VA+K S + K EIKL+ +L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD----DKMVKKIAMREIKLLKQL 81
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPN---KSLDFFLFDSTKENLLGWGTRVRIIEGIAQ 585
+H NLV LL C + + L++E++ + L+ N L + + + I
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQVVQKYLFQIIN 135
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645
G+ + H + +IHRD+K NIL+ + K+ DFG AR + + T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWY 190
Query: 646 MSPE 649
+PE
Sbjct: 191 RAPE 194
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 48/221 (21%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGQEEFKNEIKLIA 526
+ T +LG G F V K R G + A K + SS+ G +E+ + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---- 582
++QH N++ L + ILI E + LFD + E
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFD-------------FLAEKESLT 112
Query: 583 ----------IAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARIFG 628
I G+ YLH L++ H DLK NI+L KI DFG+A
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ K I GT +++PE +++D++S GV+
Sbjct: 170 FGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQH 530
+ N+ + +LG+G F V + G E A K + S + ++ + E ++ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-------- 582
N+VRL E L+++ + LF+ I+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-------------DIVAREFYSEADA 107
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQ 633
I + + Y H ++HR+LK N+LL K K++DFG+A E
Sbjct: 108 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 162
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
GT GY+SPE ++ +S D+++ GV+L
Sbjct: 163 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN 532
F LG G F V+ + L G+ A+K + +NEI ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---------- 582
+V L L+ + + L FD RI+E
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FD-------------RILERGVYTEKDASL 110
Query: 583 ----IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSK 635
+ + YLH+ ++HRDLK N+L +++ I+DFG++++ + +
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST- 166
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
GT GY++PE Q +S D +S GV+
Sbjct: 167 ---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 45/221 (20%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQSGQGQEEF------------------ 518
+G+G +G V + A+K +L Q+G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 519 ---KNEIKLIAKLQHRNLVRLLGCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLG 572
EI ++ KL H N+V+L+ ++ + +Y E + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 573 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF-GGDE 631
+ + +G+ YLH ++IHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 632 LQSKTKRIVGTYGYMSPE--YAQQGLFS-IKSDVFSFGVLL 669
L S T VGT +M+PE + +FS DV++ GV L
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 56/244 (22%)
Query: 457 TRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS------- 508
TRD+ P S N+ + LG G V + +E AVK +
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 509 --SQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDS 565
+ + +E E+ ++ K+ H N+++L L+++ M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FD- 113
Query: 566 TKENLLGWGTRVRIIEG--------------IAQGLLYLHQYSRLRVIHRDLKASNILLD 611
+ E + + + LH+ L ++HRDLK NILLD
Sbjct: 114 ------------YLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLD 158
Query: 612 KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSF 665
DMN K++DFG + E K + + GT Y++PE + + D++S
Sbjct: 159 DDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 666 GVLL 669
GV++
Sbjct: 216 GVIM 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQSGQGQEEFKN---EIKLIA 526
+ST + LG G FG V+ +EV VK ++ + EI +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 527 KLQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ 585
+++H N++++L E + L+ E + LD F F L I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVS 141
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645
+ YL +IHRD+K NI++ +D K+ DFG A +L GT Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEY 195
Query: 646 MSPEYAQQGLFSIKS------DVFSFGVLL 669
+PE + +++S GV L
Sbjct: 196 CAPE-----VLMGNPYRGPELEMWSLGVTL 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 18/180 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN-----EIKLIAKLQ 529
+ +KLGEG + VYKG+ L VA+K + + EE E+ L+ L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE----HEEGAPCTAIREVSLLKDLK 58
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
H N+V L + L++EY+ D + N++ + + +GL Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
H+ +V+HRDLK N+L+++ K++DFG+AR ++ +V T Y P+
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPD 170
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 50/181 (27%), Positives = 73/181 (40%), Gaps = 19/181 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKN----EIKLIAKL 528
+ K+GEG +G V+K R GQ VA+K S K EI+++ +L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED----DPVIKKIALREIRMLKQL 59
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
+H NLV LL L++EY + + I Q +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
+ H++ IHRD+K NIL+ K K+ DFG AR+ + T Y SP
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRSP 171
Query: 649 E 649
E
Sbjct: 172 E 172
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 31/200 (15%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+G+G F V R +L G+EVA+K + + + ++ E++++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 540 CIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG--------IAQGLLYL 590
IE E+ + LI EY + FD + G R+ E I + Y
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAH----G---RMKEKEARSKFRQIVSAVQYC 130
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE- 649
H + R++HRDLKA N+LLD DMN KI+DFG + F G Y +PE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPEL 184
Query: 650 YAQQGLFSIKSDVFSFGVLL 669
+ + + DV+S GV+L
Sbjct: 185 FQGKKYDGPEVDVWSLGVIL 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHR-NLVRLL 537
+LG G F V + GQE A K + + + E +EI ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 538 GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR---VRIIEGIAQGLLYLHQYS 594
E ILI EY + F L + +R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 595 RLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
++H DLK NILL + KI DFGM+R G + + I+GT Y++PE
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 652 QQGLFSIKSDVFSFGVLL 669
+ +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 52/269 (19%), Positives = 89/269 (33%), Gaps = 55/269 (20%)
Query: 450 NKAANSRTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--- 505
+ +S + +F SL + + + +G+G +G V A+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 506 --RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC---------------IELEEKIL 548
++ + + E K E++L+ KL H N+ RL L +K+
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRV----------------------RIIEGIAQG 586
++ + + I+ I
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 587 LLYLHQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMARIFGGDEL--QSKTKRIVGT 642
L YLH + HRD+K N L +K K+ DFG+++ F GT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 643 YGYMSPEYAQQGLFSI--KSDVFSFGVLL 669
+++PE S K D +S GVLL
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQH 530
+ N+ + +LG+G F V + G E A K + S + ++ + E ++ KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-------- 582
N+VRL E L+++ + LF+ I+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-------------DIVAREFYSEADA 130
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQ 633
I + + Y H ++HR+LK N+LL K K++DFG+A E
Sbjct: 131 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
GT GY+SPE ++ +S D+++ GV+L
Sbjct: 186 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 55/227 (24%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------SQSGQGQEEFK 519
++ KLG G +G V + E A+K + + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 520 NEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRI 579
NEI L+ L H N+++L + + L+ E+ LF+ +I
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFE-------------QI 137
Query: 580 IEG--------------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFG 622
I I G+ YLH+ ++HRD+K NILL + +N KI DFG
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
++ F D K + +GT Y++PE + ++ K DV+S GV++
Sbjct: 195 LSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
LGEG +G V + + VAVK + ++ E K EI + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 541 IELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ--------GLLYLH 591
L EY L FD + + + E AQ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-Y 650
+ + HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 651 AQQGLFSIKSDVFSFGVLL 669
++ + DV+S G++L
Sbjct: 180 KRREFHAEPVDVWSCGIVL 198
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 53/225 (23%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------SQSGQGQEEFKNEIKL 524
+ LG G G V ++VA+K +S ++ + EI++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG-- 582
+ KL H ++++ + E+ ++ E M L FD +++
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FD-------------KVVGNKR 110
Query: 583 ------------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIF 627
+ + YLH +IHRDLK N+LL ++D KI+DFG ++I
Sbjct: 111 LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 628 GGDELQSKTKRIVGTYGYMSPE---YAQQGLFSIKSDVFSFGVLL 669
G L + + GT Y++PE ++ D +S GV+L
Sbjct: 168 GETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 25/170 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKN----EIKLIAKL 528
+ ++G G +G VYK R +G VA+K R+ + G G E+ L+ +L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALLRRL 68
Query: 529 Q---HRNLVRLL----GCCIELEEKI-LIYEYMPN--KSLDFFLFDSTKENLLGWGTRVR 578
+ H N+VRL+ + E K+ L++E++ ++ D L T
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY----LDKAPPPGLPAETIKD 124
Query: 579 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
++ +GL +LH ++HRDLK NIL+ K++DFG+ARI+
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 59/229 (25%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------SQSGQGQEEFKNEIKL 524
+ ++ +G G V + G E AVK + Q + +E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 525 IAKL-QHRNLVRLLGCCIELEEKILIY---EYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
+ ++ H +++ L+ E ++ + M L FD +
Sbjct: 153 LRQVAGHPHIITLIDSY---ESSSFMFLVFDLMRKGEL----FD-------------YLT 192
Query: 581 EG--------------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626
E + + + +LH ++HRDLK NILLD +M ++SDFG +
Sbjct: 193 EKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 627 FGGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSFGVLL 669
E K + + GT GY++PE + + D+++ GV+L
Sbjct: 250 LEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 54/188 (28%), Positives = 81/188 (43%), Gaps = 29/188 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN--------EIKLIA 526
+ KLGEG +G VYK + + VA+KR+ E + E+ L+
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLK 88
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
+LQHRN++ L LI+EY L ++ D + + + + G
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPD--VSMRVIKSFLYQLING 144
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNP-----KISDFGMARIFGGDELQSKTKRIVG 641
+ + H R +HRDLK N+LL KI DFG+AR F G ++ T I+
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII- 199
Query: 642 TYGYMSPE 649
T Y PE
Sbjct: 200 TLWYRPPE 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 44/225 (19%)
Query: 467 LASVSAA--TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNE 521
+A+++ T + +LG+G F V + +L GQE A + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 522 IKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE 581
++ L+H N+VRL E LI++ + LF+ I+
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFE-------------DIVA 103
Query: 582 G--------------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMA 624
I + +L+ HQ + V+HR+LK N+LL K K++DFG+A
Sbjct: 104 REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
Query: 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
G+ Q GT GY+SPE ++ + D+++ GV+L
Sbjct: 161 IEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 53/217 (24%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLS--------SQSGQGQEEFKNEIKLIAKLQHRN 532
LG G G V ++VA++ +S ++ + EI+++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---------- 582
++++ + E+ ++ E M L FD +++
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FD-------------KVVGNKRLKEATCKL 243
Query: 583 ----IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSK 635
+ + YLH+ +IHRDLK N+LL ++D KI+DFG ++I G L
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--- 297
Query: 636 TKRIVGTYGYMSPE---YAQQGLFSIKSDVFSFGVLL 669
+ + GT Y++PE ++ D +S GV+L
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 54/214 (25%), Positives = 82/214 (38%), Gaps = 38/214 (17%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGQEEFKNEIKLIAKL 528
+ LG GGFG VY G + + VA+K + E+ L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 529 QHR--NLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG--- 582
++RLL E + LI E P D LFD E R + E
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITE-------RGALQEELAR 152
Query: 583 -----IAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARIFGGDELQSKT 636
+ + + + H V+HRD+K NIL+D + K+ DFG +
Sbjct: 153 SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---- 205
Query: 637 KRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLL 669
GT Y PE+ + + + V+S G+LL
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC 540
LGEG +G V + + VAVK + ++ E K EI + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 541 IELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQ--------GLLYLH 591
L EY L FD + + + E AQ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-Y 650
+ + HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 651 AQQGLFSIKSDVFSFGVLL 669
++ + DV+S G++L
Sbjct: 180 KRREFHAEPVDVWSCGIVL 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 40/216 (18%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGQEEFKNEIKLIAKL 528
+ LG+GGFG V+ G L + +VA+K + E+ L+ K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 529 ----QHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG- 582
H ++RLL E +E L+ E P + D LFD E + + EG
Sbjct: 92 GAGGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQD--LFDYITE-------KGPLGEGP 140
Query: 583 -------IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDELQS 634
+ + + H V+HRD+K NIL+D K+ DFG + +
Sbjct: 141 SRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-- 195
Query: 635 KTKRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLL 669
GT Y PE+ + + + + V+S G+LL
Sbjct: 196 --TDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 28/199 (14%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG G FG V G L G +VAVK R +S + K EI+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG------IAQGLLYLH 591
I ++ EY+ L FD ++ RV +E I + Y H
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKH-----GRVEEMEARRLFQQILSAVDYCH 128
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-Y 650
R V+HRDLK N+LLD MN KI+DFG++ + E +T G+ Y +PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTS--CGSPNYAAPEVI 182
Query: 651 AQQGLFSIKSDVFSFGVLL 669
+ + + D++S GV+L
Sbjct: 183 SGRLYAGPEVDIWSCGVIL 201
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 41/198 (20%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKN----EIKLIAKL 528
+ K+G+G FG V+K R GQ+VA+K + ++ +E F EIK++ L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE----KEGFPITALREIKILQLL 73
Query: 529 QHRNLVRLLGCCIELEEKI--------LIYEYMPN--KSLDFFLFDSTKENLLGWGTRVR 578
+H N+V L+ C L++++ + L + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG----LLSNVLVKFT-----LS 124
Query: 579 IIEGIAQ----GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG---GDE 631
I+ + Q GL Y+H+ +++HRD+KA+N+L+ +D K++DFG+AR F +
Sbjct: 125 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 632 LQSKTKRIVGTYGYMSPE 649
T R+V T Y PE
Sbjct: 182 PNRYTNRVV-TLWYRPPE 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 33/173 (19%)
Query: 476 NFSTENKLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQGQEEFKN--------EIKLI 525
+ ++GEG +G V+K R G+ VA+KR+ + + E+ ++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVL 65
Query: 526 AKLQ---HRNLVRLL----GCCIELEEKI-LIYEYMPN--KSLDFFLFDSTKENLLGWGT 575
L+ H N+VRL + E K+ L++E++ + D E + T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGVPTET 121
Query: 576 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628
++ + +GL +LH + RV+HRDLK NIL+ K++DFG+ARI+
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 36/191 (18%)
Query: 482 KLGEGGFGPVYKGR---LLNGQEVAVKRLS----SQSGQGQEEFKNEIKLIAKLQHRNLV 534
K+G G +G VYK + + ++ A+K++ S S EI L+ +L+H N++
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVI 81
Query: 535 RLLGCCIE-LEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG--------IA 584
L + + K+ L+++Y D + V++ G I
Sbjct: 82 SLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMARIFG--GDELQSKTKR 638
G+ YLH V+HRDLK +NIL+ + KI+D G AR+F L
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 639 IVGTYGYMSPE 649
+V T+ Y +PE
Sbjct: 196 VV-TFWYRAPE 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 54/236 (22%), Positives = 89/236 (37%), Gaps = 54/236 (22%)
Query: 468 ASVSAATANFS-----TENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNE 521
S + + F E+ LGEG V L+ QE AVK + Q G + E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 522 IKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
++++ + Q HRN++ L+ E + L++E M S+ I
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LS-------------HIH 103
Query: 581 E--------------GIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 623
+ +A L +LH + HRDLK NIL ++ KI DF +
Sbjct: 104 KRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160
Query: 624 ARIF-----GGDELQSKTKRIVGTYGYMSPE-----YAQQGLFSIKSDVFSFGVLL 669
+ G+ YM+PE + ++ + D++S GV+L
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKN-EIKLIAKLQHRN 532
++ +G G FG V++ +L+ EVA+K++ + FKN E++++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 533 LVRLLGCCIELEEKI------LIYEYMPNKSLDFFLFDSTKENLLGWGTRVR-IIEGIAQ 585
+V L +K L+ EY+P +++ K ++ + + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDE 631
L Y+H + + HRD+K N+LLD K+ DFG A+I E
Sbjct: 153 SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LGEG FG V Q+VA+K R + + EI + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFD-STKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
I I ++ EY + LFD ++ + R + I + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RH 127
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-YAQQGL 655
+++HRDLK N+LLD ++N KI+DFG++ I + G+ Y +PE +
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVINGKLY 184
Query: 656 FSIKSDVFSFGVLL 669
+ DV+S G++L
Sbjct: 185 AGPEVDVWSCGIVL 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 28/199 (14%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG G FG V G+ L G +VAVK L+ Q S + + EI+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG------IAQGLLYLH 591
I I ++ EY+ L FD +N R+ E I G+ Y H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKN-----GRLDEKESRRLFQQILSGVDYCH 133
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-Y 650
R V+HRDLK N+LLD MN KI+DFG++ + E +T G+ Y +PE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTS--CGSPNYAAPEVI 187
Query: 651 AQQGLFSIKSDVFSFGVLL 669
+ + + D++S GV+L
Sbjct: 188 SGRLYAGPEVDIWSSGVIL 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN-EIKLIAKLQHR 531
+++ +G G FG VY+ +L +G+ VA+K++ + FKN E++++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 532 NLVRLLGCCIELEEKI------LIYEYMPNKSLDFFLFDSTKENLLGWGTRVR-IIEGIA 584
N+VRL EK L+ +Y+P +++ ++ V+ + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARIFGGDE 631
+ L Y+H + HRD+K N+LLD D K+ DFG A+ E
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 47/209 (22%), Positives = 81/209 (38%), Gaps = 40/209 (19%)
Query: 479 TENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRL 536
++ LG G G V + GQ+ A+K L + + E+ + ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 537 LGCCIELEEKILIYEYMPNKSLDFF----------LFDSTKENLLGWGTR---VRIIEGI 583
L +YE M + LF +E T I+ I
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSKTKRIV 640
+ +LH + HRD+K N+L +KD K++DFG A+ + LQ+
Sbjct: 138 GTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PC 190
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T Y++PE + D++S GV++
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 43/214 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN 532
+ F E++LG G VY+ + + A+K L ++ + EI ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPN 109
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---------- 582
+++L E L+ E + L FD RI+E
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-------------RIVEKGYYSERDAAD 152
Query: 583 ----IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSK 635
I + + YLH+ ++HRDLK N+L D KI+DFG+++I
Sbjct: 153 AVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---L 206
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
K + GT GY +PE + + + D++S G++
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 46/216 (21%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHR 531
T + + +G G + + E AVK + EE I+++ + QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHP 76
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE---------- 581
N++ L + + ++ E M L D +I+
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL----LD-------------KILRQKFFSEREAS 119
Query: 582 ----GIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP---KISDFGMARIFGGDELQ 633
I + + YLH V+HRDLK SNIL D+ NP +I DFG A+ +
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T T +++PE ++ + D++S GVLL
Sbjct: 177 LMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 44/211 (20%)
Query: 478 STENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVR 535
+ LGEG F K + Q AVK +S + + + EI + + H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE-------------- 581
L + L+ E + LF+ RI +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGE----LFE-------------RIKKKKHFSETEASYIMR 113
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSKTKR 638
+ + ++H + V+HRDLK N+L + ++ KI DFG AR+ D KT
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T Y +PE Q + D++S GV+L
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 483 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEF-KNEIKLIAKLQHRNLVRLLG 538
LGEG F V R L +E A+K L + + + + E ++++L H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFL-----FDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ +EK+ Y N L ++ FD T TR E I L YLH
Sbjct: 98 TF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVSALEYLHG 148
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+IHRDLK NILL++DM+ +I+DFG A++ + Q++ VGT Y+SPE
Sbjct: 149 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+ SD+++ G ++ + ++
Sbjct: 206 EKSACKSSDLWALGCIIYQLVA 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-21
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG GGFG V+ ++ ++ A K+L+ + +G + E K++AK+ R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRI-IEGIAQGLLYLHQYSRL 596
E + + L+ M + + +++ ++N R I GL +LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+I+RDLK N+LLD D N +ISD G+A + +KTK GT G+M+PE +
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEY 366
Query: 657 SIKSDVFSFGVLLLETL 673
D F+ GV L E +
Sbjct: 367 DFSVDYFALGVTLYEMI 383
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 36/202 (17%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+G G FG R L + VAVK + + E + EI L+H N+VR I
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKE-VI 85
Query: 542 ELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVR----------IIEGIAQGLLYL 590
+ +I EY L++ R ++ G++ Y
Sbjct: 86 LTPTHLAIIMEYASGGE----LYERICNA-----GRFSEDEARFFFQQLLSGVS----YC 132
Query: 591 HQYSRLRVIHRDLKASNILLDKD--MNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
H +++ HRDLK N LLD KI DFG ++ K+ VGT Y++P
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KST--VGTPAYIAP 186
Query: 649 E-YAQQGLFSIKSDVFSFGVLL 669
E +Q +DV+S GV L
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTL 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGFG V ++ ++ A K+L + +G+ NE +++ K+ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
E ++ + L+ M L F ++ + E I GL LH R R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RER 306
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+++RDLK NILLD + +ISD G+A + K VGT GYM+PE + ++
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 363
Query: 658 IKSDVFSFGVLLLETL 673
D ++ G LL E +
Sbjct: 364 FSPDWWALGCLLYEMI 379
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 44/189 (23%), Positives = 71/189 (37%), Gaps = 55/189 (29%)
Query: 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN----EIKLIAKL 528
F E G+G FG V G+ G VA+K++ F+N ++ +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVL 76
Query: 529 QHRNLVRLLGCCIELEEK-------ILIYEYMP-------------NKSLD-----FFLF 563
H N+V+L L E+ ++ EY+P + FLF
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 564 DSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFG 622
+ + + LH S + V HRD+K N+L+++ K+ DFG
Sbjct: 137 Q------------------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 623 MARIFGGDE 631
A+ E
Sbjct: 178 SAKKLSPSE 186
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 41/216 (18%), Positives = 77/216 (35%), Gaps = 53/216 (24%)
Query: 479 TENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRL 536
T LG G G V + ++ A+K L + + E++L + ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 537 LGCC---IELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG---------- 582
+ + + ++ E + L F RI +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FS-------------RIQDRGDQAFTEREA 163
Query: 583 ------IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQ 633
I + + YLH + + HRD+K N+L + K++DFG A+
Sbjct: 164 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-- 218
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T Y++PE + D++S GV++
Sbjct: 219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 6e-20
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGQEEFKNE---IKLIAKLQHRNLVR 535
+G GGFG VY R + ++ A+K L + QG+ NE + L++ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 536 LLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRI-IEGIAQGLLYLH 591
+ +K+ I + M L + L E +R I GL ++H
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------DMRFYAAEIILGLEHMH 309
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
V++RDLK +NILLD+ + +ISD G+A F K VGT+GYM+PE
Sbjct: 310 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVL 362
Query: 652 QQGLFSIKS-DVFSFGVLLLETL 673
Q+G+ S D FS G +L + L
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLL 385
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 8e-19
Identities = 45/137 (32%), Positives = 69/137 (50%), Gaps = 11/137 (8%)
Query: 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598
+EEK L D + T E+L+ + + +A+G+ +L + +
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKC 214
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAR-IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
IHRDL A NILL + KI DFG+AR I+ + K + +M+PE +++
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYT 273
Query: 658 IKSDVFSFGVLLLETLS 674
I+SDV+SFGVLL E S
Sbjct: 274 IQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 32/159 (20%), Positives = 54/159 (33%), Gaps = 19/159 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQG-QEEFKNEIKLIAKL 528
LG G FG V + + VAVK L + +E+K++ +
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 529 -QHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
H N+V LLG C + + +I E+ +L +L R + +G
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKG 132
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
+ + I DLK + + S F +
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 33/286 (11%), Positives = 75/286 (26%), Gaps = 53/286 (18%)
Query: 482 KLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRL 536
G ++ L ++VA+ + Q +E + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRL 596
L +++ E++ SL + +R ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
V S + + D + ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 657 SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASY 716
+ + D+ G L L ++ L D ID + + S
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLP-EAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 717 LILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAF 762
+ VQ D R +++++ T
Sbjct: 239 VAAR--------SVQGDGGIRSAS-TLLNLMQQATAVADRTEVLGP 275
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 57/209 (27%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+ + +G G +G V + L + VA+K++ F++ EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 524 LIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMP---------NKSLD-----FFLFD 564
++ +L H ++V++L I + +E ++ E L L+
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163
Query: 565 STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
NLL G+ Y+H S ++HRDLK +N L+++D + K+ DFG+A
Sbjct: 164 ----NLL-------------VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
R E + I M+
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HR 531
++ KLG G + V++ + N ++V VK L +++ K EIK++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 532 NLVRLLGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVR-IIEGIAQGLL 588
N++ L + + L++E++ N T + +R + I + L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD-------IRFYMYEILKALD 144
Query: 589 YLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
Y H S ++HRD+K N+++D + ++ D+G+A Q R+ Y +
Sbjct: 145 YCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKG 198
Query: 648 PE---YAQQGLFSIKSDVFSFGVLLLETLSSKR 677
PE Q +S+ D++S G +L + K
Sbjct: 199 PELLVDYQMYDYSL--DMWSLGCMLASMIFRKE 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 44/247 (17%), Positives = 92/247 (37%), Gaps = 57/247 (23%)
Query: 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKN-EIKLIAKLQHR 531
+ +S LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV-------------- 577
N+++L+ ++ P+ ++ N
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 578 -----RIIEG-------------------IAQGLLYLHQYSRLRVIHRDLKASNILLD-K 612
++++ + + + ++H L + HRD+K N+L++ K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 613 DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY---AQQGLFSIKSDVFSFGVLL 669
D K+ DFG A+ + I + Y +PE A + ++ D++S G +
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGCVF 232
Query: 670 LETLSSK 676
E + K
Sbjct: 233 GELILGK 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEE---FKNEIKLIAKLQHRNLVRLLG 538
+G G FG V +L N +V A+K L+ + E F+ E ++ + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ + + L+ +Y L L ++ L R + E + + +HQ L
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQ---LH 195
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-----YAQ 652
+HRD+K NIL+D + + +++DFG D ++ VGT Y+SPE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGG 254
Query: 653 QGLFSIKSDVFSFGVLLLETL 673
+G + + D +S GV + E L
Sbjct: 255 KGRYGPECDWWSLGVCMYEML 275
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 49/231 (21%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEE--FKN---------EI 522
+ ++ + + G +G V G G VA+KR+ + G+ + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 523 KLIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMPN------KSLDFFLFDSTKENLL 571
+L+ H N++ L + + + L+ E M +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ------ 134
Query: 572 GWGTRVR-IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630
++ + I GL LH+ V+HRDL NILL + + I DF +AR D
Sbjct: 135 ----HIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
++ V Y +PE + K D++S G ++ E + K
Sbjct: 188 ANKTHY---VTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 19/203 (9%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEE---FKNEIKLIAKLQHRNLVRLLG 538
+G G F V ++ +V A+K ++ + E F+ E ++ R + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597
+ E + L+ EY L L E + R + E I + +H+ L
Sbjct: 128 FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDSVHR---LG 182
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-------Y 650
+HRD+K NILLD+ + +++DFG D ++ VGT Y+SPE
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 651 AQQGLFSIKSDVFSFGVLLLETL 673
G + + D ++ GV E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMF 264
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+ +G G G V + + VA+K+LS F+N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV 577
L+ + H+N++ LL E ++ ++ E M D L + L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMEL----DHE 127
Query: 578 RIIEGIAQ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634
R+ + Q G+ +LH +IHRDLK SNI++ D KI DFG+AR G + +
Sbjct: 128 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
Query: 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
V T Y +PE + D++S G ++ E +
Sbjct: 185 PY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKN---EIKLIAKLQHRNLVRLLG 538
+G+G FG V + + +++ A+K ++ Q + E +N E++++ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVR--IIEGIAQGLLYLHQY 593
+ EE + ++ + + L + L + E V+ I E + L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE------TVKLFICE-LVMALDYLQN- 133
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE--YA 651
R+IHRD+K NILLD+ + I+DF +A + + + + GT YM+PE +
Sbjct: 134 --QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSS 188
Query: 652 QQGLFSIKS-DVFSFGVLLLETLSSKR 677
++G + D +S GV E L +R
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 41/210 (19%), Positives = 78/210 (37%), Gaps = 57/210 (27%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
N+ ++ +G G +G VY + VA+K+++ F++ EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 524 LIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMP---------NKSLD-----FFLFD 564
++ +L+ ++RL I + +E ++ E L L+
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136
Query: 565 STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
NLL G ++H +IHRDLK +N LL++D + K+ DFG+A
Sbjct: 137 ----NLL-------------LGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R ++ + + +
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+ +G G G V + + VA+K+LS F+N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV 577
L+ + H+N++ LL E ++ L+ E M L + L R+
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMEL--DHERM 166
Query: 578 R-IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT 636
++ + G+ +LH +IHRDLK SNI++ D KI DFG+AR G + +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
V T Y +PE + D++S G ++ E + K
Sbjct: 224 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 60/205 (29%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+++F ++ LGEG +G V G+ VA+K++ F EIK
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 524 LIAKLQHRNLVRLL-----GCCIELEEKILIYEYMP--------NKSLD-----FFLFDS 565
++ +H N++ + E +I E M + L +F++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 566 TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
+ + LH + VIHRDLK SN+L++ + + K+ DFG+AR
Sbjct: 121 -----------------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 626 IFGGDELQSKTKRIVGTYGYMSPEY 650
I DE + G M E+
Sbjct: 161 II--DESAADNSEPTGQQSGMV-EF 182
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 69/238 (28%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
++ + +GEG +G V LN VA+K++S F++ EIK
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 524 LIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMP--------NKSLD-----FFLFDS 565
++ + +H N++ + ++++ ++ + M + L +FL+
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 566 TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
I +GL Y+H S V+HRDLK SN+LL+ + KI DFG+AR
Sbjct: 137 -----------------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 626 IFGGDELQSK--TKRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
+ D + T+ V T Y +PE + + K D++S G +L E LS++
Sbjct: 177 VADPDHDHTGFLTEY-VATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 48/225 (21%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+ + +G G +G V +G++VA+K+LS F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV 577
L+ +QH N++ LL + L+ +M D L ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---D--LQKIMGLKFS--EEKI 128
Query: 578 R-IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT 636
+ ++ + +GL Y+H V+HRDLK N+ +++D KI DFG+AR + T
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MT 181
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
V T Y +PE + S D++S G ++ E L+ K
Sbjct: 182 GY-VVTRWYRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLS----SQSGQGQEEFKNEIKLIAKLQH 530
F LG G FG V + +G A+K L + Q E NE +++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNF 100
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLL 588
LV+L + ++ EY+ + L + E R + I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH----ARFYAAQ-IVLTFE 155
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
YLH +I+RDLK N+L+D+ +++DFG A+ ++ +T + GT ++P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAP 207
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E ++ D ++ GVL+ E +
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEE---FKNEIKLIAKLQHRNLVRLLG 538
+G G FG V R + ++V A+K LS + + F E ++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
+ + + ++ EYMP L L + E R E + L +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKW----ARFYTAE-VVLALDAIHS--- 186
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ--- 652
+ IHRD+K N+LLDK + K++DFG + + VGT Y+SPE +
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQG 245
Query: 653 -QGLFSIKSDVFSFGVLLLETL 673
G + + D +S GV L E L
Sbjct: 246 GDGYYGRECDWWSVGVFLYEML 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 23/201 (11%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEF---KNEIKLIAKLQHRNLVRLLG 538
LG+G FG V + A+K L + ++E E +++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRI-IEGIAQGLLYLHQYS 594
+ +++ + EY L F L E+ R R I L YLH S
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALDYLH--S 266
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQ 652
V++RDLK N++LDKD + KI+DFG+ + I G K GT Y++PE +
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----TMKTFCGTPEYLAPEVLE 322
Query: 653 QGLFSIKSDVFSFGVLLLETL 673
+ D + GV++ E +
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMM 343
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 34/207 (16%)
Query: 483 LGEGGFGPVYKGRLLNGQEV----AVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG V+ + ++G + A+K L + + + K E ++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDFF------LFDSTKENLLGWGTRVRI-IEGIAQGLL 588
+ E K+ LI +++ L F +F E V+ + +A L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFT---EE------DVKFYLAELALALD 140
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYM 646
+LH L +I+RDLK NILLD++ + K++DFG+++ I K GT YM
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK----KAYSFCGTVEYM 193
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETL 673
+PE + + +D +SFGVL+ E L
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 57/248 (22%), Positives = 95/248 (38%), Gaps = 80/248 (32%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+ + LG GG G V+ + VA+K++ + EIK
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 524 LIAKLQHRNLVRLL--------------GCCIELEEKILIYEYMP--------NKSLD-- 559
+I +L H N+V++ G EL ++ EYM L
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 560 ---FFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMN 615
F++ + +GL Y+H + V+HRDLK +N+ ++ +D+
Sbjct: 121 HARLFMYQ------------------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159
Query: 616 PKISDFGMARIFGGDELQSK--TKRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVL 668
KI DFG+ARI ++ +V T Y SP L S + D+++ G +
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCI 214
Query: 669 LLETLSSK 676
E L+ K
Sbjct: 215 FAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 31/173 (17%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
A + +G G +G V G +VA+K+L F++ E++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV 577
L+ ++H N++ LL + + L+ +M L K LG
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131
Query: 578 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630
++ + +GL Y+H +IHRDLK N+ +++D KI DFG+AR +
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 35/164 (21%), Positives = 63/164 (38%), Gaps = 36/164 (21%)
Query: 479 TENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRL 536
T LG G G V + ++ A+K L + + E++L + Q ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 537 LGCCIELEEKILIYEYMPNKSLDFF----------LFDSTKENLLGWGTR---VRIIEGI 583
+ +YE + LF ++ T I++ I
Sbjct: 77 VD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMA 624
+ + YLH + + HRD+K N+L + K++DFG A
Sbjct: 127 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 54/208 (25%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+ KLG+G +G V+K G+ VAVK++ + F+N EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 524 LIAKLQ-HRNLVRLLGCCI--ELEEKILIYEYMP--------NKSLD-----FFLFDSTK 567
++ +L H N+V LL + L+++YM L+ + ++
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY---- 116
Query: 568 ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627
L+ + + YLH S ++HRD+K SNILL+ + + K++DFG++R F
Sbjct: 117 -QLI-------------KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+ + + + Q L
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPIL 187
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 1e-13
Identities = 36/199 (18%), Positives = 58/199 (29%), Gaps = 46/199 (23%)
Query: 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRL--------SSQSGQGQEEFKNEIKL 524
T K+GEG FG V++ + VA+K + + + EE EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 525 IAKLQ---------HRNLVRLLGCCI----ELEEKILIYEYM------PNKSLDFF---- 561
+L + L + +++ N DFF
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 562 ------------LFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609
+ + L T I+ + L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 610 LDKDMNPKISDFGMARIFG 628
L K K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEF---KNEIKLIAKLQHRNLVRLLG 538
LG+G FG V R A+K L + ++E E +++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRI-IEGIAQGLLYLHQYS 594
+ +++ + EY L F L E R R I L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIVSALEYLHS-- 123
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYAQ 652
V++RD+K N++LDKD + KI+DFG+ + I G K GT Y++PE +
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLE 178
Query: 653 QGLFSIKSDVFSFGVLLLETL 673
+ D + GV++ E +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMM 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 21/199 (10%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS--GQGQEE-FKNEIKLIAKLQHRNLVRLLG 538
LG G FG V+ R + A+K L + Q E +E +++ + H ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 539 CCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
+ ++I +I +Y+ L L S + + + E + L YLH
Sbjct: 74 TF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----AKFYAAE-VCLALEYLHSKD- 126
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+I+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKP 179
Query: 656 FSIKSDVFSFGVLLLETLS 674
++ D +SFG+L+ E L+
Sbjct: 180 YNKSIDWWSFGILIYEMLA 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 483 LGEGGFGPVYKGRLLNGQEV----AVKRLS----SQSGQGQEEFKNEIKLIAKLQHRNLV 534
LG+GG+G V++ R + G A+K L ++ + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDFF------LFDSTKENLLGWGTRVRI-IEGIAQG 586
L+ + K+ LI EY+ L F +F E+ + I+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFM---ED------TACFYLAEISMA 133
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYG 644
L +LHQ +I+RDLK NI+L+ + K++DFG+ + I G T GT
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHTFCGTIE 186
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
YM+PE + + D +S G L+ + L
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 31/168 (18%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKN---------EIK 523
+ + +G G +G V G VAVK+LS F++ E++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRV 577
L+ ++H N++ LL E + L+ M D L + K L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQKLTDDHVQ 135
Query: 578 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625
+I I +GL Y+H +IHRDLK SN+ +++D KI DFG+AR
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 45/212 (21%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKNEIK--------------LIAK 527
LG+G FG V E+ AVK L K+ + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILK----------KDVVIQDDDVECTMVEKRVLALP 77
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEG-I 583
+ L +L C + +++ + EY+ L + + + E I
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEI 130
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVG 641
A GL +L +I+RDLK N++LD + + KI+DFGM + I+ G TK G
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCG 183
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
T Y++PE + D ++FGVLL E L
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 45/212 (21%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKNEIK--------------LIAK 527
LG+G FG V R+ ++ AVK L K+ I L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLK----------KDVILQDDDVECTMTEKRILSLA 80
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEG-I 583
H L +L CC + +++ + E++ L F + S + E R R I
Sbjct: 81 RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEI 133
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA--RIFGGDELQSKTKRIVG 641
L++LH +I+RDLK N+LLD + + K++DFGM I G T G
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV----TTATFCG 186
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
T Y++PE Q+ L+ D ++ GVLL E L
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 25/203 (12%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEF---KNEIK-LIAKLQHRNLVRLL 537
+G G + V RL + A+K + + E+ + E H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRI-IEGIAQGLLYLHQY 593
C + E ++ + EY+ L F + K E R I+ L YLH+
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE- 128
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYA 651
+I+RDLK N+LLD + + K++D+GM + + GD T GT Y++PE
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEIL 182
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
+ + D ++ GVL+ E ++
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMA 205
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEF---KNEIK-LIAKLQHRNLVRLL 537
+G+G FG V R + AVK L ++ ++E +E L+ ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFF------LFDSTKENLLGWGTRVRI-IEGIAQGLLY 589
+ +K+ + +Y+ L F+ F E R R IA L Y
Sbjct: 106 -FSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EP------RARFYAAEIASALGY 154
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMS 647
LH L +++RDLK NILLD + ++DFG+ + I T GT Y++
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYLA 207
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETL 673
PE + + D + G +L E L
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 25/202 (12%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKNEIK----LIAKLQHRNLVRLL 537
LG+G FG V+ + A+K L ++ + + L +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFL--FDSTKENLLGWGTRVRIIEG-IAQGLLYLHQY 593
C + +E + + EY+ L + + + R I GL +LH
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIILGLQFLHS- 136
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYA 651
+++RDLK NILLDKD + KI+DFGM + + G KT GT Y++PE
Sbjct: 137 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYIAPEIL 190
Query: 652 QQGLFSIKSDVFSFGVLLLETL 673
++ D +SFGVLL E L
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEML 212
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 45/212 (21%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEFKNEIK--------------LIAK 527
LG+G FG V E+ AVK L K+ + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK----------KDVVIQDDDVECTMVEKRVLALP 398
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEG-I 583
+ L +L C + +++ + EY+ L + + + E I
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEI 451
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVG 641
A GL +L +I+RDLK N++LD + + KI+DFGM + I+ G TK G
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCG 504
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
T Y++PE + D ++FGVLL E L
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGT 642
I L +LH+ L +I+RD+K NILLD + + ++DFG+++ F DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGT 223
Query: 643 YGYMSPE---YAQQGLFSIKSDVFSFGVLLLETL 673
YM+P+ G D +S GVL+ E L
Sbjct: 224 IEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELL 256
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 25/203 (12%)
Query: 483 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGQEEF---KNEIK-LIAKLQHRNLVRLL 537
+G G + V RL + A++ + + E+ + E H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 538 GCCIELEEKI-LIYEYMPNKSLDFFLFDSTK--ENLLGWGTRVRIIEG-IAQGLLYLHQY 593
C + E ++ + EY+ L F + K E R I+ L YLH+
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE- 171
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAR--IFGGDELQSKTKRIVGTYGYMSPEYA 651
+I+RDLK N+LLD + + K++D+GM + + GD T GT Y++PE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEIL 225
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
+ + D ++ GVL+ E ++
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMA 248
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 20/183 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH-RNL 533
+ K+G G FG +Y G + G+EVA+K ++ Q E K+ +Q +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGI 67
Query: 534 VRLLGCCIELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ C E + +++ E + SL D F F S K +L T + + + + + Y+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL---KTVLLLADQMISRIEYIHS 123
Query: 593 YSRLRVIHRDLKASNILLDKDMNPK---ISDFGMARIFGGDE-----LQSKTKRIVGTYG 644
+ IHRD+K N L+ I DFG+A+ + + K + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 645 YMS 647
Y S
Sbjct: 181 YAS 183
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 20/183 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
F K+G G FG +Y G + +EVA+K + ++ Q E K+ LQ +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGI 65
Query: 535 -RLLGCCIELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ +E + +L+ + + SL D F F S K +L T + + + + + ++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHS 121
Query: 593 YSRLRVIHRDLKASNILLDKDMNPK---ISDFGMARIFGGDELQS-----KTKRIVGTYG 644
S +HRD+K N L+ I DFG+A+ + + K + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 645 YMS 647
Y S
Sbjct: 179 YAS 181
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 44/185 (23%), Positives = 76/185 (41%), Gaps = 22/185 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH-RNL 533
NF K+G G FG + G+ L + VA+K +S Q E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGI 67
Query: 534 VRLLGCCIELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
++ + ++ E + SL D F +L T + I + + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL---KTVLMIAIQLISRMEYVHS 123
Query: 593 YSRLRVIHRDLKASNILLDKDMNPK-----ISDFGMARIFGGDELQS-----KTKRIVGT 642
+ +I+RD+K N L+ + N I DF +A+ + E + + K + GT
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 643 YGYMS 647
YMS
Sbjct: 181 ARYMS 185
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 54/223 (24%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ----------- 529
KLG G F V+ + ++N VA+K + E ++EIKL+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 530 HRNLVRLLGC-----------CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVR 578
++++LL + E L L K+ G +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE------------VLGENLLALIKKYEHR-GIPLI 131
Query: 579 IIEGIAQ----GLLYLHQYSRLRVIHRDLKASNILLDKDMNP------KISDFGMARIFG 628
++ I++ GL Y+H R +IH D+K N+L++ +P KI+D G A +
Sbjct: 132 YVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWY 188
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+ + + T Y SPE + +D++S L+ E
Sbjct: 189 DEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 41/185 (22%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH-RNL 533
++ ++GEG FG +++G LLN Q+VA+K +S Q ++E + L +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 68
Query: 534 VRLLGCCIELEEKILIYEYMPNKSL-DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ E +L+ + + SL D K ++ T + + + +H+
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV---KTVAMAAKQMLARVQSIHE 124
Query: 593 YSRLRVIHRDLKASNILLDKDMNPK-----ISDFGMARIFGGDE-----LQSKTKRIVGT 642
S +++RD+K N L+ + + + DFGM + + + K + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 643 YGYMS 647
YMS
Sbjct: 182 ARYMS 186
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 49/216 (22%), Positives = 81/216 (37%), Gaps = 50/216 (23%)
Query: 481 NKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIAKLQHR-- 531
+ +G+G FG V K + + VA+K +Q+ + E++L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLELMNKHDT 112
Query: 532 ----NLVRLLGC-------CIELEEKILIYEYMPNKSLDFFLFDSTKEN-LLGWGTR-VR 578
+V L C+ E L + L+D + G R
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFE------------MLSYNLYDLLRNTNFRGVSLNLTR 160
Query: 579 II-EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGMARIFGGDELQSK 635
+ + LL+L L +IH DLK NILL KI DFG + G +
Sbjct: 161 KFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ- 217
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+ + Y SPE + + D++S G +L+E
Sbjct: 218 ---YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-10
Identities = 22/128 (17%), Positives = 42/128 (32%), Gaps = 19/128 (14%)
Query: 26 DNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFD 85
++++ + G L + L + Y VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52
Query: 86 SNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYL 145
L N G LV+ +Q+N IW + + + + V L N+V+ +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQSFDHPS 153
W + P+
Sbjct: 103 WATGSGPA 110
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 29/200 (14%), Positives = 73/200 (36%), Gaps = 34/200 (17%)
Query: 476 NFSTENKLGEGGFGPVYKGR---------LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIA 526
+ ++ G +Y+ Q+ ++K L ++ G+ E +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 527 KLQHRNLVRLLGC---CI---------ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWG 574
LQ +L I + + + L+ + +SL D + +++L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159
Query: 575 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMARIF--GGD 630
+ +++ + L +LH+ +H ++ A NI +D + ++ + +G A + G
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 631 EL---QSKTKRIVGTYGYMS 647
+ + G ++S
Sbjct: 217 HVAYVEGSRSPHEGDLEFIS 236
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-09
Identities = 20/126 (15%), Positives = 42/126 (33%), Gaps = 19/126 (15%)
Query: 26 DNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFD 85
+ +T + G+ L + + Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYD--HSTSVWASNTGILG-K 50
Query: 86 SNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYL 145
+ + G V+ + ++W+S+ R N V L + GN+V+ + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DI 102
Query: 146 WQSFDH 151
W + +
Sbjct: 103 WSTGTY 108
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 60/218 (27%)
Query: 483 LGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIAKLQHR---- 531
+G+G FG V K Q VA+K R Q+ EI+++ L+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLRKQDKDN 157
Query: 532 --NLVRLLGC-------CIELEEKILIYEYMPNKSLDFFLFDSTKEN-LLGWGTR-VRII 580
N++ +L C+ E L L++ K+N G+ VR
Sbjct: 158 TMNVIHMLENFTFRNHICMTFE------------LLSMNLYELIKKNKFQGFSLPLVRKF 205
Query: 581 -EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGMARIFGGDELQSKTK 637
I Q L LH + R+IH DLK NILL + K+ DFG +
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEH 253
Query: 638 RIVGTY----GYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+ V TY Y +PE + + D++S G +L E
Sbjct: 254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 37/201 (18%), Positives = 75/201 (37%), Gaps = 36/201 (17%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQ------EVAVKRLSSQSGQGQEEFKNEIKL----- 524
+ +G+GGFG +Y + + + VK S +G E K +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 525 IAKLQHRNLVRLLG----------CCIELEEKILIYEYMPNKSL-DFFLFDSTKENLLGW 573
I K ++ LG + +I + L + ++ + +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR--- 151
Query: 574 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMARIFGGDE 631
T +++ I L Y+H++ +H D+KASN+LL+ ++ D+G+A + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 632 L-----QSKTKRIVGTYGYMS 647
+ + GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-08
Identities = 19/123 (15%), Positives = 38/123 (30%), Gaps = 20/123 (16%)
Query: 26 DNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFD 85
+ + + + L + + L + + Y+ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50
Query: 86 SNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYL 145
S LT+ + G LV+ + N +W S + L G V+ L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-08
Identities = 26/124 (20%), Positives = 48/124 (38%), Gaps = 18/124 (14%)
Query: 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIF 84
+D + + G L + + L ++ + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48
Query: 85 DSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDY 144
S VL + N G LV+ + + IW+SN +R+ N L N+V+ D +S +
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD-----NSNNA 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 3e-08
Identities = 89/677 (13%), Positives = 175/677 (25%), Gaps = 228/677 (33%)
Query: 151 HPSDTLLAGMKLGW-DLKTGLERYQTSWKSD-------DDPSPGNYTHRLDIHVLPKLCT 202
H D + + D+ L ++ ++ + D P +D H++
Sbjct: 5 HHMDFETGEHQYQYKDI---LSVFEDAFVDNFDCKDVQDMPKSILSKEEID-HIIMSKDA 60
Query: 203 YNGSVKL---LCSGPWNGA-IF---AAIPSYSYLYKPTVVDNEDE-------IYYRYDSY 248
+G+++L L S F +Y +L P + I R Y
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 249 NSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSL-PDRFCQFYGH--CG----ANSICSF 301
N + K N S R A L P + G G A +C
Sbjct: 121 NDNQVFA-KYNVS--RLQPYLKLRQ----ALLELRPAKNVLIDGVLGSGKTWVALDVCL- 172
Query: 302 DKKPHC------------ECLKGFEL------------KSHHNKTRPGTCVRSQSSDCKS 337
K C C + + +++ + ++ + ++
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 338 GDRFIM-----------LDDVKLPDFVEASLNESMNVKECEAECLKNCTCRAYANSKVTG 386
R ++ L +V+ A N+ C+
Sbjct: 233 ELRRLLKSKPYENCLLVLLNVQNAKAWNA-----FNLS-----------CKI-------- 268
Query: 387 EGSGCLMWFGDLI---DIRKADDRNNGQSIYIRV--PASELETKKSQDMLQFDINMSIAT 441
L+ + D + + +I + + L + + +L ++
Sbjct: 269 -----------LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 442 RANELCKGNKAANSRTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQE 501
E+ N P L+ ++ +
Sbjct: 318 LPREVLTTN------------P-RRLSIIAESI--------------------------- 337
Query: 502 VAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEKIL--IYEYMPNKSL 558
+ + L ++ + LE +++
Sbjct: 338 --------------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD------- 376
Query: 559 DFFLF-DSTK--ENLLG--WGTRVRI-IEGIAQGLLYLHQYSRLRVIHRDLKASNI---L 609
+F S LL W ++ + + LH+YS ++ + K S I
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK---LHKYS---LVEKQPKESTISIPS 430
Query: 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSD--VFSF-G 666
+ ++ K+ + + + IV Y + L D +S G
Sbjct: 431 IYLELKVKL-----------ENEYALHRSIVDHYNIPK-TFDSDDLIPPYLDQYFYSHIG 478
Query: 667 VLLLETLSSKRNTDFSNTNSLTLLGHAW---DLWKDDRAWEL---IDPTLQNEASYLILN 720
L +R T F L + + D AW I TLQ Y
Sbjct: 479 HHLKNIEHPERMTLFRM----VFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY---K 531
Query: 721 RYINVGLLCVQEDAADR 737
YI C + +R
Sbjct: 532 PYI-----CDNDPKYER 543
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 55/339 (16%), Positives = 96/339 (28%), Gaps = 108/339 (31%)
Query: 8 YNFISCVFILSIKLSIAADNITPS----RFIRDGEKLVSSSQRF---------------- 47
Y F+ I + PS +I ++L + +Q F
Sbjct: 91 YKFLMS--------PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142
Query: 48 ---EL------------GFFSPGKS-----KYRYLGIWYKQIPDTIVW--VANRNSPIFD 85
EL G GK+ + ++ I W + N NSP
Sbjct: 143 ALLELRPAKNVLIDGVLGS---GKTWVALDVCLSYKV-QCKMDFKIFWLNLKNCNSP--- 195
Query: 86 SNAVLTISNGGKLVLLNQTNGTIWSSNLSR------EVKNPVAQLLDTGN----LVVRDN 135
VL + KL+ N T S + S ++ + +LL + L+V N
Sbjct: 196 -ETVLEMLQ--KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252
Query: 136 FSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSD-DDPSPGNYTHRLDI 194
+ W +F+ LL T T +K D S TH
Sbjct: 253 VQNAK----AWNAFNLSCKILL----------T------TRFKQVTDFLSAATTTHISLD 292
Query: 195 HVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSYSYLYKPTVV--------DNEDEI-YYRY 245
H L T + LL + +P P + D +++
Sbjct: 293 HHSMTL-TPDEVKSLLLK--YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349
Query: 246 DSYNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPD 284
+ + + ++ + L E + ++ P
Sbjct: 350 VNCD-KLTTIIES----SLNVLEPAEYRKMFDRLSVFPP 383
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-08
Identities = 15/78 (19%), Positives = 30/78 (38%), Gaps = 10/78 (12%)
Query: 71 DTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNL 130
+ +W N + + G LV++ N T+W S ++ + + V L N+
Sbjct: 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 131 VVRDNFSSNSSEDYLWQS 148
V+ + LW +
Sbjct: 106 VIYGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 18/88 (20%), Positives = 26/88 (29%), Gaps = 6/88 (6%)
Query: 61 YLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNP 120
+ P + + + LVL + N IW++N
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGC 63
Query: 121 VAQLLDTGNLVVRDNFSSNSSEDYLWQS 148
A L G LVV N +WQS
Sbjct: 64 RAVLQPDGVLVVITN-----ENVTVWQS 86
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 37/198 (18%), Positives = 73/198 (36%), Gaps = 33/198 (16%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLLNGQEVA---VKRLSSQSGQGQEEFKNEIKL-----IA 526
+ K+G GGFG +Y ++ A VK ++G E K ++ I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 527 KLQHRNLVRLLG----------CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR 576
K R + LG + ++ E + L + T
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK---STV 153
Query: 577 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMARIFGGDEL-- 632
+++ + L Y+H+ +H D+KA+N+LL ++ +D+G++ + +
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 633 ---QSKTKRIVGTYGYMS 647
++ K GT + S
Sbjct: 211 QYQENPRKGHNGTIEFTS 228
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 9e-08
Identities = 27/119 (22%), Positives = 46/119 (38%), Gaps = 15/119 (12%)
Query: 26 DNI-TPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIF 84
DNI + GE L ++ R+ + Y D +W N
Sbjct: 1 DNILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL-- 48
Query: 85 DSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDN--FSSNSS 141
D L++ + G LV+ + N IW+SN E N V L N+V+ +++ ++
Sbjct: 49 DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWATGTN 107
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 51/246 (20%), Positives = 87/246 (35%), Gaps = 42/246 (17%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ--------HRN 532
KLG G F V+ + + VA+K + S E +EI+L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 533 LVRLLGC-----------CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIE 581
+V+LL C +++E + L ++ S L +II+
Sbjct: 103 VVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQ 153
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVG 641
+ QGL YLH ++ R+IH D+K NILL + A + + V
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 642 TYGYMSPEYAQQGLFSIKSDVFS--FGVLLLETLSSKRNTDFSNTNSL----TLLGHAW- 694
T + + L ++ L K T+ T L+G +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 695 ---DLW 697
D+W
Sbjct: 272 TPADIW 277
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-06
Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 11/109 (10%)
Query: 25 ADNI-TPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPI 83
N+ S+ + D +L +++ + L + K IVW + +
Sbjct: 5 VRNVLFSSQVMYDNAQL--ATRDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55
Query: 84 FDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVV 132
+ + + + G+L + + T++ SN + + V L G VV
Sbjct: 56 -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-06
Identities = 21/115 (18%), Positives = 43/115 (37%), Gaps = 15/115 (13%)
Query: 28 ITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSN 87
+ + + +L + + +L + Y W +N + +
Sbjct: 9 LFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYGG---KYGWQSNTHGN--GEH 55
Query: 88 AVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDN--FSSNS 140
L +++ G+L++ + TIWSS S + V L D G V+ F ++S
Sbjct: 56 CFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGPAIFETSS 110
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 50/240 (20%), Positives = 78/240 (32%), Gaps = 84/240 (35%)
Query: 482 KLGEGGFGPVYKG--RLLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIAKLQHR-- 531
LGEG FG V + +VA+K + + + EI ++ K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVLKKIKEKDK 78
Query: 532 ----NLVRLLGC-------CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
V + CI E L F+ KEN + +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFE------------LLGKNTFEFLKENNFQ-PYPLPHV 125
Query: 581 EGIAQGLL----YLHQYSRLRVIHRDLKASNILLDKDMNP-------------------K 617
+A L +LH ++ H DLK NIL +
Sbjct: 126 RHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSFGVLLLE 671
++DFG A F + + IV T Y PE + + DV+S G +L E
Sbjct: 183 VADFGSA-TFDHEHHTT----IVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 40/180 (22%), Positives = 64/180 (35%), Gaps = 46/180 (25%)
Query: 482 KLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIAKLQHR--- 531
K+G+G FG V + + N + AVK + + + K E ++ K+Q+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILKKIQNDDIN 94
Query: 532 --NLVRLLGC-------CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEG 582
N+V+ G C+ E L L++ N G + I+
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFE------------PLGPSLYEIITRNNYN-GFHIEDIKL 141
Query: 583 IAQGLL----YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR 638
+L YL ++ + H DLK NILLD K G +TK
Sbjct: 142 YCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 55/240 (22%), Positives = 83/240 (34%), Gaps = 84/240 (35%)
Query: 482 KLGEGGFGPVYKG--RLLNGQEVAVK------RLSSQSGQGQEEFKNEIKLIAKLQHR-- 531
LGEG FG V + G+ VAVK R + ++EI+++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVLEHLNTTDP 73
Query: 532 ----NLVRLLGC-------CIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRII 580
V++L CI E L +D KEN R+ I
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFE------------LLGLSTYDFIKENGFL-PFRLDHI 120
Query: 581 EGIAQGLL----YLHQYSRLRVIHRDLKASNILLDKDMNP-------------------K 617
+A + +LH ++ H DLK NIL + K
Sbjct: 121 RKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSFGVLLLE 671
+ DFG A + + + +V T Y +PE + S DV+S G +L+E
Sbjct: 178 VVDFGSA-TYDDEHHST----LVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-06
Identities = 16/58 (27%), Positives = 25/58 (43%), Gaps = 2/58 (3%)
Query: 85 DSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDN--FSSNS 140
+ LT+++ G+LV+ N T+W S N A + G LVV F +
Sbjct: 48 GRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFKIDP 105
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 6e-05
Identities = 18/66 (27%), Positives = 24/66 (36%), Gaps = 2/66 (3%)
Query: 70 PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGN 129
D VW N AVL G++ +L N +W+S SR V L N
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVVRDN 135
L +
Sbjct: 225 LAIYGG 230
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 795 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.87 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.87 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.84 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.84 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.82 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.79 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.74 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.66 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.63 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.59 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.59 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.4 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.32 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.13 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.11 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.8 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.5 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.0 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.98 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.52 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.96 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 90.34 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=449.57 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=214.7
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999853 467899999987766667889999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccC----------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 549 IYEYMPNKSLDFFLFDST----------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
|||||++|+|.++|.... ....+++..+..++.||++||.|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2356899999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhc
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....... .....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i---- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECI---- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----
Confidence 99999997655444344445679999999999999999999999999999999998 899987544222 11111
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
..+.. ...+..++..+.+|+.+||+.||++|||++||+++|+...
T Consensus 244 ~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 1112234467889999999999999999999999998743
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=450.03 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=207.0
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|.+.++||+|+||+||+|++. +++.||||++........++|.+|+++|++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999853 478899999987766677889999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 549 IYEYMPNKSLDFFLFDSTK------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
|||||++|+|.+++..... ...+++.++..++.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999965432 246899999999999999999999988 9999999999999999999
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....... .....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i-- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCI-- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHH--
Confidence 9999999997655444444455789999999999999999999999999999999998 899987543221 11111
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
..+.. .+.+..++..+.+|+.+||+.||++||||+||+++|+...
T Consensus 274 --~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 274 --TQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp --HHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 11110 1112233457889999999999999999999999998743
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=437.98 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=205.3
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.+++++.++||+|+||+||+|++. ..||||+++... ....+.|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 367889999999999999999864 369999986432 3345789999999999999999999998764 56899999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
||++|+|.++|... ...+++..+..++.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999543 345899999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
........+||+.|||||++.+ ..|+.++|||||||+||||++|+.||......... ......... .|
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-~~~~~~~~~--------~p 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-IFMVGRGYA--------SP 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHHTTCC--------CC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-HHHHhcCCC--------CC
Confidence 3334456789999999999864 46999999999999999999999999754432221 111111111 11
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCC
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLP 755 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~ 755 (795)
.+ ...+..++..+.+|+.+||+.||++||||.||+++|+....++|
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11 11222345678899999999999999999999999987655443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=442.77 Aligned_cols=257 Identities=30% Similarity=0.416 Sum_probs=212.0
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++++|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999852 46789999997543 344578999999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC
Q 003786 548 LIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 614 (795)
+|||||++|+|.++|..... ...+++..+..++.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 245899999999999999999999988 99999999999999999
Q ss_pred CeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhH
Q 003786 615 NPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 615 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |..||....... .....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~i 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEMI 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999999999987654443344455789999999999999999999999999999999998 889987544222 12111
Q ss_pred hhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+.. .+.+..++..+.+|+.+||+.||++||||+||+++|+.
T Consensus 261 ----~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 261 ----RNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----HcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111 11223345678899999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=439.54 Aligned_cols=267 Identities=22% Similarity=0.228 Sum_probs=213.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.+.|++.++||+|+||.||+|++. +|+.||||+++... ...+|+.+|++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999865 58999999996542 224799999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-CeeeeccccccccCCCc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARIFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~~~~~~ 631 (795)
|+||+|.+++.. .+.+++..+..++.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999953 346999999999999999999999998 99999999999999998 69999999999765432
Q ss_pred cc---ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQ---SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~---~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||............ . ......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~----~~~~~~----- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI-A----SEPPPI----- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH-H----HSCCGG-----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-H----cCCCCc-----
Confidence 21 1223468999999999999999999999999999999999999999765433321111 0 111100
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc---cCCCCCCCCCCccc
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK---TINLPHPRQPAFSS 764 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~---~~~l~~p~~p~~~~ 764 (795)
...+...+..+.++|.+||+.||++|||+.||+++|... ...+.+|....+..
T Consensus 276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 112223456778899999999999999999999987552 34577777665543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=440.49 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=210.6
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
..|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 59999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++|+|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999998843 34899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... ....... . ..+.+ .
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~----~-----~~~~~--~ 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRD----N-----LPPRL--K 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH----S-----SCCCC--S
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHc----C-----CCCCC--C
Confidence 23345789999999999999999999999999999999999999997543221 1111111 0 00111 1
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+..+.+||.+||+.||++|||+.|+++|
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112234567899999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=442.80 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=203.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++|+|||||++++++.+.+..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 378999999999999999999864 59999999997542 334567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||+||+|.++|... +...+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999998543 3345788899999999999999999998 999999999999999999999999999876422
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.... .... .. ....
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i---~~-~~~~------- 243 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL--VLKI---IS-GSFP------- 243 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH---HH-TCCC-------
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHH---Hc-CCCC-------
Confidence 1 223456899999999999999999999999999999999999999976542221 1111 01 1100
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+...+..+.+||.+||+.||++|||+.|++++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234567899999999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=435.47 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=209.9
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999864 5899999999754 2344578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||+||+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999943 356999999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... ...... .... +
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~--~~~~--------~ 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI--FAKIIK--LEYD--------F 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH--TCCC--------C
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHc--CCCC--------C
Confidence 444455668999999999999999999999999999999999999999975442221 111100 0001 1
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 745 (795)
+.....++.++|.+||+.||++|||++|++.
T Consensus 254 ----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 ----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ----CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1122346788999999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=441.61 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=210.5
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999875 59999999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
+||+|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 99999998843 34899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ....... .. .+.+.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~----~~-----~~~~~-- 368 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRD----NL-----PPRLK-- 368 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH----SC-----CCCCS--
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHc----CC-----CCCCc--
Confidence 23345789999999999999999999999999999999999999996543221 1111111 00 01110
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+.+||.+||+.||++|||+.|+++|
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111234567889999999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=421.65 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=198.3
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeee----cceeeEE
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKILI 549 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 549 (795)
|++.++||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++++|||||+++++|.+ ....++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999865 5889999999654 23345679999999999999999999999875 3557999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-CCCCeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~vkL~DFGla~~~~ 628 (795)
||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ .+||||||||+||||+ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999953 356899999999999999999999875 3599999999999998 48999999999998644
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||........ +.... ..+....
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i----~~~~~~~---- 249 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRV----TSGVKPA---- 249 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHH----TTTCCCG----
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHH----HcCCCCC----
Confidence 32 2345789999999998875 699999999999999999999999965432221 11111 1111100
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+...+.++.++|.+||+.||++|||++|+++|
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111123457789999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=415.00 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=190.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999864 69999999997542 23456799999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+ +|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 6788888843 346999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .....+||+.|||||++.+..| +.++|||||||++|||++|+.||...+... +...... ...
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~~~~i~~----~~~------ 229 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFKNISN----GVY------ 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH----TCC------
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHc----CCC------
Confidence 32 2345789999999999998776 589999999999999999999997543221 1111111 100
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .+...+..+.+++.+||+.||++|||++|+++|
T Consensus 230 ~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 T----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 111233567889999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=424.43 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=197.9
Q ss_pred cCCccccccCcCCcccEEEeEec----CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|++.+.||+|+||+||+|+.. +++.||||++.+.. .....++.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999753 46789999997542 2334578899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||||+||+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999943 356899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.... ..... . ...
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i~---~-~~~------ 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MTMIL---K-AKL------ 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH---H-CCC------
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH--HHHHH---c-CCC------
Confidence 322 233457899999999999999999999999999999999999999976443221 11110 0 000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTM-----FEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~ 746 (795)
. .+...+..+.+++.+||+.||++|||+ +|+++|
T Consensus 244 ~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 G----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred C----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0 111234567889999999999999984 678764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=432.31 Aligned_cols=260 Identities=28% Similarity=0.390 Sum_probs=211.6
Q ss_pred HccCCccccccCcCCcccEEEeEecC------cceEEEEEecccCc-cchHHHHHHHHHHHhcCC-cccceeeeeeeec-
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQH-RNLVRLLGCCIEL- 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~- 543 (795)
..++|++.++||+|+||+||+|++.. ++.||||++..... ...+.|.+|+++|.++.| ||||+++++|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 45789999999999999999997532 46799999976433 335679999999999965 9999999998765
Q ss_pred ceeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
+..++|||||++|+|.++|..... ...+++..+..++.|||+||.|||+++ ||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 568999999999999999965332 345889999999999999999999998 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhH
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTL 689 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 689 (795)
++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||........ +
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-~ 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-H
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-H
Confidence 9999999999999997755444344556789999999999999999999999999999999998 8999976543322 1
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.... ..+.. ...+...+.++.+++.+||+.||++|||+.||+++|+.
T Consensus 298 ~~~i----~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 298 CRRL----KEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp HHHH----HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH----HcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 1111 11111 11122234578899999999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=418.56 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=200.2
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecc----eeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE----EKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 550 (795)
.+|.+.++||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999987 68999999996542 11222345666667899999999999998764 579999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC-----CCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS-----RLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
|||++|+|.+++.. ..++++.+.+++.|+++||+|||++. ..+||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 34889999999999999999999861 2359999999999999999999999999998
Q ss_pred ccCCCccc--ccccccccccccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH----
Q 003786 626 IFGGDELQ--SKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA---- 693 (795)
Q Consensus 626 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~---- 693 (795)
........ ......+||+.|||||++.+. .|+.++|||||||+||||++|.+|+.........+....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76433221 223346899999999998754 478899999999999999999887754432221111000
Q ss_pred -hhhccCcccccccCccccch-hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 694 -WDLWKDDRAWELIDPTLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 694 -~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
............++|.+... ........+.+|+.+||+.||++||||.||+++|+..
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00000000111122322221 2234567788999999999999999999999999763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=412.54 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=190.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecc--------
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE-------- 544 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 544 (795)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999864 689999999965433 34467899999999999999999999987655
Q ss_pred ----eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 545 ----EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 545 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
..++|||||++|+|.+++.........++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965544445566678899999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccc----------ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh
Q 003786 621 FGMARIFGGDELQ----------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL 690 (795)
Q Consensus 621 FGla~~~~~~~~~----------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~ 690 (795)
||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||..... .....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHHHH
Confidence 9999876543221 12234579999999999999999999999999999999996 5532111 00111
Q ss_pred HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. ..... .............+++.+||+.||++|||+.|++++
T Consensus 238 ~~----~~~~~---------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TD----VRNLK---------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH----HHTTC---------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH----HhcCC---------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 00111 011222333456789999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=410.66 Aligned_cols=266 Identities=20% Similarity=0.248 Sum_probs=202.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee------cc
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE------LE 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 544 (795)
.++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999864 69999999997543 2334678899999999999999999998764 36
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..|+|||||+ |+|.+++. +.+.+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67888884 3456999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCc--ccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 625 RIFGGDE--LQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 625 ~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+.+.... ........+||+.|||||++.+. .|+.++||||+||++|||++|++||...+..................
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764322 12234457899999999998774 67999999999999999999999997655322211110000000000
Q ss_pred cccc------------cCcccc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWEL------------IDPTLQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~------------id~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... +.+... ..........+.+|+.+||+.||++|||+.|+++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000 00111234567899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=402.95 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=201.0
Q ss_pred HHHccCCccccccCcCCcccEEEeEec----CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecce
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
....++|++.++||+|+||+||+|+.+ +++.||||++.+. ....++.+|+++|+.+ +|||||++++++.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999753 4788999998654 3456788999999998 69999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeeccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA 624 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DFGla 624 (795)
.++|||||++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999882 3889999999999999999999998 9999999999999877 79999999999
Q ss_pred cccCCCccc--------------------------ccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCC
Q 003786 625 RIFGGDELQ--------------------------SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 625 ~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~ 677 (795)
+........ ......+||+.|||||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 865432110 112345799999999998775 58999999999999999999999
Q ss_pred CCCCCCCcchhHhHhHhhh-----------ccC-----c-----cccc---------ccCcccc---------chhhHHH
Q 003786 678 NTDFSNTNSLTLLGHAWDL-----------WKD-----D-----RAWE---------LIDPTLQ---------NEASYLI 718 (795)
Q Consensus 678 p~~~~~~~~~~~~~~~~~~-----------~~~-----~-----~~~~---------~id~~l~---------~~~~~~~ 718 (795)
||.........+....... ... . .... ...+.+. .+.....
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 9965443222111110000 000 0 0000 0000000 0001123
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 719 LNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 719 ~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+..+.+|+.+||+.||++|||++|+++|
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 3567899999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=417.59 Aligned_cols=266 Identities=26% Similarity=0.305 Sum_probs=209.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHH---HHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNE---IKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|++. +|+.||||++.+.. ......+.+| +.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999875 59999999996532 2233334444 5666777999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
|||||||+||+|..+|.. .+.+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999953 456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
+.... ....+||+.|||||++.+ ..|+.++|||||||+||||++|++||..........+... .......
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~-i~~~~~~---- 412 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVE---- 412 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH-HHHCCCC----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-hcCCCCC----
Confidence 65432 345789999999999965 5899999999999999999999999975443322111111 0001111
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHHccc--------cCCCCCCCCCCc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSMLTNK--------TINLPHPRQPAF 762 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~L~~~--------~~~l~~p~~p~~ 762 (795)
.+...+..+.+||.+||+.||++|++ ++||++|-=.. ...+++|..|..
T Consensus 413 --------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 413 --------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred --------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 11223456789999999999999998 78998863211 234566777754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=418.81 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=211.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999865 5999999999776656677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC--CCeeeeccccccccCCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--MNPKISDFGMARIFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~--~~vkL~DFGla~~~~~~ 630 (795)
|+||+|.+++.. +...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999988843 2346899999999999999999999998 9999999999999854 89999999999987544
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... +.... . . +..+
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~~i~---~-~------~~~~ 375 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRNVK---S-C------DWNM 375 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH---T-T------CCCC
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHH---h-C------CCCC
Confidence 3 23456899999999999999999999999999999999999999976443222 11110 0 0 0011
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...........+.+||.+||+.||++|||+.|+++|
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111222234567899999999999999999999996
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=386.11 Aligned_cols=280 Identities=37% Similarity=0.600 Sum_probs=236.8
Q ss_pred HhHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 468 ASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 468 ~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++...+++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34455778999999999999999999998889999999998766666788999999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
+||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999865432 235889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-hhHhHhHhhhccCcccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS-LTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 705 (795)
..............||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.............
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 543332233344568999999999998999999999999999999999999997654322 2233333333344555566
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
+++.+...........+.+++.+||+.||++|||+.||+++|+..
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 677776677788889999999999999999999999999999763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=382.90 Aligned_cols=288 Identities=41% Similarity=0.681 Sum_probs=242.2
Q ss_pred CCcccHHhHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeee
Q 003786 462 FPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCC 540 (795)
Q Consensus 462 ~~~~~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 540 (795)
+..+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999976432 2344789999999999999999999999
Q ss_pred eecceeeEEeecCCCCChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 541 IELEEKILIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 541 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
.+.+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||++...+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999965443 3458999999999999999999999922239999999999999999999999
Q ss_pred ccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC---CCcchhHhHhHhhh
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS---NTNSLTLLGHAWDL 696 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~---~~~~~~~~~~~~~~ 696 (795)
|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+.. .........+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987653332 2233456999999999999889999999999999999999999999632 22233334444455
Q ss_pred ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..........+..+...........+.+++.+||+.||++|||+.||+++|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 555666667777777777888889999999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.66 Aligned_cols=284 Identities=38% Similarity=0.549 Sum_probs=229.3
Q ss_pred CCCcccHHhHHHHccCCccc------cccCcCCcccEEEeEecCcceEEEEEecccC----ccchHHHHHHHHHHHhcCC
Q 003786 461 WFPMFSLASVSAATANFSTE------NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKLQH 530 (795)
Q Consensus 461 ~~~~~~~~~i~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 530 (795)
.++.|++.++...+.+|... ++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34668888888888888776 8999999999999987 68899999986532 2335678999999999999
Q ss_pred cccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 531 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||.|||+++ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999876555567899999999999999999999998 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL 690 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~ 690 (795)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..|+...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987654332333344679999999998865 588999999999999999999999976553322111
Q ss_pred HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...............+++.+ ..........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 10101111122233334333 234556778899999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=365.39 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=210.2
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999985 4689999999977666667889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999843 24889999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ . . ... ...
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~-~---~~~-~~~------ 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-A-T---NGT-PEL------ 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-H-H---HCS-CCC------
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H-h---CCC-CCC------
Confidence 2 234467999999999999999999999999999999999999999654322211110 0 0 000 000
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..+......+.+++.+||+.||++|||+.|++++-
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 11122345678899999999999999999999853
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.74 Aligned_cols=233 Identities=19% Similarity=0.219 Sum_probs=181.3
Q ss_pred hccccccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccC----cceEEEeeCC
Q 003786 21 LSIAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDS----NAVLTISNGG 96 (795)
Q Consensus 21 ~~~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~----~~~l~~~~~g 96 (795)
.+++.|+|++||+|++|++|+|++|.|+||||+++ ++|+ |+ ..+ |||+|||++|+.++ +++|+|+.||
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 45678999999999999999999999999999554 5666 76 445 99999999999875 7899999999
Q ss_pred ceEE--eCCCCceEEeecCCCC-----ccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeeccccccC
Q 003786 97 KLVL--LNQTNGTIWSSNLSRE-----VKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTG 169 (795)
Q Consensus 97 ~lvl--~~~~~~~~Wst~~~~~-----~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~~~~ 169 (795)
|||| .|++|.+||+|+++.. ..+..|+|+|+|||||+| +.+|||| |||||+|||||||.+.++|
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--ccccccccccccccccccC
Confidence 9999 7888999999998652 345789999999999996 4689999 9999999999999999888
Q ss_pred cceeEEEecCCCCCCCCceEEeeccCCcceEEEEc-CceeEEeeCCCCCeeeeccCCCcccccceeeeCCC-eeEEEEec
Q 003786 170 LERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYN-GSVKLLCSGPWNGAIFAAIPSYSYLYKPTVVDNED-EIYYRYDS 247 (795)
Q Consensus 170 ~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~-~s~~~~~sg~w~~~~f~~~p~~~~~~~~~~~~n~~-~~~~~~~~ 247 (795)
.. | ++.+||++|.|++++++++. +++|+ ++..||++|+|+....... ....-.+.+.++.. .+.++++.
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~--l~~dGnLvl~d~~~~~vWsS~t~ 223 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAV--FQGDGNLVVYGAGNAVLWHSHTG 223 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEE--ECTTSCEEEECTTSCEEEECSCT
T ss_pred cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEE--EcCCCeEEEEeCCCcEEEEecCC
Confidence 64 5 77899999999999999884 45565 4689999999976421100 01111222333333 23333322
Q ss_pred CCCceEEEEEECCCCcEEEEEEecCCCceEEEEeccc
Q 003786 248 YNSPVIMTLKLNPSGKIQHLIWNERNRTWEAFFSLPD 284 (795)
Q Consensus 248 ~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~ 284 (795)
.....|++|+.||++++|.| ...|..++..|.
T Consensus 224 --~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 224 --GHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp --TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred --CCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 22358999999999999999 346777666664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=369.46 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=205.2
Q ss_pred HHccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
....+|++.++||+|+||.||+|+. +++.||||++.... ....+++.+|+++|++++||||+++++++.+....++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457899999999999999999986 68899999987543 23346788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++........+++..+..++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999965544455899999999999999999999875 3499999999999999999999999999986443
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... . ...
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~--~-~~~------- 257 (309)
T 3p86_A 192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGF--K-CKR------- 257 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHH--S-CCC-------
T ss_pred cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh--c-CCC-------
Confidence 22 123346799999999999999999999999999999999999999975432221 111100 0 000
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCC
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l 754 (795)
...+......+.+++.+||+.+|++|||+.+|++.|+......
T Consensus 258 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 --LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0111223456789999999999999999999999998755443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=376.32 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=211.4
Q ss_pred ccCCccccccCcCCcccEEEeEec--------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999752 35679999997543 23456789999999999 899999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
+..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965432 235788999999999999999999998 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhH
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTL 689 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999987654443333444567899999999999999999999999999999999 9999876443222
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.... ..... ...+......+.+++.+||+.+|++||++.|++++|+..
T Consensus 315 ~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 FKLL----KEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHH----HTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 11110 111222345788999999999999999999999999763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=370.17 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=207.1
Q ss_pred HHccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+++|+.++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999987 569999999996542 2345678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999988543 45889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||+....... ..... . +..
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~---~-~~~----- 231 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL--RERVL---R-GKY----- 231 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH---H-CCC-----
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHH---h-CCC-----
Confidence 432 23456899999999999887764 899999999999999999999976542221 11110 0 000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.||++|||++|++++
T Consensus 232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111233467789999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.98 Aligned_cols=261 Identities=25% Similarity=0.427 Sum_probs=211.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.++||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467999999999999999999875 5889999999776666778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999543 345899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cc------------cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc
Q 003786 633 QS------------KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD 700 (795)
Q Consensus 633 ~~------------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~----- 238 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG----- 238 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH-----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc-----
Confidence 11 1114579999999999999999999999999999999999999886543222111000000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
..+ ...+...+..+.+++.+||+.||++|||+.+++++|+....
T Consensus 239 ----~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 239 ----FLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ----HHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----ccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 00112223467889999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=363.47 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=206.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999865 68899999986543 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999884 3345899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||................ ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----~~-------- 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-----KT-------- 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-----CT--------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-----cc--------
Confidence 3333445689999999999987765 789999999999999999999997655433322211110 00
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
...........+.+++.+||+.||++|||+.|++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0001112345677899999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=362.55 Aligned_cols=250 Identities=23% Similarity=0.274 Sum_probs=206.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999875 5899999999754 234556788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988843 345889999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..... .....
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~--~~~~~-------- 223 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELIL--MEEIR-------- 223 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH--HCCCC--------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HHHHH--cCCCC--------
Confidence 22 223456899999999999999999999999999999999999999865432211 11110 00000
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L 747 (795)
.+......+.+++.+||+.||++|| +++||++|-
T Consensus 224 ----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1112345678899999999999999 899999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.44 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=207.2
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999876 6999999999876666778899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 635 (795)
++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 999998842 35899999999999999999999998 99999999999999999999999999987653321 2
Q ss_pred ccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhh
Q 003786 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .. .+.+. ..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~~----~~-----~~~~~--~~ 264 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRD----SP-----PPKLK--NS 264 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH----SS-----CCCCT--TG
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc----CC-----CCCcC--cc
Confidence 334679999999999999999999999999999999999999986543211 1111100 00 01110 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 716 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
...+..+.+++.+||+.||++|||+.|++++.-
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 123356788999999999999999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=366.38 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=207.2
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc------chHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ------GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.... ..+.+.+|+.+|++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 5899999999764322 357899999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC----Ceeeeccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~vkL~DFG 622 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999843 446899999999999999999999998 99999999999998877 79999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... ...
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~~i~----~~~- 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANIT----AVS- 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH----TTC-
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH----hcC-
Confidence 998765432 23446799999999999999999999999999999999999999965432211 11110 000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+...........+.++|.+||+.||++|||+.|++++
T Consensus 235 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 -----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111122234567899999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.18 Aligned_cols=269 Identities=25% Similarity=0.331 Sum_probs=208.2
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecce----eeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----KIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~l 548 (795)
...+|++.++||+|+||.||+|+.. ++.||||++.... .......+|+.+|++++||||+++++++.+... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3478999999999999999999874 7899999996542 334456678999999999999999999987543 699
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc----------CCCcEEeccCCCCcEEECCCCCeee
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY----------SRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
||||+++|+|.+++.. ..+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999843 3488999999999999999999988 6 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA 693 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 693 (795)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987655443333444679999999999876 3567789999999999999999999976543221111100
Q ss_pred h-hhcc-----CcccccccCccccch-hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 694 W-DLWK-----DDRAWELIDPTLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 694 ~-~~~~-----~~~~~~~id~~l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
. .... .........+.+... ........+.+++.+||+.||++|||+.||++.|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0000 000001111111111 1224556789999999999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.45 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=203.8
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..++|++.++||+|+||.||+|+..+++.||||++..... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3478999999999999999999988899999999965422 23467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++ +|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99986 66666643 2345889999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--c------
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD--R------ 701 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~------ 701 (795)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ........ .
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK--IFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH--HHHHHCCCCTTTSGGGT
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHHCCCChHHhhhhh
Confidence 2 12334578999999999876 5789999999999999999999999976553332111 11100000 0
Q ss_pred --------cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 --------AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 --------~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+.............++.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000111111111122234577899999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=372.55 Aligned_cols=267 Identities=27% Similarity=0.365 Sum_probs=212.7
Q ss_pred cHHhHHHHccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceee
Q 003786 466 SLASVSAATANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLL 537 (795)
Q Consensus 466 ~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~ 537 (795)
.........++|++.++||+|+||.||+|++ .+++.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444455678999999999999999999973 3468899999976432 3346789999999999 799999999
Q ss_pred eeeeecce-eeEEeecCCCCChhhhhhccCC-------------------------------------------------
Q 003786 538 GCCIELEE-KILIYEYMPNKSLDFFLFDSTK------------------------------------------------- 567 (795)
Q Consensus 538 ~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------- 567 (795)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99887654 8999999999999999965432
Q ss_pred --------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 568 --------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 568 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122888999999999999999999998 999999999999999999999999999876443333
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||............ . ..... .
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~----~~~~~---------~ 315 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-L----KEGTR---------M 315 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH-H----HHTCC---------C
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH-H----HcCCC---------C
Confidence 33445678999999999999999999999999999999998 99998765433221111 1 00100 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+......+.+++.+||+.||++|||+.||+++|+.
T Consensus 316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 0111233567889999999999999999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=365.67 Aligned_cols=266 Identities=24% Similarity=0.329 Sum_probs=208.4
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhc-CCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|..+|+.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999865 5899999999754 234456788999999988 7999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999998854 345899999999999999999999998 999999999999999999999999999854
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... .. ...
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i---~~-~~~----- 241 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--FEAI---LN-DEV----- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH---HH-CCC-----
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--HHHH---Hc-CCC-----
Confidence 3222 233456899999999999999999999999999999999999999976443221 1111 00 000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCH------HHHHHHHccc--------cCCCCCCCCCCc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTM------FEVVSMLTNK--------TINLPHPRQPAF 762 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~L~~~--------~~~l~~p~~p~~ 762 (795)
..+......+.+++.+||+.||++||++ .|+++|-=.. ...++.|..|..
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~ 305 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRI 305 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCC
Confidence 0111133467789999999999999998 8888853221 233555666654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=353.64 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=210.0
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36799999999999999999998888899999997543 44578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999854 2345889999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .... .... ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--~~~~----~~~~--~~~------ 227 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VEDI----STGF--RLY------ 227 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHH----HTTC--CCC------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHH----hcCc--cCC------
Confidence 22233457889999999998999999999999999999999 8988875432221 1111 0000 001
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.+......+.+++.+||+.+|++||++.|++++|+..
T Consensus 228 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 228 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1111235678899999999999999999999999763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.08 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=211.7
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|++++++++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 347899999999999999999998888899999996543 3457799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998543 345899999999999999999999998 99999999999999999999999999987654432
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||+........ ... .... ....+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~----~~~~--~~~~~--- 227 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--LKV----SQGH--RLYRP--- 227 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHH----HTTC--CCCCC---
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH--HHH----HcCC--CCCCC---
Confidence 2 2233456788999999998899999999999999999999 99998654422211 111 0000 00111
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
...+..+.+++.+||+.+|++|||+.|++++|+....
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1123467889999999999999999999999987543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=354.95 Aligned_cols=271 Identities=21% Similarity=0.248 Sum_probs=214.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecc--eeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 549 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999875 48999999997543 344577889999999999999999999988765 67999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE----CCCCCeeeecccccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAR 625 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~vkL~DFGla~ 625 (795)
|||+++++|.+++........+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555899999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCcccccccccccccccccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch--hHhHhHhh
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQ--------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL--TLLGHAWD 695 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~ 695 (795)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 765433 223457999999999886 57889999999999999999999999965432221 11111111
Q ss_pred hccCcccccc---c--------CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 696 LWKDDRAWEL---I--------DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 696 ~~~~~~~~~~---i--------d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.......... . +..............+.+++.+||+.||++|||++|++++.+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1110000000 0 00111234567778889999999999999999999999998774
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=366.88 Aligned_cols=273 Identities=20% Similarity=0.278 Sum_probs=211.1
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.++||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|..+|.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3478999999999999999999875 47889999997642 23345688999999887 8999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999988853 345899999999999999999999998 999999999999999999999999999853
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh---HhHhHhhhccCccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT---LLGHAWDLWKDDRAWE 704 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 704 (795)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .............
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 2221 2344578999999999999999999999999999999999999999654321110 0000000000000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCH------HHHHHHHccc--------cCCCCCCCCCCcc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTM------FEVVSMLTNK--------TINLPHPRQPAFS 763 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~L~~~--------~~~l~~p~~p~~~ 763 (795)
...+......+.+++.+||+.||++||++ .||+++-=.. ...+++|..|...
T Consensus 279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~ 344 (396)
T 4dc2_A 279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNIS 344 (396)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCC
T ss_pred -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCC
Confidence 01112234567899999999999999985 6787753211 2235566666543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.00 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=207.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc------cchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG------QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999875 589999999865432 2457899999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC----Ceeeeccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~vkL~DFG 622 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999843 356899999999999999999999998 99999999999999887 89999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~------ 232 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANVSAV------ 232 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHHHT------
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHHhc------
Confidence 998764332 22346799999999999999999999999999999999999999865432211 1111000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
............+..+.+++.+||+.||++|||+.|++++-
T Consensus 233 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 233 ----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp ----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred ----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 00011111122345678999999999999999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.82 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=207.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+|+.. +++.+|+|++... ....+.+.+|+.+|+.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999865 5889999998643 34456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC--CCCeeeeccccccccCCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--DMNPKISDFGMARIFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~--~~~vkL~DFGla~~~~~~ 630 (795)
+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2345899999999999999999999998 999999999999987 789999999999876543
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ... ..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~---~~~-------~~ 222 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENIMN---AEY-------TF 222 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---TCC-------CC
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--HHHHHc---CCC-------CC
Confidence 3 23346799999999999998899999999999999999999999975432211 111100 000 00
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
........+..+.+++.+||+.||++|||+.|++++-
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1111123345788999999999999999999999963
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=363.32 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=206.6
Q ss_pred ccCCccccccCcCCcccEEEeEec----CcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..+|++.+.||+|+||.||+|+.. .+..||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999864 2445999999764 33345679999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998533 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 629 GDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .... ....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~----~~~~----- 271 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--ISSV----EEGY----- 271 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHH----HTTC-----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHH----HcCC-----
Confidence 43211 12223456788999999998999999999999999999999 9999865432221 1111 0110
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
....+...+..+.+++.+||+.||++||++.||+++|+...
T Consensus 272 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 272 ----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111223457889999999999999999999999998743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=374.80 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=208.8
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3468999999999999999999976 68999999987542 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999998532 235889999999999999999999998 999999999999999999999999999865433
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
..........+++.|+|||.+....++.++|||||||++|||++ |..|+........ ... ......
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~~----~~~~~~------- 333 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--REF----VEKGGR------- 333 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHH----HHTTCC-------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH----HHcCCC-------
Confidence 22222222346788999999998899999999999999999998 9988875432211 111 111110
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 334 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 --LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111122345678899999999999999999999999763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=369.12 Aligned_cols=277 Identities=22% Similarity=0.251 Sum_probs=216.0
Q ss_pred HhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeec
Q 003786 468 ASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 468 ~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
..+....++|++.++||+|+||.||+|++. +++.||||++.+. .....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344456689999999999999999999875 4889999999653 223345688999999999999999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 34889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL----FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD 699 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.... .... ...
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i---~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YSKI---MNH 288 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH---HTH
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--HHHH---Hhc
Confidence 987654332 2234578999999999997654 88999999999999999999999975442221 1110 000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHHcccc--------CCCCCCCCCCccc
Q 003786 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAAD--RPTMFEVVSMLTNKT--------INLPHPRQPAFSS 764 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L~~~~--------~~l~~p~~p~~~~ 764 (795)
...... + ........+.++|.+||+.+|++ ||+++||++|.=... ...+.|..|....
T Consensus 289 ~~~~~~--p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~ 356 (410)
T 3v8s_A 289 KNSLTF--P-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS 356 (410)
T ss_dssp HHHCCC--C-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred cccccC--C-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCC
Confidence 000000 0 00112356788999999999998 999999999743221 2245566665443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=361.72 Aligned_cols=261 Identities=28% Similarity=0.381 Sum_probs=212.5
Q ss_pred HHccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecc
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 544 (795)
...++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3457899999999999999999975 235789999997543 334567889999999999999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCC---------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccC
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTK---------------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 603 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi 603 (795)
..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999965432 234888999999999999999999998 999999
Q ss_pred CCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 003786 604 KASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFS 682 (795)
Q Consensus 604 kp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~ 682 (795)
||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..|+...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654443333444567899999999999999999999999999999999 99998754
Q ss_pred CCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 683 NTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...... ... ..... ...+...+..+.+++.+||+.||++||++.||+++|+..
T Consensus 257 ~~~~~~--~~~----~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 257 PPERLF--NLL----KTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CGGGHH--HHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHH--HHh----hcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 432221 111 11110 011122345788999999999999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.71 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=201.5
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecce-----
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 545 (795)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999876 68999999996543 3345789999999999999999999999866542
Q ss_pred ----------------------------------------------------eeEEeecCCCCChhhhhhccCCcccCCh
Q 003786 546 ----------------------------------------------------KILIYEYMPNKSLDFFLFDSTKENLLGW 573 (795)
Q Consensus 546 ----------------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~l~~ 573 (795)
.++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7899999999999999976665556667
Q ss_pred hhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc----------cccccccccc
Q 003786 574 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ----------SKTKRIVGTY 643 (795)
Q Consensus 574 ~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~ 643 (795)
..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 778999999999999999998 999999999999999999999999999876543211 1223457999
Q ss_pred ccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHH
Q 003786 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYI 723 (795)
Q Consensus 644 ~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~ 723 (795)
.|+|||++.+..++.++|||||||++|||++|..|+.. ....... .... ............+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~----~~~~---------~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITD----VRNL---------KFPLLFTQKYPQEH 303 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHH----HHTT---------CCCHHHHHHCHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHH----hhcc---------CCCcccccCChhHH
Confidence 99999999999999999999999999999998765311 0000000 0000 11122333445678
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 003786 724 NVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 724 ~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+++.+||+.||++|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=370.27 Aligned_cols=259 Identities=29% Similarity=0.400 Sum_probs=207.8
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999842 4678999999654 334456788999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccC----CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---Ceeee
Q 003786 547 ILIYEYMPNKSLDFFLFDST----KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKIS 619 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL~ 619 (795)
++||||+++|+|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996543 2245888999999999999999999998 99999999999999655 49999
Q ss_pred ccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhcc
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........ .... .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~~i----~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEFV----T 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHH----H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----H
Confidence 9999986533222223344568999999999999999999999999999999998 9999875432221 1111 1
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.... ...+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 301 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1110 011112345678999999999999999999999998763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.44 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=205.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc-----CccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999864 5899999998542 1224678999999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC---eeeecccc
Q 003786 548 LIYEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGM 623 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---vkL~DFGl 623 (795)
+||||+++++|.+.+.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999987775432 2345889999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....... . ...
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~i~---~-~~~- 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEGII---K-GKY- 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHHHH---H-TCC-
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHHHH---c-CCC-
Confidence 987654321 23345799999999999999999999999999999999999999975321 1111100 0 000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..........+..+.+++.+||+.||++|||+.|++++
T Consensus 250 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 -----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00011111234578899999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=364.07 Aligned_cols=264 Identities=27% Similarity=0.386 Sum_probs=209.9
Q ss_pred HccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+|+++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 347899999999999999999985 246689999997542 34457899999999999 8999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCc--------------------ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCC
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKE--------------------NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 604 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik 604 (795)
..++||||+++++|.+++...... ..+++..+..++.||+.||.|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 34788999999999999999999998 9999999
Q ss_pred CCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 003786 605 ASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSN 683 (795)
Q Consensus 605 p~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~ 683 (795)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986644332233344567889999999999999999999999999999998 999987654
Q ss_pred CcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCC
Q 003786 684 TNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTIN 753 (795)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
..... .... .... ....+...+..+.+++.+||+.||.+||++.+|+++|......
T Consensus 280 ~~~~~-~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDANF-YKLI----QNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHHH-HHHH----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHHH-HHHH----hcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 32221 1111 1110 0011112345788899999999999999999999999875443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.33 Aligned_cols=274 Identities=25% Similarity=0.373 Sum_probs=205.9
Q ss_pred ccCCccccccCcCCcccEEEeEe-----cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec--cee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.++|++.++||+|+||.||+|++ .+++.||||++........+.+.+|+++|++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 47899999999999999999973 35889999999876666667899999999999999999999998654 458
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 234889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH-hhhccCccccc
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA-WDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 704 (795)
....... .......++..|+|||.+.+..++.++|||||||++|||++|..|+.............. ..........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433211 222334578889999999999999999999999999999999988754221100000000 00000000000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.+........+...+..+.+++.+||+.||++|||+.||++.|+....
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000111111222345678899999999999999999999999977543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.26 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=205.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999864 588999999855332 2346788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ...... . +.
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~~-~-----~~ 231 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-----KHIQDS-V-----PN 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-----HHHSSC-C-----CC
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhhcc-C-----CC
Confidence 321 22334679999999999999999999999999999999999999997543222111 000100 0 00
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHccc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRP-TMFEVVSMLTNK 750 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~~ 750 (795)
.........+..+.+++.+||+.||++|| +++++.+.|...
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 11112223446788999999999999999 899999998773
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.02 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=205.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+++|+.++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999865 48889999986532 34457788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999853 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccccccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||................. ..
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~~----- 236 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---TV----- 236 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---CC-----
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---cc-----
Confidence 32 2345789999999999864 4689999999999999999999999976543332211111000 00
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPT-MFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~ 746 (795)
...+......+.+++.+||+.||++||+ +++|+++
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0011123457889999999999999998 7888764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=370.07 Aligned_cols=268 Identities=27% Similarity=0.365 Sum_probs=215.8
Q ss_pred HccCCccccccCcCCcccEEEeEec--------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIE 542 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 542 (795)
..++|.+.++||+|+||.||+|+.. .++.||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999852 23579999997643 23446789999999999 99999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEE
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 609 (795)
.+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999965432 245899999999999999999999998 999999999999
Q ss_pred ECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 003786 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLT 688 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 688 (795)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..|+........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987655443334445567899999999999999999999999999999999 9999875432221
Q ss_pred HhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCCCC
Q 003786 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPR 758 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~p~ 758 (795)
... ....... ..+......+.+++.+||+.+|++|||+.||+++|+......+...
T Consensus 303 -~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 303 -FKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp -HHH----HHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred -HHH----HHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 111 1111110 0111234568889999999999999999999999988544444433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=363.54 Aligned_cols=264 Identities=27% Similarity=0.388 Sum_probs=212.8
Q ss_pred HHHccCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345688999999999999999999864 34789999997643 23356789999999999999999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCC---------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEecc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTK---------------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 602 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrD 602 (795)
+..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999965321 156889999999999999999999998 99999
Q ss_pred CCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 003786 603 LKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDF 681 (795)
Q Consensus 603 ikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~ 681 (795)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987644333233344578999999999998899999999999999999999 9989865
Q ss_pred CCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 682 SNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
...... ... ....... ..+...+..+.+++.+||+.+|++||++.+|+++|+....
T Consensus 280 ~~~~~~--~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEEV--IYY----VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHHH--HHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHHH--HHH----HhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 432211 111 1111110 1112234578899999999999999999999999988543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=371.05 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=204.7
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
..++|++.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999864 68999999986543 23346789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC---CCCCeeeeccccccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMARI 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~---~~~~vkL~DFGla~~ 626 (795)
|||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999888854 345899999999999999999999998 99999999999998 568899999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... .... ...
T Consensus 163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--~~~i~----~~~~-~~~ 233 (444)
T 3soa_A 163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQQIK----AGAY-DFP 233 (444)
T ss_dssp CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH----HTCC-CCC
T ss_pred ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--HHHHH----hCCC-CCC
Confidence 65432 122346799999999999999999999999999999999999999865432221 11110 0000 000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+..+.+++.+||+.||++|||+.|++++
T Consensus 234 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 -----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01111234567899999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=350.27 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=201.6
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 588999999965432 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|++++.+..+.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 998755554442 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc--ccccc--
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR--AWELI-- 706 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~i-- 706 (795)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..|+......... ............ .+..+
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhhhhhcc
Confidence 2233457899999999987765 899999999999999999998886433322221 111111111000 00000
Q ss_pred -----------CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 -----------DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 -----------d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...............+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000011122344577899999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=362.82 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=199.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-Ccce----EEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQE----VAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999854 3444 588877543 3345678999999999999999999999998754 78
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+|+||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998543 345889999999999999999999998 999999999999999999999999999977
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||+.......... . ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~----~~~~----- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--L----EKGE----- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--H----HTTC-----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH--H----HcCC-----
Confidence 65443333444567889999999999999999999999999999999 9999876543332111 1 0010
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
....+......+.+++.+||+.+|++||++.|++++|+..
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011122345678899999999999999999999998663
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=369.19 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=196.5
Q ss_pred ccCCccccccCcCCcccEEEeEec----CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..+|++.+.||+|+||.||+|++. ++..||||++.... ....+.+.+|+.+|++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 367999999999999999999864 47789999997542 3345679999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999542 345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 629 GDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||........ .... ....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~~i----~~~~----- 267 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IKAV----DEGY----- 267 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HHHH----HTTE-----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----HcCC-----
Confidence 33211 11222345778999999999999999999999999999998 9999865432211 1111 0110
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 268 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 268 ----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0111122345788999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.19 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=206.9
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..++|++.+.||+|+||.||+++..+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 357899999999999999999998888899999997543 3457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999998542 345899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .... .... .
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~----~~~~---------~ 239 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHI----AQGL---------R 239 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHH----HTTC---------C
T ss_pred -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HHHH----hccc---------C
Confidence 22233456888999999998899999999999999999998 9999865432211 1111 0000 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...+......+.+++.+||+.+|++|||+.|++++|..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00111123567889999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=362.24 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=204.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999865 58999999996543 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---Ceeeecccccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL~DFGla~~~ 627 (795)
||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999888843 346899999999999999999999998 99999999999998654 5999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.... ..... .... .
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i~----~~~~-~--- 248 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YAQIK----AGAY-D--- 248 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH----HTCC-C---
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH----hCCC-C---
Confidence 5332 22346799999999999999999999999999999999999999865432211 11110 0000 0
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+..+.+++.+||+.||++||++.|++++
T Consensus 249 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011112234567899999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=349.57 Aligned_cols=260 Identities=27% Similarity=0.351 Sum_probs=201.9
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHh--cCCcccceeeeeeeec----ceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAK--LQHRNLVRLLGCCIEL----EEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 547 (795)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999987 7899999998643 34566777777776 7999999999986653 4578
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHH--------hcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH--------QYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
+||||+++|+|.+++. ...+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 235889999999999999999999 665 9999999999999999999999
Q ss_pred ccccccccCCCccc--ccccccccccccccccccccC------CCCcccchhhHHHHHHHHHhC----------CCCCCC
Q 003786 620 DFGMARIFGGDELQ--SKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSS----------KRNTDF 681 (795)
Q Consensus 620 DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvil~elltG----------~~p~~~ 681 (795)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999865433221 112335799999999999876 456799999999999999999 777654
Q ss_pred CCCcchhHhHhHhhhccCcccccccCccc-cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 682 SNTNSLTLLGHAWDLWKDDRAWELIDPTL-QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.................... .+.+ ...........+.+++.+||+.||++|||+.||++.|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 33222211111111111111 1111 112334567789999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=368.35 Aligned_cols=264 Identities=20% Similarity=0.229 Sum_probs=209.6
Q ss_pred HHhHHHHccCCccccccCcCCcccEEEeEecC-cceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeee
Q 003786 467 LASVSAATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 467 ~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
+..+....++|++.++||+|+||.||+|++.. ++.||||++.+.. ....+.+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445567899999999999999999999764 7889999996532 2233458999999999999999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
.+..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999542 345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+.... .....
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~~i~--- 294 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YGKIM--- 294 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHH---
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--HHhhh---
Confidence 9986643322 2233468999999999986 56789999999999999999999999975442221 11110
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHH
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAAD--RPTMFEVVSML 747 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L 747 (795)
..... ..-+.. .......+.++|.+||+.+|++ ||+++|++++-
T Consensus 295 ~~~~~--~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 295 NHKER--FQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp THHHH--CCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred hcccc--ccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 00000 000000 0112346778999999998888 99999999973
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.75 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=196.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--------------------------cchHHHHHHHHHHH
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--------------------------QGQEEFKNEIKLIA 526 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 526 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999864 588999999865421 12356889999999
Q ss_pred hcCCcccceeeeeeee--cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCC
Q 003786 527 KLQHRNLVRLLGCCIE--LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 604 (795)
Q Consensus 527 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik 604 (795)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||++||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56789999999999998765 2346899999999999999999999998 9999999
Q ss_pred CCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCC
Q 003786 605 ASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDF 681 (795)
Q Consensus 605 p~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~ 681 (795)
|+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654321 223467999999999997654 47899999999999999999999865
Q ss_pred CCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 682 SNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... ...... .... .. + .....+..+.+++.+||+.||++||++.|++++
T Consensus 243 ~~~~~--~~~~~~----~~~~-~~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERIMC--LHSKIK----SQAL-EF--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSHHH--HHHHHH----HCCC-CC--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccHHH--HHHHHh----cccC-CC--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 33211 111110 0000 00 0 011233567899999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.98 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=201.2
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.++||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999986543 23347788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++ +|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 887777432 345889999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--------ccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD--------RAW 703 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~ 703 (795)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........... ...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhcc
Confidence 12233578999999999876 4689999999999999999999999976442221 11111110000 000
Q ss_pred cccCccc-------cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTL-------QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l-------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...++.+ ...........+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011110 011112234577899999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=361.17 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=205.7
Q ss_pred HHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhc-CCcccceeeeeeeecce
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
....++|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345689999999999999999999875 58899999997642 34456788999999887 89999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999853 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...... ..
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~--~~------ 234 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRM--DN------ 234 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH--CC------
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHh--CC------
Confidence 643222 223457899999999999999999999999999999999999999975432211 111100 00
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHH-HHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMF-EVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~ 746 (795)
+.+ +......+.+++.+||+.||++||++. +|+++
T Consensus 235 --~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 235 --PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 001 111335678899999999999999998 88765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=353.92 Aligned_cols=246 Identities=25% Similarity=0.312 Sum_probs=205.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999875 58999999997542 23456788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999854 345889999999999999999999988 99999999999999999999999999987542
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... .... . .
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i---~~~~-~------~ 221 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEKI---LNAE-L------R 221 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH---HHCC-C------C
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHH---HhCC-C------C
Confidence 2 3346899999999999999999999999999999999999999965432111 1111 0100 0 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.+......+.+++.+||+.||++|| +++||++|
T Consensus 222 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1112335678899999999999999 89999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=353.36 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=206.1
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.+.||+|+||.||+|+. .++.||||++... ...+.+.+|+++|++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 36789999999999999999987 4788999998643 34577999999999999999999999887 4589999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC-eeeeccccccccCCCcc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-PKISDFGMARIFGGDEL 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-vkL~DFGla~~~~~~~~ 632 (795)
++++|.+++........+++..+..++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976555556788899999999999999999943334999999999999998887 799999999765322
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+............. .. .... .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~-~~~~-----~--- 224 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV---HN-GTRP-----P--- 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH---HT-TCCC-----C---
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH---hc-CCCC-----C---
Confidence 2234689999999999999999999999999999999999999975443332221111 01 1100 1
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCCCCCCC
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPA 761 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~p~~p~ 761 (795)
.....+..+.+++.+||+.+|++|||+.|++++|+......+.+..|.
T Consensus 225 -~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 225 -LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp -CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred -cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 111233567889999999999999999999999988665555554443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=362.14 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=207.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999865 5889999999766555567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC--CCCeeeeccccccccCCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--DMNPKISDFGMARIFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~--~~~vkL~DFGla~~~~~~ 630 (795)
+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988432 335899999999999999999999998 999999999999974 578999999999876543
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||....... ........ . .. .+
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i~~~----~-~~-~~--- 270 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKRC----D-WE-FD--- 270 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHC----C-CC-CC---
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHHHhC----C-CC-CC---
Confidence 32 233579999999999999999999999999999999999999997543211 11111000 0 00 01
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+..+.++|.+||+.||++|||+.|++++
T Consensus 271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112234567899999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=354.55 Aligned_cols=259 Identities=18% Similarity=0.183 Sum_probs=207.2
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 468999999986542 345689999999999 99999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC-----eeeeccccccc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISDFGMARI 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-----vkL~DFGla~~ 626 (795)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 346899999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 627 FGGDELQS-----KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 627 ~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD---TK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH---HH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh---hh
Confidence 64332211 12456899999999999999999999999999999999999999986543322111110000 00
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
... . ........+ .+.+++..||+.+|.+||++++|++.|+.
T Consensus 237 ~~~--~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 237 RAT--P---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHS--C---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ccC--C---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 0 000001123 78899999999999999999999998865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.79 Aligned_cols=253 Identities=31% Similarity=0.452 Sum_probs=196.8
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCc----cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG----QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|++ .++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999987 488999999865432 3356789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC--------CCCeeeecc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--------DMNPKISDF 621 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~--------~~~vkL~DF 621 (795)
|||+++++|.+++. ...+++..+..++.|+++||.|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999883 345889999999999999999999987555899999999999986 778999999
Q ss_pred ccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 622 GMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
|++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .......
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~~~ 231 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-----GVAMNKL 231 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-----HHHTSCC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----hhhcCCC
Confidence 9998654332 223578999999999999999999999999999999999999997543222111 0001110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+...+..+.+++.+||+.+|++|||+.|++++|+.
T Consensus 232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 ---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 011112234578899999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=359.05 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=205.1
Q ss_pred HccCCccccccCcCCcccEEEeEecC-cceEEEEEeccc---CccchHHHHHHHHHHHhc-CCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|+... ++.||||++.+. .....+.+.+|..+|..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999998764 889999999754 234456788999999988 7999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999853 245899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..... . ...
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~---~-~~~----- 238 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIM---E-HNV----- 238 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH---H-CCC-----
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH--HHHHH---h-CCC-----
Confidence 3221 223457899999999999999999999999999999999999999975432211 11110 0 000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 746 (795)
..+......+.+++.+||+.||++||+ +++|+++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011123457789999999999999995 5888876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.11 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=212.4
Q ss_pred HccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999974 3468899999975533 3457789999999999 9999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCC---------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEE
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTK---------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 609 (795)
..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999865432 124889999999999999999999998 999999999999
Q ss_pred ECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 003786 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLT 688 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 688 (795)
++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |..|+.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987654433333344567889999999999999999999999999999998 99998765433221
Q ss_pred HhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
. ..... .. ....+...+..+.+++.+||+.||++|||+.|++++|+...
T Consensus 258 ~-~~~~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 Y-KMIKE----GF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp H-HHHHH----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HHhcc----CC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 11100 00 00011123456789999999999999999999999997643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=360.80 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=193.8
Q ss_pred HHccCCccccccCcCCcccEEEeEecC-cc---eEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLLN-GQ---EVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
...++|++.+.||+|+||.||+|+... ++ .||||++... .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999998654 32 7999999754 33445789999999999999999999999988766
Q ss_pred e------eEEeecCCCCChhhhhhccCC---cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 546 K------ILIYEYMPNKSLDFFLFDSTK---ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 546 ~------~lv~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
. ++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 899999999999999854322 225889999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......... ...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--~~~-- 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY--NYL-- 252 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHH--
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH--HHH--
Confidence 9999999987654433333334567889999999999999999999999999999999 89888754432221 111
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..... ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 253 --~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 253 --IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp --HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00100 011122335688999999999999999999999998774
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.19 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=203.6
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|++ .+++.||||++.+.. ......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999986 468999999986532 23346789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+ +|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788777743 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+........ ..+..
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~ 222 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNS 222 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCS
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHc
Confidence 33 2344679999999999988776 78999999999999999999999754322210 00000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. ....+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 0 0011222345678899999999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.51 Aligned_cols=263 Identities=21% Similarity=0.224 Sum_probs=213.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999875 58999999996542 23457788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998542 45889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ..... .
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i----~~~~~------~ 256 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YEKI----VSGKV------R 256 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH----HHCCC------C
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH--HHHH----HcCCC------C
Confidence 2 2346899999999999999999999999999999999999999975432111 1111 00110 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHHccc--------cCCCCCCCCCCcc
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSMLTNK--------TINLPHPRQPAFS 763 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~L~~~--------~~~l~~p~~p~~~ 763 (795)
.+......+.+++.+||+.||++||+ ++||+++--.. ...++.|..|.+.
T Consensus 257 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~ 319 (350)
T 1rdq_E 257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCC
Confidence 11123456789999999999999998 89998864221 2245566666543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=358.51 Aligned_cols=255 Identities=20% Similarity=0.284 Sum_probs=203.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.+... ...+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999875 588999999976432 2345688999999988 89999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999998853 345899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh---HhHhHhhhccCcccccc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT---LLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 705 (795)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..............
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 236 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 236 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence 221 2234568999999999999999999999999999999999999999653221110 00000000000000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCH------HHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTM------FEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~ 746 (795)
..+......+.+++.+||+.||++||++ .|+++|
T Consensus 237 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0111234567889999999999999995 688776
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=375.33 Aligned_cols=258 Identities=28% Similarity=0.398 Sum_probs=210.4
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..++|++.++||+|+||.||+|++.+++.||||++.... ...+.+.+|+.+|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 457799999999999999999998888899999997543 45788999999999999999999999986 6678999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999995432 235788899999999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+++.|+|||++....++.++|||||||++|||++ |+.||........ ...... .. .
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~----~~---------~ 403 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IRALER----GY---------R 403 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHHHH----TC---------C
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc----CC---------C
Confidence 11223456789999999998999999999999999999999 9999875432221 111100 00 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
...+...+..+.+++.+||+.||++|||+++|+++|+....
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11112234578899999999999999999999999988543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=363.67 Aligned_cols=275 Identities=27% Similarity=0.360 Sum_probs=211.0
Q ss_pred ccCCccccccCcCCcccEEEeEe-----cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeee--eccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI--ELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 546 (795)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999983 358899999998776666678999999999999999999999887 45668
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999998542 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.|+........................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 653322 1223345688899999999999999999999999999999999998754221110000000000000000111
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCC
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTIN 753 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
+........+...+..+.+++.+||+.||++|||+.|++++|+.....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111111122233456788999999999999999999999999875443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=376.38 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=211.9
Q ss_pred ccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+|++.++||+|+||.||+|++.. ++.||||++.... ...+++.+|+.+|++++||||+++++++.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4678999999999999999998765 8899999996543 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999996432 345889999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+++.|+|||++....++.++|||||||++|||++ |..|+........ .... ... ..
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~~~~----~~~---------~~ 437 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELL----EKD---------YR 437 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHH----HTT---------CC
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----HcC---------CC
Confidence 22233456789999999999999999999999999999999 8888876443221 1111 111 11
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
...+..++..+.+++.+||+.+|++|||+.+|++.|+...
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1122234467889999999999999999999999998743
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.12 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=197.7
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCC--cccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQH--RNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.+|++++| |||+++++++.+....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456799999999999999999998889999999986542 2334678999999999986 999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 578899999854 345889999999999999999999998 99999999999997 6789999999998765
Q ss_pred CCccccccccccccccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQ-----------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+. ..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~~- 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----AI- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HH-
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH----HH-
Confidence 4433333345679999999999864 6789999999999999999999999964322211111 11
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+++......+......+.+++.+||+.||++|||+.|++++.
T Consensus 234 --------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 --------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111111111234677899999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.55 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=207.6
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3478999999999999999999875 68999999986543 234578899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999884 3345889999999999999999999998 999999999999999999999999999865433
Q ss_pred cccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
..........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||.............. .... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~--~~--- 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKT--YL--- 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTCT--TS---
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hccc--cc---
Confidence 32233345679999999999987665 7899999999999999999999976554332222111 0000 00
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+.+++.+||+.||++|||+.|++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0111234567789999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.99 Aligned_cols=270 Identities=18% Similarity=0.231 Sum_probs=206.2
Q ss_pred HccCCccccccCcC--CcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEG--GFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999875 68999999997543 233467889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999985432 245889999999999999999999998 999999999999999999999999998654
Q ss_pred CCCc-----cccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc---
Q 003786 628 GGDE-----LQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW--- 697 (795)
Q Consensus 628 ~~~~-----~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--- 697 (795)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2111 1112233478999999999987 67999999999999999999999999765433321110000000
Q ss_pred cC-----cc-------------cccccC---c------cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 KD-----DR-------------AWELID---P------TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ~~-----~~-------------~~~~id---~------~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .. ....+. + .............+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00 000000 0 00001222344568899999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=373.90 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=206.8
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..++|++.++||+|+||.||+|++..+..||||++.... ...+.+.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346789999999999999999998877889999997543 346789999999999999999999999876 778999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999532 2245889999999999999999999998 99999999999999999999999999987653322
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+++.|+|||.+....++.++|||||||++|||++ |+.|+........ .... ..+. .
T Consensus 336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i----~~~~---------~ 399 (452)
T 1fmk_A 336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQV----ERGY---------R 399 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHH----HTTC---------C
T ss_pred -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----HcCC---------C
Confidence 12223456889999999998999999999999999999999 8988865432211 1111 1110 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCC
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPH 756 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~ 756 (795)
...+...+..+.+++.+||+.+|++|||+++|+++|+......+.
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111223445788999999999999999999999999886544433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=357.40 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=202.6
Q ss_pred cCCccccccCcCCcccEEEeEec-Ccce----EEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQE----VAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 67999999999999999999864 4554 7777775432 334467889999999999999999999885 567899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998543 346889999999999999999999998 9999999999999999999999999999875
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............|++.|+|||++.+..++.++|||||||++|||++ |+.||............ ...... .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~~~~--~- 237 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL------EKGERL--A- 237 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH------HTTCBC--C-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH------HcCCCC--C-
Confidence 5443334445678889999999999999999999999999999999 99999765433321111 111000 0
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.+......+.+++.+||+.||++||++.|++++|...
T Consensus 238 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 238 ------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111223566899999999999999999999999774
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=351.96 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=190.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999865 58999999986543 2345778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccC---CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 552 YMPNKSLDFFLFDST---KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|++ ++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875432 1235888999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc--Cccccc-
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK--DDRAWE- 704 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~- 704 (795)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ........ ....+.
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL--KLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCTTTCGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCChhHhhh
Confidence 322 12234578999999999876 46899999999999999999999999765432211 11101000 000000
Q ss_pred -----ccCccc------------cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 705 -----LIDPTL------------QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 705 -----~id~~l------------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+.+ ...........+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 000111234578899999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=364.32 Aligned_cols=263 Identities=20% Similarity=0.219 Sum_probs=208.4
Q ss_pred HHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeee
Q 003786 467 LASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 467 ~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
+..+....++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|..++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4444556789999999999999999999875 68999999996532 2234568899999999999999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
.+..++||||+++|+|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999542 235889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQ-------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 695 (795)
+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+.... ....
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~i-- 282 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--YGKI-- 282 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH--
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--HHHH--
Confidence 9987654322 1223468999999999987 35789999999999999999999999975442221 1110
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCC---CCHHHHHHHH
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADR---PTMFEVVSML 747 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~R---Pt~~evl~~L 747 (795)
...... ..-+. .....+..+.++|.+||+ +|++| |+++||++|-
T Consensus 283 -~~~~~~--~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 283 -VHYKEH--LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp -HTHHHH--CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred -HhcccC--cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 000000 00010 112234577899999999 99998 6999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=358.72 Aligned_cols=254 Identities=23% Similarity=0.240 Sum_probs=194.3
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3478999999999999999999875 68899999996543 345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC--eeeeccccccccCC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGMARIFGG 629 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--vkL~DFGla~~~~~ 629 (795)
|+++++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999998843 345899999999999999999999998 999999999999987765 99999999974322
Q ss_pred CcccccccccccccccccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIK-SDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k-~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... ..........
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-~~~~~~~~~~------- 239 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK-TIQRILSVKY------- 239 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH-HHHHHHTTCC-------
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhcCCC-------
Confidence 2 22334579999999999988877655 8999999999999999999976543222111 0001100000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...........+.+++.+||+.||++|||+.|+++|
T Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000001123567899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=340.55 Aligned_cols=254 Identities=27% Similarity=0.486 Sum_probs=204.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccc-------hHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG-------QEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999864 68999999986543222 267899999999999999999999986655
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC-----eeeec
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISD 620 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-----vkL~D 620 (795)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999998887543 346899999999999999999999875 34999999999999988876 99999
Q ss_pred cccccccCCCcccccccccccccccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ--QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.................
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 245 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-- 245 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--
Confidence 999985432 233467999999999984 45688999999999999999999999976554443322221111
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
. .....+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus 246 -~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 -G---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -C---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -C---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0 0111122234578899999999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.19 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=190.5
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999876 47889999997542 44678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeeccccccccC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMARIFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFGla~~~~ 628 (795)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998843 345899999999999999999999998 999999999999975 8899999999998754
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||............ . .. ... ...
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-i---~~-~~~-~~~-- 271 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-I---LN-CEY-YFI-- 271 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-H---HT-TCC-CCC--
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-H---Hh-CCC-ccC--
Confidence 322 223467999999999999999999999999999999999999998654432211111 1 00 000 000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..........+.+++.+||+.||++|||+.|++++
T Consensus 272 ---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 ---SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112234567899999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.03 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=195.6
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeeccee---
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK--- 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 546 (795)
.++|++.+.||+|+||.||+|++ .+++.||||++...... ....+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999986 46899999999764322 235788999999999999999999998876644
Q ss_pred -eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 547 -ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 547 -~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999853 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 626 IFGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-----~~~~~~~~- 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-----HVREDPIP- 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHCCCCC-
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----HhcCCCCC-
Confidence 6643321 1223345799999999999999999999999999999999999999975442221111 01111000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+..+.+++.+||+.||++||++.+++++
T Consensus 239 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 239 ------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp ------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 001111234568899999999999999977776654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=358.12 Aligned_cols=249 Identities=27% Similarity=0.349 Sum_probs=198.6
Q ss_pred ccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCCC
Q 003786 478 STENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
...+.||+|+||.||+|+.. +++.||||++........+.+.+|+++|++++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999864 58999999998766566788999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE--CCCCCeeeeccccccccCCCcccc
Q 003786 557 SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll--~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 998888532 345889999999999999999999998 9999999999999 667889999999998765433
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......||+.|+|||++....++.++|||||||++|||++|+.||........ ...... .. +. +....
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~---~~--~~-----~~~~~ 311 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILA---CR--WD-----LEDEE 311 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---TC--CC-----SCSGG
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh---cc--CC-----CChhh
Confidence 22335799999999999999999999999999999999999999975442221 111100 00 00 01111
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.......+.+++.+||+.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12234578899999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=354.87 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=195.9
Q ss_pred ccCCccccccCcCCcccEEEeEe----cCcceEEEEEecccC----ccchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+++. .+++.||||++.+.. ......+.+|+.+|++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 468899999997642 2334568899999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998853 345888999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... . .
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~---~-~---- 237 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--IDKILK---C-K---- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH---T-C----
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHh---C-C----
Confidence 543221 123346799999999999999999999999999999999999999975432211 111100 0 0
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L 747 (795)
. ..+......+.+++.+||+.||++|| ++.|+++|-
T Consensus 238 --~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 238 --L----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp --C----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred --C----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 0 01112345678899999999999999 788998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=355.15 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=209.9
Q ss_pred HccCCccccccCcCCcccEEEeEec--------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIE 542 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 542 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999853 46789999997543 23456789999999999 89999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEE
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 609 (795)
.+..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965432 234888999999999999999999998 999999999999
Q ss_pred ECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 003786 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLT 688 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 688 (795)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..|+........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 99999999999999987655443333444567889999999998899999999999999999999 9999865432221
Q ss_pred HhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.... ..... ...+......+.+++.+||+.+|++||++.|++++|+..
T Consensus 269 -~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 269 -FKLL----KEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp -HHHH----HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHH----hcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 00100 001112345678899999999999999999999999774
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.38 Aligned_cols=270 Identities=26% Similarity=0.379 Sum_probs=204.5
Q ss_pred cCCccccccCcCCcccEEEeEe-----cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec--cee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.+|++.++||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999983 358899999997543 34457899999999999999999999999877 668
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998543 245889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
....... .......||..|+|||.+.+..++.++||||||+++|+|++|..|+..........................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543321 223345688899999999999999999999999999999999987532110000000000000000000000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 00111111222344678899999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.00 Aligned_cols=263 Identities=16% Similarity=0.194 Sum_probs=210.5
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999986 46899999998643 2345689999999999 79999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC-----eeeeccccccc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISDFGMARI 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-----vkL~DFGla~~ 626 (795)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998543 235899999999999999999999988 999999999999987776 99999999987
Q ss_pred cCCCccc-----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCc
Q 003786 627 FGGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDD 700 (795)
Q Consensus 627 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~ 700 (795)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 123456799999999999999999999999999999999999999976543222 1111110000000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCC
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTIN 753 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
.. .......+..+.+++.+||+.+|++||++++|++.|+.....
T Consensus 241 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 241 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 00 011112345788999999999999999999999999875443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=364.57 Aligned_cols=253 Identities=25% Similarity=0.308 Sum_probs=197.9
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcC--CcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQ--HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 549 (795)
..+|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.+|++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45699999999999999999998789999999986542 334577899999999996 59999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999998543 35788899999999999999999988 99999999999995 58999999999987654
Q ss_pred Cccccccccccccccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQ-----------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+. ...
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~----~~~- 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----AII- 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----HHH-
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH----HHh-
Confidence 332223345679999999999865 4689999999999999999999999965332211111 111
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
++......+......+.+++.+||+.||++||++.|++++.
T Consensus 282 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11111111111134678899999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.44 Aligned_cols=268 Identities=29% Similarity=0.399 Sum_probs=205.1
Q ss_pred CccccccCcCCcccEEEeEe-----cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeE
Q 003786 477 FSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKIL 548 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 548 (795)
|++.++||+|+||.||++.+ .+++.||||++.... ....+.+.+|+++|++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999988753 257889999997653 23456789999999999999999999999874 67899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 23889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.|+........................+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43221 22334568889999999999899999999999999999999999875422111100000000000000111111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
.......+...+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111222334567889999999999999999999999997743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=363.92 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=206.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|.+.+.||+|+||.||+|++. +|+.||||++.+.. ....+.+.+|+.+|+.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999875 69999999996542 23456789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999843 445899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+....... .... ..+..
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~~i----~~~~~------ 233 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--FKKI----CDGIF------ 233 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--HHHH----HTTCC------
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--HHHH----hcCCc------
Confidence 32 2334679999999999988765 7899999999999999999999975443221 1111 01100
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.||++|||+.|++++
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0011123467889999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.06 Aligned_cols=264 Identities=20% Similarity=0.221 Sum_probs=203.4
Q ss_pred HhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc-----CccchHHHHHHHHHHHhcCCcccceeeeeee
Q 003786 468 ASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI 541 (795)
Q Consensus 468 ~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 541 (795)
.++....++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 345566788999999999999999999864 5888999998653 2344578999999999999999999999999
Q ss_pred ecceeeEEeecCCCCChhhhhhccC-------------------------------------CcccCChhhHHHHHHHHH
Q 003786 542 ELEEKILIYEYMPNKSLDFFLFDST-------------------------------------KENLLGWGTRVRIIEGIA 584 (795)
Q Consensus 542 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~ 584 (795)
+.+..++||||+++++|.+++.... ....+++..+..++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999999884211 012245677889999999
Q ss_pred HHHHHHHhcCCCcEEeccCCCCcEEECCCC--CeeeeccccccccCCCc--cccccccccccccccccccccc--CCCCc
Q 003786 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDM--NPKISDFGMARIFGGDE--LQSKTKRIVGTYGYMSPEYAQQ--GLFSI 658 (795)
Q Consensus 585 ~~l~~LH~~~~~~iiHrDikp~NIll~~~~--~vkL~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~--~~~~~ 658 (795)
+||.|||+.+ |+||||||+|||++.++ .+||+|||++..+.... .........||+.|+|||++.+ ..++.
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999998 99999999999998776 89999999998653211 1112344679999999999865 67899
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCC
Q 003786 659 KSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRP 738 (795)
Q Consensus 659 k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP 738 (795)
++|||||||++|||++|+.||......... ... ...... ............+.+++.+||+.+|++||
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~---~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQV---LNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHH---HHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHH--HHH---Hhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999999754422211 111 111000 01111112345678999999999999999
Q ss_pred CHHHHHHH
Q 003786 739 TMFEVVSM 746 (795)
Q Consensus 739 t~~evl~~ 746 (795)
++.|++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.23 Aligned_cols=264 Identities=26% Similarity=0.370 Sum_probs=201.3
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC-----ccchHHHHHHHHHHHhcC---Ccccceeeeeeeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS-----GQGQEEFKNEIKLIAKLQ---HRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 543 (795)
..++|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999986 468999999986432 122356778888887775 99999999999876
Q ss_pred c-----eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 544 E-----EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 544 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5789999998 59988885432 234899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc-
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW- 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~- 697 (795)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence 9999998764332 23446789999999999999999999999999999999999999976543222 11111110
Q ss_pred --cCccccc-------ccC---ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 --KDDRAWE-------LID---PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 --~~~~~~~-------~id---~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....... ... +.............+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 000 000011122344678899999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.29 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=203.9
Q ss_pred ccCCccccccCcCCcccEEEeEecC-c-------ceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|+... + +.||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998643 3 4699999977766677889999999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC--------ee
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--------PK 617 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--------vk 617 (795)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999543 334889999999999999999999998 999999999999998887 99
Q ss_pred eeccccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 618 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+......... .....
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~-- 232 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYE-- 232 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHH--
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhh--
Confidence 999999875432 223568899999999987 77999999999999999999966554332221111 11100
Q ss_pred ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
...... +. ....+.+++.+||+.||++|||+.|++++|+....
T Consensus 233 -~~~~~~----~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 -DRHQLP----AP--------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -TTCCCC----CC--------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -ccCCCC----CC--------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 001110 00 12356789999999999999999999999988543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=356.52 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=211.3
Q ss_pred HHHccCCccccccCcCCcccEEEeEec------CcceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeec
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
....++|++.+.||+|+||.||+|+.. .++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 445688999999999999999999754 377899999975432 3345788999999999999999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCC-------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTK-------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 999999999999999999854321 245688999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..|+........ ....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~-- 253 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LRFV-- 253 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HHHH--
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--HHHH--
Confidence 9999999986644333333344567899999999999999999999999999999999 7888765432211 1111
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...... ..+...+..+.+++.+||+.+|++|||+.|++++|+..
T Consensus 254 --~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 254 --MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp --HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 111110 01112345678899999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.39 Aligned_cols=246 Identities=25% Similarity=0.277 Sum_probs=194.3
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.++||+|+||.||+|+.. +++.||||++..... ....++..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999876 689999999865432 2334455666666555 899999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 66888777543 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... +...... .
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~--------~ 268 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQG--------Y 268 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTT--------C
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhcc--------C
Confidence 32 2334569999999998876 789999999999999999999776542110 1111111 1
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
............+.+++.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1112223345678899999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=367.94 Aligned_cols=250 Identities=28% Similarity=0.411 Sum_probs=204.8
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecc-eeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE-EKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E 551 (795)
..++|++.++||+|+||.||+|+.. ++.||||++.... ..+.+.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467999999999999999999874 7899999997543 5678999999999999999999999987765 7899999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999643 2334788999999999999999999998 999999999999999999999999999854322
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.|+........ .... ..+.
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i----~~~~--------- 403 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRV----EKGY--------- 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHH----HTTC---------
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----HcCC---------
Confidence 122357889999999999999999999999999999998 9999876543322 1111 1110
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+..++..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011122344678899999999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.10 Aligned_cols=268 Identities=17% Similarity=0.192 Sum_probs=201.5
Q ss_pred ccCCccccccCcCCcccEEEeEec----CcceEEEEEecccCcc-----------chHHHHHHHHHHHhcCCcccceeee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQ-----------GQEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
.++|++.+.||+|+||.||+|+.. .+..+|||++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 5788999998654321 1234667888999999999999999
Q ss_pred eeee----cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC
Q 003786 539 CCIE----LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 539 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 614 (795)
++.. ....++||||+ +++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77889999999 99999998433 36899999999999999999999998 99999999999999887
Q ss_pred --CeeeeccccccccCCCcc-----cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 003786 615 --NPKISDFGMARIFGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687 (795)
Q Consensus 615 --~vkL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 687 (795)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643211 1112445799999999999999999999999999999999999999964332222
Q ss_pred hHhHhHhhhccCcccccccCccccch-hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCC
Q 003786 688 TLLGHAWDLWKDDRAWELIDPTLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754 (795)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l 754 (795)
........... .+...+... .....+..+.+++.+||+.+|++||++.+|++.|+....++
T Consensus 269 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 269 AVQTAKTNLLD------ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHH------TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHHHHhhcc------cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 11111111000 000000000 00023457889999999999999999999999998855533
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.58 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=206.1
Q ss_pred ccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.++||+|+||.||+|+... ++.+|+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999998754 778999999876667778999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---CCCCCeeeeccccccccCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~vkL~DFGla~~~~~ 629 (795)
+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999888844 345889999999999999999999998 9999999999999 7889999999999987654
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||........ .... ..... .
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~----~~~~~------~ 225 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--MLKI----REGTF------T 225 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH----HHCCC------C
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HHHH----HhCCC------C
Confidence 32 23345799999999988654 89999999999999999999999875432221 1110 00000 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111234578899999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.34 Aligned_cols=264 Identities=25% Similarity=0.287 Sum_probs=200.1
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|++.++||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999875 4899999998654322 24668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 345889999999999999999999998 9999999999999999999999999998765322
Q ss_pred cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh---------hhccCcc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW---------DLWKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~---------~~~~~~~ 701 (795)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............... ..+....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 12234578999999999876 67899999999999999999999999765432221111000 0000000
Q ss_pred c---ccccCccccc---hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 A---WELIDPTLQN---EASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~---~~~id~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ....++.... ......+..+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000110000 0112234568899999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=351.68 Aligned_cols=267 Identities=26% Similarity=0.385 Sum_probs=200.2
Q ss_pred HHHHccCCccccccCcCCcccEEEeEec----CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
+....++|.+.+.||+|+||.||+|+.. .++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3345678999999999999999999754 35589999986542 23346789999999999999999999999876
Q ss_pred ce-----eeEEeecCCCCChhhhhhcc---CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 544 EE-----KILIYEYMPNKSLDFFLFDS---TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 544 ~~-----~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
+. .++||||+++++|..++... .....+++..+..++.||++||.|||+++ |+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 54 48999999999999988533 23456899999999999999999999988 999999999999999999
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHh
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 694 (795)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..|+........ ....
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~- 262 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDYL- 262 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHH-
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHH-
Confidence 99999999987654433233344567889999999999999999999999999999999 8888865443222 1111
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCC
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l 754 (795)
..... ...+...+..+.+++.+||+.+|++||++.+++++|+.....+
T Consensus 263 ---~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 ---LHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ---HTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00100 0111223457889999999999999999999999998754433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=348.89 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=206.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc------chHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ------GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999875 5899999998654322 357899999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC----Ceeeeccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~vkL~DFG 622 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999853 345889999999999999999999998 99999999999999888 79999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... ...
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~----~~~- 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANIT----SVS- 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH----TTC-
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH----hcc-
Confidence 998765432 22345799999999999999999999999999999999999999865432211 11110 000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...........+..+.+++.+||+.||++|||+.|++++
T Consensus 235 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 -----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111122234567899999999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.82 Aligned_cols=266 Identities=27% Similarity=0.370 Sum_probs=211.6
Q ss_pred HhHHHHccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeee
Q 003786 468 ASVSAATANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGC 539 (795)
Q Consensus 468 ~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~ 539 (795)
.......++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444568899999999999999999974 3468899999976432 2346789999999999 79999999999
Q ss_pred eeecc-eeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCC
Q 003786 540 CIELE-EKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKA 605 (795)
Q Consensus 540 ~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp 605 (795)
+...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 88765 48999999999999999965432 123788899999999999999999998 99999999
Q ss_pred CcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 003786 606 SNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNT 684 (795)
Q Consensus 606 ~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~ 684 (795)
+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..|+.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987654433333444678899999999999999999999999999999998 9999876443
Q ss_pred cchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 685 NSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..... ... ...... ..+......+.+++.+||+.||++|||+.||+++|+..
T Consensus 257 ~~~~~-~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 257 DEEFC-RRL----KEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SHHHH-HHH----HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHH-HHh----ccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 32211 111 001000 01111235678899999999999999999999999763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=369.63 Aligned_cols=250 Identities=23% Similarity=0.263 Sum_probs=196.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.+. .......+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 5899999999753 233446678899999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||+++++|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988843 3458999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .....
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~--~~~~~------- 367 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELIL--MEEIR------- 367 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH--HCCCC-------
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HHHHH--hCCCC-------
Confidence 222 223457899999999999999999999999999999999999999965432221 11110 00001
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L 747 (795)
.+......+.+++.+||+.||++|| +++|+++|-
T Consensus 368 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 368 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 1112235678999999999999999 999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=343.00 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=209.2
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36799999999999999999998888899999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999998543 345889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+........ .... .... ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~i----~~~~--~~~------ 225 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VEDI----STGF--RLY------ 225 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHH----HTTC--CCC------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--HHHH----hcCC--cCC------
Confidence 12233467889999999998899999999999999999999 8888865432111 1111 0110 000
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.+......+.+++.+||+.+|++||++.+++++|+..
T Consensus 226 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 226 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1112245678899999999999999999999999763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.01 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=195.1
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..++|++.++||+|+||.||+|+.. ..+|||++.... ....+.+.+|+.+|++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3478999999999999999999853 469999986543 23446789999999999999999999965 566789999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999988432 345889999999999999999999998 999999999999999999999999999865433
Q ss_pred cccccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..........||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ...... ......+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~----~~~~~~~- 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IEMVGR----GSLSPDL- 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH-HHHHHH----TSCCCCT-
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH-HHHhcc----cccCcch-
Confidence 3233334567999999999886 567899999999999999999999999764432221 111111 1110000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
.......+..+.+++.+||+.+|++||++.|++++|+...
T Consensus 248 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 ----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0111223457889999999999999999999999998743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.51 Aligned_cols=250 Identities=23% Similarity=0.249 Sum_probs=181.6
Q ss_pred ccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEeecCCCCC
Q 003786 480 ENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs 557 (795)
.++||+|+||.||+|++. +++.||||++.+. ....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999875 5899999999643 4567889999999997 9999999999999999999999999999
Q ss_pred hhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---CeeeeccccccccCCCcccc
Q 003786 558 LDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL~DFGla~~~~~~~~~~ 634 (795)
|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 9999854 345899999999999999999999998 99999999999998766 79999999998654332 2
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ............+. ......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~------~~~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD------FSFEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC------CCCCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC------CCCCcc
Confidence 23345789999999999999999999999999999999999999976442111 00000111111111 011122
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.....+..+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 223345678899999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.72 Aligned_cols=264 Identities=24% Similarity=0.306 Sum_probs=192.1
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcC-Ccccceeeeeeeecc--ee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELE--EK 546 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 546 (795)
..++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+|+++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 5899999998653 2334567889999999997 999999999997554 68
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++|||||+ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 578887743 35888999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCc-------------------cccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 003786 627 FGGDE-------------------LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686 (795)
Q Consensus 627 ~~~~~-------------------~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 686 (795)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53211 0112234579999999999876 679999999999999999999999997654222
Q ss_pred hhHhHhHhhhccCccc--cccc-------------------Cccccchhh------------HHHHHHHHHHHHhhccCC
Q 003786 687 LTLLGHAWDLWKDDRA--WELI-------------------DPTLQNEAS------------YLILNRYINVGLLCVQED 733 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~--~~~i-------------------d~~l~~~~~------------~~~~~~l~~li~~cL~~d 733 (795)
. +............ ...+ ........+ ......+.+++.+||+.|
T Consensus 239 ~--~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 239 Q--LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp H--HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred H--HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1 1111011000000 0000 000000000 022356889999999999
Q ss_pred CCCCCCHHHHHHH
Q 003786 734 AADRPTMFEVVSM 746 (795)
Q Consensus 734 P~~RPt~~evl~~ 746 (795)
|++|||+.|+++|
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.14 Aligned_cols=268 Identities=23% Similarity=0.262 Sum_probs=207.6
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeee----cceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 547 (795)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999986 5689999999976665667789999999999999999999999873 45788
Q ss_pred EEeecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
+||||+++++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999886422 2456899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCccc-------ccccccccccccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 627 FGGDELQ-------SKTKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 627 ~~~~~~~-------~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
....... .......||+.|+|||++.... ++.++|||||||++|||++|+.||+.............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---
Confidence 4321110 0112345799999999987543 78999999999999999999999853211111111000
Q ss_pred ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCC
Q 003786 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPH 756 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~ 756 (795)
... ............+.+++.+||+.||.+||++.+++++|+....+.|.
T Consensus 261 -~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 261 -QNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp -HCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred -hcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 000 00001112345788999999999999999999999999885544433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.28 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=200.0
Q ss_pred cCCccc-cccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTE-NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 551 (795)
+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+++|.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 568874 78999999999999854 6899999999776666678899999999985 79999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC---eeeeccccccccC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGMARIFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---vkL~DFGla~~~~ 628 (795)
|+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999998543 45889999999999999999999998 999999999999998776 9999999998653
Q ss_pred CCcc-----ccccccccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh--------
Q 003786 629 GDEL-----QSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL-------- 690 (795)
Q Consensus 629 ~~~~-----~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~-------- 690 (795)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223569999999999875 5689999999999999999999999976543221000
Q ss_pred -HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 691 -GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 691 -~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
............ .+...........+.+++.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 246 QNMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 000000000000 000011112345788999999999999999999999963
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.31 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=211.2
Q ss_pred HccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
...+|++.+.||+|+||.||+|++.. ++.||||++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999998764 888999999653 3446789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998543 2345889999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|+......... ... ... .
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~--~~~----~~~---------~ 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELL----EKD---------Y 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--HHH----HTT---------C
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHH----hcc---------C
Confidence 2 22333567889999999999999999999999999999999 88888754432221 111 000 0
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+...+..+.+++.+||+.||++||++.|++++|+.
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 011112234578899999999999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=367.22 Aligned_cols=261 Identities=22% Similarity=0.240 Sum_probs=196.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec------
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 543 (795)
..++|++.++||+|+||.||+|++. +++.||||++... .....+++.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999864 5889999999654 233456788999999999999999999998655
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
...++||||++++ |...+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3569999999876 444442 23788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc-----
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK----- 698 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~----- 698 (795)
++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.... .........
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPE 285 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHH
Confidence 98764332 23446899999999999999999999999999999999999999976542211 100000000
Q ss_pred --------------Cc------ccccccCccc---cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 699 --------------DD------RAWELIDPTL---QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 699 --------------~~------~~~~~id~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.. .........+ ...........+.+|+.+||+.||++|||++|+++|-
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 00 0000000000 0112223356789999999999999999999999973
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.83 Aligned_cols=249 Identities=24% Similarity=0.269 Sum_probs=194.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHH-HHhcCCcccceeeeeeeecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKL-IAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.+... ...+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999875 478899999976432 233456677776 567899999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998853 345889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.... .... ... ..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i---~~~-~~------ 256 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNI---LNK-PL------ 256 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--HHHH---HHS-CC------
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HHHH---Hhc-cc------
Confidence 221 234457899999999999999999999999999999999999999965432221 1111 000 00
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHH----HHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMF----EVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~----evl~~ 746 (795)
. .+......+.+++.+||+.||++||++. ++++|
T Consensus 257 ~----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 257 Q----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp C----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred C----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 0 1112234678899999999999999974 55554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=356.31 Aligned_cols=261 Identities=28% Similarity=0.390 Sum_probs=209.0
Q ss_pred HHccCCccccccCcCCcccEEEeEecC-c-----ceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeec
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
...++|++.+.||+|+||.||+|+... + +.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999998642 2 4799999975432 3456789999999999 899999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCC-----------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTK-----------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~ 612 (795)
+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999864321 245788999999999999999999998 999999999999999
Q ss_pred CCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhH
Q 003786 613 DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLG 691 (795)
Q Consensus 613 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 691 (795)
++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |..|+.......... .
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-K 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-H
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-H
Confidence 99999999999986543332223334567889999999999999999999999999999998 888887544332211 1
Q ss_pred hHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 692 HAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 692 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.... .. ....+...+..+.+++.+||+.||.+|||+.||+++|+.
T Consensus 279 ~~~~----~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 279 LVKD----GY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHH----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhc----CC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1100 00 000111123567889999999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=369.26 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=208.3
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||.||+|+.. +|+.||||++.+. .......+.+|+.+|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 6899999999653 23345678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++|+|..++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999885432 344899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch--hHhHhHhhhccCccccccc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL--TLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~i 706 (795)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ........ ...
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~------ 406 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPE------ 406 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCC------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccc------
Confidence 332 22345899999999999999999999999999999999999999976543211 11111100 000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
..+......+.++|.+||+.||++|| ++.||++|
T Consensus 407 ------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 ------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01122345778999999999999999 78999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=339.72 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=204.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999865 58899999986542 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC---eeeecccccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---vkL~DFGla~~~ 627 (795)
||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888743 345889999999999999999999998 999999999999987655 999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ...... ... ...
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~----~~~-~~~- 227 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YAQIKA----GAY-DYP- 227 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH----TCC-CCC-
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--HHHHHh----ccc-cCC-
Confidence 5332 22346799999999999999999999999999999999999999865432221 111100 000 000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..........+.+++.+||+.||++|||+.|++++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 ----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00111233567899999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.41 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=207.7
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46899999999999999999998888899999996543 45678999999999999999999999976 45689999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 999999998432 1235889999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..... .... . .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~----~~~~--~-------~ 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNL----ERGY--R-------M 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----HTTC--C-------C
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHH----hccc--C-------C
Confidence 12233457889999999998899999999999999999999 888886543221 11111 0010 0 0
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
..+...+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 011123457889999999999999999999999997743
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=351.97 Aligned_cols=257 Identities=23% Similarity=0.278 Sum_probs=204.6
Q ss_pred ccCCccccccCcCCcccEEEeEe----cCcceEEEEEecccC----ccchHHHHHHHHHHHhc-CCcccceeeeeeeecc
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
.++|++.++||+|+||.||+++. .+++.||||++.+.. ....+.+.+|+++|+++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999986 368999999987532 23456788899999999 6999999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..++||||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998543 45889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ........
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRILKS--- 281 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHHHC---
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH-HHHHHhcc---
Confidence 86543222 22334679999999999985 4578999999999999999999999975442221111 00010000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHHcc
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSMLTN 749 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L~~ 749 (795)
.+ ..+......+.+++.+||+.||++|| +++|++++.-.
T Consensus 282 ----~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 282 ----EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp ----CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ----CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 00 11122335677899999999999999 99999997644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.41 Aligned_cols=265 Identities=21% Similarity=0.288 Sum_probs=196.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.++||+|+||.||+|+.. +++.||||++...... ....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 6889999999654322 223456799999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 985 777777433 345889999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHhHhhhccCcccccccC---
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGHAWDLWKDDRAWELID--- 707 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~id--- 707 (795)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ..................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12234578999999999876 678999999999999999999999997654322211 111000000000000000
Q ss_pred ------cccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 708 ------PTLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 708 ------~~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+... ..........+.+++.+||+.||++|||++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 0000 011122345678999999999999999999999963
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=346.01 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=194.5
Q ss_pred HccCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 34789999999999999999998643 4569999986543 33456789999999999999999999997 456789
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998543 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
...... ......+++.|+|||++....++.++|||||||++|||++ |..||........ .... ......
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i----~~~~~~--- 236 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRI----ENGERL--- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH----HTTCCC---
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHH----HcCCCC---
Confidence 433221 2233457889999999998999999999999999999996 8889875443222 1111 001000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1112234567889999999999999999999999876
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.09 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=201.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999865 47789999986532 2345678999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999888533 45889999999999999999999988 9999999999999999999999999986543
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ...... . ..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~----~------~~ 224 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRISR----V------EF 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH----T------CC
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHHHHh----C------CC
Confidence 22 22345789999999999999999999999999999999999999875432211 111000 0 00
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
..+......+.+++.+||+.+|++|||++|++++.
T Consensus 225 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 225 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 01112335677899999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.31 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=198.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-Ccce----EEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQE----VAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999854 4554 467766443 3445678999999999999999999999998754 78
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+|+||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988543 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............+|+.|+|||.+.+..++.++|||||||++|||++ |..||........... . ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--~----~~~~----- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--L----EKGE----- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--H----HTTC-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--H----HcCC-----
Confidence 54433333344567889999999999999999999999999999999 9999876543332111 1 0010
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
....+......+.+++.+||+.||++||++.|+++.|....
T Consensus 237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00111223346788999999999999999999999998743
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=365.25 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=207.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 58999999996542 23456788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||+++|+|..++..... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998865432 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch--hHhHhHhhhccCccccccc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL--TLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~i 706 (795)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ .+.... ... ..
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~~-~~---- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LEQ-AV---- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HHC-CC----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hhc-cc----
Confidence 3321 23346899999999999999999999999999999999999999976542211 111111 000 00
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTM-----FEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~ 746 (795)
..+...+..+.+++.+||+.||++||++ .+|++|
T Consensus 411 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 411 ------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 0112234567889999999999999965 778765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=353.23 Aligned_cols=269 Identities=17% Similarity=0.189 Sum_probs=202.6
Q ss_pred HccCCccccccCcCCcccEEEeEecC------cceEEEEEecccCccc-----------hHHHHHHHHHHHhcCCcccce
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQG-----------QEEFKNEIKLIAKLQHRNLVR 535 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 535 (795)
..++|++.++||+|+||.||+|++.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 4789999986543211 112334566677788999999
Q ss_pred eeeeeeec----ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 536 LLGCCIEL----EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 536 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
+++++.+. ...++||||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998875 4589999999 99999998542 345899999999999999999999998 99999999999999
Q ss_pred --CCCCeeeeccccccccCCCccc-----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 003786 612 --KDMNPKISDFGMARIFGGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT 684 (795)
Q Consensus 612 --~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~ 684 (795)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876432211 112335699999999999999999999999999999999999999975332
Q ss_pred cchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 685 NSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.... ........ .....+++++.+.. ...+..+.+++..||+.+|++||++.+|+++|+....
T Consensus 267 ~~~~-~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 DPKY-VRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CHHH-HHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHH-HHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 2221 11111000 01111122211110 1224578899999999999999999999999876433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.08 Aligned_cols=271 Identities=24% Similarity=0.244 Sum_probs=208.9
Q ss_pred CcccHHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-----Cccccee
Q 003786 463 PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-----HRNLVRL 536 (795)
Q Consensus 463 ~~~~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 536 (795)
..+++.......++|++.++||+|+||.||+|+.. +++.||||++... ....+.+..|+.++++++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34455555566789999999999999999999874 5889999999642 334567788999999997 9999999
Q ss_pred eeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC----
Q 003786 537 LGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---- 612 (795)
Q Consensus 537 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---- 612 (795)
++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 999999885433 234889999999999999999999998 999999999999975
Q ss_pred ---------------------CCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHH
Q 003786 613 ---------------------DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671 (795)
Q Consensus 613 ---------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~e 671 (795)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999864422 234678999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCcchhHhHhHhhhccC--------------------cccccccCcccc------------chhhHHHH
Q 003786 672 TLSSKRNTDFSNTNSLTLLGHAWDLWKD--------------------DRAWELIDPTLQ------------NEASYLIL 719 (795)
Q Consensus 672 lltG~~p~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~id~~l~------------~~~~~~~~ 719 (795)
|++|+.||........ .......... ............ ........
T Consensus 252 ll~g~~pf~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEH--LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHSSCSCCCSSHHHH--HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHCCCCCCCCcHHHH--HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 9999999975442211 1110000000 000000000000 00011112
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 720 NRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 720 ~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+.+++.+||+.||++|||+.|++++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 567799999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=358.31 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=193.5
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--------ccchHHHHHHHHHHHhcCCcccceeeeeeee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--------GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
...++|.+.+.||+|+||.||+|... +++.||||++.+.. ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999864 58899999986532 122335889999999999999999999975
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---Ceeee
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKIS 619 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~vkL~ 619 (795)
.+..++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456799999999999988884 3456899999999999999999999998 99999999999997544 59999
Q ss_pred ccccccccCCCccccccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ....
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~~i--- 357 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-KDQI--- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-HHHH---
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-HHHH---
Confidence 999998765332 2344679999999999853 67889999999999999999999999754322211 1100
Q ss_pred ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... .............+.+++.+||+.||++|||+.|++++
T Consensus 358 -~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 -TSGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HTTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -hcCCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00011112234678899999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.88 Aligned_cols=243 Identities=22% Similarity=0.282 Sum_probs=201.7
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCc--------cchHHHHHHHHHHHhcCCcccceeeeeeeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSG--------QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+|++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 347899999999999999999985 4688999999975431 1345678899999999999999999999999
Q ss_pred ceeeEEeecCCCC-ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 544 EEKILIYEYMPNK-SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 544 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
+..++||||+.+| +|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99888843 345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------- 237 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------- 237 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence 998765432 2234679999999999988776 889999999999999999999985311100
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... .+......+.+++.+||+.||++|||+.|++++
T Consensus 238 -~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -EAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -hhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011123567899999999999999999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.82 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=201.2
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..++|++.+.||+|+||.||+++.. +++.||||++.+... ...+|+++|.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999875 588999999965432 345788889888 7999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-C---Ceeeeccccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-M---NPKISDFGMARI 626 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~---~vkL~DFGla~~ 626 (795)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||+..+ + .+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998853 345899999999999999999999998 9999999999998543 3 499999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCcccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 705 (795)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..||........ .+.... ..+..
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~--- 240 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKF--- 240 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCC---
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCc---
Confidence 64332 123346789999999999888899999999999999999999999975432222 111111 00110
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+...........+.+++.+||+.||++||++.|++++
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111112234567899999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=355.52 Aligned_cols=271 Identities=20% Similarity=0.246 Sum_probs=212.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecc--eeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 549 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999875 48999999997543 344577889999999999999999999998765 67999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE----CCCCCeeeecccccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAR 625 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~vkL~DFGla~ 625 (795)
|||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966554455899999999999999999999998 9999999999999 777889999999998
Q ss_pred ccCCCccccccccccccccccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch--hHhHhHhh
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQ--------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL--TLLGHAWD 695 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~ 695 (795)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 765432 2234679999999998865 5678999999999999999999999864332111 11111111
Q ss_pred hccCcccccc---c--------CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 696 LWKDDRAWEL---I--------DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 696 ~~~~~~~~~~---i--------d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.......... . +..............+.+++.+||+.||++||++.|+++.+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 0000000000 0 00111234466778889999999999999999999999987663
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=340.52 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|.+.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+++|++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999864 58899999986643 3456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---CCCCCeeeecccccccc
Q 003786 552 YMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIF 627 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~vkL~DFGla~~~ 627 (795)
|+++++|.+.+.... ....+++..+..++.||++||.|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999988885432 2356899999999999999999999998 9999999999999 45688999999999865
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||......... ... ........ ...
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~--~~~~~~~~-~~~ 248 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKA--TYKEPNYA-VEC 248 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHH--HHCCCCCC-C--
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhh--ccCCcccc-ccc
Confidence 4332 233467999999999886 56899999999999999999999999754422211 110 00111100 000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .....+.+++.+||+.||++|||+.|++++
T Consensus 249 ----~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 249 ----R----PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ----C----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 023467789999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.65 Aligned_cols=266 Identities=23% Similarity=0.288 Sum_probs=195.5
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44578999999999999999999854 688999999965432 234567899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-----CCCCeeeecccc
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-----KDMNPKISDFGM 623 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-----~~~~vkL~DFGl 623 (795)
||||+++ +|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 888888433 34889999999999999999999998 99999999999994 455699999999
Q ss_pred ccccCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH-hhhccCc-
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA-WDLWKDD- 700 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~- 700 (795)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............. .......
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 98764332 123345789999999998774 589999999999999999999999976543221111100 0000000
Q ss_pred ------------ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 ------------RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ------------~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+...........+.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000001111111122234677899999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.93 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=203.5
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec--ceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 549 (795)
.++|++.+.||+|+||.||+|+. .++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46799999999999999999997 48899999997543 33456789999999999999999999999887 778999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.... ...+++..+..++.||++||.|||+.+ ..|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999996432 235899999999999999999999864 3499999999999999999999999998764322
Q ss_pred CcccccccccccccccccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFS---IKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~---~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
....||+.|+|||.+.+..++ .++|||||||++|||++|+.||......... .. ......
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~---~~~~~~----- 228 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG--MK---VALEGL----- 228 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH--HH---HHHSCC-----
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH--HH---HHhcCC-----
Confidence 235689999999999876544 4899999999999999999998754322211 11 111110
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.+ ..+...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 229 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 RP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 01 11122345688999999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.68 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=201.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 478999999999999999999875 4899999998654322 2456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887633 345889999999999999999999998 999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhH---------hhh----
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA---------WDL---- 696 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~---------~~~---- 696 (795)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............. ...
T Consensus 178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2 122345789999999998775 789999999999999999999999976543221110000 000
Q ss_pred --ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 697 --WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 697 --~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+......+..............+..+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011111111111111122345678899999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=338.99 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=184.9
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999986 468999999996532 2334778999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998542 345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+......... . .. . .. +.
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~---~~-~---~~---~~ 229 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--N---KV-V---LA---DY 229 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C-C---SS---CC
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--H---HH-h---hc---cc
Confidence 3221 223357899999999999989999999999999999999999998754422210 0 00 0 00 00
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+||+.||++||++++++++
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 ----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0111234567889999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=375.47 Aligned_cols=259 Identities=29% Similarity=0.429 Sum_probs=210.4
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..++|++.++||+|+||.||+|++..+..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 457789999999999999999998878889999997543 446789999999999999999999999876 778999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999532 2245889999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......++..|+|||++....++.++|||||||+||||++ |+.||........ .... .... .
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--~~~i----~~~~---------~ 482 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQV----ERGY---------R 482 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--HHHH----HTTC---------C
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----HcCC---------C
Confidence 11223456789999999998999999999999999999999 8988865432211 1111 1110 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCC
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTIN 753 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
...+..++..+.+|+.+||+.||++|||+++|+++|+.....
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 111223345788999999999999999999999999885443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.04 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=199.8
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc-----chHHHHHHHHHHHhcCCcccceeeeeeeecce
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-----GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999875 5899999998653221 23568899999999999999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+++ +|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999987 77777743 2345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc---Ccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK---DDR 701 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~ 701 (795)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+|+........ +........ ...
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhh
Confidence 764322 22334678999999999865 4589999999999999999999998876542221 111111100 000
Q ss_pred cc------cccCccccc-----hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 702 AW------ELIDPTLQN-----EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 702 ~~------~~id~~l~~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.. +.+...... .........+.+++.+||+.||++|||+.|++++.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 00 000000000 1112234678899999999999999999999997543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.33 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=201.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
++|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555668999999999999864 58899999997766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-CCCeeeeccccccccCCCcc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~vkL~DFGla~~~~~~~~ 632 (795)
++++|.+++........+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999976544445678889999999999999999998 999999999999987 8999999999998764322
Q ss_pred cccccccccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.......|++.|+|||++.+. .++.++||||||+++|+|++|+.||.............. .. ...+.
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~-------~~~~~- 246 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--MF-------KVHPE- 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--HH-------CCCCC-
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--cc-------ccccc-
Confidence 122345789999999998764 389999999999999999999999864332222111110 00 00111
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+||+.||++||++.|++++
T Consensus 247 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 ---IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112234567889999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=342.55 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=206.2
Q ss_pred ccCCcccc-ccCcCCcccEEEeEec---CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 474 TANFSTEN-KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.++|.+.+ .||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 9999999999999753 57789999997643 33457789999999999999999999998 5667899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999853 3345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 629 GDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ .... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~i----~~~~~---- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFI----EQGKR---- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHH----HTTCC----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHH----hcCCc----
Confidence 33221 22233457899999999998899999999999999999998 9999875443221 1111 11110
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...+...+..+.+++.+||+.+|++||++.+++++|...
T Consensus 232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111223345788999999999999999999999998774
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=365.86 Aligned_cols=267 Identities=21% Similarity=0.243 Sum_probs=185.6
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----ce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 545 (795)
.++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+++|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 378999999999999999999865 68999999996532 23456788999999999999999999998543 56
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 68888874 3345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-------------------------ccccccccccccccccccc-ccCCCCcccchhhHHHHHHHHHh-----
Q 003786 626 IFGGDEL-------------------------QSKTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLS----- 674 (795)
Q Consensus 626 ~~~~~~~-------------------------~~~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvil~ellt----- 674 (795)
....... .......+||+.|+|||++ ....|+.++|||||||+||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7642211 0123345789999999976 56779999999999999999999
Q ss_pred ------CCCCCCCCCCcc------------------hhHhHhHhhhccCcc-----------ccc---ccCc---cccch
Q 003786 675 ------SKRNTDFSNTNS------------------LTLLGHAWDLWKDDR-----------AWE---LIDP---TLQNE 713 (795)
Q Consensus 675 ------G~~p~~~~~~~~------------------~~~~~~~~~~~~~~~-----------~~~---~id~---~l~~~ 713 (795)
|+++|+...... ...+........... ... .+.. .-...
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 555554432100 000000000000000 000 0000 00001
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
........+.+|+.+||+.||++|||++|+++|-
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 1122345788999999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=338.50 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=203.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc------cchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG------QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999876 589999999865421 2367899999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC----Ceeeeccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~vkL~DFG 622 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999853 345889999999999999999999998 99999999999998877 89999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .... ...
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~-- 226 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LTNI----SAV-- 226 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH----HTT--
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HHHh----Hhc--
Confidence 998764332 22345689999999999999999999999999999999999999875432211 1110 000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
............+..+.+++.+||+.||++||++.|++++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 ----NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ----CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ----ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0011111122234567899999999999999999999984
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=352.91 Aligned_cols=252 Identities=18% Similarity=0.214 Sum_probs=192.8
Q ss_pred ccCCccc-cccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHH-hcCCcccceeeeeeee----ccee
Q 003786 474 TANFSTE-NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIA-KLQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 546 (795)
.++|.+. +.||+|+||.||++++. +++.||||++.. ...+.+|++++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567766 68999999999999865 588999999853 356788999875 4589999999999876 6678
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeecccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFGl 623 (795)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998543 2345899999999999999999999988 999999999999997 78999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh--HhHhHhhhccCcc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT--LLGHAWDLWKDDR 701 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~ 701 (795)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ...
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~ 283 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQ 283 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCc
Confidence 98654322 234467899999999999999999999999999999999999999765432211 111000 000
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. .. ...........+.++|.+||+.||++|||+.|++++.
T Consensus 284 ~-~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 284 Y-EF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C-CC-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c-cC-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 00 0001112345678999999999999999999999963
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=343.52 Aligned_cols=261 Identities=20% Similarity=0.212 Sum_probs=199.5
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999865 6889999999754322 24678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998542 45889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.... .......|++.|+|||++.+..++.++||||||+++|||++|+.||........ .... .......
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~---~~~~~~~----- 254 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM--GAHI---NQAIPRP----- 254 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH--HHHH---HSCCCCG-----
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH--HHHh---ccCCCCc-----
Confidence 3321 122345789999999999999999999999999999999999999875432211 1100 0000000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHccccCC
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRP-TMFEVVSMLTNKTIN 753 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~~~~~ 753 (795)
.......+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus 255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011222344678899999999999999 999999999874443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=342.96 Aligned_cols=266 Identities=25% Similarity=0.370 Sum_probs=200.5
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
..+|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999986 468999999997532 23456788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999885422 2455889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.............. ........
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~--- 258 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EQCDYPPL--- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH----HTTCSCCC---
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh----hcccCCCC---
Confidence 322 122345789999999999999999999999999999999999999865433322222111 11111100
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCC
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPH 756 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~ 756 (795)
........+.+++.+||+.||++||++.+|+++|+......+.
T Consensus 259 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 -----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0112345678999999999999999999999999875444333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.93 Aligned_cols=259 Identities=29% Similarity=0.402 Sum_probs=203.3
Q ss_pred ccCCccccccCcCCcccEEEeEe------cCcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 47899999999999999999983 24778999999654 234456789999999999999999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCC----cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC---CCeeee
Q 003786 547 ILIYEYMPNKSLDFFLFDSTK----ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKIS 619 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~vkL~ 619 (795)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965432 245888899999999999999999998 9999999999999844 469999
Q ss_pred ccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhcc
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|+........ .... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~----~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEFV----T 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHH----H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH--HHHH----h
Confidence 9999986543333233344568999999999998999999999999999999998 8888865432211 1111 1
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..... ..+...+..+.+++.+||+.||++||++.+|+++|...
T Consensus 260 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11100 01112345678899999999999999999999998763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.67 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=202.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999875 6899999999766555567799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---CCCCCeeeeccccccccCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~vkL~DFGla~~~~~ 629 (795)
+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999888843 345889999999999999999999998 9999999999999 7889999999999976432
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ... .
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~----~~~-~----- 225 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEKIKE----GYY-E----- 225 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH----CCC-C-----
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHc----CCC-C-----
Confidence 2 2233568999999999999999999999999999999999999986543221 1111100 000 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+..+.+++.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011112234578899999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=342.64 Aligned_cols=261 Identities=27% Similarity=0.327 Sum_probs=204.1
Q ss_pred cCCccccccCcCCcccEEEeEecC----cceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeeccee-eE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK-IL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 548 (795)
..|...++||+|+||.||+|++.+ +..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356777999999999999998533 23699999875432 3457789999999999999999999999877665 89
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+.+++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999854 2345788999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc--cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 629 GDEL--QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.... ........+++.|+|||.+.+..++.++|||||||++|+|++|..|+........ ...... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~----~~~~---- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLA----QGRR---- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHH----TTCC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhh----cCCC----
Confidence 3321 1223345688999999999999999999999999999999996666433222111 111110 0000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCC
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l 754 (795)
...+...+..+.+++.+||+.+|++|||+++++++|+.....+
T Consensus 247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 0011122356789999999999999999999999998754443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.20 Aligned_cols=268 Identities=24% Similarity=0.336 Sum_probs=200.7
Q ss_pred HHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhc--CCcccceeeeeeeec----c
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL--QHRNLVRLLGCCIEL----E 544 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 544 (795)
....++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999874 899999998543 334555666666554 899999999999887 6
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC-----CCcEEeccCCCCcEEECCCCCeeee
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS-----RLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++. ..+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 78999999999999999843 24889999999999999999999880 1129999999999999999999999
Q ss_pred ccccccccCCCccc--ccccccccccccccccccccCCCCcc------cchhhHHHHHHHHHhC----------CCCCCC
Q 003786 620 DFGMARIFGGDELQ--SKTKRIVGTYGYMSPEYAQQGLFSIK------SDVFSFGVLLLETLSS----------KRNTDF 681 (795)
Q Consensus 620 DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k------~DvwSlGvil~elltG----------~~p~~~ 681 (795)
|||++......... .......||+.|+|||++.+..++.+ +|||||||++|||++| ..|+..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999865433221 11234579999999999987766655 9999999999999999 445443
Q ss_pred CCCcchhHhHhHhhhccCcccccccCccccc-hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 682 SNTNSLTLLGHAWDLWKDDRAWELIDPTLQN-EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
............ .... .....+.+.. .....+...+.+++.+||+.||++|||+.||+++|+...
T Consensus 265 ~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 265 LVPSDPSYEDMR-EIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TSCSSCCHHHHH-HHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCchhhhH-HHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 221111111110 0000 0111111111 123356778999999999999999999999999997743
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=350.54 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=192.3
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-Ccccceeeeeee--------
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCI-------- 541 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------- 541 (795)
....+|++.++||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34468999999999999999999864 68999999997666566678999999999996 999999999984
Q ss_pred ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecc
Q 003786 542 ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 542 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DF 621 (795)
.....++||||+. |+|.+++........+++..+..++.||+.||.|||+++ .+|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3445789999996 688888865445566999999999999999999999874 34999999999999999999999999
Q ss_pred ccccccCCCccc----------cccccccccccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 003786 622 GMARIFGGDELQ----------SKTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT 688 (795)
Q Consensus 622 Gla~~~~~~~~~----------~~~~~~~gt~~y~APE~~---~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~ 688 (795)
|++......... .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 999876432211 111235689999999998 567789999999999999999999999864322111
Q ss_pred HhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCC
Q 003786 689 LLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPH 756 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~ 756 (795)
.. . .............+.+++.+||+.||++||++.|++++|.......+.
T Consensus 262 -~~-------~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 262 -VN-------G---------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred -hc-------C---------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 00 0 000000111123467899999999999999999999999775444333
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=362.18 Aligned_cols=252 Identities=26% Similarity=0.329 Sum_probs=203.4
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
..++|++.++||+|+||.||+|+.. +++.||||++.+. .......+.+|+++|++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999875 6899999998653 234567899999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC---CCCCeeeeccccccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMARI 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~---~~~~vkL~DFGla~~ 626 (795)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888443 45899999999999999999999998 99999999999995 556799999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ...... ....
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~----~~~~--- 240 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LKRVET----GKYA--- 240 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH----TCCC---
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh----CCCC---
Confidence 64332 2334579999999999876 599999999999999999999999975432221 111100 0000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+..+.+++.+||+.+|++|||+.|++++
T Consensus 241 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011112234567899999999999999999999996
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=374.35 Aligned_cols=267 Identities=23% Similarity=0.296 Sum_probs=214.2
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhc-CCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|..+|..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999865 5888999999753 234556788999999987 7999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998543 45899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.... .... .. ...
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~~~i---~~-~~~----- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSI---ME-HNV----- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH---HS-SCC-----
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--HHHH---Hh-CCC-----
Confidence 3222 234457899999999999999999999999999999999999999976442221 1111 11 100
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHHHcc--------ccCCCCCCCCCCcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTM-----FEVVSMLTN--------KTINLPHPRQPAFS 763 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~L~~--------~~~~l~~p~~p~~~ 763 (795)
..+......+.+||.+||+.||++||++ +||+++-=. ....+++|..|...
T Consensus 560 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 560 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 0112234577899999999999999998 888875311 12345666666543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.16 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=203.4
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeee---------
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE--------- 542 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 542 (795)
...+|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999875 68999999996542 467899999999999999999998864
Q ss_pred -------cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC
Q 003786 543 -------LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 543 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 45578999999999999998543 2346889999999999999999999998 999999999999999999
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 695 (795)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+... .. ...
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~----~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----SK----FFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HH----HHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----HH----HHH
Confidence 9999999998765432 223356899999999999999999999999999999999998775311 00 001
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
...... +. ...+..+.+++.+||+.||++||++.|++++|.....
T Consensus 230 ~~~~~~--------~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DLRDGI--------IS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHTTC--------CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hhhccc--------cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111111 11 1123457789999999999999999999999987443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.12 Aligned_cols=255 Identities=29% Similarity=0.401 Sum_probs=201.9
Q ss_pred HccCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|+... +..||||++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998543 3469999997653 3345789999999999999999999999764 4578
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998542 245889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..... ....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~--~~~~~---~~~~---- 233 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--GVLEK---GDRL---- 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH--HHHHH---TCCC----
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH--HHHhc---CCCC----
Confidence 543221 2233457889999999998999999999999999999998 99998654432221 11100 0000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.+|++||++.|++++|+.
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 0111233567899999999999999999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.92 Aligned_cols=262 Identities=19% Similarity=0.229 Sum_probs=201.6
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeee-eecceeeEEe
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC-IELEEKILIY 550 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 550 (795)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999986 468899999875432 334688999999999988877766655 5667789999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---CCCCCeeeecccccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~vkL~DFGla~~~ 627 (795)
||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999988532 235899999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCccc-----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCcc
Q 003786 628 GGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDDR 701 (795)
Q Consensus 628 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~ 701 (795)
...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543221 122346799999999999999999999999999999999999999976442221 11111100000000
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
........+..+.+++.+||+.+|++||++++|++.|+...
T Consensus 239 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 ---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ---------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00011122457889999999999999999999999987743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.51 Aligned_cols=260 Identities=28% Similarity=0.388 Sum_probs=201.6
Q ss_pred HccCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeee-eccee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCI-ELEEK 546 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~ 546 (795)
...+|++.++||+|+||.||+|+... ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. .....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34678999999999999999998543 2358999987543 234567899999999999999999999854 45678
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999954 2345788999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc--ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 627 FGGDELQ--SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSS-KRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 627 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+|+.......... ... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~--~~~----~~~~- 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--YLL----QGRR- 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH--HHH----TTCC-
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH--HHh----cCCC-
Confidence 6443221 122335678899999999999999999999999999999995 45554433222211 110 0000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.. .+...+..+.+++.+||+.+|++||++.|+++.|+....
T Consensus 251 -~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 -LL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 111123468899999999999999999999999987443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=341.66 Aligned_cols=269 Identities=21% Similarity=0.301 Sum_probs=201.7
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeec-------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------- 543 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 543 (795)
.++|++.++||+|+||.||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999987 4689999999865432 2346788999999999999999999998873
Q ss_pred -ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 544 -EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 544 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
+..++||||+++ +|...+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 555555332 235899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc--ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHhHhhhcc
Q 003786 623 MARIFGGDEL--QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGHAWDLWK 698 (795)
Q Consensus 623 la~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~ 698 (795)
+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......... .........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987643221 122344678999999998876 568999999999999999999999997654322211 111000000
Q ss_pred Cc--------ccccccCc--cccchhhHH-----HHHHHHHHHHhhccCCCCCCCCHHHHHHHHc
Q 003786 699 DD--------RAWELIDP--TLQNEASYL-----ILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748 (795)
Q Consensus 699 ~~--------~~~~~id~--~l~~~~~~~-----~~~~l~~li~~cL~~dP~~RPt~~evl~~L~ 748 (795)
.. ...+.+.. ......... ....+.+++.+||+.||++|||++|++++-=
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 00 00000000 000001111 1345789999999999999999999999743
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.64 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=204.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999875 57889999986532 23456789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999988543 35889999999999999999999988 99999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|..||........ .... .. . +..
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~---~~-~------~~~ 230 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--HRRI---VN-V------DLK 230 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH---HT-T------CCC
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--HHHH---hc-c------ccC
Confidence 22 2345789999999999999999999999999999999999999875432211 1100 00 0 000
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+||+.+|++||++.|++++
T Consensus 231 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 ----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111233567889999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=360.07 Aligned_cols=199 Identities=25% Similarity=0.377 Sum_probs=166.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeec-----ce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 545 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999865 5888999999753 223456788999999999999999999999876 57
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 589888843 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------cccccccccccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003786 626 IFGGDELQ--------------------SKTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 626 ~~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvil~elltG~~p~ 679 (795)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76432211 123456899999999985 5677999999999999999999865444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=339.83 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=199.0
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3477999999999999999999875 68999999987542 33456788999999999 99999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC--------------
Q 003786 549 IYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-------------- 613 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-------------- 613 (795)
||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999864322 255899999999999999999999998 9999999999999844
Q ss_pred -----CCeeeeccccccccCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 003786 614 -----MNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687 (795)
Q Consensus 614 -----~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 687 (795)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.... ..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--QW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--HH
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--HH
Confidence 479999999998764322 24589999999998775 67789999999999999999987653221 00
Q ss_pred hHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 688 TLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......... . .+...+..+.+++.+||+.||++|||+.|++++
T Consensus 238 -------~~~~~~~~~-----~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 -------HEIRQGRLP-----R----IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHTTCCC-----C----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHcCCCC-----C----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 001111110 1 111234567889999999999999999999885
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=353.55 Aligned_cols=255 Identities=11% Similarity=0.076 Sum_probs=183.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhc--CCcccceee-------eee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKL--QHRNLVRLL-------GCC 540 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 540 (795)
..+|++.++||+|+||.||+|++. +++.||||++..... ...+.+++|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999865 689999999976532 3345678886655555 599988855 333
Q ss_pred eec-----------------ceeeEEeecCCCCChhhhhhccCCcccCChhhH------HHHHHHHHHHHHHHHhcCCCc
Q 003786 541 IEL-----------------EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTR------VRIIEGIAQGLLYLHQYSRLR 597 (795)
Q Consensus 541 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 597 (795)
... ...++||||++ ++|.+++... ...+++..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 322 34799999999 8999999543 223455556 678899999999999998
Q ss_pred EEeccCCCCcEEECCCCCeeeeccccccccCCCccccccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhC
Q 003786 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSS 675 (795)
Q Consensus 598 iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG 675 (795)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875422 113457799999999987 6899999999999999999999
Q ss_pred CCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 676 KRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 676 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.||.......... +.....................+..+.+++.+||+.||++|||+.|++++
T Consensus 290 ~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 290 FLPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SCSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99997654221110 00000000001111111112345678899999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.32 Aligned_cols=272 Identities=25% Similarity=0.380 Sum_probs=207.2
Q ss_pred ccCCccccccCcCCcccEEEeEe-----cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecc--ee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 546 (795)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46789999999999999999983 358899999998766666678999999999999999999999987654 68
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 235889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh-hhccCccccc
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW-DLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 704 (795)
....... .......++..|+|||.+.+..++.++|||||||++|||++|..|+............... .........+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 1123345788899999999888999999999999999999999887532100000000000 0000000000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.+........+...+..+.+++.+||+.||++||++.||++.|+..
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1100001111223446788999999999999999999999998763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.64 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=206.3
Q ss_pred HHhHHHHccCCccc-cccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcC-Ccccceeeeeee
Q 003786 467 LASVSAATANFSTE-NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCI 541 (795)
Q Consensus 467 ~~~i~~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 541 (795)
+.......++|.+. +.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445556778777 89999999999999865 58999999986542 334678999999999995 699999999999
Q ss_pred ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeee
Q 003786 542 ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKI 618 (795)
Q Consensus 542 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL 618 (795)
+....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999988432 2356899999999999999999999998 999999999999988 789999
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK 698 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ... ..
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--i~~-~~ 249 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN--ISQ-VN 249 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH-TC
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH--HHh-cc
Confidence 9999998764332 22346799999999999999999999999999999999999999975442222111 000 00
Q ss_pred CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. .............+.+++.+||+.||++|||++|++++-
T Consensus 250 ~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 250 V---------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp C---------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred c---------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 0 001111122345678899999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.64 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=206.5
Q ss_pred HHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHh--cCCcccceeeeeeeecc---
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAK--LQHRNLVRLLGCCIELE--- 544 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~--- 544 (795)
.....++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567899999999999999999987 5899999999643 35678889999987 78999999999998876
Q ss_pred -eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHH--------hcCCCcEEeccCCCCcEEECCCCC
Q 003786 545 -EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH--------QYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 545 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiHrDikp~NIll~~~~~ 615 (795)
..++||||+++++|.+++.. ..+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 78999999999999999843 34889999999999999999999 665 999999999999999999
Q ss_pred eeeeccccccccCCCccc--ccccccccccccccccccccC------CCCcccchhhHHHHHHHHHhC----------CC
Q 003786 616 PKISDFGMARIFGGDELQ--SKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSS----------KR 677 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvil~elltG----------~~ 677 (795)
+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876433211 123445799999999998765 334789999999999999999 55
Q ss_pred CCCCCCCcchhHhHhHhhhccCcccccccCccccc-hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 678 NTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN-EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 678 p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
||.............. ...... ...+.+.. .........+.+++.+||+.||++|||+.||+++|+..
T Consensus 266 p~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMR-KVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTTSCSSCCHHHHH-HHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCcCcccHHHHH-HHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6644322211111111 111111 11122211 12345667889999999999999999999999999774
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=347.50 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=199.7
Q ss_pred ccCCccccccCcCCcccEEEeEecC-----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|++.+.||+|+||.||+|+... +..||||++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578889999999999999998643 2459999997543 233457889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998542 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 628 GGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..... .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~----~~~~~--- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAI----NDGFR--- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH----HTTCC---
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH----HCCCc---
Confidence 433211 11223356789999999999999999999999999999998 999986443211 11111 11100
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...+...+..+.+++.+||+.+|++||++.+++++|+..
T Consensus 269 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 ------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001112345678999999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=363.93 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=205.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999875 68999999986542 34567899999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---CCCCCeeeeccccccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARI 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~vkL~DFGla~~ 626 (795)
|||+.+++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999888843 345889999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ...... ....
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~----~~~~--- 245 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--LKKVEK----GKYT--- 245 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH----CCCC---
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHc----CCCC---
Confidence 65432 2234579999999999876 699999999999999999999999976442221 111100 0000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+..+.+++.+||+.+|++|||+.|++++
T Consensus 246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0011112234567899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=362.15 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=199.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.+|+.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999875 58899999997543 344678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC---CCeeeecccccccc
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~vkL~DFGla~~~ 627 (795)
||+++|+|.+.+... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.. +.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998887433 45889999999999999999999998 9999999999999764 55999999999876
Q ss_pred CCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........ ...... ... ..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~----~~~-~~-- 256 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LRKVEK----GKY-TF-- 256 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH----TCC-CC--
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh----CCC-CC--
Confidence 5432 233467999999999886 5699999999999999999999999976443221 111100 000 00
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+..+.+++.+||+.+|++|||+.|++++
T Consensus 257 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 ---DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 011111234567899999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.96 Aligned_cols=258 Identities=24% Similarity=0.282 Sum_probs=196.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+++|++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999864 68999999986532 233467889999999999999999999988663
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899988843 35889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--c
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD--R 701 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~ 701 (795)
+..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... +.......... .
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAE 248 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHH
Confidence 875422 234678999999999877 6899999999999999999999999976542221 11100000000 0
Q ss_pred c----------------ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 702 A----------------WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 702 ~----------------~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. .......+ ..........+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0 00000000 111122345788999999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.74 Aligned_cols=253 Identities=15% Similarity=0.148 Sum_probs=204.1
Q ss_pred HHccCCccccccCcCCcccEEEeE------ecCcceEEEEEecccCccchHHHHHHHHHHHhcC---Ccccceeeeeeee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGR------LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ---HRNLVRLLGCCIE 542 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 542 (795)
...++|++.++||+|+||.||+|. ..+++.||||++... ...++..|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 446889999999653 4567888888888887 9999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccC--CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC--------
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDST--KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-------- 612 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-------- 612 (795)
.+..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999996422 3456999999999999999999999988 999999999999998
Q ss_pred ---CCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH
Q 003786 613 ---DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689 (795)
Q Consensus 613 ---~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~ 689 (795)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999997654322233345568999999999999999999999999999999999999998532211110
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCC-CCHHHHHHHHccc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADR-PTMFEVVSMLTNK 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~R-Pt~~evl~~L~~~ 750 (795)
+...+.... ....+.+++..||+.+|.+| |+++++.+.|+..
T Consensus 295 ----------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 295 ----------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ----------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ----------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 011111111 13456688999999999999 5788888777663
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.50 Aligned_cols=256 Identities=27% Similarity=0.381 Sum_probs=202.7
Q ss_pred HccCCcccc-ccCcCCcccEEEeEe---cCcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 473 ATANFSTEN-KLGEGGFGPVYKGRL---LNGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 473 ~~~~~~~~~-~LG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
...+|.+.+ .||+|+||.||+|.. ..++.||||++..... ...+++.+|++++++++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788888 999999999999954 2478899999975432 2356799999999999999999999998 66778
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999854 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........ .... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~----~~~~~-- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAML----EKGER-- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHH----HTTCC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHH----HcCCC--
Confidence 6543321 12223456789999999998889999999999999999999 9999875432221 1111 11110
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122345788999999999999999999999998763
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.31 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=202.6
Q ss_pred cCCccccccCcCCcccEEEeEec-Ccce--EEEEEeccc-CccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQE--VAVKRLSSQ-SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 549 (795)
++|++.+.||+|+||.||+|+.. +++. +|||++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999864 4554 499988653 234456789999999999 899999999999999999999
Q ss_pred eecCCCCChhhhhhccC-------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 550 YEYMPNKSLDFFLFDST-------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
|||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2346899999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||........ ...
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~--- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEK--- 253 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH---
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HHH---
Confidence 99999999743211 12233457889999999998899999999999999999998 9999865432211 111
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
...... ...+...+..+.+++.+||+.+|++|||+.|++++|....
T Consensus 254 -~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 254 -LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp -GGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111100 0111123456889999999999999999999999987743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.78 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=203.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999875 58899999987542 3345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|+++++|.+++... ..+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 99999999998543 3588999999999999999999986 6 99999999999999999999999999975422
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh----------hccCc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD----------LWKDD 700 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----------~~~~~ 700 (795)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ .....
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 12334579999999999999999999999999999999999999997654322211100000 00000
Q ss_pred --------------ccccccC----ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 --------------RAWELID----PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 --------------~~~~~id----~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+.++ ..............+.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000 000000011134568899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.51 Aligned_cols=264 Identities=14% Similarity=0.142 Sum_probs=205.2
Q ss_pred ccCCccccccCcCCcccEEEeEecC---------cceEEEEEecccCccchHHHHHHHHHHHhcCCcccce---------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN---------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR--------- 535 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 535 (795)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998753 789999998643 57889999999999999998
Q ss_pred ------eeeeeee-cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcE
Q 003786 536 ------LLGCCIE-LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNI 608 (795)
Q Consensus 536 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 608 (795)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5666665 67889999999 99999999643 2356899999999999999999999998 99999999999
Q ss_pred EECCCC--CeeeeccccccccCCCccc-----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003786 609 LLDKDM--NPKISDFGMARIFGGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDF 681 (795)
Q Consensus 609 ll~~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~ 681 (795)
|++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876432211 112335799999999999999999999999999999999999999976
Q ss_pred CCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccC
Q 003786 682 SNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTI 752 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~ 752 (795)
................. ....+.+.... ....+..+.+++.+||+.||++||++++|+++|+....
T Consensus 271 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GTTCHHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 54222222221111111 11111111100 01123568889999999999999999999999977443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.69 Aligned_cols=250 Identities=25% Similarity=0.317 Sum_probs=205.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999876 47889999986542 23456788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988743 345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... . . ...... .
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~-~----~~~~~~------~ 233 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-L-R----IKKNEY------S 233 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-H-H----HHTTCC------C
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-H-H----HhhccC------C
Confidence 22 1223457899999999999989999999999999999999999998754322111 0 0 000000 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.+......+.+++.+||+.||++|||+.|++++.
T Consensus 234 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 234 ----IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----CccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1112234677899999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.27 Aligned_cols=263 Identities=18% Similarity=0.235 Sum_probs=198.5
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecce------ee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE------KI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 547 (795)
..+|++.+.||+|+||.||+|+...+..+|+|++.... ....+|+++|+.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45799999999999999999998777779999885432 223479999999999999999999965543 78
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-CCCCeeeeccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARI 626 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~vkL~DFGla~~ 626 (795)
+||||++++.+............+++..+..++.||++||.|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998766554433334556899999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh-----------
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW----------- 694 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~----------- 694 (795)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+...........
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 643322 2345789999999988764 6999999999999999999999999765422211110000
Q ss_pred --hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 695 --DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 695 --~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+............+...........+.+++.+||+.||++|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000000011112234578899999999999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.23 Aligned_cols=260 Identities=26% Similarity=0.365 Sum_probs=204.5
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee--cceee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKI 547 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 547 (795)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3578999999999999999999875 58999999996542 2345678999999999999999999998854 56789
Q ss_pred EEeecCCCCChhhhhhccCC-cccCChhhHHHHHHHHHHHHHHHHhcC--CCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTK-ENLLGWGTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
+||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999999999999864332 345899999999999999999999976 234999999999999999999999999999
Q ss_pred cccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .... ......
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~i----~~~~~~- 234 (279)
T 2w5a_A 164 RILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKI----REGKFR- 234 (279)
T ss_dssp HHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH----HHTCCC-
T ss_pred eeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--HHHH----hhcccc-
Confidence 87643321 12345789999999999998999999999999999999999999875432211 1111 111110
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.+|++||++.||++++..
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111234578899999999999999999999997655
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=335.40 Aligned_cols=261 Identities=19% Similarity=0.230 Sum_probs=204.8
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeee-eecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCC-IELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E 551 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++.++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999986 568999999986543 345689999999999998877766655 56677899999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---CCCCCeeeeccccccccC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~vkL~DFGla~~~~ 628 (795)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 345899999999999999999999998 9999999999999 488999999999998765
Q ss_pred CCccc-----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-hhHhHhHhhhccCccc
Q 003786 629 GDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS-LTLLGHAWDLWKDDRA 702 (795)
Q Consensus 629 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 702 (795)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence 43221 11244679999999999999999999999999999999999999997644221 111111100000000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
........+..+.+++.+||+.||++||++.+|++.|+...
T Consensus 239 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 --------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp --------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred --------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00011123457889999999999999999999999997743
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.78 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=205.4
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...+|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3468999999999999999999875 47889999986542 2345678899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998843 345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... . .. .....
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~-~~----~~~~~------ 258 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-L-RI----KKNEY------ 258 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-H-HH----HHTCC------
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-H-HH----hcCCC------
Confidence 322 1233467999999999999999999999999999999999999999754322111 0 00 00000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+ +......+.+++.+||+.||++||++.|++++
T Consensus 259 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SI----PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 11123467789999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.58 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=206.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 366999999999999999999864 58899999996543 3445789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998842 45889999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+........ ..... ... .+.+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~----~~~-----~~~~- 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFLIP----KNN-----PPTL- 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHH----HSC-----CCCC-
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HHHhh----cCC-----CCCC-
Confidence 1 22345789999999999999999999999999999999999999865432211 11100 000 0111
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
....+..+.+++.+||+.+|++|||+.|++++.
T Consensus 240 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 112234678899999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=344.95 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=204.5
Q ss_pred HHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc--------chHHHHHHHHHHHhc-CCcccceeeeee
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--------GQEEFKNEIKLIAKL-QHRNLVRLLGCC 540 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~~ 540 (795)
....++|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344578999999999999999999875 6999999998654311 135678999999999 799999999999
Q ss_pred eecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 541 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999853 345889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 694 (795)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ......
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~i~ 318 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLRMIM 318 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH
Confidence 99998765432 2334679999999998853 368899999999999999999999986533211 111110
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ... ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 319 ~----~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 E----GQY------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H----TCC------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred h----CCC------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 000 00000111223567899999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.00 Aligned_cols=260 Identities=28% Similarity=0.388 Sum_probs=194.6
Q ss_pred cCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeee-cceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 548 (795)
..|++.+.||+|+||.||+|+..+ +..||||.+.... ....+++.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788999999999999998642 2468999986543 2345789999999999999999999998754 457899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999532 345788899999999999999999998 9999999999999999999999999998654
Q ss_pred CCccc--ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 629 GDELQ--SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 629 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
..... .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+|+.......... .. ..... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~--~~----~~~~~--~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--YL----LQGRR--L 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH--HH----HTTCC--C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH--HH----HcCCC--C
Confidence 33221 11233457889999999999999999999999999999999 666665544332211 11 00110 0
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCC
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINL 754 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l 754 (795)
. .+...+..+.+++.+||+.+|++||++.|++++|+.....+
T Consensus 316 ~-------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 L-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 11123456789999999999999999999999998754433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=340.01 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=202.1
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcC-Ccccceeeeeeee--cceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIE--LEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 549 (795)
.++|++.++||+|+||.||+|+. .+++.||||++.. ...+.+.+|+++|++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47899999999999999999986 4689999999864 34578999999999997 9999999999987 6678999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-CeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~~~ 628 (795)
|||+++++|..++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 3788899999999999999999998 99999999999999777 89999999998765
Q ss_pred CCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc----
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW---- 703 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 703 (795)
... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+..... ........
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~-~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK-VLGTEDLYDYID 258 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH-HHCHHHHHHHHH
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH-hcCCchhhhHHH
Confidence 432 2234578999999999877 67999999999999999999999998544332221111100 00000000
Q ss_pred -------------------cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 -------------------ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 -------------------~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..................+.+++.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000011111222245678899999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.67 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=196.7
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec-ceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-EEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+++. .++.||||++... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 47899999999999999999987 4889999999654 3557899999999999999999999987654 478999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ....+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998542 2234788899999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+........ ... ..... .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~----~~~~~---------~ 232 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR----VEKGY---------K 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHH----HTTTC---------C
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH----HhcCC---------C
Confidence 123457889999999999999999999999999999998 9999875432221 111 11110 0
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 11112234578899999999999999999999999876
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=361.76 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=201.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-------------cchHHHHHHHHHHHhcCCcccceeee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-------------QGQEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
..++|++.++||+|+||.||+|+.. +++.||||++.+... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999875 478999999865421 33567899999999999999999999
Q ss_pred eeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC---C
Q 003786 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---N 615 (795)
Q Consensus 539 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~ 615 (795)
++.+....++||||+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999888843 345899999999999999999999998 99999999999998776 6
Q ss_pred eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh
Q 003786 616 PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 616 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 695 (795)
+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........ .....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~- 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--IKKVE- 260 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-
Confidence 9999999998765432 233467999999999987 4689999999999999999999999976443221 11110
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... ..........+..+.+++.+||+.||.+|||+.|++++
T Consensus 261 ---~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 ---KGKY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---HCCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---cCCC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 00001111234578899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=350.60 Aligned_cols=247 Identities=32% Similarity=0.421 Sum_probs=198.7
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
..|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999986 4689999999865432 23357889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+. |+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9998 5676666432 345889999999999999999999998 99999999999999999999999999986542
Q ss_pred cccccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.....||+.|+|||++. ...++.++|||||||++|||++|+.|+........ .. .......
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~---~~~~~~~------ 270 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY---HIAQNES------ 270 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH---HHHHSCC------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HH---HHHhcCC------
Confidence 23357999999999884 56789999999999999999999999865432111 11 1111110
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
+... ....+..+.+++.+||+.+|++|||+.+++++.
T Consensus 271 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 271 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0010 111234677899999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=372.76 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=200.8
Q ss_pred cCCcccc-ccCcCCcccEEEeEec---CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTEN-KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
+++.+.+ +||+|+||.||+|.+. ++..||||++.... ....+++.+|+++|++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999764 46679999997653 3356789999999999999999999999876 568999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999998532 455899999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 630 DELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||........ .... ..+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~i----~~~~------ 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFI----EQGK------ 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--HHHH----HTTC------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHH----HcCC------
Confidence 3211 11222345789999999999999999999999999999998 9999876543322 1111 1111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
....+..++..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 557 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112223456788999999999999999999999998763
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=333.08 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=196.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999875 68999999986532 2345688999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998543 35889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ .... .....
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~----~~~~~----- 228 (276)
T 2h6d_A 163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--FKKI----RGGVF----- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH----HHCCC-----
T ss_pred CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHh----hcCcc-----
Confidence 432 1233578999999999987765 6899999999999999999999865432111 1111 00000
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .+......+.+++.+||+.||++|||+.|++++
T Consensus 229 -~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -Y----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -c----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 111123467789999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=342.10 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=188.1
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999864 68899999986543 33456788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhcc-----CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 550 YEYMPNKSLDFFLFDS-----TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
|||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 12355899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc---ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc
Q 003786 625 RIFGGDEL---QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD 700 (795)
Q Consensus 625 ~~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML--TLQNDPPS 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--HHTSSCCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH--HhccCCCc
Confidence 86543211 112234578999999999876 5789999999999999999999999876543322111 00000000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......++.. .......+.+++.+||+.||++||++.|++++
T Consensus 247 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000011111 11223467889999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=349.02 Aligned_cols=266 Identities=25% Similarity=0.384 Sum_probs=195.0
Q ss_pred HccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHH--HHhcCCcccceeeeeeee-----cce
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKL--IAKLQHRNLVRLLGCCIE-----LEE 545 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~ 545 (795)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 347899999999999999999976 6899999999643 23445555555 445899999999975432 335
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc---------CCCcEEeccCCCCcEEECCCCCe
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY---------SRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~iiHrDikp~NIll~~~~~v 616 (795)
.++||||+++|+|.+++... ..++..+..++.||++||.|||+. + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 68999999999999998432 347889999999999999999998 6 9999999999999999999
Q ss_pred eeeccccccccCCCcc------ccccccccccccccccccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 617 KISDFGMARIFGGDEL------QSKTKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 617 kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987643221 112234579999999999876 456789999999999999999977764322
Q ss_pred C-cchhH-hHh----------HhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 684 T-NSLTL-LGH----------AWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 684 ~-~~~~~-~~~----------~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
. ..... ... .............+.... ......+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1 11100 000 000000000000011110 112235667899999999999999999999999987744
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=358.10 Aligned_cols=243 Identities=14% Similarity=0.174 Sum_probs=188.5
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc---CccchHHHHHHH---HHHHhcCCcccceee-------ee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGQEEFKNEI---KLIAKLQHRNLVRLL-------GC 539 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 539 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ ++|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999986 46899999999743 233457789999 455566899999998 55
Q ss_pred eeecc-----------------eeeEEeecCCCCChhhhhhccCC----cccCChhhHHHHHHHHHHHHHHHHhcCCCcE
Q 003786 540 CIELE-----------------EKILIYEYMPNKSLDFFLFDSTK----ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRV 598 (795)
Q Consensus 540 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 598 (795)
+...+ ..++||||+ +|+|.+++..... ...+++..+..++.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 44443 278999999 6899999854321 122334788889999999999999998 9
Q ss_pred EeccCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccC-----------CCCcccchhhHHH
Q 003786 599 IHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-----------LFSIKSDVFSFGV 667 (795)
Q Consensus 599 iHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~k~DvwSlGv 667 (795)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999877 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 668 LLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 668 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
++|||++|+.||.......... .+.. . ....+..+.+++.+||+.||++|||+.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~--------------~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE--------------WIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSG--------------GGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchh--------------hhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999986543221100 0000 0 01123567889999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.22 Aligned_cols=271 Identities=21% Similarity=0.256 Sum_probs=199.9
Q ss_pred cHHhHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCcc-----------chHHHHHHHHHHHhcCCcccc
Q 003786 466 SLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ-----------GQEEFKNEIKLIAKLQHRNLV 534 (795)
Q Consensus 466 ~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv 534 (795)
...++....++|++.+.||+|+||.||+|+..+++.||||++...... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 345667778999999999999999999999888999999998653221 126789999999999999999
Q ss_pred eeeeeeeec-----ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEE
Q 003786 535 RLLGCCIEL-----EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 535 ~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 609 (795)
++++++... ...++||||++ ++|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35799999998 577666643 3346899999999999999999999998 999999999999
Q ss_pred ECCCCCeeeeccccccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 003786 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLT 688 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~ 688 (795)
++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ- 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999998543322 2334578999999998876 6799999999999999999999999976442211
Q ss_pred HhHhHhhhccCcc-----------ccccc-------CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 689 LLGHAWDLWKDDR-----------AWELI-------DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 689 ~~~~~~~~~~~~~-----------~~~~i-------d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
............ ..+.+ ...............+.+++.+||+.||++|||+.|++++-
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 111101000000 00000 00000111222345688999999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.37 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=198.8
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee----cceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 547 (795)
..|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888899999999999999864 57889999986542 3345678999999999999999999999875 35689
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-CCCCeeeeccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARI 626 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~vkL~DFGla~~ 626 (795)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999843 345889999999999999999999874 3499999999999997 789999999999976
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........... . .......
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~----~~~~~~~--- 248 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-R----VTSGVKP--- 248 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH-H----HTTTCCC---
T ss_pred ccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH-H----HhccCCc---
Confidence 54332 234579999999998874 589999999999999999999999975433222111 1 1111110
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||+.||++|||+.|++++
T Consensus 249 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01111123467899999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.58 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=199.9
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3478999999999999999999875 488999999987766677889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|..++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999888542 245889999999999999999999998 999999999999999999999999997643211
Q ss_pred cccccccccccccccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYA-----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~-----~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
........||+.|+|||++ ....++.++||||||+++|+|++|..|+........ .... ..... ...
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~---~~~~~-~~~- 242 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKI---AKSDP-PTL- 242 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH---HHSCC-CCC-
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHH---hccCC-ccc-
Confidence 1112335789999999988 466789999999999999999999999875432211 1110 00100 000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0112234567899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=343.91 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=205.5
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccc-----------------hHHHHHHHHHHHhcCCccccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-----------------QEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 536 (795)
.++|++.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999998 89999999986542211 1789999999999999999999
Q ss_pred eeeeeecceeeEEeecCCCCChhhh------hhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEE
Q 003786 537 LGCCIELEEKILIYEYMPNKSLDFF------LFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNIL 609 (795)
Q Consensus 537 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIl 609 (795)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 224668999999999999999999999 87 999999999999
Q ss_pred ECCCCCeeeeccccccccCCCcccccccccccccccccccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 003786 610 LDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSI-KSDVFSFGVLLLETLSSKRNTDFSNTNSL 687 (795)
Q Consensus 610 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-k~DvwSlGvil~elltG~~p~~~~~~~~~ 687 (795)
++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|||++|..||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876433 23446799999999999877 6766 99999999999999999999976543221
Q ss_pred hHhHhHhhh-ccCcc-cccccCc---cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 688 TLLGHAWDL-WKDDR-AWELIDP---TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 688 ~~~~~~~~~-~~~~~-~~~~id~---~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........ ..... ......+ ..........+..+.+++.+||+.||++||++.|++++
T Consensus 261 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 -LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111000 00000 0000000 00011112344678899999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=345.22 Aligned_cols=270 Identities=19% Similarity=0.228 Sum_probs=192.3
Q ss_pred hHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecce--
Q 003786 469 SVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE-- 545 (795)
Q Consensus 469 ~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 545 (795)
......++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999875 5899999998543 2334567788899999999999999999976544
Q ss_pred -----eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHH--hcCCCcEEeccCCCCcEEECC-CCCee
Q 003786 546 -----KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH--QYSRLRVIHRDLKASNILLDK-DMNPK 617 (795)
Q Consensus 546 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiHrDikp~NIll~~-~~~vk 617 (795)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999997544433322234556888999999999999999999 777 999999999999997 89999
Q ss_pred eeccccccccCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 618 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ......
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~ 247 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRV 247 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHH
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHH
Confidence 99999998765433 22345789999999988654 5899999999999999999999999765422211 111000
Q ss_pred ccCc--ccccccCcc----------------ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 697 WKDD--RAWELIDPT----------------LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 697 ~~~~--~~~~~id~~----------------l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.... .....+++. ............+.+++.+||+.||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 0000 000000000 00011112456788999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.40 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=198.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC----ccchHHHHHHHHHHHhcCCcccceeeeeee--eccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKLQHRNLVRLLGCCI--ELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 546 (795)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999864 58899999997542 234578999999999999999999999984 45678
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||++++ |.+++... ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 55555432 3456889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ .... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~i----~~~~~-- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL--FENI----GKGSY-- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH----HHCCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHH----hcCCC--
Confidence 65433333334567999999999987643 47899999999999999999999875432111 1110 00100
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .+......+.+++.+||+.||++|||+.|++++
T Consensus 231 ----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----A----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----C----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----C----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 111223467789999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=346.08 Aligned_cols=260 Identities=22% Similarity=0.227 Sum_probs=193.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999864 58899999996532 233467889999999999999999999987665
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999985 6766663 23788999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc------
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK------ 698 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~------ 698 (795)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .........
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 8654322 22346799999999999999999999999999999999999999976542211 100000000
Q ss_pred -------------Ccc------cccccCcc---ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 699 -------------DDR------AWELIDPT---LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 699 -------------~~~------~~~~id~~---l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
... ....+... ............+.+++.+||+.||++|||++|++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000 00000000 01112234467789999999999999999999999963
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=336.06 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=200.8
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 4899999999654 345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998852 2345889999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||.......... .. ... .. +.+
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~---~~~-~~-----~~~- 245 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MI---PTN-PP-----PTF- 245 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HH---HHS-CC-----CCC-
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--HH---hcC-CC-----ccc-
Confidence 12334578999999999999999999999999999999999999986543211110 00 000 00 000
Q ss_pred chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111234567899999999999999999999885
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.35 Aligned_cols=258 Identities=28% Similarity=0.377 Sum_probs=196.8
Q ss_pred ccCCccccccCcCCcccEEEeEec--Cc--ceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL--NG--QEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|++. ++ ..||||++.... ....+.+.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 23 368999986542 234567899999999999999999999988765 8
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999988543 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~---~~~~~~~- 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKI---DKEGERL- 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHH---HTSCCCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--HHHH---HccCCCC-
Confidence 6543221 12233567889999999998889999999999999999999 9999865432211 1111 1111100
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
..+...+..+.+++.+||+.+|++||++.+++++|....
T Consensus 245 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111223457889999999999999999999999998743
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=353.34 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=194.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec------cee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------EEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 546 (795)
..+|++.+.||+|+||.||+|++. +++.||||++.... ....+|+++|++++|||||++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346999999999999999999875 58999999986432 2345799999999999999999998643 236
Q ss_pred eEEeecCCCCChhhhhhc-cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeeccccc
Q 003786 547 ILIYEYMPNKSLDFFLFD-STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA 624 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DFGla 624 (795)
++||||+++ +|...+.. ......+++..+..++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999987 44444422 223456899999999999999999999988 9999999999999965 56899999999
Q ss_pred cccCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC----
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD---- 699 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 699 (795)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.... .....
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~-~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEII-KVLGTPTRE 279 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH-HHHCSCCHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHhCCCCHH
Confidence 8764332 12335789999999998764 799999999999999999999999976542221 11111 10000
Q ss_pred ------cccccccCccccc-----hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 700 ------DRAWELIDPTLQN-----EASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 700 ------~~~~~~id~~l~~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
....+...+.+.. .........+.+|+.+||+.||++||++.|+++|-
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0000111111111 01122346788999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=340.35 Aligned_cols=254 Identities=25% Similarity=0.321 Sum_probs=188.2
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCcc--chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQ--GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
..++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999986 46899999999754222 223345555668888999999999999999999999
Q ss_pred eecCCCCChhhhhhcc-CCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 550 YEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
|||+++ +|.+++... .....+++..+..++.||+.||.|||++ + |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 777666432 2345689999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYA----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||+............. .... .
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~-~ 232 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV----EEPS-P 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH----HSCC-C
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh----ccCC-C
Confidence 4332 22334799999999996 566789999999999999999999999975433322221111 1110 0
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 QL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred Cc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 00 111234567899999999999999999999884
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=338.26 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=197.5
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc--------cchHHHHHHHHHHHhcCCcccceeeeeeeec
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--------QGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++|++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999865 588999999865321 2234688999999999999999999998765
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC---eeeec
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISD 620 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---vkL~D 620 (795)
. .++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999998884 3346889999999999999999999998 999999999999987664 99999
Q ss_pred cccccccCCCcccccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||......... .....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~--- 233 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-KDQIT--- 233 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-HHHHH---
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-HHHHH---
Confidence 99998764332 223457899999999874 567899999999999999999999999754432211 11000
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... .............+.+++.+||+.||++||++.|++++
T Consensus 234 -~~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 -SGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -HTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -hCcc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000 00011112234678899999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=350.16 Aligned_cols=262 Identities=19% Similarity=0.235 Sum_probs=197.0
Q ss_pred HHccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec-------
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------- 543 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 543 (795)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ....+|+++|+.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 468999999986432 2345799999999999999999998543
Q ss_pred -------------------------------ceeeEEeecCCCCChhhhhhcc-CCcccCChhhHHHHHHHHHHHHHHHH
Q 003786 544 -------------------------------EEKILIYEYMPNKSLDFFLFDS-TKENLLGWGTRVRIIEGIAQGLLYLH 591 (795)
Q Consensus 544 -------------------------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH 591 (795)
...++||||+++ +|.+.+... .....+++..+..++.||++||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 337899999995 776666432 23456899999999999999999999
Q ss_pred hcCCCcEEeccCCCCcEEEC-CCCCeeeeccccccccCCCcccccccccccccccccccccccC-CCCcccchhhHHHHH
Q 003786 592 QYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLL 669 (795)
Q Consensus 592 ~~~~~~iiHrDikp~NIll~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil 669 (795)
+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 988 99999999999997 68899999999998764333 22345789999999988764 599999999999999
Q ss_pred HHHHhCCCCCCCCCCcchhHhHhHhhhcc---------------CcccccccCccccchhhHHHHHHHHHHHHhhccCCC
Q 003786 670 LETLSSKRNTDFSNTNSLTLLGHAWDLWK---------------DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDA 734 (795)
Q Consensus 670 ~elltG~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP 734 (795)
|||++|+.||......... ........ ................+...+..+.+++.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~~~~~--~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQL--VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999765422211 11100000 000000111111111222344568899999999999
Q ss_pred CCCCCHHHHHHH
Q 003786 735 ADRPTMFEVVSM 746 (795)
Q Consensus 735 ~~RPt~~evl~~ 746 (795)
++|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=373.30 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=196.3
Q ss_pred cccCcCCcccEEEeEec---CcceEEEEEecccCc--cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
++||+|+||.||+|.+. .++.||||++..... ...+++.+|+++|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 57999999999999643 467899999976432 33578999999999999999999999986 4568899999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc-cc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL-QS 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~-~~ 634 (795)
|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999943 345889999999999999999999998 99999999999999999999999999987654322 12
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ... ..... ...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~----i~~~~---------~~~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAM----LEKGE---------RMG 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHH----HHTTC---------CCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH----HHcCC---------CCC
Confidence 2233456889999999999999999999999999999998 9999876443221 111 11111 111
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+..++..+.+++.+||+.||++||++.+|+++|+.
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 122344678899999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.16 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=200.2
Q ss_pred ccHHhHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcC--Ccccceeeeee
Q 003786 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQ--HRNLVRLLGCC 540 (795)
Q Consensus 465 ~~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 540 (795)
+.+.++....++|++.+.||+|+||.||+++..+++.||||++.... ....+.+.+|++++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34445556678899999999999999999998889999999986542 234577899999999997 59999999999
Q ss_pred eecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 541 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
.+.+..++||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++ ++.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEee
Confidence 99999999999 678899999854 345888999999999999999999998 99999999999996 48999999
Q ss_pred cccccccCCCccccccccccccccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-----------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL 689 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~ 689 (795)
||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 999987654332223344679999999999865 478899999999999999999999986543221111
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. ...... .....+......+.+++.+||+.||++||++.|++++.
T Consensus 250 ~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 250 H----AIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp H----HHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred H----HHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1 111111 11111111234678899999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=347.11 Aligned_cols=260 Identities=23% Similarity=0.276 Sum_probs=185.0
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec------
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 543 (795)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999999985 468999999996532 23456788999999999999999999998754
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
...++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999998 6888888743 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc--
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD-- 700 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 700 (795)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... +..........
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGA 251 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence 9865422 234679999999999877 6899999999999999999999999976542221 11110100000
Q ss_pred ---------cccccc---Ccccc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 701 ---------RAWELI---DPTLQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 701 ---------~~~~~i---d~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.....+ ...-. ..........+.+|+.+||+.||++|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 000000 00000 001112245678999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=347.05 Aligned_cols=262 Identities=21% Similarity=0.219 Sum_probs=200.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC--------Ccccceeeeeee---
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ--------HRNLVRLLGCCI--- 541 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 541 (795)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5889999999643 334567889999999996 788999999988
Q ss_pred -ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCC-----
Q 003786 542 -ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDM----- 614 (795)
Q Consensus 542 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~----- 614 (795)
+....++||||+.+ +|.+.+... ....+++..+..++.||++||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 56688999999955 554444332 224588999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CeeeeccccccccCCCcccccccccccccccccccc
Q 003786 615 --------------------------------------------NPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650 (795)
Q Consensus 615 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 650 (795)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875422 234578999999999
Q ss_pred cccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch----hHhHhHhhhccCc-------------------ccccccC
Q 003786 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL----TLLGHAWDLWKDD-------------------RAWELID 707 (795)
Q Consensus 651 ~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~----~~~~~~~~~~~~~-------------------~~~~~id 707 (795)
+.+..++.++|||||||++|||++|+.||........ ............. ....+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999976543221 1111110100000 0000000
Q ss_pred ccc---------cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTL---------QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l---------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... ....+......+.+|+.+||+.||++|||+.|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 001245567788999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.94 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=203.9
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---------cchHHHHHHHHHHHhcC-Ccccceeeeee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---------QGQEEFKNEIKLIAKLQ-HRNLVRLLGCC 540 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 540 (795)
...++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999875 588999999865421 22356789999999996 99999999999
Q ss_pred eecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 541 IELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 541 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
.+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999854 345889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCcccccccccccccccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW 694 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 694 (795)
||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.|+........ .....
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~ 242 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LRMIM 242 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HHHHh
Confidence 99998765332 223457899999999885 45689999999999999999999999865432111 11110
Q ss_pred hhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 695 DLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ... . .........+..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~----~~~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 243 S----GNY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp H----TCC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred c----CCc-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0 000 0 0011112334578899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=351.70 Aligned_cols=199 Identities=22% Similarity=0.274 Sum_probs=171.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc------CCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL------QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 546 (795)
..+|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999865 5889999999653 23346778899998887 577999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC--eeeeccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGMA 624 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--vkL~DFGla 624 (795)
++||||+. ++|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999997 58887775432 234889999999999999999999998 999999999999999987 999999999
Q ss_pred cccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||...+
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 764322 234678999999999999999999999999999999999999997654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=349.22 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=184.4
Q ss_pred cCCcc-ccccCcCCcccEEEeEec---CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeee--cceeeE
Q 003786 475 ANFST-ENKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKIL 548 (795)
Q Consensus 475 ~~~~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 548 (795)
+.|++ +++||+|+||.||+|+.. +++.||||++... .....+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34655 568999999999999865 4788999999653 334578899999999999999999999954 678899
Q ss_pred EeecCCCCChhhhhhccC------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE----CCCCCeee
Q 003786 549 IYEYMPNKSLDFFLFDST------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKI 618 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~vkL 618 (795)
||||+.+ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6666553211 1234889999999999999999999998 9999999999999 77899999
Q ss_pred eccccccccCCCcc-ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-------hhH
Q 003786 619 SDFGMARIFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS-------LTL 689 (795)
Q Consensus 619 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-------~~~ 689 (795)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643211 122344679999999999877 469999999999999999999999997544211 011
Q ss_pred hHhHhhhccC--cccccccCc-------------cccchhh---------HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 003786 690 LGHAWDLWKD--DRAWELIDP-------------TLQNEAS---------YLILNRYINVGLLCVQEDAADRPTMFEVVS 745 (795)
Q Consensus 690 ~~~~~~~~~~--~~~~~~id~-------------~l~~~~~---------~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 745 (795)
+......... ...+..+.. ....... ......+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111110000 000000000 0000000 001346789999999999999999999999
Q ss_pred HHcc
Q 003786 746 MLTN 749 (795)
Q Consensus 746 ~L~~ 749 (795)
+-=.
T Consensus 334 hp~f 337 (405)
T 3rgf_A 334 DPYF 337 (405)
T ss_dssp SGGG
T ss_pred Chhh
Confidence 7543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.63 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=200.2
Q ss_pred cHHhHHHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeee-
Q 003786 466 SLASVSAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIE- 542 (795)
Q Consensus 466 ~~~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 542 (795)
....+....++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34444556789999999999999999999874 6899999998654 34567899999999999 79999999999987
Q ss_pred -----cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCee
Q 003786 543 -----LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 543 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vk 617 (795)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999998643 2346889999999999999999999998 99999999999999999999
Q ss_pred eeccccccccCCCcccccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh
Q 003786 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692 (795)
Q Consensus 618 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 692 (795)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||........ ..
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~- 244 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LF- 244 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH-
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HH-
Confidence 99999998654321 1223457899999999986 56789999999999999999999999865432111 10
Q ss_pred HhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 693 AWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... ........ ...+..+.+++.+||+.||++||++.+++++
T Consensus 245 --~~~~-~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 245 --LIPR-NPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --HHHH-SCCCCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --Hhhc-CccccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00111111 1123467889999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=343.90 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=201.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----cee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
..+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999865 58889999997533 23346788999999999999999999998765 367
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999985 88887743 34889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc---
Q 003786 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR--- 701 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 701 (795)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH--HHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHHHhCCCCHHH
Confidence 6433211 11244589999999998654 56899999999999999999999999765433221 11100000000
Q ss_pred cc------------cccCccc--cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 702 AW------------ELIDPTL--QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 702 ~~------------~~id~~l--~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.. ....+.. ...........+.+++.+||+.||++|||+.|++++-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 0000000 0011122345688999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=337.98 Aligned_cols=264 Identities=25% Similarity=0.304 Sum_probs=195.4
Q ss_pred ccCCccccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeee-----------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCI----------- 541 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 541 (795)
.++|++.+.||+|+||.||+|+... ++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999998764 8999999997666566678999999999999999999998873
Q ss_pred ---ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-CCCCee
Q 003786 542 ---ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPK 617 (795)
Q Consensus 542 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~vk 617 (795)
+....++||||++ ++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+||+++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 58988883 245889999999999999999999998 99999999999997 567999
Q ss_pred eeccccccccCCCcc-ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhh
Q 003786 618 ISDFGMARIFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 618 L~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 695 (795)
|+|||+++....... ........+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 999999987643211 122234567999999998765 6899999999999999999999999976542211 111000
Q ss_pred hcc---Ccccccc---c---------Cccc-cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 696 LWK---DDRAWEL---I---------DPTL-QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 696 ~~~---~~~~~~~---i---------d~~l-~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
... .....++ + .+.. ........+..+.+++.+||+.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 000 0000000 0 0000 0011122456788999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=349.54 Aligned_cols=260 Identities=19% Similarity=0.241 Sum_probs=204.6
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCC-cccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH-RNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||.||+|+. .+++.||||++.... ...++.+|+++++.++| ++|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 468999999876543 33468899999999987 555566667778888899999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---CCCCCeeeeccccccccC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARIFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~vkL~DFGla~~~~ 628 (795)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 345899999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCccc-----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hHhHhHhhhccCccc
Q 003786 629 GDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL-TLLGHAWDLWKDDRA 702 (795)
Q Consensus 629 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 702 (795)
..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----KKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----HHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----ccc
Confidence 43221 122356799999999999999999999999999999999999999976543222 11111100 000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
... .......++..+.+++..||+.+|++||++.+|+++|+..
T Consensus 234 ~~~-----~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSC-----HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccc-----HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000 0111122345788999999999999999999999988663
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.97 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=200.3
Q ss_pred HHccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
...++|++.+.||+|+||.||+|+.. ..+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 34578999999999999999999864 369999986542 23346788999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||+++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999998542 345889999999999999999999998 99999999999998 68999999999876532
Q ss_pred Cc---cccccccccccccccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 630 DE---LQSKTKRIVGTYGYMSPEYAQQ---------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 630 ~~---~~~~~~~~~gt~~y~APE~~~~---------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
.. .........|++.|+|||++.. ..++.++|||||||++|||++|+.||........ ....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~---- 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IWQM---- 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HHHH----
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHh----
Confidence 11 1122233568999999998864 4578999999999999999999999875432221 1111
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCCC
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHP 757 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~p 757 (795)
........... ..+..+.+++.+||+.+|++|||+.+++++|+.........
T Consensus 256 ~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 256 GTGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HTTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred ccCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 11111111110 12345778999999999999999999999998865544433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.05 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=197.4
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeeccee---
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK--- 546 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 546 (795)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3478999999999999999999865 58999999997542 22346788999999999999999999999887765
Q ss_pred ---eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 547 ---ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 547 ---~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
++||||+. ++|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 57777662 23889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC--c
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD--D 700 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~ 700 (795)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .......... .
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGT 263 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcH
Confidence 9865322 234578999999999877 7899999999999999999999999976542221 1111000000 0
Q ss_pred cccccc------------Ccccc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 701 RAWELI------------DPTLQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 701 ~~~~~i------------d~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.....+ ..... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 000000 00000 011122346788999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.09 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=202.9
Q ss_pred ccCCccccccCcCCcccEEEeEe--cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc------cceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL--LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN------LVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35889999999643 234567889999999997665 9999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-------------
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK------------- 612 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~------------- 612 (795)
.++||||+ +++|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889988885432 235788999999999999999999998 999999999999987
Q ss_pred ------CCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 003786 613 ------DMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686 (795)
Q Consensus 613 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 686 (795)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864322 234578999999999999999999999999999999999999997654322
Q ss_pred hh-HhHhHhh--------hccCccc-------cc-----------ccCccc-cchhhHHHHHHHHHHHHhhccCCCCCCC
Q 003786 687 LT-LLGHAWD--------LWKDDRA-------WE-----------LIDPTL-QNEASYLILNRYINVGLLCVQEDAADRP 738 (795)
Q Consensus 687 ~~-~~~~~~~--------~~~~~~~-------~~-----------~id~~l-~~~~~~~~~~~l~~li~~cL~~dP~~RP 738 (795)
.. ....... ....... +. ...+.. ...........+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 11 1100000 0000000 00 000000 0011234567788999999999999999
Q ss_pred CHHHHHHH
Q 003786 739 TMFEVVSM 746 (795)
Q Consensus 739 t~~evl~~ 746 (795)
|+.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.84 Aligned_cols=265 Identities=26% Similarity=0.365 Sum_probs=203.0
Q ss_pred HHccCCccccccCcCCcccEEEeEe--cCcceEEEEEecccCc--cchHHHHHHHHHHHhc---CCcccceeeeeee---
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL--LNGQEVAVKRLSSQSG--QGQEEFKNEIKLIAKL---QHRNLVRLLGCCI--- 541 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 541 (795)
...++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999987 3578899999865322 2234677888888777 8999999999987
Q ss_pred --ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 542 --ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 542 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5677899999998 59988885432 334889999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc-
Q 003786 620 DFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK- 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~- 698 (795)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCC
Confidence 999998654222 23346789999999999999999999999999999999999999976542221 111110000
Q ss_pred --Ccccc-------ccc---CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 699 --DDRAW-------ELI---DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 699 --~~~~~-------~~i---d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... ... ...............+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000 0000111222345677899999999999999999999975
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.77 Aligned_cols=216 Identities=13% Similarity=0.183 Sum_probs=165.0
Q ss_pred cccccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeC
Q 003786 23 IAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLN 102 (795)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 102 (795)
++.|+|.+||+|.+|++| ++|.|+|||+.+++ +.+|.. +|+||+|||+.| ..+.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 567999999999999999 58999999998875 334443 699999999988 57899999999999999
Q ss_pred CCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhh-hccCeecccc-ccCc-----ceeEE
Q 003786 103 QTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTL-LAGMKLGWDL-KTGL-----ERYQT 175 (795)
Q Consensus 103 ~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtl-Lpgqkl~~~~-~~~~-----~~~l~ 175 (795)
++|.+||+|++......+.|+|+|+|||||++ . ++||||||||||+ |||| |.|. .+|+ .+.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~-----~---~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-----P---GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-----S---EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec-----C---CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999998765556789999999999995 2 7999999998776 5554 4443 3333 55676
Q ss_pred EecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCCCCCeeeeccCCCccccc-ceeeeCCCeeEEEEecCCCceEE
Q 003786 176 SWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAIFAAIPSYSYLYK-PTVVDNEDEIYYRYDSYNSPVIM 254 (795)
Q Consensus 176 Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~w~~~~f~~~p~~~~~~~-~~~~~n~~~~~~~~~~~~~~~~~ 254 (795)
+..||++|.|+++++++| ++++++++.+||++|+|++. +...+.....-. ..+-.+..+++++|...+. ...
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~~ 215 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GRY 215 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SCC
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CCE
Confidence 478999999999999988 67888888899999999754 333332110001 1122234455555554333 468
Q ss_pred EEEECCCCcEEEEE
Q 003786 255 TLKLNPSGKIQHLI 268 (795)
Q Consensus 255 rl~L~~~G~l~~~~ 268 (795)
|++|++||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=326.27 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=202.5
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3478999999999999999999875 68999999986542 34567899999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC---CCeeeeccccccc
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGMARI 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~vkL~DFGla~~ 626 (795)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999998887532 35889999999999999999999998 9999999999999764 4699999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... ......|++.|+|||.+.+. ++.++||||||+++|+|++|..||....... ..... ......
T Consensus 174 ~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~----~~~~~~--- 240 (287)
T 2wei_A 174 FQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRV----ETGKYA--- 240 (287)
T ss_dssp BCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHCCCC---
T ss_pred ecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HcCCCC---
Confidence 64332 12334689999999988754 8999999999999999999999987543221 11111 001000
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+..+.+++.+||+.+|++|||+.|++++
T Consensus 241 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000111234567899999999999999999999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.94 Aligned_cols=264 Identities=24% Similarity=0.292 Sum_probs=200.1
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----cee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999875 58899999996532 23346788999999999999999999987754 678
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999998 588888743 35889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc--------ccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 627 FGGDELQS--------KTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 627 ~~~~~~~~--------~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~ 239 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL--IFGII 239 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--HHHHh
Confidence 64322111 1223578999999998754 7899999999999999999999999976542221111 00000
Q ss_pred cCcc---cccccC---------------ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 698 KDDR---AWELID---------------PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 698 ~~~~---~~~~id---------------~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.... ....+. ..............+.+++.+||+.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0000 000000 0000011123446788999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=344.51 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=189.4
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++|+++ +|||||++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345667889999999998776668999999998643 345678999999887 8999999999999999999999999
Q ss_pred CCCChhhhhhccCCc----ccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-------------CCe
Q 003786 554 PNKSLDFFLFDSTKE----NLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-------------MNP 616 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-------------~~v 616 (795)
. |+|.+++...... ....+..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999998643321 11244567889999999999999998 9999999999999754 479
Q ss_pred eeeccccccccCCCccc--cccccccccccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 003786 617 KISDFGMARIFGGDELQ--SKTKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNS 686 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 686 (795)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999976543211 12234679999999999865 678999999999999999999 899986543322
Q ss_pred hhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 687 LTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... ..... +.............+.+++.+||+.||++|||+.||+++
T Consensus 248 ~~i~~---~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 SNIIR---GIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHH---TCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhc---CCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 21111 00000 011111234556788899999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.25 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=191.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeee----------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE---------- 542 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 542 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999864 6899999999543 3445778999999999999999999998865
Q ss_pred ---cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeee
Q 003786 543 ---LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 543 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~ 619 (795)
....++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 45678999999999999999542 345778899999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCcc------------cccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 003786 620 DFGMARIFGGDEL------------QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686 (795)
Q Consensus 620 DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 686 (795)
|||++........ ........||+.|+|||++.+. .++.++|||||||++|||++ |+..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-R 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-H
Confidence 9999986542210 1122345789999999998764 78999999999999999998 3321111 1
Q ss_pred hhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 687 LTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...... .... ...+....+......+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~----~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKK----LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH----HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHh----cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111 0000 0011112223334567889999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=335.41 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=196.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecce-----
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 545 (795)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999864 58999999996542 2234678899999999999999999999987654
Q ss_pred -eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 546 -KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 546 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
.++||||+. ++|..++. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 57877662 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC--cc
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD--DR 701 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~ 701 (795)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... .......... ..
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 246 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 865322 234578999999998877 6889999999999999999999999976442211 1110000000 00
Q ss_pred ccc------------cc----CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 702 AWE------------LI----DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 702 ~~~------------~i----d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
... .+ .+.+ ..........+.+++.+||+.||++|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000 00 0000 111123456788999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.50 Aligned_cols=203 Identities=24% Similarity=0.317 Sum_probs=171.1
Q ss_pred HHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-Cc-----ccceeeeeeeecc
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HR-----NLVRLLGCCIELE 544 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 544 (795)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....++.+|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999865 5888999999643 233567788999998885 44 4999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC--CCCCeeeeccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFG 622 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~~vkL~DFG 622 (795)
..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||.+ ..+|+||||||+||||+ .++.+||+|||
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999999975 8888885432 23488999999999999999999953 12499999999999994 57889999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~ 683 (795)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876432 234678999999999999999999999999999999999999997654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.98 Aligned_cols=256 Identities=26% Similarity=0.366 Sum_probs=178.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc-cchHHHHHHHH-HHHhcCCcccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGQEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999875 689999999975432 23345556665 677789999999999999999999999
Q ss_pred ecCCCCChhhhhhc--cCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 551 EYMPNKSLDFFLFD--STKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 77666642 11245688999999999999999999998 7 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 628 GGDELQSKTKRIVGTYGYMSPEYA----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........... . ......
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~-~~~~~~- 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT----Q-VVKGDP- 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C----C-CCCSCC-
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH----H-HhcCCC-
Confidence 4322 12234789999999998 456789999999999999999999999875332111000 0 000000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+.+...........+.+++.+||+.||++||++.||+++
T Consensus 248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111112234578899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.01 Aligned_cols=255 Identities=18% Similarity=0.191 Sum_probs=174.5
Q ss_pred HccCCcccc-ccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeee----ccee
Q 003786 473 ATANFSTEN-KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 473 ~~~~~~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 546 (795)
..++|.+.+ .||+|+||.||+|+.. +++.||||++... .....+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357898855 6999999999999876 5899999998542 2222333344677799999999999876 4558
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeecccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFGl 623 (795)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999986432 346899999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............. ......
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~--- 248 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RRIRLG--- 248 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hhhhcc---
Confidence 98654322 234578999999999988899999999999999999999999986543222110000 000000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
...............+.+++.+||+.||++|||+.|++++.
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00001111122345678999999999999999999999953
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=362.46 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=201.7
Q ss_pred HHccCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeeccee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
...++|++.+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+.+|++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345789999999999999999998642 4569999986543 233477899999999999999999999985 5678
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++||||+++|+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999998532 235889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........ ...... ...
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~~~i~~----~~~--- 610 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIEN----GER--- 610 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHH----TCC---
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHc----CCC---
Confidence 644322 12233457889999999998999999999999999999997 8888865432211 111100 000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++.+||+.||++||++.||+++|+.
T Consensus 611 ------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 611 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01112234577899999999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=335.87 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=200.3
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcC-----------Ccccceeeeeee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-----------HRNLVRLLGCCI 541 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 541 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999986 46889999999643 234567889999999886 899999999998
Q ss_pred ecc----eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEEC-----
Q 003786 542 ELE----EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLD----- 611 (795)
Q Consensus 542 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~----- 611 (795)
... ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 665 789999999 889998885432 33488999999999999999999998 7 99999999999994
Q ss_pred -CCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc----
Q 003786 612 -KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS---- 686 (795)
Q Consensus 612 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~---- 686 (795)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999865422 233578999999999999999999999999999999999999997544211
Q ss_pred hhHhHhHhhhcc------------------CcccccccCcc----------ccchhhHHHHHHHHHHHHhhccCCCCCCC
Q 003786 687 LTLLGHAWDLWK------------------DDRAWELIDPT----------LQNEASYLILNRYINVGLLCVQEDAADRP 738 (795)
Q Consensus 687 ~~~~~~~~~~~~------------------~~~~~~~id~~----------l~~~~~~~~~~~l~~li~~cL~~dP~~RP 738 (795)
............ .......+... -....+......+.++|.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111111000 00000000000 00113356677889999999999999999
Q ss_pred CHHHHHHHH
Q 003786 739 TMFEVVSML 747 (795)
Q Consensus 739 t~~evl~~L 747 (795)
|+.|++++-
T Consensus 327 t~~ell~hp 335 (373)
T 1q8y_A 327 DAGGLVNHP 335 (373)
T ss_dssp CHHHHHTCG
T ss_pred CHHHHhhCh
Confidence 999999963
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.28 Aligned_cols=244 Identities=22% Similarity=0.349 Sum_probs=199.7
Q ss_pred HHccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCcc------chHHHHHHHHHHHhcC--Ccccceeeeeeee
Q 003786 472 AATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQ------GQEEFKNEIKLIAKLQ--HRNLVRLLGCCIE 542 (795)
Q Consensus 472 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 542 (795)
...++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999985 46889999999654322 2356778999999996 5999999999999
Q ss_pred cceeeEEeecCCC-CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-CCCCeeeec
Q 003786 543 LEEKILIYEYMPN-KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISD 620 (795)
Q Consensus 543 ~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~vkL~D 620 (795)
.+..++|+|++.+ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 899998854 345889999999999999999999998 99999999999999 789999999
Q ss_pred cccccccCCCcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccC
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKD 699 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... ..
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~-------~~ 258 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EII-------RG 258 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH-------HC
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----hhh-------cc
Confidence 99998765332 234579999999999877665 788999999999999999999986421 000 00
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
. . ... ...+..+.+++.+||+.||++|||+.||+++.
T Consensus 259 ~-~--~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 259 Q-V--FFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp C-C--CCS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred c-c--ccc--------ccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0 0 001 11234678899999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.33 Aligned_cols=262 Identities=21% Similarity=0.249 Sum_probs=198.5
Q ss_pred ccCCccccccCcCCcccEEEeEec-Cc-ceEEEEEecccCccchHHHHHHHHHHHhcCCcc------cceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NG-QEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN------LVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|+.. ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999864 34 68999999643 234567889999999998766 8999999999999
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE---------------
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL--------------- 610 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll--------------- 610 (795)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 45555555332 2245889999999999999999999988 9999999999999
Q ss_pred ----CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 003786 611 ----DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS 686 (795)
Q Consensus 611 ----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 686 (795)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999864322 234579999999999999999999999999999999999999997654322
Q ss_pred hhH-hHhHhh--------hccCccccc----ccCcc---------------ccchhhHHHHHHHHHHHHhhccCCCCCCC
Q 003786 687 LTL-LGHAWD--------LWKDDRAWE----LIDPT---------------LQNEASYLILNRYINVGLLCVQEDAADRP 738 (795)
Q Consensus 687 ~~~-~~~~~~--------~~~~~~~~~----~id~~---------------l~~~~~~~~~~~l~~li~~cL~~dP~~RP 738 (795)
... ...... ......... ..+.. ........+...+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 111 100000 000000000 00000 00011123455788999999999999999
Q ss_pred CHHHHHHH
Q 003786 739 TMFEVVSM 746 (795)
Q Consensus 739 t~~evl~~ 746 (795)
|+.|++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=338.27 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=188.4
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
..+|++.+.||+|+||.||.....+++.||||++.... ...+.+|+++|+++ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 35689999999999999766556689999999996532 23467899999999 799999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-----CCCeeeecccccccc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDFGMARIF 627 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-----~~~vkL~DFGla~~~ 627 (795)
+. ++|.+++.... ....+..+..++.||++||.|||+++ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 58888885432 23556678899999999999999998 999999999999953 235789999999876
Q ss_pred CCCcc-cccccccccccccccccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 628 GGDEL-QSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 628 ~~~~~-~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |..||........... .....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-------~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-------LGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------TTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------hccCC
Confidence 43321 12234467999999999987 4567889999999999999999 8888854332221111 00111
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... ........+.+++.+||+.||++|||+.||+++
T Consensus 247 ~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 LDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11111 112234557789999999999999999999965
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.73 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=180.3
Q ss_pred HccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc-c-hHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-G-QEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
..++|++.+.||+|+||.||+|+.. +++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3478999999999999999999875 6899999999654322 2 23344555678888999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
|||+ ++.+..+... ....+++..+..++.||++||.|||++ + |+||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4555554422 234588999999999999999999985 7 9999999999999999999999999997654
Q ss_pred CCcccccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... .... ..... .
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~---~~~~~-~ 248 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKV---LQEEP-P 248 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHH---HHSCC-C
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHHH---hccCC-C
Confidence 322 223357899999999984 457899999999999999999999998753322211 1111 01100 0
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+. .....+..+.+++.+||+.||.+||++.|++++
T Consensus 249 -----~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 -----LLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -----CCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----CCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 001123467889999999999999999999885
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.21 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=191.7
Q ss_pred HHHccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc------chHHHHHHHHHHHhc----CCcccceeeee
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ------GQEEFKNEIKLIAKL----QHRNLVRLLGC 539 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~ 539 (795)
....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344678999999999999999999864 5889999999654321 234566899999999 89999999999
Q ss_pred eeecceeeEEeec-CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-CCCCee
Q 003786 540 CIELEEKILIYEY-MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPK 617 (795)
Q Consensus 540 ~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~vk 617 (795)
+.+.+..++|+|+ +.+++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999854 335899999999999999999999998 99999999999999 889999
Q ss_pred eeccccccccCCCcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh
Q 003786 618 ISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL 696 (795)
Q Consensus 618 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|+|||++....... .....|++.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~----- 247 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EILE----- 247 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH-----
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----HHhh-----
Confidence 99999998765432 234568999999999877665 569999999999999999999986321 0000
Q ss_pred ccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 697 WKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
... . .+......+.+++.+||+.+|++||++.|++++.
T Consensus 248 -~~~--------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 248 -AEL--------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp -TCC--------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred -hcc--------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 0 1112334678899999999999999999999853
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=352.72 Aligned_cols=264 Identities=25% Similarity=0.308 Sum_probs=199.7
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeee------cce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE------LEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 545 (795)
.++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999864 5899999998654 33345678999999999999999999998765 677
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCC---eeeeccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFG 622 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---vkL~DFG 622 (795)
.++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556899999999999999999999998 999999999999997765 8999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh-----Hhhhc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH-----AWDLW 697 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-----~~~~~ 697 (795)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .....
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-WHGKVREKSNEHIV 245 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-SSTTCC------CC
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-hhhhhhcccchhhh
Confidence 998765433 22346799999999999999999999999999999999999999865321100 0000 00000
Q ss_pred cCccccc--ccCcc--ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 003786 698 KDDRAWE--LIDPT--LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVV 744 (795)
Q Consensus 698 ~~~~~~~--~id~~--l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl 744 (795)
....... ..... .........+..+.+++.+||+.||++|||+.|++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000000 00000 01223344667889999999999999999997743
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=308.98 Aligned_cols=228 Identities=13% Similarity=0.032 Sum_probs=182.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999875 4899999999765332 236789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. + ....++..++.||+.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 1 345578899999999999999998 9999999999999999999997443
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
|++| ++.++|||||||++|||++|+.||........... ....+...
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------~~~~~~~~ 221 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTAGQ 221 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------CCBCTTSC
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------HHHHhccC
Confidence 3333 68999999999999999999999976543221000 00000000
Q ss_pred c--cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 710 L--QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 710 l--~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
. ........+..+.+++.+||+.||++| |+.|+++.|...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0 011222344578899999999999999 999999999774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=348.26 Aligned_cols=237 Identities=21% Similarity=0.323 Sum_probs=190.5
Q ss_pred ccCCccccccCcCCcccEEEeEec--CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecce-----
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 545 (795)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999875 58899999986542 2344678899999999999999999999988766
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+++++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999998 9999999999999885 99999999998
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 75432 3457999999999987654 8999999999999999999887653111000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHHHc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPT-MFEVVSMLT 748 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~L~ 748 (795)
. ...........+.+++.+||+.||++||+ ++++.+.|.
T Consensus 285 -~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 -P---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -C---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -c---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 01111223457789999999999999995 455555443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.74 Aligned_cols=243 Identities=16% Similarity=0.133 Sum_probs=186.6
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccC--------ccchHHHHHHHHHHHhcC----------------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--------GQGQEEFKNEIKLIAKLQ---------------- 529 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------------- 529 (795)
.++|++.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+|++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999987 78999999997642 223478899999999986
Q ss_pred ----------Ccccceeeeeeee-------------cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHH
Q 003786 530 ----------HRNLVRLLGCCIE-------------LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586 (795)
Q Consensus 530 ----------h~niv~l~~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 586 (795)
||||+++++++.+ ....++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5566666666554 6789999999999976555522 457899999999999999
Q ss_pred HHHHH-hcCCCcEEeccCCCCcEEECCCC--------------------CeeeeccccccccCCCccccccccccccccc
Q 003786 587 LLYLH-QYSRLRVIHRDLKASNILLDKDM--------------------NPKISDFGMARIFGGDELQSKTKRIVGTYGY 645 (795)
Q Consensus 587 l~~LH-~~~~~~iiHrDikp~NIll~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 645 (795)
|.||| +++ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999875422 35799999
Q ss_pred ccccccccCCCCcccchhhHHHH-HHHHHhCCCCCCCCCCcchhHhHhHh-hhccCcccccccCccccchhhHHHHHHHH
Q 003786 646 MSPEYAQQGLFSIKSDVFSFGVL-LLETLSSKRNTDFSNTNSLTLLGHAW-DLWKDDRAWELIDPTLQNEASYLILNRYI 723 (795)
Q Consensus 646 ~APE~~~~~~~~~k~DvwSlGvi-l~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~id~~l~~~~~~~~~~~l~ 723 (795)
||||++.+.. +.++|||||+++ .++++.|..|+... ....... ...... ..............+..+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQM----TFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTC----CCSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhh----ccCcccchhhhhhcCHHHH
Confidence 9999998766 899999998777 77788898887320 0000000 000000 0111112334556778899
Q ss_pred HHHHhhccCCCCCCCCHHHHH-HH
Q 003786 724 NVGLLCVQEDAADRPTMFEVV-SM 746 (795)
Q Consensus 724 ~li~~cL~~dP~~RPt~~evl-~~ 746 (795)
+++.+||+.| |++|++ +|
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999998 64
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.15 Aligned_cols=232 Identities=18% Similarity=0.227 Sum_probs=180.2
Q ss_pred ccCCccc-cccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHH-HhcCCcccceeeeeeee----ccee
Q 003786 474 TANFSTE-NKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLI-AKLQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 546 (795)
.++|.+. +.||+|+||.||+++.. +++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3667776 78999999999999864 688999999853 35678899988 56689999999999887 6778
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeecccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFGl 623 (795)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999986532 345889999999999999999999998 999999999999998 78999999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+.... +..++.++|||||||++|||++|+.||.......... .. . ...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----~~-~--~~~ 214 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----GM-K--TRI 214 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----CS-C--CSS
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----HH-H--HHH
Confidence 86432 2456789999999999999999999986543221100 00 0 000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...............+..+.+++.+||+.||++|||+.|++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000001111112345678899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.88 Aligned_cols=243 Identities=14% Similarity=0.159 Sum_probs=179.7
Q ss_pred HccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC---ccchHHHHHHHHHHHhcCC-cccceee----------
Q 003786 473 ATANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQH-RNLVRLL---------- 537 (795)
Q Consensus 473 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~---------- 537 (795)
...+|...+.||+|+||.||+|++ .+|+.||||++.... ....+.+++|+.+++.++| +|...+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688889999999999999985 468999999987432 2336789999999999987 3221111
Q ss_pred -----------eeeee-----cceeeEEeecCCCCChhhhhhc----cCCcccCChhhHHHHHHHHHHHHHHHHhcCCCc
Q 003786 538 -----------GCCIE-----LEEKILIYEYMPNKSLDFFLFD----STKENLLGWGTRVRIIEGIAQGLLYLHQYSRLR 597 (795)
Q Consensus 538 -----------~~~~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 597 (795)
.++.. ....+++|++ .+++|.+++.. ......+++..+..++.||++||.|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111 1234556665 46788888731 223455788899999999999999999998
Q ss_pred EEeccCCCCcEEECCCCCeeeeccccccccCCCccccccccccccccccccccc----------ccCCCCcccchhhHHH
Q 003786 598 VIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA----------QQGLFSIKSDVFSFGV 667 (795)
Q Consensus 598 iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~k~DvwSlGv 667 (795)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998864322 344577 999999998 5567899999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 003786 668 LLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745 (795)
Q Consensus 668 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 745 (795)
++|||++|+.||.......... ..+... . ..+..+.+++.+||+.||++||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~--------------~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSE--------------WIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSG--------------GGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhHH--------------HHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999996543211100 000000 0 12356889999999999999999877755
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-29 Score=289.19 Aligned_cols=183 Identities=17% Similarity=0.159 Sum_probs=129.7
Q ss_pred ccCcCCcccEEEeE-ecCcceEEEEEecccC----------ccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEE
Q 003786 482 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQS----------GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 549 (795)
.++.|++|.+..++ .-.|+.+|+|++.+.. ....++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46777787777765 3458999999996542 12335789999999999 799999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||++|++|.++|... +.++. .+|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999543 33443 368999999999999998 99999999999999999999999999987653
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~ 676 (795)
.. ......+||+.|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 32 23345789999999999875 4677899999999998887654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=258.92 Aligned_cols=185 Identities=20% Similarity=0.242 Sum_probs=146.2
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEecccCcc--------chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--------GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
...+.||+|+||.||+++. .++.+++|+....... ..+++.+|+++|++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 5788999986543211 134578999999999999999777777788888999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5589999999999999998 999999999999998 999999999998754
Q ss_pred Ccccc-----ccccccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 003786 630 DELQS-----KTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 630 ~~~~~-----~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~ 679 (795)
..... ......||+.|||||++.. ..|+.++|+|+..+-..+.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1245789999999999987 67888999999999988888776544
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-23 Score=181.43 Aligned_cols=105 Identities=17% Similarity=0.365 Sum_probs=93.1
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
.|+|.+||.|.+||+|.| |.|.|.|+.+|+ +.++.. .++||+|||+.|. ...+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~---~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH---STSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTT-CCSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC---CEEEEEecCCCCC-CccEEEEEeCCccEEEECCC
Confidence 378999999999999998 889999999987 667654 4999999999997 44689999999999999999
Q ss_pred CceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 105 NGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
+.+||+|++.+....+.|+|+|||||||++ ..||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~--------~~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYG--------SDIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEEC--------CcEecC
Confidence 999999998876667789999999999996 259998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.7e-23 Score=216.21 Aligned_cols=152 Identities=17% Similarity=0.137 Sum_probs=123.1
Q ss_pred hHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCc------------------cchHHHHHHHHHHHhcCC
Q 003786 469 SVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG------------------QGQEEFKNEIKLIAKLQH 530 (795)
Q Consensus 469 ~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 530 (795)
.+......|++.+.||+|+||.||+|+..+|+.||||+++.... .....+.+|+.+|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34445566788899999999999999987799999999964321 12456889999999999
Q ss_pred cccceeeeeeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 531 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
| +++++++ +.+..++||||+++++|.+ + .......++.||++||.|||+.+ |+||||||+|||+
T Consensus 163 -~-~~v~~~~-~~~~~~lvmE~~~g~~L~~-l---------~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVY-AWEGNAVLMELIDAKELYR-V---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEE-EEETTEEEEECCCCEEGGG-C---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEE-eccceEEEEEecCCCcHHH-c---------chhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 5 6777755 3466799999999999977 4 12345679999999999999998 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCccccccccccccccccccccccc
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 653 (795)
+ ++.+||+|||+++. +..++|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9 99999999999863 345688998753
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-22 Score=176.26 Aligned_cols=110 Identities=22% Similarity=0.422 Sum_probs=96.6
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
+|+|.+||.|.+|++|+ ++|.|+|+|+.+|+ + ++|+ ..++||.||++.| +..+.|.|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 48999999999999999 99999999999886 2 6676 3799999999877 44689999999999999999
Q ss_pred CceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCc
Q 003786 105 NGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPS 153 (795)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PT 153 (795)
+.++|+|++........++|+|+|||||++ . ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~-----~---~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYG-----P---VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC-----S---EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEEC-----C---CEecCCCcCC
Confidence 999999998866667788999999999996 2 7999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=176.97 Aligned_cols=108 Identities=18% Similarity=0.332 Sum_probs=95.9
Q ss_pred cccccCCCCCccCCCCeEE--eCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEE
Q 003786 23 IAADNITPSRFIRDGEKLV--SSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVL 100 (795)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl 100 (795)
++.|+|.+||+|.+|++|+ |++|.|+|+|+.+|+ -+||++ +++||+||++.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5679999999999999999 999999999999886 257876 799999999877 4568999999999999
Q ss_pred eCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 101 LNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 101 ~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
+|.++.++|+|++........++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 9999999999998765566788999999999996 279997
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.4e-21 Score=171.76 Aligned_cols=110 Identities=18% Similarity=0.349 Sum_probs=94.6
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
.|||.+||+|.+|++|+ +|.|+|+|+.+|+ + ++|+ ..++||+||++.| +.++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 48999999999999998 7999999998885 2 2354 3799999999988 34689999999999999998
Q ss_pred CceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCch
Q 003786 105 NGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSD 154 (795)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTD 154 (795)
+.++|+|++........++|+|+|||||++ . ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~-----~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG-----P---VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC-----S---EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC-----C---CEEECCCCCCc
Confidence 999999998755556788999999999995 2 79999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6.6e-21 Score=170.88 Aligned_cols=110 Identities=25% Similarity=0.466 Sum_probs=94.5
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
+|||.+||.|.+|++| ++|.|+|+|+.+|+ + ++|++ .++||+||++.+ +.++.|.|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 47999999999986 2 45665 699999999764 456899999999999999 8
Q ss_pred CceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCC
Q 003786 105 NGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHP 152 (795)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (795)
+.++|+|.+......+.++|+++|||||++ ..+.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~-----~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYD-----NSNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEEC-----TTSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEEC-----CCCceEEECCCcc
Confidence 889999998766566788999999999997 3467999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.8e-20 Score=164.20 Aligned_cols=105 Identities=25% Similarity=0.394 Sum_probs=89.9
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
.+||.|||.|.+|+.|+ +|.|+|+|+.+|+ +.+ |.. .++||++|++.+ +..+.|.|+.||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 37899999999999997 6999999999886 333 544 699999999876 45689999999999999999
Q ss_pred CceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceeccc
Q 003786 105 NGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSF 149 (795)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSF 149 (795)
+.++|+|++.+....+.|+|+||||||||+ .++|||=
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~--------~~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYG--------TARWATG 105 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEE--------SCCCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEEC--------CCEEeCC
Confidence 999999998765556789999999999996 2799983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=159.29 Aligned_cols=105 Identities=19% Similarity=0.321 Sum_probs=89.3
Q ss_pred cccccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeC
Q 003786 23 IAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLN 102 (795)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 102 (795)
+|.|||.|||.|.+|+.|+| |.|.|.|+.+|+ +.+ |.. ++||++|++.. +..+.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 68899999999999999998 569998888775 444 554 58999999863 456899999999999999
Q ss_pred CCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 103 QTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 103 ~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
.++.++|+|++.+......|+|+||||||||+ ..+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~--------~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG--------PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec--------CCEecC
Confidence 99999999998765455789999999999996 379987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=155.07 Aligned_cols=108 Identities=18% Similarity=0.278 Sum_probs=91.9
Q ss_pred cccccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeC
Q 003786 23 IAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLN 102 (795)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 102 (795)
++.|+|.+||.|.+|+.|.+ |.|.|.|+.+|+ |.++.. -..++||.+|+..+ +..+.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 46799999999999999986 889999998886 555432 14689999999876 446899999999999999
Q ss_pred CCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 103 QTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 103 ~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
.++.++|+|++.+....+.|+|+||||||||+ ..||+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 99999999998765555789999999999995 479987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=181.21 Aligned_cols=137 Identities=15% Similarity=0.171 Sum_probs=107.5
Q ss_pred CCccccccCcCCcccEEEeEe-cCcce--EEEEEecccCcc------------------------chHHHHHHHHHHHhc
Q 003786 476 NFSTENKLGEGGFGPVYKGRL-LNGQE--VAVKRLSSQSGQ------------------------GQEEFKNEIKLIAKL 528 (795)
Q Consensus 476 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 528 (795)
-|++.+.||+|+||.||+|+. .+|+. ||||++...... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 67888 999987543111 013578999999999
Q ss_pred CCccc--ceeeeeeeecceeeEEeecCCC-C----ChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHH-hcCCCcEEe
Q 003786 529 QHRNL--VRLLGCCIELEEKILIYEYMPN-K----SLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH-QYSRLRVIH 600 (795)
Q Consensus 529 ~h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH 600 (795)
+|+++ ..++.. ...++||||+.+ | +|.+.... .++..+..++.||+.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 98864 333332 467899999942 4 56555421 235678899999999999999 887 999
Q ss_pred ccCCCCcEEECCCCCeeeecccccccc
Q 003786 601 RDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 601 rDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.8e-18 Score=150.93 Aligned_cols=109 Identities=22% Similarity=0.367 Sum_probs=90.3
Q ss_pred cccccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeC
Q 003786 23 IAADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLN 102 (795)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 102 (795)
+|.|||.|||.|.+|+.|. +|.|.|.|+.+|+ +.+ |.. +|.+|+..+ +.++.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHLK--NGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEeE--CCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 4789999999999999994 5999999998886 222 432 699998865 456899999999999999
Q ss_pred CCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhcc
Q 003786 103 QTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAG 159 (795)
Q Consensus 103 ~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpg 159 (795)
.++.++|+|++.+......|+|+||||||||+ ..+|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC-----CCccCC
Confidence 99999999998765456789999999999995 479996 555554
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-16 Score=140.95 Aligned_cols=97 Identities=22% Similarity=0.391 Sum_probs=80.0
Q ss_pred CCCccCcceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccC
Q 003786 81 SPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGM 160 (795)
Q Consensus 81 ~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgq 160 (795)
.|+.+...+|.|+.||||||++. +.+||++++.+...++.|+|+++|||||+| .+.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d------~~~~~W~S~~---------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS------GSRAIWASNT---------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE------TTEEEEECCC----------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc------CCEEEEECCc----------
Confidence 34445568899999999999987 789999998765556788999999999997 2468999994
Q ss_pred eeccccccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEc-CceeEEeeCCCCC
Q 003786 161 KLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYN-GSVKLLCSGPWNG 217 (795)
Q Consensus 161 kl~~~~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~-~s~~~~~sg~w~~ 217 (795)
+|++|.|++.++++|. +++|. +...||++++|+|
T Consensus 77 ---------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ---------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ---------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ---------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567889999999987 55665 5689999999987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.7e-16 Score=140.08 Aligned_cols=91 Identities=21% Similarity=0.328 Sum_probs=75.9
Q ss_pred cCcceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecc
Q 003786 85 DSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGW 164 (795)
Q Consensus 85 ~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~ 164 (795)
+...+|.|+.||||||++ .+.+||++++.+...++.++|+++|||||++ ..+.+|||||.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~-----~~~~~~W~S~t-------------- 78 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYD-----QSNRVIWQTKT-------------- 78 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEEC-----TTCCEEEECCC--------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEEC-----CCCcEEEecCC--------------
Confidence 446789999999999998 5889999998765556789999999999998 35689999993
Q ss_pred ccccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCCCC
Q 003786 165 DLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWN 216 (795)
Q Consensus 165 ~~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~w~ 216 (795)
+|++|.|++.++.+|. ++++++ .||+++++.
T Consensus 79 -----------------~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~ 109 (110)
T 3a0c_A 79 -----------------NGKEDHYVLVLQQDRN--VVIYGP--VVWATGSGP 109 (110)
T ss_dssp -----------------CCSSSCCEEEECTTSC--EEEECS--EEEECSCCC
T ss_pred -----------------CCCCCCEEEEEeCCcc--EEEECC--CEecCCCcC
Confidence 4567899999999986 566765 799998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=173.33 Aligned_cols=141 Identities=13% Similarity=0.134 Sum_probs=100.2
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCc--------------cchHHHHHHHHHHHhcCCcccceeeeee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--------------QGQEEFKNEIKLIAKLQHRNLVRLLGCC 540 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 540 (795)
.=|++.++||+|++|.||+|...+|+.||||+++.... ........++++.....|+|+++++...
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999988999999998753210 0111122233333333344444433221
Q ss_pred e------ecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC
Q 003786 541 I------ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 541 ~------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 614 (795)
. .....++||||++|+.|..+. .......++.||+.+|.+||+.| ||||||||.|||+++++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 1 122347999999998886543 23456678999999999999988 99999999999998877
Q ss_pred C----------eeeecccccccc
Q 003786 615 N----------PKISDFGMARIF 627 (795)
Q Consensus 615 ~----------vkL~DFGla~~~ 627 (795)
. +.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3 889999987643
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.63 E-value=8.7e-16 Score=136.80 Aligned_cols=103 Identities=15% Similarity=0.245 Sum_probs=84.3
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
.|+|.|||.|.+|+.|. +|.|.|.|+.+|+ +.+ |.. .. ||.+|+..+ +..+.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 48999999999999995 5999999998886 344 432 24 999999876 44689999999999999988
Q ss_pred Cc-eEEeecCCC--CccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 105 NG-TIWSSNLSR--EVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 105 ~~-~~Wst~~~~--~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
+. ++|+|++.. ....+.++|++|||||||+ ..+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 599999642 2345788999999999995 479987
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=4e-15 Score=134.21 Aligned_cols=87 Identities=24% Similarity=0.284 Sum_probs=73.2
Q ss_pred cceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccc
Q 003786 87 NAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 166 (795)
...|.|+.||||||++. +.+||++++.+...++.|+|+|+|||||+| ..+.+|||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d-----~~~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVIT-----NENVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC-----TTCCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEe-----CCCcEEEcCC-----------------
Confidence 45788999999999987 889999998765556789999999999998 3568999999
Q ss_pred ccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCC
Q 003786 167 KTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~ 214 (795)
.+|++|.|++.++++|. +++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35678999999999987 55665 38999987
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=4.7e-15 Score=133.26 Aligned_cols=92 Identities=29% Similarity=0.369 Sum_probs=76.9
Q ss_pred cceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccc
Q 003786 87 NAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 166 (795)
...|.|+.||||||++ .+.+||++++.+...++.++|+++|||||+| ..+.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d-----~~~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYD-----HNNNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEEC-----TTCCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEEC-----CCceEEEEcCCC---------------
Confidence 4678899999999998 5789999998755556788999999999998 346799999997
Q ss_pred ccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCCCCCee
Q 003786 167 KTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGAI 219 (795)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~w~~~~ 219 (795)
|++|.|++.++.+|. ++++++ .||++++|....
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~~ 112 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCRR 112 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBCC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCcC
Confidence 346789999999996 666765 899999998653
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9.2e-13 Score=136.85 Aligned_cols=111 Identities=21% Similarity=0.399 Sum_probs=87.0
Q ss_pred cccccCCCCCc----cCCCCeEEeC----CCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEee
Q 003786 23 IAADNITPSRF----IRDGEKLVSS----SQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISN 94 (795)
Q Consensus 23 ~~~~~l~~~~~----l~~~~~l~s~----~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~ 94 (795)
.-+|||.||+. |..|+.|.|+ .|.|.|.|...| . +.+| ++ ..+++|.+++..+ +. +.|.++.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dG---n--lvLy-~~-~~~~yW~Sgt~~~--~~-~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDG---N--LVAY-GP-NGAATWNAGTQGK--GA-VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTS---C--EEEE-CT-TSSEEEECCCTTT--TC-CEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCc---e--EEEE-eC-CCeEEEECCCCCC--cc-EEEEEcC
Confidence 35699999999 8899998664 355566554444 2 3333 32 2589999999876 33 7899999
Q ss_pred CCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCC
Q 003786 95 GGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDH 151 (795)
Q Consensus 95 ~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
||||+++|.++.++|++++.+. ....|+|++||||||++ . +++||||||
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~-----~--~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILD-----E--KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEE-----E--EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEc-----C--CCeEEccCc
Confidence 9999999998899999998754 35788999999999997 2 589999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=7.5e-12 Score=130.00 Aligned_cols=147 Identities=16% Similarity=0.069 Sum_probs=117.3
Q ss_pred HHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEE
Q 003786 471 SAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 471 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 549 (795)
......|++...++.|+.+.||++.. .++.+++|+...........+.+|+++|+.+. +..+.++++++.+....++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456788888999999999999975 36899999987533234457999999999995 67788899999888899999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc------------------------------------
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY------------------------------------ 593 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------ 593 (795)
|||++|.+|...+. +......++.+++++|..||+.
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999976531 2234557889999999999981
Q ss_pred --------------------CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 594 --------------------SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 594 --------------------~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
....++|+|++|.|||++.+..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113599999999999998765567999998753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.32 E-value=6.1e-12 Score=112.30 Aligned_cols=95 Identities=19% Similarity=0.287 Sum_probs=72.0
Q ss_pred CCCCccCcceEEEeeCCceEEeCC-CCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhc
Q 003786 80 NSPIFDSNAVLTISNGGKLVLLNQ-TNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLA 158 (795)
Q Consensus 80 ~~p~~~~~~~l~~~~~g~lvl~~~-~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLp 158 (795)
+.|+.+...+|.++.||||||++. .+.++|++++.+...++.++|+++|||||+|. .+.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~-----~~~~iW~S~t~------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD-----RLNTVFVSNTV------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TSCEEEECSCC-------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC-----CCCEEEECCCc-------
Confidence 345555678899999999999998 48999999987655567889999999999983 45789996321
Q ss_pred cCeeccccccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCC
Q 003786 159 GMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 159 gqkl~~~~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~ 214 (795)
-..|.|.+.++.+|... +|. .++|.+||
T Consensus 86 ------------------------~~~~~~~~~L~~dGnlv--ly~--~~~W~s~~ 113 (113)
T 3mez_B 86 ------------------------GQEGDYVLILQINGQAV--VYG--PAVWSTAA 113 (113)
T ss_dssp ------------------------CSSSCCEEEECTTSCEE--EEC--SEEEESCC
T ss_pred ------------------------CCCCCEEEEEcCCceEE--Eec--CCEecCCC
Confidence 01245888898888654 444 57898875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.23 E-value=3.1e-11 Score=107.27 Aligned_cols=94 Identities=18% Similarity=0.234 Sum_probs=69.6
Q ss_pred CCccCcceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCe
Q 003786 82 PIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMK 161 (795)
Q Consensus 82 p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqk 161 (795)
++.+....|.++.||||||++.++ +|++++.+....+.++|+++|||||++. ....++|||.-+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~----~~~~~vW~S~t~---------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSA----NSNTPVWVYPRS---------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECS----SCSSCSEEESSS----------
T ss_pred EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeC----CCCEEEEEeccc----------
Confidence 334456789999999999999876 9999987655567889999999999983 223459998731
Q ss_pred eccccccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCC
Q 003786 162 LGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 162 l~~~~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~ 214 (795)
.....|.|.+.++.+|... +|. .++|.++.
T Consensus 80 -------------------~~~~~~~~~l~Lq~dGNlv--ly~--~~~W~s~t 109 (111)
T 3mez_A 80 -------------------VNTVRGNYAATLGPDQHVT--IYG--PAIWSTPA 109 (111)
T ss_dssp -------------------CCCCSSCCEEEECTTSCEE--EEC--SEEEECCC
T ss_pred -------------------cCCCCcCEEEEECCCCeEE--Eec--cCEEccCC
Confidence 0112467899999888655 344 67887764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=7e-11 Score=122.14 Aligned_cols=139 Identities=17% Similarity=0.136 Sum_probs=103.6
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E 551 (795)
..++.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455554333466669999998777888999997543 3356889999999996545 4568888887778899999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS------------------------------------- 594 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 594 (795)
|++|.+|. ... .....++.++++.|..||...
T Consensus 96 ~i~G~~l~--~~~---------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH---------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC---------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc---------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 210 123366777888888888643
Q ss_pred ------------------CCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 595 ------------------RLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 595 ------------------~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
...++|+|++|.|||++.++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999999764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=103.11 Aligned_cols=85 Identities=21% Similarity=0.330 Sum_probs=64.8
Q ss_pred cceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccc
Q 003786 87 NAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 166 (795)
...|.++.||||||++. .++|++++.+....+.++|+++|||||+|. .+.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~-----~~~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD-----DFKTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT-----TCCEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC-----CCCEEEEcCCcC--------------
Confidence 47899999999999987 589999987655567889999999999983 467899975311
Q ss_pred ccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeC
Q 003786 167 KTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSG 213 (795)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg 213 (795)
..|.|.+.++.+|... +|+ ..+|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlv--ly~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGV--IYG--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEE--EEC--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEE--Eec--CCEecCC
Confidence 1245888888888644 344 3678776
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=2e-10 Score=101.78 Aligned_cols=87 Identities=23% Similarity=0.334 Sum_probs=65.3
Q ss_pred cceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccc
Q 003786 87 NAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 166 (795)
...|.|+.||||||++. +.++|++++.+....+.++|+++|||||+|. .+.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~-----~~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP-----RNNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT-----TSCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC-----CCCEEEECCCCC--------------
Confidence 57799999999999987 7899999987655567889999999999983 457899975321
Q ss_pred ccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCC
Q 003786 167 KTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~ 214 (795)
..+.|.+.++.+|... +++. .+|.+|.
T Consensus 80 -----------------~~~~~~~~L~ddGNlv--ly~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVV--IYGT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEE--EEES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEE--EECC--CEEeCCC
Confidence 1245788888887644 3432 5666553
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.2e-10 Score=100.36 Aligned_cols=92 Identities=22% Similarity=0.381 Sum_probs=69.1
Q ss_pred CCCccCcceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccC
Q 003786 81 SPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGM 160 (795)
Q Consensus 81 ~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgq 160 (795)
.|+.+....|.++.||||||+++ +|+|++.+....+.++|+++|||||+|. .+.++|+|-.
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~-----~~~~vWss~t---------- 76 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG-----DGSTVWKSGA---------- 76 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT-----TSCEEEECCC----------
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC-----CCCEEEcCCC----------
Confidence 44445567899999999999984 7999988665567889999999999983 4578897521
Q ss_pred eeccccccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCCCC
Q 003786 161 KLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWN 216 (795)
Q Consensus 161 kl~~~~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~w~ 216 (795)
....+.|.+.++.+|... ++. .++|.+++|-
T Consensus 77 ---------------------~~~~~~~~~~L~~dGNlv--ly~--~~~W~s~t~~ 107 (109)
T 3r0e_A 77 ---------------------QSVKGNYAAVVHPDGRLV--VFG--PSVFKIDPWV 107 (109)
T ss_dssp ---------------------CCSSSCCEEEEETTTEEE--EEC--SEEEEECTTS
T ss_pred ---------------------cCCCcCEEEEEcCCCeEE--EEe--cCEECCCCcc
Confidence 002356888999888544 444 6789999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=2e-09 Score=117.15 Aligned_cols=142 Identities=13% Similarity=0.225 Sum_probs=107.1
Q ss_pred cccccCcCCcccEEEeEecCcceEEEEEec--ccC-ccchHHHHHHHHHHHhcC--Ccccceeeeeeeec---ceeeEEe
Q 003786 479 TENKLGEGGFGPVYKGRLLNGQEVAVKRLS--SQS-GQGQEEFKNEIKLIAKLQ--HRNLVRLLGCCIEL---EEKILIY 550 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 550 (795)
..+.|+.|.++.||+++.. +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999999864 4688899875 322 123457889999999997 45577888888766 3478999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS------------------------------------ 594 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 594 (795)
||++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874321 123567788889999999999999831
Q ss_pred -------------------CCcEEeccCCCCcEEECCCCC--eeeeccccccc
Q 003786 595 -------------------RLRVIHRDLKASNILLDKDMN--PKISDFGMARI 626 (795)
Q Consensus 595 -------------------~~~iiHrDikp~NIll~~~~~--vkL~DFGla~~ 626 (795)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997763 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.3e-09 Score=113.79 Aligned_cols=187 Identities=19% Similarity=0.220 Sum_probs=121.6
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcC-Ccc--cceeeeeeeecc---eeeEEeecC
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRN--LVRLLGCCIELE---EKILIYEYM 553 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~ 553 (795)
.+.++.|....||++. ..+++|+.... .....+.+|+++|+.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999874 57899986432 34567899999999884 333 334444433332 347899999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS--------------------------------------- 594 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 594 (795)
+|..+..... ..++..++..++.++++.++.||...
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865332 23566777888888888888888611
Q ss_pred ----------------CCcEEeccCCCCcEEECC--CCCeeeeccccccccCCCcccccc------------cccccccc
Q 003786 595 ----------------RLRVIHRDLKASNILLDK--DMNPKISDFGMARIFGGDELQSKT------------KRIVGTYG 644 (795)
Q Consensus 595 ----------------~~~iiHrDikp~NIll~~--~~~vkL~DFGla~~~~~~~~~~~~------------~~~~gt~~ 644 (795)
...++|+|++|.||+++. ...+.|+||+.+.......-.... .......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 135899999999999998 456789999998754221100000 00001111
Q ss_pred ccc-ccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003786 645 YMS-PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 645 y~A-PE~~~~~~~~~k~DvwSlGvil~elltG~~p~ 679 (795)
... |+..... ....+.|+++.+++.+.+|..++
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 112 2222111 22358999999999999997553
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.80 E-value=2e-08 Score=88.03 Aligned_cols=56 Identities=32% Similarity=0.428 Sum_probs=45.8
Q ss_pred cceEEEeeCCceEEeCCCCceEEeecCCCCc-cccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 87 NAVLTISNGGKLVLLNQTNGTIWSSNLSREV-KNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
.-+|.++.||||||++ .+.+||++++.... ..+.+.|+++|||||+| ..+++||+|
T Consensus 20 ~y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d-----~~~~~vWss 76 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYD-----SSGRSLWAS 76 (105)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEEC-----TTCCEEEEC
T ss_pred CEEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEEC-----CCcEEEEEe
Confidence 3568899999999998 46799999986433 35678999999999998 456789986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=2.3e-07 Score=94.34 Aligned_cols=106 Identities=18% Similarity=0.318 Sum_probs=78.7
Q ss_pred cccccCCCCC-------ccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeC
Q 003786 23 IAADNITPSR-------FIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNG 95 (795)
Q Consensus 23 ~~~~~l~~~~-------~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~ 95 (795)
+..|+|.+|| .|..++.+. .|.|.|.|.+.|+ +-+|... +++|.++.... ...+.++++.+
T Consensus 123 ~g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~~~---~~~W~s~~~~~--~~~~~~~L~~~ 190 (236)
T 1dlp_A 123 NGNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDRD---DRVWSTNTAGK--GTGCRAVLQPN 190 (236)
T ss_dssp CCCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEBTT---BCCSCCCCCSS--CSSCEEEEETT
T ss_pred ccceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEcCC---EeEEeCCCcCC--CCceEEEECCC
Confidence 4568889998 566666655 5899999987762 4555433 68898876543 23578899999
Q ss_pred CceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 96 GKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 96 g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
|+|++++.++.++|.+.+........++|.++|||+++. ..+|+|
T Consensus 191 Gnl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~--------~~~W~s 235 (236)
T 1dlp_A 191 GRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 235 (236)
T ss_dssp TEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred CcEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeC--------CCCccC
Confidence 999999988889999987654445678999999999995 168876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.2e-06 Score=89.51 Aligned_cols=136 Identities=23% Similarity=0.200 Sum_probs=94.2
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCc---ccceeeeeee-ecceeeEEeecCCC
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR---NLVRLLGCCI-ELEEKILIYEYMPN 555 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~ 555 (795)
.+.++.|....||+. ++.+++|+-.. ......+.+|+++|+.+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 67899998532 23456789999999999753 2445555553 34457899999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc------------------------------------------
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY------------------------------------------ 593 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 593 (795)
..+...... .++......++.++++.|..||..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 123444455555555555555543
Q ss_pred ---------------CCCcEEeccCCCCcEEECC---CCCe-eeeccccccc
Q 003786 594 ---------------SRLRVIHRDLKASNILLDK---DMNP-KISDFGMARI 626 (795)
Q Consensus 594 ---------------~~~~iiHrDikp~NIll~~---~~~v-kL~DFGla~~ 626 (795)
....++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 4665 8999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.8e-06 Score=92.00 Aligned_cols=81 Identities=7% Similarity=-0.021 Sum_probs=57.9
Q ss_pred cccc-CcCCcccEEEeEec-------CcceEEEEEecccC---ccchHHHHHHHHHHHhcCC---cccceeeeeeeec--
Q 003786 480 ENKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQH---RNLVRLLGCCIEL-- 543 (795)
Q Consensus 480 ~~~L-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-- 543 (795)
.+.| +.|....+|+.+.. +++.+++|+..... ......+.+|+.+|+.+.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88999999998764 26789999875432 1123568899999998853 3466777776554
Q ss_pred -ceeeEEeecCCCCChhh
Q 003786 544 -EEKILIYEYMPNKSLDF 560 (795)
Q Consensus 544 -~~~~lv~E~~~~gsL~~ 560 (795)
...++|||+++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=9.2e-06 Score=84.04 Aligned_cols=135 Identities=19% Similarity=0.173 Sum_probs=97.8
Q ss_pred ccCcCCcc-cEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-CcccceeeeeeeecceeeEEeecCCCCCh
Q 003786 482 KLGEGGFG-PVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 482 ~LG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
.+..|..+ .||+.... +++.+++|+-.. .....+.+|..+|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 58988754 467899998643 23567889999999885 33366788888888999999999999887
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY--------------------------------------------- 593 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------- 593 (795)
.+.... .......+..+++..|..||..
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 665421 1223445666666667777653
Q ss_pred ----------CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 594 ----------SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 594 ----------~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999877777999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.5e-05 Score=85.45 Aligned_cols=142 Identities=16% Similarity=0.179 Sum_probs=82.3
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCc--ccceeee------eeeecceeeEEee
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR--NLVRLLG------CCIELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~E 551 (795)
.+.|+.|..+.||++...++ .+++|+... ....+..|+.+++.|... .+.+++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 35677778899999987554 599999864 234555667777666421 2333333 1234567789999
Q ss_pred cCCCCChhh--------------hhhccCC----c-------ccCChhh-------------------------------
Q 003786 552 YMPNKSLDF--------------FLFDSTK----E-------NLLGWGT------------------------------- 575 (795)
Q Consensus 552 ~~~~gsL~~--------------~l~~~~~----~-------~~l~~~~------------------------------- 575 (795)
|++|..+.. .++.... . ..-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999875430 0111000 0 0011111
Q ss_pred HHHHHHHHHHHHHHHHh----------cCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 576 RVRIIEGIAQGLLYLHQ----------YSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 576 ~~~i~~~i~~~l~~LH~----------~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
...+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 00111223445666653 1234699999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.2e-05 Score=88.36 Aligned_cols=75 Identities=13% Similarity=0.200 Sum_probs=51.5
Q ss_pred ccccCcCCcccEEEeEec-CcceEEEEEecccCc-------cchHHHHHHHHHHHhcCC--cccc-eeeeeeeecceeeE
Q 003786 480 ENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-------QGQEEFKNEIKLIAKLQH--RNLV-RLLGCCIELEEKIL 548 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 548 (795)
.+.||.|..+.||+++.. +++.++||....... ...+++..|.++|+.+.. |..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 468899998653211 234567889999988843 4444 45543 4456789
Q ss_pred EeecCCCC
Q 003786 549 IYEYMPNK 556 (795)
Q Consensus 549 v~E~~~~g 556 (795)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=7.3e-05 Score=78.14 Aligned_cols=81 Identities=16% Similarity=0.229 Sum_probs=60.8
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCc---ccceeeeeeeecceeeEEe
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR---NLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~ 550 (795)
..+...++.+|.|..+.||+.+..+|+.|++|+...........|..|+..|+.|... -+.++++. +..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 3456667889999999999999999999999987655444556789999999988532 23344443 2357899
Q ss_pred ecCCCCCh
Q 003786 551 EYMPNKSL 558 (795)
Q Consensus 551 E~~~~gsL 558 (795)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00018 Score=75.94 Aligned_cols=77 Identities=19% Similarity=0.153 Sum_probs=61.7
Q ss_pred ccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcC---CcccceeeeeeeecceeeEEeecCC
Q 003786 478 STENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
...+.|+.|....+|+... +++.+++|+.... ....+..|+..|+.|. ...+.+++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456899999999999976 5678999987532 3567889999999884 3567788888877788999999999
Q ss_pred CCCh
Q 003786 555 NKSL 558 (795)
Q Consensus 555 ~gsL 558 (795)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 9865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00017 Score=79.73 Aligned_cols=77 Identities=10% Similarity=0.078 Sum_probs=47.5
Q ss_pred CCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccccccccccc--ccccccccccccC---CCCcccchhhHHHHH
Q 003786 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVG--TYGYMSPEYAQQG---LFSIKSDVFSFGVLL 669 (795)
Q Consensus 595 ~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~---~~~~k~DvwSlGvil 669 (795)
...++|+|++|.|||++.++ ++|+||+.+....... . ...... ...|++|+..... .-....++.++...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34699999999999998876 9999999987532110 0 000111 2346676655321 112234555777777
Q ss_pred HHHHhC
Q 003786 670 LETLSS 675 (795)
Q Consensus 670 ~elltG 675 (795)
++.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00033 Score=74.20 Aligned_cols=158 Identities=15% Similarity=0.129 Sum_probs=87.1
Q ss_pred cHHhHHHHccCCcc-----ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeee
Q 003786 466 SLASVSAATANFST-----ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLG 538 (795)
Q Consensus 466 ~~~~i~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 538 (795)
+...+.....+|.+ .+.|+.|....+|+....++ .+++|+.... ...+.+..|+.+++.+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444443 35677888899999986544 7889988652 23356778888888775322 233332
Q ss_pred e------eeecceeeEEeecCCCCChhhh--------------hhccCCc------ccC---ChhhHHH-----------
Q 003786 539 C------CIELEEKILIYEYMPNKSLDFF--------------LFDSTKE------NLL---GWGTRVR----------- 578 (795)
Q Consensus 539 ~------~~~~~~~~lv~E~~~~gsL~~~--------------l~~~~~~------~~l---~~~~~~~----------- 578 (795)
. ....+..++++|+++|..+... ++..... ... .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1223556899999998754210 1110000 000 1111000
Q ss_pred -HHHHHHHHHHHHHhc----CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 579 -IIEGIAQGLLYLHQY----SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 579 -i~~~i~~~l~~LH~~----~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
+...+.+.+..++.. ....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 134699999999999998876568999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0004 Score=76.89 Aligned_cols=73 Identities=19% Similarity=0.289 Sum_probs=51.5
Q ss_pred ccccCcCCcccEEEeEecC--------cceEEEEEecccCccchHHHHHHHHHHHhcCCccc-ceeeeeeeecceeeEEe
Q 003786 480 ENKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIY 550 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 550 (795)
.+.|+.|-...||++...+ ++.+++|+.... ...+.+.+|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889999999998653 478999988432 122566689999998864444 466665542 3899
Q ss_pred ecCCCCCh
Q 003786 551 EYMPNKSL 558 (795)
Q Consensus 551 E~~~~gsL 558 (795)
||++|..+
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00096 Score=72.31 Aligned_cols=141 Identities=23% Similarity=0.275 Sum_probs=82.8
Q ss_pred cccCcCCcccEEEeEec--------CcceEEEEEecccCccchHHHHHHHHHHHhcCCccc-ceeeeeeeecceeeEEee
Q 003786 481 NKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIYE 551 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E 551 (795)
+.|..|-...+|++... +++.+++|+.... ......+.+|.++++.|...++ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 57888999999999864 2478999986432 2345667799999988853333 456666543 29999
Q ss_pred cCCCCChhhh-h----------------hccCC--cccCC--hhhHHHHHHHHH-------------------HHHHH--
Q 003786 552 YMPNKSLDFF-L----------------FDSTK--ENLLG--WGTRVRIIEGIA-------------------QGLLY-- 589 (795)
Q Consensus 552 ~~~~gsL~~~-l----------------~~~~~--~~~l~--~~~~~~i~~~i~-------------------~~l~~-- 589 (795)
|++|..|..- + +.... .+... +.++.++..++. +.+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 0 11000 01111 223333333321 11222
Q ss_pred --HHhc-CCCcEEeccCCCCcEEECCC----CCeeeeccccccc
Q 003786 590 --LHQY-SRLRVIHRDLKASNILLDKD----MNPKISDFGMARI 626 (795)
Q Consensus 590 --LH~~-~~~~iiHrDikp~NIll~~~----~~vkL~DFGla~~ 626 (795)
|... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 23469999999999999876 7899999999864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00082 Score=70.51 Aligned_cols=71 Identities=8% Similarity=0.132 Sum_probs=47.5
Q ss_pred ccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccc-eeeeeeeecceeeEEeecC-CCCC
Q 003786 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYM-PNKS 557 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~-~~gs 557 (795)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++. +++++ +.+..++++||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 67899988653221 12345788888887543343 45543 344567899999 6655
Q ss_pred h
Q 003786 558 L 558 (795)
Q Consensus 558 L 558 (795)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0042 Score=65.76 Aligned_cols=142 Identities=13% Similarity=0.165 Sum_probs=83.4
Q ss_pred cccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc--cceeeee-----eeecceeeEEeecC
Q 003786 481 NKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN--LVRLLGC-----CIELEEKILIYEYM 553 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~E~~ 553 (795)
..|+ |....||++...+|+.+++|+..... ...+.+..|..+++.+.... +.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887677789999986431 24567788999888885322 3444443 12234557899999
Q ss_pred CCCChhh-----h---------hhccC------CcccCChh-------------------hHHHHHHHHHHHHHHHHhc-
Q 003786 554 PNKSLDF-----F---------LFDST------KENLLGWG-------------------TRVRIIEGIAQGLLYLHQY- 593 (795)
Q Consensus 554 ~~gsL~~-----~---------l~~~~------~~~~l~~~-------------------~~~~i~~~i~~~l~~LH~~- 593 (795)
+|..+.. . ++... .....++. ....+...+.+.+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865421 0 01000 00111111 0000111111223333221
Q ss_pred ---CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 594 ---SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 594 ---~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0021 Score=71.48 Aligned_cols=74 Identities=14% Similarity=0.128 Sum_probs=49.9
Q ss_pred ccccCcCCcccEEEeEecC-cceEEEEEecccCccchHHHHHHHHHHHhcCCcccc-eeeeeeeecceeeEEeecCCCCC
Q 003786 480 ENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gs 557 (795)
.+.|+.|-...+|++...+ ++.+++|+....... .-...+|..+++.|...++. ++++.+. + .+|+||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678889999999998755 478999987543211 11236899999999765554 5676653 2 35999999865
Q ss_pred h
Q 003786 558 L 558 (795)
Q Consensus 558 L 558 (795)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0014 Score=70.86 Aligned_cols=74 Identities=12% Similarity=0.124 Sum_probs=46.1
Q ss_pred ccccCcCCcccEEEeEecCc---------ceEEEEEecccCccchHHHHHHHHHHHhcCCccc-ceeeeeeeecceeeEE
Q 003786 480 ENKLGEGGFGPVYKGRLLNG---------QEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILI 549 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 549 (795)
.+.|+.|....+|++...++ +.+++|+...... .......|..+++.+...++ .++++.. .-++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 35788888899999986542 6788888754321 11234688888888854443 3566543 23789
Q ss_pred eecCCCCCh
Q 003786 550 YEYMPNKSL 558 (795)
Q Consensus 550 ~E~~~~gsL 558 (795)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0047 Score=65.61 Aligned_cols=143 Identities=13% Similarity=0.108 Sum_probs=74.5
Q ss_pred ccccCcCCccc-EEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCc--ccceeeeeeeecceeeEEeecCCCC
Q 003786 480 ENKLGEGGFGP-VYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR--NLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 480 ~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~g 556 (795)
.+.|+.|.... +|+....+++.+++|...... .+.+..|+.+++.+... .+.+++.+.. +.-+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCc
Confidence 35676665554 677765446778887654321 14456778888777432 3445665532 2237899999876
Q ss_pred ChhhhhhccC---------------------Cc--ccCChhhHH-------H-------------HHHHHHHHHHHHH--
Q 003786 557 SLDFFLFDST---------------------KE--NLLGWGTRV-------R-------------IIEGIAQGLLYLH-- 591 (795)
Q Consensus 557 sL~~~l~~~~---------------------~~--~~l~~~~~~-------~-------------i~~~i~~~l~~LH-- 591 (795)
.+...+.... .. ..++..... . ....+.+.+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6643331100 00 011111000 0 0011112222221
Q ss_pred -hcCCCcEEeccCCCCcEEECCC----CCeeeecccccccc
Q 003786 592 -QYSRLRVIHRDLKASNILLDKD----MNPKISDFGMARIF 627 (795)
Q Consensus 592 -~~~~~~iiHrDikp~NIll~~~----~~vkL~DFGla~~~ 627 (795)
......++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999875 67899999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.005 Score=65.69 Aligned_cols=68 Identities=12% Similarity=0.087 Sum_probs=44.2
Q ss_pred CcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCC---cccceeeee------eeecceeeEEeecCC
Q 003786 484 GEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH---RNLVRLLGC------CIELEEKILIYEYMP 554 (795)
Q Consensus 484 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lv~E~~~ 554 (795)
|.|....||+....+| .+++|+..... ...|+.+++.|.. |++.+.+.. ....+..++||||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444678999987666 89999876533 1456666666632 224444432 233466789999999
Q ss_pred CCCh
Q 003786 555 NKSL 558 (795)
Q Consensus 555 ~gsL 558 (795)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0052 Score=60.06 Aligned_cols=103 Identities=13% Similarity=0.015 Sum_probs=65.8
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
.-+|.++|.. ....+++++++.++.|.+.+|.-+-... . -..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc---------
Confidence 3468888843 3457999999999999999987762211 1 11333557999999999998764 1110
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~ 677 (795)
.....+.|||... ...+.+.=|||||+++|..+--..
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1223466888763 345678889999999999985443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.014 Score=64.03 Aligned_cols=74 Identities=12% Similarity=0.150 Sum_probs=50.2
Q ss_pred ccccCcCCcccEEEeEecC--------cceEEEEEecccCccchHHHHHHHHHHHhcCCccc-ceeeeeeeecceeeEEe
Q 003786 480 ENKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIY 550 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 550 (795)
++.|..|-...+|+....+ ++.+++++..... .......+|..+++.+...++ .++++.+ .-++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 4678888889999998653 5789999875432 222234688999888853333 3555433 237899
Q ss_pred ecCCCCCh
Q 003786 551 EYMPNKSL 558 (795)
Q Consensus 551 E~~~~gsL 558 (795)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.96 E-value=0.14 Score=55.81 Aligned_cols=30 Identities=27% Similarity=0.383 Sum_probs=25.5
Q ss_pred cEEeccCCCCcEEE------CCCCCeeeeccccccc
Q 003786 597 RVIHRDLKASNILL------DKDMNPKISDFGMARI 626 (795)
Q Consensus 597 ~iiHrDikp~NIll------~~~~~vkL~DFGla~~ 626 (795)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567799999999864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=90.34 E-value=9.3 Score=38.56 Aligned_cols=66 Identities=15% Similarity=0.224 Sum_probs=42.3
Q ss_pred CCeEEEecCCCCC--C----ccCcceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeec
Q 003786 70 PDTIVWVANRNSP--I----FDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDN 135 (795)
Q Consensus 70 ~~t~vW~an~~~p--~----~~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~ 135 (795)
..+++|...+..+ + ..+++.+-++.++.+..+|.+|..+|...+........+..+.+||+++-+.
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 4578888876541 1 1234445556666777788889999999864222223356778888888763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 795 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-72 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-26 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-20 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-07 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-13 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-12 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-06 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 6e-72
Identities = 66/283 (23%), Positives = 130/283 (45%), Gaps = 19/283 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ ++G G FG VYKG+ V + +++ + Q + FKNE+ ++ K +H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
+G + ++ ++ SL L E + I AQG+ YLH
Sbjct: 69 FMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA--- 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ--- 652
+IHRDLK++NI L +D+ KI DFG+A + + +++ G+ +M+PE +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
+ +S +SDV++FG++L E ++ + +SN N+ + +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLP 755
L+ C+++ +RP ++++ + +LP
Sbjct: 241 AMKRLM--------AECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 6e-68
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ ++G G FG V+ G LN +VA+K + + +E+F E +++ KL H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L G C+E L++E+M + L +L + L T + + + +G+ YL +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
VIHRDL A N L+ ++ K+SDFGM R D+ + + + SPE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 178
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715
+S KSDV+SFGVL+ E S + + +NS + + L P L +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFRLYKPRLAST-- 229
Query: 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ C +E DRP ++ L
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 1e-67
Identities = 83/272 (30%), Positives = 127/272 (46%), Gaps = 21/272 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+LG G FG V+ G +VAVK L Q + F E L+ +LQH+ LVR
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L + E +I EYM N SL FL + L + + IA+G+ ++ +
Sbjct: 73 LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE--- 127
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E ++ + +PE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGT 186
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715
F+IKSDV+SFG+LL E ++ R TN + +R + ++ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------IQNLERGYRMVRPD------ 233
Query: 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ LC +E DRPT + S+L
Sbjct: 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-66
Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ + +LG G FG V G+ +VA+K + S ++EF E K++ L H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L G C + +I EYM N L +L + + + + + + + + YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+ +HRDL A N L++ K+SDFG++R DE S + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSK 177
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715
FS KSD+++FGVL+ E S + ++ + + E I L+
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRP 223
Query: 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
+L + + C E A +RPT ++S + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-65
Identities = 76/286 (26%), Positives = 129/286 (45%), Gaps = 21/286 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ E KLG+G FG V+ G VA+K L + E F E +++ KL+H LV+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L E ++ EYM SL FL T + L V + IA G+ Y+ +
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM-- 132
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+HRDL+A+NIL+ +++ K++DFG+AR+ +E ++ + +PE A G
Sbjct: 133 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGR 190
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEAS 715
F+IKSDV+SFG+LL E + R + + + ++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCP 236
Query: 716 YLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPA 761
++ C +++ +RPT + + L + + QP
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-64
Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 29/293 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGC 539
+ +G+G FG V++G+ G+EVAVK SS+ + + EI L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 540 CIE----LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ--- 592
+ + L+ +Y + SL +L + +++ A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 593 --YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF--GGDELQSKTKRIVGTYGYMSP 648
+ + HRDLK+ NIL+ K+ I+D G+A D + VGT YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 649 EYAQQGL------FSIKSDVFSFGVLLLETLSSKRNTDFSNTNS-----LTLLGHAWDLW 697
E + ++D+++ G++ E L + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 698 KDDRAWELIDPTLQNEASYL-ILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
+ + + P + N L + C + A R T + L+
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 1e-63
Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 21/273 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+ + ++KLG G +G VY+G VAVK L + + EEF E ++ +++H NLV
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+LLG C +I E+M +L +L + ++ + + + I+ + YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE--- 132
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+ IHRDL A N L+ ++ K++DFG++R+ GD + + +PE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYN 191
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714
FSIKSDV++FGVLL E + + + + +EL++ + E
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRMER 237
Query: 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ + C Q + +DRP+ E+
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 2e-63
Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 36/300 (12%)
Query: 465 FSLASVSAATANFSTE---------NKLGEGGFGPVYKGRLL----NGQEVAVKRL-SSQ 510
F+ + A F+ E +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 511 SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL 570
+ + + +F +E ++ + H N++ L G + ++I E+M N SLD FL + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 571 LGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 631 ELQSKTKRIVG---TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687
+G + +PE Q F+ SDV+S+G+++ E +S
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 688 TLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ + I+ + + + L C Q+D RP ++V+ L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 7e-63
Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 27/273 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+G+G FG V G G +VAVK + + + + F E ++ +L+H NLV+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 536 LLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
LLG +E + + ++ EYM SL +L ++LG ++ + + + YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+HRDL A N+L+ +D K+SDFG+ + E S + +PE ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 175
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714
FS KSDV+SFG+LL E S R + ++ + +A
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKDVVPRVEKGYKMDA 221
Query: 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
V C DAA RP+ ++ L
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 4e-62
Identities = 64/298 (21%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQHRNL 533
+F ++LG G G V+K +G +A K + + + + E++++ + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
V G E + E+M SLD L K + ++ + +GL YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR-- 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ +++HRD+K SNIL++ K+ DFG++ S VGT YMSPE Q
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL----------------------- 690
+S++SD++S G+ L+E + + L L+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 691 -GHAWDLWKDDRAWELIDPTLQNEASYLILNRY----INVGLLCVQEDAADRPTMFEV 743
+ D +EL+D + L + + C+ ++ A+R + ++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-62
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 30/286 (10%)
Query: 480 ENKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQSGQGQ--EEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V KG + VAVK L +++ +E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
R++G C E E +L+ E L+ +L + + + ++ ++ G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE-- 125
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD-ELQSKTKRIVGTYGYMSPEYAQQ 653
+HRDL A N+LL KISDFG+++ D + +PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713
FS KSDV+SFGVL+ E S + + K +++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERMG 230
Query: 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN---KTINLPH 756
++ LC D +RP V L N +N H
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 7e-62
Identities = 68/288 (23%), Positives = 112/288 (38%), Gaps = 25/288 (8%)
Query: 480 ENKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLVR 535
+ +LG G FG V +G +VA+K L + + EE E +++ +L + +VR
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
L+G C + E +L+ E L FL K + ++ ++ G+ YL +
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMARIFG-GDELQSKTKRIVGTYGYMSPEYAQQG 654
+HRDL A N+LL KISDFG+++ G D + + +PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714
FS +SDV+S+GV + E LS + + K I+ + E
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIEQGKRMEC 233
Query: 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPAF 762
+ C DRP V + +L +
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 5e-61
Identities = 71/300 (23%), Positives = 119/300 (39%), Gaps = 45/300 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQ-SGQGQEEFKNEIKLIAKL 528
N +GEG FG V++ R VAVK L + S Q +F+ E L+A+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL------------------ 570
+ N+V+LLG C + L++EYM L+ FL + +
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 571 ---LGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627
L ++ I +A G+ YL + + +HRDL N L+ ++M KI+DFG++R
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687
+ +M PE ++ +SDV+++GV+L E S + +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 249
Query: 688 TLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+D + N+ LC + ADRP+ + +L
Sbjct: 250 ----EVIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 6e-61
Identities = 65/273 (23%), Positives = 116/273 (42%), Gaps = 22/273 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLS-SQSGQGQEEFKNEIKLIAKLQHRNL 533
++ LGEG +G V + VAVK + ++ E K EI + L H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
V+ G E + L EY L + + R + G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ + HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE ++
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 654 GLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
F + DV+S G++L L+ + D + + WK+ + + + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKTYLNPWKKIDS 234
Query: 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
L+ + E+ + R T+ ++
Sbjct: 235 APLALLHK--------ILVENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (521), Expect = 2e-60
Identities = 81/305 (26%), Positives = 129/305 (42%), Gaps = 37/305 (12%)
Query: 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQHRN 532
FS ++G G FG VY R + N + VA+K++S QS + ++ E++ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
++ GC + L+ EY + D + L + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+IHRD+KA NILL + K+ DFG A I + VGT +M+PE
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 653 ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709
+G + K DV+S G+ +E K N N+++ L H
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVS---MLTNKTINLPHPR-QPAFSSI 765
+N + + C+Q+ DRPT ++ +L + + Q ++
Sbjct: 243 FRN----FVDS--------CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290
Query: 766 RGLKN 770
R L N
Sbjct: 291 RELDN 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-60
Identities = 74/279 (26%), Positives = 129/279 (46%), Gaps = 26/279 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSGQGQ-EEFKNEIKLIAKLQ 529
+ + +G G FG VYKG L VA+K L + + Q +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
H N++RL G + + ++I EYM N +LD FL + K+ V ++ GIA G+ Y
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKY 125
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT-KRIVGTYGYMSP 648
L + +HRDL A NIL++ ++ K+SDFG++R+ D + T + +P
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708
E F+ SDV+SFG+++ E ++ + +N + I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------------HEVMKAIND 228
Query: 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ + + + C Q++ A RP ++VS+L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-59
Identities = 74/277 (26%), Positives = 122/277 (44%), Gaps = 27/277 (9%)
Query: 480 ENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
+G G FG VY G LL+ AVK L+ + G+ +F E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
LLG C+ E ++ YM + L F+ + + + + +A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM---KFL 146
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR--IVGTYGYMSPEYA 651
+ + +HRDL A N +LD+ K++DFG+AR E S + +M+ E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
Q F+ KSDV+SFGVLL E ++ + + N+ + L + R L+ P
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDIT---VYLLQGRR---LLQPE-- 257
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
+ V L C A RP+ E+VS ++
Sbjct: 258 -----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 70/295 (23%), Positives = 111/295 (37%), Gaps = 39/295 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKL 528
S LG G FG V + VAVK L + + E +E+K+++ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 529 -QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENL---------------LG 572
H N+V LLG C ++I EY L FL + L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 573 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632
+ +A+G+ +L IHRDL A NILL KI DFG+AR D
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692
+M+PE +++ +SDV+S+G+ L E S +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------------ 248
Query: 693 AWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ D + +++I + + ++ C D RPT ++V ++
Sbjct: 249 -PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-59
Identities = 72/300 (24%), Positives = 115/300 (38%), Gaps = 44/300 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKL 528
N LG G FG V +VAVK L ++ + E +E+K++ +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 529 -QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTK-------------------- 567
H N+V LLG C LI+EY L +L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 568 ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627
N+L + + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL 687
D +M+PE +G+++IKSDV+S+G+LL E S +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPVD 273
Query: 688 TLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
++LI + + + + C D+ RP+ + S L
Sbjct: 274 ANF------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-59
Identities = 63/274 (22%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 480 ENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRL 536
+ ++G G F VYKG EVA L + + ++ FK E +++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 537 LGCCIELEEK----ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ +L+ E M + +L +L + ++ I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 593 YSRLRVIHRDLKASNILL-DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+ +IHRDLK NI + + KI D G+A + S K ++GT +M+PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMY 185
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
++ + DV++FG+ +LE +S+ +S + + + D
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI---YRRVTSGVKPASFDKVAI 239
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
E +I C++++ +R ++ ++++
Sbjct: 240 PEVKEIIEG--------CIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-59
Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRN 532
++ +G G +G K R +G+ + K L S + ++ +E+ L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 533 LVRLLGCCIELEEKIL--IYEYMPNKSLDFFLFDSTKEN-LLGWGTRVRIIEGIAQGLLY 589
+VR I+ L + EY L + TKE L +R++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 590 LHQYSR--LRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
H+ S V+HRDLK +N+ LD N K+ DFG+ARI D S K VGT YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMS 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707
PE + ++ KSD++S G LL E + F+ + L G + + I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKI-----REGKFRRIP 235
Query: 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVV 744
+E + +I + RP++ E++
Sbjct: 236 YRYSDELNEIITR--------MLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 26/274 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+ +LG+G FG VYK + A K + ++S + E++ EI ++A H N+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+LL ++ E+ ++D + + E L + + L YLH
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD-- 128
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ-- 652
++IHRDLKA NIL D + K++DFG++ + +GT +M+PE
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCE 185
Query: 653 ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709
+ K+DV+S G+ L+E + N + +L + K +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVL---LKIAKSEPPTLAQPSR 240
Query: 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
+ + C++++ R T ++
Sbjct: 241 WSSNFKDFLKK--------CLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-58
Identities = 71/308 (23%), Positives = 132/308 (42%), Gaps = 40/308 (12%)
Query: 477 FSTENKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-SQSGQGQEEFKNEIKLIAKLQH 530
F LG G FG VYKG + E VA+K L + S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
++ RLLG C+ LI + MP L ++ + ++ +G + IA+G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
R++HRDL A N+L+ + KI+DFG+A++ G +E + + +M+ E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710
+++ +SDV+S+GV + E ++ +D +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230
Query: 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT--------------NKTINLPH 756
+ + + + C DA RP E++ + ++ ++LP
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 757 PRQPAFSS 764
P F
Sbjct: 291 PTDSNFYR 298
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 74/281 (26%), Positives = 108/281 (38%), Gaps = 27/281 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKL 528
+ KLG+G FG V +G VAVK L + ++F E+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
HRNL+RL G + ++ E P SL L + GT R +A+G+
Sbjct: 69 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 125
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG-GDELQSKTKRIVGTYGYMS 647
YL R IHRDL A N+LL KI DFG+ R D+ + + + +
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707
PE + FS SD + FGV L E + + + N +L + K+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQ-EPWIGLNGSQIL---HKIDKEGERLPRPE 238
Query: 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLT 748
NV + C DRPT + L
Sbjct: 239 D---------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-57
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 23/279 (8%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKL 524
S+ SV ++ K+G+G G VY + GQEVA+++++ Q +E NEI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
+ + ++ N+V L + +E ++ EY+ SL + ++ + G +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECL 126
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ NILL D + K++DFG + QSK +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
+M+PE + + K D++S G++ +E + + + N N L L + + +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL---YLIATNGTPEL 236
Query: 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
L + C+ D R + E+
Sbjct: 237 QNPEKLSAIFRDFLNR--------CLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-57
Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 38/290 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNG---QEVAVKRLS-SQSGQGQEEFKNEIKLIAKL-QH 530
+ ++ +GEG FG V K R+ + A+KR+ S +F E++++ KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFL-------------FDSTKENLLGWGTRV 577
N++ LLG C L EY P+ +L FL ++ + L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 578 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTK 637
+A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R E+ K
Sbjct: 131 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKT 184
Query: 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697
+M+ E +++ SDV+S+GVLL E +S +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------------TPYCGM 230
Query: 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+E + + E + ++ C +E +RP+ +++ L
Sbjct: 231 TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-56
Identities = 71/302 (23%), Positives = 129/302 (42%), Gaps = 33/302 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGQEEFKNEIKLIAKL 528
+ +LG+G FG VY+G VA+K ++ + S + + EF NE ++ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLF-------DSTKENLLGWGTRVRIIE 581
++VRLLG + + ++I E M L +L ++ +++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 582 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVG 641
IA G+ YL+ + +HRDL A N ++ +D KI DFGM R + K + +
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701
+MSPE + G+F+ SDV+SFGV+L E + + +++
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNEQ 243
Query: 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQPA 761
+ + + + +C Q + RP+ E++S + K P R+ +
Sbjct: 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI--KEEMEPGFREVS 301
Query: 762 FS 763
F
Sbjct: 302 FY 303
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-56
Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 30/274 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQHR 531
+F LG+G FG VY R + +A+K L + + + + E+++ + L+H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
N++RL G + LI EY P ++ L +K I +A L Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH 123
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
RVIHRD+K N+LL KI+DFG + + + GT Y+ PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMI 176
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
+ + K D++S GVL E L K F + + + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKP--PFEANTYQETYKRI--SRVEFTFPDFVTEGAR 232
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVS 745
+ +++R ++ + + RP + EV+
Sbjct: 233 D-----LISR-------LLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 62/279 (22%), Positives = 109/279 (39%), Gaps = 26/279 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQG-QEEFKNEIKLIAKLQH 530
+GEG FG V++G ++ VA+K + + +E+F E + + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
++V+L+G E +I E L FL ++ L + + ++ L YL
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYL 124
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
R +HRD+ A N+L+ + K+ DFG++R K + +M+PE
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPES 180
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710
F+ SDV+ FGV + E L N+ + + +R + P
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GRIENGERLP--MPPNC 234
Query: 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
L+ C D + RP E+ + L+
Sbjct: 235 PPTLYSLMTK--------CWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (463), Expect = 7e-52
Identities = 61/271 (22%), Positives = 108/271 (39%), Gaps = 23/271 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
++ +LG G FG V++ G A K + + +E + EI+ ++ L+H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
L + E ++IYE+M L + D + N + V + + +GL ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 595 RLRVIHRDLKASNILLDKDMNP--KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+H DLK NI+ + K+ DFG+ + K GT + +PE A+
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAE 198
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
+D++S GVL LS N + + D DD A+ I ++
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 713 EASYLILNRYINVGLLCVQEDAADRPTMFEV 743
+ + + D R T+ +
Sbjct: 259 -----FIRK-------LLLADPNTRMTIHQA 277
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-52
Identities = 71/296 (23%), Positives = 112/296 (37%), Gaps = 38/296 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQG-QEEFKNEIKLIAK- 527
LG G FG V + + VAVK L + +E+K++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 528 LQHRNLVRLLGCCIELEEKILI-YEYMPNKSLDFFLF-------------DSTKENLLGW 573
H N+V LLG C + +++ E+ +L +L + ++ L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 574 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633
+ +A+G+ +L + IHRDL A NILL + KI DFG+AR D
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHA 693
+ +M+PE +++I+SDV+SFGVLL E S + + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEF 246
Query: 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
K+ D L C + + RPT E+V L N
Sbjct: 247 CRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-52
Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 40/295 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGQEEFKNEIKLIA 526
LGEG FG V + +VAVK L S + + + +E++++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 527 KL-QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLF-------------DSTKENLLG 572
+ +H+N++ LLG C + +I EY +L +L E L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 573 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632
V +A+G+ YL + IHRDL A N+L+ +D KI+DFG+AR +
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH 692
KT +M+PE +++ +SDV+SFGVLL E +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--------------S 236
Query: 693 AWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSML 747
+ + ++L+ + + N + C + RPT ++V L
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-50
Identities = 65/286 (22%), Positives = 106/286 (37%), Gaps = 30/286 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQHR 531
+F LGEG F V R L +E A+K L E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
V+L + E+ Y N L ++ G A+ + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALE 122
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRDLK NILL++DM+ +I+DFG A++ + Q++ VGT Y+SPE
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
+ SD+++ G ++ + ++ F N + K +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLI------FQKIIKLEYDFPEKFF 234
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHP 757
+A L+ + DA R E+ K HP
Sbjct: 235 PKARDLVEK--------LLVLDATKRLGCEEMEGYGPLKA----HP 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (448), Expect = 1e-49
Identities = 57/273 (20%), Positives = 112/273 (41%), Gaps = 27/273 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V++ G+ K +++ + KNEI ++ +L H L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
L + E +LI E++ L + + ++ + + + +GL ++H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH--- 144
Query: 595 RLRVIHRDLKASNILLDKDMNP--KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
++H D+K NI+ + KI DFG+A DE+ K T + +PE
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVD 201
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH--AWDLWKDDRAWELIDPTL 710
+ +D+++ GVL LS F+ + L L + D D+ A+ + P
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
++ + +Q++ R T+ +
Sbjct: 260 KD-----FIKN-------LLQKEPRKRLTVHDA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 5e-47
Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 31/275 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNE---IKLIAKL 528
+FS +G GGFG VY R G+ A+K L + QG+ NE + L++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
+V + ++ I + M L + L + + I GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLE 121
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSP 648
++H V++RDLK +NILLD+ + +ISD G+A F + K VGT+GYM+P
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAP 174
Query: 649 EYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707
E Q+G+ + +D FS G +L + L T + L +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFS 233
Query: 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFE 742
P L++ +L +Q D R
Sbjct: 234 PELRS-----LLEG-------LLQRDVNRRLGCLG 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 63/322 (19%), Positives = 123/322 (38%), Gaps = 36/322 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+ LG G FG V++ + + K + + G Q K EI ++ +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNIL 64
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
L +EE ++I+E++ + + +T L V + + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 595 RLRVIHRDLKASNILLDKDMNP--KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+ H D++ NI+ + KI +FG AR + + + Y +PE Q
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
+ S +D++S G L+ LS + + D+ A++ I +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 713 EASYLILNRYINVGLLCVQEDAADRPTMFEV---------VSMLTNKTINLPHPRQPAFS 763
++R + ++ R T E + ++ K I R+ +
Sbjct: 237 -----FVDR-------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
Query: 764 SIRGLKNTILPANGKARVCSGN 785
I+ N ++ A AR+ G
Sbjct: 285 LIKKDLNMVVSA---ARISCGG 303
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 4e-46
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 26/272 (9%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEE-FKNEIKLIAKLQHRNLV 534
+ + LG G F V + VA+K ++ ++ +G+E +NEI ++ K++H N+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
L LI + + L + ++ R+I + + YLH
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDL- 126
Query: 595 RLRVIHRDLKASNILL---DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
++HRDLK N+L D+D ISDFG++++ S GT GY++PE
Sbjct: 127 --GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVL 181
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
Q +S D +S GV+ L N L + D W+ I + +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
+ + +++D R T +
Sbjct: 242 D-----FIRH-------LMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 4e-46
Identities = 62/281 (22%), Positives = 112/281 (39%), Gaps = 28/281 (9%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQ---EEFKNEIKLIAKLQHRN 532
+ LG GG V+ R L ++VAVK L + + F+ E + A L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 533 LVRLLGCCIELEEKI----LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
+V + ++ EY+ +L + + + +I Q L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALN 125
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG-GDELQSKTKRIVGTYGYMS 647
+ H + +IHRD+K +NI++ K+ DFG+AR ++T ++GT Y+S
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707
PE A+ +SDV+S G +L E L+ + + S+ D E +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 708 PTLQNEASYLILNRYINVGLLCVQEDAADRP-TMFEVVSML 747
L ++ + + ++ +R T E+ + L
Sbjct: 243 ADLDA-----VVLK-------ALAKNPENRYQTAAEMRADL 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 7e-46
Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 26/288 (9%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQ-EEFKNEIKLIAKLQHRNLV 534
++ + +GEG +G V +N VA+K++S Q + EIK++ + +H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+ + + Y+ + L+ K L + I +GL Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-- 127
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKT-KRIVGTYGYMSPEYAQQ 653
V+HRDLK SN+LL+ + KI DFG+AR+ D + V T Y +PE
Sbjct: 128 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 654 GLFSIKS-DVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
KS D++S G +L E LS++ F + L L H + +L
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 713 EASYLILNRYINVGLL-----------------CVQEDAADRPTMFEV 743
+YL+ + N + + R + +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (410), Expect = 2e-45
Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 38/285 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---------QGQEEFKNEIKLI 525
N+ + LG G V + +E AVK + G + +E E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 526 AKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
K+ H N+++L L+++ M L +L T++ L +I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYG 644
+ + LH +L ++HRDLK NILLD DMN K++DFG + E K + + GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 645 YMSPEYAQ------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK 698
Y++PE + + + D++S GV++ L+ + + + +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 699 DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
W+ T+++ +++R + R T E
Sbjct: 235 GSPEWDDYSDTVKD-----LVSR-------FLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 7e-45
Identities = 51/282 (18%), Positives = 95/282 (33%), Gaps = 24/282 (8%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ K+G G FG +Y G + G+EVA+K ++ + E K+ +Q +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSR 595
+ C + ++ + SL+ + T + + + + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 596 LRVIHRDLKASNIL---LDKDMNPKISDFGMARIFGGDELQS-----KTKRIVGTYGYMS 647
IHRD+K N L K I DFG+A+ + + K + GT Y S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707
S + D+ S G +L+ + K E++
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
+E + + C D+P + + N
Sbjct: 242 KGYPSEFATYL--------NFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 1e-44
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGQEEFKNEIKLIAKLQHR 531
+F LG G FG V+ R NG+ A+K L + E +E +++ + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
++R+ G + ++ +I +Y+ L L S + + L YLH
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLH 121
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+I+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVV 173
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKR 677
++ D +SFG+L+ E L+
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 6e-43
Identities = 65/270 (24%), Positives = 101/270 (37%), Gaps = 29/270 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGQEEFKNEIKLIAK-LQH 530
+F LG+G FG V+ Q A+K L E E ++++ +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYL 590
L + E + EY+ L + + K I GL +L
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL 119
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
H +++RDLK NILLDKD + KI+DFGM + + +KT GT Y++PE
Sbjct: 120 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEI 174
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710
++ D +SFGVLL E L + + F + L L
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIR------MDNPFYPRWL 226
Query: 711 QNEASYLILNRYINVGLLCVQEDAADRPTM 740
+ EA L++ + R +
Sbjct: 227 EKEAKDLLVK--------LFVREPEKRLGV 248
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 26/302 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
NF K+GEG +G VYK R L G+ VA+K RL +++ EI L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+V+LL + L++E++ F D++ + + + QGL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-YA 651
+ RV+HRDLK N+L++ + K++DFG+AR FG V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL---------TLLGHAWDLWKDDRA 702
+S D++S G + E ++ + + T W
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 703 WELIDPTLQNEASYLILNRYINVGL----LCVQEDAADRPTMFEVVSM--LTNKTINLPH 756
++ P + ++ G + D R + ++ + T +PH
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
Query: 757 PR 758
R
Sbjct: 296 LR 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 4e-42
Identities = 43/285 (15%), Positives = 93/285 (32%), Gaps = 26/285 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
++ ++GEG FG +++G LLN Q+VA+K +S + ++E + L +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
+ + ++ + SL+ L T + + + +H+
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE-- 119
Query: 595 RLRVIHRDLKASNILLDKDMNP-----KISDFGMARIFGGDELQS-----KTKRIVGTYG 644
+++RD+K N L+ + + + DFGM + + + + K + GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
YMS S + D+ + G + + L + K
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749
+ E + P + + +
Sbjct: 239 ELCAGFPEEFYKYM--------HYARNLAFDATPDYDYLQGLFSK 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 7e-42
Identities = 60/284 (21%), Positives = 112/284 (39%), Gaps = 24/284 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ K+GEG +G VYK + G+ A+K RL + EI ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY 593
V+L + +L++E++ E L T + + G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPE-YAQ 652
RV+HRDLK N+L++++ KI+DFG+AR FG K + T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMG 174
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712
+S D++S G + E ++ + + + + W + +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 713 EASYLILNRYINVGLL-------------CVQEDAADRPTMFEV 743
+ ++ + L ++ D R T +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-41
Identities = 65/318 (20%), Positives = 113/318 (35%), Gaps = 34/318 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV 534
+++ +G G FG VY+ +L +G+ VA+K++ Q + E++++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 535 RLLGCCIELEEK------ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLL 588
RL EK L+ +Y+P S + L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 589 YLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
Y+H + HRD+K N+LLD D K+ DFG A+ E I Y
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAP 191
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL----------GHAWDLW 697
++ DV+S G +L E L + F + + L
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 698 KDDRAWELIDPTLQNEASYLILNRYINVGLL-----CVQEDAADRPTMFEVVSMLTNKTI 752
+ E P ++ + + ++ R T E + +
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 753 NLPHPRQPAFSSIRGLKN 770
P+ + P L N
Sbjct: 310 RDPNVKLPNGRDTPALFN 327
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 31/291 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSGQG--QEEFKNEIKLIAKL--- 528
+ ++GEG +G V+K R L G+ VA+KR+ Q+G+ E+ ++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLD---FFLFDSTKENLLGWGTRVRIIEGIAQ 585
+H N+VRL C + + +D D E + T ++ + +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGY 645
GL +LH RV+HRDLK NIL+ K++DFG+ARI+ Q +V T Y
Sbjct: 128 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWY 181
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL--------W 697
+PE Q ++ D++S G + E K F ++ + LG D+ W
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP--LFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 698 KDDRAWELIDPTLQNEASYLILNRYINVGLL-----CVQEDAADRPTMFEV 743
D A ++ I+ C+ + A R + +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 70/309 (22%), Positives = 117/309 (37%), Gaps = 45/309 (14%)
Query: 481 NKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGQEE-----FKNEIKLIAKLQHRNLV 534
+ LGEG F VYK R N Q VA+K++ ++ EIKL+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYS 594
LL L++++M +L + QGL YLHQ+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQ- 653
++HRDLK +N+LLD++ K++DFG+A+ FG V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175
Query: 654 GLFSIKSDVFSFGVLLLETLSSK--------------------RNTDFSNTNSLTLLGHA 693
++ + D+++ G +L E L T+ + +L +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 694 WDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM--LTNKT 751
I ++ LI + R T + + M +N+
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQG--------LFLFNPCARITATQALKMKYFSNRP 287
Query: 752 INLPHPRQP 760
P + P
Sbjct: 288 GPTPGCQLP 296
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 63/278 (22%), Positives = 111/278 (39%), Gaps = 32/278 (11%)
Query: 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRL------SSQSGQGQEEFKNEIKLIAKLQ 529
+ T +LG G F V K R G + A K + SS+ G +E+ + E+ ++ ++Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLY 589
H N++ L + ILI E + L FL ++ L ++ I G
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG--- 125
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMARIFGGDELQSKTKRIVGTYGY 645
++ L++ H DLK NI+L P KI DFG+A ++ K I GT +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 182
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705
++PE +++D++S GV+ LS A + +D +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
++ + R + +D R T+ +
Sbjct: 243 TSALAKD-----FIRR-------LLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 60/278 (21%), Positives = 98/278 (35%), Gaps = 42/278 (15%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEE------FKNEIKLIAKLQ 529
+ LG GGFG VY G + + VA+K + E E+ L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 530 --HRNLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGL 587
++RLL + +LI E F T+ L + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+ H V+HRD+K NIL+D + K+ DFG + + GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYS 176
Query: 647 SPEY-AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705
PE+ + V+S G+LL + + F + + R
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEII------------RGQVF 222
Query: 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
+ +E +LI C+ +DRPT E+
Sbjct: 223 FRQRVSSECQHLIRW--------CLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-39
Identities = 51/274 (18%), Positives = 98/274 (35%), Gaps = 29/274 (10%)
Query: 479 TENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRL 536
T LG G G V + ++ A+K L Q + + E++L + Q ++VR+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRI 70
Query: 537 LGCCIELEEK----ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+ L +++ E + L + D + I++ I + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 593 YSRLRVIHRDLKASNILLDKDMNP---KISDFGMARIFGGDELQSKTKRIVGTYGYMSPE 649
+ + HRD+K N+L K++DFG A+ T Y++PE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPE 183
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709
+ D++S GV++ L ++ +++
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
+ E LI N ++ + R T+ E
Sbjct: 244 VSEEVKMLIRN--------LLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-39
Identities = 57/298 (19%), Positives = 113/298 (37%), Gaps = 36/298 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRN 532
+ K+G+G FG V+K R GQ+VA+K++ ++ EIK++ L+H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 533 LVRLLGCCIELEEKI--------LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIA 584
+V L+ C L++++ + K R+++ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLL 127
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKR--IVGT 642
GL Y+H+ +++HRD+KA+N+L+ +D K++DFG+AR F + + V T
Sbjct: 128 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 643 YGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL---------TLLGH 692
Y PE + D++ G ++ E + + ++
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 693 AWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLL-------CVQEDAADRPTMFEV 743
W + +E ++ + + + D A R +
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 40/293 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL-NGQEVAVK--RLSSQSGQGQEEFKNEIKLIAKLQHRN 532
+ K+GEG +G V+K + + VA+K RL EI L+ +L+H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ 592
+VRL ++ L++E+ +F + G + + Q L L
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGF 116
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQ 652
V+HRDLK N+L++++ K+++FG+AR F G ++ + +V +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL----------------------L 690
L+S D++S G + E ++ R N L
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEV 743
+ ++ + + P L L+ N ++ + R + E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQN--------LLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 9e-38
Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 28/269 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEE---FKNEIKLIAKLQHR 531
+F LG+G FG V R G+ A+K L + ++E E +++ +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
L L + + EY L F L T R A+ + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALE 119
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
V++RD+K N++LDKD + KI+DFG+ + D + K GT Y++PE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 177
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
+ + D + GV++ E + + F N + L L ++ R + P +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELI--LMEEIRFPRTLSPEAK 233
Query: 712 NEASYLILNRYINVGLLCVQEDAADRPTM 740
+ +L +++D R
Sbjct: 234 S-----LLAG-------LLKKDPKQRLGG 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 65/292 (22%), Positives = 112/292 (38%), Gaps = 38/292 (13%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGQEEFKNEIKLIAKLQHRNL 533
+ +G G +G V G +VA+K+L QS + E++L+ ++H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 534 VRLLGCCIELE------EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGL 587
+ LL E + L+ +M K LG ++ + +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLKGL 134
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMS 647
Y+H +IHRDLK N+ +++D KI DFG+AR + S+ V T Y +
Sbjct: 135 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRA 186
Query: 648 PEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSL---------TLLGHAWDLW 697
PE + ++ D++S G ++ E ++ K S+ T
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 698 KDDRAWELIDPTLQNEASYL--ILNRYINVGL----LCVQEDAADRPTMFEV 743
+ D A + + E IL + + + DA R T E
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 2e-34
Identities = 54/267 (20%), Positives = 95/267 (35%), Gaps = 31/267 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHR 531
F LG G FG V + +G A+K L Q + E NE +++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
LV+L + ++ EY+ + L + I YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
L +I+RDLK N+L+D+ +++DFG A+ + +T + GT ++PE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEII 210
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQ 711
++ D ++ GVL+ E + F + +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQIYEKIVSGKVR------FPSHFS 262
Query: 712 NEASYLILNRYINVGLLCVQEDAADRP 738
++ L+ N +Q D R
Sbjct: 263 SDLKDLLRN--------LLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLS----SQSGQGQEEFKNEIKLIAK 527
NF LG G +G V+ R + G+ A+K L Q + E + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 528 LQHR-NLVRLLGCCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
++ LV L + LI +Y+ L L + T + + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF------TEHEVQIYVGEI 138
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+L L +L +I+RD+K NILLD + + ++DFG+++ F DE + GT YM
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYM 197
Query: 647 SPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704
+P+ + G D +S GVL+ E L+ + L + +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTM 740
+ ++ ++ R + +D R
Sbjct: 258 EMSALAKD-----LIQR-------LLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (319), Expect = 9e-33
Identities = 54/296 (18%), Positives = 108/296 (36%), Gaps = 43/296 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNL 533
++ KLG G + V++ + N ++V VK L +++ K EIK++ L+ N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92
Query: 534 VRLLGCCIELEEK--ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
+ L + + L++E++ N L + I + L Y H
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 146
Query: 592 QYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEY 650
+ ++HRD+K N+++D + ++ D+G+A + + + V + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 651 AQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL------LGHAWDLWKDDRAW 703
++ D++S G +L + K + N L LG D+
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 704 ELIDPTLQNEASYLILNRYINVGLL----------------CVQEDAADRPTMFEV 743
+DP + R+ ++ D R T E
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS--SQSGQGQEEFKNEIKLIAKLQHRN 532
+ +G G G V + + VA+K+LS Q+ + E+ L+ + H+N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 533 LVRLLGCCI------ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
++ LL E ++ L+ E M + ++ + G
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCG 131
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+ +LH +IHRDLK SNI++ D KI DFG+AR G V T Y
Sbjct: 132 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+PE + D++S G ++ E + K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLS--SQSGQGQEEFKNEIKLIAKLQHRN 532
+ + +G G +G V G VAVK+LS QS + E++L+ ++H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 533 LVRLLGCCIELEEKILI-YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH 591
++ LL Y+ + L + K L +I I +GL Y+H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRDLK SN+ +++D KI DFG+AR T + +
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML 191
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSK 676
++ D++S G ++ E L+ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-28
Identities = 41/215 (19%), Positives = 81/215 (37%), Gaps = 18/215 (8%)
Query: 477 FSTENKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR 535
+ KLG G F V+ + ++N VA+K + E ++EIKL+ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 536 LLGCCIELEEKILIYEYMPNKSLDFF-------------LFDSTKENLLGWGTRVRIIEG 582
K+L + + L + + +I +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARIFGGDELQSKTKRIVG 641
+ GL Y+H+ R +IH D+K N+L++ D + +A + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
T Y SPE + +D++S L+ E ++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 105 bits (263), Expect = 1e-26
Identities = 34/205 (16%), Positives = 70/205 (34%), Gaps = 33/205 (16%)
Query: 481 NKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQ--------GQEEFKNEIKLIAKLQH 530
+GEG V+ E VK ++ S + G F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 531 RNLVRLLGCCI----ELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQG 586
R L +L G + E ++ E + K L +++ I +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMILEE 115
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYM 646
+ + ++H DL N+L+ + I DF + G + + +R V +
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV---RNI 168
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLE 671
+++ + + D+ S +L+
Sbjct: 169 ITYFSRT--YRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 85.8 bits (212), Expect = 1e-20
Identities = 21/118 (17%), Positives = 46/118 (38%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTIS 93
+ +GE L + Q ++ + + L ++ T VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDH 151
+ G V+ + ++W+S+ R N V L + GN+V+ + +W + +
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 65.0 bits (158), Expect = 2e-13
Identities = 25/126 (19%), Positives = 42/126 (33%), Gaps = 20/126 (15%)
Query: 26 DNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFD 85
+ + + GE L + F L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 SNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYL 145
+ L++ G LV+ N +N IW+SN + N V L N+V+
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDH 151
W + H
Sbjct: 102 WATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 64.9 bits (158), Expect = 2e-13
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 9/97 (9%)
Query: 64 IWYKQIP-DTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVA 122
I Y D + + S L++ LVL ++ + +WS+N + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 123 QLLDTGNLVVRDNFSSNSSEDYLWQSFD--HPSDTLL 157
L G + V N +W S + +
Sbjct: 71 VLQPNGRMDVLTN-----QNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.2 bits (112), Expect = 4e-07
Identities = 14/64 (21%), Positives = 24/64 (37%)
Query: 71 DTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNL 130
D V + N+ + + G++ +L N +W+S SR V L NL
Sbjct: 51 DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNL 110
Query: 131 VVRD 134
+
Sbjct: 111 AIYG 114
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 63.5 bits (154), Expect = 7e-13
Identities = 19/109 (17%), Positives = 38/109 (34%), Gaps = 18/109 (16%)
Query: 40 LVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLV 99
++ + + + + Y + +W N AVL G LV
Sbjct: 25 ILFGTHVYRFIMQTDCNL------VLYD--NNNPIWATNTGGLGNGCRAVLQ--PDGVLV 74
Query: 100 LLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148
++ N T+W S ++ + + V L N+V+ + LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 61.0 bits (147), Expect = 5e-12
Identities = 26/130 (20%), Positives = 49/130 (37%), Gaps = 18/130 (13%)
Query: 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIF 84
+D + + G L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNL------VLYD--NNRAVWASGTNGKA- 49
Query: 85 DSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDY 144
S VL + N G LV+ + + IW+SN +R+ N L N+V+ DN ++
Sbjct: 50 -SGCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSNN-----A 102
Query: 145 LWQSFDHPSD 154
+W + + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 45.7 bits (108), Expect = 1e-06
Identities = 17/74 (22%), Positives = 27/74 (36%), Gaps = 5/74 (6%)
Query: 70 PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGN 129
D VW +N + + + G LV+L N WSS + N V L
Sbjct: 43 SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRT 99
Query: 130 LVVRDN--FSSNSS 141
+ + + S +S
Sbjct: 100 VTIYGPGLWDSGTS 113
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 42.2 bits (99), Expect = 2e-05
Identities = 21/131 (16%), Positives = 35/131 (26%), Gaps = 39/131 (29%)
Query: 64 IWY-KQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVA 122
I + + + + S+ T+ + LVL + + +W+SN + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRA 60
Query: 123 QLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDD 182
L G LV+ + W S
Sbjct: 61 VLQSDGLLVIL-----TAQNTIRWSSGTK------------------------------- 84
Query: 183 PSPGNYTHRLD 193
S GNY L
Sbjct: 85 GSIGNYVLVLQ 95
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 795 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.88 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.86 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.7 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.65 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.56 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.52 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.38 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.95 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.93 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.76 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.77 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.73 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.04 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=422.61 Aligned_cols=254 Identities=25% Similarity=0.315 Sum_probs=207.3
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999875 68999999996543 2345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999984 3456899999999999999999999998 9999999999999999999999999999765444
Q ss_pred ccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||............... ...
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~-----~~~-------- 224 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKT-------- 224 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-----TCT--------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----CCC--------
Confidence 3344456789999999999988775 67899999999999999999999765543332221110 000
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+..+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001111233567789999999999999999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=417.86 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=209.3
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
++|++.++||+|+||+||+|++ .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999986 469999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 99999988743 35899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.......||+.|||||++.+..|+.++|||||||++|||++|+.||........ ..... .... .. + .
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~---~~~~-~~-----~--~ 237 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA---TNGT-PE-----L--Q 237 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHH---HHCS-CC-----C--S
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HHHHH---hCCC-CC-----C--C
Confidence 223456899999999999999999999999999999999999999965432221 11110 0000 00 0 1
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+...+..+.+++.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122234567899999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-50 Score=417.66 Aligned_cols=264 Identities=26% Similarity=0.412 Sum_probs=205.3
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||.||+|+.. ..||||+++.. .....+.|++|+++|++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999863 46999998654 33445789999999999999999999998754 56899999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
||++|+|.+++... ...+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998543 345899999999999999999999988 9999999999999999999999999998765444
Q ss_pred cccccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.........||+.|||||++.. ..|+.++|||||||+||||++|+.||......... .............
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~p~~------ 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IFMVGRGYLSPDL------ 231 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHHHTSCCCCG------
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-HHHHhcCCCCCcc------
Confidence 3344456789999999999864 45899999999999999999999999754432221 1111111111110
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCC
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLP 755 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~ 755 (795)
...+...+..+.+++.+||+.||++|||++||+++|+.....+|
T Consensus 232 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 ---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11222344678899999999999999999999999987655444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=413.19 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=206.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 67999999999999999999875 5889999998653 2344678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999999865433
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
......||+.|||||++.+..|+.++|||||||++|||++|+.||+..+.... .... .... ..
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i----~~~~------~~- 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRI----SRVE------FT- 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH----HTTC------CC-
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH--HHHH----HcCC------CC-
Confidence 23446899999999999999999999999999999999999999975432221 1111 0111 00
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+...+..+.+++.+||+.||++|||++|+++|
T Consensus 223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111234567889999999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=414.06 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=198.9
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
++|++.++||+|+||.||+|++.+++.||||++... ....++|.+|++++++++|||||++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578999999999999999999988889999999753 4556789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+|+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 99999988543 345889999999999999999999988 999999999999999999999999999876543322
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN-TDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......||+.|||||++.+..|+.++|||||||++|||++++.| ++.... ......... .. ...
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~---~~---~~~------- 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDIST---GF---RLY------- 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHH---TC---CCC-------
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHh---cC---CCC-------
Confidence 22345789999999999999999999999999999999996544 433221 111211111 00 011
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+.++.+++.+||+.||++||||+||+++|+.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111234567899999999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-49 Score=413.84 Aligned_cols=257 Identities=28% Similarity=0.395 Sum_probs=211.2
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.++||+|+||+||+|++. +++.||||++... ....++|.+|+++|++++|||||+++++|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467899999999999999999875 5889999998654 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
|++|+|..++... ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998543 3356899999999999999999999998 99999999999999999999999999997654432
Q ss_pred cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. ......|++.|||||++.+..|+.++|||||||++|||++|+.|+........ .... ...+ ...
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~----i~~~---------~~~ 235 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYEL----LEKD---------YRM 235 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHH----HHTT---------CCC
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHH----HhcC---------CCC
Confidence 2 23335689999999999999999999999999999999998776543222111 1111 1111 111
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+.++.+|+.+||+.||++|||++||+++|+..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12223445788999999999999999999999998763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=413.60 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=204.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++++.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999874 6899999999653 2344577999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999988843 346899999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
..........||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... .... . .... .+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i---~-~~~~------~~ 229 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--FQKI---I-KLEY------DF 229 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH---H-TTCC------CC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH--HHHH---H-cCCC------CC
Confidence 444444557899999999999999999999999999999999999999975432221 1111 0 0110 01
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+......+.++|.+||+.||++|||++|++++
T Consensus 230 ----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 ----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11233567899999999999999999997543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=413.29 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=207.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
+.|++.++||+|+||.||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999864 58899999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++|+|..++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 999999987432 345899999999999999999999998 999999999999999999999999999764322 1
Q ss_pred ccccccccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 634 SKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.......||+.|||||++. ...|+.++|||||||++|||++|+.||........ .... .... ...
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i---~~~~-~~~---- 234 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKI---AKSE-PPT---- 234 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH---HHSC-CCC----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHH---HcCC-CCC----
Confidence 2234568999999999883 45689999999999999999999999975443222 1111 0111 000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+ ..+...+..+.+++.+||+.||++|||++|+++|
T Consensus 235 -~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 -L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1112234577899999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=411.05 Aligned_cols=255 Identities=31% Similarity=0.453 Sum_probs=207.0
Q ss_pred ccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecC
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 553 (795)
.++|++.++||+|+||.||+|++.+++.||||++... ....+.|.+|+++|++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3679999999999999999999988889999999654 3456789999999999999999999998754 5679999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++|+|.+++... ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 999999887432 2235899999999999999999999988 99999999999999999999999999998754432
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.......||+.|||||++.+..++.++|||||||++|||++|+.|+....... ...... ..+. ...
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i----~~~~---------~~~ 230 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL----ERGY---------RMV 230 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH----HTTC---------CCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHH----HhcC---------CCC
Confidence 22334678999999999999999999999999999999999766654322211 111111 1110 011
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+..+.+++.+||+.||++||||+||+++|+.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 112234568899999999999999999999998875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=414.32 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=195.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee--cceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 549 (795)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999864 68999999986643 2334678899999999999999999999865 4567899
Q ss_pred eecCCCCChhhhhhccC-CcccCChhhHHHHHHHHHHHHHHHHhcC--CCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 550 YEYMPNKSLDFFLFDST-KENLLGWGTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
||||++|+|.+++.... ....+++..+..++.||+.||.|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885432 3456999999999999999999999875 23599999999999999999999999999998
Q ss_pred cCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .......||+.|||||++.+..|+.++|||||||++|||++|+.||...+... ..... ......
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i----~~~~~~--- 232 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKI----REGKFR--- 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH----HHTCCC---
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHH----HcCCCC---
Confidence 65432 22345789999999999999999999999999999999999999997543222 11111 111111
Q ss_pred CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 707 DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111234568899999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=420.52 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=205.3
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|++.++||+|+||+||+|++. +|+.||||++.... ....+++.+|+.+|++++|||||+++++|.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999864 68999999997543 3335678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||++|+|.+++.. .+.+++..+..++.||++||.|||++ + |+||||||+||||+.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999853 34589999999999999999999974 6 99999999999999999999999999986532
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc----------
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD---------- 700 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 700 (795)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.................
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2234578999999999999999999999999999999999999999765533321111000000000
Q ss_pred c-cc-cccCcccc----------------chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 R-AW-ELIDPTLQ----------------NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 ~-~~-~~id~~l~----------------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .. ...+.... ..........+.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00 00000000 00000123467889999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=403.75 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=211.9
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
++|++.++||+|+||+||+|++++++.||||++++. ....++|.+|+.++++++|||||++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 689999999999999999999988889999999754 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+|+|..++... ...+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999887433 345889999999999999999999988 999999999999999999999999999876544332
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||+....... .... ..+.. ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~~i----~~~~~---------~~ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHI----AQGLR---------LY 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHH----HTTCC---------CC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HHHH----HhCCC---------CC
Confidence 2334678999999999999999999999999999999998 7888876543222 1111 11110 11
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+..+.+++.+||+.||++|||++||+++|..
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 112233578899999999999999999999999854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=419.30 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=207.5
Q ss_pred cCCccccccCcCCcccEEEeEecC-c-----ceEEEEEeccc-CccchHHHHHHHHHHHhc-CCcccceeeeeeeeccee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSSQ-SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
++|++.++||+|+||+||+|+... + ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 679999999999999999998643 2 36999998654 334456789999999998 899999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCC--------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCC
Q 003786 547 ILIYEYMPNKSLDFFLFDSTK--------------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 606 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~ 606 (795)
++|||||++|+|.+++..... ...+++..+..++.||++||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965432 235889999999999999999999998 999999999
Q ss_pred cEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 003786 607 NILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTN 685 (795)
Q Consensus 607 NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~ 685 (795)
|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654443333445678999999999999999999999999999999997 89998764433
Q ss_pred chhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 686 SLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.. +.... ..+. ....+...+..+.+||.+||+.||++|||++||+++|.-
T Consensus 274 ~~-~~~~~----~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 AN-FYKLI----QNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HH-HHHHH----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-HHHHH----hcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 22 11111 1111 111222334578899999999999999999999999953
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=407.57 Aligned_cols=265 Identities=29% Similarity=0.416 Sum_probs=207.7
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 554 (795)
++|++.+.||+|+||.||+|++.+++.||||++... ....+.|.+|+.+|++++|||||++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 679999999999999999999988888999999644 455678999999999999999999999985 456899999999
Q ss_pred CCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcccc
Q 003786 555 NKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 634 (795)
+|+|..++.... ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 999998885432 345899999999999999999999998 99999999999999999999999999987654332 2
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccccchh
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......||+.|+|||++..+.++.++|||||||++|||++|+.|+........ ...... ... ..+.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~----~~~---------~~~~ 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVE----RGY---------RMPC 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHH----TTC---------CCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHH----hcC---------CCCC
Confidence 23346789999999999999999999999999999999997766544332221 121111 110 1112
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccccCCCCCCCCC
Q 003786 715 SYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKTINLPHPRQP 760 (795)
Q Consensus 715 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~~~l~~p~~p 760 (795)
+...+.++.++|.+||+.||++||++++|+++|+......+++.+|
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 2233457889999999999999999999999998855544444333
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-47 Score=414.12 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=210.4
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999864 6899999999876666677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC--CCCCeeeeccccccccCCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~~vkL~DFGla~~~~~~ 630 (795)
|++|+|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999888432 345899999999999999999999998 99999999999996 4688999999999876543
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... ....... . ...
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i~~~---~-------~~~ 244 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRNVKSC---D-------WNM 244 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHT---C-------CCS
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHhC---C-------CCC
Confidence 3 23446899999999999999999999999999999999999999975432221 1111100 0 001
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+..+.++|.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122234567899999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=401.23 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=197.4
Q ss_pred CccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee----cceeeEE
Q 003786 477 FSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKILI 549 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 549 (795)
|++.++||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++|++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367778999999999999875 58899999986542 3345678999999999999999999999875 3457899
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC-CCCCeeeeccccccccC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARIFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~vkL~DFGla~~~~ 628 (795)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999843 345899999999999999999999875 4599999999999996 57999999999998654
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCc
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ......||+.|||||++.+ .|+.++|||||||++|||++|+.||........ +.... ..+....
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i----~~~~~~~---- 232 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRV----TSGVKPA---- 232 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHH----TTTCCCG----
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHH----HcCCCCc----
Confidence 32 2345689999999999875 599999999999999999999999964432221 11111 1111000
Q ss_pred cccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 709 TLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..+.....++.+++.+||+.||++|||++|+++|
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111123457789999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-48 Score=412.31 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=196.6
Q ss_pred cCCccccccCcCCcccEEEeEecC-cc---eEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQ---EVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
++|++.+.||+|+||.||+|++.. ++ .||||++... .....++|.+|+++|++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999998643 32 5889988654 333456799999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||||++|+|.+++.. ..+.+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 2345899999999999999999999988 99999999999999999999999999987654
Q ss_pred Ccccc---cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 630 DELQS---KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~~~~---~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
..... ......||+.|||||.+.+..|+.++|||||||++|||++ |+.||....... ..... ..+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i----~~~~---- 250 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAI----EQDY---- 250 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH----HTTC----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcCC----
Confidence 32221 1222457999999999999999999999999999999998 888886543221 11111 1110
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.||++|||+.||+++|+..
T Consensus 251 -----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 -----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112223456788999999999999999999999998763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-48 Score=408.83 Aligned_cols=251 Identities=23% Similarity=0.279 Sum_probs=191.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
+.|++.+.||+|+||+||+|++. +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56999999999999999999875 58999999997543 23345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC---CCCCeeeeccccccccCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMARIFGG 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~---~~~~vkL~DFGla~~~~~ 629 (795)
|++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999843 456999999999999999999999998 99999999999994 578999999999987643
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ .... ..... .
T Consensus 163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i---~~~~~-------~ 227 (307)
T d1a06a_ 163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FEQI---LKAEY-------E 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH---HTTCC-------C
T ss_pred CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHH---hccCC-------C
Confidence 32 23346799999999999999999999999999999999999999975432221 1111 11110 0
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.........+..+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111122334578899999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-47 Score=411.72 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=209.8
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 367999999999999999999864 6999999999776655667889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC--CCCCeeeeccccccccCCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~~vkL~DFGla~~~~~~ 630 (795)
|++|+|.+.+.. ....+++.++..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.....
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887633 2345899999999999999999999998 99999999999998 6789999999999987644
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......||+.|||||++.+..|+.++|||||||++|||++|+.||........ ...... . +...
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~i~~----~------~~~~ 247 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQNVKR----C------DWEF 247 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHHH----C------CCCC
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh----C------CCCC
Confidence 3 23446799999999999999999999999999999999999999975442221 111100 0 0001
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+..+.+||.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122234567899999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=402.52 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=197.1
Q ss_pred cccCcCCcccEEEeEec---CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeecCCC
Q 003786 481 NKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 555 (795)
++||+|+||.||+|.+. .++.||||++.... ....++|.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999754 35689999996542 2234679999999999999999999999854 567899999999
Q ss_pred CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc-cc
Q 003786 556 KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL-QS 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~-~~ 634 (795)
|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....... ..
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999853 345899999999999999999999988 99999999999999999999999999987654332 22
Q ss_pred cccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccch
Q 003786 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||........ ... ...+.. ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~~----i~~~~~---------~~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAM----LEKGER---------MG 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHH----HHTTCC---------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HHH----HHcCCC---------CC
Confidence 3334578999999999999999999999999999999998 8999875442221 111 111111 11
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 714 ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 122334578899999999999999999999988865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=402.39 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=205.3
Q ss_pred cCCcccc-ccCcCCcccEEEeEec---CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTEN-KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
++|.+.+ +||+|+||.||+|.+. ++..||||++.... ....++|.+|+++|++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566766 4999999999999753 35579999997543 3345789999999999999999999999864 568999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||||++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 2346899999999999999999999988 99999999999999999999999999997754
Q ss_pred Ccc-cccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 630 DEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... ........||+.|||||++....++.++|||||||++|||++ |+.||........ ... ...+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~----i~~~~~----- 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAF----IEQGKR----- 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHH----HHTTCC-----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HHH----HHcCCC-----
Confidence 332 222334578999999999999999999999999999999998 8999876543221 111 111111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+.+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11222344678899999999999999999999998865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=402.00 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=199.4
Q ss_pred cCCccccccCcCCcccEEEeEecCc-----ceEEEEEecccCc-cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNG-----QEVAVKRLSSQSG-QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..|++.+.||+|+||.||+|++... ..||||++..... ....+|.+|+++|++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999986532 4699999965432 334578999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+.++++.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998877433 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.|+....... ...... ..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i----~~~------- 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAI----NDG------- 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHH----HTT-------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHH----hcc-------
Confidence 43221 22234568999999999999999999999999999999999766654332221 111111 111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+...+..+.+|+.+||+.||++||||.||+++|+..
T Consensus 230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11112223446788999999999999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=400.86 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=207.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC------ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS------GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++++.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999874 68999999986532 223578999999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC----Ceeeecccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFGM 623 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~vkL~DFGl 623 (795)
+|||||++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999854 346899999999999999999999998 99999999999998776 499999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+....... ......||+.|||||++.+..++.++|||||||++|||++|+.||...+.... .... ...
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i----~~~--- 231 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANV----SAV--- 231 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH----HTT---
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HHHH----Hhc---
Confidence 98765332 23346799999999999999999999999999999999999999975432221 1111 000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
............+..+.++|.+||+.||++|||++|++++
T Consensus 232 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 ---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111112222344577899999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=404.86 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=207.8
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 549 (795)
.++|++++.||+|+||.||+|+. .+++.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999986 46999999999754 234467789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||||++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999998843 445889999999999999999999998 99999999999999999999999999986543
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|++||...+.... ...... ....
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~i~~--~~~~-------- 223 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELILM--EEIR-------- 223 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH--CCCC--------
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HHHHhc--CCCC--------
Confidence 22 233457899999999999999999999999999999999999999976543222 111100 0001
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 746 (795)
.+...+..+.++|.+||+.||++||+ ++|+++|
T Consensus 224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11123346788999999999999994 8899886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=408.30 Aligned_cols=246 Identities=30% Similarity=0.422 Sum_probs=201.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCc---cchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
+.|+..++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999864 688999999976432 23356889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||++|+|+.++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999876633 345899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||........ .... .... ......
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~~~i---~~~~-~~~~~~ 236 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI---AQNE-SPALQS 236 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH---HHSC-CCCCSC
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHH---HhCC-CCCCCC
Confidence 234679999999999864 4689999999999999999999999865432211 1111 1111 111111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...+..+.+++.+||+.||++|||++|+++|
T Consensus 237 --------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 237 --------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1223567899999999999999999999984
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-47 Score=401.98 Aligned_cols=263 Identities=27% Similarity=0.387 Sum_probs=211.2
Q ss_pred HHHHccCCccccccCcCCcccEEEeEec------CcceEEEEEecccCcc-chHHHHHHHHHHHhcCCcccceeeeeeee
Q 003786 470 VSAATANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQ-GQEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 470 i~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
+....++|++.++||+|+||+||+|+.. +++.||||++...... ..++|.+|+++|++++||||+++++++.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999853 3578999999754333 35679999999999999999999999999
Q ss_pred cceeeEEeecCCCCChhhhhhccC---------------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEec
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDST---------------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 601 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHr 601 (795)
.+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ ||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 999999999999999999985422 1234788899999999999999999998 9999
Q ss_pred cCCCCcEEECCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCC-CCC
Q 003786 602 DLKASNILLDKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR-NTD 680 (795)
Q Consensus 602 Dikp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~-p~~ 680 (795)
||||+||||+.++.+||+|||+++...............||+.|||||.+.+..|+.++|||||||++|||++|.. |+.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999987654443444455678999999999999999999999999999999999964 554
Q ss_pred CCCCcchhHhHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 681 FSNTNSLTLLGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
...... .... ...+... ..+...+.++.+|+.+||+.+|++||||.||+++|++.
T Consensus 245 ~~~~~e--~~~~----v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 245 GMAHEE--VIYY----VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TSCHHH--HHHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCHHH--HHHH----HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 433222 1111 1111111 11222345788999999999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-46 Score=398.71 Aligned_cols=245 Identities=26% Similarity=0.321 Sum_probs=205.0
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|++++.||+|+||+||+|++. +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 67999999999999999999874 5899999999653 2344678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
|||++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999988843 345788899999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... ...... ....
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~--~~~~--------- 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEKILN--AELR--------- 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH--CCCC---------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH--HHHHHc--CCCC---------
Confidence 2346899999999999999999999999999999999999999975432221 111100 0000
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 746 (795)
.+...+..+.+++.+||+.||++|| |++|+++|
T Consensus 220 ---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1112335677899999999999996 89999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=400.73 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=200.5
Q ss_pred cCCccccccCcCCcccEEEeEec-Ccc----eEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|+++++||+|+||+||+|++. +|+ +||+|++... .....+++.+|+++|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 56999999999999999999864 344 5888888653 344567899999999999999999999999764 5678
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
++||+.+++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998877543 456899999999999999999999988 9999999999999999999999999999876
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............||+.|||||++.++.|+.++|||||||++|||+| |..|++........ ... ..+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~--~~i----~~~~------ 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SIL----EKGE------ 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH--HHH----HHTC------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH--HHH----HcCC------
Confidence 5444334444678999999999999999999999999999999998 78887654433221 111 1111
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
....+...+..+.+++.+||+.||++|||+.||+++|..
T Consensus 231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 011122234577899999999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=393.40 Aligned_cols=258 Identities=24% Similarity=0.303 Sum_probs=197.6
Q ss_pred cccccCcCCcccEEEeEec-CcceEEEEEecccCcc-----chHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 479 TENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-----GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.+++||+|+||+||+|++. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999864 5899999998654221 235688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+.++++..++ .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9998887665 33456899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc---Ccccc---cc
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK---DDRAW---EL 705 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~---~~ 705 (795)
......+||+.|||||++.. ..|+.++|||||||++|||++|..||......+. +........ ..... ..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTSS
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHHhcCCCChhhccchhcc
Confidence 22334679999999998865 5689999999999999999999999876543221 111111000 00000 00
Q ss_pred ---cC-cccc----chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 706 ---ID-PTLQ----NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 706 ---id-~~l~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .... ..........+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 0000 01111234578899999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=396.27 Aligned_cols=259 Identities=28% Similarity=0.392 Sum_probs=197.8
Q ss_pred ccCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhc-CCcccceeeeeeeec-c
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL-E 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 544 (795)
.++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|..++.++ +|+|||++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367999999999999999999753 35689999986543 23456678888888777 689999999987765 4
Q ss_pred eeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEEC
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 611 (795)
..++|||||++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999964332 345889999999999999999999998 99999999999999
Q ss_pred CCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhHh
Q 003786 612 KDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTNSLTLL 690 (795)
Q Consensus 612 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............||+.|||||++.+..++.++|||||||++|||++|. +|++....... +.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence 99999999999998765544444445578999999999999999999999999999999999875 46654433221 11
Q ss_pred HhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 691 GHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
... ..+... ..+...+.++.+++.+||+.||++|||++||+++|+.
T Consensus 248 ~~~----~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 248 RRL----KEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHH----HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH----hcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 111111 1112234567899999999999999999999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-45 Score=397.62 Aligned_cols=263 Identities=21% Similarity=0.235 Sum_probs=214.4
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 550 (795)
++|+++++||+|+||.||+|++. +|+.||||++.+. .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999874 6999999998653 2334567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~ 630 (795)
||+.+|+|..++.. .+.+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999998843 345899999999999999999999998 999999999999999999999999999876532
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||...+... ....... ....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~~--~~~~--------- 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYEKIVS--GKVR--------- 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH--CCCC---------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--HHHHHhc--CCCC---------
Confidence 234689999999999999999999999999999999999999997543211 1111110 0000
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH--Hcc------ccCCCCCCCCCCccc
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM--LTN------KTINLPHPRQPAFSS 764 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~--L~~------~~~~l~~p~~p~~~~ 764 (795)
.+...+..+.+++.+||+.||.+|+ |++|+++| +.+ ....++.|..|.+..
T Consensus 257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~ 320 (350)
T d1rdqe_ 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred ---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCC
Confidence 1112345678999999999999994 99999985 222 123456677776543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=389.10 Aligned_cols=248 Identities=28% Similarity=0.407 Sum_probs=196.8
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec-ceeeEEeecC
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-EEKILIYEYM 553 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~ 553 (795)
++|++.++||+|+||.||+|++ .|.+||||+++.. ...+.+.+|+++|++++|||||++++++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5788999999999999999998 5788999999653 4457899999999999999999999998654 5689999999
Q ss_pred CCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCccc
Q 003786 554 PNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~~ 633 (795)
++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999998543 2345899999999999999999999987 999999999999999999999999999865432
Q ss_pred ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccCccccc
Q 003786 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTLQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.|+......+. .... ..+. ..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--~~~i----~~~~---------~~ 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRV----EKGY---------KM 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHH----TTTC---------CC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH--HHHH----HcCC---------CC
Confidence 233568899999999999999999999999999999998 6766655432222 1111 1111 11
Q ss_pred hhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 713 EASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
+.+...+.++.+++.+||+.||++||||.||+++|+.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1222334577899999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-45 Score=385.42 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=204.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc---------chHHHHHHHHHHHhcC-Ccccceeeeeeeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---------GQEEFKNEIKLIAKLQ-HRNLVRLLGCCIEL 543 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 543 (795)
++|++.+.||+|+||+||+|+.. +++.||||++.+.... ..+.+.+|+.+|++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999864 6899999999764321 1245789999999997 99999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
+..++|||||++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999953 346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQ------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLW 697 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ .... .
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--~~~i---~ 228 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LRMI---M 228 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH---H
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--HHHH---H
Confidence 98765432 2334679999999998853 4578999999999999999999999975442221 1111 0
Q ss_pred cCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 KDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... . .........+.++.+++.+||+.||++|||++||+++
T Consensus 229 ~~~~--~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNY--Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCC--C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCC--C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 0 0111122344578899999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=393.16 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=206.9
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
.++|++.+.||+|+||+||+|++. +++.||||++.... .....+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999875 58899999997653 3346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC--CCeeeeccccccccCCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--MNPKISDFGMARIFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~--~~vkL~DFGla~~~~~~ 630 (795)
|++|+|.+++... ...+++.++..++.||++||.|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998432 235899999999999999999999998 9999999999999854 58999999999876543
Q ss_pred cccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||........ .... .... ..+
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~~i---~~~~-------~~~ 222 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENI---MNAE-------YTF 222 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH---HHTC-------CCC
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HHHH---HhCC-------CCC
Confidence 3 23446789999999999999999999999999999999999999976442221 1111 0000 001
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
........+.++.+++.+||+.||++|||+.|+++|
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122234567899999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=390.52 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=194.9
Q ss_pred ccCCccccccCcCCcccEEEeEecC----cceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeE
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+++|++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3679999999999999999998643 3468999886543 333567999999999999999999999985 567899
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccC
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 628 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~ 628 (795)
||||+++|+|..++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988743 3346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccccC
Q 003786 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+|+........ .... ..+...
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~i----~~~~~~---- 228 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRI----ENGERL---- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH----HTTCCC----
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HHHH----HcCCCC----
Confidence 4332 22344678999999999999999999999999999999998 7888876543322 1111 111110
Q ss_pred ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 708 PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.++|.+||+.||++|||+.||+++|+.
T Consensus 229 -----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122334578899999999999999999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=390.17 Aligned_cols=255 Identities=28% Similarity=0.374 Sum_probs=195.9
Q ss_pred cCCccccccCcCCcccEEEeEecC----cceEEEEEecccC---ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS---GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.+.||+|+||.||+|++.. ...||||++.+.. .+..++|.+|+.+|++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999997532 2368999986542 3334679999999999999999999999965 4678
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+||||+++|++.+++... .+.+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999998877543 345899999999999999999999988 999999999999999999999999999987
Q ss_pred CCCccc-ccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 628 GGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......|+..|+|||++.+..++.++|||||||++|||++ |+.||...+.... ... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~---i~~~~~~--- 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHK---IDKEGER--- 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH---HHTSCCC---
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHH---HHhCCCC---
Confidence 544322 22334567889999999999999999999999999999998 8999865432221 111 1111111
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.+.+...+..+.+++.+||+.||++|||+.||++.|.+
T Consensus 234 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11122234568899999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-45 Score=386.04 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=199.9
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCcc---chHHHHHHHHHHHhcCCcccceeeeeeeecce----
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQ---GQEEFKNEIKLIAKLQHRNLVRLLGCCIELEE---- 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 545 (795)
.++|++.+.||+|+||.||+|++ .+++.||||++.+.... ..+.+.+|+++|++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999986 46999999999764332 34578999999999999999999999887643
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+++++|..++.. .+.+++.++..++.||++||.|||+++ |+||||||+|||++.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988743 345899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCc-ccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 626 IFGGDE-LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
...... .........||+.|||||++.+..++.++|||||||++|||++|+.||......... . .........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~----~~~~~~~~~- 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-Y----QHVREDPIP- 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-H----HHHHCCCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH-H----HHHhcCCCC-
Confidence 653322 222344568999999999999999999999999999999999999999754322211 1 111111110
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHcc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRP-TMFEVVSMLTN 749 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~ 749 (795)
........+..+.+++.+||+.||++|| |++++++.|..
T Consensus 234 ------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 ------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0111122345788999999999999999 89999887754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=393.60 Aligned_cols=259 Identities=28% Similarity=0.391 Sum_probs=207.2
Q ss_pred ccCCccccccCcCCcccEEEeEecC--------cceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeec
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.++|++++.||+|+||.||+|+... +..||||++++... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3689999999999999999997532 34799999976543 3457788999999888 799999999999999
Q ss_pred ceeeEEeecCCCCChhhhhhccCC-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 544 EEKILIYEYMPNKSLDFFLFDSTK-------------ENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
...++||||+++|+|.+++..... ...+++..+..++.||++||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 245899999999999999999999998 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhH
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTNSLTL 689 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+|+....... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--H
Confidence 9999999999999997765544444556789999999999999999999999999999999998 677776443222 1
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
. ..+..+... ..+...+.++.+++.+||+.||++|||+.||+++|++.
T Consensus 247 ~----~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 F----KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H----HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 111111111 11122345688999999999999999999999999763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=389.65 Aligned_cols=264 Identities=24% Similarity=0.324 Sum_probs=202.2
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|+++++||+|+||+||+|++ .+++.||||++.... ....+.+.+|+++|++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 468999999996543 2345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
|+.++.+..... .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765554432 23455899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccccccccccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhcc-Cccccc-----
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWK-DDRAWE----- 704 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~----- 704 (795)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+...... ........ ....+.
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH-HHHHhcCCCchhhccccccc
Confidence 2234467999999999877654 5899999999999999999999997654222111 10000000 000000
Q ss_pred -----ccCccccch---hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 705 -----LIDPTLQNE---ASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 705 -----~id~~l~~~---~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
......... ........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000 111233577899999999999999999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-45 Score=399.94 Aligned_cols=250 Identities=26% Similarity=0.313 Sum_probs=201.2
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC---ccchHHHHHH---HHHHHhcCCcccceeeeeeeeccee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGQEEFKNE---IKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|++. +|+.||||++.+.. ......+.+| +++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999875 58999999986432 2233344444 6667777899999999999999999
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
++|||||++|+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+++.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999853 345789999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccc
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
+.... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+... . ....
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~-~~~~---- 225 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--T-LTMA---- 225 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH--S-SSCC----
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--c-ccCC----
Confidence 65432 344679999999999865 5799999999999999999999999976554332211110 0 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 003786 706 IDPTLQNEASYLILNRYINVGLLCVQEDAADRPT-----MFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 746 (795)
. ..+...+..+.++|.+||+.||++||| ++|+++|
T Consensus 226 --~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 --V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --C----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --C----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0 011123456789999999999999999 6999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=396.05 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=210.1
Q ss_pred ccCCccccccCcCCcccEEEeEe------cCcceEEEEEecccCc-cchHHHHHHHHHHHhc-CCcccceeeeeeeecce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSG-QGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
.++|+++++||+|+||.||+|++ .+++.||||+++.... ....++.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 36899999999999999999975 2467899999976433 3445789999999999 69999999999999999
Q ss_pred eeEEeecCCCCChhhhhhccC---------------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEE
Q 003786 546 KILIYEYMPNKSLDFFLFDST---------------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 610 (795)
.++|||||++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986533 2235889999999999999999999998 9999999999999
Q ss_pred CCCCCeeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCcchhH
Q 003786 611 DKDMNPKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN-TDFSNTNSLTL 689 (795)
Q Consensus 611 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p-~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++++.| +........ +
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-H
Confidence 99999999999999987654444444557899999999999999999999999999999999995555 443332221 1
Q ss_pred hHhHhhhccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 690 LGHAWDLWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.... ..+ .....+...+..+.+||.+||+.||++||||+||+++|++
T Consensus 258 ~~~i----~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 258 YKMI----KEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHH----HHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH----hcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111 111 1111112234578899999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=391.45 Aligned_cols=253 Identities=18% Similarity=0.196 Sum_probs=201.3
Q ss_pred ccCCcccc-ccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhc-CCcccceeeeeeee----ccee
Q 003786 474 TANFSTEN-KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~~~~~~-~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 546 (795)
.++|++.+ .||+|+||+||+|++ .+++.||||++.. ...+.+|++++.++ +|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999986 4689999999853 35688999997655 89999999999875 4668
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeecccc
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFGl 623 (795)
++|||||+||+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999542 2346899999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc
Q 003786 624 ARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
++...... ......||+.|||||++.+..|+.++|||||||++|+|++|+.||........... .......
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~--~~~~i~~---- 231 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRM---- 231 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS----
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--HHHHHhc----
Confidence 98765433 23446899999999999999999999999999999999999999975442221100 0000000
Q ss_pred cccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
....+........+.++.+++.+||+.||++|||+.|+++|
T Consensus 232 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 --GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111122334456788999999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=393.61 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=203.6
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEeccc---CccchHHHHHHHHHHH-hcCCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGQEEFKNEIKLIA-KLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 549 (795)
++|++++.||+|+||+||+|++. +++.||||++.+. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999875 5899999999753 2344556777777765 68999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCC
Q 003786 550 YEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~ 629 (795)
||||++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999853 345889999999999999999999998 99999999999999999999999999986543
Q ss_pred CcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCcc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPT 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.... ..... ... +.
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i~--~~~--------~~ 221 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIR--MDN--------PF 221 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH--HCC--------CC
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHH--cCC--------CC
Confidence 32 233446899999999999999999999999999999999999999976443221 11110 001 11
Q ss_pred ccchhhHHHHHHHHHHHHhhccCCCCCCCCHH-HHHHH
Q 003786 710 LQNEASYLILNRYINVGLLCVQEDAADRPTMF-EVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~ 746 (795)
.+...+.++.+||.+||+.||++||++. |+++|
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 1112345678999999999999999996 78764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=390.52 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=209.8
Q ss_pred cCCccccccCcCCcccEEEeEec------CcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.++||+|+||.||+|++. +++.||||+++... ......|.+|++++++++|||||++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 68899999999999999999753 35789999997543 233456899999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccC-------CcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeec
Q 003786 548 LIYEYMPNKSLDFFLFDST-------KENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~D 620 (795)
+||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999885432 2234688899999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhHhHhHhhhccC
Q 003786 621 FGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTNSLTLLGHAWDLWKD 699 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. .|+....... ..... ..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~~~i----~~ 250 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFV----ME 250 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHH----HT
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----Hh
Confidence 99998775544444445567999999999999999999999999999999999985 5554432211 11111 11
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHccc
Q 003786 700 DRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNK 750 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~ 750 (795)
+... ..+...+..+.+++.+||+.+|++||||++|+++|+..
T Consensus 251 ~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111 11122345788999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=389.67 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=202.9
Q ss_pred cCCccccccCcCCcccEEEeEecC-cc--eEEEEEeccc-CccchHHHHHHHHHHHhc-CCcccceeeeeeeecceeeEE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGQEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 549 (795)
++|++.++||+|+||.||+|++.+ +. .||||++... .....+.+.+|+++|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 679999999999999999998754 43 4788887543 334567899999999999 799999999999999999999
Q ss_pred eecCCCCChhhhhhcc-------------CCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCe
Q 003786 550 YEYMPNKSLDFFLFDS-------------TKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~v 616 (795)
|||+++|+|.+++... .....+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23456899999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCCCcchhHhHhHhh
Q 003786 617 KISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR-NTDFSNTNSLTLLGHAWD 695 (795)
Q Consensus 617 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++...... ......||..|+|||.+.+..|+.++|||||||++|||++|.. |+...+.. .+....
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL-- 239 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHG--
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHH--
Confidence 999999998654222 2234568999999999999999999999999999999999765 55433221 112111
Q ss_pred hccCcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 696 LWKDDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
..+.. ...+...+.++.++|.+||+.||++||||+||+++|+...
T Consensus 240 --~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 240 --PQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp --GGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11110 1112223457889999999999999999999999987743
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-44 Score=381.76 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=203.6
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 552 (795)
++|++.++||+|+||+||+|++++++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999996542 33457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
+.++.+..+. ...+.+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988887776 33456999999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc-----------
Q 003786 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD----------- 700 (795)
Q Consensus 633 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 700 (795)
......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+. ...........
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhh
Confidence 2334568999999998865 5679999999999999999999999975442221 11111100000
Q ss_pred -c---cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 701 -R---AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 701 -~---~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. ......+.............+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000001110111122234577899999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=383.86 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=199.2
Q ss_pred cCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHH--HHHHHHHhcCCcccceeeeeeeecc----eeeE
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFK--NEIKLIAKLQHRNLVRLLGCCIELE----EKIL 548 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 548 (795)
++|.+.++||+|+||.||+|++ +|+.||||++.... .+++. .|+..+.+++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4678889999999999999986 68899999996432 33343 4555556789999999999998764 5789
Q ss_pred EeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc-----CCCcEEeccCCCCcEEECCCCCeeeecccc
Q 003786 549 IYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY-----SRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 549 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiHrDikp~NIll~~~~~vkL~DFGl 623 (795)
|||||++|+|.+++.. ..+++..+..++.|++.||+|||+. .+.+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999954 2488999999999999999999974 124599999999999999999999999999
Q ss_pred ccccCCCcc--cccccccccccccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh-
Q 003786 624 ARIFGGDEL--QSKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW- 694 (795)
Q Consensus 624 a~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~- 694 (795)
++....... ........||+.|||||++.+. .++.++|||||||+||||++|..|+...............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987644322 1233456899999999998754 3678999999999999999999887543322211110000
Q ss_pred ----hhccCcccccccCccccch-hhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 695 ----DLWKDDRAWELIDPTLQNE-ASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 695 ----~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.........+..+|.+... ........+.+++.+||+.||++|||+.||+++|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0000000111122222222 233456678899999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=384.95 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=199.9
Q ss_pred cccccCcCCcccEEEeEecCc----ceEEEEEeccc-CccchHHHHHHHHHHHhcCCcccceeeeeeeec-ceeeEEeec
Q 003786 479 TENKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQ-SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-EEKILIYEY 552 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 552 (795)
+.++||+|+||+||+|++.++ ..||||++.+. .....++|.+|+++|++++|||||++++++.+. ...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 357899999999999986432 25899999753 334457899999999999999999999998764 578999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCcc
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~~ 632 (795)
|++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999988543 344677889999999999999999998 99999999999999999999999999997654332
Q ss_pred c--ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccccccCccc
Q 003786 633 Q--SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWELIDPTL 710 (795)
Q Consensus 633 ~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||.+....++.++||||||+++|||++|+.|+....... ...... . .+.. ..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i---~-~g~~--~~---- 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYL---L-QGRR--LL---- 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH---H-TTCC--CC----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHH---H-cCCC--CC----
Confidence 2 22233578999999999999999999999999999999999888875433211 111111 1 1110 01
Q ss_pred cchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcccc
Q 003786 711 QNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTNKT 751 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~~~ 751 (795)
.+...+..+.+++.+||+.||++||+|.||+++|+...
T Consensus 255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11123456889999999999999999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-44 Score=379.80 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=200.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-C-cceEEEEEecccC--ccchHHHHHHHHHHHhc---CCcccceeeeeeee----
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-N-GQEVAVKRLSSQS--GQGQEEFKNEIKLIAKL---QHRNLVRLLGCCIE---- 542 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 542 (795)
.++|+++++||+|+||+||+|++. + ++.||||++.... ......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999863 4 5679999986542 22344677888887776 79999999999863
Q ss_pred -cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecc
Q 003786 543 -LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 543 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DF 621 (795)
....+++|||+.++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 356789999999988765542 33456889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhh-----
Q 003786 622 GMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDL----- 696 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~----- 696 (795)
|+++..... .......||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... +......
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCc
Confidence 999865332 234457899999999999999999999999999999999999999976542221 1111000
Q ss_pred ---ccCc-c----cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 697 ---WKDD-R----AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 697 ---~~~~-~----~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
+... . ....................+.+|+.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 000000000111122234567789999999999999999999885
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=379.99 Aligned_cols=241 Identities=22% Similarity=0.362 Sum_probs=196.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCcc------chHHHHHHHHHHHhcC--Ccccceeeeeeeecc
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ------GQEEFKNEIKLIAKLQ--HRNLVRLLGCCIELE 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 544 (795)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.... ...++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999864 6899999998654211 2245778999999997 899999999999999
Q ss_pred eeeEEeecCCC-CChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCC-CCeeeeccc
Q 003786 545 EKILIYEYMPN-KSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFG 622 (795)
Q Consensus 545 ~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~vkL~DFG 622 (795)
..++||||+.+ +++.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999986 567666633 346899999999999999999999998 9999999999999854 789999999
Q ss_pred cccccCCCcccccccccccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcc
Q 003786 623 MARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+++..... ......||+.|||||++.+..+ +.++|||||||++|||++|+.||.... ... ....
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i~-------~~~~ 221 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EII-------RGQV 221 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH-------HCCC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HHh-------hccc
Confidence 99875433 2344689999999999987654 678999999999999999999986421 100 0000
Q ss_pred cccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 702 AWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.+.+ ..+.++.+++.+||+.||++|||++|++++
T Consensus 222 ---~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 ---FFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111 123567889999999999999999999885
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=376.78 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=197.7
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCCcccceeeeeeeec------ceee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL------EEKI 547 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 547 (795)
.+|+..++||+|+||+||+|++. +|+.||||++.+.. ..+.+|+++|++++|||||+++++|... .+.+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 36888999999999999999975 58999999996542 2345799999999999999999998643 3468
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-Ceeeeccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARI 626 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~ 626 (795)
+|||||+++.+..+.........+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999998766555443344567899999999999999999999988 99999999999999875 899999999987
Q ss_pred cCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhH-h--------Hhhh
Q 003786 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLG-H--------AWDL 696 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~-~--------~~~~ 696 (795)
..... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||............ . .+..
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 65433 2234679999999998765 57999999999999999999999999765422211000 0 0000
Q ss_pred cc----CcccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 697 WK----DDRAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 697 ~~----~~~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .......................+.+|+.+||+.||++|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000000001111122334567899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=368.50 Aligned_cols=268 Identities=21% Similarity=0.304 Sum_probs=198.4
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEeccc--CccchHHHHHHHHHHHhcCCcccceeeeeeee--------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE-------- 542 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 542 (795)
.++|+++++||+|+||+||+|++ .+|+.||||++... .....+++.+|+++|++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999986 46999999998654 33345778999999999999999999998865
Q ss_pred cceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccc
Q 003786 543 LEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFG 622 (795)
....++||||+.++.+.... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999988876554 33445888999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc--ccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHhHhhhcc
Q 003786 623 MARIFGGDELQ--SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGHAWDLWK 698 (795)
Q Consensus 623 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~ 698 (795)
+++........ .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.......... .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876533221 223345799999999988754 78999999999999999999999997544222111 111100000
Q ss_pred Cc--------ccccccCcc--ccchhhH-----HHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 003786 699 DD--------RAWELIDPT--LQNEASY-----LILNRYINVGLLCVQEDAADRPTMFEVVSML 747 (795)
Q Consensus 699 ~~--------~~~~~id~~--l~~~~~~-----~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 747 (795)
.. .....+... ....... .....+.+|+.+||+.||++|||++|+++|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 00 011111000 0011111 1124567899999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=375.42 Aligned_cols=259 Identities=24% Similarity=0.271 Sum_probs=193.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecc------
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999864 59999999997542 233467889999999999999999999998665
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
+.++||||+ +.+|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 556766653 345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHh-HhHh--------
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLL-GHAW-------- 694 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~-~~~~-------- 694 (795)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+....... ....
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876432 344679999999998876 5679999999999999999999999976542211100 0000
Q ss_pred hhccCc-------ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 695 DLWKDD-------RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 695 ~~~~~~-------~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
...... ...+. ...-...........+.+|+.+||+.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcc-cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000 0000011112233467789999999999999999999997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=372.91 Aligned_cols=264 Identities=21% Similarity=0.237 Sum_probs=198.0
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC-ccchHHHHHHHHHHHhcCCcccceeeeeeeecc----eee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS-GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELE----EKI 547 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 547 (795)
+.+|+++++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 479999999997543 233467889999999999999999999987654 335
Q ss_pred EEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccccc
Q 003786 548 LIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 627 (795)
Q Consensus 548 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~ 627 (795)
+++||+.+++|.+++.. ..+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66677889999999843 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc--
Q 003786 628 GGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW-- 703 (795)
Q Consensus 628 ~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 703 (795)
..... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||............. .........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL--GILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCSCCHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh--hhccCCChhhh
Confidence 43322 122345679999999999854 578999999999999999999999997654322211100 000000000
Q ss_pred ---------c---ccCcccc---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 ---------E---LIDPTLQ---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 ---------~---~id~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
. .+..... .........++.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 01111223467899999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=368.28 Aligned_cols=271 Identities=23% Similarity=0.286 Sum_probs=211.0
Q ss_pred ccCCccccccCcCCcccEEEeEec----CcceEEEEEecccC----ccchHHHHHHHHHHHhcCC-cccceeeeeeeecc
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS----GQGQEEFKNEIKLIAKLQH-RNLVRLLGCCIELE 544 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 544 (795)
.++|+++++||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 377999999999999999999752 47899999986532 2345678899999999976 89999999999999
Q ss_pred eeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccc
Q 003786 545 EKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla 624 (795)
..++||||+.+++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998543 34678899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccc
Q 003786 625 RIFGGDELQSKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRA 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+.+..... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||.....................
T Consensus 177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-- 253 (322)
T d1vzoa_ 177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-- 253 (322)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--
T ss_pred hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--
Confidence 87654332 223446799999999988654 5788999999999999999999999765533322111111100000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH--Hcc------ccCCCCCCCCCCcc
Q 003786 703 WELIDPTLQNEASYLILNRYINVGLLCVQEDAADRP-----TMFEVVSM--LTN------KTINLPHPRQPAFS 763 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~--L~~------~~~~l~~p~~p~~~ 763 (795)
..+......+.+++.+||+.||++|| |++|+++| +.+ ....+|+|..|.+.
T Consensus 254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence 11122346788899999999999999 58999875 222 23345666666554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-41 Score=365.33 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=198.9
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-Ccccceeeeeeeec--ceeeEEe
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIEL--EEKILIY 550 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 550 (795)
++|+++++||+|+||+||+|+.. +++.||||++... ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999874 6899999998643 3567899999999995 99999999998744 5689999
Q ss_pred ecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCC-CeeeeccccccccCC
Q 003786 551 EYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARIFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~vkL~DFGla~~~~~ 629 (795)
||+++++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 34889999999999999999999998 99999999999998765 599999999987654
Q ss_pred CcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHh-----------hhc
Q 003786 630 DELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAW-----------DLW 697 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-----------~~~ 697 (795)
.. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||............... ...
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 23446789999999987764 5899999999999999999999998765432221111000 000
Q ss_pred cCc---cccccc--------CccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 KDD---RAWELI--------DPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~---~~~~~i--------d~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
... ...... ..............++.+|+.+||+.||++|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000 0011111222334567899999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=359.92 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=204.2
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeecceeeEEee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 551 (795)
++|+++++||+|+||+||+|++. +++.||||+++... ....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999864 68899999986543 2335788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeeccccccccCCCc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~~~~~~ 631 (795)
++.+++|..++. ..+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988774 3455789999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCc---cc-----
Q 003786 632 LQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDD---RA----- 702 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~----- 702 (795)
. ......+++.|+|||.+... .++.++|||||||++|||++|+.|+.......... .......... ..
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHhhcCCCChhhhhhhhh
Confidence 2 22334678899999988765 47999999999999999999999975433222211 1111111100 00
Q ss_pred ------ccccC-ccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 703 ------WELID-PTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 703 ------~~~id-~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
..... ..............+.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000111222334567889999999999999999999885
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-41 Score=359.64 Aligned_cols=259 Identities=19% Similarity=0.213 Sum_probs=195.5
Q ss_pred cCCccccccCcCCcccEEEeEe-cCcceEEEEEecccCccchHHHHHHHHHHHhcCCcccce-eeeeeeecceeeEEeec
Q 003786 475 ANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLVR-LLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~E~ 552 (795)
++|++.++||+|+||.||+|++ .+|+.||||++.... ..+++..|++++++++|+|++. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999986 458999999986543 3356889999999998777555 55566777888999999
Q ss_pred CCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC---CCCeeeeccccccccCC
Q 003786 553 MPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMARIFGG 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~vkL~DFGla~~~~~ 629 (795)
+.+ ++...+.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 955 55444432 2345899999999999999999999998 999999999999864 55799999999997654
Q ss_pred Cccc-----ccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCccccc
Q 003786 630 DELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAWE 704 (795)
Q Consensus 630 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
.... .......||+.|||||.+.+..++.++|||||||++|||++|+.||................. ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---~~~~- 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKMS- 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---HHHH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---ccCC-
Confidence 3221 223456899999999999999999999999999999999999999976543222111100000 0000
Q ss_pred ccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 705 LIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
. .........+.++.+++..||+.+|++||+++++.+.|+.
T Consensus 235 --~--~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 --T--PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp --S--CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred --C--ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0 0011112234578899999999999999999998887765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-41 Score=355.39 Aligned_cols=259 Identities=17% Similarity=0.198 Sum_probs=205.0
Q ss_pred ccCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcCC-cccceeeeeeeecceeeEEee
Q 003786 474 TANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQH-RNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 551 (795)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999865 5899999998654 234568899999999975 899999999999999999999
Q ss_pred cCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECC-----CCCeeeeccccccc
Q 003786 552 YMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDFGMARI 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-----~~~vkL~DFGla~~ 626 (795)
|+ +++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 68888887432 345889999999999999999999998 999999999999974 57899999999997
Q ss_pred cCCCcc-----cccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhH-hHhHhhhccCc
Q 003786 627 FGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTL-LGHAWDLWKDD 700 (795)
Q Consensus 627 ~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~ 700 (795)
+..... ........||+.|||||.+.+..++.++|||||||++|||++|+.||.......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 643221 122345689999999999999999999999999999999999999997655332211 11110000000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHcc
Q 003786 701 RAWELIDPTLQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSMLTN 749 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~ 749 (795)
.. .+.....+.++.+++..|++.+|++||+++.+.+.|..
T Consensus 236 ~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred Ch---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 00 11112234568889999999999999999998887765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=364.35 Aligned_cols=260 Identities=22% Similarity=0.214 Sum_probs=192.6
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeee------cce
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIE------LEE 545 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 545 (795)
++|+++++||+|+||+||+|++. +|+.||||++.+.. .....++.+|+.+|++++|||||+++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999875 59999999996543 2334568899999999999999999999864 367
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++||||+.++.+..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999877665442 34789999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHh--H----hhhc--
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGH--A----WDLW-- 697 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~--~----~~~~-- 697 (795)
...... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...+......... . ...+
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 654332 2344679999999999999999999999999999999999999987544221100000 0 0000
Q ss_pred ---------cC------cccccccCcc---ccchhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 698 ---------KD------DRAWELIDPT---LQNEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 698 ---------~~------~~~~~~id~~---l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.. .......... ............+.+|+.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000011111 1122334566788999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=363.14 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=196.3
Q ss_pred ccCCccccccCcCCcccEEEeEe-cCcceEEEEEecccC--ccchHHHHHHHHHHHhcCCcccceeeeeeeec-----ce
Q 003786 474 TANFSTENKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGQEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EE 545 (795)
Q Consensus 474 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 545 (795)
.++|++.++||+|+||+||+|++ .+|+.||||++.+.. ....+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999986 469999999997543 23345788999999999999999999998643 34
Q ss_pred eeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 546 KILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 546 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.++++||+.+|+|.+++.. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999998832 34899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCcccccccccccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhHhHhHhhhccCcccc-
Q 003786 626 IFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTNSLTLLGHAWDLWKDDRAW- 703 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 703 (795)
... .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+....................
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 643 223446799999999986664 5789999999999999999999999765422221111000000000000
Q ss_pred --------cccC--ccc-c---chhhHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 003786 704 --------ELID--PTL-Q---NEASYLILNRYINVGLLCVQEDAADRPTMFEVVSM 746 (795)
Q Consensus 704 --------~~id--~~l-~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 746 (795)
.... +.. . ..........+.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 000 0 00011234567899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-36 Score=330.20 Aligned_cols=263 Identities=20% Similarity=0.198 Sum_probs=193.1
Q ss_pred cCCccccccCcCCcccEEEeEec-CcceEEEEEecccCccchHHHHHHHHHHHhcC-----------Ccccceeeeeeee
Q 003786 475 ANFSTENKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-----------HRNLVRLLGCCIE 542 (795)
Q Consensus 475 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 542 (795)
.+|+++++||+|+||+||+|+.. +|+.||||++.+.. ...+.+.+|+++|++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999864 69999999997542 23467788999998885 4789999988765
Q ss_pred c--ceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHh-cCCCcEEeccCCCCcEEECCCCC----
Q 003786 543 L--EEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMN---- 615 (795)
Q Consensus 543 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~---- 615 (795)
. ...+++++++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4566777777665544444344455668889999999999999999998 66 999999999999987654
Q ss_pred --eeeeccccccccCCCcccccccccccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc----hhH
Q 003786 616 --PKISDFGMARIFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTNS----LTL 689 (795)
Q Consensus 616 --vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~----~~~ 689 (795)
+||+|||.+..... ......||+.|+|||++....++.++||||+||++++|++|+.||....... ...
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 99999999986532 2234679999999999999999999999999999999999999986543211 100
Q ss_pred -hHhHhhh-----------------ccCcccccccCcc----------ccchhhHHHHHHHHHHHHhhccCCCCCCCCHH
Q 003786 690 -LGHAWDL-----------------WKDDRAWELIDPT----------LQNEASYLILNRYINVGLLCVQEDAADRPTMF 741 (795)
Q Consensus 690 -~~~~~~~-----------------~~~~~~~~~id~~----------l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ 741 (795)
......+ +........+... ............+.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000 0000000000000 01112345677889999999999999999999
Q ss_pred HHHHH
Q 003786 742 EVVSM 746 (795)
Q Consensus 742 evl~~ 746 (795)
|+|+|
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99986
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.88 E-value=4.8e-23 Score=182.46 Aligned_cols=112 Identities=23% Similarity=0.433 Sum_probs=97.5
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
+|||.|||.|.+|++|+| |.|.|+|+.+|+ +.++.. .++||.||++.| ...+.|.|+.||+|||+|+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEcC---CcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence 589999999999999986 999999999997 666654 499999999988 4457899999999999996
Q ss_pred CceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCch
Q 003786 105 NGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSD 154 (795)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTD 154 (795)
+.++|++++.+......|+|+|+|||||++ ..+.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~-----~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYD-----NSNNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEEC-----TTSCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEEC-----CCCcEEecCCCccCC
Confidence 577888888776667789999999999998 456789999999975
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.88 E-value=1e-22 Score=178.57 Aligned_cols=107 Identities=23% Similarity=0.363 Sum_probs=95.0
Q ss_pred cccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCC
Q 003786 25 ADNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQT 104 (795)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (795)
.|+|.+||.|.+|++|. +|.|.|+|+.+|+ +.||.. .++||.||++.| +..+.|.++.||||||++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC---CceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 47899999999999996 4999999999997 677765 489999999988 55678999999999999999
Q ss_pred CceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCC
Q 003786 105 NGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDH 151 (795)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
|.+||+|++.+.....+|+|+||||||||+. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999988776777889999999999962 48999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=6.3e-23 Score=201.21 Aligned_cols=164 Identities=17% Similarity=0.173 Sum_probs=123.0
Q ss_pred CccccccCcCCcccEEEeEecCcceEEEEEecccCc------------------cchHHHHHHHHHHHhcCCcccceeee
Q 003786 477 FSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG------------------QGQEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 477 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
+.++++||+|+||.||+|+..+|++||||+++.... .....+.+|...+.++.|+++++.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999988899999998753210 01123456889999999999998876
Q ss_pred eeeecceeeEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhcCCCcEEeccCCCCcEEECCCCCeee
Q 003786 539 CCIELEEKILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 539 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~vkL 618 (795)
+. ..+++|||+++..+.. ++...+..++.|++++|.|||+++ |+||||||+|||+++++ ++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 53 3479999998865532 456677889999999999999998 99999999999998655 899
Q ss_pred eccccccccCCCcccccccccccccccccc------cccccCCCCcccchhhHHHHH
Q 003786 619 SDFGMARIFGGDELQSKTKRIVGTYGYMSP------EYAQQGLFSIKSDVFSFGVLL 669 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP------E~~~~~~~~~k~DvwSlGvil 669 (795)
+|||+|......... .|... |. ....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999999765432211 11111 11 135688999999976444
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.86 E-value=6.6e-22 Score=173.37 Aligned_cols=107 Identities=19% Similarity=0.320 Sum_probs=93.3
Q ss_pred ccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCC
Q 003786 26 DNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTN 105 (795)
Q Consensus 26 ~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~ 105 (795)
|+|.|||.|.+|++|.+ |.|.|+|+.+|+ +.++.. .++||+||++.|. ...+.|.|+.||||||+|++|
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~~---~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYDH---STSVWASNTGILG-KKGCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTT-CCCCEEEECTTSCEEEECSSS
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEeC---CEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCCC
Confidence 78999999999999986 899999999887 555544 4899999999997 446889999999999999999
Q ss_pred ceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCC
Q 003786 106 GTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDH 151 (795)
Q Consensus 106 ~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
.+||+|+++.......|+|+||||||||++ .+|||+-|
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 999999987666677889999999999962 49999865
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.70 E-value=4.8e-17 Score=143.87 Aligned_cols=103 Identities=17% Similarity=0.351 Sum_probs=84.2
Q ss_pred ccCCCCCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCC
Q 003786 26 DNITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTN 105 (795)
Q Consensus 26 ~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~ 105 (795)
++|.++|+| .+.+..|.|.|.|+.+|+ |.++ + ..++||.||+..+ +..+.|.|+.||+|||+|++|
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCC
Confidence 455555555 346679999999999997 4443 3 2589999999877 446889999999999999999
Q ss_pred ceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccC
Q 003786 106 GTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFD 150 (795)
Q Consensus 106 ~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (795)
.+||++++.+.....+++|+||||||||+ .++|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 99999999877677788999999999995 36999864
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.65 E-value=9.6e-17 Score=142.42 Aligned_cols=101 Identities=21% Similarity=0.264 Sum_probs=85.4
Q ss_pred EEEeccC-CCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCc
Q 003786 63 GIWYKQI-PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSS 141 (795)
Q Consensus 63 ~iw~~~~-~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~ 141 (795)
-|||..+ .++++|++|++.|+....-+|.++.||||||++. +.++|++++.+.+..+.|.|+++|||||+| .+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d-----~~ 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLT-----NQ 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEE-----TT
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEc-----CC
Confidence 5889888 6799999999999977777899999999999985 678999999877777889999999999998 46
Q ss_pred ccceecccCCCchhhhccCeeccccccCcceeEEEecCCCCCCCCceEEeeccCCcceE
Q 003786 142 EDYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKL 200 (795)
Q Consensus 142 ~~~~WqSFd~PTDtlLpgqkl~~~~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~ 200 (795)
+++|||||. +.++|.|.+.++.+|...+
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 789999984 2356789999998886543
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.56 E-value=3.6e-15 Score=130.70 Aligned_cols=98 Identities=22% Similarity=0.339 Sum_probs=80.2
Q ss_pred CccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCCceEEee
Q 003786 32 RFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSS 111 (795)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst 111 (795)
|.|.++|.|. +|.|.|.|+.+|+ |.++.. .++||.+|+.. ...+++.|+.||||||+|.++.+||++
T Consensus 15 ~tl~~~~~l~--~g~~~l~~q~DGN-----LvL~~~---~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 15 QTLHAAQSLE--LSSFRFTMQSDCN-----LVLFDS---DVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp SCCCTTCEEC--STTEEEEECTTSC-----EEEEES---SSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred ceecCCCcEE--cCCEEEEECCCCe-----EEEEcC---CeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEEc
Confidence 5566666663 5889999999997 666553 48999999764 336789999999999999999999999
Q ss_pred cCCCCccccEEEEccCCCeEEeecCCCCCcccceecccC
Q 003786 112 NLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFD 150 (795)
Q Consensus 112 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (795)
.+.......+++|++|||||||+ ..+|+|-.
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt 112 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGT 112 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEEC--------SEEEECSC
T ss_pred CCCCCCCCEEEEECCCCcEEEeC--------CCeecCCC
Confidence 99877777889999999999995 26899853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=4.3e-15 Score=130.15 Aligned_cols=109 Identities=23% Similarity=0.256 Sum_probs=87.1
Q ss_pred EEeccC-CCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcc
Q 003786 64 IWYKQI-PDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSE 142 (795)
Q Consensus 64 iw~~~~-~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~ 142 (795)
|||.-. ..+..|+.+.+.++.+...+|.|+.||||||++ .+.++|++++.+. .++.|.|+++|||||++ ..+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d-----~~~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILT-----AQN 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBC-----TTT
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEc-----cCC
Confidence 555533 457779999999998777899999999999998 5678999998764 45678999999999998 467
Q ss_pred cceecccCCCchhhhccCeeccccccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCC
Q 003786 143 DYLWQSFDHPSDTLLAGMKLGWDLKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 143 ~~~WqSFd~PTDtlLpgqkl~~~~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~ 214 (795)
.+||||+- +.++|.|.+.++++|.. ++|. .++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNl--vlY~--~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTV--TIYG--PGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCE--EEEC--SEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcE--EEeC--CCeecCCC
Confidence 89999863 34678999999999875 4453 46888765
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.38 E-value=4e-13 Score=118.68 Aligned_cols=98 Identities=20% Similarity=0.365 Sum_probs=77.4
Q ss_pred CCccCCCCeEEeCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEecCCCCCCccCcceEEEeeCCceEEeCCCCceEEe
Q 003786 31 SRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIPDTIVWVANRNSPIFDSNAVLTISNGGKLVLLNQTNGTIWS 110 (795)
Q Consensus 31 ~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~Ws 110 (795)
.+.|.+++.|. .|.|.|.|..+|+ |.|+.. ..+||.++.... +..+.+.|+.+|||||+|.++.++|+
T Consensus 23 ~~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~~---~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 23 PQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDR---DDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp CCEECSSCCCB--CSSCEEEEETTTE-----EEEEBT---TBCCSCCCCCSS--CSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred ccEEcCCCeeE--cCCEEEEEcCCCc-----EEEecC---CcEEEEEccccC--CCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 34555555553 3779999998886 556543 478999986543 55678999999999999999999999
Q ss_pred ecCCCCccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 111 SNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 111 t~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
|++.+.....+++|++|||||||+ ..+|.|
T Consensus 91 S~t~~~~~~~~l~Lq~DGnlvlY~--------~~~W~t 120 (120)
T d1dlpa2 91 SGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 120 (120)
T ss_dssp CCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred eCCCCCCCcEEEEECCCCcEEEeC--------CCcccC
Confidence 999877677788999999999995 258976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.95 E-value=1.4e-09 Score=95.30 Aligned_cols=85 Identities=25% Similarity=0.300 Sum_probs=65.3
Q ss_pred eEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccccc
Q 003786 89 VLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDLKT 168 (795)
Q Consensus 89 ~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~~~ 168 (795)
.|.++.||||||+++ +.++|++++.+....+.+.|+++|||||++ ..+.+||+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d-----~~g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVIT-----NENVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC-----TTCCEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEEC-----CCCcEEEECCC------------------
Confidence 588999999999975 568999999877667788999999999998 45778897531
Q ss_pred CcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCC
Q 003786 169 GLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 169 ~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~ 214 (795)
.-+.|.|.+.++.+|...+ |. .++|.++.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVI--YG--DALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence 1134678889998886543 42 35787654
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.93 E-value=1.6e-09 Score=93.51 Aligned_cols=55 Identities=27% Similarity=0.492 Sum_probs=47.3
Q ss_pred ceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecc
Q 003786 88 AVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQS 148 (795)
Q Consensus 88 ~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
-+|.++.||||||++ .+.+||++++.+.+..+.+.|+++|||||++ ..+.+||+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~-----~~g~~vWsS 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYN-----PSNKPIWAS 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEEC-----TTCCEEEEC
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEEC-----CCccceEEc
Confidence 468899999999997 5679999999877667788999999999998 467889986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.76 E-value=2e-08 Score=86.42 Aligned_cols=87 Identities=26% Similarity=0.355 Sum_probs=63.7
Q ss_pred cceEEEeeCCceEEeCCCCceEEeecCCCCc-cccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeeccc
Q 003786 87 NAVLTISNGGKLVLLNQTNGTIWSSNLSREV-KNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWD 165 (795)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~ 165 (795)
.-.|.|+.||||||++ .+.+||++++.... ..+.+.|+++|||||++ ..+.++|+|=
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~-----~~g~~vW~s~---------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYD-----AEGRSLWASH---------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEEC-----SSSCEEEECC----------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEe-----CCCcEEEEEe----------------
Confidence 3568899999999997 56799999987543 35678999999999998 4678899861
Q ss_pred cccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcCceeEEeeCC
Q 003786 166 LKTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 166 ~~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~s~~~~~sg~ 214 (795)
...+.|.|.+.++.+|... ++. .++|.|+.
T Consensus 78 ---------------t~~~~~~~~l~L~ddGNlv--ly~--~~~W~S~t 107 (109)
T d1kj1a_ 78 ---------------SVRGNGNYVLVLQEDGNVV--IYG--SDIWSTGT 107 (109)
T ss_dssp ---------------CCCCSSCCEEEECTTSCEE--EEC--CEEEECCC
T ss_pred ---------------eECCCCCEEEEEeCCCcEE--EEC--CCEecCCC
Confidence 1113466888898888654 453 35786654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=1.6e-07 Score=94.39 Aligned_cols=150 Identities=15% Similarity=0.073 Sum_probs=108.2
Q ss_pred HhHHHHccCCccccccCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcC-Ccccceeeeeeeeccee
Q 003786 468 ASVSAATANFSTENKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEK 546 (795)
Q Consensus 468 ~~i~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 546 (795)
.++....+.|+..+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 34556667888877766666678998864 56778899887665556667889999988875 43456788888888889
Q ss_pred eEEeecCCCCChhhhhhccCCcccCChhhHHHHHHHHHHHHHHHHhc---------------------------------
Q 003786 547 ILIYEYMPNKSLDFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLHQY--------------------------------- 593 (795)
Q Consensus 547 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------- 593 (795)
++|||+++|..+..... +......++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988755431 1223334555566666666642
Q ss_pred -----------------------CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 594 -----------------------SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 594 -----------------------~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112389999999999999776667999998764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.58 E-value=1.3e-07 Score=81.78 Aligned_cols=88 Identities=23% Similarity=0.410 Sum_probs=64.5
Q ss_pred cceEEEeeCCceEEeCCCCceEEeecCCCCccccEEEEccCCCeEEeecCCCCCcccceecccCCCchhhhccCeecccc
Q 003786 87 NAVLTISNGGKLVLLNQTNGTIWSSNLSREVKNPVAQLLDTGNLVVRDNFSSNSSEDYLWQSFDHPSDTLLAGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~Wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 166 (795)
.-.|.|+.||||||++ .+.+||++++.+....+.++|+.+|||||++. ++.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~------~~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG------SRAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET------TEEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec------CCeEEEE------------------
Confidence 3578899999999997 56799999987666667789999999999972 4456653
Q ss_pred ccCcceeEEEecCCCCCCCCceEEeeccCCcceEEEEcC-ceeEEeeCC
Q 003786 167 KTGLERYQTSWKSDDDPSPGNYTHRLDIHVLPKLCTYNG-SVKLLCSGP 214 (795)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~ys~~~~~~~~~~~~~~~~-s~~~~~sg~ 214 (795)
...-..|.|.+.++.+|... +++. ..+.|.|+.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlv--ly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVV--IYDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEE--EECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEE--EECCCCcEEecCCC
Confidence 11223466888998888654 4443 356887765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=3.5e-05 Score=76.29 Aligned_cols=131 Identities=18% Similarity=0.168 Sum_probs=86.9
Q ss_pred ccCcCCc-ccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCc--ccceeeeeeeecceeeEEeecCCCCCh
Q 003786 482 KLGEGGF-GPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHR--NLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 482 ~LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL 558 (795)
.+..|.. +.||+....++..+++|..... ....+..|...|+.+... .+.+++.+..+.+..++|||+++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 5789998877888999986543 234578888888877533 355678887888888999999998766
Q ss_pred hhhhhccCCcccCChhhHHHHHHHHHHHHHHHH-----------------------------------------------
Q 003786 559 DFFLFDSTKENLLGWGTRVRIIEGIAQGLLYLH----------------------------------------------- 591 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----------------------------------------------- 591 (795)
..... .....+.++++.|.-||
T Consensus 94 ~~~~~-----------~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSHL-----------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSCC-----------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc-----------cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 43210 00111122222222222
Q ss_pred ----hc----CCCcEEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 592 ----QY----SRLRVIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 592 ----~~----~~~~iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
.. ....++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 122489999999999999876678999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=0.00014 Score=77.05 Aligned_cols=76 Identities=12% Similarity=0.167 Sum_probs=50.7
Q ss_pred ccccCcCCcccEEEeEecC-cceEEEEEeccc-------CccchHHHHHHHHHHHhcC-C-cc-cceeeeeeeecceeeE
Q 003786 480 ENKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-------SGQGQEEFKNEIKLIAKLQ-H-RN-LVRLLGCCIELEEKIL 548 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~n-iv~l~~~~~~~~~~~l 548 (795)
.+.||.|....||+++..+ ++.++||.-... .....++...|++.|+.+. + |. +.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3579999999999998654 678999964321 1223456778998888773 2 33 4445543 5567789
Q ss_pred EeecCCCCC
Q 003786 549 IYEYMPNKS 557 (795)
Q Consensus 549 v~E~~~~gs 557 (795)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0019 Score=65.96 Aligned_cols=136 Identities=14% Similarity=0.146 Sum_probs=80.8
Q ss_pred cccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCccc--ceee-----eeeeecceeeEEeecCCCCChhh
Q 003786 488 FGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNL--VRLL-----GCCIELEEKILIYEYMPNKSLDF 560 (795)
Q Consensus 488 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~gsL~~ 560 (795)
--.||+++.++|+.+++|+.+.. ....+++..|...|..|....+ +..+ ..+......+.++++++|..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999989999999998654 2356778899999988853222 1111 12334556678899988754321
Q ss_pred -----h------h---h----c--cCCcc-------------------cCChhhHHHHHHHHHHHHHHHHhc----CCCc
Q 003786 561 -----F------L---F----D--STKEN-------------------LLGWGTRVRIIEGIAQGLLYLHQY----SRLR 597 (795)
Q Consensus 561 -----~------l---~----~--~~~~~-------------------~l~~~~~~~i~~~i~~~l~~LH~~----~~~~ 597 (795)
+ + + . ...+. .++......+...+.+.+..+... ....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0 0 0 00011 112222222332333334444332 2346
Q ss_pred EEeccCCCCcEEECCCCCeeeeccccccc
Q 003786 598 VIHRDLKASNILLDKDMNPKISDFGMARI 626 (795)
Q Consensus 598 iiHrDikp~NIll~~~~~vkL~DFGla~~ 626 (795)
+||+|+.|.|||++.+ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45889998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.77 E-value=0.0019 Score=67.92 Aligned_cols=72 Identities=19% Similarity=0.292 Sum_probs=50.1
Q ss_pred cccCcCCcccEEEeEecC--------cceEEEEEecccCccchHHHHHHHHHHHhcCCcccc-eeeeeeeecceeeEEee
Q 003786 481 NKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYE 551 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E 551 (795)
++|+.|-.-.+|++...+ .+.|.+++... ........+|..+++.+.-.++. ++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 678889999999998643 24566666542 23344567899999988644554 67776642 68999
Q ss_pred cCCCCCh
Q 003786 552 YMPNKSL 558 (795)
Q Consensus 552 ~~~~gsL 558 (795)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.73 E-value=0.047 Score=54.65 Aligned_cols=157 Identities=11% Similarity=0.003 Sum_probs=81.4
Q ss_pred cHHhHHHHccCCccccc-----cCcCCcccEEEeEecCcceEEEEEecccCccchHHHHHHHHHHHhcCCcc-----cce
Q 003786 466 SLASVSAATANFSTENK-----LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGQEEFKNEIKLIAKLQHRN-----LVR 535 (795)
Q Consensus 466 ~~~~i~~~~~~~~~~~~-----LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~ 535 (795)
+.+++.....+|.+++. |..|---+.|+.+..+ ..+++|++... ...+++..|+++|..|.+.+ .+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-CcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccce
Confidence 34455566666766433 4456667789988654 46999998653 23456677788887774322 221
Q ss_pred ee-e--eeeecceeeEEeecCCCCChhhhh--------------h----cc--C------------------CcccCChh
Q 003786 536 LL-G--CCIELEEKILIYEYMPNKSLDFFL--------------F----DS--T------------------KENLLGWG 574 (795)
Q Consensus 536 l~-~--~~~~~~~~~lv~E~~~~gsL~~~l--------------~----~~--~------------------~~~~l~~~ 574 (795)
.. | +.........++.++.+....... + .. . ........
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 0 112233445556555543321100 0 00 0 00001111
Q ss_pred hHHHHHHHHHHHHHHHHhc-CCCcEEeccCCCCcEEECCCCCeeeecccccc
Q 003786 575 TRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAR 625 (795)
Q Consensus 575 ~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~vkL~DFGla~ 625 (795)
.....+..+...+...+.. -+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2222233333333333321 23469999999999999988777899999975
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.04 E-value=0.07 Score=33.30 Aligned_cols=32 Identities=31% Similarity=0.626 Sum_probs=25.7
Q ss_pred ccCCCCcCCCCCcccCCC-CCCCCCccccccccC
Q 003786 285 RFCQFYGHCGANSICSFD-KKPHCECLKGFELKS 317 (795)
Q Consensus 285 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~gf~~~~ 317 (795)
|+|.+-..|| +|.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6899999999 6889743 345799999999864
|